[{"letter": "3,4-Methylenedioxyamphetamine", "count": 6}, {"letter": "mercaptopurine", "count": 1}, {"letter": "A Fibers", "count": 1}, {"letter": "DNA, A-Form", "count": 1}, {"letter": "Abbreviations", "count": 8}, {"letter": "Abdomen", "count": 25}, {"letter": "Abdominal Cramps", "count": 1}, {"letter": "Abdomen distended", "count": 1}, {"letter": "Abdominal Pain", "count": 2}, {"letter": "Abdominal Muscles", "count": 1}, {"letter": "Excessive body weight gain", "count": 1}, {"letter": "Congenital Abnormality", "count": 86}, {"letter": "teratologic", "count": 47}, {"letter": "Multiple congenital anomalies", "count": 4}, {"letter": "Spontaneous abortion", "count": 3}, {"letter": "Abscess", "count": 1}, {"letter": "Abstracting", "count": 16}, {"letter": "Academic Medical Centers", "count": 2}, {"letter": "Academies", "count": 3}, {"letter": "Accidental Falls", "count": 12}, {"letter": "Accidents", "count": 1}, {"letter": "Incised wound", "count": 33}, {"letter": "Visual Accommodation", "count": 11}, {"letter": "Accounting (activity)", "count": 11}, {"letter": "Acculturation", "count": 2}, {"letter": "acetaminophen", "count": 6}, {"letter": "Acetylaminofluorene", "count": 2}, {"letter": "acetylcarnitine", "count": 1}, {"letter": "Achievement", "count": 25}, {"letter": "Acids", "count": 1}, {"letter": "Acne Vulgaris", "count": 1}, {"letter": "Acoustics", "count": 1}, {"letter": "Acquired Immunodeficiency Syndrome", "count": 1}, {"letter": "Acromion", "count": 2}, {"letter": "Actinium", "count": 13}, {"letter": "Actins", "count": 1}, {"letter": "Action Potentials", "count": 1}, {"letter": "Activities of Daily Living (activity)", "count": 73}, {"letter": "Actuarial Analysis", "count": 1}, {"letter": "Acupuncture therapy discipline", "count": 5}, {"letter": "Acupuncture Points", "count": 1}, {"letter": "Acute Disease", "count": 1}, {"letter": "Adaptation, Physiological", "count": 1}, {"letter": "Adenocarcinoma", "count": 3}, {"letter": "adenosine", "count": 3}, {"letter": "adenosine triphosphate", "count": 2}, {"letter": "Adenoviruses", "count": 1}, {"letter": "Tissue Adhesions", "count": 6}, {"letter": "Adhesives", "count": 1}, {"letter": "Adipose tissue", "count": 39}, {"letter": "Immunologic Adjuvants", "count": 5}, {"letter": "Pharmaceutical Adjuvants", "count": 4}, {"letter": "Administration occupational activities", "count": 312}, {"letter": "administration & dosage", "count": 1}, {"letter": "Administration, Cutaneous", "count": 2}, {"letter": "Administration, Oral", "count": 27}, {"letter": "Administration, Topical", "count": 2}, {"letter": "Adoption", "count": 11}, {"letter": "Adrenal Cortex Hormones", "count": 20}, {"letter": "Adrenergic beta-Antagonists", "count": 1}, {"letter": "Adult", "count": 18}, {"letter": "aspects of adverse effects", "count": 137}, {"letter": "Exercise, Aerobic", "count": 12}, {"letter": "beta-Aminoethylisothiuronium Dihydrobromide", "count": 16}, {"letter": "Affect (mental function)", "count": 37}, {"letter": "Affective Symptoms", "count": 1}, {"letter": "Aftercare", "count": 296}, {"letter": "Afterimage", "count": 1}, {"letter": "Age", "count": 143}, {"letter": "Age Factors", "count": 4}, {"letter": "Osteoporosis, Age-Related", "count": 2}, {"letter": "Elderly (population group)", "count": 16}, {"letter": "Aggressive behavior", "count": 5}, {"letter": "Aging", "count": 12}, {"letter": "Air (substance)", "count": 9}, {"letter": "Air Pressure", "count": 1}, {"letter": "Airway Resistance Test", "count": 25}, {"letter": "alanine", "count": 1}, {"letter": "Alanine Transaminase", "count": 25}, {"letter": "Albumins", "count": 14}, {"letter": "Albuminuria", "count": 1}, {"letter": "Alcohol consumption", "count": 19}, {"letter": "Alcohol Use Disorder", "count": 3}, {"letter": "ethanol", "count": 16}, {"letter": "Alcoholic Beverages", "count": 1}, {"letter": "Alcoholic Intoxication, Chronic", "count": 5}, {"letter": "Alcohols", "count": 3}, {"letter": "Alexithymia", "count": 1}, {"letter": "algorithm", "count": 50}, {"letter": "Alkalies", "count": 1}, {"letter": "Alkaline Phosphatase", "count": 26}, {"letter": "Alleles", "count": 23}, {"letter": "Allergy Specialty", "count": 5}, {"letter": "Alopecia", "count": 30}, {"letter": "alpha-Fetoproteins", "count": 1}, {"letter": "eflornithine", "count": 6}, {"letter": "Alternative Splicing", "count": 1}, {"letter": "Altitude", "count": 14}, {"letter": "Altruism", "count": 2}, {"letter": "ambulatory care services", "count": 5}, {"letter": "Ambulatory Care Facilities", "count": 52}, {"letter": "Amenorrhea", "count": 22}, {"letter": "American Cancer Society", "count": 3}, {"letter": "American Heart Association", "count": 4}, {"letter": "Amides", "count": 1}, {"letter": "Amino Acids", "count": 6}, {"letter": "Aminoimidazole Carboxamide", "count": 1}, {"letter": "Transaminases", "count": 4}, {"letter": "amitriptyline", "count": 1}, {"letter": "amylase", "count": 3}, {"letter": "Serum amyloid A protein", "count": 1}, {"letter": "Pain management", "count": 18}, {"letter": "Analgesics", "count": 61}, {"letter": "Analgesics, Opioid", "count": 4}, {"letter": "Analysis of substances", "count": 395}, {"letter": "Analysis of Variance", "count": 18}, {"letter": "Epidemiologic Studies", "count": 10}, {"letter": "anaphylaxis", "count": 5}, {"letter": "Science of Anatomy", "count": 3}, {"letter": "Androgens", "count": 1}, {"letter": "androstenedione", "count": 2}, {"letter": "Anemia", "count": 10}, {"letter": "Anesthesia procedures", "count": 18}, {"letter": "Anesthesia, Conduction", "count": 2}, {"letter": "General Anesthesia", "count": 4}, {"letter": "Local anesthesia", "count": 3}, {"letter": "Spinal Anesthesia", "count": 1}, {"letter": "Anesthesiology", "count": 1}, {"letter": "Anesthetics", "count": 4}, {"letter": "Local Anesthetics", "count": 4}, {"letter": "Aneuploidy", "count": 2}, {"letter": "Anger", "count": 11}, {"letter": "Angina Pectoris", "count": 1}, {"letter": "Angina, Unstable", "count": 1}, {"letter": "Angiogenesis Factor", "count": 4}, {"letter": "angiogram", "count": 3}, {"letter": "Receptor, Angiotensin II", "count": 1}, {"letter": "Angiotensins", "count": 1}, {"letter": "Animals", "count": 4}, {"letter": "Animals, Domestic", "count": 4}, {"letter": "Animals, Transgenic", "count": 2}, {"letter": "Ankle", "count": 3}, {"letter": "Ankle joint structure", "count": 2}, {"letter": "Anode", "count": 2}, {"letter": "Anorexia", "count": 24}, {"letter": "Anthropometry", "count": 24}, {"letter": "Anti-Infective Agents", "count": 1}, {"letter": "Anti-Inflammatory Agents", "count": 6}, {"letter": "Anti-Inflammatory Agents, Non-Steroidal", "count": 4}, {"letter": "Antibiotics", "count": 12}, {"letter": "Anthracycline Antibiotics", "count": 34}, {"letter": "Antibiotics, Antitubercular", "count": 11}, {"letter": "Antibodies", "count": 79}, {"letter": "Antibodies, Anti-Idiotypic", "count": 34}, {"letter": "Monoclonal Antibodies", "count": 24}, {"letter": "Antibody Formation", "count": 6}, {"letter": "Antibody-Dependent Cellular Cytotoxicity", "count": 7}, {"letter": "Anticoagulants", "count": 1}, {"letter": "Anticonvulsants", "count": 1}, {"letter": "Antidepressive Agents", "count": 6}, {"letter": "Antidiarrheals", "count": 4}, {"letter": "Antiemetics", "count": 30}, {"letter": "Immune complex", "count": 2}, {"letter": "Antigen-Presenting Cells", "count": 1}, {"letter": "Epitopes", "count": 10}, {"letter": "Antigens", "count": 17}, {"letter": "Antigens, Bacterial", "count": 1}, {"letter": "Antigens, Tumor-Associated, Carbohydrate", "count": 1}, {"letter": "Antihypertensive Agents", "count": 2}, {"letter": "Antineoplastic Agents", "count": 24}, {"letter": "Antineoplastic Combined Chemotherapy Protocols", "count": 2}, {"letter": "Antioxidants", "count": 5}, {"letter": "Antipyretics", "count": 1}, {"letter": "antithrombin III", "count": 1}, {"letter": "Ants", "count": 1}, {"letter": "Anus", "count": 1}, {"letter": "Anxiety", "count": 288}, {"letter": "Anxiety Disorders", "count": 4}, {"letter": "Aortic valve structure", "count": 1}, {"letter": "Aortic Valve Insufficiency", "count": 53}, {"letter": "Apatites", "count": 1}, {"letter": "Appendix", "count": 13}, {"letter": "Desire for food", "count": 10}, {"letter": "Appointments", "count": 29}, {"letter": "aprotinin", "count": 4}, {"letter": "Aptitude Tests", "count": 4}, {"letter": "Architecture", "count": 10}, {"letter": "archive", "count": 23}, {"letter": "arginine", "count": 1}, {"letter": "Arousal", "count": 12}, {"letter": "Cardiac Arrhythmia", "count": 16}, {"letter": "Arts", "count": 1}, {"letter": "Arteries", "count": 8}, {"letter": "Structure of arteriole", "count": 1}, {"letter": "Arthralgia", "count": 34}, {"letter": "Arthritis", "count": 6}, {"letter": "Arthroplasty", "count": 1}, {"letter": "Artificial Intelligence", "count": 5}, {"letter": "Ascending aorta structure", "count": 1}, {"letter": "Ascites", "count": 9}, {"letter": "Asepsis", "count": 6}, {"letter": "Asia", "count": 1}, {"letter": "Aspartate Transaminase", "count": 23}, {"letter": "Inspiration function", "count": 5}, {"letter": "Aspirations (Psychology)", "count": 4}, {"letter": "aspirin", "count": 6}, {"letter": "Assertiveness", "count": 2}, {"letter": "Mental association", "count": 105}, {"letter": "Asthenia", "count": 8}, {"letter": "Ataxia Telangiectasia", "count": 7}, {"letter": "Cervical Atlas", "count": 1}, {"letter": "Attention", "count": 105}, {"letter": "Attitude", "count": 41}, {"letter": "Attitude to Health", "count": 1}, {"letter": "Auditory Perception", "count": 3}, {"letter": "Auscultation", "count": 1}, {"letter": "Australia", "count": 6}, {"letter": "Austria", "count": 3}, {"letter": "Autoantibodies", "count": 1}, {"letter": "Autogenic Training", "count": 1}, {"letter": "Autoimmune Diseases", "count": 1}, {"letter": "Autoimmune state", "count": 1}, {"letter": "Automation", "count": 1}, {"letter": "Automobile Driving", "count": 1}, {"letter": "Automobiles", "count": 19}, {"letter": "Autonomic nervous system", "count": 9}, {"letter": "Autophagy", "count": 7}, {"letter": "Autoradiography", "count": 1}, {"letter": "Awareness", "count": 28}, {"letter": "Axilla", "count": 230}, {"letter": "Structure of axillary vein", "count": 2}, {"letter": "Axis vertebra", "count": 7}, {"letter": "Axon", "count": 1}, {"letter": "azacitidine", "count": 6}, {"letter": "B-Lymphocytes", "count": 8}, {"letter": "Back", "count": 3}, {"letter": "Back Pain", "count": 3}, {"letter": "Background Radiation", "count": 1}, {"letter": "Bacteremia", "count": 1}, {"letter": "Bacteria", "count": 8}, {"letter": "Bacteroides", "count": 3}, {"letter": "Bandage", "count": 3}, {"letter": "Bar Codes", "count": 1}, {"letter": "Barbados", "count": 3}, {"letter": "Base Ratio", "count": 8}, {"letter": "Base Sequence", "count": 18}, {"letter": "Basement membrane", "count": 1}, {"letter": "Beak", "count": 1}, {"letter": "Ursidae Family", "count": 1}, {"letter": "Beauty", "count": 1}, {"letter": "Bed rest", "count": 1}, {"letter": "Beds", "count": 35}, {"letter": "Behavior", "count": 296}, {"letter": "Behavior Therapy", "count": 6}, {"letter": "Mental disorders", "count": 6}, {"letter": "Behavioral Medicine", "count": 1}, {"letter": "Belgium", "count": 3}, {"letter": "Beliefs", "count": 57}, {"letter": "Benzodiazepines", "count": 1}, {"letter": "City of Berlin", "count": 2}, {"letter": "beta-Endorphin", "count": 1}, {"letter": "Beverages", "count": 7}, {"letter": "Bias (Epidemiology)", "count": 1}, {"letter": "Bicarbonates", "count": 5}, {"letter": "Bicycling (recreational activity)", "count": 5}, {"letter": "Bilirubin", "count": 25}, {"letter": "Binding, Competitive", "count": 1}, {"letter": "Binomial Distribution", "count": 8}, {"letter": "Biochemistry", "count": 15}, {"letter": "Biomaterials", "count": 1}, {"letter": "Biological Assay", "count": 13}, {"letter": "Biological Availability", "count": 8}, {"letter": "Biological Factors", "count": 16}, {"letter": "Biological Markers", "count": 765}, {"letter": "Biological Response Modifiers", "count": 5}, {"letter": "Biological Response Modifier Therapy", "count": 5}, {"letter": "Biological Transport", "count": 11}, {"letter": "biology (field)", "count": 47}, {"letter": "Biomechanics", "count": 1}, {"letter": "Biometry", "count": 1}, {"letter": "Biorhythm", "count": 5}, {"letter": "Biopsy", "count": 282}, {"letter": "Needle biopsy procedure", "count": 5}, {"letter": "Birth Rate", "count": 1}, {"letter": "Birth", "count": 2}, {"letter": "Bisexuality", "count": 32}, {"letter": "Urinary Bladder", "count": 6}, {"letter": "Malignant neoplasm of urinary bladder", "count": 5}, {"letter": "Bulla", "count": 1}, {"letter": "Blood", "count": 1}, {"letter": "In Blood", "count": 43}, {"letter": "Blood Cell Count", "count": 8}, {"letter": "Blood Cells", "count": 17}, {"letter": "Blood Chemical Analysis", "count": 4}, {"letter": "Blood Circulation", "count": 6}, {"letter": "Blood coagulation", "count": 5}, {"letter": "Blood Coagulation Factor", "count": 1}, {"letter": "Apheresis (procedure)", "count": 1}, {"letter": "Blood Flow Velocity", "count": 2}, {"letter": "Blood Glucose", "count": 10}, {"letter": "Blood Group (classification)", "count": 2}, {"letter": "Blood Physiological Phenomena", "count": 5}, {"letter": "Blood Platelets", "count": 26}, {"letter": "Blood Pressure", "count": 12}, {"letter": "Blood pressure determination", "count": 5}, {"letter": "Blood Proteins", "count": 1}, {"letter": "Collection of blood specimen for laboratory procedure", "count": 10}, {"letter": "Blood Stains", "count": 1}, {"letter": "Blood Transfusion", "count": 16}, {"letter": "Blood typing procedure", "count": 1}, {"letter": "Blood urea nitrogen measurement", "count": 9}, {"letter": "Blood Vessel", "count": 29}, {"letter": "Blood Volume", "count": 3}, {"letter": "Blood - brain barrier anatomy", "count": 1}, {"letter": "Western Blotting", "count": 2}, {"letter": "Body Composition", "count": 73}, {"letter": "Body Constitution", "count": 1}, {"letter": "Body Fluid Compartments", "count": 1}, {"letter": "Body Fluids", "count": 6}, {"letter": "Body Height", "count": 56}, {"letter": "Body Image", "count": 62}, {"letter": "Body mass index procedure", "count": 7}, {"letter": "Body Regions", "count": 2}, {"letter": "Body Size", "count": 1}, {"letter": "Body Surface Area", "count": 1}, {"letter": "Body Temperature", "count": 24}, {"letter": "Body Temperature Changes", "count": 2}, {"letter": "Body water (substance)", "count": 10}, {"letter": "Body Weight", "count": 52}, {"letter": "Body Weight Changes", "count": 23}, {"letter": "Bone and Bones", "count": 16}, {"letter": "Biopsy of bone", "count": 1}, {"letter": "Bone Density", "count": 41}, {"letter": "Bone Development", "count": 3}, {"letter": "Bone Diseases", "count": 4}, {"letter": "Bone Marrow", "count": 10}, {"letter": "Bone Marrow Cells", "count": 1}, {"letter": "Bone Marrow Examination", "count": 1}, {"letter": "Bone Marrow Transplantation", "count": 2}, {"letter": "Bone Mineral Content", "count": 2}, {"letter": "Bone neoplasms", "count": 1}, {"letter": "Bone Resorption", "count": 9}, {"letter": "Bone Wires", "count": 1}, {"letter": "Books", "count": 4}, {"letter": "Structure of brachial artery", "count": 10}, {"letter": "Brachytherapy", "count": 3}, {"letter": "Brain", "count": 87}, {"letter": "Brain Death", "count": 1}, {"letter": "Brain Diseases", "count": 1}, {"letter": "Brain Neoplasms", "count": 7}, {"letter": "Brazil", "count": 17}, {"letter": "Breast", "count": 1504}, {"letter": "Malignant neoplasm of breast", "count": 894}, {"letter": "Breast Cyst", "count": 1}, {"letter": "Breast Diseases", "count": 18}, {"letter": "Breast Feeding", "count": 7}, {"letter": "Swelling of breast", "count": 9}, {"letter": "Breath Tests", "count": 7}, {"letter": "British Columbia", "count": 2}, {"letter": "British Indian Ocean Territory", "count": 2}, {"letter": "Bronchoalveolar Lavage Fluid", "count": 1}, {"letter": "Bronchodilator Agents", "count": 1}, {"letter": "Budgets", "count": 1}, {"letter": "Buffers", "count": 3}, {"letter": "bupivacaine", "count": 2}, {"letter": "Burkitt Lymphoma", "count": 30}, {"letter": "Burn injury", "count": 3}, {"letter": "busulfan", "count": 4}, {"letter": "Belarus", "count": 278}, {"letter": "DNA, Complementary", "count": 4}, {"letter": "C-Peptide", "count": 7}, {"letter": "C-reactive protein", "count": 25}, {"letter": "CA-125 Antigen", "count": 6}, {"letter": "Mucin-1 Antigen", "count": 11}, {"letter": "CA-19-9 Antigen", "count": 2}, {"letter": "Cachexia", "count": 6}, {"letter": "Cadherins", "count": 2}, {"letter": "caffeine", "count": 1}, {"letter": "Bone structure of calcaneum", "count": 2}, {"letter": "calcifediol", "count": 1}, {"letter": "Physiologic calcification", "count": 19}, {"letter": "Calcinosis", "count": 2}, {"letter": "calcitriol", "count": 6}, {"letter": "calcium", "count": 9}, {"letter": "Calcium, Dietary", "count": 6}, {"letter": "Calculi", "count": 1}, {"letter": "Calibration", "count": 11}, {"letter": "California", "count": 2}, {"letter": "Energy Intake", "count": 9}, {"letter": "Calorimetry, Indirect", "count": 1}, {"letter": "Calusterone", "count": 2}, {"letter": "Cameroon", "count": 15}, {"letter": "Canada", "count": 2}, {"letter": "Malignant Neoplasms", "count": 156}, {"letter": "Blood capillaries", "count": 2}, {"letter": "Capital", "count": 1}, {"letter": "capsaicin", "count": 3}, {"letter": "capsule (pharmacologic)", "count": 7}, {"letter": "captopril", "count": 15}, {"letter": "Carbamates", "count": 1}, {"letter": "Carbohydrates", "count": 23}, {"letter": "Carbon", "count": 2}, {"letter": "carbon dioxide", "count": 2}, {"letter": "carbon monoxide", "count": 3}, {"letter": "Carboxylic Acids", "count": 8}, {"letter": "Carcinoembryonic Antigen", "count": 2}, {"letter": "Carcinogens, Environmental", "count": 1}, {"letter": "Carcinoma", "count": 17}, {"letter": "Carcinoma in Situ", "count": 30}, {"letter": "Malignant tumor of colon", "count": 3}, {"letter": "Female Breast Carcinoma", "count": 43}, {"letter": "Adenocarcinoma of prostate", "count": 5}, {"letter": "Rectal Carcinoma", "count": 1}, {"letter": "Malignant neoplasm of skin", "count": 2}, {"letter": "Malignant neoplasm of thyroid", "count": 1}, {"letter": "Noninfiltrating Intraductal Carcinoma", "count": 148}, {"letter": "Mucinous Adenocarcinoma", "count": 1}, {"letter": "Non-Small Cell Lung Carcinoma", "count": 12}, {"letter": "Squamous cell carcinoma", "count": 1}, {"letter": "Carcinoma, Transitional Cell", "count": 3}, {"letter": "Cardiac Output", "count": 4}, {"letter": "Cardiac Tamponade", "count": 1}, {"letter": "Cardiac Volume", "count": 3}, {"letter": "Cardiography, Impedance", "count": 4}, {"letter": "Cardiolipins", "count": 1}, {"letter": "Cardiology discipline", "count": 15}, {"letter": "Cardiomyopathy, Dilated", "count": 1}, {"letter": "Cardiopulmonary Resuscitation", "count": 9}, {"letter": "Cardiovascular Agents", "count": 2}, {"letter": "Cardiovascular Diseases", "count": 15}, {"letter": "Cardiovascular system", "count": 42}, {"letter": "carnitine", "count": 1}, {"letter": "Carotenoids", "count": 3}, {"letter": "Carpal Tunnel Syndrome", "count": 1}, {"letter": "Genetic Carriers", "count": 30}, {"letter": "Cartilage", "count": 1}, {"letter": "Cartoons", "count": 1}, {"letter": "Case Reports Publication Type", "count": 2}, {"letter": "Case-Control Studies", "count": 5}, {"letter": "Catalysis", "count": 1}, {"letter": "Catchment Area (Health)", "count": 2}, {"letter": "Cathepsins", "count": 1}, {"letter": "Catheterization", "count": 2}, {"letter": "Arterial catheterization", "count": 1}, {"letter": "Cattle", "count": 2}, {"letter": "Caucasian", "count": 1}, {"letter": "Cause of Death", "count": 990}, {"letter": "Celiac Artery", "count": 1}, {"letter": "Cell Adhesion Molecules", "count": 1}, {"letter": "Cell Count", "count": 55}, {"letter": "Cell Culture Techniques", "count": 2}, {"letter": "Cell Cycle", "count": 4}, {"letter": "Cell Death", "count": 3}, {"letter": "Cell Differentiation process", "count": 8}, {"letter": "Cell Growth", "count": 9}, {"letter": "Cultured Cell Line", "count": 9}, {"letter": "Plasma membrane", "count": 3}, {"letter": "Cell Nucleolus", "count": 4}, {"letter": "Cell Nucleus", "count": 10}, {"letter": "Cell physiology", "count": 6}, {"letter": "Cell Separation", "count": 3}, {"letter": "Cell Survival", "count": 7}, {"letter": "Cells", "count": 214}, {"letter": "Cellulitis", "count": 4}, {"letter": "Censuses", "count": 1}, {"letter": "Centers for Disease Control and Prevention (U.S.)", "count": 9}, {"letter": "Central City", "count": 1}, {"letter": "CNS disorder", "count": 28}, {"letter": "Centrifugation", "count": 2}, {"letter": "Cerebral cortex", "count": 5}, {"letter": "Cerebrospinal Fluid", "count": 8}, {"letter": "In Cerebrospinal Fluid", "count": 6}, {"letter": "Cerebrovascular Circulation", "count": 1}, {"letter": "Certification", "count": 8}, {"letter": "Neck Pain", "count": 3}, {"letter": "Uterine Cervical Neoplasm", "count": 1}, {"letter": "Cervix Uteri", "count": 1}, {"letter": "Personality Character", "count": 3}, {"letter": "charge amounts", "count": 2}, {"letter": "Charts (device)", "count": 4}, {"letter": "Science of Chemistry", "count": 30}, {"letter": "Chemistry, Clinical", "count": 18}, {"letter": "Macrophage Chemotactic Factors", "count": 1}, {"letter": "chenodeoxycholic acid", "count": 1}, {"letter": "Chest Pain", "count": 12}, {"letter": "Oral Tobacco", "count": 1}, {"letter": "Chi-Square Test", "count": 38}, {"letter": "Child", "count": 10}, {"letter": "Developmental Disabilities", "count": 2}, {"letter": "Child health care", "count": 1}, {"letter": "Chimera organism", "count": 1}, {"letter": "China", "count": 17}, {"letter": "Chinese Language", "count": 29}, {"letter": "Chinese Americans", "count": 1}, {"letter": "chlordiazepoxide", "count": 1}, {"letter": "Chlorides", "count": 2}, {"letter": "chloroquine", "count": 4}, {"letter": "Choice Behavior", "count": 44}, {"letter": "cholecalciferol", "count": 19}, {"letter": "Cholecystectomy procedure", "count": 1}, {"letter": "Cholestanes", "count": 1}, {"letter": "cholesterol", "count": 19}, {"letter": "choline", "count": 8}, {"letter": "Chromatin", "count": 3}, {"letter": "Chromatography", "count": 3}, {"letter": "Gas Chromatography", "count": 3}, {"letter": "High pressure liquid chromatography procedure", "count": 1}, {"letter": "Liquid Chromatography", "count": 19}, {"letter": "Chromosomes", "count": 2}, {"letter": "Chronic disease", "count": 39}, {"letter": "Chronology as Topic", "count": 2}, {"letter": "Cicatrization", "count": 1}, {"letter": "Circadian Rhythms", "count": 6}, {"letter": "cisplatin", "count": 22}, {"letter": "citalopram", "count": 2}, {"letter": "Cities", "count": 6}, {"letter": "Citrates", "count": 1}, {"letter": "Classification", "count": 234}, {"letter": "Taxonomic", "count": 11}, {"letter": "Bone structure of clavicle", "count": 4}, {"letter": "Clients", "count": 3}, {"letter": "Climacteric", "count": 27}, {"letter": "Climate", "count": 1}, {"letter": "Clinic Visits", "count": 29}, {"letter": "Distributions, Clinical", "count": 1}, {"letter": "Clinical Investigators", "count": 9}, {"letter": "Markers, Clinical", "count": 4}, {"letter": "Clinical Medicine", "count": 2}, {"letter": "Clinical Protocols", "count": 3}, {"letter": "Clinical Research", "count": 16}, {"letter": "Clinical Skill", "count": 1}, {"letter": "Clinical Trials", "count": 226}, {"letter": "Clitoris", "count": 1}, {"letter": "Clone Cells", "count": 2}, {"letter": "Clothing", "count": 19}, {"letter": "statistical cluster", "count": 16}, {"letter": "cobalt", "count": 1}, {"letter": "cocaine", "count": 1}, {"letter": "codeine", "count": 2}, {"letter": "Coding", "count": 14}, {"letter": "Coffee", "count": 1}, {"letter": "Cognition", "count": 136}, {"letter": "Cognition Disorders", "count": 1}, {"letter": "Cognitive Therapy", "count": 8}, {"letter": "Cohort Effect", "count": 2}, {"letter": "Cohort Studies", "count": 147}, {"letter": "Coitus", "count": 34}, {"letter": "Cold Temperature", "count": 3}, {"letter": "Colitis", "count": 2}, {"letter": "collagen", "count": 11}, {"letter": "collagen type II", "count": 1}, {"letter": "Collagen Type IV", "count": 3}, {"letter": "Colon structure (body structure)", "count": 3}, {"letter": "colonoscopy", "count": 2}, {"letter": "Colony-Stimulating Factors", "count": 1}, {"letter": "Color", "count": 6}, {"letter": "Colorado", "count": 1}, {"letter": "Colorectal Carcinoma", "count": 20}, {"letter": "Colorimetry", "count": 2}, {"letter": "Colposcopy", "count": 1}, {"letter": "Combined Modality Therapy", "count": 142}, {"letter": "Common Cold", "count": 2}, {"letter": "Communicable Diseases", "count": 68}, {"letter": "Communication", "count": 71}, {"letter": "Communication Barriers", "count": 1}, {"letter": "Communications Media", "count": 4}, {"letter": "Community", "count": 21}, {"letter": "community development", "count": 1}, {"letter": "Community Health Workers", "count": 1}, {"letter": "Community Health Centers", "count": 3}, {"letter": "Comorbidity", "count": 29}, {"letter": "Complement System Proteins", "count": 4}, {"letter": "Complement 3", "count": 2}, {"letter": "Complement component C4", "count": 2}, {"letter": "Complete Blood Count", "count": 8}, {"letter": "Biomechanical compliance", "count": 5}, {"letter": "Complication", "count": 122}, {"letter": "Computer simulation", "count": 3}, {"letter": "Computers", "count": 41}, {"letter": "Conditioning (Psychology)", "count": 3}, {"letter": "Operant Conditioning", "count": 1}, {"letter": "Confidence Intervals", "count": 465}, {"letter": "Confidential Information", "count": 1}, {"letter": "confidentiality", "count": 3}, {"letter": "Conflict (Psychology)", "count": 11}, {"letter": "Confusion", "count": 1}, {"letter": "Connective Tissue", "count": 20}, {"letter": "Consciousness related finding", "count": 1}, {"letter": "Consent Forms", "count": 9}, {"letter": "Constipation", "count": 12}, {"letter": "Consultant", "count": 4}, {"letter": "Consultation", "count": 71}, {"letter": "Consumer Satisfaction", "count": 1}, {"letter": "Consumption of goods", "count": 115}, {"letter": "Continuity of Patient Care", "count": 1}, {"letter": "Contraceptive Agents", "count": 5}, {"letter": "Contraceptives, Oral", "count": 1}, {"letter": "Contracture", "count": 7}, {"letter": "Contrast Media", "count": 43}, {"letter": "Control Groups", "count": 77}, {"letter": "Contusions", "count": 6}, {"letter": "Coping Behavior", "count": 61}, {"letter": "copper", "count": 1}, {"letter": "Copyright", "count": 1}, {"letter": "Coronary Arteriosclerosis", "count": 3}, {"letter": "Coronary heart disease", "count": 2}, {"letter": "Coronary Vessels", "count": 1}, {"letter": "Correlation of Data", "count": 7}, {"letter": "Correlation Study", "count": 26}, {"letter": "Cosmetic Techniques", "count": 1}, {"letter": "Cosmetics", "count": 19}, {"letter": "Cost Analysis", "count": 8}, {"letter": "Cost Measures", "count": 6}, {"letter": "Cost Effectiveness", "count": 41}, {"letter": "Financial cost", "count": 122}, {"letter": "Costs and Cost Analysis", "count": 4}, {"letter": "Coughing", "count": 3}, {"letter": "Counseling", "count": 10}, {"letter": "Couples (persons)", "count": 9}, {"letter": "Cox Models", "count": 25}, {"letter": "Cox Proportional Hazards Models", "count": 23}, {"letter": "Craniosynostosis", "count": 3}, {"letter": "Craniotomy", "count": 1}, {"letter": "creatine", "count": 4}, {"letter": "Creatine Kinase", "count": 5}, {"letter": "Creatine Kinase MB Isoenzyme", "count": 2}, {"letter": "creatinine", "count": 16}, {"letter": "Care of intensive care unit patient", "count": 1}, {"letter": "Croatia", "count": 4}, {"letter": "Cross Reactions", "count": 1}, {"letter": "Cross-Sectional Studies", "count": 11}, {"letter": "Crossing Over, Genetic", "count": 42}, {"letter": "Prostheses, Dental, Fixed, Crown, Total, Temporary", "count": 2}, {"letter": "Crying", "count": 1}, {"letter": "Cryopreservation", "count": 3}, {"letter": "Cryosurgery", "count": 24}, {"letter": "Cues", "count": 1}, {"letter": "Anthropological Culture", "count": 17}, {"letter": "Culture Media", "count": 15}, {"letter": "Cumulative Survival Rate", "count": 1}, {"letter": "curcumin", "count": 6}, {"letter": "Educational Curriculum", "count": 1}, {"letter": "cyclophosphamide", "count": 41}, {"letter": "cycloserine", "count": 3}, {"letter": "cyclosporine", "count": 1}, {"letter": "Cyprus", "count": 1}, {"letter": "Cystatins", "count": 1}, {"letter": "cysteine", "count": 1}, {"letter": "caspase", "count": 1}, {"letter": "Cyst", "count": 1}, {"letter": "CYTOCHROME C OXIDASE", "count": 9}, {"letter": "Cytochromes", "count": 2}, {"letter": "Cytogenetics", "count": 2}, {"letter": "Cytokeratin", "count": 4}, {"letter": "Cytological Techniques", "count": 3}, {"letter": "Cytology", "count": 4}, {"letter": "Cellular aspects of", "count": 6}, {"letter": "Cytomegalovirus", "count": 1}, {"letter": "Cytopenia", "count": 1}, {"letter": "Cytoplasm", "count": 8}, {"letter": "cytosine", "count": 1}, {"letter": "Cytoskeletal Filaments", "count": 1}, {"letter": "Tissue damage", "count": 13}, {"letter": "Dancing", "count": 1}, {"letter": "Danish language", "count": 6}, {"letter": "Darkness", "count": 1}, {"letter": "Data Analysis", "count": 35}, {"letter": "Data Collection", "count": 26}, {"letter": "Data Reporting", "count": 5}, {"letter": "Date in time", "count": 1136}, {"letter": "Daughter", "count": 1}, {"letter": "Dichlorodiphenyl Dichloroethylene", "count": 1}, {"letter": "Cessation of life", "count": 646}, {"letter": "Death Records", "count": 2}, {"letter": "Debridement", "count": 5}, {"letter": "Decision Analysis", "count": 1}, {"letter": "Decision Making", "count": 60}, {"letter": "Decompression Sickness", "count": 1}, {"letter": "diethyltoluamide", "count": 1}, {"letter": "Defecation", "count": 3}, {"letter": "Deficiency", "count": 1}, {"letter": "Deglutition Disorders", "count": 2}, {"letter": "Dehydration", "count": 1}, {"letter": "prasterone", "count": 1}, {"letter": "Dejerine-Sottas Disease (disorder)", "count": 6}, {"letter": "Delaware", "count": 15}, {"letter": "Delirium", "count": 1}, {"letter": "Obstetric Delivery", "count": 25}, {"letter": "Delivery of Health Care", "count": 2}, {"letter": "Hepatitis Delta Virus", "count": 1}, {"letter": "Presenile dementia", "count": 1}, {"letter": "Demographic Factors", "count": 5}, {"letter": "Demography", "count": 62}, {"letter": "Dendritic Cells", "count": 7}, {"letter": "Denial (Psychology)", "count": 1}, {"letter": "Denmark", "count": 1}, {"letter": "Densitometry", "count": 2}, {"letter": "Dental Assistants", "count": 4}, {"letter": "Dental caries", "count": 4}, {"letter": "Dentures", "count": 2}, {"letter": "Dentist", "count": 1}, {"letter": "Deoxycytidine", "count": 4}, {"letter": "emotional dependency", "count": 1}, {"letter": "Mental Depression", "count": 256}, {"letter": "Depressive disorder", "count": 1}, {"letter": "Depth Perception", "count": 1}, {"letter": "Dermatitis", "count": 15}, {"letter": "Exfoliative dermatitis", "count": 1}, {"letter": "Dermatology field", "count": 3}, {"letter": "Dermis", "count": 3}, {"letter": "Deuterium", "count": 3}, {"letter": "Development Planning", "count": 2}, {"letter": "dexamethasone", "count": 6}, {"letter": "dextromethorphan", "count": 32}, {"letter": "Diabetes Mellitus", "count": 18}, {"letter": "Diabetes Mellitus, Insulin-Dependent", "count": 1}, {"letter": "Diabetes Mellitus, Non-Insulin-Dependent", "count": 1}, {"letter": "Diagnosis", "count": 228}, {"letter": "Laboratory Diagnosis", "count": 1}, {"letter": "Diagnostic Imaging", "count": 171}, {"letter": "Diarrhea", "count": 38}, {"letter": "Diastole", "count": 24}, {"letter": "Diathermy", "count": 1}, {"letter": "dichloroacetate", "count": 1}, {"letter": "Dictionary, Medical", "count": 3}, {"letter": "didanosine", "count": 12}, {"letter": "Diet", "count": 59}, {"letter": "Diet Records", "count": 7}, {"letter": "Diet therapy", "count": 2}, {"letter": "Formula - diet", "count": 3}, {"letter": "Dietary Fiber", "count": 2}, {"letter": "Ditiocarb", "count": 5}, {"letter": "Diffusion", "count": 18}, {"letter": "Gastrointestinal system", "count": 7}, {"letter": "digoxin", "count": 11}, {"letter": "hydromorphone", "count": 4}, {"letter": "Dihydroxycholecalciferols", "count": 1}, {"letter": "Dilatation and Curettage", "count": 1}, {"letter": "Pathological Dilatation", "count": 1}, {"letter": "dinoprostone", "count": 3}, {"letter": "Dioxins", "count": 2}, {"letter": "diphenhydramine", "count": 2}, {"letter": "Diphosphonates", "count": 6}, {"letter": "Diplopia", "count": 1}, {"letter": "Disadvantaged Populations", "count": 1}, {"letter": "Disasters", "count": 1}, {"letter": "Body Fluid Discharge", "count": 17}, {"letter": "Disclosure", "count": 6}, {"letter": "Discriminant Analysis", "count": 1}, {"letter": "Discrimination (process of differentiation)", "count": 8}, {"letter": "Disease", "count": 663}, {"letter": "Animal Disease Models", "count": 1}, {"letter": "Disease Outbreaks", "count": 1}, {"letter": "Disease susceptibility", "count": 7}, {"letter": "Dislocations", "count": 2}, {"letter": "Spatial Displacement", "count": 17}, {"letter": "Tissue Dissection", "count": 6}, {"letter": "Distance", "count": 87}, {"letter": "disulfiram", "count": 8}, {"letter": "Diuretics", "count": 1}, {"letter": "Divorce", "count": 1}, {"letter": "Dizziness", "count": 4}, {"letter": "DNA", "count": 75}, {"letter": "DNA Damage", "count": 11}, {"letter": "Topoisomerase II", "count": 1}, {"letter": "Markers, DNA", "count": 2}, {"letter": "DNA Mutational Analysis", "count": 1}, {"letter": "DNA Repair", "count": 2}, {"letter": "DNA Viruses", "count": 1}, {"letter": "DNA, Mitochondrial", "count": 1}, {"letter": "DNA, Neoplasm", "count": 14}, {"letter": "Recombinant DNA", "count": 1}, {"letter": "Canis familiaris", "count": 8}, {"letter": "Dosage Forms", "count": 4}, {"letter": "Double-Blind Method", "count": 3}, {"letter": "Down-Regulation", "count": 6}, {"letter": "doxorubicin", "count": 47}, {"letter": "Drainage procedure", "count": 3}, {"letter": "Drawings (art)", "count": 52}, {"letter": "Dreams", "count": 1}, {"letter": "Medical dressing", "count": 1}, {"letter": "intravenous administration", "count": 3}, {"letter": "Intrinsic drive", "count": 2}, {"letter": "Dropouts", "count": 10}, {"letter": "Drowsiness", "count": 10}, {"letter": "Drug abuse", "count": 8}, {"letter": "Drug Administration Routes", "count": 6}, {"letter": "Drug Combinations", "count": 11}, {"letter": "Drug Control", "count": 1}, {"letter": "Drug Evaluation", "count": 366}, {"letter": "Drug Allergy", "count": 2}, {"letter": "Drug Labeling", "count": 1}, {"letter": "Drug Packaging", "count": 3}, {"letter": "Drug resistance", "count": 3}, {"letter": "Pharmacotherapy", "count": 175}, {"letter": "pharmacotherapeutic", "count": 43}, {"letter": "Combination Drug Therapy", "count": 13}, {"letter": "Drug Tolerance", "count": 30}, {"letter": "Drug toxicity", "count": 11}, {"letter": "Pharmaceutical Preparations", "count": 426}, {"letter": "Investigational New Drugs", "count": 5}, {"letter": "pentetic acid", "count": 3}, {"letter": "Dutch Population", "count": 5}, {"letter": "Dyes", "count": 10}, {"letter": "Dysgeusia", "count": 2}, {"letter": "Dysmenorrhea", "count": 5}, {"letter": "Dyspepsia", "count": 5}, {"letter": "Dyspnea", "count": 37}, {"letter": "Dysuria", "count": 1}, {"letter": "Ear structure", "count": 2}, {"letter": "External auditory canal structure", "count": 1}, {"letter": "Eating", "count": 17}, {"letter": "Echocardiography", "count": 43}, {"letter": "Echocardiography, Doppler", "count": 1}, {"letter": "2D Echocardiography", "count": 2}, {"letter": "Ecology", "count": 1}, {"letter": "Models, Economic", "count": 1}, {"letter": "Economics", "count": 3}, {"letter": "Economic", "count": 18}, {"letter": "Medical Economics", "count": 13}, {"letter": "Edema", "count": 15}, {"letter": "Edema, Cardiac", "count": 1}, {"letter": "edetic acid", "count": 8}, {"letter": "Knowledge acquisition", "count": 8}, {"letter": "Educational aspects", "count": 8}, {"letter": "Educational Activities", "count": 1}, {"letter": "Educational Status", "count": 31}, {"letter": "Effect Modifier, Epidemiologic", "count": 2}, {"letter": "Efficiency", "count": 17}, {"letter": "effusion", "count": 1}, {"letter": "Egg Food Product", "count": 2}, {"letter": "Egypt", "count": 11}, {"letter": "Eicosanoids", "count": 5}, {"letter": "elasticity", "count": 4}, {"letter": "elastin", "count": 1}, {"letter": "Elbow", "count": 27}, {"letter": "Elbow joint structure", "count": 14}, {"letter": "Electric Conductivity", "count": 1}, {"letter": "Shock from electric current", "count": 2}, {"letter": "Electric stimulation technique", "count": 1}, {"letter": "Electricity", "count": 13}, {"letter": "Electroacupuncture", "count": 9}, {"letter": "Electrocardiogram", "count": 54}, {"letter": "Holter Electrocardiography", "count": 6}, {"letter": "Electroconvulsive Therapy", "count": 7}, {"letter": "electrode", "count": 12}, {"letter": "Electroencephalography", "count": 11}, {"letter": "Electrolytes", "count": 4}, {"letter": "Electromyography", "count": 3}, {"letter": "Email", "count": 5}, {"letter": "Electronic", "count": 1}, {"letter": "Electrons", "count": 2}, {"letter": "Electrophoresis", "count": 1}, {"letter": "Elements", "count": 18}, {"letter": "Elephantiasis", "count": 1}, {"letter": "Eligibility Determination", "count": 16}, {"letter": "Embolism, Tumor", "count": 1}, {"letter": "Embryo", "count": 2}, {"letter": "Emergency medical service", "count": 2}, {"letter": "Emetics", "count": 8}, {"letter": "Emotional Disturbances", "count": 1}, {"letter": "Emotions", "count": 72}, {"letter": "Empathy", "count": 8}, {"letter": "Employment", "count": 26}, {"letter": "Status, Occupational", "count": 2}, {"letter": "enalapril", "count": 3}, {"letter": "Subacute Bacterial Endocarditis", "count": 31}, {"letter": "Endocardium", "count": 1}, {"letter": "Endocrine System Diseases", "count": 5}, {"letter": "Endocrine Gland Neoplasms", "count": 2}, {"letter": "Endocrine system", "count": 134}, {"letter": "Endometrial Hyperplasia", "count": 1}, {"letter": "Endometrium", "count": 1}, {"letter": "Endorphins", "count": 1}, {"letter": "Endoscopy (procedure)", "count": 6}, {"letter": "Endothelium", "count": 11}, {"letter": "Endothelium, Vascular", "count": 1}, {"letter": "Endotoxins", "count": 1}, {"letter": "Energy Metabolism", "count": 5}, {"letter": "England", "count": 4}, {"letter": "Environment", "count": 24}, {"letter": "Environmental Exposure", "count": 2}, {"letter": "Environmental Pollutants", "count": 5}, {"letter": "Enzyme-Linked Immunosorbent Assay", "count": 82}, {"letter": "Enzymes", "count": 19}, {"letter": "enzymology", "count": 1}, {"letter": "eosine yellowish", "count": 48}, {"letter": "eosinophil", "count": 5}, {"letter": "Epidemiology", "count": 11}, {"letter": "epidemiologic", "count": 4}, {"letter": "Toxic Epidermal Necrolysis", "count": 14}, {"letter": "Epidermis", "count": 4}, {"letter": "epinephrine", "count": 2}, {"letter": "epirubicin", "count": 11}, {"letter": "Epistaxis", "count": 1}, {"letter": "Epithelial atrophy", "count": 1}, {"letter": "Epithelial Cells", "count": 2}, {"letter": "Epithelial hyperplasia", "count": 1}, {"letter": "Epithelium", "count": 3}, {"letter": "Epstein-Barr virus", "count": 1}, {"letter": "Equatorial Guinea", "count": 1}, {"letter": "Equilibrium", "count": 7}, {"letter": "Equipment", "count": 1}, {"letter": "Erythema Multiforme", "count": 934}, {"letter": "Red Blood Cell Count measurement", "count": 6}, {"letter": "Erythrocyte Membrane", "count": 1}, {"letter": "Erythrocytes", "count": 5}, {"letter": "erythromycin", "count": 1}, {"letter": "Esophageal Perforation", "count": 1}, {"letter": "Esophagus", "count": 2}, {"letter": "Esthetics (discipline)", "count": 51}, {"letter": "Estonian language", "count": 5}, {"letter": "estradiol", "count": 49}, {"letter": "estramustine", "count": 3}, {"letter": "estrogens, conjugated (USP)", "count": 1}, {"letter": "estrogens", "count": 37}, {"letter": "estrone", "count": 19}, {"letter": "Estrus", "count": 1}, {"letter": "ethacrynic acid", "count": 10}, {"letter": "Ethers", "count": 1}, {"letter": "amifostine", "count": 1}, {"letter": "Ethnicity", "count": 38}, {"letter": "Etiology aspects", "count": 71}, {"letter": "etoposide", "count": 2}, {"letter": "Europe", "count": 4}, {"letter": "Methodology, Evaluation", "count": 1}, {"letter": "Evaluation Research", "count": 2}, {"letter": "Evaluation Studies", "count": 15}, {"letter": "Biological Evolution", "count": 59}, {"letter": "Exanthema", "count": 19}, {"letter": "Complete excision", "count": 4}, {"letter": "removal technique", "count": 23}, {"letter": "Excoriation", "count": 1}, {"letter": "Exercise", "count": 77}, {"letter": "Exercise stress test", "count": 11}, {"letter": "Exertion", "count": 34}, {"letter": "Exhibits as Topic", "count": 12}, {"letter": "Existentialism", "count": 15}, {"letter": "Expenditures", "count": 6}, {"letter": "Health Expenditures", "count": 1}, {"letter": "Exploratory Behavior", "count": 1}, {"letter": "Exposure to radiation", "count": 3}, {"letter": "Extracellular Fluid", "count": 7}, {"letter": "Extracellular Matrix", "count": 1}, {"letter": "Extracellular Space", "count": 3}, {"letter": "Extravasation", "count": 4}, {"letter": "Extraversion, Psychological", "count": 5}, {"letter": "Limb structure", "count": 69}, {"letter": "Eye", "count": 12}, {"letter": "Disorder of eye", "count": 2}, {"letter": "Eye Drops", "count": 2}, {"letter": "F Factor", "count": 1}, {"letter": "Face", "count": 29}, {"letter": "Facial Expression", "count": 1}, {"letter": "factor IX", "count": 3}, {"letter": "Factor V", "count": 2}, {"letter": "factor VIII", "count": 4}, {"letter": "factor XIII", "count": 1}, {"letter": "Faeroe Islands", "count": 4}, {"letter": "Family", "count": 57}, {"letter": "Family Relationship", "count": 2}, {"letter": "Fascia", "count": 1}, {"letter": "Fasting", "count": 94}, {"letter": "Fat necrosis", "count": 9}, {"letter": "Father (person)", "count": 1}, {"letter": "Fatigue", "count": 477}, {"letter": "Mental Fatigue", "count": 8}, {"letter": "Fatty acid glycerol esters", "count": 1}, {"letter": "Fatty Acids", "count": 9}, {"letter": "Nonesterified Fatty Acids", "count": 1}, {"letter": "omega-3 fatty acids", "count": 12}, {"letter": "Fatty Acids, Unsaturated", "count": 1}, {"letter": "Fatty Acids, Volatile", "count": 2}, {"letter": "Fear (Mental Process)", "count": 33}, {"letter": "Feasibility Studies", "count": 35}, {"letter": "Feces", "count": 33}, {"letter": "Feedback - system communication", "count": 30}, {"letter": "Feeding behaviors", "count": 1}, {"letter": "Fees", "count": 2}, {"letter": "Female Sterilization", "count": 1}, {"letter": "Structure of femoral artery", "count": 2}, {"letter": "Femur", "count": 9}, {"letter": "Structure of neck of femur", "count": 8}, {"letter": "fentanyl", "count": 11}, {"letter": "Ferritin", "count": 1}, {"letter": "Fertility", "count": 14}, {"letter": "Fertilization", "count": 1}, {"letter": "Fertilization in Vitro", "count": 2}, {"letter": "Fetal Growth Retardation", "count": 1}, {"letter": "Fetal Membranes, Premature Rupture", "count": 9}, {"letter": "Fetus", "count": 1}, {"letter": "Fever", "count": 27}, {"letter": "Fiber Optic Technology", "count": 1}, {"letter": "Fibrin", "count": 1}, {"letter": "fibrinogen", "count": 4}, {"letter": "Fibroblast Growth Factor", "count": 4}, {"letter": "Fibroblasts", "count": 3}, {"letter": "Fibromyalgia", "count": 2}, {"letter": "Fibrosis", "count": 33}, {"letter": "Ficoll", "count": 1}, {"letter": "File (record)", "count": 6}, {"letter": "filtration", "count": 1}, {"letter": "Fingers", "count": 8}, {"letter": "Finland", "count": 3}, {"letter": "pathologic fistula", "count": 2}, {"letter": "Flame Ionization", "count": 1}, {"letter": "Flattened", "count": 3}, {"letter": "Flatulence", "count": 1}, {"letter": "Flexible fiberoptic sigmoidoscopy", "count": 1}, {"letter": "floor (object)", "count": 19}, {"letter": "Florida", "count": 1}, {"letter": "Flowcharts (Computer)", "count": 2}, {"letter": "Flow Cytometry", "count": 52}, {"letter": "Fluorescence", "count": 26}, {"letter": "Fluorescent Probes", "count": 1}, {"letter": "Fluorides", "count": 192}, {"letter": "Fluoroacetates", "count": 1}, {"letter": "Fluorometry", "count": 1}, {"letter": "fluorouracil", "count": 29}, {"letter": "Flushing", "count": 5}, {"letter": "Focus Groups", "count": 8}, {"letter": "folic acid", "count": 1}, {"letter": "Folic Acid Deficiency", "count": 3}, {"letter": "Follow-Up Studies", "count": 5}, {"letter": "Food", "count": 36}, {"letter": "Food Analysis", "count": 1}, {"letter": "Food Habits", "count": 1}, {"letter": "Food Allergy", "count": 1}, {"letter": "Food Selection", "count": 1}, {"letter": "Foot", "count": 29}, {"letter": "Forearm", "count": 10}, {"letter": "Projections and Predictions", "count": 5}, {"letter": "Foreign Bodies", "count": 1}, {"letter": "Foreign-Body Reaction", "count": 1}, {"letter": "Forelimb", "count": 1}, {"letter": "Foundations", "count": 9}, {"letter": "Chemical fractionation", "count": 1}, {"letter": "Fractures, Multiple", "count": 1}, {"letter": "Fracture", "count": 23}, {"letter": "Pathological fracture", "count": 14}, {"letter": "France", "count": 2}, {"letter": "Freckles", "count": 1}, {"letter": "Freedom", "count": 9}, {"letter": "Freezing", "count": 7}, {"letter": "Friedreich Ataxia", "count": 8}, {"letter": "frontal lobe", "count": 1}, {"letter": "Fruit", "count": 8}, {"letter": "Frustration", "count": 5}, {"letter": "Human Follicle-Stimulating Hormone", "count": 18}, {"letter": "Funds", "count": 8}, {"letter": "Furniture", "count": 1}, {"letter": "Future", "count": 145}, {"letter": "gadolinium", "count": 4}, {"letter": "Gait", "count": 9}, {"letter": "Galactosidase", "count": 1}, {"letter": "Galvanic Skin Response", "count": 2}, {"letter": "Gamma Cameras", "count": 6}, {"letter": "Gamma-glutamyl transferase", "count": 8}, {"letter": "Ganglia", "count": 2}, {"letter": "Gases", "count": 8}, {"letter": "gastroenterology (field)", "count": 1}, {"letter": "Gastrointestinal Diseases", "count": 1}, {"letter": "Gastrointestinal Hemorrhage", "count": 1}, {"letter": "Gastrointestinal tract structure", "count": 1}, {"letter": "Gated Blood-Pool Imaging", "count": 3}, {"letter": "Gel", "count": 12}, {"letter": "Gender Identity", "count": 1}, {"letter": "Gene Amplification", "count": 1}, {"letter": "Gene Deletion", "count": 1}, {"letter": "Gene Expression", "count": 25}, {"letter": "Gene Expression Regulation", "count": 1}, {"letter": "Gene Frequency", "count": 8}, {"letter": "Gene Rearrangement", "count": 8}, {"letter": "gene therapy", "count": 3}, {"letter": "patient care", "count": 16}, {"letter": "General Practitioners", "count": 3}, {"letter": "Generalization, Psychological", "count": 1}, {"letter": "Genes", "count": 123}, {"letter": "Genes, MHC Class II", "count": 1}, {"letter": "Genes, MHC Class I", "count": 2}, {"letter": "Genetic Counseling", "count": 39}, {"letter": "Genetic Engineering", "count": 1}, {"letter": "Encounter for Genetic screening NEC in ICD9CM", "count": 4}, {"letter": "Science of genetics", "count": 9}, {"letter": "Genetics, Population", "count": 1}, {"letter": "Genitalia", "count": 1}, {"letter": "Female genitalia", "count": 1}, {"letter": "Genome", "count": 65}, {"letter": "Genome, Human", "count": 1}, {"letter": "Genotype", "count": 42}, {"letter": "Geographic Locations", "count": 54}, {"letter": "Geriatric Assessment", "count": 34}, {"letter": "Germ Line", "count": 28}, {"letter": "germanium", "count": 4}, {"letter": "Germany", "count": 17}, {"letter": "Gestures", "count": 3}, {"letter": "Giant Cells", "count": 1}, {"letter": "Gilbert Disease (disorder)", "count": 1}, {"letter": "Gingiva", "count": 2}, {"letter": "Glioblastoma", "count": 4}, {"letter": "Globulins", "count": 1}, {"letter": "Glomerular Filtration Rate", "count": 1}, {"letter": "Glomerulonephritis", "count": 1}, {"letter": "Gloves, Surgical", "count": 3}, {"letter": "Glucocorticoids", "count": 2}, {"letter": "glucosamine", "count": 4}, {"letter": "glucose", "count": 68}, {"letter": "glucose oxidase", "count": 1}, {"letter": "Glucose tolerance test", "count": 1}, {"letter": "glutamine", "count": 2}, {"letter": "glutathione", "count": 5}, {"letter": "Hemoglobin, Glycosylated", "count": 2}, {"letter": "nitroglycerin", "count": 21}, {"letter": "Glycol", "count": 1}, {"letter": "Glycolysis", "count": 2}, {"letter": "Glycosaminoglycans", "count": 1}, {"letter": "objective (goal)", "count": 91}, {"letter": "Goggles", "count": 2}, {"letter": "gold", "count": 4}, {"letter": "Gonadotropins", "count": 1}, {"letter": "Government", "count": 2}, {"letter": "Ovarian Follicle", "count": 3}, {"letter": "Graft Rejection", "count": 1}, {"letter": "Graft-vs-Host Disease", "count": 3}, {"letter": "Granulation Tissue", "count": 2}, {"letter": "granulocyte", "count": 15}, {"letter": "Gray Matter", "count": 2}, {"letter": "Grooming (animal)", "count": 1}, {"letter": "Growth", "count": 1}, {"letter": "Epiphysial cartilage", "count": 2}, {"letter": "Growth Factor", "count": 14}, {"letter": "guanine", "count": 1}, {"letter": "Guernsey (geographic location)", "count": 2}, {"letter": "Guilt", "count": 2}, {"letter": "Gynecology", "count": 20}, {"letter": "H-Reflex", "count": 1}, {"letter": "Habilitation", "count": 1}, {"letter": "Behaviorial Habits", "count": 16}, {"letter": "hafnium", "count": 1}, {"letter": "Hair", "count": 10}, {"letter": "Hair Diseases", "count": 1}, {"letter": "General hair removal - epilation", "count": 5}, {"letter": "Haiti", "count": 1}, {"letter": "Half-Life", "count": 51}, {"letter": "Hallucinations", "count": 3}, {"letter": "Hallux structure", "count": 4}, {"letter": "Hand", "count": 144}, {"letter": "Disabled Persons", "count": 3}, {"letter": "Haplotypes", "count": 2}, {"letter": "Happiness", "count": 9}, {"letter": "Hardness", "count": 14}, {"letter": "Hate", "count": 1}, {"letter": "Head", "count": 14}, {"letter": "Headache", "count": 16}, {"letter": "Health", "count": 451}, {"letter": "Health behavior", "count": 12}, {"letter": "Health Care Systems", "count": 3}, {"letter": "Health education", "count": 11}, {"letter": "Health care facility", "count": 9}, {"letter": "Medicare", "count": 5}, {"letter": "Health Workforce", "count": 1}, {"letter": "Health Personnel", "count": 41}, {"letter": "Health Planning", "count": 5}, {"letter": "Health Promotion", "count": 5}, {"letter": "Health Resources", "count": 5}, {"letter": "Health Services", "count": 12}, {"letter": "Health Services Administration", "count": 1}, {"letter": "Health Services Research", "count": 7}, {"letter": "Health Status", "count": 184}, {"letter": "Health Status Indicators", "count": 6}, {"letter": "Health Surveys", "count": 63}, {"letter": "Hearing", "count": 3}, {"letter": "Hearing Loss, Partial", "count": 1}, {"letter": "Hearing Tests", "count": 2}, {"letter": "Heart", "count": 80}, {"letter": "Cardiac Arrest", "count": 4}, {"letter": "Heart Diseases", "count": 9}, {"letter": "Cardiomegaly", "count": 1}, {"letter": "Heart failure", "count": 38}, {"letter": "Congestive heart failure", "count": 20}, {"letter": "Heart Function Tests", "count": 1}, {"letter": "Heart Injuries", "count": 3}, {"letter": "heart rate", "count": 88}, {"letter": "Cardiac Surgery procedures", "count": 2}, {"letter": "Heart Transplantation", "count": 4}, {"letter": "Heart Ventricle", "count": 3}, {"letter": "Heat (physical force)", "count": 9}, {"letter": "Heat Shock Protein 27", "count": 1}, {"letter": "Heat shock proteins", "count": 1}, {"letter": "Hebrew language", "count": 2}, {"letter": "Heel", "count": 10}, {"letter": "helium", "count": 6}, {"letter": "Helminths", "count": 1}, {"letter": "Helper-Inducer T-Lymphocyte", "count": 9}, {"letter": "Helping Behavior", "count": 16}, {"letter": "Hemagglutination Inhibition Tests", "count": 5}, {"letter": "Hematocrit procedure", "count": 8}, {"letter": "Hematologic Agents", "count": 1}, {"letter": "Hematologic Tests", "count": 55}, {"letter": "Hematology (discipline)", "count": 42}, {"letter": "Hematoma", "count": 6}, {"letter": "Hematopoiesis", "count": 1}, {"letter": "Hematopoietic stem cells", "count": 4}, {"letter": "Hematoxylin", "count": 44}, {"letter": "Hematuria", "count": 2}, {"letter": "Hemodynamics", "count": 7}, {"letter": "Glycosylated hemoglobin A", "count": 4}, {"letter": "Hemoglobin A2", "count": 1}, {"letter": "Hemoglobin concentration result", "count": 10}, {"letter": "Hemoglobin", "count": 46}, {"letter": "Hemoptysis", "count": 3}, {"letter": "Hemorrhage", "count": 68}, {"letter": "Hemorrhagic Fever with Renal Syndrome", "count": 2}, {"letter": "heparin", "count": 2}, {"letter": "Hepatitis A", "count": 3}, {"letter": "Hepatomegaly", "count": 1}, {"letter": "Angioedemas, Hereditary", "count": 1}, {"letter": "Hereditary Diseases", "count": 1}, {"letter": "Heterogeneity", "count": 15}, {"letter": "Heterosexuality", "count": 3}, {"letter": "Heterozygote", "count": 1}, {"letter": "Hiccough", "count": 1}, {"letter": "Hip structure", "count": 35}, {"letter": "Hip Fractures", "count": 4}, {"letter": "Hippocampus (Brain)", "count": 1}, {"letter": "histamine", "count": 1}, {"letter": "Histamine H1 Antagonists", "count": 1}, {"letter": "histidine", "count": 3}, {"letter": "Histiocytes", "count": 1}, {"letter": "Histocompatibility Testing", "count": 1}, {"letter": "Histological Techniques", "count": 2}, {"letter": "Histology", "count": 9}, {"letter": "Histone H1", "count": 2}, {"letter": "Histone H2a", "count": 2}, {"letter": "Histones", "count": 2}, {"letter": "HLA-A Antigens", "count": 8}, {"letter": "HLA-A2 Antigen", "count": 2}, {"letter": "HLA-B Antigens", "count": 1}, {"letter": "HLA-DR Antigens", "count": 4}, {"letter": "HMGB1 Protein", "count": 2}, {"letter": "Hobbies", "count": 1}, {"letter": "Holidays", "count": 1}, {"letter": "Holistic Health", "count": 2}, {"letter": "Home Care Services", "count": 1}, {"letter": "Homeostasis", "count": 2}, {"letter": "Ethidium Bromide", "count": 1}, {"letter": "Homozygote", "count": 2}, {"letter": "Hong Kong", "count": 1}, {"letter": "Hormone Receptor", "count": 24}, {"letter": "Hormones", "count": 58}, {"letter": "Hospital Information Systems", "count": 16}, {"letter": "Hospital Records", "count": 4}, {"letter": "Hospital Referral", "count": 3}, {"letter": "Hospitalization", "count": 139}, {"letter": "Hospitals", "count": 26}, {"letter": "Hospitals, Cancer", "count": 1}, {"letter": "Hospitals, Community", "count": 2}, {"letter": "Hospitals, County", "count": 1}, {"letter": "Hospitals, District", "count": 1}, {"letter": "Hospitals, Maternity", "count": 1}, {"letter": "Hospitals, Public", "count": 1}, {"letter": "Hospitals, State", "count": 1}, {"letter": "Teaching Hospitals", "count": 1}, {"letter": "Hospitals, University", "count": 3}, {"letter": "Hospitals, Urban", "count": 1}, {"letter": "Hostility", "count": 7}, {"letter": "Hotlines", "count": 1}, {"letter": "Households", "count": 6}, {"letter": "Housekeeping", "count": 16}, {"letter": "Housing", "count": 4}, {"letter": "Humanities", "count": 3}, {"letter": "Bone structure of humerus", "count": 1}, {"letter": "Humor", "count": 5}, {"letter": "Hunger", "count": 1}, {"letter": "Hybrid Cells", "count": 2}, {"letter": "Crossbreeding", "count": 1}, {"letter": "Hybrids", "count": 5}, {"letter": "hydralazine", "count": 1}, {"letter": "Hydrocarbons, Chlorinated", "count": 1}, {"letter": "hydrocodone", "count": 2}, {"letter": "hydrocortisone", "count": 27}, {"letter": "hydrogen", "count": 1}, {"letter": "hydrogen peroxide", "count": 1}, {"letter": "Hydrogen-Ion Concentration", "count": 2}, {"letter": "hydroxychloroquine", "count": 6}, {"letter": "Hydroxycholesterols", "count": 1}, {"letter": "hetastarch", "count": 1}, {"letter": "Hygiene", "count": 1}, {"letter": "Hyperalgesia", "count": 3}, {"letter": "Hyperbaric oxygenation therapy", "count": 1}, {"letter": "Hypercalcemia", "count": 14}, {"letter": "Hypercapnia", "count": 1}, {"letter": "Hypercholesterolemia", "count": 2}, {"letter": "Hyperdistention", "count": 2}, {"letter": "Hyperesthesia", "count": 3}, {"letter": "Hyperglycemia", "count": 9}, {"letter": "Hyperkalemia", "count": 4}, {"letter": "Hyperlipidemia", "count": 5}, {"letter": "Hypernatremia", "count": 3}, {"letter": "Hyperphagia", "count": 1}, {"letter": "Hyperplasia", "count": 3}, {"letter": "Hypersensitivity", "count": 34}, {"letter": "Delayed Hypersensitivity", "count": 5}, {"letter": "Immediate hypersensitivity", "count": 3}, {"letter": "Hypertensive disease", "count": 1}, {"letter": "Pulmonary Hypertension", "count": 1}, {"letter": "Induced Hyperthermia", "count": 1}, {"letter": "Hyperthermia, Local", "count": 1}, {"letter": "Hyperthyroidism", "count": 1}, {"letter": "Hypertrophy", "count": 1}, {"letter": "Hypesthesia", "count": 7}, {"letter": "Hypnotherapy", "count": 13}, {"letter": "Hypnotics", "count": 1}, {"letter": "Hypnotics and Sedatives", "count": 2}, {"letter": "Hypocalcemia", "count": 6}, {"letter": "Hypoglycemia", "count": 2}, {"letter": "Hypoglycemic Agents", "count": 1}, {"letter": "Hypogonadism", "count": 1}, {"letter": "Hypokalemia", "count": 7}, {"letter": "Hyponatremia", "count": 6}, {"letter": "Hypoparathyroidism", "count": 1}, {"letter": "Hypotension", "count": 9}, {"letter": "Hypothermia, natural", "count": 1}, {"letter": "Hypothyroidism", "count": 7}, {"letter": "Hysterectomy", "count": 1}, {"letter": "ibuprofen", "count": 4}, {"letter": "Ice", "count": 3}, {"letter": "Iceland", "count": 7}, {"letter": "Icelandic language", "count": 1}, {"letter": "Identification (Psychology)", "count": 74}, {"letter": "idoxuridine", "count": 1}, {"letter": "Immunoglobulin D", "count": 1}, {"letter": "immunoglobulin G", "count": 1}, {"letter": "Image Enhancement", "count": 1}, {"letter": "Optical Image Reconstruction", "count": 10}, {"letter": "Immobilization", "count": 4}, {"letter": "Immune system", "count": 6}, {"letter": "Immune Tolerance", "count": 1}, {"letter": "Immune response", "count": 80}, {"letter": "Cellular Immunity", "count": 5}, {"letter": "Humoral Immunity", "count": 3}, {"letter": "Immunization", "count": 2}, {"letter": "Immunization Schedule", "count": 1}, {"letter": "Secondary Immunization", "count": 7}, {"letter": "Immunoassay method", "count": 8}, {"letter": "Immunoblotting", "count": 2}, {"letter": "Immunogenetics", "count": 1}, {"letter": "Immunoglobulin Isotypes", "count": 3}, {"letter": "Immunoglobulins", "count": 2}, {"letter": "Immunohistochemistry", "count": 223}, {"letter": "Immunodiagnosis", "count": 1}, {"letter": "Immune System Diseases", "count": 12}, {"letter": "Immunologic Factors", "count": 3}, {"letter": "Immunologic Surveillance", "count": 1}, {"letter": "Immunologic Tests", "count": 1}, {"letter": "Immunosuppressive Agents", "count": 3}, {"letter": "Immunotherapy", "count": 15}, {"letter": "Implants", "count": 45}, {"letter": "Implantation procedure", "count": 44}, {"letter": "Imprinting (Psychology)", "count": 1}, {"letter": "Impulsive Behavior", "count": 1}, {"letter": "In Vitro [Publication Type]", "count": 13}, {"letter": "Encounter due to economic problem", "count": 1}, {"letter": "Incidence", "count": 125}, {"letter": "Incidence Studies", "count": 4}, {"letter": "Decompressive incision", "count": 1}, {"letter": "Income", "count": 8}, {"letter": "Incontinence", "count": 3}, {"letter": "Indexing", "count": 1}, {"letter": "Indicators", "count": 52}, {"letter": "indium", "count": 5}, {"letter": "Individuality", "count": 11}, {"letter": "indocyanine green", "count": 16}, {"letter": "Infant", "count": 5}, {"letter": "Infant, Newborn", "count": 1}, {"letter": "Infarction", "count": 4}, {"letter": "Infectious Bovine Rhinotracheitis", "count": 1}, {"letter": "Infertility", "count": 2}, {"letter": "Mammary Ductal Carcinoma", "count": 1}, {"letter": "Inflammation", "count": 78}, {"letter": "Chronic inflammation", "count": 5}, {"letter": "Serous inflammation", "count": 2}, {"letter": "Economic Inflation", "count": 1}, {"letter": "Influenza", "count": 1}, {"letter": "Influenza virus vaccine", "count": 2}, {"letter": "Information Systems", "count": 8}, {"letter": "Informed Consent", "count": 17}, {"letter": "Infrared Rays", "count": 1}, {"letter": "Intra-Arterial Infusions", "count": 1}, {"letter": "Intravenous infusion procedures", "count": 22}, {"letter": "Psychological inhibition", "count": 1}, {"letter": "Metabolic Inhibition", "count": 7}, {"letter": "Injection of therapeutic agent", "count": 73}, {"letter": "intradermal injection", "count": 2}, {"letter": "Injections, Intralesional", "count": 2}, {"letter": "Intravenous Injections", "count": 2}, {"letter": "Subcutaneous Injections", "count": 4}, {"letter": "Ink (substance)", "count": 3}, {"letter": "inpatient", "count": 49}, {"letter": "Institutes", "count": 15}, {"letter": "Institutional Practice", "count": 2}, {"letter": "Institutionalization", "count": 2}, {"letter": "Insufflation", "count": 1}, {"letter": "Insulin", "count": 17}, {"letter": "Insulin Resistance", "count": 29}, {"letter": "Insulin-Like Growth Factor I", "count": 31}, {"letter": "insulin-like growth factor 2", "count": 8}, {"letter": "Insurance", "count": 11}, {"letter": "Health Insurance", "count": 5}, {"letter": "Integrins", "count": 1}, {"letter": "Intelligence", "count": 1}, {"letter": "intensive care unit", "count": 5}, {"letter": "Interobserver Variation", "count": 1}, {"letter": "Interest Groups", "count": 5}, {"letter": "interferon type II", "count": 25}, {"letter": "Interferons", "count": 5}, {"letter": "interleukin-1, beta", "count": 30}, {"letter": "Interleukin-1", "count": 10}, {"letter": "Interleukin-2", "count": 22}, {"letter": "interleukin-3", "count": 1}, {"letter": "interleukin-4", "count": 12}, {"letter": "interleukin-5", "count": 3}, {"letter": "interleukin-6", "count": 96}, {"letter": "interleukin-7", "count": 2}, {"letter": "Interleukins", "count": 25}, {"letter": "Intermediate Filament Proteins", "count": 2}, {"letter": "International System of Units", "count": 4}, {"letter": "Interpersonal Relations", "count": 13}, {"letter": "Interviewers", "count": 3}, {"letter": "Interview", "count": 76}, {"letter": "Interviews, Telephone", "count": 13}, {"letter": "Intestines", "count": 12}, {"letter": "Intraobserver Variation", "count": 1}, {"letter": "Intracellular Fluid", "count": 2}, {"letter": "Intraoperative Complications", "count": 1}, {"letter": "Intrauterine Devices", "count": 2}, {"letter": "intrinsic factor", "count": 1}, {"letter": "Introns", "count": 6}, {"letter": "Investments", "count": 2}, {"letter": "Iodides", "count": 182}, {"letter": "Ions", "count": 1}, {"letter": "Iran", "count": 19}, {"letter": "Ireland", "count": 2}, {"letter": "Radiation injury of bone", "count": 14}, {"letter": "Irrigation", "count": 1}, {"letter": "Irritable Mood", "count": 3}, {"letter": "Ischemia", "count": 8}, {"letter": "Transient ischemia", "count": 2}, {"letter": "Isoflavones", "count": 3}, {"letter": "isoleucine", "count": 1}, {"letter": "Isomerism (chemical phenomenon)", "count": 2}, {"letter": "Isometric Contraction", "count": 9}, {"letter": "Isopaque", "count": 1}, {"letter": "inosine pranobex", "count": 7}, {"letter": "Isotopes", "count": 12}, {"letter": "Israel", "count": 3}, {"letter": "Italy", "count": 11}, {"letter": "Incontinentia Pigmenti Achromians", "count": 3}, {"letter": "Japan", "count": 6}, {"letter": "Icterus", "count": 2}, {"letter": "Job Description", "count": 4}, {"letter": "Joints", "count": 19}, {"letter": "Judgment", "count": 35}, {"letter": "Justice", "count": 5}, {"letter": "Kearns-Sayre syndrome", "count": 1}, {"letter": "Kell Blood-Group System", "count": 1}, {"letter": "Kenya", "count": 2}, {"letter": "Ketalar", "count": 1}, {"letter": "ketamine", "count": 3}, {"letter": "ketoconazole", "count": 2}, {"letter": "Ketone Bodies", "count": 1}, {"letter": "Ketones", "count": 1}, {"letter": "ketoprofen", "count": 1}, {"letter": "Ketosis", "count": 2}, {"letter": "Kidney", "count": 12}, {"letter": "Kidney Failure, Chronic", "count": 1}, {"letter": "Kidney Function Tests", "count": 1}, {"letter": "Kidney Papillary Necrosis", "count": 7}, {"letter": "Natural Killer Cells", "count": 42}, {"letter": "Kinesthesis", "count": 1}, {"letter": "Kinetics", "count": 13}, {"letter": "Kyrgyzstan", "count": 1}, {"letter": "Knee", "count": 10}, {"letter": "Knee joint", "count": 4}, {"letter": "Knowledge Bases", "count": 4}, {"letter": "Korea", "count": 2}, {"letter": "South Korea", "count": 2}, {"letter": "Korean language", "count": 3}, {"letter": "Kynurenine", "count": 1}, {"letter": "Kyphosis deformity of spine", "count": 1}, {"letter": "Labor (Childbirth)", "count": 2}, {"letter": "Laboratory", "count": 288}, {"letter": "Laboratory Research", "count": 5}, {"letter": "Lactalbumin", "count": 2}, {"letter": "Lactate Dehydrogenase", "count": 14}, {"letter": "Lactates", "count": 3}, {"letter": "lactulose", "count": 3}, {"letter": "Languages", "count": 13}, {"letter": "Language Tests", "count": 2}, {"letter": "Lasers", "count": 15}, {"letter": "Handedness", "count": 1}, {"letter": "Latvia", "count": 16}, {"letter": "Rules of conduct", "count": 2}, {"letter": "Learning", "count": 23}, {"letter": "Least-Squares Analysis", "count": 15}, {"letter": "Lower Extremity", "count": 44}, {"letter": "Cramps of lower extremities", "count": 2}, {"letter": "Fibroid Tumor", "count": 1}, {"letter": "Leisure Activities", "count": 17}, {"letter": "Length of Stay", "count": 15}, {"letter": "Lesch-Nyhan Syndrome", "count": 3}, {"letter": "Lethargy", "count": 2}, {"letter": "leucine", "count": 1}, {"letter": "leucovorin", "count": 1}, {"letter": "Leukapheresis", "count": 3}, {"letter": "leukemia", "count": 1}, {"letter": "Acute lymphocytic leukemia", "count": 5}, {"letter": "Acute Megakaryocytic Leukemias", "count": 5}, {"letter": "Leukemia, Myelocytic, Acute", "count": 5}, {"letter": "White Blood Cell Count procedure", "count": 13}, {"letter": "Leukocytes", "count": 43}, {"letter": "Leukocytosis", "count": 4}, {"letter": "Leukopenia", "count": 34}, {"letter": "Leukorrhea", "count": 1}, {"letter": "levamisole", "count": 1}, {"letter": "Lewis Blood-Group System", "count": 4}, {"letter": "luteinizing hormone", "count": 2}, {"letter": "gonadorelin", "count": 2}, {"letter": "Libraries", "count": 7}, {"letter": "Lice", "count": 1}, {"letter": "License", "count": 17}, {"letter": "lidocaine", "count": 3}, {"letter": "Life Change Events", "count": 2}, {"letter": "Life Expectancy", "count": 3}, {"letter": "Life Experiences", "count": 35}, {"letter": "Life Style", "count": 22}, {"letter": "Life Tables", "count": 1}, {"letter": "Ligands", "count": 15}, {"letter": "Light", "count": 30}, {"letter": "Lighting", "count": 1}, {"letter": "Radiotherapy Systems, Linear Accelerator", "count": 1}, {"letter": "Linear Models", "count": 109}, {"letter": "Linear Regression", "count": 56}, {"letter": "Linguistics", "count": 4}, {"letter": "genetic linkage", "count": 9}, {"letter": "linoleic acid", "count": 4}, {"letter": "Lip structure", "count": 6}, {"letter": "lipase", "count": 5}, {"letter": "Lipid A", "count": 1}, {"letter": "Lipid Peroxidation", "count": 2}, {"letter": "Lipids", "count": 15}, {"letter": "Lipopolysaccharides", "count": 8}, {"letter": "High Density Lipoproteins", "count": 4}, {"letter": "High Density Lipoprotein Cholesterol", "count": 11}, {"letter": "Low-Density Lipoproteins", "count": 6}, {"letter": "LDL Cholesterol Lipoproteins", "count": 12}, {"letter": "Very low density lipoprotein cholesterol", "count": 1}, {"letter": "Literacy", "count": 18}, {"letter": "Liver", "count": 38}, {"letter": "Liver diseases", "count": 1}, {"letter": "Liver Function Tests", "count": 16}, {"letter": "Liver neoplasms", "count": 2}, {"letter": "LIVING STATUS", "count": 2}, {"letter": "Logic", "count": 4}, {"letter": "Logistic Models", "count": 41}, {"letter": "London", "count": 1}, {"letter": "Loneliness", "count": 9}, {"letter": "long-term care", "count": 2}, {"letter": "Longevity", "count": 1}, {"letter": "Longitudinal Studies", "count": 27}, {"letter": "Longterm Effects", "count": 7}, {"letter": "loperamide", "count": 3}, {"letter": "Lordosis", "count": 1}, {"letter": "Los Angeles", "count": 6}, {"letter": "Love", "count": 1}, {"letter": "Low Back Pain", "count": 1}, {"letter": "Low-Income Population", "count": 1}, {"letter": "Lubrication", "count": 11}, {"letter": "Lumbar Region", "count": 1}, {"letter": "Bone structure of lumbar vertebra", "count": 39}, {"letter": "Mass in breast", "count": 13}, {"letter": "Lung", "count": 57}, {"letter": "Lung diseases", "count": 1}, {"letter": "Pulmonary function tests", "count": 2}, {"letter": "Luteal Phase", "count": 2}, {"letter": "Lymph", "count": 38}, {"letter": "Lymph node excision", "count": 15}, {"letter": "lymph nodes", "count": 301}, {"letter": "Lymphangiography", "count": 7}, {"letter": "Lymphatic System", "count": 3}, {"letter": "Lymphedema", "count": 197}, {"letter": "Lymphocele", "count": 1}, {"letter": "Lymphocyte Activation", "count": 1}, {"letter": "Lymphocyte", "count": 53}, {"letter": "Lymphography", "count": 3}, {"letter": "Lymphoid Tissue", "count": 1}, {"letter": "Lymphoma", "count": 30}, {"letter": "Lymphoma, Non-Hodgkin", "count": 3}, {"letter": "lysine", "count": 8}, {"letter": "Lysis", "count": 4}, {"letter": "Lactic acid dehydrogenase isoenzyme 5", "count": 1}, {"letter": "Macrophage Activation", "count": 1}, {"letter": "macrophage", "count": 16}, {"letter": "Magic", "count": 1}, {"letter": "magnesium", "count": 6}, {"letter": "magnesium oxide", "count": 1}, {"letter": "Magnetic Resonance Imaging", "count": 498}, {"letter": "Magnetic Resonance Spectroscopy", "count": 2}, {"letter": "Study of magnetics", "count": 6}, {"letter": "Mail", "count": 4}, {"letter": "Maintenance", "count": 41}, {"letter": "Malaysia", "count": 19}, {"letter": "Male sterilization", "count": 1}, {"letter": "Malignant neoplasm of stomach", "count": 22}, {"letter": "Malpractice", "count": 1}, {"letter": "Animal Mammary Neoplasms", "count": 1}, {"letter": "Mammography", "count": 277}, {"letter": "Manganese Superoxide Dismutase", "count": 2}, {"letter": "Manikins", "count": 1}, {"letter": "mannitol", "count": 2}, {"letter": "Manuals as Topic", "count": 5}, {"letter": "Marijuana Abuse", "count": 1}, {"letter": "Marital Relationship", "count": 1}, {"letter": "Marital Status", "count": 14}, {"letter": "Market Research", "count": 1}, {"letter": "Marketing", "count": 1}, {"letter": "Marriage, life event", "count": 6}, {"letter": "Martinique", "count": 4}, {"letter": "Gas Chromatography-Mass Spectrometry", "count": 4}, {"letter": "Massage", "count": 8}, {"letter": "mast cell", "count": 1}, {"letter": "Mastectomy", "count": 162}, {"letter": "Modified radical mastectomy", "count": 6}, {"letter": "Segmental Mastectomy", "count": 37}, {"letter": "Simple mastectomy", "count": 10}, {"letter": "Mastectomy, Subcutaneous", "count": 5}, {"letter": "Mastodynia", "count": 37}, {"letter": "Matched Groups", "count": 2}, {"letter": "Mathematics", "count": 6}, {"letter": "Mauritania", "count": 4}, {"letter": "Maytansine", "count": 10}, {"letter": "McGill Pain Questionnaire", "count": 7}, {"letter": "Measles", "count": 1}, {"letter": "Structure of median nerve", "count": 2}, {"letter": "Mediastinal Diseases", "count": 1}, {"letter": "Medical Assistance", "count": 3}, {"letter": "Medical Devices", "count": 26}, {"letter": "Examiner, Medical", "count": 22}, {"letter": "Medical Imaging", "count": 9}, {"letter": "Medical oncology specialty", "count": 5}, {"letter": "Medical Records", "count": 78}, {"letter": "Medical Staff", "count": 7}, {"letter": "Medication Systems", "count": 4}, {"letter": "Medicine", "count": 12}, {"letter": "Megakaryocytes", "count": 1}, {"letter": "Melancholia", "count": 1}, {"letter": "Melanins", "count": 2}, {"letter": "melanoma", "count": 11}, {"letter": "melatonin", "count": 9}, {"letter": "memantine", "count": 1}, {"letter": "Membrane Proteins", "count": 1}, {"letter": "Tissue membrane", "count": 2}, {"letter": "Memory Disorders", "count": 1}, {"letter": "Memory, Short-Term", "count": 40}, {"letter": "Male population group", "count": 15}, {"letter": "Menarche", "count": 1}, {"letter": "Meningitis", "count": 2}, {"letter": "Menopausal syndrome", "count": 1}, {"letter": "Menopause", "count": 659}, {"letter": "Premature Menopause", "count": 3}, {"letter": "Menstrual cycle", "count": 11}, {"letter": "Menstruation", "count": 21}, {"letter": "mental health", "count": 67}, {"letter": "Mental Health Services", "count": 2}, {"letter": "Mentally Ill Persons", "count": 10}, {"letter": "Mental Processes", "count": 2}, {"letter": "Mental Tests", "count": 2}, {"letter": "Mentors", "count": 1}, {"letter": "meperidine", "count": 2}, {"letter": "Mesothelioma", "count": 1}, {"letter": "Metabolic Clearance Rate", "count": 5}, {"letter": "Metabolic Diseases", "count": 4}, {"letter": "Metabolism", "count": 14}, {"letter": "metabolic aspects", "count": 25}, {"letter": "Metacarpophalangeal joint structure", "count": 4}, {"letter": "Metals", "count": 1}, {"letter": "metformin", "count": 37}, {"letter": "methadone", "count": 1}, {"letter": "Study, Methodological", "count": 1}, {"letter": "Methods", "count": 371}, {"letter": "Methods aspects", "count": 90}, {"letter": "methotrexate", "count": 3}, {"letter": "Methylation", "count": 1}, {"letter": "methylene blue", "count": 2}, {"letter": "methylphenidate", "count": 3}, {"letter": "Mexico", "count": 2}, {"letter": "Mice, Inbred CBA", "count": 2}, {"letter": "Mice, Inbred ICR", "count": 15}, {"letter": "Laboratory mice", "count": 2}, {"letter": "Micelles", "count": 2}, {"letter": "Michigan (geographic location)", "count": 2}, {"letter": "Science of Microbiology", "count": 3}, {"letter": "Microbiological", "count": 3}, {"letter": "Microcirculation", "count": 1}, {"letter": "Micronucleus - abnormality", "count": 2}, {"letter": "Microprocessors", "count": 1}, {"letter": "Microscopy", "count": 10}, {"letter": "Microscopy, Phase-Contrast", "count": 1}, {"letter": "Microspheres", "count": 1}, {"letter": "Microsurgery", "count": 1}, {"letter": "Microtubule Proteins", "count": 1}, {"letter": "Microtubules", "count": 1}, {"letter": "microwave electromagnetic radiation", "count": 2}, {"letter": "midazolam", "count": 34}, {"letter": "mifepristone", "count": 6}, {"letter": "Minerals", "count": 6}, {"letter": "Minnesota", "count": 2}, {"letter": "Minority Groups", "count": 1}, {"letter": "Minor (person)", "count": 12}, {"letter": "minoxidil", "count": 1}, {"letter": "Mitochondria", "count": 6}, {"letter": "Mitochondria, Muscle", "count": 2}, {"letter": "Mitosis", "count": 3}, {"letter": "MNSs Blood-Group System", "count": 1}, {"letter": "Models, Anatomic", "count": 1}, {"letter": "Models, Binomial", "count": 2}, {"letter": "Models, Genetic", "count": 4}, {"letter": "Models, Molecular", "count": 1}, {"letter": "Models, Statistical", "count": 1}, {"letter": "Theoretical model", "count": 2}, {"letter": "Molecular Biology", "count": 4}, {"letter": "Molecular Conformation", "count": 3}, {"letter": "Molecular Weight", "count": 2}, {"letter": "Mongolian language", "count": 1}, {"letter": "Blood pressure monitoring", "count": 3}, {"letter": "Monitoring, Immunologic", "count": 1}, {"letter": "Monitoring, Physiologic", "count": 2}, {"letter": "Monocytes", "count": 25}, {"letter": "Monte Carlo Method", "count": 5}, {"letter": "Mood (psychological function)", "count": 60}, {"letter": "Morality", "count": 7}, {"letter": "Morbidity - disease rate", "count": 279}, {"letter": "morphine", "count": 61}, {"letter": "Mortality Vital Statistics", "count": 60}, {"letter": "Aspects of mortality statistics", "count": 1}, {"letter": "Mother (person)", "count": 7}, {"letter": "Motion", "count": 24}, {"letter": "Motivation", "count": 25}, {"letter": "Physical activity", "count": 166}, {"letter": "Motor Skills", "count": 1}, {"letter": "Mouth Diseases", "count": 5}, {"letter": "Oral mucous membrane structure", "count": 5}, {"letter": "Mouthwash", "count": 2}, {"letter": "Movement", "count": 75}, {"letter": "Movement Disorders", "count": 1}, {"letter": "Moxibustion", "count": 2}, {"letter": "mRNA Precursor", "count": 1}, {"letter": "Mucociliary Clearance", "count": 1}, {"letter": "Mucous Membrane", "count": 2}, {"letter": "Mucous body substance", "count": 2}, {"letter": "Multiple Myeloma", "count": 20}, {"letter": "Multivariate Analysis", "count": 7}, {"letter": "Mus", "count": 2}, {"letter": "Muscle Contraction", "count": 9}, {"letter": "Muscle Cramp", "count": 5}, {"letter": "Muscle Hypertonia", "count": 2}, {"letter": "Muscle Proteins", "count": 1}, {"letter": "Muscle relaxation phase", "count": 1}, {"letter": "Muscle Tissue", "count": 75}, {"letter": "Musculoskeletal Diseases", "count": 10}, {"letter": "Musculoskeletal Pain", "count": 10}, {"letter": "Musculoskeletal System", "count": 8}, {"letter": "Mustard Gas", "count": 9}, {"letter": "Mutation", "count": 59}, {"letter": "Mycoplasma", "count": 1}, {"letter": "Acute Myeloid Leukemia, M1", "count": 32}, {"letter": "peroxidase", "count": 1}, {"letter": "Myocardial Infarction", "count": 2}, {"letter": "Myocardial Revascularization", "count": 1}, {"letter": "Myocardium", "count": 12}, {"letter": "Myofascial Pain Syndromes", "count": 1}, {"letter": "Myoma", "count": 1}, {"letter": "NADH", "count": 1}, {"letter": "Nail plate", "count": 6}, {"letter": "Persons", "count": 237}, {"letter": "Human Age Group", "count": 14}, {"letter": "Name", "count": 23}, {"letter": "Narcotic Analgesics", "count": 1}, {"letter": "Narcotics", "count": 6}, {"letter": "National Health Insurance", "count": 1}, {"letter": "Health Services, National", "count": 3}, {"letter": "National Institute of Mental Health (U.S.)", "count": 2}, {"letter": "United States National Institutes of Health", "count": 30}, {"letter": "Nationality", "count": 2}, {"letter": "Nauru", "count": 2}, {"letter": "Nausea", "count": 7}, {"letter": "Nausea and vomiting", "count": 27}, {"letter": "Neck", "count": 13}, {"letter": "Necrosis", "count": 27}, {"letter": "Avascular necrosis of bone", "count": 3}, {"letter": "Necrotic debris", "count": 2}, {"letter": "Needle device", "count": 17}, {"letter": "Needs", "count": 133}, {"letter": "African", "count": 1}, {"letter": "Zinostatin", "count": 2}, {"letter": "neon", "count": 14}, {"letter": "Circulating Neoplastic Cells", "count": 48}, {"letter": "Neoplasm Invasiveness", "count": 1}, {"letter": "Neoplasm Metastasis", "count": 211}, {"letter": "Neoplasm Proteins", "count": 1}, {"letter": "Neoplasm Recurrence, Local", "count": 2}, {"letter": "Diagnostic Neoplasm Staging", "count": 13}, {"letter": "Neoplasms", "count": 1200}, {"letter": "Neoplasms by Histologic Type", "count": 2}, {"letter": "Neoplasms by Site", "count": 8}, {"letter": "Neoplasms, Multiple Primary", "count": 1}, {"letter": "Neoplasms, Radiation-Induced", "count": 3}, {"letter": "Neoplastic Syndromes, Hereditary", "count": 1}, {"letter": "Pathologic Neovascularization", "count": 3}, {"letter": "Nephritis", "count": 1}, {"letter": "Nerve", "count": 5}, {"letter": "Nerve Block", "count": 2}, {"letter": "Nerve Fibers", "count": 2}, {"letter": "nervous system disorder", "count": 2}, {"letter": "Nervous System Physiological Phenomena", "count": 3}, {"letter": "Nervousness", "count": 5}, {"letter": "Nested Case-Control Studies", "count": 1}, {"letter": "Netherlands", "count": 3}, {"letter": "Nerve conduction function", "count": 1}, {"letter": "Neural Tube Defects", "count": 3}, {"letter": "Neuralgia", "count": 38}, {"letter": "Neurodermatitis", "count": 1}, {"letter": "Neurofilaments", "count": 1}, {"letter": "Neuroleptic Malignant Syndrome", "count": 8}, {"letter": "Neurologic Examination", "count": 10}, {"letter": "Neurology speciality", "count": 2}, {"letter": "Neuronal Plasticity", "count": 1}, {"letter": "Neuropeptides", "count": 1}, {"letter": "Neuropsychological Tests", "count": 16}, {"letter": "Neurosecretory Systems", "count": 1}, {"letter": "Neutropenia", "count": 65}, {"letter": "neutrophil", "count": 44}, {"letter": "Nevus", "count": 1}, {"letter": "New Caledonia", "count": 1}, {"letter": "New England", "count": 1}, {"letter": "New York (geographic location)", "count": 5}, {"letter": "New York City", "count": 1}, {"letter": "nicotine", "count": 1}, {"letter": "Nicotine Dependence", "count": 3}, {"letter": "Nigeria", "count": 4}, {"letter": "Night sweats", "count": 5}, {"letter": "Nightmares", "count": 2}, {"letter": "nimodipine", "count": 1}, {"letter": "Nipples", "count": 34}, {"letter": "nitric oxide", "count": 22}, {"letter": "Nitrites", "count": 1}, {"letter": "Nodule", "count": 1}, {"letter": "Noise", "count": 5}, {"letter": "norepinephrine", "count": 5}, {"letter": "Normal Statistical Distribution", "count": 11}, {"letter": "North America", "count": 1}, {"letter": "Nose", "count": 3}, {"letter": "Nuclear Magnetic Resonance", "count": 1}, {"letter": "Discipline of Nuclear Medicine", "count": 1}, {"letter": "Nucleotides", "count": 6}, {"letter": "Numbness", "count": 13}, {"letter": "Nurse Administrator", "count": 4}, {"letter": "nurse practitioner", "count": 4}, {"letter": "Nurse-Patient Relations", "count": 3}, {"letter": "Nurses", "count": 47}, {"letter": "Discipline of Nursing", "count": 1}, {"letter": "Care given by nurses", "count": 2}, {"letter": "Nursing Staff", "count": 1}, {"letter": "Nursing, Team", "count": 1}, {"letter": "Science of nutrition", "count": 7}, {"letter": "Nutrition Assessment", "count": 2}, {"letter": "Nylons", "count": 2}, {"letter": "Obesity", "count": 29}, {"letter": "Discipline of obstetrics", "count": 4}, {"letter": "Obstruction", "count": 2}, {"letter": "Occult blood screen", "count": 1}, {"letter": "Occupations", "count": 9}, {"letter": "octreotide", "count": 1}, {"letter": "Odds Ratio", "count": 16}, {"letter": "Odors", "count": 3}, {"letter": "Office Visits", "count": 1}, {"letter": "Ohio", "count": 2}, {"letter": "Olfactory Nerve", "count": 2}, {"letter": "Oligomenorrhea", "count": 1}, {"letter": "Oligonucleotides", "count": 1}, {"letter": "Omentum", "count": 1}, {"letter": "omeprazole", "count": 17}, {"letter": "Oncogene Proteins", "count": 1}, {"letter": "Oncogenes", "count": 7}, {"letter": "Oncology Nursing", "count": 2}, {"letter": "Online Systems", "count": 1}, {"letter": "Ontario", "count": 11}, {"letter": "Oocytes", "count": 6}, {"letter": "Decreased translucency", "count": 1}, {"letter": "Operating Room", "count": 2}, {"letter": "Ophthalmic Solution", "count": 1}, {"letter": "Ophthalmology specialty", "count": 2}, {"letter": "Opportunistic Infections", "count": 1}, {"letter": "Oral contraception", "count": 1}, {"letter": "Oral Glucose Tolerance Test", "count": 5}, {"letter": "Organelles", "count": 2}, {"letter": "Organism", "count": 6}, {"letter": "Physiologic Organization", "count": 1}, {"letter": "Organization administrative structures", "count": 9}, {"letter": "Organoids", "count": 10}, {"letter": "Orgasm", "count": 12}, {"letter": "Mental Orientation", "count": 7}, {"letter": "Degenerative polyarthritis", "count": 23}, {"letter": "Osteoblasts", "count": 3}, {"letter": "Osteocalcin", "count": 1}, {"letter": "Osteochondritis", "count": 2}, {"letter": "Osteoclasts", "count": 1}, {"letter": "Osteogenesis", "count": 6}, {"letter": "Osteopenia", "count": 15}, {"letter": "Osteoporosis", "count": 21}, {"letter": "Ostomy", "count": 2}, {"letter": "Outpatient Clinics, Hospital", "count": 2}, {"letter": "Outpatients", "count": 43}, {"letter": "Ovarian Cysts", "count": 1}, {"letter": "Ovariectomy", "count": 6}, {"letter": "Ovary", "count": 4}, {"letter": "Drug Overdose", "count": 3}, {"letter": "Oxidation", "count": 3}, {"letter": "oxycodone", "count": 5}, {"letter": "oxygen", "count": 14}, {"letter": "Oxyhemoglobin", "count": 4}, {"letter": "Package Inserts", "count": 1}, {"letter": "Plasminogen Activator Inhibitor 1", "count": 2}, {"letter": "Pain", "count": 36}, {"letter": "Pain in limb", "count": 2}, {"letter": "Pain Measurement", "count": 84}, {"letter": "Pain, Postoperative", "count": 67}, {"letter": "Palliative Care", "count": 24}, {"letter": "Pallor", "count": 1}, {"letter": "Palpation", "count": 18}, {"letter": "Palpitations", "count": 6}, {"letter": "Pamphlets", "count": 9}, {"letter": "Pancreas", "count": 9}, {"letter": "Structure of beta Cell of islet", "count": 1}, {"letter": "Panniculitis", "count": 4}, {"letter": "Paper", "count": 1}, {"letter": "Papilloma", "count": 3}, {"letter": "Parabens", "count": 2}, {"letter": "paraffin", "count": 2}, {"letter": "Parasites", "count": 1}, {"letter": "Parasomnia", "count": 1}, {"letter": "Parathyroid gland", "count": 1}, {"letter": "Parenteral Nutrition", "count": 1}, {"letter": "Parenteral Nutrition, Total", "count": 2}, {"letter": "parent", "count": 15}, {"letter": "Paresthesia", "count": 6}, {"letter": "Parity", "count": 2}, {"letter": "Parotid Gland", "count": 1}, {"letter": "Activated Partial Thromboplastin Time measurement", "count": 5}, {"letter": "Patella", "count": 2}, {"letter": "Pathogenicity Aspects", "count": 1}, {"letter": "Pathologic Processes", "count": 2}, {"letter": "Pathology", "count": 35}, {"letter": "Pathology Department, Hospital", "count": 1}, {"letter": "Pathology, Clinical", "count": 3}, {"letter": "Surgical Pathology specialty", "count": 11}, {"letter": "Patient Acceptance of Health Care", "count": 37}, {"letter": "Patient Admission", "count": 1}, {"letter": "Patient Appointments", "count": 2}, {"letter": "Patient Care Management", "count": 14}, {"letter": "Patient Discharge", "count": 17}, {"letter": "Patient education (procedure)", "count": 9}, {"letter": "Patient Monitoring", "count": 50}, {"letter": "Patient Outcome Assessment", "count": 3}, {"letter": "Patient Participation", "count": 15}, {"letter": "Patient Representatives", "count": 1}, {"letter": "Client satisfaction", "count": 136}, {"letter": "Schedules, Patient", "count": 5}, {"letter": "Pectoralis Muscles", "count": 3}, {"letter": "Pediatrics", "count": 1}, {"letter": "genetic pedigree", "count": 3}, {"letter": "Hip Bone", "count": 1}, {"letter": "Pelvic Pain", "count": 3}, {"letter": "Pelvis", "count": 16}, {"letter": "penicillin G", "count": 3}, {"letter": "Penile Erection", "count": 5}, {"letter": "Endopeptidases", "count": 1}, {"letter": "Peptides", "count": 11}, {"letter": "Perception", "count": 363}, {"letter": "Perfusion (procedure)", "count": 23}, {"letter": "Pericardial effusion", "count": 3}, {"letter": "Pericardial sac structure", "count": 1}, {"letter": "Perimetry", "count": 4}, {"letter": "Periodicals", "count": 12}, {"letter": "Peripheral Neuropathy", "count": 39}, {"letter": "Peripheral Nerves", "count": 3}, {"letter": "Laparoscopy", "count": 1}, {"letter": "Peritoneum", "count": 2}, {"letter": "Permeability", "count": 5}, {"letter": "Structure of common peroneal nerve", "count": 1}, {"letter": "Persian language", "count": 10}, {"letter": "Personality", "count": 8}, {"letter": "Personality inventories", "count": 149}, {"letter": "Personnel Turnover", "count": 3}, {"letter": "Pesticides", "count": 3}, {"letter": "Pet Animal", "count": 67}, {"letter": "Phagocytes", "count": 1}, {"letter": "Phagocytosis", "count": 2}, {"letter": "Pharmacy facility", "count": 1}, {"letter": "Pharmacist", "count": 2}, {"letter": "Pharmacogenetics", "count": 7}, {"letter": "Drug Kinetics", "count": 39}, {"letter": "Pharmacokinetic aspects", "count": 260}, {"letter": "Pharmacology", "count": 4}, {"letter": "Clinical pharmacology discipline", "count": 1}, {"letter": "Pharmacy (field)", "count": 5}, {"letter": "Pharyngitis", "count": 1}, {"letter": "Pharyngeal structure", "count": 2}, {"letter": "Phenotype", "count": 48}, {"letter": "phenylephrine", "count": 1}, {"letter": "Philosophy", "count": 1}, {"letter": "Phosphates", "count": 1}, {"letter": "phosphatidylinositols", "count": 3}, {"letter": "Phosphocreatine", "count": 1}, {"letter": "Phosphoric Monoester Hydrolases", "count": 6}, {"letter": "Phosphoproteins", "count": 1}, {"letter": "Phosphoric Acid Esters", "count": 8}, {"letter": "phosphorus", "count": 5}, {"letter": "Phosphorylation", "count": 3}, {"letter": "Phosphotransferases", "count": 10}, {"letter": "Photogrammetry", "count": 9}, {"letter": "Photography", "count": 6}, {"letter": "Phototherapy", "count": 1}, {"letter": "Phycoerythrin", "count": 1}, {"letter": "Physical Examination", "count": 130}, {"letter": "Physical Fitness", "count": 8}, {"letter": "Physical Stimulation", "count": 2}, {"letter": "Physician-Patient Relations", "count": 8}, {"letter": "Physicians", "count": 168}, {"letter": "Physics", "count": 1}, {"letter": "Physiology", "count": 1}, {"letter": "physiological aspects", "count": 53}, {"letter": "physiopathological", "count": 17}, {"letter": "phytosterols", "count": 12}, {"letter": "Pigmentation", "count": 5}, {"letter": "pilocarpine", "count": 2}, {"letter": "Pilot Projects", "count": 10}, {"letter": "Pineal gland", "count": 1}, {"letter": "Placebos", "count": 185}, {"letter": "Cognitive function: planning", "count": 19}, {"letter": "Planning Techniques", "count": 1}, {"letter": "Plant Oils", "count": 1}, {"letter": "Plant Proteins", "count": 1}, {"letter": "Plants", "count": 1}, {"letter": "Plasma", "count": 566}, {"letter": "Plasma Cells", "count": 2}, {"letter": "Plasma Proteins", "count": 3}, {"letter": "Blood Plasma Volume", "count": 2}, {"letter": "Plasmids", "count": 4}, {"letter": "Plasminogen Inactivators", "count": 1}, {"letter": "Plastics", "count": 11}, {"letter": "Platelet Count measurement", "count": 14}, {"letter": "Platelet-Derived Growth Factor", "count": 1}, {"letter": "platinum", "count": 5}, {"letter": "Pleomorphism (morphologic abnormality)", "count": 1}, {"letter": "Plethysmography", "count": 4}, {"letter": "Pleural effusion disorder", "count": 4}, {"letter": "Ploidies", "count": 4}, {"letter": "Pneumonia", "count": 14}, {"letter": "Aspiration Pneumonia", "count": 1}, {"letter": "Pneumothorax", "count": 6}, {"letter": "Poisson Distribution", "count": 1}, {"letter": "Poly A", "count": 5}, {"letter": "Polyamines", "count": 1}, {"letter": "Polybrominated Biphenyls", "count": 1}, {"letter": "Polychlorinated Biphenyls", "count": 2}, {"letter": "Polycyclic Hydrocarbons, Aromatic", "count": 1}, {"letter": "Polycystic Ovary Syndrome", "count": 1}, {"letter": "Polymerase Chain Reaction", "count": 257}, {"letter": "Polymers", "count": 3}, {"letter": "Genetic Polymorphism", "count": 34}, {"letter": "Adenomatous Polyposis Coli", "count": 3}, {"letter": "polyps", "count": 2}, {"letter": "Polysaccharides", "count": 1}, {"letter": "Polyunsaturated Fatty Acids", "count": 2}, {"letter": "Pongidae", "count": 1}, {"letter": "geographic population", "count": 399}, {"letter": "Population Characteristics", "count": 16}, {"letter": "Population Control", "count": 1}, {"letter": "Population Programs", "count": 5}, {"letter": "Population Size", "count": 1}, {"letter": "Population Surveillance", "count": 1}, {"letter": "Porifera", "count": 1}, {"letter": "Portuguese population", "count": 8}, {"letter": "Positron-Emission Tomography", "count": 76}, {"letter": "Positrons", "count": 1}, {"letter": "Postoperative Care", "count": 1}, {"letter": "Postoperative Complications", "count": 30}, {"letter": "Postoperative Hemorrhage", "count": 3}, {"letter": "Postoperative Period", "count": 273}, {"letter": "potassium", "count": 10}, {"letter": "potassium iodide", "count": 6}, {"letter": "Potato", "count": 1}, {"letter": "Poverty", "count": 17}, {"letter": "Power (Psychology)", "count": 61}, {"letter": "Pre-Post Tests", "count": 2}, {"letter": "Prealbumin", "count": 3}, {"letter": "Precancerous Conditions", "count": 1}, {"letter": "Precipitating Factors", "count": 9}, {"letter": "prednisolone", "count": 1}, {"letter": "prednisone", "count": 2}, {"letter": "Pregnancy", "count": 4}, {"letter": "Pregnancy Complications", "count": 1}, {"letter": "Pregnancy Outcome", "count": 8}, {"letter": "Pregnancy Rate", "count": 2}, {"letter": "Pregnancy, Prolonged", "count": 1}, {"letter": "Pregnant Women", "count": 7}, {"letter": "Premature Ejaculation", "count": 1}, {"letter": "Premedication", "count": 5}, {"letter": "Prenatal care", "count": 6}, {"letter": "Prescription procedure", "count": 8}, {"letter": "Drug Prescriptions", "count": 6}, {"letter": "Biologic Preservation", "count": 7}, {"letter": "Pressure- physical agent", "count": 7}, {"letter": "pretesting", "count": 1}, {"letter": "Statistical Prevalence", "count": 20}, {"letter": "prevention & control", "count": 10}, {"letter": "Pricing", "count": 1}, {"letter": "Puncture wound", "count": 6}, {"letter": "Primary Care Physicians", "count": 3}, {"letter": "Primary Health Care", "count": 8}, {"letter": "Primary Prevention", "count": 4}, {"letter": "Primary Schools", "count": 1}, {"letter": "Printing", "count": 6}, {"letter": "Prions", "count": 1}, {"letter": "Private Practice", "count": 1}, {"letter": "Private Room", "count": 1}, {"letter": "Probability", "count": 108}, {"letter": "Problem Solving (mental process)", "count": 3}, {"letter": "Problem", "count": 87}, {"letter": "Procollagen", "count": 2}, {"letter": "production", "count": 14}, {"letter": "Productivity", "count": 16}, {"letter": "Progestins", "count": 1}, {"letter": "Progestational Hormones, Synthetic", "count": 1}, {"letter": "progesterone", "count": 16}, {"letter": "Forecast of outcome", "count": 47}, {"letter": "Program Development", "count": 1}, {"letter": "Program Effectiveness", "count": 4}, {"letter": "Program Evaluation", "count": 7}, {"letter": "Projection Defense Mechanism", "count": 1}, {"letter": "prolactin", "count": 1}, {"letter": "proline", "count": 40}, {"letter": "Promoter Regions, Genetic", "count": 1}, {"letter": "Promotion (action)", "count": 14}, {"letter": "Pronation", "count": 3}, {"letter": "Prone Position", "count": 23}, {"letter": "Complement Factor B", "count": 3}, {"letter": "propofol", "count": 3}, {"letter": "Proportional Hazards Models", "count": 22}, {"letter": "propranolol", "count": 2}, {"letter": "Proprioception", "count": 3}, {"letter": "Prospective Studies", "count": 6}, {"letter": "Prostate", "count": 22}, {"letter": "Prostatectomy", "count": 3}, {"letter": "Prostatic Neoplasms", "count": 1}, {"letter": "Protective Devices", "count": 5}, {"letter": "protein C", "count": 1}, {"letter": "Protein Kinases", "count": 1}, {"letter": "Post-Translational Protein Processing", "count": 11}, {"letter": "Protein Tyrosine Kinase", "count": 1}, {"letter": "Proteins", "count": 77}, {"letter": "Proteinuria", "count": 3}, {"letter": "prothrombin", "count": 1}, {"letter": "Prothrombin time assay", "count": 4}, {"letter": "Protons", "count": 18}, {"letter": "Pruritus", "count": 43}, {"letter": "Psychiatrist", "count": 1}, {"letter": "Psychological Factors", "count": 2}, {"letter": "Psychologist", "count": 3}, {"letter": "Psychology", "count": 1}, {"letter": "psychological aspects", "count": 1}, {"letter": "Psychology, Social", "count": 2}, {"letter": "Psychometrics", "count": 24}, {"letter": "Psychopathology", "count": 2}, {"letter": "Psychosocial Factors", "count": 5}, {"letter": "Psychotherapy", "count": 2}, {"letter": "Psychotherapy, Multiple", "count": 10}, {"letter": "Psychotropic Drugs", "count": 4}, {"letter": "public health medicine (field)", "count": 2}, {"letter": "Publications", "count": 18}, {"letter": "Publishing", "count": 16}, {"letter": "Puerto Rico", "count": 1}, {"letter": "Pulmonary Diffusing Capacity", "count": 1}, {"letter": "Pulmonary Edema", "count": 2}, {"letter": "Pulmonary Embolism", "count": 2}, {"letter": "Pulmonary Fibrosis", "count": 2}, {"letter": "Pulse taking", "count": 1}, {"letter": "Oximetry, Pulse", "count": 1}, {"letter": "Paracentesis", "count": 3}, {"letter": "Puncture procedure", "count": 3}, {"letter": "Purines", "count": 1}, {"letter": "Purpura", "count": 1}, {"letter": "Pus", "count": 1}, {"letter": "pyridoxine", "count": 2}, {"letter": "pyrimethamine", "count": 16}, {"letter": "Pyruvate Kinase", "count": 1}, {"letter": "Pyruvates", "count": 1}, {"letter": "Qualitative Evaluation", "count": 11}, {"letter": "quality control", "count": 2}, {"letter": "Quality of Health Care", "count": 8}, {"letter": "Quality of life", "count": 829}, {"letter": "Quantitative Evaluation", "count": 10}, {"letter": "Questionnaire Design", "count": 2}, {"letter": "Questionnaires", "count": 2012}, {"letter": "R Factors", "count": 1}, {"letter": "Racial Groups", "count": 1}, {"letter": "Radar", "count": 2}, {"letter": "Structure of radial nerve", "count": 3}, {"letter": "Electromagnetic Radiation", "count": 4}, {"letter": "Effects of radiation", "count": 16}, {"letter": "aspects of radiation effects", "count": 3}, {"letter": "Radiation injury", "count": 1}, {"letter": "Radiation Syndrome", "count": 1}, {"letter": "Radiation Tolerance", "count": 3}, {"letter": "Ionizing radiation", "count": 1}, {"letter": "Radiation, Nonionizing", "count": 1}, {"letter": "Radio communications", "count": 7}, {"letter": "Radio Waves", "count": 2}, {"letter": "Radioactivity", "count": 41}, {"letter": "Radiation-Induced Dermatitis", "count": 47}, {"letter": "roentgenographic", "count": 6}, {"letter": "Radioimmunoassay", "count": 15}, {"letter": "Radioisotopes", "count": 6}, {"letter": "Radiology Specialty", "count": 15}, {"letter": "Radiometry", "count": 45}, {"letter": "Radionuclide Imaging", "count": 60}, {"letter": "radiotherapeutic", "count": 103}, {"letter": "Bone structure of radius", "count": 1}, {"letter": "Rage", "count": 1}, {"letter": "Rales", "count": 1}, {"letter": "Randomization", "count": 1272}, {"letter": "rapid eye movement", "count": 1}, {"letter": "ras Oncogene", "count": 2}, {"letter": "Rats, Inbred WF", "count": 2}, {"letter": "Rattus", "count": 1}, {"letter": "Reaction Time", "count": 208}, {"letter": "Reading (activity)", "count": 84}, {"letter": "Reagents", "count": 1}, {"letter": "Mental Recall", "count": 119}, {"letter": "Recanalization", "count": 1}, {"letter": "Receiver Operating Characteristic", "count": 37}, {"letter": "Androgen Receptor", "count": 3}, {"letter": "Receptors, Antigen", "count": 1}, {"letter": "Receptors, Antigen, B-Cell", "count": 2}, {"letter": "T-Cell Receptor", "count": 13}, {"letter": "Receptors, Cell Surface", "count": 1}, {"letter": "Opioid Receptor", "count": 1}, {"letter": "Epidermal Growth Factor Receptor", "count": 1}, {"letter": "Estrogen Receptors", "count": 37}, {"letter": "Fc Receptor", "count": 9}, {"letter": "Histamine Receptor", "count": 1}, {"letter": "Receptors, Immunologic", "count": 1}, {"letter": "Insulin Receptor", "count": 1}, {"letter": "Interleukin 2 Receptor", "count": 1}, {"letter": "Receptors, Progesterone", "count": 32}, {"letter": "Receptors, Steroid", "count": 5}, {"letter": "Recommendation", "count": 368}, {"letter": "Records", "count": 784}, {"letter": "Postoperative anesthesia care unit (PACU)", "count": 29}, {"letter": "recreational activity", "count": 4}, {"letter": "Recurrence", "count": 337}, {"letter": "Reference Standards", "count": 8}, {"letter": "Patient referral", "count": 52}, {"letter": "Registries", "count": 25}, {"letter": "Regression Analysis", "count": 15}, {"letter": "Rehabilitation therapy", "count": 6}, {"letter": "Rehabilitation aspects", "count": 5}, {"letter": "Rehydration", "count": 3}, {"letter": "Psychological reinforcement", "count": 1}, {"letter": "Relapse", "count": 32}, {"letter": "Relative Value Scales", "count": 1}, {"letter": "Relaxation", "count": 14}, {"letter": "Relaxation Techniques", "count": 5}, {"letter": "Reliability and Validity", "count": 7}, {"letter": "Repeat Surgery", "count": 19}, {"letter": "Cumulative Trauma Disorders", "count": 1}, {"letter": "Surgical Replantation", "count": 1}, {"letter": "Repression, Psychology", "count": 2}, {"letter": "Reproduction", "count": 14}, {"letter": "research", "count": 18}, {"letter": "Research Design", "count": 19}, {"letter": "Research Institutes", "count": 4}, {"letter": "Research Personnel", "count": 1137}, {"letter": "Residual volume", "count": 2}, {"letter": "resorts", "count": 1}, {"letter": "Resources", "count": 63}, {"letter": "Respiration", "count": 13}, {"letter": "Respiratory Distress Syndrome, Adult", "count": 1}, {"letter": "Respiratory System", "count": 2}, {"letter": "Respiratory physiology", "count": 2}, {"letter": "Rest", "count": 89}, {"letter": "Restaurants", "count": 1}, {"letter": "Resuscitation procedure", "count": 1}, {"letter": "Reticulocytes", "count": 1}, {"letter": "Retinoblastoma", "count": 4}, {"letter": "Retinol Binding Proteins", "count": 1}, {"letter": "Retirement", "count": 1}, {"letter": "Retrospective Studies", "count": 12}, {"letter": "Rewards", "count": 2}, {"letter": "Rhabdomyosarcoma", "count": 1}, {"letter": "Rheumatoid Factor", "count": 1}, {"letter": "Rhode Island", "count": 3}, {"letter": "Rib Fractures", "count": 6}, {"letter": "ribose", "count": 1}, {"letter": "Ribosomes", "count": 1}, {"letter": "Bone structure of rib", "count": 7}, {"letter": "Risk", "count": 301}, {"letter": "risk factors", "count": 24}, {"letter": "Risk Management", "count": 5}, {"letter": "RNA", "count": 48}, {"letter": "RNA, Double-Stranded", "count": 1}, {"letter": "RNA, Messenger", "count": 35}, {"letter": "RNA, Neoplasm", "count": 6}, {"letter": "RNA, Ribosomal, 16S", "count": 3}, {"letter": "Robotics", "count": 7}, {"letter": "ROC Curve", "count": 16}, {"letter": "Social Role", "count": 138}, {"letter": "Rotation", "count": 8}, {"letter": "Ribosomal RNA Genes", "count": 3}, {"letter": "Rubber", "count": 1}, {"letter": "Running (physical activity)", "count": 7}, {"letter": "Russian language", "count": 1}, {"letter": "Rwanda", "count": 2}, {"letter": "Safety", "count": 29}, {"letter": "Wages", "count": 1}, {"letter": "Sales - occupational activity", "count": 3}, {"letter": "Saline Solution", "count": 1}, {"letter": "saliva", "count": 11}, {"letter": "Salpingo-oophorectomy", "count": 3}, {"letter": "San Francisco", "count": 3}, {"letter": "San Marino", "count": 1}, {"letter": "Malignant neoplasm musculoskeletal", "count": 1}, {"letter": "Financial savings", "count": 5}, {"letter": "Scalp structure", "count": 4}, {"letter": "Bone structure of scapula", "count": 4}, {"letter": "School", "count": 2}, {"letter": "Schools, Medical", "count": 1}, {"letter": "Science", "count": 19}, {"letter": "Sclerosis", "count": 4}, {"letter": "Scoring Methods", "count": 9}, {"letter": "Sea", "count": 8}, {"letter": "Seasons", "count": 1}, {"letter": "Sebum", "count": 2}, {"letter": "Second Opinion", "count": 1}, {"letter": "Metastatic to", "count": 205}, {"letter": "Schools, Secondary", "count": 1}, {"letter": "Process of secretion", "count": 6}, {"letter": "Bodily secretions", "count": 1}, {"letter": "Plant seeds", "count": 4}, {"letter": "Seizures", "count": 20}, {"letter": "Self", "count": 139}, {"letter": "Self Administration", "count": 3}, {"letter": "Self-Assessment", "count": 50}, {"letter": "Self-care interventions", "count": 86}, {"letter": "Self Concept", "count": 1}, {"letter": "Self Determination", "count": 6}, {"letter": "Self Disclosure", "count": 3}, {"letter": "Self Esteem", "count": 15}, {"letter": "Self Medication", "count": 2}, {"letter": "Self-Evaluation Programs", "count": 1}, {"letter": "Support Groups", "count": 7}, {"letter": "Semantics", "count": 4}, {"letter": "Esthesia", "count": 29}, {"letter": "Statistical sensitivity", "count": 104}, {"letter": "Sensitivity and Specificity", "count": 71}, {"letter": "Sensitivity Training Groups", "count": 5}, {"letter": "Diastasis", "count": 5}, {"letter": "Study of serum", "count": 3}, {"letter": "serotonin", "count": 1}, {"letter": "Serum Albumin", "count": 7}, {"letter": "serum albumin, bovine", "count": 1}, {"letter": "Serum alkaline phosphatase measurement", "count": 7}, {"letter": "Serum Calcium Level", "count": 5}, {"letter": "SERUM CHLORIDE ION TESTS", "count": 3}, {"letter": "Serum Phosphate Test", "count": 4}, {"letter": "Serum Proteins", "count": 6}, {"letter": "Serum Alanine Transaminase tests", "count": 1}, {"letter": "Set (Psychology)", "count": 1}, {"letter": "Sex Behavior", "count": 92}, {"letter": "Sex Hormone-Binding Globulin", "count": 1}, {"letter": "Gonadal Steroid Hormones", "count": 9}, {"letter": "Sexual Partners", "count": 2}, {"letter": "Sexuality", "count": 7}, {"letter": "Sexually Transmitted Diseases", "count": 25}, {"letter": "Shame", "count": 1}, {"letter": "Ships", "count": 2}, {"letter": "Shock", "count": 1}, {"letter": "Shoes", "count": 7}, {"letter": "Shotguns", "count": 2}, {"letter": "Shoulder", "count": 176}, {"letter": "Joint structure of shoulder region", "count": 3}, {"letter": "Shoulder Pain", "count": 17}, {"letter": "Sigmoidoscopy (procedure)", "count": 1}, {"letter": "Signal Pathways", "count": 1}, {"letter": "Signal Processing, Computer-Assisted", "count": 1}, {"letter": "Signal Transduction", "count": 8}, {"letter": "Signs and Symptoms", "count": 11}, {"letter": "silicones", "count": 1}, {"letter": "Silver", "count": 1}, {"letter": "silymarin", "count": 1}, {"letter": "Simple cyst", "count": 1}, {"letter": "Singapore", "count": 1}, {"letter": "Unmarried person", "count": 56}, {"letter": "situational stress", "count": 1}, {"letter": "Skeletal system", "count": 32}, {"letter": "skilled nursing facility", "count": 2}, {"letter": "Integumentary system", "count": 2}, {"letter": "Skin Abnormalities", "count": 1}, {"letter": "Dermatologic disorders", "count": 18}, {"letter": "Skin Diseases, Infectious", "count": 4}, {"letter": "Skin lesion", "count": 6}, {"letter": "Skin Neoplasms", "count": 1}, {"letter": "Skin nodule", "count": 2}, {"letter": "Skin Pigmentation", "count": 2}, {"letter": "Skin Temperature", "count": 4}, {"letter": "Hypersensitivity skin testing", "count": 3}, {"letter": "Skin Transplantation", "count": 2}, {"letter": "Skin Ulcer", "count": 2}, {"letter": "Skinfold Thickness", "count": 1}, {"letter": "Bone structure of cranium", "count": 15}, {"letter": "Sleep", "count": 147}, {"letter": "Sleep disturbances", "count": 36}, {"letter": "Sleep, REM", "count": 3}, {"letter": "Smell Perception", "count": 4}, {"letter": "Smoking", "count": 6}, {"letter": "Snails", "count": 1}, {"letter": "Social Adjustment", "count": 54}, {"letter": "Social Behavior", "count": 1}, {"letter": "Social Change", "count": 18}, {"letter": "Social Characteristics", "count": 1}, {"letter": "Social Conditions", "count": 1}, {"letter": "Social Environment", "count": 2}, {"letter": "Social Interaction", "count": 3}, {"letter": "Social isolation", "count": 9}, {"letter": "Social Justice", "count": 1}, {"letter": "Social Perception", "count": 1}, {"letter": "Social Sciences", "count": 2}, {"letter": "Social Security Program", "count": 1}, {"letter": "Social support", "count": 25}, {"letter": "Social Values", "count": 1}, {"letter": "Social Work (discipline)", "count": 3}, {"letter": "social worker", "count": 1}, {"letter": "Societies", "count": 27}, {"letter": "Societies, Nursing", "count": 2}, {"letter": "Socioeconomic Factors", "count": 1}, {"letter": "sodium", "count": 17}, {"letter": "sodium chloride", "count": 3}, {"letter": "sodium iodide", "count": 1}, {"letter": "sodium tetradecyl sulfate", "count": 1}, {"letter": "Computer software", "count": 74}, {"letter": "Solubility", "count": 1}, {"letter": "Solutions", "count": 2}, {"letter": "Solvents", "count": 2}, {"letter": "Somalia", "count": 62}, {"letter": "Somatoform Disorder", "count": 1}, {"letter": "Somatomedins", "count": 8}, {"letter": "Somatosensory Cortex", "count": 3}, {"letter": "Somatotype", "count": 1}, {"letter": "Sound - physical agent", "count": 9}, {"letter": "South Carolina", "count": 1}, {"letter": "Soybeans", "count": 2}, {"letter": "Spanish Language", "count": 25}, {"letter": "Spasm", "count": 1}, {"letter": "Spatial Distribution", "count": 38}, {"letter": "Specialization", "count": 1}, {"letter": "Medical Specialities", "count": 3}, {"letter": "Specificity", "count": 88}, {"letter": "Specimen processing (procedure)", "count": 7}, {"letter": "Spectrophotometry", "count": 4}, {"letter": "Spectrum Analysis", "count": 2}, {"letter": "Mass Spectrometry", "count": 14}, {"letter": "Spectrum Analysis, Raman", "count": 3}, {"letter": "Speech", "count": 3}, {"letter": "Spices", "count": 1}, {"letter": "Spinal Cord", "count": 2}, {"letter": "Compression of spinal cord", "count": 17}, {"letter": "Spinal Cord Injuries", "count": 1}, {"letter": "Spinal Cord Neoplasms", "count": 2}, {"letter": "Spinal nerve structure", "count": 1}, {"letter": "Vertebral column", "count": 9}, {"letter": "Spirometry", "count": 1}, {"letter": "Spleen", "count": 1}, {"letter": "Splenic Rupture", "count": 2}, {"letter": "Splenomegaly", "count": 1}, {"letter": "Splint Device", "count": 1}, {"letter": "Spondylitis", "count": 2}, {"letter": "Sports", "count": 5}, {"letter": "sports medicine specialty", "count": 5}, {"letter": "Stainless Steel", "count": 1}, {"letter": "Stains", "count": 10}, {"letter": "Standardization", "count": 3}, {"letter": "standards characteristics", "count": 14}, {"letter": "Dihydrotestosterone", "count": 1}, {"letter": "Staphylococcal Protein A", "count": 7}, {"letter": "Reflex, Startle", "count": 1}, {"letter": "Statistical Study", "count": 2}, {"letter": "Science of Statistics", "count": 382}, {"letter": "Steel", "count": 1}, {"letter": "Stem cells", "count": 8}, {"letter": "Stereotyped Behavior", "count": 1}, {"letter": "Stereotypic Movement Disorder", "count": 1}, {"letter": "Sternum", "count": 4}, {"letter": "Steroids", "count": 25}, {"letter": "Stigmatization", "count": 1}, {"letter": "Sting Injury", "count": 1}, {"letter": "Compression Stockings", "count": 1}, {"letter": "Stomach", "count": 20}, {"letter": "Gastric Content", "count": 4}, {"letter": "Stomatitis", "count": 9}, {"letter": "Stress", "count": 57}, {"letter": "Post-Traumatic Stress Disorder", "count": 12}, {"letter": "Stress, Psychological", "count": 2}, {"letter": "stressful events", "count": 1}, {"letter": "Area striata structure", "count": 20}, {"letter": "Cerebrovascular accident", "count": 3}, {"letter": "Stroke Volume", "count": 3}, {"letter": "student", "count": 4}, {"letter": "Submersion", "count": 1}, {"letter": "Substance Abuse Detection", "count": 9}, {"letter": "Substance P", "count": 2}, {"letter": "Suction drainage", "count": 1}, {"letter": "Suction Lipectomy", "count": 3}, {"letter": "therapeutic suggestion", "count": 10}, {"letter": "Sulfates, Inorganic", "count": 2}, {"letter": "Sulfhydryl Compounds", "count": 2}, {"letter": "sulfur dioxide", "count": 2}, {"letter": "Supine Position", "count": 60}, {"letter": "Manufactured Supplies", "count": 1}, {"letter": "Structure of sural nerve", "count": 3}, {"letter": "Surgery specialty", "count": 22}, {"letter": "Surgical aspects", "count": 58}, {"letter": "Endocrine Surgical Procedures", "count": 2}, {"letter": "Minor Surgical Procedures", "count": 1}, {"letter": "Surgical Clips", "count": 1}, {"letter": "Surgical Flaps", "count": 26}, {"letter": "Surgical Wound Dehiscence", "count": 3}, {"letter": "Surgical Wound Infection", "count": 24}, {"letter": "Suriname", "count": 2}, {"letter": "Surveys", "count": 390}, {"letter": "Continuance of life", "count": 401}, {"letter": "Survival Analysis", "count": 19}, {"letter": "Survival Rate", "count": 72}, {"letter": "Suspensions", "count": 6}, {"letter": "Surgical sutures", "count": 2}, {"letter": "Sweating", "count": 11}, {"letter": "Sweden", "count": 5}, {"letter": "Swelling", "count": 8}, {"letter": "Swimming", "count": 1}, {"letter": "Switzerland", "count": 2}, {"letter": "Syncope", "count": 22}, {"letter": "Syndrome", "count": 17}, {"letter": "Synovial Membrane", "count": 1}, {"letter": "Syria", "count": 1}, {"letter": "Syringes", "count": 3}, {"letter": "Systems Analysis", "count": 5}, {"letter": "Systole", "count": 37}, {"letter": "T-Lymphocyte", "count": 87}, {"letter": "Cytotoxic T-Lymphocytes", "count": 12}, {"letter": "Regulatory T-Lymphocytes", "count": 19}, {"letter": "CD4 Positive T Lymphocytes", "count": 5}, {"letter": "Table - furniture", "count": 53}, {"letter": "Tablet Dosage Form", "count": 31}, {"letter": "Tachycardia", "count": 8}, {"letter": "Tail", "count": 19}, {"letter": "Taiwan", "count": 3}, {"letter": "tamoxifen", "count": 105}, {"letter": "Target Population", "count": 15}, {"letter": "Task Performance", "count": 13}, {"letter": "Taste Perception", "count": 3}, {"letter": "Taste Disorders", "count": 1}, {"letter": "Tattooing", "count": 4}, {"letter": "Tea", "count": 1}, {"letter": "Educational process of instructing", "count": 19}, {"letter": "Teaching Materials", "count": 8}, {"letter": "Technetium", "count": 5}, {"letter": "technetium Tc-99m sulfur colloid", "count": 1}, {"letter": "Technology", "count": 57}, {"letter": "Technology Assessment", "count": 2}, {"letter": "Telangiectasis", "count": 14}, {"letter": "Telephone", "count": 28}, {"letter": "Television", "count": 2}, {"letter": "tellurium", "count": 3}, {"letter": "Temperament", "count": 1}, {"letter": "Temperature", "count": 26}, {"letter": "Thermosensing", "count": 2}, {"letter": "Tendon structure", "count": 2}, {"letter": "Tennessee", "count": 1}, {"letter": "Tennis (activity)", "count": 2}, {"letter": "Terminally Ill", "count": 1}, {"letter": "testosterone", "count": 16}, {"letter": "Tetradecanoylphorbol Acetate", "count": 1}, {"letter": "dronabinol", "count": 1}, {"letter": "Tetrahydrouridine", "count": 1}, {"letter": "Tetrameres", "count": 3}, {"letter": "Textbooks", "count": 1}, {"letter": "Textiles", "count": 2}, {"letter": "Thai language", "count": 1}, {"letter": "Therapeutic Equivalency", "count": 9}, {"letter": "therapeutic use - qualifier", "count": 1}, {"letter": "therapeutic aspects", "count": 365}, {"letter": "Thermal Conductivity", "count": 1}, {"letter": "thermography", "count": 5}, {"letter": "Thermometer, device", "count": 7}, {"letter": "Theses", "count": 34}, {"letter": "Thigh structure", "count": 12}, {"letter": "Thinking, function", "count": 60}, {"letter": "Thioethers", "count": 6}, {"letter": "Plain chest X-ray", "count": 7}, {"letter": "threonine", "count": 1}, {"letter": "thrombin", "count": 1}, {"letter": "Thrombocythemia, Essential", "count": 224}, {"letter": "Thrombocytopenia", "count": 47}, {"letter": "Thromboembolism", "count": 3}, {"letter": "Thrombolytic Therapy", "count": 1}, {"letter": "Thromboplastin", "count": 1}, {"letter": "Thumb structure", "count": 3}, {"letter": "thymidine", "count": 1}, {"letter": "Thymidine Kinase", "count": 2}, {"letter": "Thymus Gland", "count": 2}, {"letter": "Thyroid Diseases", "count": 1}, {"letter": "Thyroid Function Tests", "count": 1}, {"letter": "Thyroid Gland", "count": 8}, {"letter": "Thyroid Hormones", "count": 1}, {"letter": "Thyroidectomy", "count": 3}, {"letter": "thyrotropin", "count": 1}, {"letter": "Bone structure of tibia", "count": 3}, {"letter": "Ticks", "count": 1}, {"letter": "Tidal Volume", "count": 2}, {"letter": "Time", "count": 3494}, {"letter": "Time Factors", "count": 2}, {"letter": "Time Perception", "count": 1}, {"letter": "Time Studies", "count": 65}, {"letter": "tin", "count": 4}, {"letter": "Tinnitus", "count": 1}, {"letter": "Tissue Banks", "count": 8}, {"letter": "Tissue culture", "count": 1}, {"letter": "Drug or chemical Tissue Distribution", "count": 3}, {"letter": "Tissue Donors", "count": 5}, {"letter": "Tissue Expansion Devices", "count": 17}, {"letter": "Tissue Expansion", "count": 5}, {"letter": "Tissue Survival", "count": 1}, {"letter": "Body tissue", "count": 98}, {"letter": "titanium", "count": 1}, {"letter": "Encounter due to tobacco use", "count": 2}, {"letter": "Toes", "count": 6}, {"letter": "Toilet Facilities", "count": 1}, {"letter": "Tokyo", "count": 7}, {"letter": "tomography", "count": 3}, {"letter": "Tomography, Emission-Computed", "count": 46}, {"letter": "Tomography, Emission-Computed, Single-Photon", "count": 15}, {"letter": "X-Ray Computed Tomography", "count": 96}, {"letter": "Tongue", "count": 2}, {"letter": "Tonometry", "count": 2}, {"letter": "Tooth structure", "count": 2}, {"letter": "Impacted tooth", "count": 4}, {"letter": "Toothbrushing", "count": 1}, {"letter": "Musculoskeletal torsion, function", "count": 6}, {"letter": "Tosylarginine Methyl Ester", "count": 1}, {"letter": "Toxicity aspects", "count": 491}, {"letter": "Toxicology", "count": 11}, {"letter": "Track (course)", "count": 44}, {"letter": "Trail Making Test", "count": 20}, {"letter": "Training Programs", "count": 16}, {"letter": "tramadol", "count": 5}, {"letter": "Tranquilizing Agents", "count": 3}, {"letter": "Anti-Anxiety Agents", "count": 2}, {"letter": "Transcription, Genetic", "count": 24}, {"letter": "Transcutaneous Electric Nerve Stimulation", "count": 1}, {"letter": "Transducers", "count": 5}, {"letter": "Transferrin", "count": 2}, {"letter": "cell transformation", "count": 18}, {"letter": "Transforming Growth Factor alpha", "count": 1}, {"letter": "Transforming Growth Factor beta", "count": 6}, {"letter": "Transforming Growth Factors", "count": 2}, {"letter": "Translating", "count": 23}, {"letter": "disease transmission qualifier", "count": 4}, {"letter": "Transplantation", "count": 4}, {"letter": "transplantation aspects", "count": 6}, {"letter": "Transportation", "count": 5}, {"letter": "travel", "count": 2}, {"letter": "Treatment Protocols", "count": 244}, {"letter": "Refusal of Treatment", "count": 2}, {"letter": "Trees (plant)", "count": 1}, {"letter": "trends qualifier", "count": 8}, {"letter": "tretinoin", "count": 5}, {"letter": "Triage", "count": 1}, {"letter": "Triglycerides", "count": 28}, {"letter": "liothyronine", "count": 2}, {"letter": "Trinidad and Tobago", "count": 2}, {"letter": "Tritium", "count": 1}, {"letter": "troleandomycin", "count": 1}, {"letter": "Troponin", "count": 21}, {"letter": "Salpingectomy", "count": 1}, {"letter": "Tuberculin Test", "count": 1}, {"letter": "Tubulin", "count": 6}, {"letter": "Tumeric", "count": 1}, {"letter": "Tumor Antigens", "count": 6}, {"letter": "Tumor Markers", "count": 38}, {"letter": "Biomarkers, Tumor", "count": 27}, {"letter": "Tumor Necrosis Factors", "count": 8}, {"letter": "Turbidimetry", "count": 3}, {"letter": "Twin sibling (person)", "count": 1}, {"letter": "Tympanic membrane structure", "count": 2}, {"letter": "collagen type I", "count": 7}, {"letter": "Procollagen Type I", "count": 3}, {"letter": "ubidecarenone", "count": 2}, {"letter": "Ulcer", "count": 9}, {"letter": "Ultrasonography", "count": 61}, {"letter": "Ultrasonic Shockwave", "count": 5}, {"letter": "Ultraviolet Rays", "count": 2}, {"letter": "Umbilicus (Anatomy)", "count": 2}, {"letter": "Underweight", "count": 5}, {"letter": "Unemployment", "count": 42}, {"letter": "United Kingdom", "count": 5}, {"letter": "United Nations", "count": 3}, {"letter": "United States", "count": 33}, {"letter": "United States Food and Drug Administration", "count": 11}, {"letter": "Universities", "count": 19}, {"letter": "Adverse reaction to drug", "count": 33}, {"letter": "Erythema", "count": 40}, {"letter": "Up-Regulation (Physiology)", "count": 2}, {"letter": "Upper Respiratory Infections", "count": 1}, {"letter": "uracil", "count": 2}, {"letter": "urea", "count": 4}, {"letter": "Urethra", "count": 2}, {"letter": "uric acid", "count": 7}, {"letter": "uridine", "count": 1}, {"letter": "Urinalysis", "count": 29}, {"letter": "Urinary Incontinence", "count": 2}, {"letter": "Urinary tract", "count": 12}, {"letter": "Urination", "count": 8}, {"letter": "Urine", "count": 54}, {"letter": "In Urine", "count": 3}, {"letter": "Urine pH measurement", "count": 1}, {"letter": "Genitourinary system", "count": 6}, {"letter": "urokinase", "count": 5}, {"letter": "Urticaria", "count": 1}, {"letter": "Use-Effectiveness", "count": 2}, {"letter": "Utah", "count": 3}, {"letter": "Uterus", "count": 8}, {"letter": "E-Cadherin", "count": 2}, {"letter": "Vaccination", "count": 31}, {"letter": "Vaccine Therapy", "count": 2}, {"letter": "Vaccines", "count": 47}, {"letter": "vaccinia virus", "count": 7}, {"letter": "Vacuum (physical force)", "count": 6}, {"letter": "Aspirator", "count": 1}, {"letter": "Vagina", "count": 33}, {"letter": "Pruritus of vagina", "count": 26}, {"letter": "Vaginal Tablet", "count": 2}, {"letter": "Vagus nerve structure", "count": 1}, {"letter": "Validity of Results", "count": 1}, {"letter": "valine", "count": 1}, {"letter": "valproic acid", "count": 1}, {"letter": "Values", "count": 611}, {"letter": "Vanuatu", "count": 1}, {"letter": "Variation (Genetics)", "count": 18}, {"letter": "Varicosity", "count": 1}, {"letter": "Vascularization", "count": 7}, {"letter": "Vasculitis", "count": 7}, {"letter": "Vasoconstrictor Agents", "count": 1}, {"letter": "Vasodilator Agents", "count": 1}, {"letter": "Vegetables", "count": 6}, {"letter": "Drug vehicle", "count": 4}, {"letter": "Veins", "count": 5}, {"letter": "Vendors", "count": 1}, {"letter": "Venezuela", "count": 19}, {"letter": "Venous Engorgement", "count": 1}, {"letter": "Venous Insufficiency", "count": 1}, {"letter": "Venous Thrombosis", "count": 2}, {"letter": "Ventricular Ejection Fraction", "count": 2}, {"letter": "Ventricular Fibrillation", "count": 1}, {"letter": "Verbal Learning", "count": 16}, {"letter": "Vesicular Exanthema of Swine", "count": 3}, {"letter": "Vestibule", "count": 1}, {"letter": "Veterans", "count": 1}, {"letter": "Video Recording", "count": 1}, {"letter": "videocassette", "count": 14}, {"letter": "Vietnamese language", "count": 1}, {"letter": "Viremia", "count": 1}, {"letter": "United States Virgin Islands", "count": 2}, {"letter": "Virtues", "count": 1}, {"letter": "Virus Replication", "count": 1}, {"letter": "Virus", "count": 8}, {"letter": "Viscera", "count": 1}, {"letter": "Viscosity", "count": 2}, {"letter": "Vision", "count": 96}, {"letter": "Visual Acuity", "count": 2}, {"letter": "Manufactured Visual Aid", "count": 2}, {"letter": "Visual Analog Pain Scale", "count": 295}, {"letter": "Visual Perception", "count": 1}, {"letter": "Vital capacity", "count": 2}, {"letter": "vitamin D", "count": 15}, {"letter": "Vitamin D Deficiency", "count": 4}, {"letter": "vitamin E", "count": 6}, {"letter": "Vocabulary", "count": 4}, {"letter": "Vocabulary Tests", "count": 3}, {"letter": "Voice", "count": 4}, {"letter": "Volition", "count": 12}, {"letter": "Voluntary Workers", "count": 3}, {"letter": "Vomiting", "count": 13}, {"letter": "Vomitus", "count": 9}, {"letter": "von Willebrand factor", "count": 2}, {"letter": "Vulva", "count": 11}, {"letter": "vulvovaginal", "count": 4}, {"letter": "Waiting Lists (patient)", "count": 16}, {"letter": "Wake Island", "count": 7}, {"letter": "Wakefulness", "count": 14}, {"letter": "Washington state", "count": 2}, {"letter": "water", "count": 46}, {"letter": "Weather", "count": 1}, {"letter": "Weight Gain", "count": 2}, {"letter": "Weight", "count": 49}, {"letter": "Weights and Measures", "count": 9}, {"letter": "Wellness Programs", "count": 7}, {"letter": "Welsh population", "count": 1}, {"letter": "wheelchair", "count": 2}, {"letter": "Whole-Body Irradiation", "count": 1}, {"letter": "Wisconsin", "count": 4}, {"letter": "Wiskott-Aldrich Syndrome", "count": 8}, {"letter": "Wit", "count": 1}, {"letter": "Wolman Disease", "count": 2}, {"letter": "Woman", "count": 562}, {"letter": "Women's Status", "count": 1}, {"letter": "Word Association Tests", "count": 1}, {"letter": "Work", "count": 173}, {"letter": "World Health", "count": 1}, {"letter": "World Health Organization", "count": 35}, {"letter": "Wound Healing", "count": 20}, {"letter": "Wound Infection", "count": 15}, {"letter": "Injury wounds", "count": 28}, {"letter": "Wounds and Injuries", "count": 8}, {"letter": "Wrist", "count": 34}, {"letter": "Writing (occupation or discipline)", "count": 4}, {"letter": "Diagnostic radiologic examination", "count": 31}, {"letter": "X-Ray Diffraction", "count": 2}, {"letter": "X-Ray Film", "count": 2}, {"letter": "Roentgen Rays", "count": 3}, {"letter": "Xenobiotics", "count": 1}, {"letter": "Xerostomia", "count": 10}, {"letter": "Yeasts", "count": 2}, {"letter": "Yoga (philosophy)", "count": 21}, {"letter": "Zambia", "count": 1}, {"letter": "zinc", "count": 1}, {"letter": "pamidronate", "count": 2}, {"letter": "1,4,7-triazacyclononane-N,N',N''-triacetic acid", "count": 3}, {"letter": "1-dodecylpyridoxal", "count": 3}, {"letter": "1-Phosphatidylinositol 3-Kinase", "count": 12}, {"letter": "15-Hydroxyprostaglandin dehydrogenase (NAD+)", "count": 1}, {"letter": "gemcitabine", "count": 30}, {"letter": "2,3-bis(3'-hydroxybenzyl)butyrolactone", "count": 1}, {"letter": "2,5-dichloro-4-bromophenol", "count": 3}, {"letter": "2-(4-toluidino)-6-naphthalenesulfonic acid", "count": 1}, {"letter": "fluorodeoxyglucose F18", "count": 58}, {"letter": "4,17 beta-dihydroxy-4-androstene-3-one", "count": 1}, {"letter": "4-(4-(bis(2-chloroethyl)amino)phenyl)-1-hydroxybutane-1,1-bisphosphonic acid", "count": 1}, {"letter": "4-amino-4'-hydroxylaminodiphenylsulfone", "count": 16}, {"letter": "4-hydroxy-N-desmethyltamoxifen", "count": 26}, {"letter": "4-maleimido-2,2,6,6-tetramethylpiperidinooxyl", "count": 25}, {"letter": "doxifluridine", "count": 7}, {"letter": "decitabine", "count": 7}, {"letter": "5-fluoro-2'-deoxycytidine", "count": 1}, {"letter": "mirtazapine", "count": 1}, {"letter": "prostaglandin M", "count": 2}, {"letter": "8-Hydroxy-2'-Deoxyguanosine", "count": 2}, {"letter": "Conjugated Linoleic Acid", "count": 7}, {"letter": "A 17", "count": 1}, {"letter": "A(2)C", "count": 2}, {"letter": "A-factor (Streptomyces)", "count": 6}, {"letter": "cyclophosphamide/doxorubicin protocol", "count": 8}, {"letter": "acetohydroxamic acid", "count": 3}, {"letter": "adriamycinol", "count": 1}, {"letter": "amlodipine", "count": 4}, {"letter": "amsonic acid", "count": 3}, {"letter": "antibiotic K 4", "count": 1}, {"letter": "antineoplaston A10", "count": 138}, {"letter": "artesunate", "count": 54}, {"letter": "AS 6", "count": 2}, {"letter": "doxorubicin/mitomycin/vinblastine protocol", "count": 1}, {"letter": "BCD protocol", "count": 6}, {"letter": "N,N-bis(2-hydroxyethyl)aminoethanesulfonic acid", "count": 2}, {"letter": "bisphenol A", "count": 4}, {"letter": "nesiritide", "count": 11}, {"letter": "CAC protocol", "count": 1}, {"letter": "cyclophosphamide/doxorubicin/fluorouracil protocol", "count": 1}, {"letter": "Ryanodine Receptor Calcium Release Channel", "count": 1}, {"letter": "carbene", "count": 1}, {"letter": "carvedilol", "count": 1}, {"letter": "catechol", "count": 1}, {"letter": "Chromogranin A", "count": 1}, {"letter": "citric acid", "count": 1}, {"letter": "Clostridium perfringens epsilon-toxin", "count": 2}, {"letter": "cordycepin", "count": 1}, {"letter": "creatinol phosphate", "count": 12}, {"letter": "CT protocol", "count": 1}, {"letter": "cyclobenzaprine", "count": 1}, {"letter": "cytidylyl-3'-5'-guanosine", "count": 1}, {"letter": "D-Alanine Transaminase", "count": 29}, {"letter": "Deoxyhemoglobin", "count": 1}, {"letter": "deoxypyridinoline", "count": 1}, {"letter": "deoxyuridine triphosphate", "count": 1}, {"letter": "1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride", "count": 1}, {"letter": "desethylchloroquine", "count": 1}, {"letter": "diacetoxyscirpenol", "count": 10}, {"letter": "dibenzo(1,4)dioxin", "count": 1}, {"letter": "icosapent ethyl", "count": 1}, {"letter": "Focal Adhesion Kinase 1", "count": 1}, {"letter": "annexin A5", "count": 2}, {"letter": "Staphylococcal Enterotoxin E", "count": 5}, {"letter": "epigallocatechin gallate", "count": 3}, {"letter": "estrone sulfate", "count": 3}, {"letter": "Estrone sulfotransferase", "count": 1}, {"letter": "FEC protocol", "count": 6}, {"letter": "Fenretinide", "count": 1}, {"letter": "fiberglass", "count": 1}, {"letter": "finasteride", "count": 2}, {"letter": "furan", "count": 1}, {"letter": "gabapentin", "count": 1}, {"letter": "genistein", "count": 3}, {"letter": "gluconolactone", "count": 1}, {"letter": "ondansetron", "count": 4}, {"letter": "HAC protocol", "count": 4}, {"letter": "hemorrhagic proteinase IV", "count": 5}, {"letter": "HS 3", "count": 1}, {"letter": "PPY protein, human", "count": 15}, {"letter": "Hydroxymethylglutaryl coenzyme A reductase", "count": 2}, {"letter": "Intercellular adhesion molecule 1", "count": 1}, {"letter": "Receptors, Interleukin-1", "count": 2}, {"letter": "Interleukin 6 Receptor", "count": 1}, {"letter": "iso-sulfan blue", "count": 3}, {"letter": "itraconazole", "count": 4}, {"letter": "Lignans", "count": 2}, {"letter": "lipid-associated sialic acid", "count": 3}, {"letter": "lipomodulin", "count": 1}, {"letter": "lycopene", "count": 1}, {"letter": "calcipotriene", "count": 1}, {"letter": "megestrol acetate", "count": 3}, {"letter": "microbial alkaline proteinase inhibitor", "count": 3}, {"letter": "ML 9", "count": 1}, {"letter": "lysophosphatidic acid", "count": 1}, {"letter": "morin", "count": 2}, {"letter": "mullerian-inhibiting hormone", "count": 1}, {"letter": "mutalipocin II", "count": 1}, {"letter": "N,N'-bis(1-adamantyl)ethylenediamine", "count": 2}, {"letter": "N-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide", "count": 6}, {"letter": "N-(4-carboxyphenyl)retinamide", "count": 1}, {"letter": "N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide", "count": 1}, {"letter": "NOAC protocol", "count": 11}, {"letter": "O Antigens", "count": 3}, {"letter": "omega-N-Methylarginine", "count": 7}, {"letter": "erbB-2 Receptor", "count": 62}, {"letter": "ORALIT", "count": 1}, {"letter": "oxaliplatin", "count": 9}, {"letter": "oxybutynin", "count": 13}, {"letter": "oxytocin, 1-desamino-(O-Et-Tyr)(2)-", "count": 5}, {"letter": "paroxetine", "count": 8}, {"letter": "phthalate 4,5-dioxygenase", "count": 3}, {"letter": "IGFBP1 protein, human", "count": 3}, {"letter": "Pneumovax", "count": 1}, {"letter": "poly ICLC", "count": 1}, {"letter": "poly(lactide)", "count": 1}, {"letter": "Cystatin C (substance)", "count": 2}, {"letter": "Procollagen type I carboxy terminal peptide", "count": 1}, {"letter": "procollagen Type I N-terminal peptide", "count": 5}, {"letter": "Proliferating Cell Nuclear Antigen", "count": 1}, {"letter": "Promega", "count": 1}, {"letter": "promestriene", "count": 10}, {"letter": "prostaglandin E3", "count": 1}, {"letter": "protein S", "count": 2}, {"letter": "prothrombin fragment 1.2", "count": 1}, {"letter": "ERBB3 Receptor Protein-Tyrosine Kinase", "count": 1}, {"letter": "Proto-Oncogene Protein c-kit", "count": 1}, {"letter": "bleomycin/cisplatin/vinblastine protocol", "count": 5}, {"letter": "Pycnogenol", "count": 1}, {"letter": "pyridinoline", "count": 1}, {"letter": "pyruvic acid", "count": 10}, {"letter": "sirolimus", "count": 11}, {"letter": "rebeccamycin", "count": 1}, {"letter": "Blood group antigen D", "count": 21}, {"letter": "Rhodamine 123", "count": 1}, {"letter": "Ribosomal Protein S6", "count": 2}, {"letter": "Ribosomal Protein S6 Kinase", "count": 2}, {"letter": "RID", "count": 3}, {"letter": "rifaximin", "count": 2}, {"letter": "riluzole", "count": 1}, {"letter": "ropivacaine", "count": 1}, {"letter": "ketorolac", "count": 1}, {"letter": "salicylhydroxamic acid", "count": 11}, {"letter": "secoisolariciresinol", "count": 2}, {"letter": "simvastatin", "count": 5}, {"letter": "Insulin-Like Growth-Factor-Binding Proteins", "count": 1}, {"letter": "SR-AT", "count": 1}, {"letter": "Stathmin", "count": 2}, {"letter": "TANDEM (Brand Name)", "count": 4}, {"letter": "technetium Tc 99m diphosphonate", "count": 1}, {"letter": "temozolomide", "count": 14}, {"letter": "Thomsen-Friedenreich antibodies", "count": 5}, {"letter": "thymus-leukemia antigens", "count": 1}, {"letter": "tibolone", "count": 2}, {"letter": "Tn antigen", "count": 5}, {"letter": "Tolerogen", "count": 1}, {"letter": "toxin V", "count": 2}, {"letter": "transcription factor USF", "count": 1}, {"letter": "triciribine phosphate", "count": 1}, {"letter": "trimix", "count": 3}, {"letter": "triptorelin", "count": 2}, {"letter": "Troponin I", "count": 10}, {"letter": "Troponin T", "count": 2}, {"letter": "Tumor Necrosis Factor Receptor", "count": 3}, {"letter": "ubiquinone Q2", "count": 2}, {"letter": "urapidil", "count": 1}, {"letter": "Vascular Cell Adhesion Molecule-1", "count": 5}, {"letter": "vascular factor", "count": 1}, {"letter": "Vascular Endothelial Growth Factor A", "count": 2}, {"letter": "vinorelbine", "count": 25}, {"letter": "cisplatin/etoposide protocol", "count": 1}, {"letter": "W 12 (Calmodulin Antagonist)", "count": 3}, {"letter": "W7 (Calmodulin Antagonist)", "count": 3}, {"letter": "Patient-Controlled Analgesia", "count": 5}, {"letter": "Asians", "count": 1}, {"letter": "Bankruptcy", "count": 1}, {"letter": "Intraoperative Hemorrhage", "count": 2}, {"letter": "carboplatin", "count": 74}, {"letter": "Pap smear", "count": 13}, {"letter": "Medical Records, Computerized", "count": 1}, {"letter": "Conscious Sedation", "count": 2}, {"letter": "Cosmetic surgery specialty", "count": 1}, {"letter": "County", "count": 3}, {"letter": "Cranial Irradiation", "count": 1}, {"letter": "cytokine", "count": 124}, {"letter": "Dilution technique", "count": 2}, {"letter": "DNA Fingerprinting", "count": 1}, {"letter": "Euglycemic Clamp", "count": 2}, {"letter": "Acoustic Evoked Brain Stem Potentials", "count": 4}, {"letter": "fibroblast growth factor-1", "count": 1}, {"letter": "Fluorescence-Activated Cell Sorting", "count": 8}, {"letter": "friend", "count": 9}, {"letter": "Gender", "count": 46}, {"letter": "Generations", "count": 13}, {"letter": "Tumor Suppressor Genes", "count": 1}, {"letter": "Genes, vif", "count": 7}, {"letter": "Granulocyte Colony-Stimulating Factor", "count": 49}, {"letter": "Granulocyte-Macrophage Colony-Stimulating Factor", "count": 8}, {"letter": "HRAS gene", "count": 1}, {"letter": "Homing Receptors, T-Cell", "count": 1}, {"letter": "tamoxifen citrate", "count": 5}, {"letter": "Imaging Techniques", "count": 159}, {"letter": "Immunofluorescence assay", "count": 37}, {"letter": "Immunophenotyping", "count": 10}, {"letter": "Adoptive Immunotherapy", "count": 3}, {"letter": "interleukin-8", "count": 6}, {"letter": "Lymphocyte Immunophenotyping", "count": 1}, {"letter": "Lymphocyte Subset", "count": 4}, {"letter": "Lymphocytes, Tumor-Infiltrating", "count": 15}, {"letter": "B-Cell Lymphomas", "count": 1}, {"letter": "Macrophage Colony-Stimulating Factor", "count": 1}, {"letter": "Measures", "count": 393}, {"letter": "Medicare Part B", "count": 1}, {"letter": "Moon", "count": 7}, {"letter": "Mutagenesis Process", "count": 1}, {"letter": "Mutagenesis, Insertional", "count": 1}, {"letter": "Mutagenesis, Site-Directed", "count": 1}, {"letter": "Nerve Transfer", "count": 1}, {"letter": "NF-kappa B", "count": 7}, {"letter": "Open Reading Frames", "count": 1}, {"letter": "National origin", "count": 2}, {"letter": "Passive Range of Motion function", "count": 1}, {"letter": "Pleural Effusion, Malignant", "count": 1}, {"letter": "Post Technique", "count": 2}, {"letter": "Prices", "count": 1}, {"letter": "Privacy", "count": 2}, {"letter": "Protein p53", "count": 1}, {"letter": "Quality-Adjusted Life Years", "count": 26}, {"letter": "Range of Motion, Articular", "count": 24}, {"letter": "Reading Frames (Nucleotide Sequence)", "count": 1}, {"letter": "Regret", "count": 14}, {"letter": "Relative (related person)", "count": 40}, {"letter": "Research Subject", "count": 1}, {"letter": "Retinoblastoma Protein", "count": 7}, {"letter": "S Phase", "count": 2}, {"letter": "Self-Examination", "count": 1}, {"letter": "Special Events", "count": 2}, {"letter": "Spinal Fractures", "count": 2}, {"letter": "Muscle strain", "count": 1}, {"letter": "T-Lymphocyte Subsets", "count": 8}, {"letter": "TGFB1 protein, human", "count": 3}, {"letter": "Training Techniques", "count": 1}, {"letter": "Ultrasonography, Mammary", "count": 30}, {"letter": "Left Ventricular Function", "count": 7}, {"letter": "Ventricular Function, Right", "count": 3}, {"letter": "Walking (activity)", "count": 109}, {"letter": "Women's Health", "count": 3}, {"letter": "Microbial Biofilms", "count": 6}, {"letter": "poliovirus receptor", "count": 1}, {"letter": "trestolone", "count": 1}, {"letter": "Mammaplasty", "count": 82}, {"letter": "Fungemia", "count": 2}, {"letter": "Ovarian Hyperstimulation Syndrome", "count": 1}, {"letter": "Morphologic artifacts", "count": 13}, {"letter": "Peripheral Vascular Diseases", "count": 1}, {"letter": "Drug Delivery Systems", "count": 28}, {"letter": "Breast Self-Examination", "count": 2}, {"letter": "SCID Mice", "count": 1}, {"letter": "Workload", "count": 4}, {"letter": "Cessation of smoking", "count": 5}, {"letter": "Central Nervous System Neoplasms", "count": 4}, {"letter": "Ergometry", "count": 3}, {"letter": "tacrolimus", "count": 1}, {"letter": "Generic Drugs", "count": 38}, {"letter": "Bacterial Vaginosis", "count": 1}, {"letter": "Anticarcinogenic Agents", "count": 1}, {"letter": "Needlestick Injuries", "count": 1}, {"letter": "Neoplasms, Second Primary", "count": 37}, {"letter": "telomere", "count": 1}, {"letter": "Cryoultramicrotomy", "count": 4}, {"letter": "Esophagectomy", "count": 1}, {"letter": "Radiosurgery", "count": 5}, {"letter": "Gestational Diabetes", "count": 1}, {"letter": "Ovarian Failure, Premature", "count": 3}, {"letter": "Mice, Inbred NOD", "count": 1}, {"letter": "Tissue Fixation", "count": 1}, {"letter": "Bone remodeling", "count": 11}, {"letter": "leuprolide", "count": 1}, {"letter": "Addictive Behavior", "count": 4}, {"letter": "Meridians", "count": 2}, {"letter": "interleukin-10", "count": 36}, {"letter": "Sudden Cardiac Death", "count": 1}, {"letter": "Human Platelet Antigens", "count": 1}, {"letter": "CD8 Antigens", "count": 1}, {"letter": "muromonab-CD3", "count": 4}, {"letter": "Oxidants", "count": 1}, {"letter": "Salvage Therapy", "count": 2}, {"letter": "Anisotropy", "count": 8}, {"letter": "United States Department of Agriculture", "count": 1}, {"letter": "Treatment outcome", "count": 42}, {"letter": "Drug Monitoring", "count": 1}, {"letter": "Professional Autonomy", "count": 1}, {"letter": "Reminder Systems", "count": 1}, {"letter": "Chemotherapy, Adjuvant", "count": 60}, {"letter": "Caregiver", "count": 26}, {"letter": "pravastatin", "count": 2}, {"letter": "Cost Savings", "count": 2}, {"letter": "Health Care Costs", "count": 17}, {"letter": "Hospice Care", "count": 5}, {"letter": "Outcome Assessment, Health Care", "count": 28}, {"letter": "Process Assessment, Health Care", "count": 3}, {"letter": "catheter device", "count": 5}, {"letter": "Chills", "count": 6}, {"letter": "Ventricular arrhythmia", "count": 1}, {"letter": "Orthopnea", "count": 2}, {"letter": "Burning sensation", "count": 12}, {"letter": "Agitation", "count": 6}, {"letter": "Mood swings", "count": 7}, {"letter": "Falls", "count": 35}, {"letter": "Peripheral edema", "count": 3}, {"letter": "Onycholysis", "count": 3}, {"letter": "Secondary carcinoma", "count": 1}, {"letter": "Hypophosphatemia", "count": 3}, {"letter": "Ability", "count": 248}, {"letter": "Administrators", "count": 1}, {"letter": "Adriamycin", "count": 2}, {"letter": "African American", "count": 9}, {"letter": "Biological Aging", "count": 1}, {"letter": "Analysis, Factor", "count": 9}, {"letter": "Androgen Binding Protein", "count": 3}, {"letter": "Arbitrating", "count": 1}, {"letter": "Artificial Ventricle", "count": 3}, {"letter": "aspartate", "count": 5}, {"letter": "Independence", "count": 43}, {"letter": "Case management (procedure)", "count": 1}, {"letter": "Case Study", "count": 21}, {"letter": "Cell Line, Tumor", "count": 1}, {"letter": "Cephalopelvic Disproportion", "count": 3}, {"letter": "Pan Genus", "count": 7}, {"letter": "Cloning Vectors", "count": 3}, {"letter": "Analysis, Cohort", "count": 11}, {"letter": "Color Vision", "count": 15}, {"letter": "Competence", "count": 10}, {"letter": "Mental concentration", "count": 127}, {"letter": "Conferences", "count": 3}, {"letter": "Decision Aids", "count": 26}, {"letter": "Depressive Symptoms", "count": 85}, {"letter": "Device Failure", "count": 1}, {"letter": "Safety of devices", "count": 2}, {"letter": "Diagnostic tests", "count": 10}, {"letter": "Dietary Habits", "count": 3}, {"letter": "Dietary Modification", "count": 13}, {"letter": "Dissociation", "count": 3}, {"letter": "Divorced state", "count": 1}, {"letter": "Emotional Stress", "count": 2}, {"letter": "Enzyme Immunoassay", "count": 5}, {"letter": "science of ergonomics", "count": 2}, {"letter": "Red Blood Cell Transfusion", "count": 2}, {"letter": "Family Caregivers", "count": 5}, {"letter": "Family Demography", "count": 1}, {"letter": "Family member", "count": 13}, {"letter": "Females", "count": 36}, {"letter": "Forests", "count": 2}, {"letter": "Futility", "count": 5}, {"letter": "Immune response gene", "count": 2}, {"letter": "Grains", "count": 1}, {"letter": "Halsted Mastectomy", "count": 2}, {"letter": "Health Benefits", "count": 1}, {"letter": "Health Care", "count": 37}, {"letter": "Medical Care Team", "count": 5}, {"letter": "hepatology (field)", "count": 1}, {"letter": "Hispanics", "count": 7}, {"letter": "Homo sapiens", "count": 56}, {"letter": "Hypokinesia", "count": 1}, {"letter": "Latinos", "count": 1}, {"letter": "Leisure", "count": 14}, {"letter": "TAP-144", "count": 1}, {"letter": "Liver Dysfunction", "count": 4}, {"letter": "Lymphoid Cells", "count": 1}, {"letter": "Males", "count": 4}, {"letter": "Managed Care", "count": 1}, {"letter": "Surrogate Markers", "count": 22}, {"letter": "Mediate", "count": 7}, {"letter": "MYC gene", "count": 3}, {"letter": "Benign Neoplasm", "count": 2}, {"letter": "Normal Range", "count": 34}, {"letter": "Change, Organizational", "count": 2}, {"letter": "Outcomes Research", "count": 2}, {"letter": "Health Services, Outpatient", "count": 1}, {"letter": "Paired Comparisons", "count": 1}, {"letter": "Genus Panax", "count": 1}, {"letter": "Personal Communication", "count": 1}, {"letter": "Photons", "count": 2}, {"letter": "Platelet Transfusion", "count": 12}, {"letter": "Structure of posterior tibial artery", "count": 1}, {"letter": "Process Measures", "count": 8}, {"letter": "Programmed Learning", "count": 6}, {"letter": "Promoter", "count": 3}, {"letter": "Repetitive Region", "count": 1}, {"letter": "Ethics Committees, Research", "count": 3}, {"letter": "Research Methodology", "count": 4}, {"letter": "Risk Assessment", "count": 13}, {"letter": "Risk Behavior", "count": 1}, {"letter": "Schedule (document type)", "count": 83}, {"letter": "Selection for Treatment", "count": 18}, {"letter": "Self-Management", "count": 18}, {"letter": "Signal Transduction Pathways", "count": 6}, {"letter": "Socioeconomic Status", "count": 9}, {"letter": "Hospital specialist", "count": 2}, {"letter": "Spouse Caregivers", "count": 1}, {"letter": "Step Test", "count": 5}, {"letter": "Stereophotogrammetry", "count": 3}, {"letter": "Synapsin I", "count": 1}, {"letter": "Telomerase", "count": 2}, {"letter": "Thrombus", "count": 1}, {"letter": "Tissue Banking", "count": 1}, {"letter": "Treadmill Test", "count": 15}, {"letter": "Therapeutic procedure", "count": 3106}, {"letter": "Treatment Costs", "count": 13}, {"letter": "Treatment Effectiveness", "count": 62}, {"letter": "Uncertainty", "count": 36}, {"letter": "Uninsured", "count": 1}, {"letter": "Unmarried", "count": 113}, {"letter": "vitamin B6", "count": 1}, {"letter": "levocarnitine", "count": 5}, {"letter": "Vocations", "count": 1}, {"letter": "4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one", "count": 2}, {"letter": "receptor for advanced glycation endproducts", "count": 1}, {"letter": "alendronate", "count": 5}, {"letter": "AS 2", "count": 3}, {"letter": "AT 17", "count": 1}, {"letter": "Proto-Oncogene Proteins B-raf", "count": 1}, {"letter": "Inhibin-beta Subunits", "count": 1}, {"letter": "Calnexin", "count": 1}, {"letter": "CD14 Antigen", "count": 2}, {"letter": "TFRC protein, human", "count": 1}, {"letter": "CDK2 protein, human", "count": 1}, {"letter": "Cyclin E", "count": 2}, {"letter": "cystatin SN", "count": 1}, {"letter": "dexmedetomidine", "count": 2}, {"letter": "Dimesna", "count": 3}, {"letter": "Euthyroid (finding)", "count": 2}, {"letter": "GA-Binding Protein Transcription Factor", "count": 1}, {"letter": "goserelin", "count": 11}, {"letter": "human pancreatic eicosapeptide", "count": 14}, {"letter": "Insulin-Like Growth-Factor Binding Protein 1", "count": 4}, {"letter": "Insulin-Like Growth Factor Binding Protein 2", "count": 1}, {"letter": "Receptors, IgG", "count": 2}, {"letter": "India ink stain", "count": 3}, {"letter": "insulin receptor substrate 1 protein", "count": 1}, {"letter": "Insulin-Like Growth Factor Binding Protein 3", "count": 15}, {"letter": "interleukin-12", "count": 5}, {"letter": "irinotecan", "count": 5}, {"letter": "Isothiocyanate", "count": 1}, {"letter": "microtubule associated protein 4", "count": 1}, {"letter": "Interstitial Collagenase", "count": 3}, {"letter": "Mediator brand of benfluorex hydrochloride", "count": 21}, {"letter": "ML 7", "count": 2}, {"letter": "Navelbine", "count": 2}, {"letter": "Nitric Oxide Synthase", "count": 1}, {"letter": "fatty acids, omega-6", "count": 2}, {"letter": "PDCD1 protein, human", "count": 5}, {"letter": "phthalates", "count": 2}, {"letter": "pre-HbA1c", "count": 1}, {"letter": "pro-gastrin", "count": 16}, {"letter": "Prohibit", "count": 3}, {"letter": "Prostate-Specific Antigen", "count": 14}, {"letter": "Receptors, Opioid, delta", "count": 20}, {"letter": "Serial C", "count": 1}, {"letter": "PI3 protein, human", "count": 2}, {"letter": "SN 38", "count": 9}, {"letter": "Sodium Butyrate", "count": 1}, {"letter": "spasmolytic A29", "count": 4}, {"letter": "Stem Cell Factor", "count": 1}, {"letter": "sufentanil", "count": 3}, {"letter": "paclitaxel", "count": 297}, {"letter": "tetraethylpyrazine", "count": 2}, {"letter": "topotecan", "count": 1}, {"letter": "TP53 protein, human", "count": 27}, {"letter": "Thrombospondin 1", "count": 1}, {"letter": "Vascular Endothelial Growth Factor Receptor", "count": 2}, {"letter": "Zoladex", "count": 6}, {"letter": "Skin structure of breast", "count": 12}, {"letter": "Dehiscence", "count": 6}, {"letter": "HIGH DOSE CHEMOTHEARPY", "count": 2}, {"letter": "Left Ventricular Hypertrophy", "count": 2}, {"letter": "neurological pain", "count": 1}, {"letter": "nipple discharge", "count": 4}, {"letter": "prescription refill", "count": 1}, {"letter": "Somatization", "count": 3}, {"letter": "biological adaptation to stress", "count": 10}, {"letter": "Deep Vein Thrombosis", "count": 2}, {"letter": "Humoral hypercalcemia of malignancy (disorder)", "count": 6}, {"letter": "Small cell carcinoma of lung", "count": 3}, {"letter": "Feeling hopeless", "count": 9}, {"letter": "Chronic pain", "count": 25}, {"letter": "Disturbed sensory perception", "count": 11}, {"letter": "Broken skin", "count": 6}, {"letter": "Spiritual distress", "count": 1}, {"letter": "Convenience Sampling", "count": 1}, {"letter": "DIAGNOSTIC STANDARD", "count": 5}, {"letter": "Cross-Over Studies", "count": 37}, {"letter": "Data Set", "count": 11}, {"letter": "Economic Evaluation", "count": 8}, {"letter": "likelihood ratio", "count": 4}, {"letter": "MATCHING", "count": 10}, {"letter": "Random Sampling", "count": 1}, {"letter": "Blinded", "count": 91}, {"letter": "CRITERION STANDARD", "count": 17}, {"letter": "gold standard", "count": 41}, {"letter": "psychological masking", "count": 1}, {"letter": "unaware", "count": 5}, {"letter": "Activity care", "count": 2}, {"letter": "Alleviating anxiety", "count": 13}, {"letter": "Bathing", "count": 2}, {"letter": "Decision making encouragement", "count": 3}, {"letter": "Ambulation therapy", "count": 1}, {"letter": "Range of motion exercise", "count": 37}, {"letter": "Fall prevention", "count": 1}, {"letter": "Family support (regime/therapy)", "count": 1}, {"letter": "Treatment of fever", "count": 1}, {"letter": "Medication Management", "count": 104}, {"letter": "meditation", "count": 4}, {"letter": "Present", "count": 729}, {"letter": "Preventive monitoring", "count": 36}, {"letter": "Surveillance: safety", "count": 1}, {"letter": "Group education", "count": 4}, {"letter": "Taking vital signs", "count": 43}, {"letter": "Application of bandage (procedure)", "count": 2}, {"letter": "Cardiac monitoring", "count": 1}, {"letter": "Caring", "count": 2}, {"letter": "educational programs", "count": 1}, {"letter": "game", "count": 2}, {"letter": "Sets goals", "count": 3}, {"letter": "Advice", "count": 8}, {"letter": "assessment.initial", "count": 61}, {"letter": "Preventing injury", "count": 1}, {"letter": "Instrumental activities of daily living (assessment scale)", "count": 25}, {"letter": "intradermal", "count": 1}, {"letter": "Perioperative Care", "count": 1}, {"letter": "Shelter facility", "count": 2}, {"letter": "Skin Care", "count": 3}, {"letter": "Social Networks", "count": 3}, {"letter": "Stress management", "count": 5}, {"letter": "Patient Holding Stretchers", "count": 1}, {"letter": "Toileting activity", "count": 1}, {"letter": "Biopsy of skin procedure", "count": 3}, {"letter": "patient is male", "count": 1}, {"letter": "patient is female", "count": 9}, {"letter": "head and scalp", "count": 1}, {"letter": "Sensory neuropathy", "count": 11}, {"letter": "laboratory: chemistry", "count": 6}, {"letter": "Serum calcium, mg%", "count": 1}, {"letter": "Hormone level abnormal", "count": 1}, {"letter": "Premature Birth", "count": 13}, {"letter": "Electrolytes abnormal", "count": 2}, {"letter": "Myocardial fibrosis", "count": 3}, {"letter": "Growth retardation", "count": 1}, {"letter": "Hypermagnesemia", "count": 2}, {"letter": "Hypomagnesemia", "count": 4}, {"letter": "Injection Site Reaction", "count": 3}, {"letter": "Myocardial Ischemia", "count": 1}, {"letter": "Abnormal renal function", "count": 1}, {"letter": "Liver function tests abnormal finding", "count": 2}, {"letter": "Cutaneous Melanoma", "count": 1}, {"letter": "Muscle Weakness", "count": 1}, {"letter": "Skin necrosis", "count": 28}, {"letter": "Bone pain", "count": 2}, {"letter": "Injection site pain", "count": 1}, {"letter": "Prolonged QT interval", "count": 3}, {"letter": "Alanine Aminotransferase Increased", "count": 1}, {"letter": "Discoloration of skin", "count": 3}, {"letter": "Dry skin", "count": 1}, {"letter": "White blood cell abnormality", "count": 1}, {"letter": "Polyneuropathy", "count": 3}, {"letter": "Sensory Disorders", "count": 2}, {"letter": "Skin irritation", "count": 2}, {"letter": "Chinese (ethnic group)", "count": 3}, {"letter": "Immunology", "count": 18}, {"letter": "Therapeutic tactile stimulation", "count": 14}, {"letter": "Transection (procedure)", "count": 7}, {"letter": "Drug withdrawal syndrome", "count": 2}, {"letter": "Fatty degeneration", "count": 3}, {"letter": "Incision and drainage", "count": 2}, {"letter": "Malignant tumor of peritoneum", "count": 3}, {"letter": "Uterine Cancer", "count": 3}, {"letter": "Malignant neoplasm of brain", "count": 1}, {"letter": "Secondary malignant neoplasm of skin", "count": 1}, {"letter": "Secondary malignant neoplasm of bone", "count": 34}, {"letter": "Stage 0 Breast Carcinoma", "count": 15}, {"letter": "Disorder of endocrine ovary", "count": 1}, {"letter": "Rumination Disorders", "count": 5}, {"letter": "Acute myocardial infarction", "count": 1}, {"letter": "Acute pericarditis", "count": 1}, {"letter": "Excessive attrition of teeth", "count": 8}, {"letter": "Fibrosclerosis of breast", "count": 9}, {"letter": "Fat necrosis of breast", "count": 4}, {"letter": "Uterine Polyp", "count": 1}, {"letter": "Irregular Menstruation", "count": 1}, {"letter": "Postmenopausal atrophic vaginitis", "count": 3}, {"letter": "Congenital anomaly of lung", "count": 1}, {"letter": "General symptom", "count": 3}, {"letter": "Injury of liver", "count": 2}, {"letter": "Late effect of radiation", "count": 3}, {"letter": "Nerve injury", "count": 4}, {"letter": "Central nervous system complication", "count": 1}, {"letter": "Operation on ovary", "count": 1}, {"letter": "Joint stiffness", "count": 4}, {"letter": "DNA Sequence", "count": 23}, {"letter": "RNA Sequence", "count": 6}, {"letter": "Hexosaminidase A", "count": 1}, {"letter": "Cell Density", "count": 1}, {"letter": "Comprehension", "count": 91}, {"letter": "anthropological customs", "count": 4}, {"letter": "Interstitial Fluid", "count": 6}, {"letter": "Umbilical Cord Blood", "count": 1}, {"letter": "Killing", "count": 5}, {"letter": "Differential white blood cell count procedure", "count": 1}, {"letter": "spouse", "count": 5}, {"letter": "Intention - mental process", "count": 35}, {"letter": "Malnutrition", "count": 8}, {"letter": "Journal", "count": 6}, {"letter": "Advisory Committees", "count": 6}, {"letter": "Social Impact", "count": 1}, {"letter": "Doppler Ultrasound (procedure)", "count": 3}, {"letter": "Surrogate Endpoints", "count": 1}, {"letter": "Markers, Immunologic", "count": 37}, {"letter": "Serum Markers", "count": 57}, {"letter": "Transcriptional Activation", "count": 1}, {"letter": "Exercise Tolerance", "count": 3}, {"letter": "Chemiluminescence", "count": 1}, {"letter": "Prion Diseases", "count": 1}, {"letter": "Bioelectrical Impedance", "count": 15}, {"letter": "electric impedance", "count": 33}, {"letter": "Glycation End Products, Advanced", "count": 2}, {"letter": "Workplace", "count": 4}, {"letter": "Public Domain", "count": 1}, {"letter": "Stromal Cells", "count": 3}, {"letter": "Photoplethysmography", "count": 2}, {"letter": "Titration Method", "count": 2}, {"letter": "Viral Shedding", "count": 2}, {"letter": "Apoptosis", "count": 23}, {"letter": "treatment failure", "count": 5}, {"letter": "Telemedicine", "count": 5}, {"letter": "technetium Tc 99m sestamibi", "count": 1}, {"letter": "Friction", "count": 1}, {"letter": "Cost of Illness", "count": 11}, {"letter": "Polysomnography", "count": 10}, {"letter": "Pain Threshold", "count": 22}, {"letter": "Echo-Planar Imaging", "count": 6}, {"letter": "Fusion protein", "count": 2}, {"letter": "Reactive Oxygen Species", "count": 1}, {"letter": "Thiobarbituric Acid Reactive Substances", "count": 1}, {"letter": "In Situ Hybridization", "count": 7}, {"letter": "Fluorescent in Situ Hybridization", "count": 7}, {"letter": "Guidelines", "count": 138}, {"letter": "Sequence Analysis", "count": 15}, {"letter": "CD45RO Antigens", "count": 2}, {"letter": "Structure of radial artery", "count": 3}, {"letter": "Structure of ulnar artery", "count": 3}, {"letter": "Common carotid artery", "count": 2}, {"letter": "Tunica Media", "count": 1}, {"letter": "sulforafan", "count": 5}, {"letter": "Fibrin split products", "count": 2}, {"letter": "A 7", "count": 18}, {"letter": "Relate - vinyl resin", "count": 44}, {"letter": "Matrix Metalloproteinase 3", "count": 1}, {"letter": "Proto-Oncogene Proteins c-akt", "count": 12}, {"letter": "Matrix Metalloproteinase 9", "count": 2}, {"letter": "pro-concanavalin A", "count": 2}, {"letter": "BaseLine dental cement", "count": 19}, {"letter": "Mitogen-Activated Protein Kinase Kinases", "count": 1}, {"letter": "DDIT3 protein, human", "count": 1}, {"letter": "Brachyury protein", "count": 4}, {"letter": "olanzapine", "count": 6}, {"letter": "Matrix Metalloproteinase 2", "count": 2}, {"letter": "27-hydroxycholesterol", "count": 1}, {"letter": "Matrix Metalloproteinase 11", "count": 1}, {"letter": "Cyclin D1", "count": 2}, {"letter": "anterior cingulate gyrus", "count": 1}, {"letter": "Posterior Cingulate Cortex", "count": 1}, {"letter": "Nucleus solitarius", "count": 1}, {"letter": "Open", "count": 42}, {"letter": "Burning sensation quality", "count": 2}, {"letter": "Circulating", "count": 119}, {"letter": "Imagery", "count": 8}, {"letter": "Act of Documentation", "count": 26}, {"letter": "Health evaluation", "count": 15}, {"letter": "Mats", "count": 5}, {"letter": "Prosthesis", "count": 1}, {"letter": "Secondary to", "count": 177}, {"letter": "Transvaginal approach", "count": 2}, {"letter": "Manual", "count": 49}, {"letter": "Standards of Weights and Measures", "count": 2}, {"letter": "ultrasonography aspects", "count": 10}, {"letter": "Medical pins", "count": 5}, {"letter": "Caliper, device (physical object)", "count": 14}, {"letter": "Clamp (device)", "count": 2}, {"letter": "Clip", "count": 33}, {"letter": "Bands", "count": 5}, {"letter": "Stimulator", "count": 4}, {"letter": "biomedical tube device", "count": 15}, {"letter": "Scissors (device)", "count": 2}, {"letter": "Freezer", "count": 1}, {"letter": "Telephone consultation", "count": 12}, {"letter": "Oral Medication", "count": 2}, {"letter": "Natural History", "count": 1}, {"letter": "Cardiologists", "count": 7}, {"letter": "Day care center (for any age)", "count": 1}, {"letter": "Protoplasm", "count": 1}, {"letter": "Other CT scan", "count": 1}, {"letter": "Magnetic Resonance Imaging (MRI) of Spine", "count": 2}, {"letter": "Bone Mineral Density Test", "count": 30}, {"letter": "Rotational test", "count": 1}, {"letter": "Complications of pregnancy, childbirth and the puerperium", "count": 1}, {"letter": "signs and symptoms of ill-defined conditions", "count": 2}, {"letter": "Vascular System Injuries", "count": 4}, {"letter": "breast implant procedure", "count": 3}, {"letter": "Raised prostate specific antigen", "count": 1}, {"letter": "Fibroadenoma of breast", "count": 7}, {"letter": "Jewish, follower of religion", "count": 1}, {"letter": "Avoidance Behavior", "count": 1}, {"letter": "Base", "count": 22}, {"letter": "body density", "count": 2}, {"letter": "career", "count": 1}, {"letter": "Cellular", "count": 22}, {"letter": "communication behavior", "count": 2}, {"letter": "concept", "count": 39}, {"letter": "court", "count": 1}, {"letter": "Cross link", "count": 3}, {"letter": "density", "count": 86}, {"letter": "Dosage", "count": 1375}, {"letter": "evaluation/testing", "count": 6}, {"letter": "food resource", "count": 1}, {"letter": "Gene Fusion", "count": 2}, {"letter": "Gene Dosage", "count": 1}, {"letter": "glucose tolerance", "count": 2}, {"letter": "Health administration", "count": 1}, {"letter": "Histogenic Process", "count": 1}, {"letter": "Homovanillate", "count": 1}, {"letter": "human study", "count": 2}, {"letter": "Image Processing", "count": 13}, {"letter": "Intracellular", "count": 5}, {"letter": "method development", "count": 2}, {"letter": "Tumor Stage Classification", "count": 1}, {"letter": "Organ", "count": 74}, {"letter": "Perinatal period", "count": 1}, {"letter": "Reactive Hyperemia", "count": 1}, {"letter": "Rural Area", "count": 2}, {"letter": "suburb", "count": 1}, {"letter": "Thermometry", "count": 2}, {"letter": "Tumor Progression", "count": 580}, {"letter": "Incident Reporting", "count": 1}, {"letter": "Quality monitoring", "count": 1}, {"letter": "Blood specimen", "count": 334}, {"letter": "Care plan", "count": 4}, {"letter": "quality assurance", "count": 1}, {"letter": "Accelerometer", "count": 41}, {"letter": "Analyzer, device", "count": 14}, {"letter": "Applicator - device", "count": 1}, {"letter": "Balance, device", "count": 4}, {"letter": "Basin", "count": 2}, {"letter": "Binder, device", "count": 1}, {"letter": "Analyzers, Physiologic, Body Composition", "count": 2}, {"letter": "Bottle, device", "count": 4}, {"letter": "Box", "count": 9}, {"letter": "Breast Prosthesis, Internal", "count": 5}, {"letter": "Brush device", "count": 1}, {"letter": "CALIBRATOR", "count": 1}, {"letter": "Camera, device", "count": 5}, {"letter": "Cart, device", "count": 8}, {"letter": "Peripherally inserted central catheter (physical object)", "count": 9}, {"letter": "Chamber (physical object)", "count": 9}, {"letter": "Cold pack (medical device)", "count": 1}, {"letter": "Compresses (device)", "count": 3}, {"letter": "Containers", "count": 5}, {"letter": "Gamma counter", "count": 3}, {"letter": "Covers (device)", "count": 11}, {"letter": "Blood pressure cuff", "count": 3}, {"letter": "Cup Device", "count": 2}, {"letter": "Dilator", "count": 1}, {"letter": "Distractors", "count": 1}, {"letter": "Doppler device", "count": 1}, {"letter": "Drain device", "count": 29}, {"letter": "Wound drain", "count": 2}, {"letter": "Dynamometer", "count": 60}, {"letter": "Electrocardiographic monitoring", "count": 2}, {"letter": "Ergometers", "count": 6}, {"letter": "Exerciser", "count": 11}, {"letter": "Explorers", "count": 1}, {"letter": "file device", "count": 2}, {"letter": "Filter Papers", "count": 2}, {"letter": "Filters", "count": 3}, {"letter": "Fluoroscopes", "count": 1}, {"letter": "Frame (physical object)", "count": 10}, {"letter": "Goniometers", "count": 35}, {"letter": "Catheter guide wire, device", "count": 1}, {"letter": "Professional guide", "count": 44}, {"letter": "Hematocytometers", "count": 1}, {"letter": "Halo brace", "count": 6}, {"letter": "Intravenous analgesia unit", "count": 2}, {"letter": "Injector", "count": 4}, {"letter": "Labels (device)", "count": 6}, {"letter": "Light source", "count": 5}, {"letter": "LINER device", "count": 1}, {"letter": "Bone marker", "count": 32}, {"letter": "Analyzers, Physiologic, Metabolic Rate, Oxygen/Carbon Dioxide Based", "count": 2}, {"letter": "Microscopes", "count": 2}, {"letter": "Monitor Device", "count": 34}, {"letter": "Mounts", "count": 1}, {"letter": "Aspiration needles", "count": 1}, {"letter": "Pulse oximeter", "count": 2}, {"letter": "Pads", "count": 2}, {"letter": "Perforator", "count": 7}, {"letter": "Pillow", "count": 1}, {"letter": "Pneumotachograph", "count": 1}, {"letter": "Positron emission tomography unit", "count": 1}, {"letter": "Pressure monitor", "count": 1}, {"letter": "Probes", "count": 8}, {"letter": "pump (device)", "count": 15}, {"letter": "Punches, Biopsy (device)", "count": 1}, {"letter": "Radiopharmaceuticals", "count": 2}, {"letter": "Physiologic monitoring recorder", "count": 2}, {"letter": "Chart recorder", "count": 1}, {"letter": "Regulators (device)", "count": 5}, {"letter": "Rotators", "count": 1}, {"letter": "Scanning Systems", "count": 14}, {"letter": "Echocardiographs", "count": 2}, {"letter": "sensor (device)", "count": 31}, {"letter": "Separators", "count": 3}, {"letter": "Bed sheets", "count": 1}, {"letter": "Shield", "count": 1}, {"letter": "Sleeve", "count": 2}, {"letter": "Spectrometers", "count": 1}, {"letter": "Spectrophotometers", "count": 3}, {"letter": "Sphygmomanometers", "count": 12}, {"letter": "Spirometer (device)", "count": 2}, {"letter": "Contraceptive Sponge - device", "count": 1}, {"letter": "Stethoscopes", "count": 1}, {"letter": "Stool seat", "count": 3}, {"letter": "Strap device", "count": 12}, {"letter": "Support, device", "count": 50}, {"letter": "Swab specimen", "count": 2}, {"letter": "Biomedical tape", "count": 9}, {"letter": "Tester device", "count": 5}, {"letter": "Tissue Markers", "count": 22}, {"letter": "Tray - device", "count": 3}, {"letter": "Microplates", "count": 2}, {"letter": "Treadmill, device", "count": 5}, {"letter": "Tubes, Blood Collection", "count": 23}, {"letter": "Tubing", "count": 2}, {"letter": "Vial device", "count": 2}, {"letter": "Vibrator, device", "count": 2}, {"letter": "Lesion Localization Wires", "count": 1}, {"letter": "Activity Component", "count": 1}, {"letter": "Improved", "count": 35}, {"letter": "Stabilized (qualifier value)", "count": 3}, {"letter": "Dying Process", "count": 33}, {"letter": "Acute onset pain", "count": 13}, {"letter": "Nursing status report", "count": 49}, {"letter": "Chemotherapy care", "count": 2}, {"letter": "Care for Medication Side Effects", "count": 2}, {"letter": "Normal diet", "count": 3}, {"letter": "Mental health care", "count": 3}, {"letter": "Interventional procedure", "count": 81}, {"letter": "Hospital admission", "count": 17}, {"letter": "Discharge to home", "count": 1}, {"letter": "Patient disposition", "count": 1}, {"letter": "Chart evaluation by non-healthcare professional", "count": 3}, {"letter": "Disability evaluation procedure", "count": 5}, {"letter": "Surgical incisions", "count": 8}, {"letter": "Bifurcation (procedure)", "count": 1}, {"letter": "Partial excision", "count": 1}, {"letter": "Reexcision", "count": 18}, {"letter": "Radical excision", "count": 1}, {"letter": "Excision biopsy", "count": 4}, {"letter": "Incisional biopsy - action", "count": 1}, {"letter": "Shave biopsy - action", "count": 1}, {"letter": "Toilet procedure", "count": 2}, {"letter": "Insertion of pack (procedure)", "count": 1}, {"letter": "Reparative closure", "count": 9}, {"letter": "Closure by clip procedure", "count": 1}, {"letter": "Fixation - action", "count": 2}, {"letter": "Imbrication (procedure)", "count": 1}, {"letter": "Removal by grinding", "count": 18}, {"letter": "Electrodesiccation with curettage", "count": 4}, {"letter": "Therapeutic Mobilization", "count": 3}, {"letter": "Extraction", "count": 40}, {"letter": "Expression procedure", "count": 425}, {"letter": "Application procedure", "count": 56}, {"letter": "Operation on bone", "count": 10}, {"letter": "Muscle biopsy", "count": 7}, {"letter": "Muscle transplantation (procedure)", "count": 3}, {"letter": "Anterior tibialis tendon transfer for repair of flat foot", "count": 1}, {"letter": "Puncture of artery (procedure)", "count": 2}, {"letter": "Venous blood sampling", "count": 12}, {"letter": "Incision of skin", "count": 6}, {"letter": "Incision of axilla", "count": 1}, {"letter": "Procedures on breast", "count": 14}, {"letter": "breast: excisions", "count": 7}, {"letter": "Excision of breast tissue", "count": 36}, {"letter": "Excision of bilateral breasts", "count": 2}, {"letter": "Breast injection (procedure)", "count": 2}, {"letter": "Removal of breast implant", "count": 1}, {"letter": "Nipple reconstruction (procedure)", "count": 3}, {"letter": "Destruction of tissue of breast", "count": 2}, {"letter": "Anastomosis of intestine", "count": 1}, {"letter": "Operation on gallbladder", "count": 1}, {"letter": "Endoscopic retrograde cholangiography", "count": 2}, {"letter": "Operation on lymph node", "count": 9}, {"letter": "Biopsy of lymph node", "count": 15}, {"letter": "Core needle biopsy of lymph node", "count": 1}, {"letter": "Excision of axillary lymph nodes group", "count": 34}, {"letter": "Tonsillectomy and adenoidectomy", "count": 21}, {"letter": "Autologous bone marrow transplant", "count": 1}, {"letter": "Partial nephrectomy", "count": 2}, {"letter": "Radical prostatectomy", "count": 3}, {"letter": "Biopsy of lesion of vulva", "count": 3}, {"letter": "Vaginal biopsy (procedure)", "count": 1}, {"letter": "Biopsy of ovary", "count": 1}, {"letter": "Excision of bilateral fallopian tubes and ovaries", "count": 4}, {"letter": "Excision of brain", "count": 1}, {"letter": "Operative procedure on peripheral nerve", "count": 1}, {"letter": "Division of peripheral nerve", "count": 1}, {"letter": "Manipulation of Diaphragm", "count": 1}, {"letter": "Abdomen incision", "count": 1}, {"letter": "Abdominoplasty (procedure)", "count": 1}, {"letter": "Medical service", "count": 182}, {"letter": "Medical procedure", "count": 19}, {"letter": "General treatment", "count": 1}, {"letter": "Preventive service healthcare", "count": 1}, {"letter": "Prophylactic treatment", "count": 25}, {"letter": "History taking", "count": 1}, {"letter": "Inspection (procedure)", "count": 12}, {"letter": "Screening for cancer", "count": 58}, {"letter": "Continuous Positive Airway Pressure", "count": 3}, {"letter": "Mechanical ventilation", "count": 2}, {"letter": "Cardiotachometry", "count": 4}, {"letter": "Vascular oscillometry", "count": 1}, {"letter": "Administration of antibiotic", "count": 6}, {"letter": "Examination of breast", "count": 24}, {"letter": "Transfusion - action", "count": 1}, {"letter": "Gynecological examination", "count": 5}, {"letter": "Manual pelvic examination (procedure)", "count": 1}, {"letter": "Sensory testing", "count": 2}, {"letter": "Nerve conduction study", "count": 4}, {"letter": "Ophthalmic examination and evaluation", "count": 4}, {"letter": "Specimen Collection", "count": 18}, {"letter": "Urine Specimen Collection", "count": 1}, {"letter": "Specimen preparation (procedure)", "count": 1}, {"letter": "Laboratory reporting", "count": 3}, {"letter": "Lipid panel", "count": 2}, {"letter": "Hematology procedure", "count": 75}, {"letter": "Complete blood count without differential", "count": 7}, {"letter": "Neutrophil count (procedure)", "count": 8}, {"letter": "Lymphocyte Count measurement", "count": 8}, {"letter": "Eosinophil count procedure", "count": 4}, {"letter": "Platelet mean volume determination (procedure)", "count": 1}, {"letter": "Immunocytochemical stain", "count": 1}, {"letter": "Stereo microscopy", "count": 1}, {"letter": "Morphometric analysis", "count": 2}, {"letter": "Image analysis (procedure)", "count": 9}, {"letter": "Cytopathology procedure, preparation of smear, genital source", "count": 4}, {"letter": "DNA analysis", "count": 3}, {"letter": "Polymerase chain reaction analysis", "count": 4}, {"letter": "Prostate specific antigen measurement", "count": 3}, {"letter": "CA 125 measurement", "count": 8}, {"letter": "Cytokine assay", "count": 2}, {"letter": "IL-1 Beta assay", "count": 1}, {"letter": "Cr^51^ release assay", "count": 1}, {"letter": "Cytotoxicity assay", "count": 1}, {"letter": "C-reactive protein measurement", "count": 3}, {"letter": "Rheumatoid Factor Measurement", "count": 1}, {"letter": "Chemical procedure", "count": 1}, {"letter": "Chemiluminescence assay", "count": 6}, {"letter": "Pharmacokinetic study", "count": 397}, {"letter": "Stimulation test", "count": 2}, {"letter": "Rate measurement", "count": 5}, {"letter": "Uptake measurement", "count": 1}, {"letter": "Fecal occult blood test", "count": 2}, {"letter": "Adrenocorticotropic hormone measurement", "count": 1}, {"letter": "Alanine aminotransferase measurement", "count": 1}, {"letter": "Aspartate aminotransferase measurement", "count": 1}, {"letter": "Cholesterol measurement test", "count": 1}, {"letter": "Creatinine measurement", "count": 755}, {"letter": "Creatinine measurement, serum (procedure)", "count": 4}, {"letter": "Dehydroepiandrosterone sulfate measurement (procedure)", "count": 4}, {"letter": "Fecal analysis procedure", "count": 1}, {"letter": "Follicle stimulating hormone measurement", "count": 6}, {"letter": "Glucose measurement, serum", "count": 3}, {"letter": "Plasma Glucose Measurement", "count": 1}, {"letter": "Glucose measurement, fasting", "count": 6}, {"letter": "Glucohemoglobin measurement", "count": 4}, {"letter": "Insulin measurement", "count": 3}, {"letter": "Insulin C-peptide measurement", "count": 1}, {"letter": "Luteinizing hormone measurement", "count": 1}, {"letter": "Neuron specific enolase measurement", "count": 1}, {"letter": "Parathyroid hormone measurement", "count": 1}, {"letter": "Hydrogen ion concentration measurement", "count": 2}, {"letter": "blood phenylalanine measurement by Guthrie microbiologic assay", "count": 1}, {"letter": "Phospholipid measurement", "count": 2}, {"letter": "Protein measurement", "count": 4}, {"letter": "Sex hormone binding globulin measurement", "count": 2}, {"letter": "Somatomedin-C measurement", "count": 23}, {"letter": "Free Testosterone Measurement", "count": 3}, {"letter": "Thyroid stimulating hormone measurement", "count": 3}, {"letter": "Ethanol measurement, breath", "count": 1}, {"letter": "Aluminum measurement", "count": 215}, {"letter": "MRI with contrast", "count": 2}, {"letter": "Chest CT", "count": 14}, {"letter": "Magnetic Resonance Imaging (MRI) of Chest", "count": 12}, {"letter": "Mammography of bilateral breasts", "count": 1}, {"letter": "Screening mammography", "count": 51}, {"letter": "Specimen mammography", "count": 2}, {"letter": "Breast thermography", "count": 1}, {"letter": "Radiography of hand", "count": 1}, {"letter": "Echography of kidney", "count": 1}, {"letter": "Transvaginal echography", "count": 3}, {"letter": "hyperthermia treatment", "count": 3}, {"letter": "Nuclear medicine procedure", "count": 8}, {"letter": "Radionuclide uptake study", "count": 1}, {"letter": "Radioisotope scan of bone", "count": 23}, {"letter": "Whole Body Imaging", "count": 4}, {"letter": "Imaging of brain", "count": 1}, {"letter": "Body measure procedure", "count": 21}, {"letter": "Measurement of girth", "count": 1}, {"letter": "Gait evaluation", "count": 1}, {"letter": "Measurement of interstitial fluid pressure", "count": 1}, {"letter": "Psychological assessment", "count": 2}, {"letter": "Wechsler adult intelligence scale (assessment scale)", "count": 4}, {"letter": "Individual psychotherapy", "count": 1}, {"letter": "Group reassurance", "count": 7}, {"letter": "Contacting nurse", "count": 1}, {"letter": "Feeding patient", "count": 4}, {"letter": "Isolation procedure", "count": 3}, {"letter": "Soaking Procedure", "count": 1}, {"letter": "elevation of arm", "count": 1}, {"letter": "Diet education", "count": 1}, {"letter": "Nutrition education", "count": 2}, {"letter": "Shearing (procedure)", "count": 2}, {"letter": "Coronary artery", "count": 3}, {"letter": "Hepatic", "count": 16}, {"letter": "Cervical", "count": 12}, {"letter": "Ovarian", "count": 20}, {"letter": "Testiculo-", "count": 1}, {"letter": "Chest wall structure", "count": 69}, {"letter": "Moderate (severity modifier)", "count": 156}, {"letter": "Severe (severity modifier)", "count": 494}, {"letter": "Late", "count": 245}, {"letter": "End-stage", "count": 104}, {"letter": "Right", "count": 46}, {"letter": "Left", "count": 54}, {"letter": "Unilateral", "count": 31}, {"letter": "Lateral", "count": 34}, {"letter": "Anterior", "count": 20}, {"letter": "Dorsal", "count": 29}, {"letter": "Caudal", "count": 4}, {"letter": "Medial", "count": 19}, {"letter": "Central", "count": 98}, {"letter": "Peripheral", "count": 53}, {"letter": "Extrinsic", "count": 50}, {"letter": "Internal", "count": 12}, {"letter": "Intermediate", "count": 316}, {"letter": "Downward", "count": 3}, {"letter": "Transverse - anatomical location", "count": 1}, {"letter": "Proximal", "count": 43}, {"letter": "Distal (qualifier value)", "count": 36}, {"letter": "Apical", "count": 2}, {"letter": "Basal", "count": 23}, {"letter": "Circumferential", "count": 6}, {"letter": "Adjacent", "count": 53}, {"letter": "Square shape", "count": 3}, {"letter": "Segmental", "count": 18}, {"letter": "Coronal (qualifier value)", "count": 10}, {"letter": "Superficial", "count": 22}, {"letter": "Deep (qualifier value)", "count": 48}, {"letter": "Horizontal", "count": 36}, {"letter": "Longitudinal", "count": 55}, {"letter": "Vertical", "count": 27}, {"letter": "Axial", "count": 4}, {"letter": "Linear", "count": 128}, {"letter": "Bent", "count": 5}, {"letter": "Curved", "count": 273}, {"letter": "Over (spatial)", "count": 16}, {"letter": "Hemispheric", "count": 2}, {"letter": "Rectangular", "count": 6}, {"letter": "Angular", "count": 20}, {"letter": "Site", "count": 55}, {"letter": "Area", "count": 323}, {"letter": "regional", "count": 45}, {"letter": "Surface", "count": 31}, {"letter": "Capsular", "count": 3}, {"letter": "Along edge (qualifier value)", "count": 13}, {"letter": "Sectional Distribution", "count": 2}, {"letter": "Previous", "count": 172}, {"letter": "Remote", "count": 14}, {"letter": "Negative", "count": 245}, {"letter": "Abnormal", "count": 43}, {"letter": "Equal", "count": 304}, {"letter": "Major", "count": 61}, {"letter": "Minor (value)", "count": 25}, {"letter": "Long", "count": 61}, {"letter": "Thin (qualifier value)", "count": 1}, {"letter": "Bad", "count": 39}, {"letter": "Good", "count": 264}, {"letter": "Singular", "count": 904}, {"letter": "Double (qualifier value)", "count": 12}, {"letter": "Triplicate", "count": 69}, {"letter": "Active", "count": 219}, {"letter": "acute", "count": 181}, {"letter": "Advanced phase", "count": 111}, {"letter": "Benign", "count": 81}, {"letter": "Inoperable", "count": 16}, {"letter": "Operable", "count": 9}, {"letter": "Borderline", "count": 8}, {"letter": "chronic", "count": 61}, {"letter": "Combined", "count": 163}, {"letter": "Communicating", "count": 15}, {"letter": "Complete", "count": 1278}, {"letter": "Composite", "count": 73}, {"letter": "Confluent", "count": 9}, {"letter": "Corrected", "count": 42}, {"letter": "Crossed (qualifier value)", "count": 3}, {"letter": "Scab", "count": 1}, {"letter": "Clinical", "count": 582}, {"letter": "Subclinical", "count": 17}, {"letter": "High frequency", "count": 11}, {"letter": "Low frequency (qualifier value)", "count": 6}, {"letter": "Common (qualifier value)", "count": 3}, {"letter": "Decreased", "count": 69}, {"letter": "Increased", "count": 185}, {"letter": "Diffuse", "count": 10}, {"letter": "Disseminated", "count": 9}, {"letter": "Dry", "count": 11}, {"letter": "Essential", "count": 4}, {"letter": "Primary", "count": 7}, {"letter": "Endogenous", "count": 7}, {"letter": "Expanding", "count": 36}, {"letter": "shrinking", "count": 14}, {"letter": "Extensive", "count": 29}, {"letter": "Fine - adjective", "count": 4}, {"letter": "Firm", "count": 4}, {"letter": "Focal", "count": 41}, {"letter": "Discriminate", "count": 11}, {"letter": "False", "count": 34}, {"letter": "True", "count": 77}, {"letter": "Dissecting", "count": 4}, {"letter": "Cleaved", "count": 5}, {"letter": "Functional", "count": 231}, {"letter": "Generalized", "count": 311}, {"letter": "Healed", "count": 3}, {"letter": "High", "count": 1758}, {"letter": "low", "count": 59}, {"letter": "Immature", "count": 3}, {"letter": "Immediate", "count": 40}, {"letter": "Sedentary", "count": 15}, {"letter": "Incomplete", "count": 2}, {"letter": "Indeterminate", "count": 6}, {"letter": "Determinate", "count": 2}, {"letter": "Occult", "count": 6}, {"letter": "Induce (action)", "count": 232}, {"letter": "Initially", "count": 72}, {"letter": "Intact", "count": 14}, {"letter": "Intermittent", "count": 14}, {"letter": "Unresponsive to Treatment", "count": 25}, {"letter": "Irregular", "count": 5}, {"letter": "Regular", "count": 42}, {"letter": "Latent", "count": 6}, {"letter": "Local", "count": 496}, {"letter": "Postural", "count": 8}, {"letter": "Identical", "count": 11}, {"letter": "Invasive", "count": 381}, {"letter": "Malignant - descriptor", "count": 64}, {"letter": "Contiguous", "count": 1}, {"letter": "Marginal", "count": 3}, {"letter": "Mature", "count": 10}, {"letter": "Microscopic (qualifier value)", "count": 23}, {"letter": "Maximal (qualifier value)", "count": 82}, {"letter": "Multifocal", "count": 12}, {"letter": "Natural", "count": 19}, {"letter": "Non-healed", "count": 1}, {"letter": "Non-invasive", "count": 89}, {"letter": "Normal", "count": 175}, {"letter": "Known", "count": 302}, {"letter": "Paroxysmal", "count": 1}, {"letter": "Original", "count": 68}, {"letter": "New", "count": 323}, {"letter": "Oblique", "count": 2}, {"letter": "Notched (qualifier value)", "count": 1}, {"letter": "Uncontrolled", "count": 7}, {"letter": "Manifest", "count": 5}, {"letter": "Penetration", "count": 6}, {"letter": "Persistent", "count": 45}, {"letter": "Pitting", "count": 1}, {"letter": "Flat shape", "count": 1}, {"letter": "Progressive", "count": 100}, {"letter": "Punctate", "count": 1}, {"letter": "Reactive", "count": 11}, {"letter": "Relapsing course", "count": 156}, {"letter": "Reducible", "count": 6}, {"letter": "Reinfection", "count": 1}, {"letter": "Repaired", "count": 1}, {"letter": "Repeat", "count": 135}, {"letter": "Responsive", "count": 37}, {"letter": "Reversible", "count": 5}, {"letter": "Absolute", "count": 246}, {"letter": "Relative", "count": 208}, {"letter": "Modified By", "count": 38}, {"letter": "Proportional", "count": 27}, {"letter": "Simple", "count": 67}, {"letter": "Habitual", "count": 20}, {"letter": "Permanent", "count": 48}, {"letter": "Smooth", "count": 1}, {"letter": "Soft", "count": 11}, {"letter": "Spontaneous", "count": 14}, {"letter": "Stable status", "count": 34}, {"letter": "Steady", "count": 10}, {"letter": "Stratified", "count": 118}, {"letter": "Striated", "count": 1}, {"letter": "Subacute", "count": 2}, {"letter": "Suppressive", "count": 2}, {"letter": "Specific qualifier value", "count": 691}, {"letter": "Unspecified", "count": 9}, {"letter": "Tertiary", "count": 7}, {"letter": "Systemic", "count": 118}, {"letter": "Transitory", "count": 10}, {"letter": "Uniform - quality", "count": 7}, {"letter": "Vesicular", "count": 4}, {"letter": "Visible", "count": 33}, {"letter": "Walled", "count": 1}, {"letter": "Moist", "count": 17}, {"letter": "Branching (qualifier value)", "count": 1}, {"letter": "Few", "count": 8}, {"letter": "Phase", "count": 228}, {"letter": "Widespread", "count": 7}, {"letter": "Some (qualifier value)", "count": 14}, {"letter": "Most", "count": 133}, {"letter": "Other", "count": 65}, {"letter": "Miscellaneous", "count": 2}, {"letter": "Identified", "count": 215}, {"letter": "seen", "count": 47}, {"letter": "Invisible", "count": 1}, {"letter": "Thickened", "count": 8}, {"letter": "Prominent", "count": 6}, {"letter": "Extreme", "count": 147}, {"letter": "Serious", "count": 170}, {"letter": "Loose", "count": 2}, {"letter": "Isolated", "count": 6}, {"letter": "Sufficient", "count": 271}, {"letter": "Adequate", "count": 19}, {"letter": "Inadequate (qualifier)", "count": 18}, {"letter": "Patchy distribution", "count": 7}, {"letter": "Balanced - adjective", "count": 37}, {"letter": "Lobular", "count": 7}, {"letter": "Aggregate", "count": 14}, {"letter": "Variant", "count": 144}, {"letter": "Concurrent", "count": 40}, {"letter": "Deferred", "count": 106}, {"letter": "Certain (qualifier value)", "count": 98}, {"letter": "Unidentified - modifier", "count": 1}, {"letter": "Mixed (qualifier value)", "count": 128}, {"letter": "Formed", "count": 6}, {"letter": "First (number)", "count": 1668}, {"letter": "second (number)", "count": 74}, {"letter": "Third", "count": 96}, {"letter": "Fourth", "count": 17}, {"letter": "Fifth", "count": 8}, {"letter": "Sixth", "count": 11}, {"letter": "Seventh", "count": 4}, {"letter": "Eighth", "count": 3}, {"letter": "Ninth", "count": 4}, {"letter": "Tenth", "count": 6}, {"letter": "Twelfth", "count": 2}, {"letter": "One", "count": 994}, {"letter": "Two", "count": 1010}, {"letter": "Three", "count": 381}, {"letter": "Four", "count": 304}, {"letter": "Five", "count": 333}, {"letter": "Six", "count": 142}, {"letter": "Seven", "count": 83}, {"letter": "Eight", "count": 53}, {"letter": "Nine", "count": 44}, {"letter": "Ten", "count": 32}, {"letter": "Number eleven", "count": 3}, {"letter": "Twelve", "count": 18}, {"letter": "biological", "count": 26}, {"letter": "Histologic", "count": 119}, {"letter": "Physiological", "count": 43}, {"letter": "pharmacological", "count": 4}, {"letter": "virologic", "count": 1}, {"letter": "Pathological aspects", "count": 94}, {"letter": "immunologic", "count": 41}, {"letter": "Cytologic", "count": 20}, {"letter": "Biochemical", "count": 24}, {"letter": "Medical", "count": 173}, {"letter": "Oncologic", "count": 13}, {"letter": "Gynecologic", "count": 4}, {"letter": "Radiologic", "count": 17}, {"letter": "Obstetrical", "count": 1}, {"letter": "Physical", "count": 27}, {"letter": "Psychologic", "count": 3}, {"letter": "Psychiatric", "count": 2}, {"letter": "Hematologic", "count": 55}, {"letter": "Dermatologic", "count": 3}, {"letter": "Neurologic (qualifier value)", "count": 27}, {"letter": "Scheduled - procedure status", "count": 8}, {"letter": "Approved", "count": 26}, {"letter": "Rescheduled", "count": 1}, {"letter": "Referring", "count": 136}, {"letter": "Routine", "count": 89}, {"letter": "Stat (do immediately)", "count": 138}, {"letter": "Series", "count": 2}, {"letter": "Automated (qualifier value)", "count": 60}, {"letter": "Special", "count": 31}, {"letter": "Qualitative", "count": 85}, {"letter": "False Positive", "count": 39}, {"letter": "False Negative", "count": 48}, {"letter": "True positive", "count": 22}, {"letter": "True negative", "count": 19}, {"letter": "Clinical stage finding", "count": 15}, {"letter": "Clinical stage I", "count": 2}, {"letter": "Clinical stage II", "count": 2}, {"letter": "Well Differentiated", "count": 28}, {"letter": "Poorly differentiated", "count": 85}, {"letter": "Undifferentiated", "count": 1}, {"letter": "Microinvasive tumor", "count": 2}, {"letter": "Adolescent (age group)", "count": 5}, {"letter": "Active Site", "count": 1}, {"letter": "Waist-Hip Ratio", "count": 12}, {"letter": "Choroid Plexus Papilloma", "count": 1}, {"letter": "Death Rate", "count": 8}, {"letter": "Postoperative Procedures", "count": 1}, {"letter": "Radiotherapy, Targeted", "count": 1}, {"letter": "Thymic Carcinoma", "count": 3}, {"letter": "2-mercaptoethanesulfonic acid", "count": 8}, {"letter": "Biochemical Marker", "count": 6}, {"letter": "Logistic Regression", "count": 68}, {"letter": "Logit Models", "count": 2}, {"letter": "Clinical Trials, Randomized", "count": 5}, {"letter": "Subfamily lentivirinae", "count": 1}, {"letter": "Elective Surgical Procedures", "count": 3}, {"letter": "Pneumonia, Interstitial", "count": 1}, {"letter": "Lung Diseases, Interstitial", "count": 6}, {"letter": "Radiation Pneumonitis", "count": 9}, {"letter": "Karnofsky Performance Status", "count": 18}, {"letter": "Rectus Abdominis", "count": 1}, {"letter": "Protective gloves", "count": 4}, {"letter": "Reproductive History", "count": 6}, {"letter": "Adipocytes", "count": 3}, {"letter": "Age of Onset", "count": 25}, {"letter": "Cell Transplants", "count": 1}, {"letter": "Premenopause", "count": 3}, {"letter": "Models, Nonlinear", "count": 8}, {"letter": "Hospital Costs", "count": 6}, {"letter": "Ki-1+ Anaplastic Large Cell Lymphoma", "count": 3}, {"letter": "Long-Term Survivors", "count": 2}, {"letter": "Survivors", "count": 129}, {"letter": "Seafood", "count": 1}, {"letter": "Time Management", "count": 32}, {"letter": "Safety Management", "count": 3}, {"letter": "Carrying", "count": 63}, {"letter": "Lifting", "count": 9}, {"letter": "Pelvic Diaphragm", "count": 1}, {"letter": "Autonomic nerve structure", "count": 1}, {"letter": "Fatal Outcome", "count": 2}, {"letter": "Asp snake", "count": 1}, {"letter": "Economics, Pharmaceutical", "count": 1}, {"letter": "Receptor Protein-Tyrosine Kinases", "count": 1}, {"letter": "Oligonucleotide Primers", "count": 2}, {"letter": "Rod Photoreceptors", "count": 1}, {"letter": "Retinal Cone", "count": 6}, {"letter": "Antigen Presentation", "count": 2}, {"letter": "Growth Factor Receptors", "count": 1}, {"letter": "Biological Specimen Banks", "count": 4}, {"letter": "Germ-Line Mutation", "count": 12}, {"letter": "Endometrial Stromal Sarcoma", "count": 3}, {"letter": "Fibroadenoma", "count": 1}, {"letter": "Alveolar rhabdomyosarcoma", "count": 15}, {"letter": "herpesvirus 1, human", "count": 1}, {"letter": "Carcinoma, Lobular", "count": 1}, {"letter": "Cholangiocarcinoma", "count": 1}, {"letter": "Ki-67 Antigen", "count": 1}, {"letter": "human REG1A protein", "count": 3}, {"letter": "Chemokine (C-C Motif) Ligand 4", "count": 1}, {"letter": "PDGF AA", "count": 1}, {"letter": "filgrastim", "count": 3}, {"letter": "pemetrexed", "count": 7}, {"letter": "CCL7 protein, human", "count": 1}, {"letter": "Interleukin-13", "count": 3}, {"letter": "taxane", "count": 26}, {"letter": "Hypoxia-Inducible Factor 1", "count": 2}, {"letter": "sargramostim", "count": 1}, {"letter": "Ensure (product)", "count": 19}, {"letter": "Chemokine CXCL12", "count": 1}, {"letter": "aldesleukin", "count": 3}, {"letter": "Adult Non-Hodgkin Lymphoma", "count": 2}, {"letter": "Adult Soft Tissue Sarcoma", "count": 7}, {"letter": "Childhood Hodgkin Lymphoma", "count": 1}, {"letter": "Metastatic malignant neoplasm to brain", "count": 78}, {"letter": "Meningeal Carcinomatosis", "count": 2}, {"letter": "Anabolism", "count": 14}, {"letter": "anatomic", "count": 17}, {"letter": "biopsy characteristics", "count": 106}, {"letter": "Chemicals", "count": 14}, {"letter": "Cost aspects", "count": 14}, {"letter": "Equipment used", "count": 6}, {"letter": "Evaluation", "count": 2614}, {"letter": "fee characteristics", "count": 2}, {"letter": "Financial management aspects", "count": 3}, {"letter": "glutamate", "count": 5}, {"letter": "grasp", "count": 26}, {"letter": "growth aspects", "count": 12}, {"letter": "guiding characteristics", "count": 3}, {"letter": "hydroxide ion", "count": 11}, {"letter": "incidence of cases", "count": 980}, {"letter": "isolation aspects", "count": 8}, {"letter": "aspects of laws", "count": 1}, {"letter": "Lightheadedness", "count": 2}, {"letter": "Legal procedural aspects", "count": 1}, {"letter": "morbidity aspects", "count": 21}, {"letter": "organizational", "count": 9}, {"letter": "phthalate", "count": 4}, {"letter": "Polish population", "count": 2}, {"letter": "Predisposition -- attribute", "count": 11}, {"letter": "Prevalence aspects", "count": 87}, {"letter": "prognostic", "count": 97}, {"letter": "regulatory", "count": 8}, {"letter": "Screening procedure", "count": 146}, {"letter": "Aspects of disease screening", "count": 88}, {"letter": "Aspects of signs", "count": 6}, {"letter": "surveillance aspects", "count": 4}, {"letter": "survival aspects", "count": 5}, {"letter": "systematic", "count": 11}, {"letter": "Tokelau", "count": 2}, {"letter": "Mental tolerance", "count": 1}, {"letter": "Training", "count": 29}, {"letter": "Ultrasonic", "count": 4}, {"letter": "White color", "count": 7}, {"letter": "DSM-IV", "count": 6}, {"letter": "Metabolic acidosis", "count": 1}, {"letter": "Ketoacidosis", "count": 1}, {"letter": "Cyclic neutropenia", "count": 9}, {"letter": "Surgical Complication", "count": 19}, {"letter": "Impaired", "count": 13}, {"letter": "Pel Ebstein fever", "count": 1}, {"letter": "Excretory function", "count": 78}, {"letter": "Blood group antibody H", "count": 1}, {"letter": "Blood group antibody I", "count": 50}, {"letter": "Blood group antibody S", "count": 2}, {"letter": "Muscular stiffness", "count": 1}, {"letter": "Judge", "count": 37}, {"letter": "Lesion", "count": 763}, {"letter": "Lytic lesion", "count": 2}, {"letter": "Yellow color", "count": 5}, {"letter": "Traumatic injection site", "count": 12}, {"letter": "Fissure in skin", "count": 1}, {"letter": "Tattoo disorder", "count": 8}, {"letter": "Leptocyte", "count": 5}, {"letter": "Atrophic Vaginitis", "count": 2}, {"letter": "Illness (finding)", "count": 50}, {"letter": "clinical syndromes", "count": 1}, {"letter": "Teacher", "count": 1}, {"letter": "Painter", "count": 1}, {"letter": "Arterial", "count": 15}, {"letter": "Lesion of brain", "count": 4}, {"letter": "Stomach ache", "count": 1}, {"letter": "Nature of Complaint", "count": 1}, {"letter": "Breast hemorrhage", "count": 1}, {"letter": "Pain in esophagus (finding)", "count": 1}, {"letter": "Reaction emotional", "count": 1}, {"letter": "Skin reaction", "count": 38}, {"letter": "Diastasis recti", "count": 1}, {"letter": "Oral pain", "count": 1}, {"letter": "DNA hybridization", "count": 1}, {"letter": "Epithelial", "count": 12}, {"letter": "Cutaneous", "count": 3}, {"letter": "Stratum Basale", "count": 1}, {"letter": "Cutaneous fluid", "count": 2}, {"letter": "Hair follicle structure", "count": 2}, {"letter": "Structure of beard", "count": 1}, {"letter": "Nail bed structure", "count": 1}, {"letter": "Structure of nail of thumb", "count": 1}, {"letter": "Structure of nail of toe", "count": 1}, {"letter": "Integumentary scale", "count": 249}, {"letter": "Skin region", "count": 2}, {"letter": "Skin structure of face", "count": 1}, {"letter": "Skin of chest", "count": 11}, {"letter": "Skin structure of nipple", "count": 2}, {"letter": "Skin of upper arm", "count": 1}, {"letter": "Skin structure of hand", "count": 1}, {"letter": "Subcutaneous Fat", "count": 26}, {"letter": "Right breast", "count": 8}, {"letter": "Left breast", "count": 12}, {"letter": "Female breast", "count": 13}, {"letter": "Both breasts", "count": 1}, {"letter": "Areola", "count": 16}, {"letter": "Axillary tail of breast", "count": 1}, {"letter": "Breast lobule", "count": 1}, {"letter": "Interlobular mammary connective tissue", "count": 3}, {"letter": "Cancellous Bone", "count": 1}, {"letter": "Cell of bone", "count": 2}, {"letter": "Structure of articular surface of bone", "count": 12}, {"letter": "Structure of epicondyle", "count": 9}, {"letter": "Body of vertebra", "count": 2}, {"letter": "Third lumbar vertebra", "count": 1}, {"letter": "Structure of posterior superior iliac spine", "count": 2}, {"letter": "Iliac crest structure", "count": 1}, {"letter": "Structure of medial epicondyle of humerus", "count": 1}, {"letter": "Structure of styloid process of ulna", "count": 2}, {"letter": "Structure of triangular bone", "count": 2}, {"letter": "Trapezoid bone structure", "count": 5}, {"letter": "Phalanx of hand", "count": 1}, {"letter": "Structure of greater trochanter of femur", "count": 2}, {"letter": "Structure of lateral epicondyle of femur", "count": 1}, {"letter": "Structure of base of phalanx of great toe", "count": 1}, {"letter": "Structure of teres major muscle", "count": 2}, {"letter": "Structure of deltoid muscle", "count": 3}, {"letter": "Structure of erector spinae muscle", "count": 2}, {"letter": "Structure of multifidus muscle", "count": 1}, {"letter": "Structure of rotator muscle", "count": 1}, {"letter": "Skeletal muscle structure of back", "count": 1}, {"letter": "Skeletal muscle structure of thorax", "count": 2}, {"letter": "Pectoralis minor muscle structure", "count": 1}, {"letter": "Structure of serratus anterior muscle", "count": 6}, {"letter": "Structure of trapezius muscle", "count": 8}, {"letter": "Structure of latissimus dorsi muscle", "count": 4}, {"letter": "Structure of levator scapulae muscle", "count": 4}, {"letter": "Skeletal muscle structure of thigh", "count": 2}, {"letter": "Structure of quadriceps femoris muscle", "count": 9}, {"letter": "Structure of vastus lateralis muscle", "count": 8}, {"letter": "Structure of vastus medialis muscle", "count": 1}, {"letter": "Structure of vastus intermedius muscle", "count": 1}, {"letter": "Skeletal muscle structure of lower leg", "count": 2}, {"letter": "Carpometacarpal joint structure", "count": 1}, {"letter": "Aponeurosis structure", "count": 4}, {"letter": "soft tissue", "count": 20}, {"letter": "Endothelial Cells", "count": 3}, {"letter": "Breath", "count": 10}, {"letter": "Alveolar wall", "count": 1}, {"letter": "Left lung", "count": 1}, {"letter": "Pleural fluid", "count": 1}, {"letter": "Structure of base of heart", "count": 1}, {"letter": "Myocytes, Cardiac", "count": 1}, {"letter": "Right ventricular structure", "count": 1}, {"letter": "Left ventricular structure", "count": 26}, {"letter": "Myocardium of left ventricle", "count": 1}, {"letter": "Structure of anulus fibrosus of mitral orifice", "count": 1}, {"letter": "Structure of small blood vessel (organ)", "count": 1}, {"letter": "Large blood vessel structure", "count": 1}, {"letter": "Internal jugular vein structure", "count": 1}, {"letter": "Structure of cardiac vein", "count": 1}, {"letter": "Structure of vein of upper extremity", "count": 2}, {"letter": "Structure of median antebrachial vein", "count": 1}, {"letter": "Oral cavity", "count": 5}, {"letter": "Dental", "count": 6}, {"letter": "Tooth Crowns", "count": 2}, {"letter": "Inferior esophageal sphincter structure", "count": 3}, {"letter": "Fundus of reticulum", "count": 1}, {"letter": "Papilla of duodenum", "count": 1}, {"letter": "Hepatocyte", "count": 1}, {"letter": "Both kidneys", "count": 1}, {"letter": "Vaginal mucous membrane", "count": 1}, {"letter": "Body of uterus", "count": 1}, {"letter": "Structure of uterine serosa", "count": 1}, {"letter": "Endometrial", "count": 17}, {"letter": "Structure of left ovary", "count": 1}, {"letter": "Structure of cumulus oophorus", "count": 1}, {"letter": "Free nerve ending", "count": 1}, {"letter": "Spinal epidural space", "count": 1}, {"letter": "Nodulus cerebelli", "count": 2}, {"letter": "Left eye structure", "count": 30}, {"letter": "Ear lobe", "count": 1}, {"letter": "Hematopoietic", "count": 3}, {"letter": "Segmented neutrophil", "count": 1}, {"letter": "peripheral blood", "count": 159}, {"letter": "Capillary blood", "count": 2}, {"letter": "Serum", "count": 226}, {"letter": "Lateral cervical lymph node group", "count": 1}, {"letter": "Structure of supraclavicular lymph node", "count": 10}, {"letter": "Internal Mammary Lymph Node", "count": 10}, {"letter": "Structure of lateral axillary lymph node", "count": 5}, {"letter": "Pectoral lymph node group", "count": 3}, {"letter": "Structure of lymph nodes of body as a whole", "count": 11}, {"letter": "Lymphatic vessel", "count": 21}, {"letter": "Entire body as a whole", "count": 25}, {"letter": "Body part", "count": 5}, {"letter": "Upper body part structure", "count": 1}, {"letter": "Body organ structure", "count": 2}, {"letter": "Surgical margins", "count": 71}, {"letter": "Psyche structure", "count": 46}, {"letter": "Side of head", "count": 1}, {"letter": "Vertex", "count": 1}, {"letter": "Oral region", "count": 3}, {"letter": "Cranial cavity structure", "count": 2}, {"letter": "Midclavicular line of trunk", "count": 2}, {"letter": "Structure of waist (surface region)", "count": 18}, {"letter": "Lower back structure", "count": 1}, {"letter": "Infraclavicular region structure", "count": 11}, {"letter": "Region of breast", "count": 5}, {"letter": "Pectoral region structure", "count": 1}, {"letter": "Thoracic mammary region", "count": 17}, {"letter": "Thoracic cavity structure", "count": 3}, {"letter": "Upper abdomen (surface region)", "count": 1}, {"letter": "Abdominal Cavity", "count": 1}, {"letter": "Greater omentum", "count": 1}, {"letter": "Both upper extremities", "count": 3}, {"letter": "Structure of axillary soft tissues", "count": 4}, {"letter": "Right upper arm structure", "count": 3}, {"letter": "Left upper arm structure", "count": 5}, {"letter": "Both upper arms", "count": 1}, {"letter": "Back of hand", "count": 9}, {"letter": "Index finger", "count": 2}, {"letter": "Middle finger structure", "count": 6}, {"letter": "Fifth finger", "count": 7}, {"letter": "Structure of right knee", "count": 1}, {"letter": "Structure of calf of leg", "count": 1}, {"letter": "Both lower legs", "count": 1}, {"letter": "Structure of dorsum of foot", "count": 1}, {"letter": "Sole of Foot", "count": 13}, {"letter": "Plantar surface of great toe", "count": 1}, {"letter": "Interchromatin granule", "count": 23}, {"letter": "cell process structure", "count": 1}, {"letter": "Lipid droplet", "count": 1}, {"letter": "Residual body", "count": 1}, {"letter": "Mitochondrial Membrane, Outer", "count": 2}, {"letter": "Normal general body function", "count": 13}, {"letter": "Disability", "count": 172}, {"letter": "Invalidism", "count": 6}, {"letter": "Failure (biologic function)", "count": 159}, {"letter": "Failed", "count": 20}, {"letter": "Chronic failure", "count": 1}, {"letter": "Insufficiency", "count": 7}, {"letter": "Insufficient (qualifier)", "count": 21}, {"letter": "compensatory", "count": 5}, {"letter": "adaptive", "count": 24}, {"letter": "Physiologic tolerance", "count": 5}, {"letter": "tolerant", "count": 1}, {"letter": "intolerance function", "count": 1}, {"letter": "predisposed", "count": 4}, {"letter": "Multiple symptoms", "count": 8}, {"letter": "Malaise", "count": 5}, {"letter": "Symptomatic", "count": 97}, {"letter": "Asymptomatic (finding)", "count": 75}, {"letter": "Crisis", "count": 3}, {"letter": "Exhausting", "count": 1}, {"letter": "Fatigability", "count": 2}, {"letter": "Fluctuation", "count": 1}, {"letter": "Fluctuant", "count": 1}, {"letter": "Fluctuating (qualifier value)", "count": 2}, {"letter": "Complicated", "count": 4}, {"letter": "Early complication", "count": 1}, {"letter": "Increased body mass index", "count": 1}, {"letter": "Postoperative state", "count": 3}, {"letter": "Status post", "count": 523}, {"letter": "stressful", "count": 11}, {"letter": "Decreased stress", "count": 3}, {"letter": "Distress", "count": 154}, {"letter": "Childhood", "count": 3}, {"letter": "Senility", "count": 7}, {"letter": "Deficient Food Intake", "count": 1}, {"letter": "Decisional conflict", "count": 25}, {"letter": "Mild anxiety", "count": 8}, {"letter": "Moderate anxiety", "count": 8}, {"letter": "Avoidance coping", "count": 2}, {"letter": "Mobile", "count": 3}, {"letter": "Immobile", "count": 1}, {"letter": "Musculoskeletal symptom", "count": 9}, {"letter": "Extended", "count": 1}, {"letter": "Hyperextension", "count": 3}, {"letter": "Flexion, function", "count": 55}, {"letter": "Abduction, function", "count": 48}, {"letter": "Adduction", "count": 11}, {"letter": "Rotated", "count": 1}, {"letter": "Internal rotation", "count": 14}, {"letter": "External rotation", "count": 40}, {"letter": "Standing position", "count": 22}, {"letter": "Active movement", "count": 2}, {"letter": "Muscle function", "count": 2}, {"letter": "Antagonist muscle action", "count": 2}, {"letter": "Muscle property", "count": 1}, {"letter": "Myalgia", "count": 18}, {"letter": "Muscle twitch", "count": 2}, {"letter": "Bone turnover rate", "count": 1}, {"letter": "Osteoclastic resorption", "count": 1}, {"letter": "Limitation of joint movement", "count": 1}, {"letter": "Step-off", "count": 2}, {"letter": "Elbow flexion test", "count": 2}, {"letter": "Circling gait", "count": 4}, {"letter": "Expiration, function", "count": 11}, {"letter": "Respiratory rate", "count": 16}, {"letter": "Slow respiration", "count": 1}, {"letter": "Chest expansion", "count": 2}, {"letter": "Lung Volumes", "count": 1}, {"letter": "Pulse Rate", "count": 11}, {"letter": "Cardiac function", "count": 30}, {"letter": "Decreased cardiac function", "count": 1}, {"letter": "Cardiac ejection fraction", "count": 1}, {"letter": "Cardiac end-diastolic volume", "count": 1}, {"letter": "Cardiac rhythm type", "count": 1}, {"letter": "Alteration in heart rate (finding)", "count": 10}, {"letter": "Fibrillation", "count": 1}, {"letter": "Sinus rhythm", "count": 1}, {"letter": "Cardiac conduction", "count": 2}, {"letter": "Abnormal cardiac conduction", "count": 1}, {"letter": "Continuous murmur", "count": 82}, {"letter": "Pericardial knock", "count": 1}, {"letter": "Protodiastolic gallop with abnormally audible third heart sound", "count": 1}, {"letter": "Chest tightness", "count": 1}, {"letter": "Right axis deviation", "count": 4}, {"letter": "Vascular function", "count": 3}, {"letter": "Blood flow", "count": 11}, {"letter": "Normal Capillary Refill Time", "count": 12}, {"letter": "Cold sweat", "count": 2}, {"letter": "Acid mantle", "count": 2}, {"letter": "Decrease in appetite", "count": 7}, {"letter": "Ingestion", "count": 2}, {"letter": "Acute vomiting", "count": 4}, {"letter": "Retching", "count": 9}, {"letter": "Rumination", "count": 8}, {"letter": "Liver function", "count": 9}, {"letter": "Renal function", "count": 11}, {"letter": "Renal clearance function", "count": 5}, {"letter": "Urinary concentration", "count": 7}, {"letter": "Bladder function", "count": 1}, {"letter": "Migratory (qualifier value)", "count": 3}, {"letter": "migrated", "count": 1}, {"letter": "fertilized", "count": 1}, {"letter": "Estrus suppression", "count": 1}, {"letter": "Postmenopausal state", "count": 60}, {"letter": "Term Birth", "count": 8}, {"letter": "Breast function", "count": 2}, {"letter": "Lactation normal", "count": 1}, {"letter": "Psychological symptom", "count": 9}, {"letter": "Psychological function", "count": 4}, {"letter": "Psychiatric symptom", "count": 1}, {"letter": "Nonpersistence", "count": 1}, {"letter": "Selective inattention", "count": 1}, {"letter": "Personal appearance", "count": 261}, {"letter": "Emotional disorder", "count": 3}, {"letter": "Worried", "count": 40}, {"letter": "apprehension", "count": 3}, {"letter": "Feeling despair", "count": 1}, {"letter": "Elation", "count": 1}, {"letter": "Tension", "count": 17}, {"letter": "Feeling mixed emotions", "count": 1}, {"letter": "Insecurity", "count": 2}, {"letter": "Demoralization", "count": 2}, {"letter": "Abnormal behavior", "count": 2}, {"letter": "Maladaptive behavior associated with physical illness", "count": 4}, {"letter": "Butting", "count": 23}, {"letter": "Physical wandering", "count": 1}, {"letter": "excitement emotion", "count": 1}, {"letter": "Disturbance in thinking", "count": 1}, {"letter": "Mental blocking", "count": 2}, {"letter": "Noesis", "count": 1}, {"letter": "Acrophobia", "count": 2}, {"letter": "Algophobia", "count": 2}, {"letter": "Naming, function", "count": 5}, {"letter": "Repetition of words", "count": 3}, {"letter": "Perceptual disturbance", "count": 1}, {"letter": "Insight", "count": 13}, {"letter": "Personality Traits", "count": 7}, {"letter": "Abnormal nerve conduction", "count": 1}, {"letter": "Summation (function)", "count": 15}, {"letter": "Temporal summation", "count": 6}, {"letter": "Facilitation", "count": 3}, {"letter": "Neuromuscular fatigue", "count": 4}, {"letter": "Inhibitory potential", "count": 2}, {"letter": "Motor function (observable entity)", "count": 2}, {"letter": "Ankle reflex", "count": 1}, {"letter": "Cold Sensation", "count": 4}, {"letter": "Heat sensation", "count": 2}, {"letter": "Nociception", "count": 2}, {"letter": "Vibratory sense, function", "count": 4}, {"letter": "Absence of vibratory sense", "count": 1}, {"letter": "Threshold perception", "count": 2}, {"letter": "Baresthesia", "count": 1}, {"letter": "Absence of pain", "count": 36}, {"letter": "Painless", "count": 4}, {"letter": "Indolent", "count": 1}, {"letter": "Superficial pain", "count": 1}, {"letter": "Deep pain", "count": 1}, {"letter": "Pain, Burning", "count": 1}, {"letter": "Sore to touch", "count": 7}, {"letter": "Tender", "count": 5}, {"letter": "Ache", "count": 1}, {"letter": "Pain and tenderness", "count": 2}, {"letter": "Central pain", "count": 2}, {"letter": "Visceral Pain", "count": 1}, {"letter": "Pain, Referred", "count": 1}, {"letter": "Mechanical pain", "count": 1}, {"letter": "Pain at rest", "count": 16}, {"letter": "Electrical activity of brain", "count": 1}, {"letter": "Stimulus", "count": 24}, {"letter": "Conditioned stimulus", "count": 2}, {"letter": "Awake (finding)", "count": 6}, {"letter": "Generalized seizures", "count": 1}, {"letter": "Cerebrospinal fluid circulation", "count": 1}, {"letter": "Visual", "count": 89}, {"letter": "Emmetropia", "count": 2}, {"letter": "Speaking (activity)", "count": 20}, {"letter": "Baying", "count": 4}, {"letter": "Peripheral motor neuropathy", "count": 2}, {"letter": "Neurologic Symptoms", "count": 5}, {"letter": "Neurotoxicity Syndromes", "count": 45}, {"letter": "Respiratory Depression", "count": 2}, {"letter": "Feeling tense", "count": 4}, {"letter": "Mental distress", "count": 1}, {"letter": "Euphoric mood", "count": 2}, {"letter": "Restless sleep", "count": 1}, {"letter": "Sleep loss", "count": 1}, {"letter": "Difficulty sleeping", "count": 22}, {"letter": "Excitability", "count": 2}, {"letter": "Character change in", "count": 2}, {"letter": "Bitter", "count": 1}, {"letter": "Upset stomach", "count": 2}, {"letter": "Hepatotoxicity", "count": 5}, {"letter": "Edema of breast", "count": 4}, {"letter": "Malignant neoplasm of female breast", "count": 4}, {"letter": "Chest discomfort", "count": 2}, {"letter": "Breath Holding", "count": 3}, {"letter": "Lack of Efficacy", "count": 1}, {"letter": "Benign neoplasm of female breast", "count": 1}, {"letter": "Cerebral atrophy", "count": 1}, {"letter": "Absence attacks", "count": 1}, {"letter": "Pancreatic carcinoma", "count": 1}, {"letter": "Jaw pain", "count": 2}, {"letter": "Mucosal ulcer", "count": 1}, {"letter": "Menopausal symptom", "count": 16}, {"letter": "Vaginal discomfort", "count": 26}, {"letter": "Serum cortisol measurement", "count": 2}, {"letter": "Direct reacting bilirubin", "count": 2}, {"letter": "Serum chemistry test", "count": 14}, {"letter": "Stress Disorders, Traumatic, Acute", "count": 1}, {"letter": "relational problems", "count": 1}, {"letter": "Thickness of endometrium", "count": 6}, {"letter": "Discipline", "count": 1}, {"letter": "residence", "count": 5}, {"letter": "Role change", "count": 1}, {"letter": "spirituality", "count": 3}, {"letter": "Emotional Stability", "count": 1}, {"letter": "Pain - other", "count": 2}, {"letter": "Temperature change at anatomical site", "count": 1}, {"letter": "Physical activity - other", "count": 1}, {"letter": "Actual", "count": 130}, {"letter": "Individual", "count": 139}, {"letter": "treatments and procedures", "count": 1}, {"letter": "Gynecologist", "count": 5}, {"letter": "Neurologists", "count": 1}, {"letter": "Optimism", "count": 8}, {"letter": "reading aloud", "count": 2}, {"letter": "self actualization", "count": 1}, {"letter": "Adaptability", "count": 4}, {"letter": "Test Administration", "count": 11}, {"letter": "Agencies", "count": 6}, {"letter": "Response Amplitude", "count": 1}, {"letter": "Social Approval", "count": 1}, {"letter": "Arrested progression", "count": 2}, {"letter": "Chance", "count": 14}, {"letter": "Social Cohesion", "count": 1}, {"letter": "Physical Comfort", "count": 4}, {"letter": "Self Confidence", "count": 55}, {"letter": "Confidence Limit", "count": 25}, {"letter": "conformity", "count": 1}, {"letter": "Professional Consultation - dental", "count": 11}, {"letter": "group discussion", "count": 8}, {"letter": "Frequency Distribution", "count": 8}, {"letter": "Response Duration", "count": 614}, {"letter": "Practice Experience", "count": 619}, {"letter": "Frequency of Responses", "count": 1318}, {"letter": "social influences", "count": 6}, {"letter": "Automated Information Retrieval", "count": 1}, {"letter": "insensitivity", "count": 4}, {"letter": "Interaction Analysis", "count": 2}, {"letter": "Social Norms", "count": 1}, {"letter": "Numbers", "count": 2835}, {"letter": "Response Parameters", "count": 5}, {"letter": "management planning", "count": 6}, {"letter": "Measurement Profiles", "count": 1}, {"letter": "Learning Recall", "count": 3}, {"letter": "Recovery - action", "count": 51}, {"letter": "Self-referral", "count": 3}, {"letter": "Test-Retest Reliability", "count": 26}, {"letter": "test reliability", "count": 1}, {"letter": "Resistance (Psychotherapeutic)", "count": 9}, {"letter": "Peeling of skin", "count": 14}, {"letter": "Test scores", "count": 9}, {"letter": "Emotional Security", "count": 1}, {"letter": "Propensity to adverse reactions to drug", "count": 1}, {"letter": "Marital separation", "count": 5}, {"letter": "Sharing (Social Behavior)", "count": 8}, {"letter": "Statistical Significance", "count": 76}, {"letter": "Group Size", "count": 1}, {"letter": "Sorting (Cognition)", "count": 1}, {"letter": "standardized tests", "count": 3}, {"letter": "Physical Strength", "count": 5}, {"letter": "Statistical Test", "count": 25}, {"letter": "Trust (Social Behavior)", "count": 7}, {"letter": "test validity", "count": 1}, {"letter": "Response Variability", "count": 1}, {"letter": "statistical weight", "count": 1}, {"letter": "Carcinoma of Male Breast", "count": 2}, {"letter": "Fallopian Tube Carcinoma", "count": 2}, {"letter": "Myositis, Inclusion Body", "count": 1}, {"letter": "Gastrointestinal Stromal Tumors", "count": 1}, {"letter": "Muscular Dystrophy, Facioscapulohumeral", "count": 17}, {"letter": "Young Adult", "count": 3}, {"letter": "Southeast Asian People", "count": 1}, {"letter": "Australian", "count": 5}, {"letter": "Baker, general", "count": 15}, {"letter": "Bilateral", "count": 65}, {"letter": "Bone lesion", "count": 12}, {"letter": "Bone marrow: tumor cells", "count": 2}, {"letter": "brazilian", "count": 11}, {"letter": "Red breast", "count": 4}, {"letter": "Canadian", "count": 9}, {"letter": "Chilean", "count": 3}, {"letter": "Consciousness clear", "count": 5}, {"letter": "Esophageal bleeding", "count": 1}, {"letter": "European (ethnic group)", "count": 118}, {"letter": "Edema of lower extremity", "count": 1}, {"letter": "Arm Pain", "count": 5}, {"letter": "FEMORAL BONE MASS", "count": 8}, {"letter": "Low grade fever", "count": 1}, {"letter": "Pain in finger", "count": 2}, {"letter": "supination of forearm", "count": 3}, {"letter": "Hand pain", "count": 1}, {"letter": "Paresthesia of hand", "count": 3}, {"letter": "Harlequin Fetus", "count": 1}, {"letter": "Hepatojugular reflux", "count": 1}, {"letter": "Hospital patient (finding)", "count": 2}, {"letter": "HYPERGLYCEMIA, SEVERE", "count": 1}, {"letter": "Hypoalbuminemia", "count": 5}, {"letter": "Recurrent infections", "count": 2}, {"letter": "intracranial metastatic tumor", "count": 2}, {"letter": "Israeli (population group)", "count": 1}, {"letter": "Knee flexion", "count": 4}, {"letter": "LYMPHATIC DRAINAGE NODULE", "count": 1}, {"letter": "Mg reduced", "count": 1}, {"letter": "Mg++ increased", "count": 2}, {"letter": "medication use", "count": 37}, {"letter": "Mediterranean", "count": 1}, {"letter": "Menstrual period late", "count": 2}, {"letter": "Mexican", "count": 1}, {"letter": "movement pain", "count": 8}, {"letter": "Muscle mass", "count": 14}, {"letter": "Night time", "count": 25}, {"letter": "opioid use", "count": 11}, {"letter": "birth control pill use", "count": 1}, {"letter": "Personality Change", "count": 1}, {"letter": "PROGRESSIVE SYMPTOMS", "count": 1}, {"letter": "Rural", "count": 4}, {"letter": "Winged scapula", "count": 1}, {"letter": "Sexually active", "count": 1}, {"letter": "Shoulder stiff", "count": 1}, {"letter": "Ecchymosis of skin", "count": 1}, {"letter": "Skin Induration", "count": 3}, {"letter": "Lichenification of skin", "count": 1}, {"letter": "Pain of skin", "count": 2}, {"letter": "Cutaneous plaque", "count": 2}, {"letter": "Scar Tissue", "count": 27}, {"letter": "spring (season)", "count": 2}, {"letter": "Does squat (finding)", "count": 8}, {"letter": "post operative (finding)", "count": 178}, {"letter": "UPPER EXTREMITY FLEXION", "count": 4}, {"letter": "Atrophy of vagina", "count": 9}, {"letter": "Vaginal dryness", "count": 1}, {"letter": "Wound hemorrhage", "count": 1}, {"letter": "X-linked inheritance", "count": 1}, {"letter": "combative", "count": 1}, {"letter": "Diabetic", "count": 3}, {"letter": "Familial", "count": 3}, {"letter": "Family history (finding)", "count": 26}, {"letter": "Generalized fatigue", "count": 12}, {"letter": "Hypomania", "count": 1}, {"letter": "Impairment of balance", "count": 1}, {"letter": "Pulmonary congestion", "count": 1}, {"letter": "Suspicion", "count": 1}, {"letter": "Violent", "count": 2}, {"letter": "Pelvic Inflammatory Disease", "count": 2}, {"letter": "Hypoxia", "count": 9}, {"letter": "SGOT - Glutamate oxaloacetate transaminase", "count": 14}, {"letter": "Data Files", "count": 1}, {"letter": "Bayesian Method", "count": 1}, {"letter": "Sugars", "count": 3}, {"letter": "Data Linkage", "count": 1}, {"letter": "Educational workshop", "count": 6}, {"letter": "Compassion", "count": 4}, {"letter": "Employment status", "count": 13}, {"letter": "Evaluation Report", "count": 4}, {"letter": "Serum folate level (result)", "count": 2}, {"letter": "Dietary Supplements", "count": 11}, {"letter": "Dietary Supplementation", "count": 19}, {"letter": "Fostering", "count": 1}, {"letter": "furuncle", "count": 2}, {"letter": "Dyslipidemias", "count": 2}, {"letter": "Immunocytochemistry", "count": 6}, {"letter": "Databases", "count": 29}, {"letter": "Partner Communication", "count": 1}, {"letter": "Malignant neoplasm of lung", "count": 6}, {"letter": "Lymph Node Dissection", "count": 10}, {"letter": "Immediate Recall", "count": 4}, {"letter": "Opioids", "count": 52}, {"letter": "Physiologic Coordination", "count": 2}, {"letter": "Logistics", "count": 4}, {"letter": "Satisfaction", "count": 382}, {"letter": "Sore Throat", "count": 1}, {"letter": "Population at Risk", "count": 7}, {"letter": "Policy", "count": 1}, {"letter": "Response Latency", "count": 1}, {"letter": "Thesaurus", "count": 2}, {"letter": "Interdisciplinary Studies", "count": 6}, {"letter": "Research Activities", "count": 97}, {"letter": "Summary Report", "count": 5}, {"letter": "Data Quality", "count": 12}, {"letter": "Measurement", "count": 2461}, {"letter": "Living Arrangements", "count": 1}, {"letter": "Relative Risk", "count": 16}, {"letter": "Self-Perception", "count": 7}, {"letter": "Unequal", "count": 2}, {"letter": "Fluorescence Spectroscopy", "count": 1}, {"letter": "Drug usage", "count": 10}, {"letter": "Inheritance", "count": 1}, {"letter": "Program Sustainability", "count": 1}, {"letter": "Risk Reduction Behavior", "count": 2}, {"letter": "Data Storage", "count": 2}, {"letter": "Residual Cancer", "count": 77}, {"letter": "Neoplasm, Residual", "count": 17}, {"letter": "Oxidative Stress", "count": 7}, {"letter": "Centrosome", "count": 2}, {"letter": "Sample Size", "count": 39}, {"letter": "CD8-Positive T-Lymphocytes", "count": 34}, {"letter": "T-helper cell type 1", "count": 1}, {"letter": "T-helper cell type 2", "count": 1}, {"letter": "Sickness Impact Profile", "count": 1}, {"letter": "P-Glycoprotein", "count": 3}, {"letter": "Disease Progression", "count": 362}, {"letter": "husband", "count": 1}, {"letter": "Reproductive Health", "count": 3}, {"letter": "Tibialis anterior muscle structure", "count": 1}, {"letter": "Skeletal muscle structure", "count": 8}, {"letter": "Soleus muscle structure", "count": 1}, {"letter": "Muscle Fibers", "count": 15}, {"letter": "Ventricular Dysfunction, Left", "count": 9}, {"letter": "Hyperoxia", "count": 1}, {"letter": "Plant Leaves", "count": 2}, {"letter": "Tropism", "count": 1}, {"letter": "Planet Mars", "count": 5}, {"letter": "Stem of plant", "count": 2}, {"letter": "disease transmission", "count": 1}, {"letter": "Progression-Free Survival", "count": 1156}, {"letter": "Disease-Free Survival", "count": 448}, {"letter": "Patient Recruitment", "count": 7}, {"letter": "Selection Criteria", "count": 2}, {"letter": "Patient Selection", "count": 5}, {"letter": "Sick Days", "count": 6}, {"letter": "Sick Leave", "count": 7}, {"letter": "Pliability", "count": 51}, {"letter": "Human body", "count": 7}, {"letter": "Saints", "count": 1}, {"letter": "Minisatellite Repeats", "count": 1}, {"letter": "Muscle Fibers, Fast-Twitch", "count": 1}, {"letter": "Blood Pressure Monitoring, Ambulatory", "count": 1}, {"letter": "Monitoring, Ambulatory", "count": 1}, {"letter": "Toxicity Tests", "count": 1}, {"letter": "Anesthetics, Intravenous", "count": 1}, {"letter": "Kolmogorov-Smirnov Test", "count": 5}, {"letter": "Mann-Whitney U Test", "count": 9}, {"letter": "Rank-Sum Tests", "count": 47}, {"letter": "Spearman Rank Correlation Coefficient", "count": 10}, {"letter": "Wilcoxon Rank Test", "count": 14}, {"letter": "Analgesics, Non-Narcotic", "count": 1}, {"letter": "Radiotherapy, Adjuvant", "count": 17}, {"letter": "Human Identification", "count": 1}, {"letter": "ERBB2 gene", "count": 98}, {"letter": "DNA Adducts", "count": 1}, {"letter": "Hand Strength", "count": 47}, {"letter": "Genetic Heterogeneity", "count": 5}, {"letter": "Systemic Inflammatory Response Syndrome", "count": 3}, {"letter": "Fat-Restricted Diet", "count": 1}, {"letter": "Diet, Protein-Restricted", "count": 1}, {"letter": "Radiation Oncology specialty", "count": 56}, {"letter": "Patient-Centered Care", "count": 1}, {"letter": "Genes, erbB", "count": 3}, {"letter": "Inflammation Mediators", "count": 1}, {"letter": "Heat-Shock Proteins 70", "count": 4}, {"letter": "HSP90 Heat-Shock Proteins", "count": 3}, {"letter": "Cyclin-Dependent Kinases", "count": 6}, {"letter": "Genetic Research", "count": 2}, {"letter": "defects aspect", "count": 9}, {"letter": "Analog", "count": 49}, {"letter": "assay qualifier", "count": 104}, {"letter": "inhibitors", "count": 4}, {"letter": "microvasculature", "count": 1}, {"letter": "sequelae aspects", "count": 8}, {"letter": "Finding", "count": 50}, {"letter": "Funding", "count": 3}, {"letter": "development aspects", "count": 6}, {"letter": "purification aspects", "count": 1}, {"letter": "occurrence characteristics", "count": 123}, {"letter": "science of Cytology and Pathology", "count": 3}, {"letter": "Histopathological aspects", "count": 1}, {"letter": "Uptake", "count": 49}, {"letter": "pharmacodynamic aspects", "count": 39}, {"letter": "control aspects", "count": 283}, {"letter": "cognitive aspects", "count": 4}, {"letter": "emotional aspects", "count": 4}, {"letter": "psychosocial aspects", "count": 4}, {"letter": "supply aspects", "count": 10}, {"letter": "peroperative procedures", "count": 1}, {"letter": "urinary levels", "count": 2}, {"letter": "numerical data", "count": 6}, {"letter": "pyruvate", "count": 3}, {"letter": "raloxifene", "count": 3}, {"letter": "4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine", "count": 1}, {"letter": "duloxetine", "count": 2}, {"letter": "docetaxel", "count": 111}, {"letter": "letrozole", "count": 132}, {"letter": "remifentanil", "count": 7}, {"letter": "nanocoll", "count": 1}, {"letter": "CEF regimen", "count": 2}, {"letter": "paricalcitol", "count": 3}, {"letter": "Cyclin-Dependent Kinase Inhibitor p16", "count": 4}, {"letter": "Phospholipase C beta", "count": 1}, {"letter": "WNT5A Protein, human", "count": 2}, {"letter": "Stat3 protein", "count": 1}, {"letter": "EIF4EBP1 protein, human", "count": 6}, {"letter": "Interleukin-15", "count": 1}, {"letter": "ANC 1", "count": 2}, {"letter": "B 003", "count": 7}, {"letter": "CDK7 protein, human", "count": 1}, {"letter": "zoledronic acid", "count": 27}, {"letter": "Wound dehiscence", "count": 17}, {"letter": "Dermatologist", "count": 4}, {"letter": "Diet, Carbohydrate-Restricted", "count": 2}, {"letter": "Oncologists", "count": 31}, {"letter": "Moxa", "count": 1}, {"letter": "tumor proteins", "count": 1}, {"letter": "Liquid nitrogen", "count": 1}, {"letter": "Proton magnetic resonance", "count": 1}, {"letter": "parent and child", "count": 1}, {"letter": "hospital pharmacies", "count": 1}, {"letter": "Physiologist", "count": 3}, {"letter": "Radical therapy", "count": 1}, {"letter": "Radiation--Measurement", "count": 1}, {"letter": "radiologist", "count": 24}, {"letter": "medical referral", "count": 2}, {"letter": "Oral and Maxillofacial Surgeons", "count": 6}, {"letter": "Technologist", "count": 7}, {"letter": "Need for influenza vaccination", "count": 2}, {"letter": "Family history of cancer", "count": 7}, {"letter": "examination; follow-up", "count": 4}, {"letter": "Laboratory examination", "count": 4}, {"letter": "Administration of analgesic", "count": 4}, {"letter": "Mammography abnormal", "count": 6}, {"letter": "anxiety generalized", "count": 3}, {"letter": "Breast tenderness", "count": 7}, {"letter": "cardiac problem", "count": 2}, {"letter": "Cerebral dysfunction", "count": 2}, {"letter": "Compression fracture of vertebral column", "count": 1}, {"letter": "COUNSELLING VISIT", "count": 1}, {"letter": "Molecular Abnormality", "count": 11}, {"letter": "History of present illness (finding)", "count": 3}, {"letter": "Pigmented skin lesion", "count": 2}, {"letter": "Seroma", "count": 20}, {"letter": "Recurrent urinary tract infection", "count": 1}, {"letter": "Research data collection", "count": 3}, {"letter": "drug management", "count": 21}, {"letter": "Urine protein test", "count": 1}, {"letter": "Medical History", "count": 28}, {"letter": "Skeletal bone", "count": 110}, {"letter": "Acute dermatitis", "count": 1}, {"letter": "Cutaneous Vasculitis", "count": 1}, {"letter": "Pyotraumatic dermatitis", "count": 3}, {"letter": "Keratosis pilaris", "count": 1}, {"letter": "Alopecia totalis", "count": 2}, {"letter": "Early radiation dermatitis", "count": 6}, {"letter": "Chronic radiodermatitis", "count": 1}, {"letter": "Disorder of skeletal system", "count": 4}, {"letter": "Osteoarthritis of the hand", "count": 1}, {"letter": "Non-infectious pneumonia", "count": 1}, {"letter": "Chronic heart failure", "count": 1}, {"letter": "Conduction disorder of the heart", "count": 1}, {"letter": "Severe sinus bradycardia", "count": 1}, {"letter": "Chronic acquired lymphedema", "count": 2}, {"letter": "Cohen syndrome", "count": 2}, {"letter": "Freeman-Sheldon syndrome", "count": 1}, {"letter": "Coffin-Siris syndrome", "count": 8}, {"letter": "Cat eye syndrome", "count": 1}, {"letter": "Congenital absence of lung", "count": 2}, {"letter": "Congenital anomaly of the kidney", "count": 1}, {"letter": "Actinic cheilitis", "count": 6}, {"letter": "Typhlitis", "count": 1}, {"letter": "Gross' disease", "count": 1}, {"letter": "Body fluid retention", "count": 4}, {"letter": "Hyperosmolality", "count": 1}, {"letter": "Triglyceride storage disease with ichthyosis", "count": 3}, {"letter": "Multiple Sulfatase Deficiency Disease", "count": 5}, {"letter": "Infantile neuronal ceroid lipofuscinosis", "count": 2}, {"letter": "Lysinuric Protein Intolerance", "count": 2}, {"letter": "Induration of breast", "count": 2}, {"letter": "Generalized Anxiety Disorder", "count": 21}, {"letter": "Infantile Neuroaxonal Dystrophy", "count": 1}, {"letter": "Toxic polyneuropathy", "count": 1}, {"letter": "Cortical cataract", "count": 4}, {"letter": "Glucose Intolerance (disease)", "count": 1}, {"letter": "Relative anemia", "count": 1}, {"letter": "Toxic neutropenia", "count": 1}, {"letter": "Familial Hemophagocytic Lymphocytosis", "count": 1}, {"letter": "Disorder of lymph node", "count": 2}, {"letter": "Fracture of temporal bone", "count": 2}, {"letter": "Lung Injury", "count": 1}, {"letter": "Injury due to exposure to external cause", "count": 6}, {"letter": "Selenium poisoning", "count": 1}, {"letter": "Trachymene species poisoning", "count": 1}, {"letter": "Struck", "count": 1}, {"letter": "primary disorders", "count": 7}, {"letter": "Recurrent disease", "count": 56}, {"letter": "Local disease", "count": 54}, {"letter": "Death of unknown cause", "count": 1}, {"letter": "Unexpected death", "count": 8}, {"letter": "Functional disorder", "count": 31}, {"letter": "Social stigmata", "count": 2}, {"letter": "Absence of signs", "count": 1}, {"letter": "Onset of illness", "count": 2}, {"letter": "Apyrexial", "count": 1}, {"letter": "Abnormal vital signs", "count": 4}, {"letter": "Anatomical position", "count": 1}, {"letter": "Sitting position", "count": 48}, {"letter": "Lying in bed", "count": 2}, {"letter": "Barefoot walking", "count": 3}, {"letter": "Mental state", "count": 3}, {"letter": "Acceptance of illness", "count": 2}, {"letter": "Sexual function", "count": 62}, {"letter": "Male sexual function", "count": 2}, {"letter": "Female sexual function", "count": 8}, {"letter": "Musth", "count": 5}, {"letter": "Absence of sensation", "count": 1}, {"letter": "Mild pain", "count": 14}, {"letter": "Moderate pain", "count": 24}, {"letter": "Severe pain", "count": 37}, {"letter": "Prognosis good", "count": 2}, {"letter": "Prognosis bad", "count": 5}, {"letter": "Local excision", "count": 2}, {"letter": "Prescribed", "count": 59}, {"letter": "Functional assessment", "count": 158}, {"letter": "Subcutaneous Tissue", "count": 4}, {"letter": "All extremities", "count": 1}, {"letter": "Structure of interdigital space", "count": 1}, {"letter": "Carcinoma breast stage I", "count": 3}, {"letter": "Breast cancer stage II", "count": 5}, {"letter": "Stage III Breast Cancer AJCC v6", "count": 6}, {"letter": "Carcinoma breast stage IV", "count": 135}, {"letter": "Stage IIIA Breast Carcinoma", "count": 1}, {"letter": "Breast cancer recurrent", "count": 35}, {"letter": "Metastatic Carcinoma to the Uterine Cervix", "count": 2}, {"letter": "Inflammatory Breast Carcinoma", "count": 11}, {"letter": "Radiation therapist", "count": 3}, {"letter": "oncology field", "count": 32}, {"letter": "Recurrent ovarian cancer", "count": 3}, {"letter": "Endometrial neoplasm malignant metastatic", "count": 1}, {"letter": "Adult Glioblastoma", "count": 1}, {"letter": "Metastatic melanoma", "count": 2}, {"letter": "chemoprevention of cancer", "count": 6}, {"letter": "New York Heart Association Class III/IV", "count": 5}, {"letter": "Metastatic non-small cell lung cancer", "count": 4}, {"letter": "Malignant Head and Neck Neoplasm", "count": 1}, {"letter": "Tumor Cell Derivative Vaccine", "count": 1}, {"letter": "Hormone Therapy", "count": 209}, {"letter": "Laser Therapy, Low-Level", "count": 1}, {"letter": "Childhood Solid Neoplasm", "count": 19}, {"letter": "Prior Radiation Therapy", "count": 4}, {"letter": "Doxil", "count": 3}, {"letter": "Hyperbaric Oxygen (substance)", "count": 1}, {"letter": "Plastic surgeon", "count": 13}, {"letter": "Lobular carcinoma in situ of breast", "count": 19}, {"letter": "Invasive Lobular Breast Carcinoma", "count": 1}, {"letter": "Monoclonal Antibody Therapy", "count": 1}, {"letter": "Conventional (Clear Cell) Renal Cell Carcinoma", "count": 5}, {"letter": "Premenopausal - menopausal status", "count": 24}, {"letter": "Estrogen receptor positive", "count": 34}, {"letter": "Estrogen receptor negative", "count": 31}, {"letter": "progesterone receptor positive", "count": 826}, {"letter": "progesterone receptor negative", "count": 56}, {"letter": "Negative Axillary Lymph Node", "count": 5}, {"letter": "chlorambucil/etoposide/lomustine", "count": 1}, {"letter": "aminoglutethimide/danazol/hydrocortisone/tamoxifen", "count": 5}, {"letter": "Adult Solid Neoplasm", "count": 4}, {"letter": "Solid Neoplasm", "count": 78}, {"letter": "stage, prostate cancer", "count": 1}, {"letter": "site, metastatic cancer", "count": 2}, {"letter": "altretamine/etoposide/methotrexate protocol", "count": 1}, {"letter": "metabolic abnormality assessment", "count": 10}, {"letter": "Aromatase Inhibition Therapy", "count": 2}, {"letter": "Bone Marrow Suppression", "count": 7}, {"letter": "Educational Intervention", "count": 10}, {"letter": "Screening for malignant neoplasm of breast", "count": 40}, {"letter": "Screening for Colorectal Cancer", "count": 9}, {"letter": "Screening for Prostate Cancer", "count": 2}, {"letter": "Cervical Cancer Screening", "count": 8}, {"letter": "Breast Cancer Prevention", "count": 7}, {"letter": "Cancer Prevention", "count": 1}, {"letter": "Prior Adjuvant Chemotherapy", "count": 1}, {"letter": "bilateral breast cancer", "count": 1}, {"letter": "Carboplatin/Paclitaxel", "count": 10}, {"letter": "antiangiogenesis therapy", "count": 2}, {"letter": "Cyclophosphamide/Epirubicin", "count": 3}, {"letter": "Adenocarcinoma of pancreas", "count": 1}, {"letter": "Cyclophosphamide/Doxorubicin/Paclitaxel", "count": 1}, {"letter": "interleukin-3/interleukin-6", "count": 1}, {"letter": "Screening for Ovarian Cancer", "count": 1}, {"letter": "Cyclophosphamide/Methotrexate Regimen", "count": 4}, {"letter": "Cisplatin/Etoposide/Paclitaxel", "count": 1}, {"letter": "Assessment of quality of life", "count": 116}, {"letter": "Daflon 500", "count": 10}, {"letter": "Skin problem", "count": 2}, {"letter": "Generalized aches and pains", "count": 4}, {"letter": "global assessment", "count": 12}, {"letter": "Placement Evaluation", "count": 1}, {"letter": "screening examination", "count": 4}, {"letter": "steroid use", "count": 2}, {"letter": "Surgery, Day", "count": 35}, {"letter": "Qigong", "count": 1}, {"letter": "Internet", "count": 47}, {"letter": "Recycling", "count": 1}, {"letter": "Collaboration", "count": 10}, {"letter": "Baseline Survey", "count": 5}, {"letter": "Respondents", "count": 66}, {"letter": "Tissue Stains", "count": 1}, {"letter": "Aplasia Cutis Congenita", "count": 1}, {"letter": "Relaxation Therapy", "count": 3}, {"letter": "Therapeutic Human Experimentation", "count": 2}, {"letter": "Virginity", "count": 1}, {"letter": "Sexual abuse", "count": 1}, {"letter": "Descriptors", "count": 18}, {"letter": "Thyronine", "count": 1}, {"letter": "Hormone replacement therapy", "count": 9}, {"letter": "Correspondence as Topic", "count": 15}, {"letter": "Overall Publication Type", "count": 689}, {"letter": "Technical Report", "count": 3}, {"letter": "Guideline [Publication Type]", "count": 21}, {"letter": "News [Publication Type]", "count": 7}, {"letter": "Randomized Controlled Trials as Topic", "count": 5}, {"letter": "Review Literature", "count": 3}, {"letter": "Review [Publication Type]", "count": 48}, {"letter": "Clinical Practice Guideline", "count": 3}, {"letter": "Meta-Analysis (publications)", "count": 2}, {"letter": "Phase 2 Clinical Trials", "count": 86}, {"letter": "Phase 3 Clinical Trials", "count": 3}, {"letter": "Phase 4 Clinical Trials", "count": 1}, {"letter": "Biodiversity", "count": 2}, {"letter": "Structure of germinal center of lymph node", "count": 1}, {"letter": "Surgical Endoscopy", "count": 4}, {"letter": "Chemoprevention", "count": 10}, {"letter": "Coculture Techniques", "count": 4}, {"letter": "chemokine", "count": 9}, {"letter": "Monocyte Chemoattractant Proteins", "count": 4}, {"letter": "Epitopes, T-Lymphocyte", "count": 1}, {"letter": "Delivery of Health Care, Integrated", "count": 1}, {"letter": "Myomatous neoplasm", "count": 1}, {"letter": "Vascular Neoplasms", "count": 2}, {"letter": "Phantoms, Imaging", "count": 1}, {"letter": "Acupressure (regime/therapy)", "count": 9}, {"letter": "Cell Respiration", "count": 10}, {"letter": "Critical Pathways", "count": 5}, {"letter": "Health food", "count": 4}, {"letter": "Antibodies, Blocking", "count": 1}, {"letter": "R-40", "count": 1}, {"letter": "Simulate composite resin", "count": 15}, {"letter": "N-telopeptide", "count": 14}, {"letter": "RAC-Alpha Serine/Threonine Kinase", "count": 2}, {"letter": "bicalutamide", "count": 10}, {"letter": "atorvastatin", "count": 4}, {"letter": "Platelet-Derived Growth Factor beta Receptor", "count": 1}, {"letter": "ADAM11 protein, human", "count": 1}, {"letter": "Reliance resin cement", "count": 1}, {"letter": "anastrozole", "count": 82}, {"letter": "AS 8", "count": 9}, {"letter": "caspase-3", "count": 17}, {"letter": "CA 27-29 antigen", "count": 6}, {"letter": "Receptor, Transforming Growth Factor-beta Type I", "count": 1}, {"letter": "FKBP12-rapamycin associated protein", "count": 1}, {"letter": "Antral", "count": 1}, {"letter": "8-isoprostaglandin F2alpha", "count": 1}, {"letter": "PO-2", "count": 1}, {"letter": "leptin", "count": 10}, {"letter": "SOX2 Transcription Factor", "count": 4}, {"letter": "colloid sulfur", "count": 3}, {"letter": "5-Trimethoxyamphetamine", "count": 1}, {"letter": "distilled alcoholic beverage", "count": 2}, {"letter": "Metabolic Suppression", "count": 23}, {"letter": "Competitive inhibition", "count": 2}, {"letter": "Reduction (chemical)", "count": 35}, {"letter": "phosphatidylserine", "count": 3}, {"letter": "Indirect reacting bilirubin", "count": 1}, {"letter": "Steroid hormone", "count": 2}, {"letter": "Hypothalamic inhibiting factor", "count": 2}, {"letter": "Immunostimulating conjugate (antigen)", "count": 3}, {"letter": "Graft acceptance", "count": 10}, {"letter": "Fragility", "count": 6}, {"letter": "Leucocytic infiltrate", "count": 1}, {"letter": "Telephone Call", "count": 18}, {"letter": "Cell Therapy", "count": 1}, {"letter": "Thiocyanate measurement", "count": 3}, {"letter": "Systemic poison", "count": 2}, {"letter": "Therapeutic", "count": 7}, {"letter": "Test of Visual Evoked Responses in Children", "count": 2}, {"letter": "Pathological fracture of vertebra", "count": 2}, {"letter": "Observation in research", "count": 9}, {"letter": "spells (neurological symptom)", "count": 1}, {"letter": "iron", "count": 4}, {"letter": "Disorder calcium (NOS)", "count": 1}, {"letter": "Cervix carcinoma", "count": 13}, {"letter": "Skin tanning", "count": 1}, {"letter": "Angiogenic Process", "count": 22}, {"letter": "Liquid Crystals", "count": 2}, {"letter": "Guide device", "count": 27}, {"letter": "Couples Therapy", "count": 1}, {"letter": "Instruction [Publication Type]", "count": 2}, {"letter": "Vitamin supplementation", "count": 1}, {"letter": "Native (qualifier value)", "count": 10}, {"letter": "Liquid substance", "count": 15}, {"letter": "solid substance", "count": 28}, {"letter": "Radicals (chemistry)", "count": 1}, {"letter": "Carbon-11", "count": 1}, {"letter": "Fluorine-18", "count": 32}, {"letter": "iodine I-131", "count": 3}, {"letter": "Copper-64", "count": 1}, {"letter": "chromium Cr-51", "count": 2}, {"letter": "Gallium-68", "count": 5}, {"letter": "Radium-223", "count": 2}, {"letter": "Thorium-227", "count": 2}, {"letter": "Palladium-100", "count": 1}, {"letter": "Yttrium-90", "count": 1}, {"letter": "technetium 99m", "count": 7}, {"letter": "Blue light", "count": 1}, {"letter": "Fluorescent stain", "count": 9}, {"letter": "Prescription Drugs", "count": 2}, {"letter": "Experimental drug", "count": 1}, {"letter": "Therapeutic agent", "count": 2}, {"letter": "Potassium supplement", "count": 3}, {"letter": "Cytotoxic agent (product)", "count": 3}, {"letter": "Nail polish", "count": 2}, {"letter": "albumin human, USP", "count": 2}, {"letter": "Gamma globulin serum", "count": 1}, {"letter": "favor", "count": 5}, {"letter": "FLAIR (product)", "count": 1}, {"letter": "PREVENT (product)", "count": 57}, {"letter": "SABER (substance)", "count": 3}, {"letter": "survive", "count": 48}, {"letter": "Today", "count": 5}, {"letter": "VITAMIN A/VITAMIN D", "count": 4}, {"letter": "Severe malnutrition", "count": 1}, {"letter": "Obesity, Abdominal", "count": 1}, {"letter": "Physical findings", "count": 134}, {"letter": "Difficulty walking", "count": 1}, {"letter": "Metabolic", "count": 1}, {"letter": "catabolic", "count": 1}, {"letter": "inhibited", "count": 3}, {"letter": "Oxidative", "count": 2}, {"letter": "fluid pressure", "count": 2}, {"letter": "Bioaccumulation", "count": 1}, {"letter": "Exudative", "count": 1}, {"letter": "Increased bilirubin level (finding)", "count": 2}, {"letter": "DNA, Double-Stranded", "count": 1}, {"letter": "Alkaline phosphatase isoenzyme, bone fraction", "count": 16}, {"letter": "Menstrual spotting", "count": 1}, {"letter": "Personality Sensitivity", "count": 7}, {"letter": "Free thyroxin", "count": 2}, {"letter": "Neoantigen", "count": 11}, {"letter": "T cell antibody", "count": 2}, {"letter": "Response to immunization", "count": 2}, {"letter": "Immune effector cell", "count": 4}, {"letter": "Blood group antigen p k", "count": 273}, {"letter": "Blood group antigen Sd^a^", "count": 2}, {"letter": "Genetic", "count": 38}, {"letter": "Human gene", "count": 2}, {"letter": "Genetic Predisposition to Disease", "count": 2}, {"letter": "Infectious agent", "count": 2}, {"letter": "Cellulosimicrobium cellulans", "count": 1}, {"letter": "Canine enteric calicivirus", "count": 2}, {"letter": "Equus asinus", "count": 13}, {"letter": "Rex cat breed (mammal)", "count": 3}, {"letter": "Meriones unguiculatus", "count": 1}, {"letter": "Polar Bears", "count": 1}, {"letter": "Martes pennanti", "count": 11}, {"letter": "Phocidae", "count": 3}, {"letter": "Meleagris gallopavo", "count": 1}, {"letter": "Ani (bird)", "count": 1}, {"letter": "nightingale", "count": 1}, {"letter": "Cardinalis cardinalis", "count": 1}, {"letter": "Trachinotus falcatus", "count": 2}, {"letter": "Cone (plant)", "count": 10}, {"letter": "Juniperus oxycedrus", "count": 2}, {"letter": "Ginkgo biloba", "count": 1}, {"letter": "Piper", "count": 16}, {"letter": "Beta plant", "count": 11}, {"letter": "Gossypium hirsutum", "count": 1}, {"letter": "Acer", "count": 2}, {"letter": "basel", "count": 1}, {"letter": "High Chemical", "count": 1}, {"letter": "Johnson and Johnson", "count": 2}, {"letter": "campbell", "count": 1}, {"letter": "Roche (company)", "count": 4}, {"letter": "Ross - Pharmaceutical Company", "count": 1}, {"letter": "Phoenix Pharmaceuticals", "count": 4}, {"letter": "3M pharmaceuticals", "count": 2}, {"letter": "DeKroyft-Metz health care distributor", "count": 1}, {"letter": "Past history of", "count": 1}, {"letter": "No family history of", "count": 1}, {"letter": "No evidence of", "count": 6}, {"letter": "No treatment required for", "count": 5}, {"letter": "Examined", "count": 123}, {"letter": "Prior diagnosis", "count": 4}, {"letter": "Preliminary diagnosis qualifier value", "count": 7}, {"letter": "Principal diagnosis", "count": 4}, {"letter": "Secondary diagnosis", "count": 1}, {"letter": "Diagnosis, clinical", "count": 2}, {"letter": "Pathology diagnosis", "count": 4}, {"letter": "Final diagnosis (discharge)", "count": 18}, {"letter": "Suspected diagnosis", "count": 36}, {"letter": "Probable diagnosis", "count": 14}, {"letter": "Possible", "count": 39}, {"letter": "Before", "count": 353}, {"letter": "Requested by patient", "count": 11}, {"letter": "Did not receive therapy or drug for", "count": 61}, {"letter": "Return to (contextual qualifier) (qualifier value)", "count": 108}, {"letter": "Exposure to", "count": 135}, {"letter": "Contact with", "count": 51}, {"letter": "Onset of (contextual qualifier)", "count": 26}, {"letter": "Moderate risk of", "count": 1}, {"letter": "High risk of", "count": 71}, {"letter": "Time frame (qualifier value)", "count": 42}, {"letter": "Daytime", "count": 29}, {"letter": "Morning", "count": 9}, {"letter": "Daily", "count": 289}, {"letter": "Weekly", "count": 739}, {"letter": "Monthly (qualifier value)", "count": 449}, {"letter": "Trimonthly", "count": 34}, {"letter": "Annual", "count": 62}, {"letter": "Periodic", "count": 7}, {"letter": "Frequently", "count": 73}, {"letter": "Recent", "count": 54}, {"letter": "Definite time", "count": 5}, {"letter": "Episode of", "count": 33}, {"letter": "Impending", "count": 1}, {"letter": "Posterolateral", "count": 1}, {"letter": "Exclude", "count": 18}, {"letter": "Absent", "count": 50}, {"letter": "Blocking", "count": 16}, {"letter": "Acinar", "count": 1}, {"letter": "Difficult (qualifier value)", "count": 7}, {"letter": "Easy", "count": 229}, {"letter": "Cross-linking", "count": 4}, {"letter": "Satellite (minor structure)", "count": 3}, {"letter": "Approximate", "count": 171}, {"letter": "Topical surface", "count": 7}, {"letter": "Indifferent", "count": 2}, {"letter": "Young", "count": 23}, {"letter": "Equivocal", "count": 18}, {"letter": "Sliding", "count": 2}, {"letter": "Evolving", "count": 3}, {"letter": "Fragment of (qualifier value)", "count": 1}, {"letter": "Containing (qualifier)", "count": 50}, {"letter": "Including (qualifier)", "count": 1469}, {"letter": "Compressing (action)", "count": 5}, {"letter": "Spreading (qualifier value)", "count": 4}, {"letter": "Lacking", "count": 38}, {"letter": "Alternating", "count": 9}, {"letter": "Worsening pattern", "count": 3}, {"letter": "Better", "count": 476}, {"letter": "Through", "count": 80}, {"letter": "Associated with", "count": 557}, {"letter": "Following", "count": 643}, {"letter": "Followed by", "count": 496}, {"letter": "Arising in", "count": 2}, {"letter": "Within", "count": 902}, {"letter": "Into", "count": 15}, {"letter": "In addition to", "count": 1919}, {"letter": "Without", "count": 133}, {"letter": "Transmitted by", "count": 2}, {"letter": "Consistent with", "count": 30}, {"letter": "Independent of", "count": 34}, {"letter": "Treated with", "count": 266}, {"letter": "Resulting in", "count": 76}, {"letter": "Free of (attribute)", "count": 389}, {"letter": "Bounded by", "count": 3}, {"letter": "Controlled by", "count": 2}, {"letter": "Suggestive of", "count": 9}, {"letter": "Except for", "count": 12}, {"letter": "Radiating to", "count": 3}, {"letter": "Brought on by", "count": 4}, {"letter": "Relieved by", "count": 3}, {"letter": "With staging", "count": 44}, {"letter": "Quality", "count": 267}, {"letter": "Type - attribute", "count": 414}, {"letter": "With time", "count": 13}, {"letter": "Sensitive", "count": 33}, {"letter": "Resistant (qualifier value)", "count": 24}, {"letter": "pT0 Stage Finding", "count": 13}, {"letter": "pT1 stage", "count": 2}, {"letter": "pT2 Stage Finding", "count": 1}, {"letter": "pN0 Stage Finding", "count": 7}, {"letter": "pN1 category", "count": 3}, {"letter": "Normal tissue morphology", "count": 42}, {"letter": "Morphologically abnormal structure (morphologic abnormality)", "count": 1}, {"letter": "Infiltration", "count": 38}, {"letter": "Minimal lesion", "count": 1}, {"letter": "Disruption", "count": 35}, {"letter": "disrupted", "count": 1}, {"letter": "Compressed structure", "count": 4}, {"letter": "Plaque (lesion)", "count": 3}, {"letter": "Folded structure", "count": 48}, {"letter": "Widening", "count": 36}, {"letter": "Shapes", "count": 30}, {"letter": "Abnormal shape", "count": 1}, {"letter": "Round shape", "count": 17}, {"letter": "Spherical shape", "count": 3}, {"letter": "Normal size", "count": 16}, {"letter": "Abnormal size", "count": 1}, {"letter": "Increased size (finding)", "count": 3}, {"letter": "Increase in circumference", "count": 1}, {"letter": "Decreased size", "count": 16}, {"letter": "Shrinkage", "count": 202}, {"letter": "Asymmetry (qualifier value)", "count": 10}, {"letter": "Symmetrical", "count": 22}, {"letter": "Circumference", "count": 69}, {"letter": "Retraction (finding)", "count": 22}, {"letter": "Decreased thickness", "count": 1}, {"letter": "Consistency", "count": 480}, {"letter": "Induration", "count": 16}, {"letter": "Friability (finding)", "count": 1}, {"letter": "Abnormal color", "count": 1}, {"letter": "macular", "count": 1}, {"letter": "Redness", "count": 13}, {"letter": "Green color", "count": 6}, {"letter": "Pink color", "count": 1}, {"letter": "Abnormal number", "count": 1}, {"letter": "Normal morphological distribution", "count": 1}, {"letter": "Aggregation", "count": 26}, {"letter": "Dispersion", "count": 37}, {"letter": "No evidence of neoplasm", "count": 11}, {"letter": "Traumatic", "count": 7}, {"letter": "minor injury", "count": 8}, {"letter": "Thermal injury", "count": 1}, {"letter": "Surgical wound", "count": 3}, {"letter": "Transplanted tissue", "count": 4}, {"letter": "Traumatic implants", "count": 2}, {"letter": "Divide", "count": 406}, {"letter": "Operative site", "count": 2}, {"letter": "Anastomosis", "count": 1}, {"letter": "Persistent embryonic structure", "count": 78}, {"letter": "shift displacement", "count": 30}, {"letter": "Version", "count": 870}, {"letter": "Anteversion", "count": 2}, {"letter": "Retroversion", "count": 1}, {"letter": "protrusion", "count": 1}, {"letter": "deformed", "count": 8}, {"letter": "Retention of content", "count": 26}, {"letter": "Retained", "count": 32}, {"letter": "Narrow", "count": 3}, {"letter": "Acute obstruction", "count": 1}, {"letter": "thromboembolic", "count": 1}, {"letter": "Accumulation of fluid", "count": 7}, {"letter": "Acute edema", "count": 1}, {"letter": "Pitting edema", "count": 3}, {"letter": "Massive edema", "count": 1}, {"letter": "Extravasation of lymph", "count": 2}, {"letter": "Hemorrhagic", "count": 1}, {"letter": "Body cavities", "count": 11}, {"letter": "Inflammatory", "count": 109}, {"letter": "Acute inflammation", "count": 3}, {"letter": "Acute and chronic inflammation", "count": 1}, {"letter": "Chronic lymphocytic inflammation", "count": 3}, {"letter": "Tumor necrosis", "count": 4}, {"letter": "Deposition", "count": 8}, {"letter": "Fatty infiltration", "count": 1}, {"letter": "Pigmented", "count": 1}, {"letter": "Atrophic", "count": 9}, {"letter": "Depletion", "count": 4}, {"letter": "Chimerism", "count": 3}, {"letter": "Abnormal cell", "count": 3}, {"letter": "Central cores", "count": 1}, {"letter": "Cleaved cell", "count": 7}, {"letter": "Cytologic atypia", "count": 1}, {"letter": "Binucleate cell", "count": 2}, {"letter": "Stain reaction", "count": 1}, {"letter": "Atypical hyperplasia", "count": 2}, {"letter": "Epithelialization", "count": 1}, {"letter": "Mild dysplasia", "count": 223}, {"letter": "Moderate dysplasia", "count": 30}, {"letter": "Proliferation (morphologic abnormality)", "count": 74}, {"letter": "Epithelial proliferation", "count": 1}, {"letter": "fibrotic", "count": 1}, {"letter": "Sclerotic (qualifier value)", "count": 1}, {"letter": "Surgical scar", "count": 8}, {"letter": "adherent", "count": 10}, {"letter": "Tumor cells, malignant", "count": 52}, {"letter": "Benign Epithelioma", "count": 1}, {"letter": "Adenocarcinoma in Situ", "count": 11}, {"letter": "Non-infiltrating lobular carcinoma", "count": 8}, {"letter": "Medical pathologist", "count": 58}, {"letter": "Orthopedic Surgeons", "count": 1}, {"letter": "Diagnostic radiologist", "count": 1}, {"letter": "Statistician", "count": 5}, {"letter": "Actuary", "count": 1}, {"letter": "Actor", "count": 1}, {"letter": "manager", "count": 1}, {"letter": "Messenger (Occupation)", "count": 1}, {"letter": "Demonstrator", "count": 2}, {"letter": "Cooking (activity)", "count": 1}, {"letter": "Cartwright", "count": 1}, {"letter": "Carpenter, general (occupation)", "count": 2}, {"letter": "Metal device", "count": 1}, {"letter": "Robotic arm", "count": 1}, {"letter": "Wig, device", "count": 1}, {"letter": "Therapeutic Device", "count": 1}, {"letter": "Measuring tape", "count": 38}, {"letter": "Patient scale", "count": 27}, {"letter": "Endotracheal tube", "count": 1}, {"letter": "Electronic monitor, device (physical object)", "count": 2}, {"letter": "Fist", "count": 1}, {"letter": "Dart missile", "count": 5}, {"letter": "Spear", "count": 1}, {"letter": "Arrow", "count": 4}, {"letter": "Ladder", "count": 1}, {"letter": "Matches", "count": 3}, {"letter": "Machine", "count": 12}, {"letter": "Combine", "count": 40}, {"letter": "Tool, device (physical object)", "count": 12}, {"letter": "Pliers", "count": 1}, {"letter": "Railway train", "count": 9}, {"letter": "Motor bus", "count": 1}, {"letter": "Tank - military vehicle", "count": 1}, {"letter": "Leisure physical activity", "count": 11}, {"letter": "Work-related activity", "count": 3}, {"letter": "Hot water", "count": 1}, {"letter": "Lake (environment)", "count": 3}, {"letter": "Environmental pool", "count": 4}, {"letter": "Electrical battery", "count": 47}, {"letter": "Entrance", "count": 1}, {"letter": "Chain device", "count": 2}, {"letter": "Scaffold", "count": 1}, {"letter": "Physical restraint equipment (device)", "count": 93}, {"letter": "Quadrantectomy of breast", "count": 7}, {"letter": "Estradiol measurement", "count": 11}, {"letter": "Glucagon measurement", "count": 1}, {"letter": "Glucose measurement", "count": 3}, {"letter": "Thyroglobulin measurement", "count": 2}, {"letter": "Psychosocial status", "count": 2}, {"letter": "Social Factors", "count": 1}, {"letter": "Sister", "count": 1}, {"letter": "Brothers", "count": 1}, {"letter": "Bachelor", "count": 1}, {"letter": "contact person", "count": 5}, {"letter": "Smoker", "count": 3}, {"letter": "Non-smoker", "count": 1}, {"letter": "Mormon", "count": 26}, {"letter": "Economic Status", "count": 2}, {"letter": "Austrians", "count": 1}, {"letter": "Greeks", "count": 1}, {"letter": "Norwegians (ethnic group)", "count": 2}, {"letter": "Poles", "count": 1}, {"letter": "Indonesians", "count": 1}, {"letter": "Site of care", "count": 9}, {"letter": "Private physicians' group office", "count": 2}, {"letter": "Disease/diagnosis", "count": 5}, {"letter": "Herceptin", "count": 45}, {"letter": "Intraoperative radiation therapy", "count": 24}, {"letter": "Cisplatin/Gemcitabine", "count": 5}, {"letter": "Paclitaxel/Trastuzumab", "count": 3}, {"letter": "Postoperative hematoma", "count": 2}, {"letter": "Frontotemporal dementia", "count": 13}, {"letter": "Impaired cognition", "count": 43}, {"letter": "Mixed anxiety and depressive disorder", "count": 58}, {"letter": "Vitelliform Macular Dystrophy", "count": 1}, {"letter": "Transjugular intrahepatic portosystemic shunt procedure", "count": 5}, {"letter": "Familial dilated cardiomyopathy", "count": 16}, {"letter": "Myocardial dysfunction", "count": 1}, {"letter": "Venous hemorrhage", "count": 1}, {"letter": "Electromechanical dissociation", "count": 1}, {"letter": "Anaphylactoid Reaction", "count": 1}, {"letter": "Bone marrow transplant failure", "count": 1}, {"letter": "Counsel - legal", "count": 2}, {"letter": "Adult Fanconi syndrome", "count": 14}, {"letter": "Severe pre-eclampsia", "count": 2}, {"letter": "Euthyroid hypothyroxinemia", "count": 1}, {"letter": "Hypophysitis", "count": 1}, {"letter": "Electrolyte imbalance", "count": 1}, {"letter": "Fish-Eye Disease", "count": 14}, {"letter": "Milia, Multiple Eruptive", "count": 3}, {"letter": "Capillary Leak Syndrome", "count": 1}, {"letter": "Drainage of abscess", "count": 1}, {"letter": "Magnetic resonance imaging of breast", "count": 58}, {"letter": "Sedation procedure", "count": 17}, {"letter": "Supportive care", "count": 20}, {"letter": "Absence of pain sensation", "count": 8}, {"letter": "Blistering eruption", "count": 1}, {"letter": "Depressed mood", "count": 39}, {"letter": "Body Fat", "count": 15}, {"letter": "Personal status", "count": 1}, {"letter": "Vegan diet", "count": 1}, {"letter": "Stomach cramps (finding)", "count": 1}, {"letter": "Bilirubin measurement", "count": 2}, {"letter": "Hydrogen breath test", "count": 2}, {"letter": "Histology Procedure", "count": 44}, {"letter": "Aniridia type 1", "count": 495}, {"letter": "Left ventricular abnormality", "count": 1}, {"letter": "Malignant neoplasm of liver", "count": 1}, {"letter": "Stage 0 Skin Melanoma", "count": 4}, {"letter": "Breast Cancer, Familial", "count": 4}, {"letter": "Benign neoplasm of breast", "count": 2}, {"letter": "Multiple malignancy", "count": 1}, {"letter": "Malignant neoplasm of pancreas", "count": 8}, {"letter": "Disseminated Malignant Neoplasm", "count": 52}, {"letter": "Secondary malignant neoplasm of bone marrow", "count": 4}, {"letter": "Secondary malignant neoplasm of female breast", "count": 14}, {"letter": "Secondary malignant neoplasm of spinal cord", "count": 1}, {"letter": "Buckle fracture", "count": 1}, {"letter": "Chest swelling", "count": 1}, {"letter": "Chest mass", "count": 1}, {"letter": "Limb Prosthesis", "count": 4}, {"letter": "percent uptake", "count": 136}, {"letter": "Feet, unit of measurement", "count": 13}, {"letter": "cells/L", "count": 1}, {"letter": "During", "count": 247}, {"letter": "During values", "count": 68}, {"letter": "Metals, Heavy", "count": 2}, {"letter": "Physical object", "count": 19}, {"letter": "Surgical transfer - action", "count": 1}, {"letter": "Venous", "count": 6}, {"letter": "Intravenous", "count": 23}, {"letter": "Thyroid dysfunction", "count": 1}, {"letter": "Open approach", "count": 9}, {"letter": "Diagnostic", "count": 111}, {"letter": "taught", "count": 1}, {"letter": "Qualitative form", "count": 16}, {"letter": "Condition", "count": 45}, {"letter": "Quantitative impedance", "count": 1}, {"letter": "Malignant Central Nervous System Neoplasm", "count": 1}, {"letter": "Toxic liver disease", "count": 2}, {"letter": "Mental and behavioral disorders due to use of alcohol, harmful use", "count": 7}, {"letter": "Nonorganic psychosis", "count": 1}, {"letter": "Depressive episode, unspecified", "count": 1}, {"letter": "Other anxiety disorders", "count": 1}, {"letter": "Behavioral syndrome associated with physiological disturbance and physical factors", "count": 1}, {"letter": "Red wine (substance)", "count": 1}, {"letter": "White wine", "count": 2}, {"letter": "Potato chips", "count": 1}, {"letter": "Single organ dysfunction", "count": 2}, {"letter": "Nature", "count": 5}, {"letter": "Aspiration-action", "count": 7}, {"letter": "endometriosis drugs", "count": 1}, {"letter": "oral supplement", "count": 1}, {"letter": "Pneumococcal vaccine", "count": 2}, {"letter": "Immune Globulin (Human)", "count": 2}, {"letter": "Muscle relaxants", "count": 2}, {"letter": "Analgesics and non-steroidal anti-inflammatory drugs", "count": 1}, {"letter": "Enrich (product)", "count": 18}, {"letter": "Provide (product)", "count": 1}, {"letter": "morphine Oral Product", "count": 3}, {"letter": "Oral form dexamethasone", "count": 1}, {"letter": "mometasone", "count": 2}, {"letter": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", "count": 5}, {"letter": "Prediabetes syndrome", "count": 5}, {"letter": "pH:LsCnc:Pt:Ser/Plas:Qn", "count": 3}, {"letter": "Specimen volume:Vol:Pt:Bld:Qn", "count": 4}, {"letter": "Specimen volume:Vol:Pt:Plas:Qn", "count": 5}, {"letter": "Specimen volume:Vol:Pt:XXX:Qn", "count": 2}, {"letter": "cisplatin dose", "count": 1}, {"letter": "digoxin dose", "count": 1}, {"letter": "fentanyl:mass:point in time:dose med or substance:quantitative", "count": 3}, {"letter": "midazolam:mass:point in time:dose med or substance:quantitative", "count": 3}, {"letter": "morphine dose", "count": 8}, {"letter": "Total bilirubin level", "count": 10}, {"letter": "Carbon dioxide, total", "count": 1}, {"letter": "Colony count", "count": 1}, {"letter": "Cytomegalovirus DNA", "count": 1}, {"letter": "Epstein-Barr virus DNA", "count": 1}, {"letter": "Free estradiol", "count": 3}, {"letter": "H NOS Antibodies", "count": 4}, {"letter": "Hexokinase 1", "count": 1}, {"letter": "M NOS ANTIBODY", "count": 61}, {"letter": "N not otherwise specified Antibody", "count": 75}, {"letter": "Molecular oxygen saturation", "count": 10}, {"letter": "P Blood group antibodies", "count": 41}, {"letter": "Specimen", "count": 232}, {"letter": "Specimen mass", "count": 2}, {"letter": "Specimen volume", "count": 2}, {"letter": "Bioavailable testosterone", "count": 2}, {"letter": "Aspirate substance", "count": 1}, {"letter": "whole blood", "count": 7}, {"letter": "Arsenic measurement", "count": 291}, {"letter": "Glycated Proteins", "count": 1}, {"letter": "Magnesium measurement", "count": 1}, {"letter": "Progesterone measurement", "count": 1}, {"letter": "Pyruvate kinase measurement", "count": 84}, {"letter": "Therapeutic procedure, one or more areas, each 15 minutes; massage, including effleurage, petrissage and/or tapotement (stroking, compression, percussion)", "count": 2}, {"letter": "Therapeutic procedure(s), group (2 or more individuals)", "count": 35}, {"letter": "Surgical repair", "count": 11}, {"letter": "Malignant neoplasm of vulva", "count": 1}, {"letter": "SGPT - Glutamate pyruvate transaminase", "count": 1}, {"letter": "Marrow", "count": 5}, {"letter": "Comb animal structure", "count": 2}, {"letter": "Gastrin", "count": 1}, {"letter": "Opiates", "count": 2}, {"letter": "Individual Adjustment", "count": 30}, {"letter": "The Sun", "count": 2}, {"letter": "Dutch Language", "count": 2}, {"letter": "financial", "count": 17}, {"letter": "funding aspects", "count": 3}, {"letter": "Japanese language", "count": 5}, {"letter": "Maori Language", "count": 2}, {"letter": "With frequency", "count": 201}, {"letter": "Portuguese language", "count": 2}, {"letter": "lactate", "count": 1}, {"letter": "PLAUR protein, human", "count": 2}, {"letter": "Machine Learning", "count": 3}, {"letter": "Behavior Control", "count": 2}, {"letter": "Cardiac Death", "count": 17}, {"letter": "Consensus", "count": 16}, {"letter": "Oral Examination", "count": 2}, {"letter": "Manufactured form", "count": 55}, {"letter": "Protein Glycosylation", "count": 1}, {"letter": "International Aspects", "count": 1}, {"letter": "fMRI", "count": 16}, {"letter": "National Health and Nutrition Examination Survey", "count": 5}, {"letter": "Malignant neoplasm of prostate", "count": 10}, {"letter": "Delayed Memory", "count": 3}, {"letter": "Research Priorities", "count": 1}, {"letter": "Ventilation Tests", "count": 1}, {"letter": "Tai Ji", "count": 3}, {"letter": "Patient Non-Compliance", "count": 6}, {"letter": "Granulovirus", "count": 4}, {"letter": "Patient Preference", "count": 20}, {"letter": "DNA Methylation", "count": 6}, {"letter": "Retreatments", "count": 16}, {"letter": "BCL2 gene", "count": 3}, {"letter": "Adoptive Cell Transfer", "count": 1}, {"letter": "Adoptive Transfer", "count": 1}, {"letter": "Spectroscopy, Near-Infrared", "count": 2}, {"letter": "Entropy", "count": 5}, {"letter": "Capnography", "count": 1}, {"letter": "Hematologic Neoplasms", "count": 13}, {"letter": "Knowledge", "count": 136}, {"letter": "Humoralism", "count": 1}, {"letter": "Life", "count": 177}, {"letter": "Recombinant Granulocyte Colony Stimulating Factor", "count": 1}, {"letter": "BRCA1 gene", "count": 7}, {"letter": "Torque", "count": 5}, {"letter": "Vaccines, DNA", "count": 2}, {"letter": "ABCB1 gene", "count": 1}, {"letter": "Insurance Coverage", "count": 2}, {"letter": "Disease Management", "count": 7}, {"letter": "Addresses (publication format)", "count": 4}, {"letter": "Animation", "count": 2}, {"letter": "Catalogs", "count": 1}, {"letter": "Cancer Vaccines", "count": 1}, {"letter": "Diary", "count": 71}, {"letter": "DNA Fragmentation", "count": 1}, {"letter": "Postprandial Period", "count": 4}, {"letter": "Poster", "count": 2}, {"letter": "Health Care Surveys", "count": 1}, {"letter": "Area Under Curve", "count": 447}, {"letter": "Programs - Publication Format", "count": 29}, {"letter": "CEACAM8 protein, human", "count": 1}, {"letter": "((5,6-dichloro-2,3,9,9a-tetrahydro-3-oxo-9a-propyl-1H-fluoren-7-yl)oxy)acetic acid", "count": 2}, {"letter": "Vascular Endothelial Growth Factor Receptor-1", "count": 2}, {"letter": "Vascular Endothelial Growth Factor Receptor-2", "count": 7}, {"letter": "WHO 2017", "count": 1}, {"letter": "ibandronate", "count": 1}, {"letter": "pros protein, Drosophila", "count": 1}, {"letter": "caveolin 1", "count": 3}, {"letter": "mesothelin", "count": 1}, {"letter": "Platinol-Fluororuracil Regimen", "count": 33}, {"letter": "ferumoxtran-10", "count": 1}, {"letter": "TM 1", "count": 1}, {"letter": "Cyclin D", "count": 2}, {"letter": "Vascular Endothelial Growth Factor C", "count": 2}, {"letter": "Adiponectin", "count": 2}, {"letter": "RET protein, human", "count": 3}, {"letter": "PicoGreen", "count": 1}, {"letter": "Blood viscosity examination", "count": 2}, {"letter": "Physiologic pulse", "count": 11}, {"letter": "Physical activity decreased", "count": 1}, {"letter": "Pain Disorder", "count": 10}, {"letter": "Providing presence (regime/therapy)", "count": 269}, {"letter": "Clammy skin", "count": 2}, {"letter": "Influenza-like symptoms", "count": 1}, {"letter": "pedaling", "count": 4}, {"letter": "Physiologic warmth", "count": 6}, {"letter": "Blood glucose measurement", "count": 2}, {"letter": "Nutritional status", "count": 23}, {"letter": "scalpel", "count": 2}, {"letter": "Lights, manufactured", "count": 1}, {"letter": "Breast infection", "count": 1}, {"letter": "Ability to perform cognitive activity", "count": 24}, {"letter": "cooperation", "count": 1}, {"letter": "Cutaneous Receptive Fields", "count": 2}, {"letter": "Hope (emotion)", "count": 23}, {"letter": "ideation", "count": 2}, {"letter": "information seeking", "count": 1}, {"letter": "Intrinsic motivation", "count": 2}, {"letter": "life satisfaction", "count": 15}, {"letter": "Prayer", "count": 3}, {"letter": "Indication of (contextual qualifier)", "count": 264}, {"letter": "Decreased platelet count", "count": 6}, {"letter": "Counts per minute", "count": 5}, {"letter": "Hereditary hemochromatosis", "count": 1}, {"letter": "Induced abortion (procedure)", "count": 2}, {"letter": "Adverse effect of radiation therapy", "count": 10}, {"letter": "Postoperative infection", "count": 1}, {"letter": "Adaptation", "count": 76}, {"letter": "Exhaustion", "count": 21}, {"letter": "Dysesthesia", "count": 2}, {"letter": "Lengthened (qualifier value)", "count": 1}, {"letter": "Changing", "count": 4050}, {"letter": "Collapsed", "count": 3}, {"letter": "In prison (finding)", "count": 1}, {"letter": "Localized", "count": 25}, {"letter": "Reduced", "count": 299}, {"letter": "Affecting", "count": 86}, {"letter": "Timed", "count": 16}, {"letter": "Quantitative (qualifier value)", "count": 123}, {"letter": "infusion of drug", "count": 5}, {"letter": "Articular system", "count": 1}, {"letter": "Vaginal secretion", "count": 2}, {"letter": "Topography Axis", "count": 1}, {"letter": "Chemotherapy Regimen", "count": 499}, {"letter": "zoledronate", "count": 5}, {"letter": "Docetaxel/Epirubicin Regimen", "count": 1}, {"letter": "potassium oxonate", "count": 1}, {"letter": "Level of Evidence", "count": 1}, {"letter": "rituximab", "count": 2}, {"letter": "Radiation therapy complication", "count": 2}, {"letter": "Initial insomnia", "count": 1}, {"letter": "Middle insomnia", "count": 1}, {"letter": "Acupuncture procedure", "count": 26}, {"letter": "Wound infiltration", "count": 1}, {"letter": "Removal of catheter", "count": 1}, {"letter": "Complete axillary lymphadenectomy (procedure)", "count": 2}, {"letter": "Sampling of lymph node", "count": 1}, {"letter": "Biopsy of axillary lymph node", "count": 1}, {"letter": "Drainage of lymphatics", "count": 6}, {"letter": "Midline deviation of dental arch", "count": 1}, {"letter": "Chronic diarrhea", "count": 2}, {"letter": "Adjudicator", "count": 1}, {"letter": "Estimator", "count": 2}, {"letter": "District nurse", "count": 1}, {"letter": "Clinic nurse", "count": 1}, {"letter": "Community Pharmacists", "count": 1}, {"letter": "Scientist", "count": 1}, {"letter": "Gate-keeper", "count": 1}, {"letter": "Miller", "count": 37}, {"letter": "tailor", "count": 15}, {"letter": "Construction worker", "count": 1}, {"letter": "Oocyte Retrieval", "count": 2}, {"letter": "Breast stimulation", "count": 1}, {"letter": "Uterine lavage", "count": 3}, {"letter": "Biopsy of breast", "count": 48}, {"letter": "Cyclical mastalgia", "count": 1}, {"letter": "Rupture of breast implant", "count": 1}, {"letter": "Lupus erythematosus tumidus", "count": 3}, {"letter": "Hypoplastic enamel-onycholysis-hypohidrosis syndrome", "count": 1}, {"letter": "Post-mastectomy pain", "count": 1}, {"letter": "Flap loss", "count": 3}, {"letter": "Procedure on foot", "count": 1}, {"letter": "Nodular fasciitis", "count": 2}, {"letter": "Soft tissue lesion", "count": 1}, {"letter": "Muscle damage", "count": 1}, {"letter": "Tubular Aggregate Myopathy", "count": 1}, {"letter": "Collapse of vertebra", "count": 1}, {"letter": "Removal of drain", "count": 14}, {"letter": "Mammogram - symptomatic", "count": 10}, {"letter": "Fluoroscopy of diaphragm", "count": 1}, {"letter": "Radioisotope scan of lymphatic system", "count": 12}, {"letter": "Radionuclide imaging of thyroid using iodine-131", "count": 3}, {"letter": "Extracellular fluid volume measurement", "count": 1}, {"letter": "Positron emission tomography of brain", "count": 1}, {"letter": "Ophthalmic echography, A-mode", "count": 2}, {"letter": "Fetal anatomy study", "count": 2}, {"letter": "CT of breast", "count": 1}, {"letter": "Computed tomography of heart", "count": 1}, {"letter": "CT of abdomen", "count": 1}, {"letter": "Computed Tomography (CT) of Liver", "count": 1}, {"letter": "Magnetic Resonance Imaging (MRI) of Heart", "count": 18}, {"letter": "Magnetic Resonance Imaging (MRI) of Liver", "count": 2}, {"letter": "MRI of thigh", "count": 1}, {"letter": "Barotrauma of descent", "count": 7}, {"letter": "Grasped with hand", "count": 2}, {"letter": "Pinched", "count": 3}, {"letter": "Recommendation to exercise", "count": 1}, {"letter": "Change of employment", "count": 1}, {"letter": "Patient reassurance", "count": 1}, {"letter": "Medical therapy", "count": 3}, {"letter": "Oral chemotherapy", "count": 1}, {"letter": "Teleradiotherapy procedure", "count": 2}, {"letter": "Muscle strength exercise", "count": 1}, {"letter": "NPO - Nothing by mouth", "count": 1}, {"letter": "Social care", "count": 1}, {"letter": "Osteopathic procedures", "count": 19}, {"letter": "Exploration with a probe", "count": 1}, {"letter": "Livebirth", "count": 2}, {"letter": "Gynecological follow-up assessment", "count": 1}, {"letter": "Alcohol consumption screening", "count": 1}, {"letter": "Adult screening", "count": 1}, {"letter": "Vitamin D supplement therapy", "count": 1}, {"letter": "Drug not taken NOS", "count": 46}, {"letter": "Medication decreased", "count": 1}, {"letter": "Long-term drug therapy", "count": 2}, {"letter": "Other follow-up", "count": 2}, {"letter": "Follow-up 1 day", "count": 3}, {"letter": "Follow-up 2 weeks", "count": 2}, {"letter": "Follow-up 3 weeks", "count": 2}, {"letter": "Follow-up 1 year", "count": 5}, {"letter": "Referral to social worker", "count": 1}, {"letter": "Inpatient stay", "count": 1}, {"letter": "Endocrine symptom change", "count": 1}, {"letter": "Screening - general (procedure)", "count": 1}, {"letter": "Cancer cervix screening status", "count": 2}, {"letter": "Breast neoplasm screening status", "count": 1}, {"letter": "Patient address", "count": 1}, {"letter": "Patient date of birth", "count": 4}, {"letter": "Patient telephone number", "count": 1}, {"letter": "Patient registration", "count": 1}, {"letter": "Medicals/reports NOS", "count": 2}, {"letter": "Notifications (procedure)", "count": 4}, {"letter": "Follow-up consultation", "count": 2}, {"letter": "Frequency of encounter", "count": 2}, {"letter": "Opportunistic screening", "count": 1}, {"letter": "Cohort screening", "count": 1}, {"letter": "Clinical function", "count": 6}, {"letter": "Examination/signs NOS", "count": 2}, {"letter": "Symptom distribution", "count": 1}, {"letter": "Neurological observations", "count": 18}, {"letter": "Central nervous system symptom", "count": 1}, {"letter": "Quality of focus", "count": 1}, {"letter": "Lacrimation", "count": 1}, {"letter": "Sensory symptoms", "count": 5}, {"letter": "Joint position sense", "count": 1}, {"letter": "Abnormal sensation", "count": 1}, {"letter": "Altered sensation of skin", "count": 1}, {"letter": "Pain character", "count": 1}, {"letter": "Facet joint pain", "count": 1}, {"letter": "Painful intercourse female", "count": 33}, {"letter": "Thickness of skin", "count": 6}, {"letter": "Skin elasticity", "count": 2}, {"letter": "Staining of skin", "count": 1}, {"letter": "Skin eschar", "count": 1}, {"letter": "Lanugo", "count": 9}, {"letter": "Feeling content", "count": 49}, {"letter": "Intellectual ability", "count": 1}, {"letter": "Above average intellect", "count": 27}, {"letter": "Memory, Long-Term", "count": 1}, {"letter": "Feeling suicidal (finding)", "count": 3}, {"letter": "Orientated", "count": 6}, {"letter": "Heightened perception", "count": 3}, {"letter": "Level of interest", "count": 1}, {"letter": "Loss of interest", "count": 1}, {"letter": "Initiative", "count": 6}, {"letter": "limited concentration", "count": 5}, {"letter": "Enjoyment of life", "count": 14}, {"letter": "Level of hope", "count": 3}, {"letter": "Pessimism", "count": 2}, {"letter": "Anxiety about body function or health", "count": 1}, {"letter": "Fear of infection", "count": 1}, {"letter": "Sense of identity (observable entity)", "count": 9}, {"letter": "Hyperactive behavior", "count": 3}, {"letter": "Social disinhibition", "count": 1}, {"letter": "Fighting", "count": 3}, {"letter": "Breath holding with temper", "count": 3}, {"letter": "Erotic interest", "count": 4}, {"letter": "Erotic feeling", "count": 24}, {"letter": "Eating problem", "count": 1}, {"letter": "Asleep", "count": 22}, {"letter": "Absences finding", "count": 1}, {"letter": "Response to pain finding", "count": 6}, {"letter": "Bleeds profusely", "count": 1}, {"letter": "Quality of sleep", "count": 92}, {"letter": "Duration of sleep", "count": 14}, {"letter": "General health", "count": 45}, {"letter": "Psychological Well Being", "count": 16}, {"letter": "Vitality", "count": 39}, {"letter": "Frailty", "count": 3}, {"letter": "Obese build", "count": 9}, {"letter": "Loss of subcutaneous fat", "count": 3}, {"letter": "Height and weight", "count": 1}, {"letter": "Standing height", "count": 2}, {"letter": "Weight symptom (finding)", "count": 3}, {"letter": "Weight for height", "count": 1}, {"letter": "Total body fat", "count": 4}, {"letter": "Lean body mass", "count": 22}, {"letter": "Fat-free mass", "count": 10}, {"letter": "Skin-fold thickness (finding)", "count": 1}, {"letter": "Circumference measure", "count": 38}, {"letter": "Fever symptoms (finding)", "count": 26}, {"letter": "Breath symptom", "count": 1}, {"letter": "Lump size", "count": 3}, {"letter": "Lump volume", "count": 1}, {"letter": "Social and personal history", "count": 1}, {"letter": "Family problems", "count": 3}, {"letter": "Death of relative", "count": 7}, {"letter": "Early retirement", "count": 1}, {"letter": "Return to Work", "count": 6}, {"letter": "Child at risk", "count": 1}, {"letter": "Engaged to be married", "count": 60}, {"letter": "Relationship problems (finding)", "count": 1}, {"letter": "Mobility as a finding", "count": 67}, {"letter": "Confined to chair", "count": 1}, {"letter": "Bed-ridden", "count": 4}, {"letter": "Personal status - Adopted", "count": 12}, {"letter": "Dietary history", "count": 5}, {"letter": "Dietary Restriction", "count": 2}, {"letter": "dietary protein intake", "count": 1}, {"letter": "dietary fat intake", "count": 1}, {"letter": "Respiratory System Finding", "count": 8}, {"letter": "Irregular breathing", "count": 1}, {"letter": "Cardiovascular finding", "count": 1}, {"letter": "Pulse volume", "count": 1}, {"letter": "Heart beat", "count": 4}, {"letter": "Position of apex beat", "count": 1}, {"letter": "Jugular venous engorgement", "count": 1}, {"letter": "Sexual symptom", "count": 1}, {"letter": "Improved sex life", "count": 2}, {"letter": "Breast finding", "count": 1}, {"letter": "Absence of breast (finding)", "count": 4}, {"letter": "Position of the breast", "count": 3}, {"letter": "Symmetry of breasts", "count": 4}, {"letter": "Breast size", "count": 15}, {"letter": "Contour of breast", "count": 1}, {"letter": "Peau d'orange surface of breast", "count": 2}, {"letter": "Breast hot", "count": 1}, {"letter": "Diameter of ovary", "count": 1}, {"letter": "Date of last menstrual period", "count": 2}, {"letter": "Duration of menstrual flow", "count": 2}, {"letter": "Secondary amenorrhea", "count": 1}, {"letter": "Urinary symptoms", "count": 4}, {"letter": "Gastrointestinal symptom", "count": 5}, {"letter": "Altered appetite", "count": 1}, {"letter": "Frequency of bowel action", "count": 2}, {"letter": "Consistency of stool", "count": 1}, {"letter": "Musculoskeletal System Finding", "count": 2}, {"letter": "Short arm", "count": 3}, {"letter": "Arm length", "count": 1}, {"letter": "Motor symptoms", "count": 8}, {"letter": "Stiffness", "count": 28}, {"letter": "Movement measurement", "count": 1}, {"letter": "Movement of shoulder", "count": 7}, {"letter": "Finding of power of skeletal muscle", "count": 4}, {"letter": "Control of movement", "count": 1}, {"letter": "Muscle Tension", "count": 1}, {"letter": "Form of joint", "count": 1}, {"letter": "Transferrin level result", "count": 1}, {"letter": "Red cell distribution width determination", "count": 1}, {"letter": "White blood cell count laboratory result", "count": 7}, {"letter": "Platelet distribution width measurement", "count": 1}, {"letter": "Protein concentration, test strip measurement", "count": 7}, {"letter": "Blood concentration results", "count": 4}, {"letter": "Glucose concentration, test strip measurement", "count": 1}, {"letter": "Presence of cells", "count": 13}, {"letter": "Human cells", "count": 1}, {"letter": "Determination of bacterial growth", "count": 1}, {"letter": "Antimicrobial susceptibility", "count": 2}, {"letter": "Gross pathology (finding)", "count": 1}, {"letter": "Biochemical finding", "count": 1}, {"letter": "Urine level measurement", "count": 4}, {"letter": "Methionine measurement", "count": 97}, {"letter": "Poison measurement", "count": 1}, {"letter": "Mercury measurement", "count": 1}, {"letter": "Presence of drug", "count": 1}, {"letter": "Detection of poison procedure", "count": 1}, {"letter": "Finding of creatinine level", "count": 2}, {"letter": "Urine creatinine level finding", "count": 4}, {"letter": "Finding of potassium level", "count": 1}, {"letter": "Alkaline phosphatase level - finding", "count": 2}, {"letter": "Aspartate transaminase level", "count": 1}, {"letter": "Serum insulin measurement", "count": 6}, {"letter": "Serum ACTH measurement", "count": 1}, {"letter": "Cortisol level", "count": 12}, {"letter": "Insulin level result", "count": 13}, {"letter": "Follicle stimulating hormone level result", "count": 4}, {"letter": "Progesterone level", "count": 5}, {"letter": "Prolactin level result", "count": 2}, {"letter": "Testosterone level result", "count": 4}, {"letter": "Serum testosterone measurement", "count": 3}, {"letter": "TSH - Thyroid stimulating hormone level result", "count": 1}, {"letter": "Serum bilirubin measurement", "count": 2}, {"letter": "Finding of lipid level", "count": 5}, {"letter": "Measurement of serum lipid level", "count": 4}, {"letter": "Serum lipids high (finding)", "count": 1}, {"letter": "Cholesterol level test result", "count": 1}, {"letter": "Serum HDL cholesterol measurement", "count": 1}, {"letter": "Triglyceride level - finding", "count": 1}, {"letter": "Protein level - finding", "count": 7}, {"letter": "Plasma C-reactive protein measurement", "count": 1}, {"letter": "C-reactive protein level", "count": 9}, {"letter": "Immunoglobulin level - finding", "count": 4}, {"letter": "Glucose level - finding", "count": 5}, {"letter": "Finding of blood glucose level", "count": 4}, {"letter": "Fasting blood glucose measurement", "count": 4}, {"letter": "Serum vitamin A measurement", "count": 1}, {"letter": "Serum vitamin D measurement", "count": 2}, {"letter": "End tidal carbon dioxide partial pressure", "count": 1}, {"letter": "Arteriovenous difference", "count": 1}, {"letter": "Expiratory time", "count": 8}, {"letter": "Airway device cuff pressure", "count": 1}, {"letter": "Flow volume loop", "count": 2}, {"letter": "Intensity change", "count": 24}, {"letter": "Temporal resolution", "count": 7}, {"letter": "Left ventricular ejection fraction", "count": 125}, {"letter": "Cardiac index", "count": 1}, {"letter": "Myocardial perfusion", "count": 4}, {"letter": "Myocardial perfusion defect", "count": 1}, {"letter": "Diastolic blood pressure", "count": 4}, {"letter": "Mean blood pressure", "count": 13}, {"letter": "Supraventricular arrhythmia", "count": 1}, {"letter": "Bradycardia", "count": 6}, {"letter": "Junctional premature complex (disorder)", "count": 2}, {"letter": "QRS complex duration (observable entity)", "count": 1}, {"letter": "QT interval feature (observable entity)", "count": 21}, {"letter": "Segment deviation (ECG)", "count": 1}, {"letter": "Electrocardiogram: P-R interval", "count": 1}, {"letter": "R wave feature", "count": 1}, {"letter": "S wave feature", "count": 1}, {"letter": "QRS complex feature", "count": 4}, {"letter": "T wave feature", "count": 4}, {"letter": "Vascular resistance (finding)", "count": 1}, {"letter": "Minimal effective dose", "count": 1}, {"letter": "Breath test finding", "count": 1}, {"letter": "Vaginal pH", "count": 6}, {"letter": "Grip strength", "count": 2}, {"letter": "Loss of reactivity", "count": 1}, {"letter": "EMG amplitude", "count": 2}, {"letter": "Nerve Conduction velocity Finding", "count": 2}, {"letter": "Electrical threshold", "count": 3}, {"letter": "Vibration threshold", "count": 7}, {"letter": "Vertex distance", "count": 1}, {"letter": "Oxygen uptake", "count": 11}, {"letter": "Total body water", "count": 3}, {"letter": "Maximum oxygen uptake", "count": 1}, {"letter": "Respiratory quotient", "count": 1}, {"letter": "Forced expiratory volume in 1 second finding", "count": 2}, {"letter": "Transfer coefficient (respiratory measure)", "count": 1}, {"letter": "Alveolar volume", "count": 1}, {"letter": "Fluid intake", "count": 2}, {"letter": "Vascular measure", "count": 16}, {"letter": "Arterial measure", "count": 2}, {"letter": "Principal Component Analysis", "count": 1}, {"letter": "Total blood volume", "count": 2}, {"letter": "PD 20", "count": 4}, {"letter": "Number of miscarriages or induced terminations of pregnancy", "count": 1}, {"letter": "Test distance", "count": 1}, {"letter": "Test time", "count": 8}, {"letter": "Measurement period", "count": 1}, {"letter": "Bowels: fully continent (finding)", "count": 1}, {"letter": "Chair/bed transfer ability", "count": 1}, {"letter": "diagnostic procedure", "count": 15}, {"letter": "Fasting lipid profile", "count": 1}, {"letter": "Urine pregnancy test", "count": 1}, {"letter": "Serum pregnancy test NOS", "count": 1}, {"letter": "Blood cell analysis", "count": 1}, {"letter": "Cell marker analysis", "count": 1}, {"letter": "Immunology profile", "count": 1}, {"letter": "Light Microscopy", "count": 2}, {"letter": "Laboratory culture", "count": 13}, {"letter": "Antigen assay", "count": 2}, {"letter": "Electrocardiography, 12-Lead", "count": 26}, {"letter": "Cardiovascular stress test using treadmill", "count": 1}, {"letter": "24 Hour ECG", "count": 1}, {"letter": "Transthoracic echocardiography", "count": 2}, {"letter": "Continuous wave ultrasonic Doppler", "count": 1}, {"letter": "6-Minute Walk Test", "count": 26}, {"letter": "12-minute walk test", "count": 1}, {"letter": "Stair-climbing test", "count": 1}, {"letter": "Skin prick test", "count": 1}, {"letter": "Scratch test", "count": 8}, {"letter": "Test of the limb", "count": 2}, {"letter": "Test of the hip", "count": 4}, {"letter": "Test of the hand", "count": 4}, {"letter": "Manual muscle-testing of hand", "count": 8}, {"letter": "Electrocorticogram", "count": 10}, {"letter": "Sensory nerve conduction study", "count": 3}, {"letter": "Surface Electromyography", "count": 1}, {"letter": "Quantitative sensory test", "count": 6}, {"letter": "Applanation tonometry", "count": 2}, {"letter": "Fluorescence Imaging", "count": 7}, {"letter": "Photography of patient", "count": 4}, {"letter": "Breast photography", "count": 3}, {"letter": "Diagnostic assessment", "count": 2}, {"letter": "Tumor cells, uncertain whether benign or malignant", "count": 143}, {"letter": "Blood group antibody A", "count": 8}, {"letter": "Fracture of distal end of radius and ulna", "count": 1}, {"letter": "General examination of patient", "count": 15}, {"letter": "Examination of skin", "count": 1}, {"letter": "Volumetry", "count": 7}, {"letter": "Spectrometry", "count": 4}, {"letter": "Proton Therapy", "count": 13}, {"letter": "Combined radiotherapy", "count": 3}, {"letter": "Symptom modification", "count": 73}, {"letter": "Symptom pattern", "count": 1}, {"letter": "Symptom aggravating factors", "count": 4}, {"letter": "Symptom mild", "count": 23}, {"letter": "Symptom severe", "count": 38}, {"letter": "Symptom frequency", "count": 12}, {"letter": "Time symptom lasts", "count": 3}, {"letter": "Standard chest X-ray abnormal", "count": 1}, {"letter": "Computed tomography result abnormal", "count": 1}, {"letter": "Transcranial magnetic stimulation", "count": 2}, {"letter": "Examination finding", "count": 2}, {"letter": "Electrocardiogram finding", "count": 31}, {"letter": "Normal Laboratory Test Result", "count": 1}, {"letter": "Laboratory test result abnormal", "count": 100}, {"letter": "Liver enzymes abnormal", "count": 1}, {"letter": "Blood urea abnormal", "count": 1}, {"letter": "Flap failure", "count": 4}, {"letter": "Vaginal discharge symptom", "count": 2}, {"letter": "Suicidal", "count": 1}, {"letter": "Chest pressure", "count": 1}, {"letter": "Transaminases increased", "count": 1}, {"letter": "Saliva specimen", "count": 4}, {"letter": "Fluid specimen", "count": 2}, {"letter": "Bone marrow specimen", "count": 2}, {"letter": "Latissimus dorsi myocutaneous flap", "count": 1}, {"letter": "Spinal frame", "count": 1}, {"letter": "Living Alone", "count": 2}, {"letter": "Throat swab sample", "count": 1}, {"letter": "Numerous", "count": 438}, {"letter": "Moderate number", "count": 4}, {"letter": "Roman Numeral III", "count": 88}, {"letter": "Ordinal number", "count": 2}, {"letter": ">97", "count": 7}, {"letter": ">90", "count": 6}, {"letter": "<3 (qualifier value)", "count": 463}, {"letter": "<90", "count": 162}, {"letter": "Equals", "count": 11}, {"letter": "Greater Than", "count": 135}, {"letter": "Greek letter alpha (qualifier value)", "count": 1}, {"letter": "Beta greek letter", "count": 4}, {"letter": "Greek letter kappa", "count": 22}, {"letter": "Unit", "count": 61}, {"letter": "mEq", "count": 1}, {"letter": "counts", "count": 55}, {"letter": "Fraction of total", "count": 3}, {"letter": "Optical density units", "count": 3}, {"letter": "Percent (qualifier value)", "count": 457}, {"letter": "Percent normal", "count": 6}, {"letter": "Percent Activity", "count": 18}, {"letter": "Percentage aggregation", "count": 1}, {"letter": "Percentage fetal cells", "count": 1}, {"letter": "Percentage of total", "count": 71}, {"letter": "Percentage of total protein", "count": 1}, {"letter": "percent positive cells", "count": 36}, {"letter": "Arbitrary unit", "count": 5}, {"letter": "Equivalent Weight", "count": 44}, {"letter": "Parts per million (qualifier value)", "count": 3}, {"letter": "millimole", "count": 7}, {"letter": "pmol", "count": 1}, {"letter": "Micromole", "count": 1}, {"letter": "fmol", "count": 1}, {"letter": "millimeter", "count": 55}, {"letter": "Micron", "count": 3}, {"letter": "Inch Unit of Length", "count": 3}, {"letter": "gram", "count": 11}, {"letter": "Kilogram", "count": 114}, {"letter": "milligram", "count": 10}, {"letter": "microgram", "count": 13}, {"letter": "nanogram", "count": 5}, {"letter": "picogram", "count": 2}, {"letter": "Pounds", "count": 11}, {"letter": "Unit of time", "count": 8}, {"letter": "millisecond", "count": 11}, {"letter": "Hour", "count": 113}, {"letter": "day", "count": 1008}, {"letter": "week", "count": 1096}, {"letter": "month", "count": 808}, {"letter": "Minute of time", "count": 89}, {"letter": "year", "count": 457}, {"letter": "degrees Celsius", "count": 15}, {"letter": "Unit of volume", "count": 3}, {"letter": "deciliter", "count": 1}, {"letter": "milliliter", "count": 28}, {"letter": "Cubic Millimeter", "count": 4}, {"letter": "Microkatal", "count": 1}, {"letter": "megajoule", "count": 2}, {"letter": "kilocalorie", "count": 3}, {"letter": "Watt", "count": 2}, {"letter": "Unit of concentration", "count": 7}, {"letter": "Gram per Deciliter", "count": 80}, {"letter": "Microgram per Milliliter", "count": 26}, {"letter": "mg/dL", "count": 57}, {"letter": "ug/g", "count": 25}, {"letter": "Microgram per Liter", "count": 57}, {"letter": "Nanomole/liter", "count": 3}, {"letter": "Picomole per Liter", "count": 3}, {"letter": "Kilogram per Cubic Meter", "count": 9}, {"letter": "Nanogram per Liter", "count": 75}, {"letter": "Micromole/liter", "count": 2}, {"letter": "Unit per Liter", "count": 6}, {"letter": "Microunit per Milliliter", "count": 2}, {"letter": "mEq/L", "count": 3}, {"letter": "cells/uL", "count": 1}, {"letter": "beats per minute", "count": 17}, {"letter": "breaths per minute", "count": 2}, {"letter": "Milliliter per Second", "count": 2}, {"letter": "mL/min/kg", "count": 4}, {"letter": "g/24h", "count": 6}, {"letter": "milligram/day", "count": 3}, {"letter": "mL/min", "count": 4}, {"letter": "Milliliter per Day", "count": 3}, {"letter": "International Unit", "count": 45}, {"letter": "Milliinternational Unit", "count": 1}, {"letter": "International Unit per Liter", "count": 5}, {"letter": "IU/mL", "count": 2}, {"letter": "Microinternational Unit per Milliliter", "count": 4}, {"letter": "IU/day", "count": 9}, {"letter": "Kilogram-Force", "count": 4}, {"letter": "newton per square metre", "count": 1}, {"letter": "mmHg", "count": 37}, {"letter": "cmH2O", "count": 1}, {"letter": "Unit of area", "count": 2}, {"letter": "sq. cm", "count": 6}, {"letter": "Hertz (Hz)", "count": 19}, {"letter": "m/s", "count": 1}, {"letter": "Kilometer per Hour", "count": 1}, {"letter": "per day", "count": 31}, {"letter": "per year", "count": 442}, {"letter": "/40", "count": 30}, {"letter": "times/hour", "count": 5}, {"letter": "times/day", "count": 12}, {"letter": "per milliliter", "count": 81}, {"letter": "per period (qualifier value)", "count": 31}, {"letter": "Dimensions", "count": 188}, {"letter": "Medium", "count": 5}, {"letter": "Heavy (weight) (qualifier value)", "count": 19}, {"letter": "Black color", "count": 4}, {"letter": "Certainties", "count": 1}, {"letter": "Definite", "count": 36}, {"letter": "Time patterns", "count": 1}, {"letter": "Points in time (qualifier value)", "count": 9}, {"letter": "Temporal periods of day", "count": 24}, {"letter": "Arising from bed", "count": 3}, {"letter": "Acute phase", "count": 2}, {"letter": "Phase 1 (qualifier value)", "count": 129}, {"letter": "Phase 2", "count": 249}, {"letter": "Phase 3", "count": 3}, {"letter": "Phase 4 (qualifier value)", "count": 1}, {"letter": "Pre-dose", "count": 95}, {"letter": "Post-dose", "count": 59}, {"letter": "1 hour post-dose", "count": 1}, {"letter": "3 hours post-dose", "count": 1}, {"letter": "Post-chemotherapy", "count": 64}, {"letter": "Synchronous", "count": 1}, {"letter": "Overnight", "count": 10}, {"letter": "48 hour time frame", "count": 29}, {"letter": "Exercise time", "count": 7}, {"letter": "Prolonged", "count": 54}, {"letter": "Long duration", "count": 1}, {"letter": "Cyclical", "count": 2}, {"letter": "non-recurrent", "count": 1}, {"letter": "Continual", "count": 6}, {"letter": "Frequencies (time pattern)", "count": 243}, {"letter": "Random", "count": 9}, {"letter": "Priorities", "count": 6}, {"letter": "Urgent", "count": 5}, {"letter": "Preliminary", "count": 126}, {"letter": "True primary (qualifier value)", "count": 61}, {"letter": "First episode", "count": 3}, {"letter": "Revisions", "count": 3}, {"letter": "Revision", "count": 1}, {"letter": "First presentation", "count": 2}, {"letter": "First insertion", "count": 2}, {"letter": "Primary operation", "count": 17}, {"letter": "Sheets (formation)", "count": 1}, {"letter": "Band form", "count": 1}, {"letter": "Quiet", "count": 4}, {"letter": "Subjective observation (qualifier value)", "count": 131}, {"letter": "Voluntary", "count": 14}, {"letter": "Beginning", "count": 712}, {"letter": "Hereditary", "count": 10}, {"letter": "Acquired (qualifier value)", "count": 26}, {"letter": "Immune", "count": 205}, {"letter": "Infected", "count": 4}, {"letter": "Purulent", "count": 1}, {"letter": "Gestational (qualifier value)", "count": 7}, {"letter": "Unknown", "count": 37}, {"letter": "Intrinsic origin", "count": 15}, {"letter": "Myeloid", "count": 11}, {"letter": "Lytic", "count": 2}, {"letter": "Follicular", "count": 1}, {"letter": "Speckled", "count": 3}, {"letter": "With pattern", "count": 2}, {"letter": "Full field", "count": 2}, {"letter": "Eccentric", "count": 9}, {"letter": "Scattered", "count": 24}, {"letter": "Multicentric", "count": 8}, {"letter": "Concentric", "count": 12}, {"letter": "Grouped (qualifier value)", "count": 24}, {"letter": "Spatial Mosaic", "count": 1}, {"letter": "Entire", "count": 156}, {"letter": "Directions", "count": 5}, {"letter": "Elevation procedure", "count": 1}, {"letter": "Forward", "count": 24}, {"letter": "Backward (qualifier value)", "count": 5}, {"letter": "Out (direction)", "count": 213}, {"letter": "Extent", "count": 92}, {"letter": "Severities", "count": 347}, {"letter": "Dense", "count": 23}, {"letter": "Channel", "count": 6}, {"letter": "Limited (extensiveness)", "count": 133}, {"letter": "Tumor Debulking", "count": 1}, {"letter": "Gross (qualifier value)", "count": 11}, {"letter": "Radical (qualifier value)", "count": 6}, {"letter": "Profound", "count": 1}, {"letter": "Full thickness", "count": 5}, {"letter": "Total", "count": 895}, {"letter": "Completeness", "count": 2}, {"letter": "Tactile", "count": 14}, {"letter": "Tightness sensation quality", "count": 8}, {"letter": "Highly sensitive (qualifier value)", "count": 1}, {"letter": "Sensibilities", "count": 7}, {"letter": "Verbal", "count": 25}, {"letter": "Auditory", "count": 5}, {"letter": "Olfactory", "count": 1}, {"letter": "Variable (uniformity)", "count": 369}, {"letter": "Velocity", "count": 5}, {"letter": "Gradual", "count": 1}, {"letter": "Slow", "count": 66}, {"letter": "Stationary", "count": 3}, {"letter": "Conversions (qualifier value)", "count": 41}, {"letter": "Ambulatory - qualifier value", "count": 4}, {"letter": "Covered (qualifier value)", "count": 19}, {"letter": "Unaided", "count": 2}, {"letter": "Relationships", "count": 1399}, {"letter": "Inverse", "count": 3}, {"letter": "Direct type of relationship", "count": 39}, {"letter": "Indirect", "count": 8}, {"letter": "Congruent relationship", "count": 6}, {"letter": "Complex", "count": 7}, {"letter": "Unsatisfactory", "count": 5}, {"letter": "Dependence", "count": 1}, {"letter": "Conventional", "count": 83}, {"letter": "Autologous (qualifier value)", "count": 16}, {"letter": "Substance", "count": 7}, {"letter": "Mixture", "count": 2}, {"letter": "Tobacco smoke", "count": 7}, {"letter": "Acrylic dental material", "count": 2}, {"letter": "Genetic Materials", "count": 2}, {"letter": "Frozen embryo", "count": 3}, {"letter": "Circulating blood", "count": 4}, {"letter": "Human tissue", "count": 2}, {"letter": "Lymph Node Tissue", "count": 1}, {"letter": "Inflammatory cell", "count": 2}, {"letter": "Solid organ", "count": 1}, {"letter": "Pencil", "count": 2}, {"letter": "Shopping cart", "count": 1}, {"letter": "Meters (physical object)", "count": 36}, {"letter": "Single probe", "count": 1}, {"letter": "Cuffs device", "count": 6}, {"letter": "Tube cuff", "count": 4}, {"letter": "Hooked wire", "count": 1}, {"letter": "Conduit implant", "count": 1}, {"letter": "Static", "count": 21}, {"letter": "photograph", "count": 8}, {"letter": "Picture", "count": 22}, {"letter": "Event", "count": 700}, {"letter": "Clinical action", "count": 70}, {"letter": "Surgical advancement - action", "count": 2}, {"letter": "Coagulation procedure", "count": 3}, {"letter": "Surgical construction", "count": 5}, {"letter": "Demand (clinical)", "count": 2}, {"letter": "Radiofrequency destruction", "count": 1}, {"letter": "Fitting - action", "count": 4}, {"letter": "Clinical act of insertion", "count": 12}, {"letter": "Reduction - action", "count": 2}, {"letter": "Sampling - Surgical action", "count": 65}, {"letter": "Scanning", "count": 92}, {"letter": "Anatomical segmentation", "count": 29}, {"letter": "Wash (cleansing action)", "count": 3}, {"letter": "Activities", "count": 230}, {"letter": "Everyday tasks", "count": 2}, {"letter": "Accelerometry", "count": 5}, {"letter": "Hormone measurement", "count": 4}, {"letter": "Typing Classification", "count": 2}, {"letter": "Mechanism (attribute)", "count": 40}, {"letter": "Force", "count": 38}, {"letter": "Type 1", "count": 9}, {"letter": "Type 2", "count": 3}, {"letter": "Type 3", "count": 3}, {"letter": "Type 4", "count": 8}, {"letter": "Autosomal recessive inheritance", "count": 1}, {"letter": "Stage 0 (qualifier value)", "count": 6}, {"letter": "Stage level 1", "count": 210}, {"letter": "Stage level 2", "count": 307}, {"letter": "Stage 2A", "count": 1}, {"letter": "Stage 2B", "count": 3}, {"letter": "Stage level 3", "count": 30}, {"letter": "Stage level 4", "count": 5}, {"letter": "Stage level 5", "count": 2}, {"letter": "Stage C", "count": 2}, {"letter": "Stage C3", "count": 1}, {"letter": "Editions", "count": 12}, {"letter": "Fourth edition", "count": 1}, {"letter": "Grading values", "count": 1}, {"letter": "Grade", "count": 614}, {"letter": "Numeric grade", "count": 1}, {"letter": "Grade two rank", "count": 224}, {"letter": "Grade five rank", "count": 78}, {"letter": "Grade B", "count": 1}, {"letter": "Groups", "count": 236}, {"letter": "Group A (qualifier value)", "count": 45}, {"letter": "Group C", "count": 4}, {"letter": "Group E", "count": 4}, {"letter": "Group G", "count": 1}, {"letter": "Group H (alphabetic group)", "count": 2}, {"letter": "Group I (alphabetic group)", "count": 3}, {"letter": "Group M", "count": 4}, {"letter": "Group X", "count": 4}, {"letter": "Numeric group", "count": 1}, {"letter": "Group 1", "count": 18}, {"letter": "Group 1A", "count": 1}, {"letter": "Group 1B", "count": 1}, {"letter": "Group 2", "count": 34}, {"letter": "Group 2A", "count": 1}, {"letter": "Group 3", "count": 15}, {"letter": "Group 4 (qualifier value)", "count": 16}, {"letter": "Class 1", "count": 3}, {"letter": "Class 2", "count": 4}, {"letter": "Class 3", "count": 6}, {"letter": "Class 4", "count": 8}, {"letter": "Levels (qualifier value)", "count": 712}, {"letter": "UICC (tumor staging)", "count": 1}, {"letter": "AJCC tumor staging", "count": 16}, {"letter": "N+ (tumor staging)", "count": 21}, {"letter": "M+ (tumor staging)", "count": 16}, {"letter": "Level I", "count": 7}, {"letter": "Hepatic Involvement", "count": 17}, {"letter": "pre-surgery", "count": 60}, {"letter": "Node stage N0", "count": 9}, {"letter": "N2 category (finding)", "count": 11}, {"letter": "N3 category (finding)", "count": 1}, {"letter": "Node stage N1", "count": 3}, {"letter": "90 degrees", "count": 5}, {"letter": "Side", "count": 195}, {"letter": "Contralateral", "count": 202}, {"letter": "Ipsilateral", "count": 268}, {"letter": "Lower - spatial qualifier", "count": 126}, {"letter": "Left anterior", "count": 3}, {"letter": "Upper anterior", "count": 4}, {"letter": "Digital X-ray", "count": 7}, {"letter": "Muscular", "count": 4}, {"letter": "Oral", "count": 131}, {"letter": "Pericardial body location", "count": 2}, {"letter": "Peroneal", "count": 1}, {"letter": "Popliteal", "count": 1}, {"letter": "Radial", "count": 1}, {"letter": "Salivary", "count": 14}, {"letter": "Visceral", "count": 7}, {"letter": "Medial part", "count": 1}, {"letter": "Lower segment", "count": 9}, {"letter": "Inframammary", "count": 1}, {"letter": "Intramuscular", "count": 3}, {"letter": "Intravaginal", "count": 10}, {"letter": "Midclavicular", "count": 1}, {"letter": "Parasternal", "count": 4}, {"letter": "Paravertebral", "count": 2}, {"letter": "Subcostal", "count": 1}, {"letter": "Endoscopic approach - access", "count": 3}, {"letter": "Place", "count": 30}, {"letter": "Home environment", "count": 9}, {"letter": "Urban environment", "count": 2}, {"letter": "Streams", "count": 7}, {"letter": "Stadium", "count": 3}, {"letter": "Clinic", "count": 12}, {"letter": "Bank (environment)", "count": 24}, {"letter": "Post office", "count": 1}, {"letter": "Office", "count": 10}, {"letter": "Waking", "count": 9}, {"letter": "end diastolic", "count": 1}, {"letter": "Peak systolic", "count": 2}, {"letter": "Protocols documentation", "count": 123}, {"letter": "Balke protocol", "count": 6}, {"letter": "Bruce protocol", "count": 1}, {"letter": "Modified Bruce protocol", "count": 1}, {"letter": "Naughton protocol", "count": 1}, {"letter": "Present one plus out of three plus", "count": 1}, {"letter": "Detected (finding)", "count": 151}, {"letter": "Weakly positive", "count": 5}, {"letter": "No status change", "count": 34}, {"letter": "Noninflammatory", "count": 1}, {"letter": "6/5", "count": 26}, {"letter": "Distance vision 6/6", "count": 2}, {"letter": "Distance vision 6/9", "count": 2}, {"letter": "Distance vision 6/12", "count": 3}, {"letter": "Distance vision 6/18", "count": 2}, {"letter": "Distance vision 6/24", "count": 1}, {"letter": "3/4", "count": 5}, {"letter": "3/5", "count": 8}, {"letter": "3/6", "count": 8}, {"letter": "3/9", "count": 1}, {"letter": "3/12", "count": 4}, {"letter": "3/24", "count": 1}, {"letter": "N6", "count": 2}, {"letter": "Decreasing", "count": 18}, {"letter": "Efficient", "count": 8}, {"letter": "Enlarged", "count": 1}, {"letter": "Excessive (qualifier value)", "count": 24}, {"letter": "Very high", "count": 7}, {"letter": "Increase", "count": 932}, {"letter": "Increasing (qualifier value)", "count": 54}, {"letter": "Very low (qualifier value)", "count": 8}, {"letter": "Normal limits", "count": 20}, {"letter": "Raised", "count": 2}, {"letter": "Strong", "count": 49}, {"letter": "trace amount", "count": 3}, {"letter": "Very", "count": 344}, {"letter": "Well defined", "count": 1}, {"letter": "Electrical (qualifier value)", "count": 8}, {"letter": "malignant disease", "count": 8}, {"letter": "Neuropathy", "count": 102}, {"letter": "Systemic disease", "count": 8}, {"letter": "Cosmetic procedure", "count": 173}, {"letter": "Salvage procedure", "count": 4}, {"letter": "Imaging guidance", "count": 1}, {"letter": "Ultrasonic guidance procedure", "count": 3}, {"letter": "Simon", "count": 6}, {"letter": "Leukocyte buffy coat", "count": 5}, {"letter": "Platelets Product", "count": 10}, {"letter": "Aberrant", "count": 6}, {"letter": "Above threshold", "count": 2}, {"letter": "Accurate (qualifier)", "count": 121}, {"letter": "At rest (qualifier value)", "count": 2}, {"letter": "Autogenous", "count": 1}, {"letter": "Autoimmune reaction", "count": 5}, {"letter": "Baseline pressure", "count": 3}, {"letter": "Bipolar", "count": 1}, {"letter": "Bony", "count": 2}, {"letter": "Brain activity", "count": 4}, {"letter": "Bravo (Serotype)", "count": 1}, {"letter": "Breaking down", "count": 8}, {"letter": "Brisk", "count": 12}, {"letter": "Changed status", "count": 355}, {"letter": "Convergence - direction", "count": 5}, {"letter": "Definitive", "count": 119}, {"letter": "Differential quality", "count": 30}, {"letter": "Dissimilar", "count": 2}, {"letter": "Distant", "count": 2}, {"letter": "Divergence", "count": 4}, {"letter": "Dull", "count": 1}, {"letter": "Established", "count": 78}, {"letter": "Extrusion", "count": 2}, {"letter": "Flexible", "count": 6}, {"letter": "Fresh (qualifier value)", "count": 1}, {"letter": "Full", "count": 101}, {"letter": "Largest", "count": 52}, {"letter": "Impulse technique", "count": 13}, {"letter": "Inaccurate", "count": 3}, {"letter": "Integral", "count": 12}, {"letter": "Long-term", "count": 61}, {"letter": "Maculopapular", "count": 1}, {"letter": "Mechanical Methods", "count": 11}, {"letter": "Microvascular", "count": 2}, {"letter": "Modulated", "count": 50}, {"letter": "nodal (pertaining to a node)", "count": 7}, {"letter": "Pathological staging", "count": 1}, {"letter": "Reaction", "count": 51}, {"letter": "Restricted", "count": 43}, {"letter": "Revealed", "count": 16}, {"letter": "Second degree", "count": 1}, {"letter": "Separate", "count": 100}, {"letter": "Several", "count": 23}, {"letter": "short-term", "count": 44}, {"letter": "subcutaneous", "count": 47}, {"letter": "Sustained", "count": 34}, {"letter": "Turnover technique", "count": 10}, {"letter": "Uncomplicated", "count": 1}, {"letter": "Unresolved", "count": 5}, {"letter": "Viable", "count": 28}, {"letter": "Watery", "count": 1}, {"letter": "Analyte", "count": 18}, {"letter": "Polymorphonuclear neutrophil elastase", "count": 1}, {"letter": "Free testosterone", "count": 2}, {"letter": "Total immunoglobulin level result", "count": 62}, {"letter": "Specific antibody", "count": 2}, {"letter": "Salivary immunoglobulin A", "count": 1}, {"letter": "Procollagen peptide", "count": 1}, {"letter": "Carbohydrate antigen", "count": 1}, {"letter": "volatile substances", "count": 1}, {"letter": "Pathology specimen", "count": 7}, {"letter": "Breast tissue sample", "count": 69}, {"letter": "Hair Specimen", "count": 8}, {"letter": "Skin Specimen", "count": 28}, {"letter": "Vesicle fluid specimen", "count": 1}, {"letter": "Smear test", "count": 1}, {"letter": "Vulval swab (specimen)", "count": 1}, {"letter": "Venous blood specimen", "count": 9}, {"letter": "Lymph node specimen", "count": 10}, {"letter": "Plasma specimen", "count": 59}, {"letter": "Milk Specimen", "count": 4}, {"letter": "Recumbent body position", "count": 1}, {"letter": "Access", "count": 17}, {"letter": "Central venous", "count": 2}, {"letter": "End of protocol", "count": 2}, {"letter": "In situ", "count": 45}, {"letter": "0.5", "count": 162}, {"letter": "First degree", "count": 2}, {"letter": "Breakthrough", "count": 2}, {"letter": "Statistical mean", "count": 449}, {"letter": "Peak level", "count": 137}, {"letter": "Trough", "count": 46}, {"letter": "Incidental", "count": 2}, {"letter": "Flexion/extension", "count": 3}, {"letter": "Hot sensation quality", "count": 5}, {"letter": "Right sided", "count": 17}, {"letter": "Ostium", "count": 1}, {"letter": "Whole body", "count": 24}, {"letter": "Middle", "count": 30}, {"letter": "Fluid behavior", "count": 9}, {"letter": "Crystal Structure", "count": 4}, {"letter": "Master", "count": 2}, {"letter": "Anatomic Plane", "count": 10}, {"letter": "Core", "count": 4}, {"letter": "Calculated", "count": 222}, {"letter": "Radiographic", "count": 120}, {"letter": "Recorded voice", "count": 1}, {"letter": "Circulatory arrest", "count": 1}, {"letter": "Position change", "count": 1}, {"letter": "Standing up", "count": 6}, {"letter": "A 102", "count": 2}, {"letter": "All", "count": 181}, {"letter": "Constant current", "count": 3}, {"letter": "Continuous infusion", "count": 2}, {"letter": "Duplex", "count": 2}, {"letter": "Duration of treatment", "count": 60}, {"letter": "End", "count": 65}, {"letter": "High dose", "count": 61}, {"letter": "Loop", "count": 2}, {"letter": "M0 Stage Finding", "count": 4}, {"letter": "Mean pressure", "count": 1}, {"letter": "Node stage N2a", "count": 1}, {"letter": "Node stage N2b", "count": 1}, {"letter": "NT/C", "count": 1}, {"letter": "NX Stage Finding", "count": 1}, {"letter": "No metastases", "count": 1}, {"letter": "Not used", "count": 1}, {"letter": "Number of sites", "count": 1}, {"letter": "Neoplasm present", "count": 10}, {"letter": "No neoplasm", "count": 16}, {"letter": "Non-nodal", "count": 5}, {"letter": "Number of breaks", "count": 1}, {"letter": "Post-radiation", "count": 44}, {"letter": "Power output", "count": 1}, {"letter": "Prophylactic behavior", "count": 15}, {"letter": "Preoperative", "count": 140}, {"letter": "Related personal status", "count": 81}, {"letter": "Rotational", "count": 1}, {"letter": "Same", "count": 310}, {"letter": "Sensory (qualifier value)", "count": 55}, {"letter": "Socks", "count": 1}, {"letter": "Secondary procedure", "count": 2}, {"letter": "Straight", "count": 4}, {"letter": "Toxin typing", "count": 3}, {"letter": "V 2", "count": 1}, {"letter": "Volumetric", "count": 36}, {"letter": "Roman numeral VII", "count": 1}, {"letter": "Human patch material", "count": 1}, {"letter": "Carlos", "count": 1}, {"letter": "Mini", "count": 15}, {"letter": "Non-dominant side", "count": 1}, {"letter": "Low dose", "count": 38}, {"letter": "Morphological type", "count": 1}, {"letter": "Microorganism", "count": 6}, {"letter": "Anatomical reference plane", "count": 10}, {"letter": "Transverse plane", "count": 4}, {"letter": "C5 level", "count": 1}, {"letter": "C6 level", "count": 2}, {"letter": "C7 level", "count": 1}, {"letter": "T6 level", "count": 1}, {"letter": "L2 level", "count": 8}, {"letter": "L4 level", "count": 1}, {"letter": "region supraclavicular", "count": 2}, {"letter": "Surface region of side of chest", "count": 18}, {"letter": "Upper arm", "count": 923}, {"letter": "Tip of middle finger", "count": 5}, {"letter": "Peripheral nerve of lower limb", "count": 5}, {"letter": "Mastoid process", "count": 1}, {"letter": "Branch of left coronary artery", "count": 1}, {"letter": "Lymph node group", "count": 1}, {"letter": "Subclavian lymph node", "count": 1}, {"letter": "Internal mammary node", "count": 4}, {"letter": "Lateral wall of vagina", "count": 5}, {"letter": "Entire proximal interphalangeal joint of great toe", "count": 1}, {"letter": "First dorsal interosseous of hand", "count": 6}, {"letter": "Posterior crural muscle structure", "count": 1}, {"letter": "OSS tumor staging notations", "count": 1}, {"letter": "aVF", "count": 4}, {"letter": "Concept Attribute", "count": 40}, {"letter": "Temporal relationship", "count": 4}, {"letter": "Measurement frequency", "count": 1}, {"letter": "Duration (temporal concept)", "count": 733}, {"letter": "Period of collection", "count": 2}, {"letter": "Timing", "count": 48}, {"letter": "Time of onset", "count": 23}, {"letter": "Time course", "count": 8}, {"letter": "Speed of test", "count": 4}, {"letter": "Context", "count": 1}, {"letter": "Progression", "count": 34}, {"letter": "Clinical course", "count": 1}, {"letter": "Reversibility", "count": 4}, {"letter": "Elicited by", "count": 14}, {"letter": "Extent of procedure", "count": 1}, {"letter": "Extent of disease", "count": 5}, {"letter": "Extent of defect", "count": 1}, {"letter": "Degree or extent", "count": 225}, {"letter": "Limitation", "count": 60}, {"letter": "Clearance", "count": 4}, {"letter": "Insertion of drain - attribute", "count": 1}, {"letter": "Method of administration of drug", "count": 3}, {"letter": "Method of biopsy", "count": 14}, {"letter": "Method of detection", "count": 3}, {"letter": "Method of extraction", "count": 2}, {"letter": "Connection", "count": 34}, {"letter": "Observation parameter", "count": 390}, {"letter": "Staging system", "count": 29}, {"letter": "Borg scale", "count": 3}, {"letter": "Source", "count": 26}, {"letter": "SPECIMEN SOURCE", "count": 1}, {"letter": "Component object", "count": 71}, {"letter": "Manufactured aid", "count": 12}, {"letter": "Patient status", "count": 20}, {"letter": "Status", "count": 432}, {"letter": "Clinical status", "count": 6}, {"letter": "Marker status", "count": 10}, {"letter": "Receptor status", "count": 28}, {"letter": "Route", "count": 3}, {"letter": "Approach (spatial)", "count": 131}, {"letter": "Presentation", "count": 244}, {"letter": "Lesion size", "count": 25}, {"letter": "Nodule size", "count": 3}, {"letter": "Volume", "count": 129}, {"letter": "cell type", "count": 8}, {"letter": "Type of food", "count": 2}, {"letter": "Type of device", "count": 4}, {"letter": "Type of reconstruction (attribute)", "count": 2}, {"letter": "Type of scan", "count": 1}, {"letter": "Type of stimulus", "count": 1}, {"letter": "Subtype (attribute)", "count": 118}, {"letter": "Type of antibody", "count": 1}, {"letter": "Test type", "count": 1}, {"letter": "Histological type", "count": 7}, {"letter": "Histological finding", "count": 1}, {"letter": "Qualitative observation", "count": 1}, {"letter": "Nodularity", "count": 1}, {"letter": "Qualitative mobility", "count": 8}, {"letter": "Regularity", "count": 3}, {"letter": "With texture", "count": 31}, {"letter": "Specific site", "count": 11}, {"letter": "Muscle involved", "count": 2}, {"letter": "Affected site", "count": 3}, {"letter": "Site of catheter", "count": 1}, {"letter": "Site of incision", "count": 12}, {"letter": "Site of involvement", "count": 1}, {"letter": "Site of lesion", "count": 4}, {"letter": "Site of primary lesion", "count": 6}, {"letter": "Part", "count": 340}, {"letter": "Dominant hand", "count": 4}, {"letter": "Direction", "count": 6}, {"letter": "Measured from", "count": 159}, {"letter": "Patterns", "count": 131}, {"letter": "Distribution pattern", "count": 1}, {"letter": "Pattern of disease", "count": 2}, {"letter": "Number of occurrences", "count": 4}, {"letter": "Number of lesions (observable entity)", "count": 18}, {"letter": "Number of foreign bodies", "count": 1}, {"letter": "Number of metastases", "count": 6}, {"letter": "Number of oocytes", "count": 6}, {"letter": "Number of biopsies", "count": 7}, {"letter": "Number of times", "count": 21}, {"letter": "Wavelength", "count": 1}, {"letter": "Prognostic score", "count": 4}, {"letter": "Multiplicity", "count": 7}, {"letter": "Geometry", "count": 5}, {"letter": "With configuration", "count": 4}, {"letter": "Patient position finding", "count": 3}, {"letter": "Techniques", "count": 175}, {"letter": "Threshold", "count": 68}, {"letter": "Use of implant", "count": 1}, {"letter": "Mount used", "count": 2}, {"letter": "Contrast used", "count": 7}, {"letter": "Test conditions", "count": 2}, {"letter": "View", "count": 57}, {"letter": "System", "count": 249}, {"letter": "System involved", "count": 1}, {"letter": "Metastases status", "count": 1}, {"letter": "Post-processing", "count": 3}, {"letter": "Serotype", "count": 1}, {"letter": "Number of points", "count": 3}, {"letter": "Number of units", "count": 3}, {"letter": "Presence of infection", "count": 1}, {"letter": "Volume of fluid used", "count": 2}, {"letter": "Initial presentation", "count": 2}, {"letter": "Type of restoration", "count": 3}, {"letter": "First sign", "count": 11}, {"letter": "First value", "count": 9}, {"letter": "Present procedure", "count": 2}, {"letter": "Temperature change", "count": 2}, {"letter": "Enzyme method", "count": 3}, {"letter": "Rebreathing method", "count": 1}, {"letter": "Very large", "count": 4}, {"letter": "Fasciocutaneous flap", "count": 4}, {"letter": "Myocutaneous flap", "count": 1}, {"letter": "Blood component", "count": 1}, {"letter": "Pathogenic organism", "count": 8}, {"letter": "16/16", "count": 2}, {"letter": "18/22", "count": 2}, {"letter": "18/25", "count": 4}, {"letter": "alphanumeric label - 1A", "count": 38}, {"letter": "1B (qualifier value)", "count": 36}, {"letter": "2/5", "count": 11}, {"letter": "23", "count": 109}, {"letter": "2b", "count": 14}, {"letter": "31", "count": 29}, {"letter": "Three-dimensional", "count": 30}, {"letter": "Serotype 3c (qualifier value)", "count": 1}, {"letter": "4/5", "count": 7}, {"letter": "4a serotype", "count": 7}, {"letter": "Serotype 4b", "count": 2}, {"letter": "4c serotype", "count": 2}, {"letter": "4d serotype", "count": 3}, {"letter": "Serotype 4e", "count": 1}, {"letter": "55", "count": 23}, {"letter": "65", "count": 1}, {"letter": "68", "count": 16}, {"letter": "Numeral 69", "count": 11}, {"letter": "71", "count": 2}, {"letter": "40mm", "count": 1}, {"letter": "ph+", "count": 28}, {"letter": "Lateral to the left", "count": 3}, {"letter": "Linear longitudinal", "count": 1}, {"letter": "To the left (qualifier value)", "count": 1}, {"letter": "Location", "count": 70}, {"letter": "Agent", "count": 2}, {"letter": "Stops device", "count": 1}, {"letter": "Assessment scales", "count": 93}, {"letter": "Addiction severity index", "count": 2}, {"letter": "Alcohol dependence scale", "count": 3}, {"letter": "Alcohol use disorders identification test", "count": 9}, {"letter": "Alzheimer's Disease Assessment Scale", "count": 2}, {"letter": "Barthel index", "count": 1}, {"letter": "Beck depression inventory", "count": 15}, {"letter": "Blessed dementia rating scale", "count": 1}, {"letter": "Boston Naming Test", "count": 1}, {"letter": "Cage questionnaire", "count": 1}, {"letter": "Cognitions questionnaire", "count": 4}, {"letter": "Cognitive failures questionnaire", "count": 3}, {"letter": "Daily activities questionnaire", "count": 1}, {"letter": "Depression anxiety scale", "count": 23}, {"letter": "Depression self rating scale", "count": 1}, {"letter": "Dermatology life quality index", "count": 4}, {"letter": "Diagnostic interview schedule", "count": 2}, {"letter": "Eating inventory", "count": 1}, {"letter": "European Organisation for Research and Treatment of Cancer - Quality of Life questionnaire", "count": 78}, {"letter": "EuroQOL (assessment scale)", "count": 73}, {"letter": "FIRST screening test", "count": 2}, {"letter": "Frenchay activities index", "count": 4}, {"letter": "Functional assessment measure", "count": 21}, {"letter": "Functional independence measure (assessment scale)", "count": 1}, {"letter": "General health questionnaire", "count": 4}, {"letter": "Geriatric depression scale (assessment scale)", "count": 4}, {"letter": "Hamilton rating scale for depression", "count": 2}, {"letter": "Health assessment questionnaire", "count": 3}, {"letter": "Hopelessness scale", "count": 2}, {"letter": "Hopkins symptom checklist", "count": 2}, {"letter": "Impact of event scale", "count": 18}, {"letter": "Jebsen hand function test", "count": 1}, {"letter": "Likert scale", "count": 356}, {"letter": "Medical outcomes study short form general health survey", "count": 6}, {"letter": "Mini-mental state examination", "count": 9}, {"letter": "Multilingual Aphasia Examination", "count": 1}, {"letter": "Neuropsychological battery", "count": 1}, {"letter": "Oxford grading scale for muscle strength", "count": 5}, {"letter": "Pain diary", "count": 6}, {"letter": "Patient satisfaction score", "count": 4}, {"letter": "Profile of mood states", "count": 22}, {"letter": "Quality of life scale", "count": 86}, {"letter": "Rotterdam symptom check list", "count": 8}, {"letter": "Social adjustment scale self - report", "count": 1}, {"letter": "Social support questionnaire", "count": 3}, {"letter": "Spielberger state-trait anxiety inventory", "count": 9}, {"letter": "Spitzer quality of life index", "count": 12}, {"letter": "Subjective global assessment", "count": 9}, {"letter": "Symbol Digit Modalities Test", "count": 3}, {"letter": "Symptom checklist", "count": 12}, {"letter": "Time line follow back", "count": 1}, {"letter": "Wechsler Memory Scale", "count": 1}, {"letter": "WHO depression scale", "count": 2}, {"letter": "Patient review", "count": 4}, {"letter": "Medication commenced", "count": 1}, {"letter": "Pain relief", "count": 10}, {"letter": "Belt, device", "count": 1}, {"letter": "Physical therapy exercises", "count": 8}, {"letter": "Therapeutic diet", "count": 1}, {"letter": "Diet, Healthy", "count": 4}, {"letter": "Drink (dietary substance)", "count": 2}, {"letter": "Spaghetti", "count": 1}, {"letter": "Processed meat", "count": 1}, {"letter": "Brassica vegetable - dietary", "count": 1}, {"letter": "Watercress", "count": 3}, {"letter": "Carbohydrate food", "count": 1}, {"letter": "Rich food", "count": 1}, {"letter": "Brassiere", "count": 6}, {"letter": "Combinations (Undergarment)", "count": 14}, {"letter": "Stocking (hosiery)", "count": 3}, {"letter": "Tights", "count": 1}, {"letter": "Tie (garment)", "count": 9}, {"letter": "dress garment", "count": 2}, {"letter": "Trainers", "count": 1}, {"letter": "Button", "count": 3}, {"letter": "Tobacco smoking behavior", "count": 25}, {"letter": "Cognitive intervention strategies", "count": 3}, {"letter": "Psychosocial intervention strategy", "count": 1}, {"letter": "Radiotherapy planning", "count": 3}, {"letter": "Brachytherapy implant", "count": 1}, {"letter": "Patient dimensions", "count": 2}, {"letter": "Irradiated volume", "count": 1}, {"letter": "Clinical target volume", "count": 1}, {"letter": "Planning target volume", "count": 2}, {"letter": "Number of centers", "count": 1}, {"letter": "Brachytherapy radiation dose", "count": 1}, {"letter": "Number of fractions", "count": 1}, {"letter": "High dose brachytherapy (procedure)", "count": 1}, {"letter": "Isotonic exercise", "count": 14}, {"letter": "Exercise class", "count": 2}, {"letter": "Upper limb exercises", "count": 1}, {"letter": "Shoulder exercises", "count": 1}, {"letter": "Shoulder press", "count": 4}, {"letter": "Bench press", "count": 4}, {"letter": "Lower limb exercises", "count": 1}, {"letter": "Manual Therapies", "count": 11}, {"letter": "Country", "count": 3}, {"letter": "Asian country", "count": 1}, {"letter": "Cos (Greek island)", "count": 2}, {"letter": "Rhodes", "count": 2}, {"letter": "Cleveland", "count": 1}, {"letter": "Kent (geographic location)", "count": 1}, {"letter": "Collection of stool specimen", "count": 1}, {"letter": "Scalp cooling", "count": 4}, {"letter": "Injection of heart", "count": 1}, {"letter": "Personal assessment", "count": 2}, {"letter": "Showing emotion", "count": 1}, {"letter": "Serum follicle stimulating hormone measurement", "count": 2}, {"letter": "Plasma glucose result", "count": 5}, {"letter": "Corrected serum calcium measurement", "count": 8}, {"letter": "Serum sex hormone binding globulin measurement", "count": 1}, {"letter": "PMH - past medical history", "count": 1}, {"letter": "History of malignant neoplasm", "count": 1}, {"letter": "History of surgery", "count": 1}, {"letter": "History of exposure to radiation", "count": 4}, {"letter": "History of - risk factor", "count": 1}, {"letter": "Administration type", "count": 19}, {"letter": "Procedure type", "count": 1}, {"letter": "Increased energy", "count": 1}, {"letter": "Neurological investigation", "count": 1}, {"letter": "Left ventricular mass", "count": 4}, {"letter": "Waist Circumference", "count": 27}, {"letter": "Left ventricular end-systolic cavity size", "count": 4}, {"letter": "Left ventricular end-diastolic cavity size", "count": 4}, {"letter": "Vibration - treatment", "count": 3}, {"letter": "Disease classification level", "count": 284}, {"letter": "Qualitative Displacement", "count": 1}, {"letter": "Adjustment Action", "count": 92}, {"letter": "Null Value", "count": 11}, {"letter": "Microbiology subtype strains", "count": 1}, {"letter": "Aortic Pressure", "count": 1}, {"letter": "Contents", "count": 31}, {"letter": "Core body temperature", "count": 2}, {"letter": "Proven findings", "count": 17}, {"letter": "Unproven", "count": 4}, {"letter": "Test interpretation", "count": 2}, {"letter": "Type of bridge device", "count": 16}, {"letter": "Class", "count": 36}, {"letter": "size", "count": 116}, {"letter": "Hospital acquired", "count": 1}, {"letter": "10*9 cells/L", "count": 7}, {"letter": "platelets/L", "count": 1}, {"letter": "M - Metastasis stages", "count": 4}, {"letter": "Gauges (qualifier value)", "count": 8}, {"letter": "Angular degrees", "count": 5}, {"letter": "Stage 1B", "count": 172}, {"letter": "Stage 3A", "count": 2}, {"letter": "Ratio", "count": 268}, {"letter": "Pedicle", "count": 1}, {"letter": "Million per Microliter", "count": 1}, {"letter": "Billion per Liter", "count": 57}, {"letter": "10*6/liter", "count": 5}, {"letter": "Degrees fahrenheit", "count": 4}, {"letter": "26G", "count": 1}, {"letter": "kcal/day", "count": 3}, {"letter": "Millimeter Per Second", "count": 1}, {"letter": "U/hour", "count": 1}, {"letter": "Kilogram Per Square Meter", "count": 7}, {"letter": "/10 min", "count": 7}, {"letter": "per 30 minutes", "count": 20}, {"letter": "per 12 hours (qualifier value)", "count": 7}, {"letter": "per 24 hours", "count": 92}, {"letter": "times/week", "count": 10}, {"letter": "g.m", "count": 2}, {"letter": "square millimeter (qualifier value)", "count": 3}, {"letter": "Image-Guided Biopsy", "count": 1}, {"letter": "CT guided biopsy", "count": 2}, {"letter": "TNM certainty factor C1", "count": 18}, {"letter": "Intraoperative", "count": 64}, {"letter": "Level 1", "count": 18}, {"letter": "Level 2 (qualifier value)", "count": 47}, {"letter": "Level 3", "count": 13}, {"letter": "Level 4", "count": 13}, {"letter": "Level 5", "count": 34}, {"letter": "Rapid", "count": 102}, {"letter": "20 feet", "count": 2}, {"letter": "Automated endodontic technique", "count": 2}, {"letter": "specific antigen", "count": 5}, {"letter": "Sidedness", "count": 3}, {"letter": "Usage", "count": 62}, {"letter": "Morning stiffness - joint", "count": 1}, {"letter": "Whole breast", "count": 11}, {"letter": "Stage 1 lower case a", "count": 30}, {"letter": "Stage 2 lower case a", "count": 8}, {"letter": "Stage 2 lower case b", "count": 5}, {"letter": "Stage 3 lower case a", "count": 2}, {"letter": "Stage 3 lower case c", "count": 2}, {"letter": "Greater than 50 degrees C", "count": 1}, {"letter": "Spot urine specimen", "count": 1}, {"letter": "square metres", "count": 26}, {"letter": "Radiographic imaging - action", "count": 10}, {"letter": "Cord blood specimen", "count": 1}, {"letter": "Accelerated phase", "count": 1}, {"letter": "Type of fracture", "count": 1}, {"letter": "Sensory nerve conduction velocity", "count": 1}, {"letter": "Type of impression", "count": 1}, {"letter": "seconds", "count": 124}, {"letter": "types of lesions", "count": 1}, {"letter": "Reflex latency", "count": 1}, {"letter": "Conduction Phenomenon", "count": 2}, {"letter": "Non-compliance", "count": 17}, {"letter": "Severity score", "count": 15}, {"letter": "On admission", "count": 1}, {"letter": "Discontinuation (procedure)", "count": 33}, {"letter": "biological tissue", "count": 2}, {"letter": "Type 5", "count": 3}, {"letter": "Scale type", "count": 5}, {"letter": "Combined oral contraceptive - use", "count": 1}, {"letter": "Finger-prick sampling (procedure)", "count": 3}, {"letter": "Type of drug", "count": 17}, {"letter": "Numerical range", "count": 3}, {"letter": "Current non-drinker of alcohol", "count": 4}, {"letter": "Mastectomy incision", "count": 1}, {"letter": "Temporal incision", "count": 4}, {"letter": "Residential flat", "count": 12}, {"letter": "Short form McGill pain questionnaire", "count": 5}, {"letter": "Well baby", "count": 1}, {"letter": "Drug-induced", "count": 1}, {"letter": "Hormonal", "count": 48}, {"letter": "Sev (substance)", "count": 1}, {"letter": "Complex Regional Pain Syndromes", "count": 1}, {"letter": "Allodynia", "count": 3}, {"letter": "Verbal Rating Scale", "count": 1}, {"letter": "Fearful (qualifier value)", "count": 2}, {"letter": "Trigger point", "count": 4}, {"letter": "Site of radiation", "count": 2}, {"letter": "Arm position finding", "count": 6}, {"letter": "Type of activity", "count": 14}, {"letter": "Normal result", "count": 2}, {"letter": "Abnormal result", "count": 3}, {"letter": "Indeterminate result", "count": 1}, {"letter": "Subscale score", "count": 102}, {"letter": "Interpretation Process", "count": 38}, {"letter": "Sympathetic nerve structure", "count": 1}, {"letter": "Vibration - physical agent", "count": 8}, {"letter": "New relationship", "count": 2}, {"letter": "Conservative Treatment", "count": 5}, {"letter": "Abstract thinking ability", "count": 1}, {"letter": "Bone structure of T1", "count": 1}, {"letter": "Bone structure of T9", "count": 1}, {"letter": "body system", "count": 11}, {"letter": "Head and neck structure", "count": 9}, {"letter": "Trunk structure", "count": 18}, {"letter": "Back structure, including back of neck", "count": 54}, {"letter": "Final report (report type)", "count": 2}, {"letter": "Depression motion", "count": 3}, {"letter": "Pressure (finding)", "count": 36}, {"letter": "Human body structure", "count": 13}, {"letter": "Wound Dressings (device)", "count": 1}, {"letter": "Message", "count": 17}, {"letter": "Availability of", "count": 208}, {"letter": "2000", "count": 11}, {"letter": "3000", "count": 5}, {"letter": "1 Minute", "count": 4}, {"letter": "per 7.5 Milliliters", "count": 1}, {"letter": "lifescan", "count": 2}, {"letter": "Blood glucose meters (medical device)", "count": 2}, {"letter": "Hemopoietic stem cell transplant", "count": 2}, {"letter": "McKeown esophagectomy", "count": 10}, {"letter": "Pilot", "count": 35}, {"letter": "Flap ischemia", "count": 1}, {"letter": "Induction of general anesthesia", "count": 2}, {"letter": "Local anesthetic agent poisoning", "count": 6}, {"letter": "Reduction of edema", "count": 2}, {"letter": "Disease behavior", "count": 1}, {"letter": "Behavior showing increased motor activity", "count": 3}, {"letter": "Sleep behavior finding", "count": 9}, {"letter": "Disruptive Behavior", "count": 1}, {"letter": "Self-care behavior", "count": 4}, {"letter": "Diarrhea and vomiting, symptom", "count": 1}, {"letter": "Serum inhibitory titer test", "count": 2}, {"letter": "Antibody titer measurement", "count": 3}, {"letter": "Serum estradiol measurement", "count": 15}, {"letter": "Estriol level", "count": 1}, {"letter": "Hemoglobin A1c measurement", "count": 3}, {"letter": "Tumor marker measurement", "count": 32}, {"letter": "Color doppler ultrasound", "count": 1}, {"letter": "Neoplasm by Morphology", "count": 3}, {"letter": "Percentage total hemoglobin", "count": 5}, {"letter": "Titer", "count": 50}, {"letter": "Meter", "count": 46}, {"letter": "centimeter", "count": 67}, {"letter": "liter", "count": 19}, {"letter": "Ischemic", "count": 2}, {"letter": "localization", "count": 49}, {"letter": "Tumor grade G1", "count": 106}, {"letter": "G2 stage (tumor staging)", "count": 1}, {"letter": "Tumor grade G3", "count": 368}, {"letter": "Tumor Volume", "count": 51}, {"letter": "Large tumor", "count": 8}, {"letter": "Stage R", "count": 25}, {"letter": "Stage R0", "count": 1}, {"letter": "Health center", "count": 8}, {"letter": "Harbor", "count": 9}, {"letter": "Color change", "count": 1}, {"letter": "Total estrogens", "count": 1}, {"letter": "Tumor tissue sample", "count": 403}, {"letter": "T0 stage", "count": 28}, {"letter": "Tumor stage T3", "count": 2}, {"letter": "Tumor stage T1a", "count": 1}, {"letter": "Tumor stage T1b", "count": 2}, {"letter": "Tumor stage T1c", "count": 2}, {"letter": "Tumor stage T4a", "count": 1}, {"letter": "Tumor stage T4b", "count": 1}, {"letter": "Tumor stage T4c", "count": 1}, {"letter": "Tumor stage T4d", "count": 1}, {"letter": "Standardized technique", "count": 3}, {"letter": "Tumor stage Tis", "count": 38}, {"letter": "Extent of tumor", "count": 6}, {"letter": "Tumor size", "count": 138}, {"letter": "Tumor site", "count": 12}, {"letter": "Site of primary tumor", "count": 16}, {"letter": "Number of tumors", "count": 5}, {"letter": "T - Tumor stage", "count": 3}, {"letter": "Antibodies, Neutralizing", "count": 7}, {"letter": "Coping behavior inventory", "count": 1}, {"letter": "Home exercise program", "count": 1}, {"letter": "Tumor status", "count": 19}, {"letter": "1/3 meter (distance vision finding)", "count": 3}, {"letter": "General anesthesia - under adequate anesthesia", "count": 1}, {"letter": "Residual tumor stage R1 (finding)", "count": 1}, {"letter": "Residual tumor stage R2 (finding)", "count": 2}, {"letter": "Endometrial Carcinoma", "count": 4}, {"letter": "Skin loss", "count": 4}, {"letter": "Developmental symptoms", "count": 5}, {"letter": "Dyslexia", "count": 1}, {"letter": "Cardiovascular symptoms", "count": 1}, {"letter": "Musculoskeletal chest pain", "count": 2}, {"letter": "Non-cardiac chest pain", "count": 2}, {"letter": "Echocardiogram abnormal (finding)", "count": 22}, {"letter": "Encounter due to occupational exposure to radiation", "count": 1}, {"letter": "Physical and emotional exhaustion state", "count": 1}, {"letter": "Encounter due to prophylactic surgery, unspecified", "count": 1}, {"letter": "Other chemotherapy", "count": 3}, {"letter": "Radiotherapy session", "count": 1}, {"letter": "Maintenance Chemotherapy", "count": 2}, {"letter": "Surgical follow-up", "count": 4}, {"letter": "Live Birth", "count": 3}, {"letter": "medical insurance", "count": 2}, {"letter": "cd4 and cd8+", "count": 1}, {"letter": "O NOS Ab", "count": 32}, {"letter": "Prothrombin time ratio", "count": 1}, {"letter": "Laboratory observation of character", "count": 6}, {"letter": "Clarity", "count": 15}, {"letter": "Composition", "count": 62}, {"letter": "Du antigen", "count": 1}, {"letter": "Mg antigen", "count": 61}, {"letter": "Staining method", "count": 82}, {"letter": "T lymphocyte antigen", "count": 2}, {"letter": "Width", "count": 12}, {"letter": "serum/plasma", "count": 5}, {"letter": "Body temperature:Temperature:Point in time:Mouth:Quantitative", "count": 2}, {"letter": "Intravascular mean:Pressure:Point in time:Arterial system:Quantitative", "count": 3}, {"letter": "PR interval:Time:Point in time:Heart:Quantitative:EKG", "count": 3}, {"letter": "QT interval:Time:Point in time:Heart:Quantitative:EKG", "count": 16}, {"letter": "RR interval:Time:Point in time:Heart:Quantitative:EKG", "count": 5}, {"letter": "Physical findings:Finding:Point in time:Heart:Nominal:Observed", "count": 1}, {"letter": "Ejection fraction:Volume Fraction:Point in time:Heart.ventricle.left:Quantitative", "count": 77}, {"letter": "Stools:Appearance:Point in time:Lower GI tract:Nominal", "count": 1}, {"letter": "Breaths:Number = Count/Time:Point in time:Respiratory system:Quantitative", "count": 4}, {"letter": "Body surface", "count": 3}, {"letter": "Energy requirement", "count": 1}, {"letter": "Comparison study", "count": 5}, {"letter": "Ejection fraction (procedure)", "count": 1}, {"letter": "EKG impression", "count": 13}, {"letter": "fat intake", "count": 3}, {"letter": "History of allergies", "count": 1}, {"letter": "protein intake", "count": 2}, {"letter": "QTC interval", "count": 4}, {"letter": "Study duration", "count": 9}, {"letter": "Style", "count": 12}, {"letter": "Height", "count": 18}, {"letter": "Deep Tendon Reflex", "count": 5}, {"letter": "Mathematical formula", "count": 92}, {"letter": "heart rate measure", "count": 10}, {"letter": "heart study", "count": 3}, {"letter": "rate control", "count": 75}, {"letter": "Vascular System", "count": 1}, {"letter": "Family history of malignant neoplasm of ovary", "count": 1}, {"letter": "OSCILLOMETER", "count": 4}, {"letter": "Light microscope", "count": 3}, {"letter": "LYMPHOCYTE SEPARATION MEDIUM", "count": 1}, {"letter": "Biopsy Instruments", "count": 1}, {"letter": "Ultrasound contrast media", "count": 1}, {"letter": "IMPLANT, TEMPORAL", "count": 1}, {"letter": "Secondary malignant neoplasm of liver", "count": 10}, {"letter": "Medical care", "count": 8}, {"letter": "Sensitivity test", "count": 3}, {"letter": "Other preventive procedure", "count": 4}, {"letter": "Referral to primary care provider", "count": 1}, {"letter": "No disease", "count": 30}, {"letter": "Musculoskeletal", "count": 4}, {"letter": "joint symptom", "count": 6}, {"letter": "Overweight", "count": 16}, {"letter": "General and unspecified fear of cancer NOS", "count": 3}, {"letter": "Blood Pressure Monitor Automatic", "count": 1}, {"letter": "POST REMOVAL (NOT IN CONJUCTION WITH ENDODONTIC THERAPY)", "count": 3}, {"letter": "Motor nerve", "count": 1}, {"letter": "Sensory nerve", "count": 5}, {"letter": "Lymphoid organ structure", "count": 1}, {"letter": "Cavity of left ventricle", "count": 1}, {"letter": "Body Excretions", "count": 1}, {"letter": "Striated muscle fasciculus", "count": 1}, {"letter": "Spinal nerve branch", "count": 1}, {"letter": "Level of the fourth thoracic vertebra", "count": 1}, {"letter": "Posterior segmental bronchus", "count": 3}, {"letter": "Lateral basal segmental vein", "count": 1}, {"letter": "Posterior basal segmental vein", "count": 1}, {"letter": "Anterior bronchopulmonary segment of superior pulmonary vein", "count": 79}, {"letter": "Posterior segmental vein", "count": 14}, {"letter": "Apical segmental vein", "count": 872}, {"letter": "Wall of artery", "count": 1}, {"letter": "Level I axillary lymph node", "count": 1}, {"letter": "answer questions", "count": 12}, {"letter": "Positive social interaction", "count": 1}, {"letter": "Self-initiated health seeking behavior", "count": 3}, {"letter": "standing balance", "count": 4}, {"letter": "patience", "count": 1}, {"letter": "energy level", "count": 6}, {"letter": "Physical function", "count": 8}, {"letter": "Comfort level", "count": 6}, {"letter": "Physical Well-being", "count": 133}, {"letter": "Muscle Strength", "count": 61}, {"letter": "Muscle Endurance Measurement", "count": 5}, {"letter": "Health promotion behavior", "count": 4}, {"letter": "Purulent drainage", "count": 3}, {"letter": "Mobility level", "count": 1}, {"letter": "Muscle function outcome", "count": 4}, {"letter": "autonomic function", "count": 1}, {"letter": "body mass", "count": 17}, {"letter": "Hematocrit level", "count": 1}, {"letter": "Blood cholesterol", "count": 1}, {"letter": "body fat percentage (physical finding)", "count": 19}, {"letter": "Endurance", "count": 27}, {"letter": "Pain level", "count": 51}, {"letter": "Frequency of Pain Question", "count": 28}, {"letter": "Parenting caregiver status", "count": 2}, {"letter": "Healthcare decision making", "count": 4}, {"letter": "Development of the breasts", "count": 2}, {"letter": "Perceived quality of life", "count": 516}, {"letter": "Impaired mobility", "count": 1}, {"letter": "Dressing self-care", "count": 3}, {"letter": "Does shave (finding)", "count": 7}, {"letter": "Confidence level", "count": 3}, {"letter": "Sleep Efficiency", "count": 26}, {"letter": "Social confrontation skill", "count": 1}, {"letter": "Consideration", "count": 21}, {"letter": "Chronic fatigue", "count": 6}, {"letter": "Vital signs", "count": 121}, {"letter": "Granulation finding", "count": 1}, {"letter": "psychosocial health", "count": 1}, {"letter": "Neurocognitive", "count": 20}, {"letter": "Health behavior outcomes", "count": 12}, {"letter": "health knowledge", "count": 6}, {"letter": "Immunology procedure", "count": 2}, {"letter": "Comprehensive Metabolic Panel", "count": 1}, {"letter": "Computerized dynamic posturography procedure", "count": 2}, {"letter": "Decision for Surgery", "count": 9}, {"letter": "Chronic active hepatitis", "count": 2}, {"letter": "Arm Bones", "count": 1}, {"letter": "Materials", "count": 29}, {"letter": "Distributing", "count": 95}, {"letter": "Minor depressive disorder", "count": 1}, {"letter": "Physical disability", "count": 8}, {"letter": "Raised jugular venous pressure", "count": 1}, {"letter": "Diastolic dysfunction", "count": 3}, {"letter": "Increased cardiac stroke volume", "count": 1}, {"letter": "PR interval feature", "count": 3}, {"letter": "QRS interval, function", "count": 3}, {"letter": "Inverted T wave", "count": 1}, {"letter": "Postoperative Nausea", "count": 17}, {"letter": "Vomiting, Postoperative", "count": 4}, {"letter": "Postoperative Nausea and Vomiting", "count": 13}, {"letter": "Decreased metabolic requirement", "count": 1}, {"letter": "Premenopausal amenorrhea", "count": 1}, {"letter": "Emotional hypersensitivity", "count": 9}, {"letter": "Bacterial", "count": 12}, {"letter": "Viral", "count": 2}, {"letter": "Fungal", "count": 4}, {"letter": "No indication of", "count": 2}, {"letter": "Confirmation of", "count": 65}, {"letter": "Confirmed by", "count": 472}, {"letter": "Determined by", "count": 1138}, {"letter": "Cleared by", "count": 5}, {"letter": "Interferes with", "count": 129}, {"letter": "Recovering from", "count": 19}, {"letter": "Accelerated", "count": 3}, {"letter": "Bedtime (qualifier value)", "count": 3}, {"letter": "Infrequent", "count": 39}, {"letter": "Simultaneous", "count": 75}, {"letter": "Current (present time)", "count": 183}, {"letter": "Severity of illness", "count": 8}, {"letter": "Extracellular", "count": 13}, {"letter": "Against", "count": 13}, {"letter": "Preposition For", "count": 775}, {"letter": "Occupational", "count": 5}, {"letter": "Seropositive", "count": 1}, {"letter": "Recurrent tumor", "count": 102}, {"letter": "Eschar", "count": 1}, {"letter": "Life support procedure", "count": 1}, {"letter": "Neurostimulation procedure", "count": 2}, {"letter": "Multiple gated acquisition scanning", "count": 33}, {"letter": "Skeletal", "count": 21}, {"letter": "Spinal", "count": 4}, {"letter": "gastrointestinal", "count": 2}, {"letter": "neuronal", "count": 2}, {"letter": "Meningeal", "count": 1}, {"letter": "Leptomeningeal", "count": 7}, {"letter": "Entire ear", "count": 5}, {"letter": "Nuclear (nucleus)", "count": 13}, {"letter": "lysosomal", "count": 1}, {"letter": "Edematous skin", "count": 1}, {"letter": "Application site pain", "count": 1}, {"letter": "Gastrointestinal mucositis", "count": 8}, {"letter": "Neurologic Deficits", "count": 3}, {"letter": "Victim of neglect (finding)", "count": 3}, {"letter": "Response to treatment", "count": 89}, {"letter": "Pre-existing condition", "count": 35}, {"letter": "Associated symptom", "count": 5}, {"letter": "Symptoms of stress", "count": 5}, {"letter": "Agony", "count": 9}, {"letter": "Upright", "count": 4}, {"letter": "Edema of the upper extremity", "count": 6}, {"letter": "Acute chest pain", "count": 1}, {"letter": "ECG normal", "count": 1}, {"letter": "Electrocardiogram abnormal (finding)", "count": 28}, {"letter": "Feeling calm", "count": 10}, {"letter": "Sense of oppression", "count": 1}, {"letter": "Paralysed", "count": 2}, {"letter": "Contraindication", "count": 1}, {"letter": "Patient affected", "count": 6}, {"letter": "Patient performance", "count": 7}, {"letter": "Delay time", "count": 1}, {"letter": "Long axis", "count": 2}, {"letter": "Short axis", "count": 174}, {"letter": "Rare", "count": 27}, {"letter": "Palpable", "count": 20}, {"letter": "Massive", "count": 48}, {"letter": "Translucent", "count": 3}, {"letter": "Downstream", "count": 20}, {"letter": "With color", "count": 6}, {"letter": "With consistency", "count": 1}, {"letter": "With intensity", "count": 453}, {"letter": "With size", "count": 4}, {"letter": "Percutaneous", "count": 12}, {"letter": "Semi-quantitative", "count": 13}, {"letter": "Conjugated", "count": 28}, {"letter": "Unconjugated", "count": 37}, {"letter": "Saturated", "count": 3}, {"letter": "Xenograft type of graft", "count": 2}, {"letter": "Spiral Shape", "count": 1}, {"letter": "Severe inflammation", "count": 1}, {"letter": "Measuring ruler, device", "count": 11}, {"letter": "Diagnostic surgical procedure", "count": 2}, {"letter": "Shaving - surgical procedure", "count": 11}, {"letter": "Placement of stent", "count": 1}, {"letter": "Blast count procedure", "count": 1}, {"letter": "Hematoxylin and eosin stain method", "count": 14}, {"letter": "Wright-Giemsa stain method", "count": 2}, {"letter": "Adenosine diphosphate measurement", "count": 1}, {"letter": "Alanine measurement", "count": 4}, {"letter": "Alpha-1-acid glycoprotein measurement", "count": 2}, {"letter": "Arginine measurement", "count": 1}, {"letter": "Cholesterol/HDL ratio measurement", "count": 1}, {"letter": "VLDL cholesterol measurement", "count": 1}, {"letter": "Citrulline measurement", "count": 1}, {"letter": "Deoxycholate measurement", "count": 1}, {"letter": "Histidine measurement", "count": 12}, {"letter": "Insulin-like growth factor binding protein 3 measurement", "count": 9}, {"letter": "Iodine measurement", "count": 2}, {"letter": "Lipids measurement", "count": 18}, {"letter": "Lipoprotein lipase measurement", "count": 2}, {"letter": "Lysine measurement", "count": 2}, {"letter": "Neurotensin measurement", "count": 1}, {"letter": "Oxygen measurement", "count": 4}, {"letter": "Oxygen saturation measurement", "count": 1}, {"letter": "Proline measurement", "count": 63}, {"letter": "Prostaglandin PGE2 measurement", "count": 1}, {"letter": "Serine measurement", "count": 3}, {"letter": "Vitamin D3 measurement", "count": 8}, {"letter": "Vitronectin measurement", "count": 1}, {"letter": "Fentanyl measurement", "count": 1}, {"letter": "Oxycodone measurement", "count": 1}, {"letter": "Structure of condyle", "count": 2}, {"letter": "Structure of lumen of body system", "count": 1}, {"letter": "Luminal region", "count": 45}, {"letter": "Intracranial", "count": 51}, {"letter": "Structure of right shoulder region", "count": 1}, {"letter": "Right hip region structure", "count": 1}, {"letter": "Structure of left hip", "count": 1}, {"letter": "Drug Formulation Process", "count": 10}, {"letter": "Metabolic Syndrome X", "count": 8}, {"letter": "Recognition, Psychology", "count": 7}, {"letter": "Coins", "count": 1}, {"letter": "High Frequency Waves", "count": 3}, {"letter": "Dose Fractionation", "count": 3}, {"letter": "Thoracic Surgical Procedures", "count": 2}, {"letter": "Oral Surgical Procedures", "count": 1}, {"letter": "Reconstructive Surgical Procedures", "count": 95}, {"letter": "Loss of Heterozygosity", "count": 2}, {"letter": "Squash (Food)", "count": 1}, {"letter": "Genes, T-Cell Receptor", "count": 1}, {"letter": "Penetrance", "count": 4}, {"letter": "chemokine receptor", "count": 1}, {"letter": "Prostheses and Implants", "count": 2}, {"letter": "Ryanodine Receptor 1", "count": 1}, {"letter": "Prosthesis Implantation", "count": 8}, {"letter": "International Normalized Ratio", "count": 6}, {"letter": "Probiotics", "count": 7}, {"letter": "Genes, bcl-1", "count": 1}, {"letter": "CDKN2A gene", "count": 10}, {"letter": "Neurobehavioral Manifestations", "count": 3}, {"letter": "Clinical Chemistry Tests", "count": 4}, {"letter": "Mood Disorders", "count": 4}, {"letter": "Protocol Compliance", "count": 3}, {"letter": "Guideline Adherence", "count": 2}, {"letter": "Benchmarking", "count": 1}, {"letter": "Visually Impaired Persons", "count": 1}, {"letter": "Pharmaceutical Solutions", "count": 8}, {"letter": "bendamustine", "count": 3}, {"letter": "(18F)FES", "count": 4}, {"letter": "cinobufotalin", "count": 9}, {"letter": "AN(5)", "count": 100}, {"letter": "FGFR3 protein, human", "count": 1}, {"letter": "Estrogen Receptor beta", "count": 4}, {"letter": "Receptor, Angiotensin, Type 1", "count": 1}, {"letter": "ANGPT1 protein, human", "count": 1}, {"letter": "25-hydroxyvitamin D", "count": 1}, {"letter": "HSD17B4 protein, human", "count": 2}, {"letter": "CTAG1 protein, human", "count": 1}, {"letter": "UGT1A1 gene", "count": 1}, {"letter": "endothelial PAS domain-containing protein 1", "count": 1}, {"letter": "celecoxib", "count": 28}, {"letter": "sigma-2 receptor", "count": 2}, {"letter": "SLC16A3 protein, human", "count": 2}, {"letter": "nuclear receptor coactivator 3", "count": 1}, {"letter": "KISS1 protein, human", "count": 2}, {"letter": "PODXL protein, human", "count": 3}, {"letter": "everolimus", "count": 58}, {"letter": "changes in size", "count": 25}, {"letter": "changes in densities", "count": 12}, {"letter": "Residual Tissues", "count": 2}, {"letter": "Chart evaluation by healthcare professional", "count": 22}, {"letter": "Bathing patient", "count": 1}, {"letter": "Does turn (finding)", "count": 8}, {"letter": "Skeletal muscle atrophy", "count": 2}, {"letter": "Terminal insomnia", "count": 4}, {"letter": "good effect", "count": 2}, {"letter": "Injection site haematoma", "count": 1}, {"letter": "Irrational", "count": 1}, {"letter": "Pressure feet", "count": 3}, {"letter": "Relaxed", "count": 3}, {"letter": "Scalp numbness", "count": 1}, {"letter": "Skin test positive", "count": 1}, {"letter": "Toxic reaction (NOS)", "count": 4}, {"letter": "Environmental Carcinogenesis", "count": 1}, {"letter": "Communication aid", "count": 1}, {"letter": "Psychosocial", "count": 43}, {"letter": "Behavioral change", "count": 30}, {"letter": "Visual memory", "count": 1}, {"letter": "Inferior", "count": 139}, {"letter": "Function (attribute)", "count": 485}, {"letter": "Battery (assault)", "count": 14}, {"letter": "Sweater", "count": 1}, {"letter": "Fine needle aspiration of breast", "count": 2}, {"letter": "Forgetful", "count": 1}, {"letter": "Response to stimulus physiology", "count": 3}, {"letter": "Energy, Physics", "count": 15}, {"letter": "Serum Triglyceride Measurement", "count": 1}, {"letter": "Injury of tongue", "count": 1}, {"letter": "Poor - grade value", "count": 19}, {"letter": "Observation of Sensation", "count": 17}, {"letter": "Internal mammary lymph node group", "count": 3}, {"letter": "Natural flashes", "count": 1}, {"letter": "contextual factors", "count": 19}, {"letter": "Academic degree", "count": 17}, {"letter": "newton", "count": 4}, {"letter": "Facial edema", "count": 1}, {"letter": "Tobacco use", "count": 14}, {"letter": "Sequela of disorder", "count": 11}, {"letter": "Total cholesterol", "count": 18}, {"letter": "Operative Surgical Procedures", "count": 614}, {"letter": "Outcome Studies", "count": 37}, {"letter": "Residual Tumor", "count": 75}, {"letter": "morphological", "count": 18}, {"letter": "Interested", "count": 133}, {"letter": "Lotion", "count": 4}, {"letter": "Disease remission", "count": 31}, {"letter": "Inactivation", "count": 1}, {"letter": "Clinical stage 0", "count": 1}, {"letter": "Skeletal Function", "count": 1}, {"letter": "reception", "count": 1}, {"letter": "Hanging", "count": 2}, {"letter": "Normal variation", "count": 1}, {"letter": "surgical implants", "count": 1}, {"letter": "Somatic mutation", "count": 10}, {"letter": "Visit", "count": 242}, {"letter": "Outpatient visits", "count": 3}, {"letter": "hospital visit", "count": 4}, {"letter": "complete blood count with differential", "count": 1}, {"letter": "T cell therapy", "count": 3}, {"letter": "Metabolic procedure", "count": 1}, {"letter": "bone and joint", "count": 5}, {"letter": "coronary artery and coronary artery", "count": 1}, {"letter": "both fallopian tubes and both ovaries", "count": 4}, {"letter": "Left basal ganglia", "count": 1}, {"letter": "Vascular imaging", "count": 1}, {"letter": "Persistence", "count": 64}, {"letter": "Fluid overload", "count": 8}, {"letter": "Visual evoked potential procedure", "count": 3}, {"letter": "Malignant neoplasm of esophagus", "count": 2}, {"letter": "doxorubicin hydrochloride", "count": 1}, {"letter": "Tracking", "count": 24}, {"letter": "Minimal", "count": 33}, {"letter": "Up", "count": 54}, {"letter": "Chronicity", "count": 3}, {"letter": "Decrease", "count": 764}, {"letter": "Openness", "count": 6}, {"letter": "First grade in elementary school", "count": 7}, {"letter": "Grade four rank", "count": 4}, {"letter": "Ablation", "count": 18}, {"letter": "Preparation for procedure", "count": 2}, {"letter": "protocols: surgery", "count": 2}, {"letter": "Perforation (observation)", "count": 2}, {"letter": "Financial problem", "count": 2}, {"letter": "Pseudofolliculitis barbae (disorder)", "count": 3}, {"letter": "Preoccupation finding", "count": 4}, {"letter": "Large", "count": 77}, {"letter": "Continuous", "count": 228}, {"letter": "Priority", "count": 5}, {"letter": "Midline (qualifier value)", "count": 18}, {"letter": "None", "count": 20}, {"letter": "Obstructed", "count": 2}, {"letter": "Parameter Value", "count": 19}, {"letter": "Patient currently pregnant", "count": 29}, {"letter": "Bone structure of spine", "count": 9}, {"letter": "Turkish population", "count": 20}, {"letter": "Loss of confidence", "count": 1}, {"letter": "Recurrent Carcinoma", "count": 6}, {"letter": "Alcohol Problem", "count": 5}, {"letter": "Palmar-plantar erythrodysesthesia syndrome", "count": 5}, {"letter": "Surgical intervention (finding)", "count": 1}, {"letter": "Hemoglobin increased", "count": 3}, {"letter": "Device migration", "count": 1}, {"letter": "acneform", "count": 1}, {"letter": "Sexual Dysfunction", "count": 6}, {"letter": "Potassium abnormal NOS", "count": 1}, {"letter": "pigment changes", "count": 3}, {"letter": "Medical records:Finding:-:^Patient:Document", "count": 19}, {"letter": "Study report:Finding:Point in time:Heart:Document:EKG", "count": 1}, {"letter": "Study report:Finding:Point in time:^Patient:Document:Pathology", "count": 2}, {"letter": "Specimen volume:Vol:Pt:Body fld:Qn", "count": 2}, {"letter": "Blood flow.mean", "count": 1}, {"letter": "Collection duration", "count": 1}, {"letter": "Collection Time", "count": 2}, {"letter": "Cross-section", "count": 5}, {"letter": "Longest Diameter", "count": 192}, {"letter": "Diameter.perpendicular", "count": 1}, {"letter": "diameter.transverse", "count": 1}, {"letter": "Discharge note", "count": 1}, {"letter": "Equation", "count": 31}, {"letter": "Glucose mean value", "count": 1}, {"letter": "history of alcohol use", "count": 4}, {"letter": "Identification criteria", "count": 1}, {"letter": "Microfilaria sp identified", "count": 3}, {"letter": "oxyCODONE.free", "count": 1}, {"letter": "PROBLEM LIST", "count": 3}, {"letter": "Psychiatric findings", "count": 1}, {"letter": "Report.total", "count": 2}, {"letter": "Study observation", "count": 1}, {"letter": "referral source", "count": 1}, {"letter": "Cardiopulmonary", "count": 9}, {"letter": "emergency visit", "count": 4}, {"letter": "Hepatic function study", "count": 2}, {"letter": "Does steer", "count": 1}, {"letter": "Actual blood loss", "count": 1}, {"letter": "Ca++ increased", "count": 1}, {"letter": "BREAST PAIN FEMALE", "count": 4}, {"letter": "Squamous cell carcinoma of skin", "count": 1}, {"letter": "Diagnostic lumbar puncture", "count": 1}, {"letter": "Excisional biopsy of lymph node (procedure)", "count": 4}, {"letter": "Shepherd", "count": 4}, {"letter": "Maker (occupation)", "count": 2}, {"letter": "Smith (occupation)", "count": 3}, {"letter": "Doppler studies", "count": 5}, {"letter": "Cancer education", "count": 2}, {"letter": "Assisted breathing", "count": 1}, {"letter": "Observation of delivery outcome", "count": 1}, {"letter": "Digitalization done", "count": 1}, {"letter": "Screening for malignant neoplasm of colon", "count": 3}, {"letter": "rates reimbursement", "count": 1}, {"letter": "Married (finding)", "count": 2}, {"letter": "Urine microscopy leukocytes present finding", "count": 1}, {"letter": "Malignant Glioma", "count": 3}, {"letter": "Cerebral metastasis", "count": 1}, {"letter": "Total protein measurement", "count": 1}, {"letter": "Colorectal", "count": 26}, {"letter": "Repositioning (procedure)", "count": 1}, {"letter": "Task analysis", "count": 1}, {"letter": "N-3 fatty acid intake", "count": 1}, {"letter": "Trace element intake", "count": 1}, {"letter": "docosahexaenoic acid", "count": 3}, {"letter": "Vegetable intake", "count": 4}, {"letter": "Current drinker", "count": 2}, {"letter": "Physically active", "count": 1}, {"letter": "Activity analysis", "count": 2}, {"letter": "Cannabis oil", "count": 1}, {"letter": "Vaginal penetration", "count": 3}, {"letter": "Gray unit of radiation dose", "count": 16}, {"letter": "MBq", "count": 11}, {"letter": "radiation absorbed dose", "count": 14}, {"letter": "cGy", "count": 2}, {"letter": "Lymphedema bandaging", "count": 1}, {"letter": "MHz", "count": 5}, {"letter": "kHz", "count": 1}, {"letter": "times/month", "count": 19}, {"letter": "times/year", "count": 3}, {"letter": "days/month", "count": 1}, {"letter": "mins/day", "count": 3}, {"letter": "hours/day", "count": 19}, {"letter": "mins/week", "count": 5}, {"letter": "g/week", "count": 1}, {"letter": "g/month", "count": 1}, {"letter": "Percentage proof", "count": 5}, {"letter": "Once daily", "count": 15}, {"letter": "Three times daily", "count": 1}, {"letter": "Twice weekly", "count": 13}, {"letter": "Single episode", "count": 1}, {"letter": "Three times weekly", "count": 2}, {"letter": "Assisting (procedure)", "count": 4}, {"letter": "Discussion (procedure)", "count": 32}, {"letter": "Mother tongue", "count": 3}, {"letter": "Has religious belief", "count": 2}, {"letter": "Life event observable", "count": 8}, {"letter": "Financial circumstances", "count": 1}, {"letter": "Household income", "count": 6}, {"letter": "Individual income", "count": 1}, {"letter": "Employed", "count": 34}, {"letter": "Unpaid work", "count": 1}, {"letter": "Productivity at work", "count": 2}, {"letter": "Quality of work", "count": 2}, {"letter": "Clinical assistant", "count": 1}, {"letter": "Triage nurse", "count": 1}, {"letter": "Oncology nurse", "count": 1}, {"letter": "Room of building - Study", "count": 2}, {"letter": "Bedroom", "count": 1}, {"letter": "Landing", "count": 4}, {"letter": "Corridor", "count": 1}, {"letter": "Straight corridor", "count": 1}, {"letter": "Door (physical object)", "count": 2}, {"letter": "Window (physical object)", "count": 3}, {"letter": "Towns", "count": 1}, {"letter": "Coach (vehicle)", "count": 18}, {"letter": "Van (physical object)", "count": 1}, {"letter": "College (environment)", "count": 5}, {"letter": "Healthcare services", "count": 3}, {"letter": "Upper floor", "count": 3}, {"letter": "Services", "count": 30}, {"letter": "Night and day", "count": 3}, {"letter": "Emotional Adjustment", "count": 4}, {"letter": "Evaluating interventions", "count": 52}, {"letter": "Maximum observation", "count": 3}, {"letter": "Needs Assessment", "count": 1}, {"letter": "Pressure area care", "count": 2}, {"letter": "Functional behavioral assessment", "count": 2}, {"letter": "Dietary intake assessment", "count": 1}, {"letter": "Injury assessment", "count": 1}, {"letter": "Wound assessment", "count": 7}, {"letter": "Skin lesion assessment", "count": 4}, {"letter": "Skin assessment", "count": 10}, {"letter": "Participant observation", "count": 2}, {"letter": "Reflecting", "count": 150}, {"letter": "Intrusive thoughts", "count": 4}, {"letter": "Low motivation", "count": 4}, {"letter": "Confident", "count": 8}, {"letter": "Distorted body image", "count": 4}, {"letter": "Transsexual (finding)", "count": 1}, {"letter": "Skin appearance normal (finding)", "count": 5}, {"letter": "Ability to interact with others", "count": 1}, {"letter": "Breast changes", "count": 63}, {"letter": "Preventing pain", "count": 1}, {"letter": "Terrified", "count": 2}, {"letter": "Bed area", "count": 5}, {"letter": "Alternate days", "count": 3}, {"letter": "Hourly", "count": 1}, {"letter": "Once a week", "count": 14}, {"letter": "preference", "count": 88}, {"letter": "Surgical revision", "count": 8}, {"letter": "Vaginal irritation", "count": 2}, {"letter": "Serum blood tests", "count": 1}, {"letter": "Family history of breast cancer", "count": 6}, {"letter": "Autograft Material", "count": 2}, {"letter": "Left lateral decubitus position", "count": 1}, {"letter": "No abnormality detected", "count": 54}, {"letter": "Did not attend", "count": 2}, {"letter": "Endocrine finding", "count": 13}, {"letter": "Pentalogy of Cantrell", "count": 2}, {"letter": "Biceps brachii muscle structure", "count": 17}, {"letter": "Triceps brachii muscle structure", "count": 5}, {"letter": "Adverse reactions", "count": 38}, {"letter": "Item score", "count": 130}, {"letter": "Unstable fracture", "count": 2}, {"letter": "Normal menstruation - observation", "count": 6}, {"letter": "Replacement", "count": 12}, {"letter": "millicurie", "count": 5}, {"letter": "uCi", "count": 3}, {"letter": "nanolitre", "count": 1}, {"letter": "Medication Review", "count": 2}, {"letter": "ft/s", "count": 1}, {"letter": "inches per second", "count": 1}, {"letter": "ohm", "count": 2}, {"letter": "Unit of radiation dose rate", "count": 3}, {"letter": "electronvolt", "count": 1}, {"letter": "Mass concentration", "count": 7}, {"letter": "Ability to balance", "count": 4}, {"letter": "Does stand alone", "count": 5}, {"letter": "Volume fraction", "count": 1}, {"letter": "Does skip", "count": 5}, {"letter": "Does jump", "count": 4}, {"letter": "Unit of radiation dose", "count": 2}, {"letter": "Moving", "count": 18}, {"letter": "glasses/day", "count": 1}, {"letter": "sq. in", "count": 1}, {"letter": "Does stand from sitting", "count": 6}, {"letter": "Does sit up", "count": 1}, {"letter": "Unit of motion", "count": 1}, {"letter": "meter/second squared", "count": 1}, {"letter": "Verbal memory observable", "count": 6}, {"letter": "Memory, Episodic", "count": 7}, {"letter": "Anesthetic agent monitoring", "count": 1}, {"letter": "Does climb", "count": 1}, {"letter": "Removal of implant (procedure)", "count": 9}, {"letter": "U.S. Dollar", "count": 4}, {"letter": "Hand functions", "count": 2}, {"letter": "Examination of lymph nodes", "count": 5}, {"letter": "Church (environment)", "count": 2}, {"letter": "Empowered", "count": 10}, {"letter": "Disempowered", "count": 5}, {"letter": "Hip circumference", "count": 18}, {"letter": "Uninformed (finding)", "count": 2}, {"letter": "Victim of abuse finding", "count": 1}, {"letter": "Value of Life", "count": 1}, {"letter": "Hallway", "count": 2}, {"letter": "Accident and Emergency department", "count": 18}, {"letter": "Park (environment)", "count": 1}, {"letter": "Waterfall", "count": 3}, {"letter": "Valley", "count": 1}, {"letter": "First floor", "count": 7}, {"letter": "Second floor", "count": 1}, {"letter": "Sixth floor", "count": 1}, {"letter": "Mental function", "count": 6}, {"letter": "Catastrophization", "count": 10}, {"letter": "White light", "count": 1}, {"letter": "Taking of swab", "count": 3}, {"letter": "Magnetism", "count": 2}, {"letter": "Mechanical force", "count": 9}, {"letter": "Pressure change", "count": 2}, {"letter": "Suppression treatment", "count": 2}, {"letter": "/hour", "count": 108}, {"letter": "Feeling relief", "count": 8}, {"letter": "Manic mood", "count": 1}, {"letter": "Vitamin D intake", "count": 1}, {"letter": "Wound of skin", "count": 1}, {"letter": "Optimistic", "count": 2}, {"letter": "Level of anxiety", "count": 48}, {"letter": "Urine microalbumin level result", "count": 1}, {"letter": "personal hygiene (activity)", "count": 1}, {"letter": "Surgical biopsy", "count": 4}, {"letter": "Continuous suction drainage", "count": 2}, {"letter": "Surgical reduction of fracture", "count": 1}, {"letter": "Compression procedure", "count": 3}, {"letter": "delivery method", "count": 1}, {"letter": "per second", "count": 239}, {"letter": "Change values", "count": 29}, {"letter": "Does communicate", "count": 9}, {"letter": "Verbal impairment", "count": 1}, {"letter": "Does ask questions", "count": 3}, {"letter": "Unable to feed self", "count": 14}, {"letter": "Compliant (qualifier value)", "count": 1}, {"letter": "Partially compliant", "count": 4}, {"letter": "Abnormal Vaginal Discharge", "count": 1}, {"letter": "Vaginal problem", "count": 1}, {"letter": "Finding of menstrual bleeding", "count": 4}, {"letter": "Menopause present (finding)", "count": 11}, {"letter": "Molecule", "count": 9}, {"letter": "Self-care practice", "count": 1}, {"letter": "Transfer practice", "count": 3}, {"letter": "Breast present", "count": 1}, {"letter": "Deformity of breast", "count": 4}, {"letter": "Normal shape breast", "count": 2}, {"letter": "Symmetrical breasts", "count": 1}, {"letter": "Lesion of breast", "count": 40}, {"letter": "Breast normal", "count": 15}, {"letter": "Breast problem", "count": 6}, {"letter": "Allergy to paclitaxel", "count": 1}, {"letter": "Vaccine allergy", "count": 1}, {"letter": "Infusion procedures", "count": 112}, {"letter": "Herero language", "count": 43}, {"letter": "Adangme language", "count": 1}, {"letter": "Ga language", "count": 4}, {"letter": "Chuang language", "count": 1}, {"letter": "Mari language", "count": 1}, {"letter": "Bleeding skin", "count": 1}, {"letter": "Skin discharge finding", "count": 1}, {"letter": "Nail problem", "count": 2}, {"letter": "Loss of scalp hair", "count": 1}, {"letter": "Date of onset", "count": 5}, {"letter": "Number of admissions", "count": 3}, {"letter": "Ectopic", "count": 1}, {"letter": "Sacroiliitis", "count": 2}, {"letter": "Number of falls", "count": 5}, {"letter": "Long upper limb", "count": 1}, {"letter": "Shoulder joint - range of movement", "count": 2}, {"letter": "Screening for osteoporosis (procedure)", "count": 1}, {"letter": "Lesion of liver", "count": 1}, {"letter": "Liver normal", "count": 1}, {"letter": "Finding of lesion", "count": 8}, {"letter": "Total number of lesions", "count": 4}, {"letter": "Single lesion", "count": 9}, {"letter": "Multiple lesions", "count": 2}, {"letter": "Compressible", "count": 3}, {"letter": "Moveable", "count": 1}, {"letter": "Mass of body structure", "count": 15}, {"letter": "Mass of body region", "count": 1}, {"letter": "Swelling of arm", "count": 6}, {"letter": "Family tension", "count": 1}, {"letter": "Finding of left ventricle", "count": 2}, {"letter": "Finding present on electrocardiogram", "count": 4}, {"letter": "Myocardial lesion", "count": 1}, {"letter": "Finding of body mass index", "count": 66}, {"letter": "Procedure on axilla", "count": 3}, {"letter": "infection by site", "count": 2}, {"letter": "Does move", "count": 2}, {"letter": "Chronic Spontaneous Urticaria", "count": 1}, {"letter": "On treatment for hypertension", "count": 1}, {"letter": "Upper limb activities", "count": 14}, {"letter": "Aortic diameter", "count": 1}, {"letter": "Change of medication", "count": 14}, {"letter": "Postprocedural period", "count": 20}, {"letter": "Postmortem period", "count": 3}, {"letter": "1/2 serotype (qualifier value)", "count": 12}, {"letter": "Antibody studies (procedure)", "count": 3}, {"letter": "Treatment given", "count": 2}, {"letter": "Treatment completed", "count": 98}, {"letter": "Extracranial", "count": 28}, {"letter": "Tomography - chest", "count": 1}, {"letter": "Postoperative visit", "count": 7}, {"letter": "Operative procedure planned", "count": 6}, {"letter": "Aggressive course", "count": 9}, {"letter": "Old", "count": 20}, {"letter": "Does pull", "count": 2}, {"letter": "In care (finding)", "count": 1}, {"letter": "Standing blood pressure", "count": 1}, {"letter": "Biopsy administration", "count": 7}, {"letter": "Dependent patient", "count": 1}, {"letter": "Plasma cell count procedure", "count": 2}, {"letter": "intracranial lesion", "count": 13}, {"letter": "Inflammation of scar", "count": 1}, {"letter": "Close observation", "count": 1}, {"letter": "Functional modification", "count": 38}, {"letter": "Structural modification", "count": 10}, {"letter": "Revascularization - action", "count": 3}, {"letter": "Ultrasound procedure on topographic region", "count": 2}, {"letter": "Muscle structure of hand", "count": 1}, {"letter": "Skeletal muscle structure of trunk", "count": 3}, {"letter": "Felt faint", "count": 2}, {"letter": "In debt", "count": 1}, {"letter": "Vulval irritation", "count": 1}, {"letter": "Heavy feeling", "count": 5}, {"letter": "Medical Examination", "count": 87}, {"letter": "At risk of infection", "count": 2}, {"letter": "Pain score", "count": 114}, {"letter": "Conversation content", "count": 1}, {"letter": "Surgeon", "count": 62}, {"letter": "Regular exercise (observable entity)", "count": 3}, {"letter": "Utilities (organization)", "count": 64}, {"letter": "Preparation of patient", "count": 4}, {"letter": "Informing doctor", "count": 1}, {"letter": "Suicidal intent", "count": 1}, {"letter": "henry", "count": 1}, {"letter": "Revolutions per minute", "count": 7}, {"letter": "weber", "count": 2}, {"letter": "Head position finding", "count": 1}, {"letter": "Processing speed", "count": 23}, {"letter": "Beck anxiety inventory", "count": 5}, {"letter": "Courtauld emotional control scale", "count": 1}, {"letter": "Health value scale", "count": 2}, {"letter": "Life orientation test", "count": 4}, {"letter": "Mental adjustment to cancer scale", "count": 5}, {"letter": "Pain coping strategies questionnaire", "count": 1}, {"letter": "Perceived stress scale", "count": 25}, {"letter": "Positive and negative affect schedule", "count": 3}, {"letter": "Rosenberg Self-Esteem Scale", "count": 9}, {"letter": "Satisfaction with life scale", "count": 10}, {"letter": "Stroop neuropsychological screening test", "count": 2}, {"letter": "Revision of implant", "count": 1}, {"letter": "Digit structure", "count": 21}, {"letter": "Admission procedure", "count": 1}, {"letter": "serum glucose level", "count": 1}, {"letter": "Plasma fasting glucose measurement", "count": 2}, {"letter": "Seen by physician", "count": 1}, {"letter": "Seen by surgeon", "count": 1}, {"letter": "Referral to hospice", "count": 1}, {"letter": "Serum dehydroepiandrosterone measurement", "count": 1}, {"letter": "Joint structure of lower extremity", "count": 1}, {"letter": "Infraspinatous muscle structure", "count": 6}, {"letter": "Rectus femoris muscle structure", "count": 1}, {"letter": "Posterior muscle of thigh structure", "count": 5}, {"letter": "During day", "count": 10}, {"letter": "Days of the week", "count": 4}, {"letter": "During procedure", "count": 5}, {"letter": "On waking-temporal period", "count": 11}, {"letter": "Pregnancy time period", "count": 1}, {"letter": "Post admission", "count": 2}, {"letter": "Numerical phases", "count": 7}, {"letter": "Amount of time off work", "count": 2}, {"letter": "Minor oral aphthous ulceration", "count": 2}, {"letter": "Once per hour", "count": 1}, {"letter": "Three times monthly", "count": 1}, {"letter": "Every thirty minutes", "count": 1}, {"letter": "Every three hours", "count": 1}, {"letter": "Every four hours", "count": 2}, {"letter": "Every six hours", "count": 1}, {"letter": "Every evening", "count": 1}, {"letter": "Biweekly", "count": 9}, {"letter": "Every three weeks", "count": 13}, {"letter": "Every six weeks", "count": 15}, {"letter": "Bimonthly", "count": 4}, {"letter": "Every four months", "count": 3}, {"letter": "Every six months", "count": 46}, {"letter": "Every three years", "count": 10}, {"letter": "Every five years", "count": 8}, {"letter": "Single event", "count": 29}, {"letter": "Twice a day", "count": 9}, {"letter": "Osteosarcoma of bone", "count": 1}, {"letter": "Pectoralis major muscle structure", "count": 6}, {"letter": "Report type (record artifact)", "count": 1}, {"letter": "Patient record status", "count": 3}, {"letter": "Patient registered", "count": 3}, {"letter": "Discharge from hospital", "count": 2}, {"letter": "Emergency department patient visit", "count": 6}, {"letter": "Report status (finding)", "count": 1}, {"letter": "Skin symptom", "count": 2}, {"letter": "Specimen from breast", "count": 96}, {"letter": "Lesion specimen", "count": 5}, {"letter": "Specimen from breast obtained by biopsy", "count": 1}, {"letter": "Lymph node tissue specimen", "count": 2}, {"letter": "Lymph node biopsy specimen", "count": 1}, {"letter": "Raised TSH level", "count": 1}, {"letter": "Bone biopsy specimen", "count": 1}, {"letter": "Mastectomy sample", "count": 5}, {"letter": "Clinical oncologist", "count": 1}, {"letter": "Histopathologist", "count": 1}, {"letter": "Chest physician", "count": 1}, {"letter": "Reproductive endocrinologist", "count": 3}, {"letter": "Geriatricians", "count": 1}, {"letter": "Nuclear medicine specialist", "count": 1}, {"letter": "Breast surgeon", "count": 6}, {"letter": "Lymphedema nurse", "count": 1}, {"letter": "Normal height", "count": 2}, {"letter": "Laboratory test finding", "count": 20}, {"letter": "Before menopause", "count": 1}, {"letter": "After menopause", "count": 58}, {"letter": "Before sleeping", "count": 2}, {"letter": "During sleep", "count": 1}, {"letter": "Evening", "count": 6}, {"letter": "Serum cholesterol measurement", "count": 2}, {"letter": "Closed", "count": 39}, {"letter": "Day hospital", "count": 2}, {"letter": "Clinical oncology department", "count": 1}, {"letter": "Neurology department", "count": 1}, {"letter": "Nuclear medicine department", "count": 2}, {"letter": "Gynecology department", "count": 2}, {"letter": "Pathology department", "count": 2}, {"letter": "Radiology department", "count": 1}, {"letter": "Assessment service", "count": 1}, {"letter": "Palliative care service", "count": 1}, {"letter": "Surgical service", "count": 1}, {"letter": "Genetic counselor", "count": 6}, {"letter": "Information status", "count": 2}, {"letter": "Hospital clinic", "count": 2}, {"letter": "Physiotherapy department", "count": 1}, {"letter": "Mild depression", "count": 9}, {"letter": "Moderate depression", "count": 8}, {"letter": "Severe depression", "count": 27}, {"letter": "Graduate (person)", "count": 5}, {"letter": "Infection and inflammatory reaction due to internal orthopedic fixation device", "count": 2}, {"letter": "Cardiac measure", "count": 2}, {"letter": "Breast tissue expander", "count": 13}, {"letter": "Bone structure of proximal ulna", "count": 2}, {"letter": "Bone structure of shaft of ulna", "count": 2}, {"letter": "Bone structure of distal radius", "count": 1}, {"letter": "General observation", "count": 42}, {"letter": "Self Monitoring", "count": 2}, {"letter": "Work assessment", "count": 1}, {"letter": "Informing patient", "count": 28}, {"letter": "Exercise on prescription", "count": 8}, {"letter": "California Verbal Learning Test", "count": 2}, {"letter": "Paced Auditory Serial Addition Test", "count": 2}, {"letter": "Category test", "count": 4}, {"letter": "Ingestible alcohol", "count": 1}, {"letter": "Visual processing", "count": 2}, {"letter": "Focused attention, function", "count": 1}, {"letter": "Sustained attention", "count": 2}, {"letter": "Divided attention", "count": 2}, {"letter": "Visual attention", "count": 3}, {"letter": "Follow-up status", "count": 422}, {"letter": "Follow-up visit", "count": 60}, {"letter": "Follow-up 6 weeks", "count": 1}, {"letter": "Follow-up 6 months", "count": 9}, {"letter": "Immediate verbal memory", "count": 2}, {"letter": "Delayed verbal memory", "count": 1}, {"letter": "Processing capacity", "count": 1}, {"letter": "Memory, Prospective", "count": 2}, {"letter": "Information gathering", "count": 1}, {"letter": "Homework", "count": 2}, {"letter": "Supraclavicular approach", "count": 24}, {"letter": "Cognitive function: initiation", "count": 58}, {"letter": "Metacognition", "count": 4}, {"letter": "AT 10", "count": 8}, {"letter": "Augmentin", "count": 1}, {"letter": "Casodex", "count": 2}, {"letter": "PERATIVE", "count": 1}, {"letter": "Vagifem", "count": 2}, {"letter": "Proprietary Name", "count": 7}, {"letter": "Aromatase Inhibitors", "count": 1}, {"letter": "7+14+7", "count": 5}, {"letter": "irinotecan hydrochloride", "count": 1}, {"letter": "Intrathoracic Route of Drug Administration", "count": 1}, {"letter": "Serum phosphate concentration below normal", "count": 1}, {"letter": "Toxic nephropathy", "count": 2}, {"letter": "Stillbirth", "count": 2}, {"letter": "Mechanical Detachment", "count": 1}, {"letter": "Continuity", "count": 9}, {"letter": "Household composition", "count": 45}, {"letter": "Observation of reflex", "count": 3}, {"letter": "Does reach", "count": 5}, {"letter": "Does stand", "count": 46}, {"letter": "chloride ion", "count": 90}, {"letter": "activation product", "count": 1}, {"letter": "adduct", "count": 7}, {"letter": "Americas Ethnicity", "count": 31}, {"letter": "Angiogenesis Inhibitors", "count": 1}, {"letter": "AHR gene", "count": 1}, {"letter": "Attribution", "count": 103}, {"letter": "Basal Cell", "count": 3}, {"letter": "blood lipid", "count": 5}, {"letter": "Blood Treatment", "count": 3}, {"letter": "bone metabolism", "count": 11}, {"letter": "Brain scan", "count": 3}, {"letter": "brca gene", "count": 8}, {"letter": "british", "count": 1}, {"letter": "cancer complication", "count": 2}, {"letter": "Cancer Pain", "count": 14}, {"letter": "Cancer Risk", "count": 50}, {"letter": "Carboxyl Group", "count": 2}, {"letter": "Carcinogenesis", "count": 2}, {"letter": "Cell Proliferation", "count": 22}, {"letter": "Chemical Association", "count": 5}, {"letter": "Chemical Cleavage", "count": 1}, {"letter": "child health care personnel", "count": 1}, {"letter": "cytotoxicity", "count": 3}, {"letter": "Data Management", "count": 2}, {"letter": "digital imaging", "count": 2}, {"letter": "drug classification", "count": 1}, {"letter": "Early Diagnosis", "count": 7}, {"letter": "Experience", "count": 348}, {"letter": "Flavonoids", "count": 1}, {"letter": "fluidity", "count": 2}, {"letter": "Fluoropyrimidine", "count": 1}, {"letter": "Gel Electrophoresis (lab technique)", "count": 2}, {"letter": "Gene-Environment Interaction", "count": 1}, {"letter": "gene interaction", "count": 1}, {"letter": "Gene Mutation", "count": 72}, {"letter": "glucose metabolism", "count": 7}, {"letter": "heart electrical activity", "count": 1}, {"letter": "heart metabolism", "count": 1}, {"letter": "hormone binding protein", "count": 1}, {"letter": "human data", "count": 1}, {"letter": "Immunosenescence", "count": 2}, {"letter": "impression (attitude)", "count": 8}, {"letter": "indoleamine", "count": 1}, {"letter": "Information Seeking Behavior", "count": 1}, {"letter": "interstitial", "count": 2}, {"letter": "Intravital Microscopy", "count": 1}, {"letter": "Ionization", "count": 1}, {"letter": "Light intensity", "count": 3}, {"letter": "limb movement", "count": 2}, {"letter": "Adipogenesis", "count": 1}, {"letter": "lymph flow", "count": 2}, {"letter": "Neoplasm of lymph node", "count": 2}, {"letter": "Mammary Epithelium", "count": 2}, {"letter": "MCF-7 Cells", "count": 7}, {"letter": "medical appointment", "count": 1}, {"letter": "Membrane", "count": 8}, {"letter": "Membrane Transport Proteins", "count": 6}, {"letter": "Mental Health Personnel", "count": 1}, {"letter": "Mitochondrial Membranes", "count": 1}, {"letter": "Monitoring Device", "count": 5}, {"letter": "Mutant", "count": 21}, {"letter": "Myeloid Progenitor Cells", "count": 4}, {"letter": "Special Population", "count": 1}, {"letter": "Neoplastic Cell", "count": 11}, {"letter": "nucleic acid methylation", "count": 1}, {"letter": "oral bacteria", "count": 2}, {"letter": "organic base", "count": 1}, {"letter": "paracrine", "count": 2}, {"letter": "Particle", "count": 4}, {"letter": "Performance", "count": 191}, {"letter": "phase change", "count": 5}, {"letter": "Physical State", "count": 3}, {"letter": "postgraduate education", "count": 1}, {"letter": "potassium ion", "count": 6}, {"letter": "Protein Biosynthesis", "count": 1}, {"letter": "Protein Isoforms", "count": 5}, {"letter": "Radiotracers", "count": 22}, {"letter": "receptor", "count": 42}, {"letter": "Receptor Binding", "count": 8}, {"letter": "receptor expression", "count": 23}, {"letter": "reproductive hormone", "count": 2}, {"letter": "Saturated fat", "count": 2}, {"letter": "secretory protein", "count": 1}, {"letter": "self help", "count": 1}, {"letter": "Single-Cell Analysis", "count": 2}, {"letter": "Social Integration", "count": 2}, {"letter": "sodium cation", "count": 2}, {"letter": "sound frequency", "count": 3}, {"letter": "Steroid biosynthesis", "count": 1}, {"letter": "Stimulus Intervals", "count": 1}, {"letter": "Stressor", "count": 3}, {"letter": "subcutaneous fibrosis", "count": 1}, {"letter": "Success", "count": 78}, {"letter": "synthetic enzyme", "count": 1}, {"letter": "Tumor Suppressor Proteins", "count": 1}, {"letter": "vasoactive agent", "count": 1}, {"letter": "vibration perception", "count": 3}, {"letter": "visual stimulus", "count": 1}, {"letter": "hypothalamic-pituitary-adrenal axis", "count": 1}, {"letter": "cohesion", "count": 4}, {"letter": "AIDS diagnosis", "count": 1}, {"letter": "crystal healing", "count": 7}, {"letter": "immunoreactivity", "count": 3}, {"letter": "Energy Balance", "count": 2}, {"letter": "international center", "count": 1}, {"letter": "BRCA2 gene", "count": 15}, {"letter": "functional group", "count": 4}, {"letter": "Diagnostic Accuracy", "count": 37}, {"letter": "Microdissection", "count": 1}, {"letter": "Genotoxicity", "count": 1}, {"letter": "drug modification", "count": 1}, {"letter": "drug efficacy", "count": 17}, {"letter": "Voltage", "count": 1}, {"letter": "kindred", "count": 1}, {"letter": "fluorophore", "count": 3}, {"letter": "Functional Status", "count": 47}, {"letter": "Gene Silencing", "count": 1}, {"letter": "Lipophilicity", "count": 1}, {"letter": "Hazard", "count": 26}, {"letter": "interpersonal conflict", "count": 1}, {"letter": "Lymphoid neoplasm", "count": 3}, {"letter": "Diffusion weighted imaging", "count": 9}, {"letter": "checkup examination", "count": 1}, {"letter": "forgetting", "count": 5}, {"letter": "tumor growth", "count": 10}, {"letter": "Tumor Initiation", "count": 1}, {"letter": "Intercept Substance", "count": 10}, {"letter": "diet and cancer", "count": 2}, {"letter": "Missense Mutation", "count": 7}, {"letter": "Transition Mutation", "count": 10}, {"letter": "Reverse Transcriptase Polymerase Chain Reaction", "count": 9}, {"letter": "protein activation", "count": 4}, {"letter": "Early childhood", "count": 1}, {"letter": "Sleeping Pills", "count": 3}, {"letter": "Authority", "count": 1}, {"letter": "Cell body of neuron", "count": 21}, {"letter": "adrenergic block", "count": 3}, {"letter": "magnetic cell separation system", "count": 1}, {"letter": "TAP 2", "count": 1}, {"letter": "perfusion (blood)", "count": 3}, {"letter": "Tandem Mass Spectrometry", "count": 20}, {"letter": "intestinal bacteria", "count": 1}, {"letter": "Cohort", "count": 522}, {"letter": "Recovery of Function", "count": 2}, {"letter": "Homologous Recombination", "count": 2}, {"letter": "physical mapping", "count": 1}, {"letter": "Informatics (discipline)", "count": 1}, {"letter": "Diagnostic and Statistical Manual", "count": 1}, {"letter": "Nervous - anatomy qualifier", "count": 1}, {"letter": "Muscle satellite cell", "count": 2}, {"letter": "Non-human treatment outcome", "count": 25}, {"letter": "Dioxygenases", "count": 1}, {"letter": "disease characteristic", "count": 2}, {"letter": "Natural history of disease", "count": 2}, {"letter": "Treatment Plan", "count": 44}, {"letter": "Trait", "count": 26}, {"letter": "perimenstrual", "count": 1}, {"letter": "skin color", "count": 4}, {"letter": "radiochemical", "count": 1}, {"letter": "intervention program", "count": 15}, {"letter": "self diagnosis", "count": 2}, {"letter": "Vaccines, Peptide", "count": 4}, {"letter": "Attenuation", "count": 1}, {"letter": "Arterial Stiffness", "count": 3}, {"letter": "Emotional support", "count": 10}, {"letter": "Patient counseling", "count": 2}, {"letter": "Serum creatinine level", "count": 7}, {"letter": "Total calcium", "count": 4}, {"letter": "Diabetic monitoring - injection sites", "count": 3}, {"letter": "Stretching exercises", "count": 3}, {"letter": "Percent energy intake", "count": 3}, {"letter": "Identifier", "count": 7}, {"letter": "Blood group transfusion observation", "count": 3}, {"letter": "Obsessive compulsive behavior", "count": 1}, {"letter": "Willing", "count": 3}, {"letter": "Does stand up", "count": 4}, {"letter": "Does play", "count": 4}, {"letter": "Prostate carcinoma", "count": 36}, {"letter": "Does run (finding)", "count": 15}, {"letter": "Hot flushes", "count": 96}, {"letter": "Kinematics", "count": 3}, {"letter": "population migration", "count": 5}, {"letter": "Expert Opinion", "count": 3}, {"letter": "Family health status", "count": 1}, {"letter": "Genetic Marker Expression", "count": 6}, {"letter": "Graafian Follicle", "count": 1}, {"letter": "Bed Size", "count": 1}, {"letter": "interleukin-1 alpha", "count": 1}, {"letter": "Telling untruths", "count": 1}, {"letter": "Nomenclature", "count": 220}, {"letter": "Hospital Readmissions", "count": 5}, {"letter": "Rhodamine", "count": 1}, {"letter": "Toxic Shock Syndrome", "count": 5}, {"letter": "silybin", "count": 3}, {"letter": "Biosensors", "count": 1}, {"letter": "Advance Care Planning", "count": 1}, {"letter": "Registers (reference documentation)", "count": 15}, {"letter": "Rehabilitation Outcome", "count": 1}, {"letter": "venipuncture", "count": 4}, {"letter": "Proxy", "count": 9}, {"letter": "Base Pairing", "count": 2}, {"letter": "Gravidity", "count": 12}, {"letter": "Long Interspersed Nucleotide Element-1", "count": 5}, {"letter": "Inhibitory Concentration 50", "count": 1}, {"letter": "Catalytic Domain", "count": 8}, {"letter": "Response Elements", "count": 1}, {"letter": "Expressed Sequence Tags", "count": 1}, {"letter": "Left Ventricle Remodeling", "count": 1}, {"letter": "Radiotherapy, Conformal", "count": 7}, {"letter": "In Situ Nick-End Labeling", "count": 6}, {"letter": "Tobacco Use Cessation", "count": 2}, {"letter": "Neoadjuvant Therapy", "count": 312}, {"letter": "Self Efficacy", "count": 155}, {"letter": "DNA Microarray Chip", "count": 3}, {"letter": "Wellness Centers", "count": 11}, {"letter": "Collections (publication)", "count": 2}, {"letter": "Essay", "count": 2}, {"letter": "Exhibitions", "count": 8}, {"letter": "Indexes", "count": 15}, {"letter": "Outlines (document)", "count": 12}, {"letter": "Phrases", "count": 1}, {"letter": "Statistics (publications)", "count": 41}, {"letter": "Collected Correspondence", "count": 1}, {"letter": "Toxic effect", "count": 495}, {"letter": "RAD140", "count": 1}, {"letter": "PH.3", "count": 1}, {"letter": "Bioplex, synthetic polymer", "count": 2}, {"letter": "F 4", "count": 6}, {"letter": "V110", "count": 1}, {"letter": "R 47", "count": 1}, {"letter": "AH 31", "count": 2}, {"letter": "IR-45", "count": 2}, {"letter": "S 6", "count": 2}, {"letter": "A 137", "count": 1}, {"letter": "5-methyl-2'-fluoroarauracil", "count": 3}, {"letter": "compound NG", "count": 2}, {"letter": "21-hydroxy-9beta,10alpha-pregna-5,7-diene-3-ol-20-one", "count": 6}, {"letter": "A 19", "count": 2}, {"letter": "AN 3", "count": 25}, {"letter": "compound A 12", "count": 10}, {"letter": "3'-O-methyl-nordihydroguaiaretic acid", "count": 6}, {"letter": "FAT 16", "count": 1}, {"letter": "RATE protocol", "count": 1}, {"letter": "Matrix Metalloproteinases", "count": 3}, {"letter": "bis(beta-carboxyethyl)tin dichloride", "count": 2}, {"letter": "sural", "count": 8}, {"letter": "C-telopeptide", "count": 17}, {"letter": "N,N-dimethyl-N-hexadecyl-1-octadecylammonium chloride", "count": 2}, {"letter": "S100A6 protein, human", "count": 1}, {"letter": "3-(2-aminoethyl)-8-(3-(4-fluorobenzoyl)propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one", "count": 1}, {"letter": "PCA 10", "count": 1}, {"letter": "SDM", "count": 3}, {"letter": "N-succinimidyl-3-(2-pyridyldithio)butyrate", "count": 2}, {"letter": "pregabalin", "count": 11}, {"letter": "alpha, alpha'-bis(di(2-chloroethyl)amino)-4,4'-(2-biacetophenone)", "count": 1}, {"letter": "4-(3'-di(2-chloroethyl)aminopropionyl)biphenyl", "count": 4}, {"letter": "steroid receptor coactivator AIB1", "count": 1}, {"letter": "abacavir", "count": 19}, {"letter": "Vascular Endothelial Growth Factor D", "count": 1}, {"letter": "KRIT1 protein, human", "count": 7}, {"letter": "Estrogen Receptor alpha", "count": 10}, {"letter": "TNFSF11 protein, human", "count": 5}, {"letter": "TRANCE protein", "count": 1}, {"letter": "TNFRSF11A protein, human", "count": 91}, {"letter": "Growth Differentiation Factor 15", "count": 2}, {"letter": "AKT1 protein, human", "count": 12}, {"letter": "NOS3 protein, human", "count": 1}, {"letter": "NOS2A protein, human", "count": 2}, {"letter": "pro-brain natriuretic peptide (1-76)", "count": 17}, {"letter": "glutamyl-lysyl-alanyl-histidyl-aspartyl-glycyl-glycyl-arginine", "count": 1}, {"letter": "capecitabine", "count": 111}, {"letter": "vorinostat", "count": 10}, {"letter": "GPER protein, human", "count": 1}, {"letter": "GMNN protein, human", "count": 1}, {"letter": "CRL 1005", "count": 1}, {"letter": "Pathology processes", "count": 3}, {"letter": "Histopathology", "count": 80}, {"letter": "educate the patient", "count": 1}, {"letter": "Cigarette", "count": 3}, {"letter": "Stinging Sensation", "count": 1}, {"letter": "Behaviors and observations relating to behavior", "count": 7}, {"letter": "Walls of a building", "count": 13}, {"letter": "days/week", "count": 7}, {"letter": "Anastomosis - action", "count": 1}, {"letter": "Genetics service", "count": 1}, {"letter": "Condoms, Unspecified", "count": 2}, {"letter": "Musculoskeletal rotation", "count": 3}, {"letter": "Counter device", "count": 2}, {"letter": "Surgical action", "count": 2}, {"letter": "Plastic Surgical Procedures", "count": 2}, {"letter": "Social Deprivation", "count": 1}, {"letter": "Mevalonate", "count": 1}, {"letter": "Emotional problems", "count": 18}, {"letter": "Emotional upset", "count": 1}, {"letter": "soy protein isolate", "count": 2}, {"letter": "Thermal ablation", "count": 1}, {"letter": "Adjuvant therapy", "count": 72}, {"letter": "autologous lymphocytes", "count": 3}, {"letter": "Bilateral Malignant Neoplasm", "count": 1}, {"letter": "Biopsy specimen", "count": 51}, {"letter": "In complete remission", "count": 1336}, {"letter": "Compression Bandages", "count": 5}, {"letter": "Cytotoxic Chemotherapy", "count": 7}, {"letter": "DepoCyt", "count": 1}, {"letter": "Invasive Malignant Neoplasm", "count": 129}, {"letter": "MAGEA3 gene", "count": 1}, {"letter": "Maintenance therapy", "count": 37}, {"letter": "Ovarian ablation", "count": 3}, {"letter": "Positive Axillary Lymph Node", "count": 9}, {"letter": "Primary Neoplasm", "count": 509}, {"letter": "Progressive Neoplastic Disease", "count": 505}, {"letter": "Refractory cancer", "count": 7}, {"letter": "Sentinel node (disorder)", "count": 19}, {"letter": "Stable Disease", "count": 669}, {"letter": "Locally Advanced Malignant Neoplasm", "count": 6}, {"letter": "Negative Lymph Node", "count": 69}, {"letter": "Promegapoietin", "count": 5}, {"letter": "Taxol", "count": 3}, {"letter": "Breast Carcinoma", "count": 865}, {"letter": "Due to", "count": 811}, {"letter": "Causing", "count": 5}, {"letter": "Stenosis Morphology", "count": 2}, {"letter": "Rare Diseases", "count": 1}, {"letter": "Description", "count": 510}, {"letter": "drug consumption", "count": 2}, {"letter": "standard drink", "count": 3}, {"letter": "Responsibility", "count": 7}, {"letter": "Sake - alcoholic beverage", "count": 1}, {"letter": "Cannabis substance", "count": 1}, {"letter": "alcohol and tobacco", "count": 1}, {"letter": "Speed (motion)", "count": 31}, {"letter": "wave - physical agent", "count": 7}, {"letter": "deformability", "count": 1}, {"letter": "softness", "count": 1}, {"letter": "Cool - action", "count": 2}, {"letter": "Brightness", "count": 1}, {"letter": "Brown color", "count": 7}, {"letter": "Salty", "count": 1}, {"letter": "Steady-State", "count": 161}, {"letter": "Structure", "count": 39}, {"letter": "reaction rate", "count": 3}, {"letter": "degree of relationship - exchange", "count": 12}, {"letter": "two-dimensional chromatography", "count": 2}, {"letter": "Human Biology", "count": 1}, {"letter": "body chemistry", "count": 8}, {"letter": "Nutrients", "count": 5}, {"letter": "mineral metabolism", "count": 1}, {"letter": "Biologic Development", "count": 9}, {"letter": "drug absorption", "count": 1}, {"letter": "free drug", "count": 3}, {"letter": "drug concentration", "count": 59}, {"letter": "drug accumulation", "count": 3}, {"letter": "Drug half-life", "count": 2}, {"letter": "Drug dose (finding)", "count": 143}, {"letter": "delayed toxicity", "count": 3}, {"letter": "drug safety", "count": 28}, {"letter": "local drug administration", "count": 1}, {"letter": "systemic administration", "count": 14}, {"letter": "body balance", "count": 1}, {"letter": "ovarian function", "count": 10}, {"letter": "Immunoregulation", "count": 16}, {"letter": "Endocrine function", "count": 2}, {"letter": "hypothalamic pituitary axis", "count": 1}, {"letter": "brain function", "count": 2}, {"letter": "phenotype genotype", "count": 1}, {"letter": "Gene Mutant", "count": 14}, {"letter": "polygene", "count": 2}, {"letter": "blending", "count": 1}, {"letter": "inferiority", "count": 38}, {"letter": "literacy skills", "count": 1}, {"letter": "self-care skills", "count": 1}, {"letter": "stress reduction", "count": 6}, {"letter": "Decision", "count": 163}, {"letter": "Consciousness:status", "count": 1}, {"letter": "temperature perception", "count": 4}, {"letter": "memory process", "count": 1}, {"letter": "memory span", "count": 2}, {"letter": "encoding mental process", "count": 16}, {"letter": "Simulations", "count": 12}, {"letter": "pleasurable emotion", "count": 12}, {"letter": "anticipation", "count": 6}, {"letter": "intense emotion", "count": 1}, {"letter": "Passion", "count": 1}, {"letter": "Respect", "count": 38}, {"letter": "Low self-esteem", "count": 1}, {"letter": "Expectations", "count": 52}, {"letter": "Role Perception", "count": 1}, {"letter": "social avoidance", "count": 1}, {"letter": "Organizational Behavior", "count": 1}, {"letter": "Friendly behavior", "count": 1}, {"letter": "defensive behavior", "count": 1}, {"letter": "abstraction", "count": 2}, {"letter": "Strategy", "count": 66}, {"letter": "Inference", "count": 15}, {"letter": "prerequisite", "count": 8}, {"letter": "symbol", "count": 4}, {"letter": "health and disease", "count": 6}, {"letter": "Resting state", "count": 3}, {"letter": "multiple pathologies", "count": 4}, {"letter": "disorder analysis", "count": 4}, {"letter": "disease definition", "count": 1}, {"letter": "Diagnostic Criteria", "count": 7}, {"letter": "medical model", "count": 1}, {"letter": "disease factor", "count": 5}, {"letter": "early disease", "count": 16}, {"letter": "advanced disease", "count": 11}, {"letter": "Terminal illness", "count": 1}, {"letter": "Disease Outcome", "count": 12}, {"letter": "Disease recurrence", "count": 160}, {"letter": "physical symptom", "count": 14}, {"letter": "cardiovascular deterioration", "count": 1}, {"letter": "magnetic imaging technique", "count": 1}, {"letter": "Saliva analysis", "count": 1}, {"letter": "histological diagnosis", "count": 5}, {"letter": "Genetic screening method", "count": 30}, {"letter": "Neuroimaging", "count": 3}, {"letter": "brain diagnosis", "count": 1}, {"letter": "depression scale", "count": 23}, {"letter": "literary novel", "count": 17}, {"letter": "medical treatment method", "count": 14}, {"letter": "blood modification", "count": 20}, {"letter": "major surgery", "count": 1}, {"letter": "Participant", "count": 4394}, {"letter": "directive therapy", "count": 3}, {"letter": "Cognitive Techniques", "count": 1}, {"letter": "self-hypnosis", "count": 2}, {"letter": "Secondary Prevention", "count": 10}, {"letter": "prevention program", "count": 2}, {"letter": "prevention service", "count": 2}, {"letter": "cooperative", "count": 4}, {"letter": "Peer", "count": 5}, {"letter": "prevention approach", "count": 1}, {"letter": "Harm Reduction", "count": 1}, {"letter": "condom use", "count": 1}, {"letter": "healthy habits", "count": 2}, {"letter": "guided intervention", "count": 1}, {"letter": "family intervention", "count": 1}, {"letter": "Health Risk Assessment", "count": 1}, {"letter": "Participation", "count": 157}, {"letter": "treatment entry", "count": 1}, {"letter": "patient assessment", "count": 131}, {"letter": "Misdiagnosis", "count": 1}, {"letter": "treatment goals", "count": 23}, {"letter": "treatment program", "count": 2}, {"letter": "treatment model", "count": 22}, {"letter": "Transtheoretical Model", "count": 17}, {"letter": "Treatment Factor", "count": 16}, {"letter": "patient motivation", "count": 1}, {"letter": "patient retention", "count": 4}, {"letter": "treatment issues", "count": 1}, {"letter": "Complications of treatment", "count": 4}, {"letter": "treatment success", "count": 2}, {"letter": "relapse treatment", "count": 3}, {"letter": "self-treatment", "count": 3}, {"letter": "Health Information Systems", "count": 1}, {"letter": "health records", "count": 6}, {"letter": "health care quality control", "count": 12}, {"letter": "health care utilization review", "count": 1}, {"letter": "professional occupation status", "count": 23}, {"letter": "competition", "count": 4}, {"letter": "Empowerment", "count": 3}, {"letter": "meaninglessness", "count": 1}, {"letter": "Group Participation", "count": 2}, {"letter": "large group", "count": 6}, {"letter": "small groups", "count": 6}, {"letter": "alone - group size", "count": 209}, {"letter": "fidelity", "count": 5}, {"letter": "member", "count": 19}, {"letter": "family system", "count": 1}, {"letter": "Family functioning capacity", "count": 2}, {"letter": "Offspring", "count": 12}, {"letter": "family cohesion", "count": 3}, {"letter": "life circumstances", "count": 1}, {"letter": "Life Stage", "count": 3}, {"letter": "Personal failure", "count": 16}, {"letter": "change in self-esteem", "count": 1}, {"letter": "Eating habit change", "count": 1}, {"letter": "home context", "count": 1}, {"letter": "public area", "count": 1}, {"letter": "Month-Year", "count": 2}, {"letter": "Weekday", "count": 3}, {"letter": "Weekend", "count": 6}, {"letter": "workday", "count": 1}, {"letter": "Vacation", "count": 1}, {"letter": "alliance", "count": 9}, {"letter": "unconnected", "count": 1}, {"letter": "distancing of relations", "count": 1}, {"letter": "psychosocial interdependence", "count": 1}, {"letter": "superiority", "count": 12}, {"letter": "majority", "count": 12}, {"letter": "Disputes", "count": 1}, {"letter": "Discord", "count": 3}, {"letter": "Agreement", "count": 1551}, {"letter": "Exclusion Criteria", "count": 5}, {"letter": "Discharge (release)", "count": 1}, {"letter": "payment", "count": 1}, {"letter": "collective", "count": 4}, {"letter": "external control", "count": 1}, {"letter": "primary group", "count": 2}, {"letter": "Reference Group", "count": 4}, {"letter": "civilian", "count": 5}, {"letter": "Affirmative Action", "count": 1}, {"letter": "cultural adaptation", "count": 1}, {"letter": "peace", "count": 2}, {"letter": "Recidivism", "count": 1}, {"letter": "Amendment", "count": 2}, {"letter": "commercial", "count": 11}, {"letter": "appeal", "count": 2}, {"letter": "interrogation", "count": 2}, {"letter": "Mediation", "count": 5}, {"letter": "Adjudication", "count": 11}, {"letter": "trial procedure", "count": 1}, {"letter": "independent agency", "count": 8}, {"letter": "Centralization", "count": 12}, {"letter": "management technique", "count": 1}, {"letter": "program planning", "count": 1}, {"letter": "planning method", "count": 1}, {"letter": "program implementation", "count": 4}, {"letter": "cost (economic)", "count": 4}, {"letter": "estimation <subjective>", "count": 26}, {"letter": "solicitation", "count": 1}, {"letter": "expense", "count": 8}, {"letter": "type of insurance", "count": 2}, {"letter": "accredited", "count": 1}, {"letter": "target group", "count": 2}, {"letter": "retailing", "count": 1}, {"letter": "horizontal integration", "count": 1}, {"letter": "economic analysis", "count": 5}, {"letter": "spending", "count": 59}, {"letter": "drug price", "count": 1}, {"letter": "interest rate", "count": 2}, {"letter": "elastic (economic descriptor)", "count": 4}, {"letter": "inelastic", "count": 2}, {"letter": "economic impact", "count": 3}, {"letter": "exchange rate", "count": 2}, {"letter": "devaluation", "count": 1}, {"letter": "labor market", "count": 1}, {"letter": "labor costs", "count": 2}, {"letter": "work habit", "count": 3}, {"letter": "faith", "count": 3}, {"letter": "communication feedback", "count": 1}, {"letter": "Communicative Competence", "count": 4}, {"letter": "censorship", "count": 1}, {"letter": "effect of communication", "count": 1}, {"letter": "image management", "count": 1}, {"letter": "information acquisition", "count": 1}, {"letter": "information provision", "count": 3}, {"letter": "information event", "count": 1}, {"letter": "exposition", "count": 3}, {"letter": "independent study", "count": 1}, {"letter": "Program Descriptions", "count": 1}, {"letter": "Graph - visual representation", "count": 30}, {"letter": "Diagram", "count": 10}, {"letter": "college sports", "count": 5}, {"letter": "Demographic change", "count": 2}, {"letter": "disease mortality", "count": 1}, {"letter": "temporal distribution", "count": 8}, {"letter": "identification of new disease", "count": 1}, {"letter": "CDISC SDTM Case Finding Terminology", "count": 1}, {"letter": "Trend Analysis", "count": 1}, {"letter": "paradigm", "count": 8}, {"letter": "research question", "count": 1}, {"letter": "collaborative study", "count": 1}, {"letter": "research funding", "count": 4}, {"letter": "research study", "count": 18}, {"letter": "trial study", "count": 3}, {"letter": "national survey", "count": 1}, {"letter": "Social survey", "count": 3}, {"letter": "state survey", "count": 2}, {"letter": "telephone survey", "count": 1}, {"letter": "laboratory studies", "count": 6}, {"letter": "Study Purpose", "count": 17}, {"letter": "Validation Study", "count": 4}, {"letter": "formative evaluation", "count": 1}, {"letter": "re-evaluation", "count": 15}, {"letter": "Explanation", "count": 32}, {"letter": "Prediction", "count": 80}, {"letter": "Panel Study", "count": 31}, {"letter": "Study Subject", "count": 315}, {"letter": "Controlled Study", "count": 1}, {"letter": "study planning", "count": 1}, {"letter": "research data", "count": 14}, {"letter": "Population Study (research activity)", "count": 3}, {"letter": "indicator variable", "count": 4}, {"letter": "Measurement scales", "count": 2}, {"letter": "rating scale", "count": 109}, {"letter": "predictive", "count": 94}, {"letter": "effect modifier", "count": 2}, {"letter": "Construct Validity", "count": 7}, {"letter": "measurement error", "count": 3}, {"letter": "sensitivity of measurement", "count": 2}, {"letter": "laboratory measurement", "count": 5}, {"letter": "data collection from mental responses", "count": 1}, {"letter": "Patient Self-Report", "count": 431}, {"letter": "scale construction", "count": 1}, {"letter": "face-to-face interview", "count": 2}, {"letter": "structured interview", "count": 31}, {"letter": "content analysis", "count": 4}, {"letter": "Statistical Estimation", "count": 19}, {"letter": "Hypothesis Testing", "count": 6}, {"letter": "Coefficient of Variance", "count": 11}, {"letter": "Pearson product-moment correlation", "count": 6}, {"letter": "multiple regression", "count": 5}, {"letter": "linear-log analysis", "count": 7}, {"letter": "logistic regression analysis", "count": 11}, {"letter": "multiple analysis of variance", "count": 1}, {"letter": "bivariate analysis", "count": 1}, {"letter": "Multidimensional Scaling Analysis", "count": 1}, {"letter": "Bioanalytical Validation Method", "count": 4}, {"letter": "Cross Validation", "count": 9}, {"letter": "qualitative research method", "count": 1}, {"letter": "qualitative data analysis", "count": 2}, {"letter": "beverage industry", "count": 1}, {"letter": "Regional Differences", "count": 3}, {"letter": "Religious affiliation", "count": 1}, {"letter": "College student", "count": 1}, {"letter": "Monks", "count": 1}, {"letter": "Part-time employment (finding)", "count": 2}, {"letter": "Full-time employment (finding)", "count": 2}, {"letter": "program participant", "count": 1}, {"letter": "program completer", "count": 4}, {"letter": "Witnesses", "count": 2}, {"letter": "Cornish language", "count": 2}, {"letter": "bacteria taxonomy", "count": 1}, {"letter": "Arecaceae", "count": 1}, {"letter": "lymphoblastoid cell line", "count": 1}, {"letter": "Serous fluid", "count": 2}, {"letter": "central compartment", "count": 1}, {"letter": "Extensor muscle", "count": 1}, {"letter": "Memory T Cells", "count": 2}, {"letter": "White matter", "count": 8}, {"letter": "environmental pollutants, pesticides", "count": 1}, {"letter": "Drug Metabolism", "count": 2}, {"letter": "drug excretion", "count": 1}, {"letter": "drug distribution volume", "count": 87}, {"letter": "serum concentration", "count": 279}, {"letter": "plasma concentration", "count": 707}, {"letter": "drug clearance", "count": 15}, {"letter": "whole body drug clearance", "count": 3}, {"letter": "drug response", "count": 7}, {"letter": "dose-response curve", "count": 1}, {"letter": "topical application", "count": 6}, {"letter": "specific immunity", "count": 19}, {"letter": "mendelian inheritance", "count": 1}, {"letter": "Innovativeness", "count": 4}, {"letter": "Resilience, Psychological", "count": 6}, {"letter": "Efficacy Expectations", "count": 2}, {"letter": "Psychological adjustment", "count": 2}, {"letter": "romantic", "count": 1}, {"letter": "Mental Suffering", "count": 14}, {"letter": "Categories", "count": 291}, {"letter": "personal health", "count": 48}, {"letter": "activity level", "count": 31}, {"letter": "Poor Health", "count": 5}, {"letter": "physical illness", "count": 2}, {"letter": "clinical aspects", "count": 29}, {"letter": "disease classification", "count": 1}, {"letter": "total recovery", "count": 2}, {"letter": "Excessive drinking", "count": 1}, {"letter": "Symptoms aspect", "count": 470}, {"letter": "drug testing methods", "count": 2}, {"letter": "tests and testing", "count": 6}, {"letter": "Behavior Test", "count": 2}, {"letter": "internal-external locus of control scale", "count": 373}, {"letter": "State-trait anger expression inventory", "count": 42}, {"letter": "novel AODU treatment method", "count": 2}, {"letter": "invasive treatment", "count": 4}, {"letter": "surgical methods", "count": 8}, {"letter": "Motivational Interviewing", "count": 7}, {"letter": "disease detection", "count": 3}, {"letter": "intervention referral", "count": 2}, {"letter": "Involuntary Treatment", "count": 1}, {"letter": "patient interview", "count": 6}, {"letter": "patient family history", "count": 1}, {"letter": "patient condition", "count": 33}, {"letter": "readiness to change", "count": 7}, {"letter": "treatment options", "count": 9}, {"letter": "health care resources", "count": 7}, {"letter": "personal experience", "count": 3}, {"letter": "scenario", "count": 11}, {"letter": "free time", "count": 3}, {"letter": "interconnection", "count": 3}, {"letter": "allowing", "count": 139}, {"letter": "cultural values", "count": 1}, {"letter": "human group", "count": 3}, {"letter": "Social issues", "count": 1}, {"letter": "management by objective", "count": 1}, {"letter": "program management", "count": 8}, {"letter": "Company (organization)", "count": 5}, {"letter": "Corporation", "count": 8}, {"letter": "drug sales", "count": 1}, {"letter": "perquisite", "count": 4}, {"letter": "job content", "count": 1}, {"letter": "electronic communication", "count": 4}, {"letter": "information searching", "count": 1}, {"letter": "information use and impact", "count": 1}, {"letter": "Source of information", "count": 1}, {"letter": "teaching strategies", "count": 1}, {"letter": "junior high school level", "count": 1}, {"letter": "grade 11", "count": 2}, {"letter": "lexicon", "count": 3}, {"letter": "fact sheet", "count": 1}, {"letter": "paper document", "count": 1}, {"letter": "new technology", "count": 2}, {"letter": "Airplanes", "count": 1}, {"letter": "incidence and prevalence", "count": 1}, {"letter": "Incidence Proportion", "count": 51}, {"letter": "disorder prevalence", "count": 1}, {"letter": "local level", "count": 1}, {"letter": "state wide area", "count": 4}, {"letter": "regional area", "count": 7}, {"letter": "research program", "count": 1}, {"letter": "Research Organization", "count": 66}, {"letter": "comparative analysis", "count": 3}, {"letter": "control variable", "count": 7}, {"letter": "placebo study", "count": 1}, {"letter": "research results", "count": 14}, {"letter": "operational definition", "count": 1}, {"letter": "Disease Predictive Factor", "count": 14}, {"letter": "univariate statistics", "count": 6}, {"letter": "Demographic Characteristics", "count": 16}, {"letter": "General Population", "count": 15}, {"letter": "class differences", "count": 1}, {"letter": "poet", "count": 1}, {"letter": "high-risk group", "count": 3}, {"letter": "Eukaryota", "count": 1}, {"letter": "Skin tissue", "count": 4}, {"letter": "gut hormone", "count": 1}, {"letter": "Homeopathy", "count": 3}, {"letter": "Report (document)", "count": 536}, {"letter": "Charts (publication)", "count": 21}, {"letter": "Fourth grade in elementary school", "count": 236}, {"letter": "Drinking function", "count": 2}, {"letter": "Self-control as a personality trait", "count": 4}, {"letter": "Illumination Technique", "count": 1}, {"letter": "Chemical extraction", "count": 6}, {"letter": "Disease model", "count": 1}, {"letter": "Drivers of Vehicles", "count": 1}, {"letter": "Disease regression", "count": 108}, {"letter": "Regression - mental defense mechanism", "count": 9}, {"letter": "Emotional state observations", "count": 11}, {"letter": "Reasoning", "count": 4}, {"letter": "Impaired health", "count": 60}, {"letter": "Secondary malignant neoplasm of axilla", "count": 2}, {"letter": "Malignant neoplasm of gastrointestinal tract", "count": 8}, {"letter": "CNS metastases", "count": 15}, {"letter": "Benign neoplasm of paraganglion", "count": 2}, {"letter": "Lymph Node Metastasis", "count": 21}, {"letter": "Emotional relationship", "count": 2}, {"letter": "Prokaryote", "count": 1}, {"letter": "Patient need for (contextual qualifier)", "count": 67}, {"letter": "Unavailability", "count": 13}, {"letter": "Consequence of", "count": 56}, {"letter": "Spiritual assessment", "count": 1}, {"letter": "Structure of skeletal muscle of shoulder", "count": 2}, {"letter": "Duct (organ) structure", "count": 5}, {"letter": "Detached", "count": 8}, {"letter": "Substance of abuse", "count": 1}, {"letter": "Drug Interactions", "count": 6}, {"letter": "Chromatography Systems, Liquid, Packed Column, High-Pressure", "count": 1}, {"letter": "Thermographs", "count": 1}, {"letter": "Mullerian duct inhibiting substance", "count": 7}, {"letter": "generation difference", "count": 1}, {"letter": "Registered nurse", "count": 1}, {"letter": "Post", "count": 930}, {"letter": "Research nurse", "count": 1}, {"letter": "Grade one rank", "count": 1}, {"letter": "Third grade in elementary school", "count": 10}, {"letter": "Cancer Remission", "count": 1}, {"letter": "warming process", "count": 1}, {"letter": "medical researcher", "count": 1}, {"letter": "Risks and Benefits", "count": 4}, {"letter": "Social group", "count": 12}, {"letter": "Knowledge Management", "count": 2}, {"letter": "Taverns", "count": 1}, {"letter": "transdermal", "count": 2}, {"letter": "Intrauterine", "count": 1}, {"letter": "Cancer Genetics", "count": 13}, {"letter": "STK11 gene", "count": 1}, {"letter": "PTEN gene", "count": 31}, {"letter": "RB1 gene", "count": 3}, {"letter": "WT1 gene", "count": 2}, {"letter": "common procedures", "count": 2}, {"letter": "Modality", "count": 33}, {"letter": "Tuning fork therapy each 15 minutes", "count": 3}, {"letter": "tests and measurements", "count": 3}, {"letter": "mind body", "count": 1}, {"letter": "functional activities", "count": 6}, {"letter": "Serum ferritin measurement", "count": 2}, {"letter": "nutritional analysis", "count": 1}, {"letter": "folate serum", "count": 1}, {"letter": "Hierarchy", "count": 7}, {"letter": "Cell surface", "count": 4}, {"letter": "Cytoxan", "count": 1}, {"letter": "Trental", "count": 3}, {"letter": "Metric (substance)", "count": 57}, {"letter": "Physical therapy (field)", "count": 10}, {"letter": "Devices", "count": 136}, {"letter": "disease stage", "count": 10}, {"letter": "Cancer Relapse", "count": 6}, {"letter": "Intimate (qualifier value)", "count": 15}, {"letter": "Wealthy", "count": 4}, {"letter": "flavor perception", "count": 1}, {"letter": "Manual muscle testing", "count": 1}, {"letter": "Economic demand", "count": 6}, {"letter": "Import", "count": 2}, {"letter": "Relationship by association", "count": 200}, {"letter": "Rank", "count": 96}, {"letter": "Does carry", "count": 42}, {"letter": "age differences", "count": 3}, {"letter": "Gut", "count": 1}, {"letter": "Psychological Screening Inventory", "count": 1}, {"letter": "Quick Test of Performance Intelligence", "count": 1}, {"letter": "Blood drug concentration", "count": 24}, {"letter": "Malignant Female Reproductive System Neoplasm", "count": 7}, {"letter": "Skin carcinoma", "count": 19}, {"letter": "Catabolism", "count": 5}, {"letter": "Study of epidemiology", "count": 1}, {"letter": "Personal Experience with Chemicals Scale", "count": 15}, {"letter": "Fused", "count": 1}, {"letter": "Scientific model", "count": 3}, {"letter": "Taxotere", "count": 8}, {"letter": "Curie", "count": 1}, {"letter": "Human Resources", "count": 5}, {"letter": "Transplanted", "count": 1}, {"letter": "plastic property - rigidity", "count": 1}, {"letter": "Coordinated", "count": 3}, {"letter": "Academic achievement", "count": 2}, {"letter": "distorted", "count": 1}, {"letter": "involuted", "count": 10}, {"letter": "Pulmonary aspiration", "count": 3}, {"letter": "Dyssomnias", "count": 39}, {"letter": "Function Axis", "count": 32}, {"letter": "Intravascular line", "count": 11}, {"letter": "Does bend", "count": 1}, {"letter": "Anatomic structures", "count": 1}, {"letter": "Reporting", "count": 835}, {"letter": "Hypoxemia", "count": 1}, {"letter": "Cognitive information processing", "count": 3}, {"letter": "hydroxyl group", "count": 5}, {"letter": "Protium", "count": 12}, {"letter": "Sorting - Cell Movement", "count": 3}, {"letter": "Sectioning technique", "count": 9}, {"letter": "Small", "count": 169}, {"letter": "Patient observation", "count": 102}, {"letter": "Memory observations", "count": 38}, {"letter": "Physical shape", "count": 10}, {"letter": "Emotional distress", "count": 6}, {"letter": "Appearance", "count": 297}, {"letter": "Cardiac rehabilitation", "count": 1}, {"letter": "Reduced mobility", "count": 1}, {"letter": "epirubicin hydrochloride", "count": 1}, {"letter": "Contraceptive methods", "count": 4}, {"letter": "Increased sweating", "count": 2}, {"letter": "Anxiety state", "count": 21}, {"letter": "Science of Morphology", "count": 3}, {"letter": "Allergic", "count": 4}, {"letter": "Neurophysiology - biologic function", "count": 2}, {"letter": "Combined physical therapy", "count": 1}, {"letter": "Patient in hospital (finding)", "count": 5}, {"letter": "Caelyx", "count": 4}, {"letter": "Faslodex", "count": 9}, {"letter": "Per Minute", "count": 215}, {"letter": "Proband (finding)", "count": 5}, {"letter": "indurated", "count": 2}, {"letter": "consolidated", "count": 4}, {"letter": "Blood investigation", "count": 12}, {"letter": "Touch sensation", "count": 6}, {"letter": "Elevation", "count": 23}, {"letter": "Infiltration (procedure)", "count": 2}, {"letter": "doxorubicin liposome", "count": 4}, {"letter": "estradiol / testosterone", "count": 1}, {"letter": "a & d", "count": 5}, {"letter": "A/T/S", "count": 4}, {"letter": "Adult Pain", "count": 1}, {"letter": "Aid to Sleep", "count": 2}, {"letter": "Alert brand of caffeine", "count": 2}, {"letter": "Anti-Diarrheal", "count": 11}, {"letter": "Anti-Nausea", "count": 1}, {"letter": "CP-2", "count": 4}, {"letter": "CRM chromium picolinate", "count": 2}, {"letter": "Estrogenic", "count": 2}, {"letter": "G-1", "count": 7}, {"letter": "Halotestin", "count": 1}, {"letter": "Hyrex Brand of Dimenhydrinate", "count": 3}, {"letter": "InFed", "count": 21}, {"letter": "Iron Supplement", "count": 1}, {"letter": "Nausea Control", "count": 3}, {"letter": "Ontak", "count": 5}, {"letter": "Refresh", "count": 1}, {"letter": "SSS", "count": 4}, {"letter": "Shepards", "count": 3}, {"letter": "Singlet", "count": 1}, {"letter": "Stop brand of fluoride", "count": 19}, {"letter": "Twenties", "count": 8}, {"letter": "Xeloda", "count": 2}, {"letter": "Zemplar", "count": 1}, {"letter": "coagulation factor IX, human", "count": 1}, {"letter": "Advance -- medical device", "count": 7}, {"letter": "Comply", "count": 6}, {"letter": "Depend", "count": 77}, {"letter": "Disposable", "count": 1}, {"letter": "Dual Chamber", "count": 1}, {"letter": "Fecal Collection", "count": 1}, {"letter": "GLUCOSE CONTROL", "count": 2}, {"letter": "Ultra", "count": 7}, {"letter": "Does sit", "count": 20}, {"letter": "trastuzumab", "count": 293}, {"letter": "Ritalin", "count": 1}, {"letter": "Social", "count": 140}, {"letter": "Drug effect", "count": 6}, {"letter": "Drug effect disorder", "count": 1}, {"letter": "Compression", "count": 17}, {"letter": "Partial", "count": 15}, {"letter": "Excision", "count": 108}, {"letter": "Staff nurse", "count": 1}, {"letter": "Clinical Use Template", "count": 2}, {"letter": "Flamazine", "count": 1}, {"letter": "Stereotactic", "count": 4}, {"letter": "Dynamic", "count": 35}, {"letter": "Serum cortisol", "count": 3}, {"letter": "Memory Training", "count": 5}, {"letter": "Axillary lymph node group", "count": 138}, {"letter": "Proton beam", "count": 2}, {"letter": "Myocarditis due to infectious agent", "count": 1}, {"letter": "Carbon-13", "count": 1}, {"letter": "Constituents", "count": 1}, {"letter": "drug values", "count": 1}, {"letter": "Tip of finger", "count": 2}, {"letter": "Cardiac chamber structure", "count": 1}, {"letter": "lymphedema of arm", "count": 30}, {"letter": "Screening for disorder", "count": 1}, {"letter": "Medical records review", "count": 9}, {"letter": "Attending clinic", "count": 1}, {"letter": "Nail care procedure", "count": 2}, {"letter": "Action therapy", "count": 3}, {"letter": "Referral to breast clinic", "count": 1}, {"letter": "Selective Estrogen Receptor Modulators", "count": 5}, {"letter": "Procrit", "count": 2}, {"letter": "human leukocyte interferon", "count": 6}, {"letter": "Medical Surveillance", "count": 35}, {"letter": "Positioning Attribute", "count": 62}, {"letter": "follicle stimulating hormone", "count": 2}, {"letter": "Axillary line", "count": 1}, {"letter": "Nylon dental material", "count": 1}, {"letter": "+2", "count": 32}, {"letter": "Does swallow", "count": 2}, {"letter": "Before values", "count": 372}, {"letter": "Encounter due to counseling", "count": 6}, {"letter": "Depression screen", "count": 1}, {"letter": "Hypertension screen", "count": 2}, {"letter": "Bone scan abnormal", "count": 1}, {"letter": "Lumpectomy (breast cancer)", "count": 1}, {"letter": "Thyroid function normal", "count": 1}, {"letter": "Hyperuricemia", "count": 1}, {"letter": "Altered Taste", "count": 2}, {"letter": "Calcium abnormal NOS", "count": 1}, {"letter": "Infection Problem", "count": 1}, {"letter": "Psychosocial problem", "count": 2}, {"letter": "ACETAMINOPHEN TREATMENT", "count": 1}, {"letter": "Substance abuse problem", "count": 1}, {"letter": "Antibody test positive", "count": 5}, {"letter": "apgar", "count": 1}, {"letter": "atypia morphology", "count": 7}, {"letter": "Axillary Lymph Node Involvement", "count": 3}, {"letter": "AXILLARY LYMPH NODE METASTASIS", "count": 4}, {"letter": "Elevated total bilirubin", "count": 1}, {"letter": "biopsy nodule", "count": 2}, {"letter": "BODY ACHE", "count": 1}, {"letter": "bout", "count": 4}, {"letter": "Premenopausal breast cancer", "count": 4}, {"letter": "occult malignancy", "count": 1}, {"letter": "cancer resection", "count": 3}, {"letter": "CARDIAC ETIOLOGY", "count": 2}, {"letter": "Cardiac Events", "count": 42}, {"letter": "cardiac patient", "count": 9}, {"letter": "cardiac symptom", "count": 5}, {"letter": "carotid internal", "count": 1}, {"letter": "Elevated CEA", "count": 1}, {"letter": "Chest heaviness", "count": 1}, {"letter": "Central nervous system lesion", "count": 35}, {"letter": "Complication of procedure", "count": 1}, {"letter": "Congestive", "count": 3}, {"letter": "Symptomatic congestive heart failure", "count": 20}, {"letter": "consent signed", "count": 2}, {"letter": "contrast dye", "count": 1}, {"letter": "controlled with medications", "count": 1}, {"letter": "Acute onset cough", "count": 1}, {"letter": "craniotomy temporal", "count": 1}, {"letter": "creatinine rising", "count": 1}, {"letter": "Elevated C-reactive protein", "count": 1}, {"letter": "Computed Tomography with Contrast", "count": 2}, {"letter": "debilitation", "count": 1}, {"letter": "Dietary control", "count": 1}, {"letter": "Disposition", "count": 13}, {"letter": "Drug Exposure", "count": 13}, {"letter": "Acute dyspnea", "count": 1}, {"letter": "emotional dysfunction", "count": 1}, {"letter": "end organ damage", "count": 2}, {"letter": "error", "count": 12}, {"letter": "etiology unknown", "count": 18}, {"letter": "Incidental Findings", "count": 2}, {"letter": "lesion of finger", "count": 1}, {"letter": "heart inflammation", "count": 2}, {"letter": "heart rate average", "count": 1}, {"letter": "Maximum heart rate", "count": 5}, {"letter": "Target heart rate", "count": 1}, {"letter": "Hematocrit decreased", "count": 1}, {"letter": "hospice patient", "count": 3}, {"letter": "Prolonged hospitalization", "count": 89}, {"letter": "hypertension untreated", "count": 1}, {"letter": "knee symptoms", "count": 2}, {"letter": "lab data", "count": 1}, {"letter": "List", "count": 169}, {"letter": "liver test abnormal", "count": 1}, {"letter": "Lost", "count": 58}, {"letter": "Positive Lymph Node", "count": 73}, {"letter": "mass lesion", "count": 1}, {"letter": "Palpable mass", "count": 1}, {"letter": "MEDICATION LIST", "count": 2}, {"letter": "methylate", "count": 2}, {"letter": "mitral", "count": 1}, {"letter": "monoclonal", "count": 3}, {"letter": "Myocardial injury", "count": 3}, {"letter": "Focal Neurologic Deficits", "count": 1}, {"letter": "Febrile Neutropenia", "count": 91}, {"letter": "new onset", "count": 2}, {"letter": "NO TREATMENT", "count": 8}, {"letter": "Anatomic Node", "count": 107}, {"letter": "Nonverbal", "count": 1}, {"letter": "Oxygen saturation below reference range", "count": 1}, {"letter": "Organic", "count": 6}, {"letter": "Ovarian failure", "count": 5}, {"letter": "pain chronic management", "count": 1}, {"letter": "pain unilateral", "count": 2}, {"letter": "pap smear screening", "count": 2}, {"letter": "patient profile", "count": 7}, {"letter": "Patient-Reported", "count": 168}, {"letter": "Elective procedure", "count": 3}, {"letter": "Progress note", "count": 6}, {"letter": "Low protein level", "count": 1}, {"letter": "Psychiatric inpatient", "count": 1}, {"letter": "pus drainage", "count": 1}, {"letter": "RF", "count": 2}, {"letter": "small size", "count": 9}, {"letter": "Support System", "count": 1}, {"letter": "socioeconomic", "count": 6}, {"letter": "SYSTEMIC CHANGE", "count": 4}, {"letter": "Systolic dysfunction", "count": 8}, {"letter": "temporal pain", "count": 1}, {"letter": "threat", "count": 2}, {"letter": "Treatment Status", "count": 5}, {"letter": "tumor removal", "count": 9}, {"letter": "vasomotor symptom", "count": 5}, {"letter": "Visual changes", "count": 3}, {"letter": "White blood cell count decreased", "count": 2}, {"letter": "White blood cell count increased (lab result)", "count": 2}, {"letter": "Work-up", "count": 18}, {"letter": "blank", "count": 1}, {"letter": "Slightly (qualifier value)", "count": 8}, {"letter": "Confirmation", "count": 200}, {"letter": "apparent", "count": 127}, {"letter": "Associate - relationship", "count": 2}, {"letter": "Suspected qualifier", "count": 12}, {"letter": "Probably", "count": 99}, {"letter": "Suspicious", "count": 40}, {"letter": "most likely", "count": 1}, {"letter": "Significant", "count": 220}, {"letter": "around", "count": 3}, {"letter": "acuity", "count": 3}, {"letter": "while", "count": 27}, {"letter": "FORMER", "count": 4}, {"letter": "MILDLY", "count": 12}, {"letter": "Nonspecific", "count": 1}, {"letter": "newly", "count": 35}, {"letter": "MOSTLY", "count": 4}, {"letter": "If", "count": 1}, {"letter": "Unlikely", "count": 3}, {"letter": "omit", "count": 9}, {"letter": "Estimated", "count": 860}, {"letter": "emergent", "count": 118}, {"letter": "consider", "count": 780}, {"letter": "undefined", "count": 2}, {"letter": "Course", "count": 193}, {"letter": "Physical Appearance, Body", "count": 5}, {"letter": "Monocyte count result", "count": 2}, {"letter": "Arnold-Chiari Malformation, Type I", "count": 2}, {"letter": "Tactile Allodynia", "count": 1}, {"letter": "Chronic Insomnia", "count": 1}, {"letter": "Memory Loss", "count": 1}, {"letter": "Leptomeningeal Neoplasms", "count": 6}, {"letter": "Radiation-Induced Cancer", "count": 2}, {"letter": "Neurologic Dysfunction", "count": 1}, {"letter": "Neurologic Signs", "count": 4}, {"letter": "Upper Extremity Paresis", "count": 3}, {"letter": "Surgical Procedures, Laparoscopic", "count": 1}, {"letter": "Gene Products, Protein", "count": 2}, {"letter": "cDNA Library", "count": 2}, {"letter": "Central Nervous System Neoplasms, Primary", "count": 2}, {"letter": "Second Primary Cancers", "count": 118}, {"letter": "Basal Cell Cancer", "count": 7}, {"letter": "Cosmetic Surgical Procedures", "count": 1}, {"letter": "Trauma, Nervous System", "count": 1}, {"letter": "Proteome", "count": 6}, {"letter": "Alkaline Comet Assay", "count": 1}, {"letter": "Comet Assay", "count": 4}, {"letter": "Proteobacteria", "count": 1}, {"letter": "Alphaproteobacteria", "count": 1}, {"letter": "PDGFB gene", "count": 3}, {"letter": "Single Nucleotide Polymorphism", "count": 35}, {"letter": "Maximum Tolerated Dose", "count": 305}, {"letter": "Glucuronides", "count": 1}, {"letter": "Technology, Health Care", "count": 3}, {"letter": "Gene Expression Profiling", "count": 6}, {"letter": "Mitogen-Activated Protein Kinases", "count": 1}, {"letter": "MAPK-ERK Kinases", "count": 1}, {"letter": "valspodar", "count": 1}, {"letter": "OctreoScan", "count": 2}, {"letter": "Neuro-Oncological Ventral Antigen 2, Human", "count": 12}, {"letter": "abiraterone", "count": 3}, {"letter": "perifosine", "count": 1}, {"letter": "Amino-terminal pro-brain natriuretic peptide", "count": 6}, {"letter": "TNFSF13 protein, human", "count": 1}, {"letter": "IRX 2", "count": 1}, {"letter": "SU 5416", "count": 1}, {"letter": "metformin hydrochloride", "count": 1}, {"letter": "morphine hydrochloride", "count": 1}, {"letter": "venlafaxine hydrochloride", "count": 1}, {"letter": "gemcitabine hydrochloride", "count": 3}, {"letter": "alpha hydroxy acids", "count": 1}, {"letter": "corticotropin-releasing factor, human", "count": 21}, {"letter": "Prenatal vitamin", "count": 1}, {"letter": "dexketoprofen", "count": 1}, {"letter": "Vinorelbine-Gemcitabine Regimen", "count": 2}, {"letter": "Genetic Analysis", "count": 6}, {"letter": "5q", "count": 1}, {"letter": "Genetic Variation Analysis", "count": 3}, {"letter": "Carboplatin/Docetaxel", "count": 4}, {"letter": "bevacizumab", "count": 67}, {"letter": "iodine-125", "count": 3}, {"letter": "carboplatin/gemcitabine", "count": 1}, {"letter": "carboplatin/paclitaxel/trastuzumab", "count": 1}, {"letter": "Taxanes", "count": 57}, {"letter": "Polymorphism Analysis", "count": 2}, {"letter": "Capecitabine/Docetaxel", "count": 1}, {"letter": "Docetaxel/Gemcitabine", "count": 3}, {"letter": "CCI 779", "count": 1}, {"letter": "Gemcitabine/Monoclonal Antibody HER2", "count": 1}, {"letter": "Localized Malignant Neoplasm", "count": 1}, {"letter": "Sentinel Lymph Node Biopsy", "count": 30}, {"letter": "Challenge:Type:Point in time:^Patient:Nominal", "count": 1}, {"letter": "RR interval:Time:Stdy^mean:Heart:Qn:EKG", "count": 4}, {"letter": "Medication XXX:Dosage:Point in time:^Patient:Quantitative", "count": 33}, {"letter": "Capacity.inspiratory:Volume:Point in time:Respiratory system:Quantitative", "count": 2}, {"letter": "Capacity.total:Volume:Point in time:Respiratory system:Quantitative", "count": 1}, {"letter": "Region of interest:Presence or Identity:Point in time:*:Nominal", "count": 14}, {"letter": "Birth date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative", "count": 1}, {"letter": "Primary site:Anatomy:Point in time:Cancer.To be specified in another part of the message:Nominal", "count": 1}, {"letter": "Grade:Prid:Pt:Cancer.XXX:Nom", "count": 14}, {"letter": "Radiation Rx therapy:Type:Pt:Cancer.XXX:Nom", "count": 2}, {"letter": "Surgical approach:Type:Point in time:Surgical procedure:Nominal", "count": 1}, {"letter": "Radiation Rx:Type:Pt:Cancer.XXX:Nom", "count": 1}, {"letter": "Other Rx:Type:Point in time:Cancer.To be specified in another part of the message:Nominal", "count": 1}, {"letter": "Chemotherapy:Prid:Pt:Cancer.XXX:Nom", "count": 5}, {"letter": "Surgery:Type:Point in time:Cancer.To be specified in another part of the message:Nominal", "count": 4}, {"letter": "Physician:Identifier:Point in time:^Patient:Nominal", "count": 22}, {"letter": "Histology:Find:Pt:Cancer.XXX:Nar", "count": 2}, {"letter": "Area 2", "count": 2}, {"letter": "Aspartate aminotransferase/Alanine aminotransferase", "count": 2}, {"letter": "Cancer Registry", "count": 8}, {"letter": "Cell Fraction", "count": 1}, {"letter": "Challenge", "count": 17}, {"letter": "Circumference 2", "count": 1}, {"letter": "Code", "count": 52}, {"letter": "Coding system.original", "count": 1}, {"letter": "Completion Status", "count": 1}, {"letter": "Date last contact", "count": 56}, {"letter": "Diameter 2", "count": 1}, {"letter": "diffusion capacity", "count": 1}, {"letter": "End date", "count": 20}, {"letter": "Bioavailable estradiol", "count": 1}, {"letter": "Flow", "count": 19}, {"letter": "hospital number", "count": 5}, {"letter": "hospital reports", "count": 1}, {"letter": "Image Quality", "count": 12}, {"letter": "Insertion depth", "count": 1}, {"letter": "Lymph Node Involvement", "count": 8}, {"letter": "Maximum", "count": 189}, {"letter": "Mononuclear cells", "count": 3}, {"letter": "Pathologist interpretation", "count": 2}, {"letter": "Pathology report", "count": 36}, {"letter": "Inorganic phosphorus", "count": 1}, {"letter": "Primary tumor.clinical", "count": 1}, {"letter": "Primary tumor.pathology", "count": 3}, {"letter": "Radiology studies", "count": 4}, {"letter": "Reason for study", "count": 1}, {"letter": "Date of Recurrence", "count": 121}, {"letter": "Recurrence type", "count": 2}, {"letter": "refill", "count": 1}, {"letter": "Region of interest", "count": 7}, {"letter": "resistance.index", "count": 1}, {"letter": "Site of distant metastasis", "count": 1}, {"letter": "Slope", "count": 28}, {"letter": "Start Date", "count": 42}, {"letter": "STRENGTH (attribute)", "count": 121}, {"letter": "Study recommendation", "count": 1}, {"letter": "Susceptibility method", "count": 1}, {"letter": "Therapeutic Intervention", "count": 20}, {"letter": "Time 2", "count": 42}, {"letter": "Volume 2", "count": 1}, {"letter": "NRAS gene", "count": 1}, {"letter": "Abstractor", "count": 1}, {"letter": "Admission activity", "count": 3}, {"letter": "Kit device", "count": 30}, {"letter": "AKT1 gene", "count": 36}, {"letter": "AKT2 gene", "count": 1}, {"letter": "TIAM1 gene", "count": 1}, {"letter": "ERBB3 gene", "count": 7}, {"letter": "ERBB4 gene", "count": 2}, {"letter": "FLT1 gene", "count": 1}, {"letter": "Transcription factor genes", "count": 1}, {"letter": "SPINK1 gene", "count": 1}, {"letter": "Feels cold", "count": 1}, {"letter": "Ejection time", "count": 5}, {"letter": "Creatinine clearance", "count": 5}, {"letter": "Gradient", "count": 4}, {"letter": "S-Phase Fraction", "count": 11}, {"letter": "Chemotherapy Drugs Adminstered", "count": 8}, {"letter": "vision services", "count": 2}, {"letter": "Circadian Rhythm Disorders", "count": 1}, {"letter": "Bewilderment", "count": 5}, {"letter": "work productivity", "count": 12}, {"letter": "Serum triglycerides increased", "count": 1}, {"letter": "Medical Marijuana", "count": 1}, {"letter": "polar", "count": 14}, {"letter": "Skin Conductance", "count": 2}, {"letter": "Neuronal Hyperexcitability", "count": 1}, {"letter": "Cytometry", "count": 10}, {"letter": "Theory of Planned Behavior", "count": 5}, {"letter": "negative emotionality", "count": 2}, {"letter": "self-management skills", "count": 2}, {"letter": "behavioral self-management", "count": 2}, {"letter": "Visuospatial Ability", "count": 1}, {"letter": "Spatial Memory", "count": 5}, {"letter": "health-related beliefs", "count": 11}, {"letter": "risk perception", "count": 17}, {"letter": "subjective well-being", "count": 3}, {"letter": "Noninvasive procedure", "count": 6}, {"letter": "Alcohol Timeline Followback Method", "count": 3}, {"letter": "Temptation and Restraint Inventory", "count": 12}, {"letter": "veterans alcoholism screening test (VAST)", "count": 1}, {"letter": "Dietary Assessment", "count": 6}, {"letter": "posit", "count": 2}, {"letter": "types of therapies", "count": 1}, {"letter": "Meditation Therapy", "count": 1}, {"letter": "self-change", "count": 68}, {"letter": "prevention or treatment protocol", "count": 3}, {"letter": "risk and protective factors", "count": 13}, {"letter": "genetic risk factors", "count": 1}, {"letter": "prevention side effects", "count": 1}, {"letter": "Resistance education", "count": 1}, {"letter": "accessibility", "count": 14}, {"letter": "Assessment of lifestyle", "count": 2}, {"letter": "care by level of intensity", "count": 4}, {"letter": "Brief Interventions", "count": 7}, {"letter": "Overdiagnosis", "count": 7}, {"letter": "treatment and maintenance", "count": 3}, {"letter": "co-treatment", "count": 7}, {"letter": "Therapeutic Alliance", "count": 3}, {"letter": "duration of treatment outcome", "count": 1}, {"letter": "early treatment phase", "count": 1}, {"letter": "health care use", "count": 8}, {"letter": "health care cost-effectiveness", "count": 1}, {"letter": "social connectedness", "count": 2}, {"letter": "Parent Child Communication", "count": 1}, {"letter": "membership attrition", "count": 11}, {"letter": "Affordability", "count": 3}, {"letter": "acceptability", "count": 108}, {"letter": "appropriateness", "count": 16}, {"letter": "waiting time", "count": 3}, {"letter": "vice", "count": 5}, {"letter": "Risk Analysis", "count": 5}, {"letter": "media literacy", "count": 1}, {"letter": "overview", "count": 6}, {"letter": "collected volume", "count": 1}, {"letter": "effect size", "count": 65}, {"letter": "Ethics, Research", "count": 2}, {"letter": "Intervention Trial", "count": 6}, {"letter": "random assignment", "count": 11}, {"letter": "latent variable", "count": 2}, {"letter": "Significance Level", "count": 26}, {"letter": "Statistical Power", "count": 2}, {"letter": "type 2 error probability", "count": 1}, {"letter": "ancova", "count": 45}, {"letter": "Multilevel Analysis", "count": 23}, {"letter": "conceptual model", "count": 3}, {"letter": "undergraduate student", "count": 1}, {"letter": "left brain", "count": 1}, {"letter": "coping resources", "count": 2}, {"letter": "problem-solving skills", "count": 1}, {"letter": "Psychological Distress", "count": 60}, {"letter": "attitude towards health", "count": 1}, {"letter": "anthropometric measurement", "count": 6}, {"letter": "internal risk factors", "count": 8}, {"letter": "selective intervention", "count": 1}, {"letter": "regular physical activity", "count": 1}, {"letter": "Client Characteristics", "count": 45}, {"letter": "treatment need", "count": 3}, {"letter": "social life", "count": 3}, {"letter": "Interactive Learning", "count": 1}, {"letter": "Religious sin", "count": 1}, {"letter": "Geographic Information Systems", "count": 1}, {"letter": "Male external urethral sphincter", "count": 12}, {"letter": "Angle border of scapula", "count": 1}, {"letter": "Skeleton", "count": 1}, {"letter": "Chest", "count": 26}, {"letter": "Palm of hand", "count": 6}, {"letter": "Surface of index finger", "count": 1}, {"letter": "Region of chest wall", "count": 1}, {"letter": "Structure of parenchyma of lung", "count": 1}, {"letter": "Bone of femur", "count": 1}, {"letter": "Structure of head of metatarsal bone", "count": 1}, {"letter": "Left triceps brachii", "count": 1}, {"letter": "Extrinsic muscle of hand", "count": 3}, {"letter": "Abdominal wall structure", "count": 1}, {"letter": "Core biopsy of breast", "count": 4}, {"letter": "Grafting of fat", "count": 4}, {"letter": "Removal of tissue expander", "count": 1}, {"letter": "Vascular assessment", "count": 1}, {"letter": "Genetic assessment", "count": 3}, {"letter": "Resource education", "count": 2}, {"letter": "Systems therapy", "count": 3}, {"letter": "on anti-coagulants", "count": 3}, {"letter": "Pubic pain", "count": 2}, {"letter": "weight problem", "count": 1}, {"letter": "rundown", "count": 1}, {"letter": "Spots on skin", "count": 1}, {"letter": "Mammography, Female", "count": 2}, {"letter": "normal patient", "count": 5}, {"letter": "Removed", "count": 153}, {"letter": "remove blood", "count": 2}, {"letter": "fixate", "count": 1}, {"letter": "procedure results", "count": 3}, {"letter": "Skin damage", "count": 2}, {"letter": "cardiogram", "count": 1}, {"letter": "peri-menopausal", "count": 2}, {"letter": "change in stool", "count": 3}, {"letter": "change (in) bowel movements", "count": 1}, {"letter": "Generalized illness", "count": 6}, {"letter": "Emotional", "count": 181}, {"letter": "Feeling nervous", "count": 1}, {"letter": "Feeling tired", "count": 2}, {"letter": "Dry cough", "count": 1}, {"letter": "Laser treatment", "count": 4}, {"letter": "skin wound repair", "count": 1}, {"letter": "Radiofrequency Ablation", "count": 5}, {"letter": "Possessed", "count": 1}, {"letter": "mental state examination", "count": 1}, {"letter": "Device complication", "count": 1}, {"letter": "health information", "count": 10}, {"letter": "test results abnormal", "count": 2}, {"letter": "Heart Disease Risk Factors", "count": 7}, {"letter": "Disease risk factor", "count": 1}, {"letter": "Abnormality of blood and blood-forming tissues", "count": 7}, {"letter": "blood count low", "count": 1}, {"letter": "stop medication", "count": 1}, {"letter": "urine test results", "count": 1}, {"letter": "Increased lipid", "count": 2}, {"letter": "Digestive problems", "count": 1}, {"letter": "In situ cancer", "count": 12}, {"letter": "Lumpectomy of breast", "count": 64}, {"letter": "Pseudocoarctation", "count": 1}, {"letter": "Management of fatigue", "count": 1}, {"letter": "Regulation", "count": 17}, {"letter": "Staff", "count": 5}, {"letter": "Breast surgery specialty", "count": 113}, {"letter": "Infestation", "count": 3}, {"letter": "exemestane", "count": 43}, {"letter": "Radiation", "count": 21}, {"letter": "Pharmacodynamics", "count": 22}, {"letter": "Skin investigations", "count": 2}, {"letter": "Allergic condition", "count": 1}, {"letter": "Family issues", "count": 3}, {"letter": "Sleep Disorders", "count": 11}, {"letter": "Vaginal therapeutic procedures", "count": 1}, {"letter": "Dependent - ability", "count": 22}, {"letter": "Breast radiotherapies", "count": 4}, {"letter": "Skin radiotherapies", "count": 2}, {"letter": "Sickle Cell Dactylitis", "count": 9}, {"letter": "Completed Suicide", "count": 1}, {"letter": "Arteriopathic disease", "count": 3}, {"letter": "blood testosterone measurement", "count": 1}, {"letter": "CD4 Lymphocytes Decreased", "count": 1}, {"letter": "No adverse effect", "count": 1}, {"letter": "Induction of anesthesia", "count": 2}, {"letter": "Blood insulin", "count": 2}, {"letter": "Blood lead", "count": 2}, {"letter": "Postoperative analgesia", "count": 11}, {"letter": "Localized swelling", "count": 1}, {"letter": "Neutrophil count decreased", "count": 40}, {"letter": "Biopsy site unspecified abnormal", "count": 2}, {"letter": "Local reaction", "count": 4}, {"letter": "Invasive carcinoma of breast", "count": 159}, {"letter": "Tumor flare", "count": 1}, {"letter": "Pain worsened", "count": 1}, {"letter": "pH urine decreased", "count": 1}, {"letter": "Mucous membrane dryness", "count": 2}, {"letter": "Abnormal blood test", "count": 2}, {"letter": "Cognitive deterioration", "count": 3}, {"letter": "Myelosuppression", "count": 3}, {"letter": "Reinfusion", "count": 1}, {"letter": "Electrocardiogram change", "count": 5}, {"letter": "Corrected Prolonged QT Interval by ECG Finding", "count": 4}, {"letter": "Wound Culture", "count": 4}, {"letter": "Antibody NOS negative", "count": 1}, {"letter": "Leukemia secondary", "count": 1}, {"letter": "Mental status changes", "count": 1}, {"letter": "Endothelial dysfunction", "count": 1}, {"letter": "Sexual problem", "count": 3}, {"letter": "Acute GVH disease", "count": 6}, {"letter": "Potassium increased", "count": 1}, {"letter": "Feeling Sick", "count": 2}, {"letter": "Immediate postoperative analgesia", "count": 1}, {"letter": "Induction procedure", "count": 21}, {"letter": "Bloated feeling", "count": 1}, {"letter": "Marrow aspirate (substance)", "count": 1}, {"letter": "Granulocyte count", "count": 2}, {"letter": "Serum protein / albumin", "count": 1}, {"letter": "Plasma protein / albumin", "count": 1}, {"letter": "Plasma insulin", "count": 4}, {"letter": "Vulvovaginal atrophy", "count": 4}, {"letter": "Serum oestrogen", "count": 2}, {"letter": "Plasma Cholesterol Test", "count": 3}, {"letter": "Adenocarcinoma of breast", "count": 1}, {"letter": "Serum creatine phosphokinase MB", "count": 1}, {"letter": "Serum immunoglobulin A", "count": 1}, {"letter": "Erythema oedematous", "count": 2}, {"letter": "Toxic symptom", "count": 2}, {"letter": "Hepatitis symptom", "count": 1}, {"letter": "silence", "count": 3}, {"letter": "Dairy free diet", "count": 1}, {"letter": "Primigravida", "count": 1}, {"letter": "Drug-Induced Liver Disease", "count": 5}, {"letter": "Anxiety symptoms", "count": 34}, {"letter": "Abdomen scan", "count": 1}, {"letter": "Corrected QT Interval", "count": 8}, {"letter": "Decreased albumin", "count": 1}, {"letter": "Potassium low", "count": 1}, {"letter": "Sodium decreased", "count": 1}, {"letter": "Tomography, Spiral Computed", "count": 4}, {"letter": "Cholesterol low", "count": 1}, {"letter": "Digital Mammography", "count": 12}, {"letter": "Calcium low", "count": 1}, {"letter": "Calcium normal", "count": 1}, {"letter": "Lead increased", "count": 1}, {"letter": "Lobular Neoplasia", "count": 3}, {"letter": "Multiple cancer, primary", "count": 1}, {"letter": "Shoulder deformity", "count": 1}, {"letter": "Chronic graft-versus-host disease", "count": 2}, {"letter": "age determination", "count": 1}, {"letter": "Case (situation)", "count": 93}, {"letter": "Data Processing", "count": 3}, {"letter": "Deterioration", "count": 81}, {"letter": "Edit", "count": 1}, {"letter": "Gardening", "count": 6}, {"letter": "Human embryo", "count": 1}, {"letter": "institutional care", "count": 4}, {"letter": "moisture", "count": 1}, {"letter": "Pathway Analysis", "count": 1}, {"letter": "Relations", "count": 34}, {"letter": "Unit dose", "count": 12}, {"letter": "use studies", "count": 43}, {"letter": "Modeling", "count": 42}, {"letter": "Rule (guideline)", "count": 27}, {"letter": "Sampling", "count": 28}, {"letter": "adjectives", "count": 5}, {"letter": "Agreeableness", "count": 1}, {"letter": "alienation", "count": 1}, {"letter": "altitude effects", "count": 11}, {"letter": "analysts", "count": 3}, {"letter": "Ancestor", "count": 4}, {"letter": "automobile safety", "count": 1}, {"letter": "Avoidance", "count": 35}, {"letter": "Behavioral health", "count": 1}, {"letter": "bilingual education", "count": 1}, {"letter": "Blame", "count": 2}, {"letter": "body awareness", "count": 3}, {"letter": "brain size", "count": 1}, {"letter": "Purchase", "count": 3}, {"letter": "Calculator", "count": 6}, {"letter": "Caregiver Burden", "count": 5}, {"letter": "Child Behavior Checklist", "count": 1}, {"letter": "Assessment: Cognition", "count": 23}, {"letter": "commitment", "count": 4}, {"letter": "Communication skills (observable entity)", "count": 4}, {"letter": "Conscientiousness", "count": 5}, {"letter": "Counselee", "count": 3}, {"letter": "credibility", "count": 17}, {"letter": "Decision support tool", "count": 1}, {"letter": "Dialect", "count": 5}, {"letter": "Display - arrangement", "count": 22}, {"letter": "Dissatisfaction", "count": 30}, {"letter": "Dominance", "count": 1}, {"letter": "drug dosages", "count": 3}, {"letter": "dyads", "count": 17}, {"letter": "emotional responses", "count": 4}, {"letter": "encouragement", "count": 3}, {"letter": "Escape (mental process)", "count": 2}, {"letter": "expertise", "count": 1}, {"letter": "Exposure Therapy", "count": 1}, {"letter": "eye contact", "count": 1}, {"letter": "F-Test", "count": 7}, {"letter": "family of origin", "count": 2}, {"letter": "fatalism", "count": 4}, {"letter": "finger tapping", "count": 1}, {"letter": "fluency", "count": 6}, {"letter": "geriatric patients", "count": 3}, {"letter": "Group Development", "count": 1}, {"letter": "Group Testing", "count": 5}, {"letter": "High School Graduate", "count": 1}, {"letter": "Honest", "count": 1}, {"letter": "hospital programs", "count": 1}, {"letter": "inflection", "count": 1}, {"letter": "Internal Consistency", "count": 47}, {"letter": "Inter-rater Reliability", "count": 2}, {"letter": "Landscapes", "count": 5}, {"letter": "Lifestyle changes", "count": 4}, {"letter": "Like", "count": 16}, {"letter": "management training", "count": 1}, {"letter": "Manufacture", "count": 8}, {"letter": "matching test", "count": 1}, {"letter": "Human maturation", "count": 1}, {"letter": "Maximum Likelihood", "count": 1}, {"letter": "medical patients", "count": 18}, {"letter": "Metabolite", "count": 190}, {"letter": "metronomes", "count": 25}, {"letter": "Money", "count": 6}, {"letter": "Napping", "count": 2}, {"letter": "Neural Network Simulation", "count": 2}, {"letter": "number systems", "count": 2}, {"letter": "nurturance", "count": 1}, {"letter": "Observer", "count": 32}, {"letter": "Opinions", "count": 25}, {"letter": "Organizational Characteristics", "count": 1}, {"letter": "Paragraph", "count": 5}, {"letter": "Paid Hours", "count": 15}, {"letter": "Pearson Correlation Coefficient", "count": 19}, {"letter": "performance tests", "count": 9}, {"letter": "Phoneme", "count": 3}, {"letter": "Physical mobility", "count": 1}, {"letter": "possession", "count": 7}, {"letter": "prepulse inhibition activity", "count": 1}, {"letter": "Priming", "count": 4}, {"letter": "professional development", "count": 1}, {"letter": "Prompting", "count": 8}, {"letter": "Property (attribute)", "count": 45}, {"letter": "Prose", "count": 1}, {"letter": "psychological report", "count": 1}, {"letter": "Psychoeducation", "count": 1}, {"letter": "psychological correlates", "count": 1}, {"letter": "psychological needs", "count": 1}, {"letter": "Rating (action)", "count": 2355}, {"letter": "reality", "count": 2}, {"letter": "Relationship Therapy", "count": 6}, {"letter": "Response Probability", "count": 1}, {"letter": "Response process", "count": 1440}, {"letter": "Rhythm", "count": 2}, {"letter": "role strain", "count": 1}, {"letter": "schema", "count": 12}, {"letter": "Screening test", "count": 19}, {"letter": "Self Help Techniques", "count": 1}, {"letter": "Sexual Satisfaction", "count": 8}, {"letter": "signal intensity", "count": 8}, {"letter": "social stress", "count": 2}, {"letter": "Spatial Frequency", "count": 23}, {"letter": "Standard deviation", "count": 204}, {"letter": "Z score", "count": 30}, {"letter": "statistical analysis", "count": 37}, {"letter": "surgical patients", "count": 6}, {"letter": "Synonym", "count": 11}, {"letter": "Systolic Pressure", "count": 2}, {"letter": "t-Test", "count": 86}, {"letter": "Team", "count": 67}, {"letter": "Test Anxiety", "count": 1}, {"letter": "test forms", "count": 2}, {"letter": "test items", "count": 6}, {"letter": "Test Method", "count": 371}, {"letter": "therapist", "count": 9}, {"letter": "tool use", "count": 4}, {"letter": "Withholding Treatment", "count": 2}, {"letter": "Virtual Reality", "count": 19}, {"letter": "Cautionary Warning", "count": 6}, {"letter": "Wilcoxon Signed Rank Test", "count": 46}, {"letter": "wisdom", "count": 1}, {"letter": "desire", "count": 36}, {"letter": "Affection", "count": 7}, {"letter": "Alphabet", "count": 1}, {"letter": "Habitat", "count": 1}, {"letter": "Management of anxiety", "count": 1}, {"letter": "Clinician", "count": 67}, {"letter": "consumer surveys", "count": 1}, {"letter": "conversation", "count": 8}, {"letter": "daily activities", "count": 58}, {"letter": "Dependent Variable", "count": 12}, {"letter": "Deprivation", "count": 4}, {"letter": "Educational Counseling", "count": 1}, {"letter": "executives", "count": 7}, {"letter": "Frail", "count": 1}, {"letter": "nouns", "count": 2}, {"letter": "personal values", "count": 9}, {"letter": "physician patient interaction", "count": 9}, {"letter": "pragmatics", "count": 1}, {"letter": "reframing", "count": 1}, {"letter": "repeated measures", "count": 58}, {"letter": "Seriousness", "count": 23}, {"letter": "sign test", "count": 2}, {"letter": "sleep onset", "count": 1}, {"letter": "cultural factors", "count": 2}, {"letter": "Theory", "count": 20}, {"letter": "time out", "count": 1}, {"letter": "Time Series", "count": 3}, {"letter": "verbal fluency", "count": 14}, {"letter": "categorizing", "count": 112}, {"letter": "word meaning", "count": 1}, {"letter": "high throughput technology", "count": 3}, {"letter": "personal log/diary", "count": 1}, {"letter": "portable biomedical equipment", "count": 2}, {"letter": "Sarcopenia", "count": 7}, {"letter": "assay development", "count": 2}, {"letter": "Assisted Reproductive Technologies", "count": 1}, {"letter": "case control", "count": 1}, {"letter": "cross reactivity immunity", "count": 1}, {"letter": "disease length", "count": 37}, {"letter": "DNA Library", "count": 2}, {"letter": "Drug Development", "count": 3}, {"letter": "Flask", "count": 1}, {"letter": "Functional Disability", "count": 1}, {"letter": "Monitors, Physiologic, Glucose, Personal", "count": 1}, {"letter": "high throughput analysis", "count": 2}, {"letter": "immunogenic", "count": 4}, {"letter": "light effects", "count": 21}, {"letter": "Mental Status Tests", "count": 4}, {"letter": "Proteomics", "count": 33}, {"letter": "protocol development", "count": 1}, {"letter": "RNA Analysis", "count": 3}, {"letter": "RNA marker", "count": 1}, {"letter": "Resistance Training", "count": 14}, {"letter": "Time Interval", "count": 116}, {"letter": "tissue oxygenation", "count": 2}, {"letter": "Functional Genomics", "count": 2}, {"letter": "Liquid Chromatography Mass Spectrometry", "count": 34}, {"letter": "cancer location", "count": 4}, {"letter": "miniaturize", "count": 1}, {"letter": "Subtypes (Disorders)", "count": 1}, {"letter": "Keyboard Typing", "count": 1}, {"letter": "Thyrogen", "count": 1}, {"letter": "Aromasin", "count": 3}, {"letter": "Theatre", "count": 3}, {"letter": "Coach (occupation)", "count": 1}, {"letter": "Meaning", "count": 88}, {"letter": "Median Statistical Measurement", "count": 21}, {"letter": "Sexual Orientation - Questioning", "count": 4}, {"letter": "Sentence", "count": 1}, {"letter": "Mathematical Model", "count": 4}, {"letter": "Contour form", "count": 11}, {"letter": "Cardiotoxicity", "count": 73}, {"letter": "Estrogen Effect", "count": 4}, {"letter": "Cancer hormonal therapy", "count": 27}, {"letter": "Neutropenic sepsis", "count": 1}, {"letter": "Carbohydrate antigen 27.29", "count": 2}, {"letter": "Adverse event", "count": 1075}, {"letter": "Post procedural pain", "count": 1}, {"letter": "Medical device implantation", "count": 3}, {"letter": "Coronary revascularisation", "count": 2}, {"letter": "Thyroid malformation", "count": 1}, {"letter": "Advanced cancer", "count": 38}, {"letter": "Treatment related secondary malignancy", "count": 1}, {"letter": "Spectroscopy, Nuclear Magnetic Resonance", "count": 2}, {"letter": "Arimidex", "count": 3}, {"letter": "Intraepithelial Neoplasia", "count": 1}, {"letter": "Engineer", "count": 2}, {"letter": "Cardiomyopathies", "count": 1}, {"letter": "6-pyruvoyl-tetrahydropterin synthase deficiency", "count": 2}, {"letter": "late pregnancy", "count": 1}, {"letter": "Towelettes", "count": 1}, {"letter": "HER-2-neu peptide vaccine", "count": 202}, {"letter": "Breast Cancer Genetics", "count": 11}, {"letter": "PS 341", "count": 1}, {"letter": "Interleukin-12 Gene", "count": 1}, {"letter": "ZD1839", "count": 17}, {"letter": "panitumumab", "count": 3}, {"letter": "Surgical wound healing", "count": 1}, {"letter": "Docetaxel/Trastuzumab", "count": 1}, {"letter": "IL2 gene", "count": 16}, {"letter": "therapeutic autologous dendritic cells", "count": 29}, {"letter": "Stromal Neoplasm", "count": 5}, {"letter": "Adverse effects", "count": 94}, {"letter": "Multisection:Find:Pt:Breast:Doc:US", "count": 3}, {"letter": "Views screening:Find:Pt:Breast:Doc:MG", "count": 3}, {"letter": "Multisection:Finding:Point in time:Chest:Narrative:COMPUTERIZED TOMOGRAPHY", "count": 4}, {"letter": "Views AP", "count": 1}, {"letter": "Cell positive for CD19 antigen", "count": 1}, {"letter": "Cell positive for CD20 antigen", "count": 1}, {"letter": "Cell positive for CD3 antigen", "count": 3}, {"letter": "CD3+CD8+ cell", "count": 1}, {"letter": "Cell positive for CD34 antigen", "count": 1}, {"letter": "Cells.CD4/Cells.CD8", "count": 1}, {"letter": "Cell positive for CD56 antigen", "count": 1}, {"letter": "Differential panel", "count": 38}, {"letter": "Biopsy Guidance", "count": 1}, {"letter": "nitrates and nitrites", "count": 1}, {"letter": "Catheter placement", "count": 1}, {"letter": "Views survey", "count": 12}, {"letter": "Performed", "count": 774}, {"letter": "Cosmos", "count": 1}, {"letter": "Nursing interventions", "count": 5}, {"letter": "5 minutes Office visit", "count": 21}, {"letter": "elements of cancer genetics risk assessment and counseling", "count": 5}, {"letter": "Body temperature measurement", "count": 2}, {"letter": "Nuclear Hormone Receptors", "count": 1}, {"letter": "Imaging, Three-Dimensional", "count": 8}, {"letter": "Early endosome", "count": 14}, {"letter": "Myeloid Cells", "count": 6}, {"letter": "Allelic Imbalance", "count": 3}, {"letter": "Gene Order", "count": 1}, {"letter": "Mitochondrial Inheritance", "count": 11}, {"letter": "Genomics", "count": 38}, {"letter": "Models, Surgical", "count": 1}, {"letter": "Lumin-X", "count": 1}, {"letter": "cis-9-trans-11-octadecadienoic acid", "count": 1}, {"letter": "TACSTD1 protein, human", "count": 5}, {"letter": "TFF2 protein, human", "count": 7}, {"letter": "Multidrug Resistance Associated Protein 1", "count": 1}, {"letter": "Nitric Oxide Synthase Type III", "count": 1}, {"letter": "CR 6", "count": 3}, {"letter": "Pain-Free", "count": 1}, {"letter": "ghrelin", "count": 1}, {"letter": "A-A-1 antibiotic", "count": 4}, {"letter": "Glucagon-Like Peptide 2", "count": 2}, {"letter": "PTK 787", "count": 4}, {"letter": "Lovaza", "count": 1}, {"letter": "pegvisomant", "count": 3}, {"letter": "leptine I", "count": 1}, {"letter": "MDR Modulator CBT-1", "count": 1}, {"letter": "CTN", "count": 1}, {"letter": "MRI Scans", "count": 17}, {"letter": "concise", "count": 1}, {"letter": "Sequence Determinations, DNA", "count": 2}, {"letter": "Sequence Determinations, RNA", "count": 11}, {"letter": "Hypersomnia", "count": 1}, {"letter": "Sleeplessness", "count": 18}, {"letter": "Magnetic Resonance", "count": 4}, {"letter": "Conclude Resin", "count": 14}, {"letter": "Breast-Conserving Surgery", "count": 113}, {"letter": "Index", "count": 129}, {"letter": "ASSAY OF CARBOHYDRATE DEFICIENT TRANSFERRIN", "count": 2}, {"letter": "ovarian neoplasm", "count": 1}, {"letter": "A Codes", "count": 4}, {"letter": "Iressa", "count": 4}, {"letter": "PI-3 kinase gene", "count": 5}, {"letter": "Pathology procedure", "count": 7}, {"letter": "Nolvadex", "count": 13}, {"letter": "Arabic numeral 0", "count": 89}, {"letter": "VDR gene", "count": 1}, {"letter": "Cancer Promoting Genes", "count": 5}, {"letter": "Enzyme Inhibitor Drugs", "count": 1}, {"letter": "GSTP1 gene", "count": 2}, {"letter": "Cancer-Predisposing Gene", "count": 5}, {"letter": "MYC Family Protein", "count": 1}, {"letter": "PTTG1 gene", "count": 1}, {"letter": "KMT2A gene", "count": 1}, {"letter": "Genomic Instability", "count": 1}, {"letter": "GSTM1 gene", "count": 1}, {"letter": "Histopathologic Grade", "count": 89}, {"letter": "Anaemia prophylaxis", "count": 1}, {"letter": "Heart alternation", "count": 1}, {"letter": "Intraoperative Awareness", "count": 1}, {"letter": "Cytokine Storm", "count": 1}, {"letter": "Interleukin 6 Measurement", "count": 2}, {"letter": "Urine nitrogen", "count": 1}, {"letter": "Pulmonary toxicity", "count": 4}, {"letter": "Late diastolic murmur", "count": 1}, {"letter": "Bone densitometry procedure", "count": 3}, {"letter": "Arm operation", "count": 4}, {"letter": "Microsatellite Instability", "count": 2}, {"letter": "TACSTD2 gene", "count": 7}, {"letter": "Weight maintenance regimen", "count": 4}, {"letter": "Documentation", "count": 285}, {"letter": "Meta Analysis (statistical procedure)", "count": 2}, {"letter": "Phase I Clinical Trials", "count": 34}, {"letter": "combination cancer therapy", "count": 2}, {"letter": "Tomography, Optical Coherence", "count": 2}, {"letter": "cancer classification", "count": 1}, {"letter": "cancer palliative treatment", "count": 2}, {"letter": "cancer radiation therapy", "count": 6}, {"letter": "cancer recurrence", "count": 48}, {"letter": "cancer surgery", "count": 37}, {"letter": "cancer treatment", "count": 350}, {"letter": "cardiovascular imaging", "count": 1}, {"letter": "circulating cancer cell", "count": 3}, {"letter": "diagnosis evaluation", "count": 1}, {"letter": "disease registry", "count": 1}, {"letter": "disorder control (procedure)", "count": 257}, {"letter": "drug standard", "count": 1}, {"letter": "education planning", "count": 1}, {"letter": "embryo chemotherapy", "count": 1}, {"letter": "Environment-Related Malignant Neoplasm", "count": 1}, {"letter": "Enzyme-Linked Immunospot Assay", "count": 20}, {"letter": "Food Quality", "count": 1}, {"letter": "hormone sensitivity", "count": 1}, {"letter": "Insulin Sensitivity", "count": 3}, {"letter": "liquid chromatography mass spectroscopy", "count": 3}, {"letter": "model development", "count": 3}, {"letter": "Tumor Classification", "count": 3}, {"letter": "Neoplasm diagnosis", "count": 2}, {"letter": "neoplasm genetics", "count": 4}, {"letter": "Tumor Immunology", "count": 1}, {"letter": "neoplasm regression", "count": 2}, {"letter": "neoplasm relapse", "count": 8}, {"letter": "neoplasm remission", "count": 4}, {"letter": "neoplasm therapy", "count": 14}, {"letter": "Preoperative counseling", "count": 1}, {"letter": "spinal tract", "count": 1}, {"letter": "statistical center", "count": 1}, {"letter": "Technique Development", "count": 1}, {"letter": "blood neoplasm", "count": 3}, {"letter": "cancer care", "count": 29}, {"letter": "Cancer Diagnosis", "count": 52}, {"letter": "cancer rehabilitation", "count": 1}, {"letter": "neoplasm radiation therapy", "count": 3}, {"letter": "neoplasm surgery", "count": 10}, {"letter": "Vascular blood supply", "count": 2}, {"letter": "Epithelium of vagina", "count": 3}, {"letter": "Circumpennate", "count": 2}, {"letter": "Base of axilla", "count": 3}, {"letter": "Lobule", "count": 1}, {"letter": "Tricipital", "count": 1}, {"letter": "Musculature of limb", "count": 1}, {"letter": "Proximal end of femur", "count": 1}, {"letter": "Stroma", "count": 32}, {"letter": "Mammary gland", "count": 7}, {"letter": "Intralobular part of terminal lactiferous duct", "count": 1}, {"letter": "Left big toe", "count": 1}, {"letter": "Set of efferent lymphatic vessels", "count": 1}, {"letter": "Cortex of lymph node", "count": 1}, {"letter": "Parenchyma", "count": 13}, {"letter": "anatomical layer", "count": 24}, {"letter": "evaluation criteria", "count": 51}, {"letter": "Executive Function", "count": 33}, {"letter": "level of functioning", "count": 112}, {"letter": "Sagittal plane", "count": 3}, {"letter": "Emotional states", "count": 6}, {"letter": "Published Interview", "count": 4}, {"letter": "Docetaxel/Cyclophosphamide", "count": 3}, {"letter": "Bioavailable", "count": 1}, {"letter": "Trastuzumab/Vinorelbine", "count": 1}, {"letter": "gastrin 17 vaccine", "count": 1}, {"letter": "fulvestrant", "count": 129}, {"letter": "Antidiabetics", "count": 1}, {"letter": "CT-2103", "count": 3}, {"letter": "imatinib", "count": 1}, {"letter": "Analysis", "count": 875}, {"letter": "becatecarin", "count": 2}, {"letter": "Complementary therapies", "count": 1}, {"letter": "Metastatic Prostate Carcinoma", "count": 2}, {"letter": "darbepoetin alfa", "count": 2}, {"letter": "imatinib mesylate", "count": 1}, {"letter": "Zometa", "count": 4}, {"letter": "Additional procedure", "count": 6}, {"letter": "biopsied lesion", "count": 9}, {"letter": "functional measurement", "count": 2}, {"letter": "hemorrhage as a complication", "count": 2}, {"letter": "infection as a complication", "count": 2}, {"letter": "Precancerous lesion", "count": 2}, {"letter": "fluid aspiration", "count": 4}, {"letter": "Specimen volume:Vol:Pt:Urine:Qn", "count": 1}, {"letter": "Vital signs measurments:Finding:Point in time:^Patient:Multi", "count": 2}, {"letter": "Physical findings:Finding:Point in time:^Patient:Nominal:Observed", "count": 8}, {"letter": "Specimen weight:Mass:Pt:Tiss:Qn", "count": 1}, {"letter": "Ambulation", "count": 4}, {"letter": "axis 1", "count": 1}, {"letter": "Cognition:behavior", "count": 1}, {"letter": "Cognition:status", "count": 4}, {"letter": "Cylinder (shape)", "count": 1}, {"letter": "Meaningful life", "count": 1}, {"letter": "Pain:behavior", "count": 2}, {"letter": "Pain:status", "count": 2}, {"letter": "Photo documentation", "count": 4}, {"letter": "Physical activity behavior", "count": 2}, {"letter": "polarization", "count": 2}, {"letter": "ocular sphere", "count": 1}, {"letter": "Time last dose", "count": 3}, {"letter": "Citrus aurantiifolia (plant)", "count": 1}, {"letter": "General status", "count": 1}, {"letter": "RNIx clinical measurements", "count": 19}, {"letter": "Day sweats", "count": 2}, {"letter": "Manufacturer Name", "count": 6}, {"letter": "Physical Activity:status", "count": 1}, {"letter": "study.total", "count": 3}, {"letter": "Superior-Inferior", "count": 3}, {"letter": "Type description", "count": 1}, {"letter": "Peripheral vessels", "count": 1}, {"letter": "Comment", "count": 5}, {"letter": "Scientific Study", "count": 112}, {"letter": "Manipulation procedure", "count": 4}, {"letter": "Breast therapeutic procedures", "count": 28}, {"letter": "vascular inflammations", "count": 1}, {"letter": "Muscle therapeutic procedures", "count": 1}, {"letter": "Renal therapeutic procedures", "count": 3}, {"letter": "Electrocardiogram investigations", "count": 3}, {"letter": "Haematoma infection", "count": 2}, {"letter": "Acute Coronary Syndrome", "count": 2}, {"letter": "Vomiting of medication", "count": 1}, {"letter": "Cytokine Release Syndrome", "count": 8}, {"letter": "Carcinoma of peritoneum", "count": 1}, {"letter": "Radiotherapy to breast", "count": 29}, {"letter": "Radiotherapy to prostate", "count": 1}, {"letter": "Analgesic effect", "count": 6}, {"letter": "Ultrasound examination", "count": 7}, {"letter": "Lesion excision", "count": 3}, {"letter": "Cancer of lymph node", "count": 2}, {"letter": "Physical deconditioning", "count": 1}, {"letter": "Infusion-Related Reaction", "count": 5}, {"letter": "Absolute neutrophil count", "count": 44}, {"letter": "Hepatic impairment", "count": 1}, {"letter": "Alternative Therapies", "count": 3}, {"letter": "Antineoplastic Chemotherapy Protocols", "count": 2}, {"letter": "Pulse Pressure", "count": 1}, {"letter": "Therapies, Investigational", "count": 28}, {"letter": "formalin", "count": 1}, {"letter": "Normality", "count": 23}, {"letter": "Ovarian Stimulation", "count": 7}, {"letter": "Qualitative Research", "count": 5}, {"letter": "Western Blot", "count": 9}, {"letter": "Access to Information", "count": 1}, {"letter": "Genus Hippocampus", "count": 1}, {"letter": "Mitochondrial Proteins", "count": 1}, {"letter": "Second Look Surgery", "count": 14}, {"letter": "Antineoplastic Protocols", "count": 5}, {"letter": "tocotrienols", "count": 3}, {"letter": "Muscle Development", "count": 1}, {"letter": "Molecular Diagnostic Techniques", "count": 4}, {"letter": "Review Committees", "count": 36}, {"letter": "Physical therapy", "count": 6}, {"letter": "Reproductive Techniques, Assisted", "count": 1}, {"letter": "limonene, (+)-", "count": 1}, {"letter": "M 7", "count": 4}, {"letter": "cyclophosphamide/fluorouracil/methotrexate protocol", "count": 4}, {"letter": "sentinel", "count": 35}, {"letter": "Leukocyte L1 Antigen Complex", "count": 1}, {"letter": "AN 1", "count": 9}, {"letter": "4-hydroxy-N-desmethyltamoxifen, (Z)-isomer", "count": 2}, {"letter": "ImProv", "count": 3}, {"letter": "factor A", "count": 22}, {"letter": "MAGEA3 protein, human", "count": 1}, {"letter": "RAD 001", "count": 10}, {"letter": "Definity", "count": 2}, {"letter": "nischarin", "count": 7}, {"letter": "5'-deoxy-5-fluorocytidine", "count": 2}, {"letter": "PP regimen", "count": 1}, {"letter": "Enlight", "count": 5}, {"letter": "ZK 230211", "count": 3}, {"letter": "Lasofoxifene", "count": 2}, {"letter": "CI1033", "count": 1}, {"letter": "NB1011", "count": 2}, {"letter": "liquid crystal polymer", "count": 6}, {"letter": "rosuvastatin", "count": 19}, {"letter": "CD274 protein, human", "count": 9}, {"letter": "Methodology aspects", "count": 33}, {"letter": "alpha tocopherol", "count": 1}, {"letter": "inhibin B", "count": 3}, {"letter": "Aurora Kinase A", "count": 4}, {"letter": "Cilengitide", "count": 3}, {"letter": "Bone Growth", "count": 1}, {"letter": "Boards (medical device)", "count": 2}, {"letter": "Protein Determination Reagents, Tumor Marker", "count": 1}, {"letter": "bicarbonate ion", "count": 3}, {"letter": "LIVER FRACTION", "count": 1}, {"letter": "MILK,NONFAT", "count": 1}, {"letter": "Dexamethasone 4 MG", "count": 1}, {"letter": "glucose 50 MG/ML", "count": 1}, {"letter": "Oral Flakes", "count": 2}, {"letter": "Injectable Suspension", "count": 1}, {"letter": "Oral Solution", "count": 10}, {"letter": "Topical Lotion", "count": 2}, {"letter": "Bead Dosage Form", "count": 9}, {"letter": "Oral Tablet", "count": 3}, {"letter": "Published Database", "count": 62}, {"letter": "Pills", "count": 17}, {"letter": "Patch Dosage Form", "count": 2}, {"letter": "Orcinus orca", "count": 1}, {"letter": "cetuximab", "count": 16}, {"letter": "Bacteroidetes", "count": 2}, {"letter": "Bromus secalinus", "count": 2}, {"letter": "Cancer Genus", "count": 8}, {"letter": "Lateolabrax japonicus", "count": 1}, {"letter": "Chen", "count": 1}, {"letter": "Genus Anemia", "count": 13}, {"letter": "Microbiota (plant)", "count": 10}, {"letter": "Genus Aria", "count": 2}, {"letter": "Eragrostis", "count": 1}, {"letter": "Neopanax arboreus", "count": 1}, {"letter": "Otus", "count": 1}, {"letter": "Modulus", "count": 3}, {"letter": "Meta", "count": 1}, {"letter": "Io <gastropods>", "count": 4}, {"letter": "Maniola tithonus", "count": 1}, {"letter": "Emesis (Eukaryote)", "count": 20}, {"letter": "Genus Ada", "count": 71}, {"letter": "Bia (butterflies)", "count": 5}, {"letter": "Vertigo <invertebrate>", "count": 1}, {"letter": "Bikinia le-testui", "count": 26}, {"letter": "Carinoma", "count": 1}, {"letter": "Subgroup A Nepoviruses", "count": 26}, {"letter": "Amma", "count": 3}, {"letter": "This (eukaryote)", "count": 58}, {"letter": "Genus Phoenix", "count": 2}, {"letter": "Phoenicopterus", "count": 2}, {"letter": "Sepsis (Invertebrate)", "count": 7}, {"letter": "Ammonia Genus", "count": 2}, {"letter": "Codon Genus", "count": 1}, {"letter": "Apple", "count": 1}, {"letter": "Smoking cessation therapy", "count": 2}, {"letter": "Brain natriuretic peptide measurement", "count": 10}, {"letter": "Wound Complication", "count": 15}, {"letter": "Macrophage Activation Syndrome", "count": 2}, {"letter": "Mitochondrial toxicity", "count": 1}, {"letter": "Thrombin-antithrombin III complex Assay", "count": 1}, {"letter": "Lipoprotein (a) measurement", "count": 2}, {"letter": "Cardiac troponin measurement", "count": 4}, {"letter": "Left ventricular ejection fraction decreased", "count": 4}, {"letter": "Carcinoma excision", "count": 1}, {"letter": "Groin discomfort", "count": 2}, {"letter": "Contralateral breast cancer", "count": 135}, {"letter": "Letter [Publication Type]", "count": 13}, {"letter": "Clinical Trial [Publication Type]", "count": 54}, {"letter": "Multicenter Study", "count": 47}, {"letter": "Randomized Controlled Trial (publication)", "count": 1}, {"letter": "Clinical Trial, Phase II", "count": 1}, {"letter": "CD44 protein, human", "count": 6}, {"letter": "human AVP protein", "count": 4}, {"letter": "Alloderm", "count": 9}, {"letter": "MSI 1436", "count": 7}, {"letter": "7-ethyl-10-hydroxycamptothecin glucuronide", "count": 5}, {"letter": "Arzoxifene", "count": 2}, {"letter": "SIRT1 protein, human", "count": 1}, {"letter": "MicroRNAs", "count": 32}, {"letter": "Dictionary [Publication Type]", "count": 7}, {"letter": "Gastrooesophageal cancer", "count": 1}, {"letter": "Lymph node palpable", "count": 2}, {"letter": "Female sexual dysfunction", "count": 2}, {"letter": "Delayed Orgasm", "count": 1}, {"letter": "Aerosol Dose Form", "count": 1}, {"letter": "patient safety", "count": 11}, {"letter": "cardiovascular disorder risk", "count": 3}, {"letter": "brain volume", "count": 4}, {"letter": "Protein induced by vitamin K absence or antagonist II", "count": 1}, {"letter": "Multisection:Finding:Point in time:Breast:Narrative:MRI", "count": 2}, {"letter": "Number of previous doses:Number:Point in time:^Patient:Quantitative", "count": 2}, {"letter": "Pre-existing physician-diagnosed allergies, birth defects, medical conditions:Finding:Point in time:^Patient:Nominal", "count": 6}, {"letter": "Dose number:Number:Point in time:^Patient:Quantitative", "count": 313}, {"letter": "Date received", "count": 1}, {"letter": "Dose number", "count": 1}, {"letter": "Lot Number", "count": 30}, {"letter": "ST deviation", "count": 1}, {"letter": "Vaccinated at", "count": 4}, {"letter": "Breast Duct", "count": 2}, {"letter": "Central Vein", "count": 1}, {"letter": "View Tunnel", "count": 1}, {"letter": "HAVCR2 protein, human", "count": 2}, {"letter": "Estrogen Receptor 1", "count": 1}, {"letter": "gefitinib", "count": 4}, {"letter": "Olea europaea", "count": 2}, {"letter": "Skin", "count": 159}, {"letter": "Tamoxifen 10 MG", "count": 1}, {"letter": "tamoxifen 20 MG", "count": 6}, {"letter": "SLC29A1 protein, human", "count": 1}, {"letter": "tibolone 2.5 MG", "count": 1}, {"letter": "Hormonal Change", "count": 3}, {"letter": "Bevacizumab/Docetaxel", "count": 1}, {"letter": "Intrahepatic Infusion Procedure", "count": 3}, {"letter": "screening intervention", "count": 3}, {"letter": "Annual Screening", "count": 4}, {"letter": "Screening Questionnaire", "count": 7}, {"letter": "beta-Glucans", "count": 1}, {"letter": "Docetaxel/Ketoconazole Protocol", "count": 2}, {"letter": "ABI007", "count": 3}, {"letter": "Invasive Ductal Breast Carcinoma", "count": 3}, {"letter": "Breakthrough Pain", "count": 4}, {"letter": "Avastin", "count": 5}, {"letter": "ixabepilone", "count": 41}, {"letter": "erlotinib", "count": 7}, {"letter": "Tarceva", "count": 2}, {"letter": "COMT gene", "count": 2}, {"letter": "intraoperative magnetic resonance imaging (iMRI)", "count": 1}, {"letter": "Sustained-Release Preparations", "count": 1}, {"letter": "Narration", "count": 3}, {"letter": "Mitochondrial Membrane Transport Proteins", "count": 2}, {"letter": "Computers, Handheld", "count": 1}, {"letter": "Long-Term Synaptic Depression", "count": 5}, {"letter": "Pathogenicity", "count": 1}, {"letter": "Sirtuins", "count": 1}, {"letter": "NAD(P)H dehydrogenase (quinone) 1, human", "count": 1}, {"letter": "Orthopedic Surgical Procedures", "count": 2}, {"letter": "Ribosomal Protein S6 Kinases, 70-kDa", "count": 3}, {"letter": "Microbicides", "count": 1}, {"letter": "ICD Codes", "count": 3}, {"letter": "Receptors, Fibrinogen", "count": 1}, {"letter": "Genetic Processes", "count": 2}, {"letter": "Diagnostic and Statistical Manual of Mental Disorders", "count": 4}, {"letter": "Protein Arrays", "count": 3}, {"letter": "Behavioral Risk Factor Surveillance System", "count": 5}, {"letter": "Mobile Phone", "count": 2}, {"letter": "pegfilgrastim", "count": 43}, {"letter": "Risk Reduction", "count": 4}, {"letter": "DSM-V", "count": 2}, {"letter": "International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)", "count": 10}, {"letter": "ICD-9", "count": 3}, {"letter": "Diet, Mediterranean", "count": 2}, {"letter": "Spider Veins", "count": 2}, {"letter": "Pharmacogenomics", "count": 5}, {"letter": "Provider", "count": 80}, {"letter": "Reagents, Tumor Markers", "count": 47}, {"letter": "Monitoring Systems", "count": 2}, {"letter": "Needles, Biopsy, Breast", "count": 1}, {"letter": "Device Plate", "count": 11}, {"letter": "Recorders, Physiologic, Physical Activity", "count": 30}, {"letter": "Nursing Interventions Classification", "count": 1}, {"letter": "Healthcare Common Procedure Coding System", "count": 3}, {"letter": "Medical Dictionary for Regulatory Activities Terminology (MedDRA)", "count": 38}, {"letter": "Commodes", "count": 1}, {"letter": "Upper Extremity", "count": 139}, {"letter": "Leg", "count": 12}, {"letter": "Malignant neoplasm of ovary", "count": 52}, {"letter": "Bio-Informatics", "count": 6}, {"letter": "Contraction (finding)", "count": 21}, {"letter": "Neutralising antibodies analysis", "count": 9}, {"letter": "Bilirubin abnormal", "count": 1}, {"letter": "Nuclear magnetic resonance imaging whole body", "count": 3}, {"letter": "General physical condition", "count": 1}, {"letter": "Gastrointestinal toxicity", "count": 3}, {"letter": "satraplatin", "count": 2}, {"letter": "TNFSF10 protein, human", "count": 8}, {"letter": "lenalidomide", "count": 1}, {"letter": "Natriuretic Peptides", "count": 1}, {"letter": "Group setting", "count": 1}, {"letter": "Multi-disciplinary team", "count": 2}, {"letter": "Binding action", "count": 6}, {"letter": "Respiratory Failure", "count": 1}, {"letter": "language ability", "count": 1}, {"letter": "Vital status:Type:Point in time:^Patient:Nominal", "count": 1}, {"letter": "Date of death:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative", "count": 126}, {"letter": "Pain quality:Finding:Point in time:^Patient:Nominal", "count": 1}, {"letter": "Physical findings:Finding:Point in time:General appearance:Nominal:Observed", "count": 2}, {"letter": "CD25 cells", "count": 1}, {"letter": "Date of death", "count": 276}, {"letter": "Pain quality", "count": 8}, {"letter": "Vital Status", "count": 2}, {"letter": "general appearance (physical finding)", "count": 1}, {"letter": "Plasma arterial", "count": 1}, {"letter": "Gestational age:Time:Point in time:^Fetus:Quantitative", "count": 1}, {"letter": "Complementary Medicine", "count": 1}, {"letter": "Complementary and alternative medicine", "count": 2}, {"letter": "Molecular Sieve Chromatography", "count": 1}, {"letter": "Childbirth", "count": 2}, {"letter": "Determination Aspects", "count": 22}, {"letter": "molecular_function", "count": 1}, {"letter": "antigen binding", "count": 1}, {"letter": "telomerase activity", "count": 3}, {"letter": "aromatase activity", "count": 1}, {"letter": "interleukin-2 receptor activity", "count": 2}, {"letter": "interleukin-3 receptor activity", "count": 1}, {"letter": "interleukin-7 receptor activity", "count": 1}, {"letter": "interleukin-12 binding activity", "count": 10}, {"letter": "interleukin-15 binding activity", "count": 1}, {"letter": "immunoglobulin binding", "count": 1}, {"letter": "estrogen receptor binding", "count": 1}, {"letter": "cytokine activity", "count": 2}, {"letter": "hormone activity", "count": 1}, {"letter": "histone deacetylase activity", "count": 1}, {"letter": "caspase activity", "count": 1}, {"letter": "kinase activity", "count": 2}, {"letter": "creatine kinase activity", "count": 2}, {"letter": "cyclin-dependent protein kinase activity", "count": 1}, {"letter": "cyclin-dependent protein kinase regulator activity", "count": 1}, {"letter": "stem cell factor receptor activity", "count": 4}, {"letter": "ubiquitin-like protein ligase activity", "count": 4}, {"letter": "mannitol dehydrogenase activity", "count": 1}, {"letter": "9-cis-epoxycarotenoid dioxygenase activity", "count": 4}, {"letter": "superoxide dismutase activity", "count": 1}, {"letter": "ubiquitin-like protein conjugating enzyme activity", "count": 4}, {"letter": "naringenin-chalcone synthase activity", "count": 5}, {"letter": "cellulose synthase (UDP-forming) activity", "count": 1}, {"letter": "enzyme inhibitor activity", "count": 8}, {"letter": "Kinase Inhibitors [MoA]", "count": 1}, {"letter": "learning and/or memory", "count": 1}, {"letter": "sweet taste perception", "count": 1}, {"letter": "detection of nutrient", "count": 2}, {"letter": "Drug Transport Process", "count": 1}, {"letter": "Xenobiotic Metabolism", "count": 1}, {"letter": "response to radiation", "count": 5}, {"letter": "Immune Cell Activation Process", "count": 8}, {"letter": "T cell differentiation", "count": 3}, {"letter": "T-Cell Proliferation", "count": 2}, {"letter": "T-Cell Activation", "count": 2}, {"letter": "gamma-delta T cell activation", "count": 1}, {"letter": "Humoral immune response", "count": 3}, {"letter": "Inflammatory Response", "count": 10}, {"letter": "cellular response to DNA damage stimulus", "count": 3}, {"letter": "cellular response to unfolded protein", "count": 1}, {"letter": "intracellular signal transduction", "count": 1}, {"letter": "Chromosome Condensation", "count": 1}, {"letter": "Cell Cycle Control", "count": 3}, {"letter": "Cell Cycle Arrest", "count": 7}, {"letter": "Cell Cycle Checkpoints", "count": 7}, {"letter": "Histone Acetylation", "count": 1}, {"letter": "Inhibition of Cell Proliferation", "count": 1}, {"letter": "Growth pattern", "count": 2}, {"letter": "glutamate biosynthetic process", "count": 1}, {"letter": "Nonsense Mediated mRNA Decay", "count": 1}, {"letter": "Estrogen Metabolic Process", "count": 1}, {"letter": "fatty acid desaturation", "count": 1}, {"letter": "lipid modification", "count": 11}, {"letter": "DNA Modification Process", "count": 3}, {"letter": "recombinational repair", "count": 1}, {"letter": "double-strand break repair via homologous recombination", "count": 6}, {"letter": "Double Strand Break Repair", "count": 5}, {"letter": "mRNA modification", "count": 2}, {"letter": "Transcription Initiation", "count": 19}, {"letter": "Pyruvate Metabolism Pathway", "count": 1}, {"letter": "Protein phosphorylation", "count": 13}, {"letter": "Protein methylation", "count": 25}, {"letter": "Protein Targeting, Cellular", "count": 3}, {"letter": "glucose uptake", "count": 1}, {"letter": "water transport", "count": 1}, {"letter": "central nervous system development", "count": 1}, {"letter": "brain development", "count": 5}, {"letter": "Skeletal Development", "count": 1}, {"letter": "Chemical Conjugation", "count": 1}, {"letter": "oocyte maturation", "count": 1}, {"letter": "respiratory gaseous exchange in organisms", "count": 1}, {"letter": "viral gene expression", "count": 1}, {"letter": "Topical Gel", "count": 1}, {"letter": "Behavior assessment", "count": 2}, {"letter": "Radiation therapy education", "count": 1}, {"letter": "Compliance care assessment", "count": 2}, {"letter": "DNA replication factor A complex location", "count": 1}, {"letter": "catenin complex", "count": 2}, {"letter": "Host (organism)", "count": 6}, {"letter": "immunoglobulin complex location", "count": 2}, {"letter": "Binding (Molecular Function)", "count": 11}, {"letter": "Neutropenic infection", "count": 10}, {"letter": "Skin toxicity", "count": 60}, {"letter": "T lymphocyte count", "count": 3}, {"letter": "Cardiac Resynchronization Therapy", "count": 1}, {"letter": "Jugular vein distension", "count": 1}, {"letter": "B lymphocyte count procedure", "count": 4}, {"letter": "Alpha tumour necrosis factor measurement", "count": 1}, {"letter": "Interferon gamma level", "count": 1}, {"letter": "Segmented neutrophil count", "count": 5}, {"letter": "HIV viral load", "count": 1}, {"letter": "Squamous cell carcinoma of the head and neck", "count": 3}, {"letter": "Wake Ups", "count": 2}, {"letter": "Infertility risk", "count": 2}, {"letter": "Diarrhea care", "count": 1}, {"letter": "Fertility Preservation", "count": 16}, {"letter": "Delivery care", "count": 1}, {"letter": "Complication Aspects", "count": 14}, {"letter": "Neulasta", "count": 15}, {"letter": "Enabling", "count": 12}, {"letter": "Actigraphy", "count": 14}, {"letter": "diabetes risk", "count": 1}, {"letter": "health disparity", "count": 1}, {"letter": "kinase inhibitor [EPC]", "count": 6}, {"letter": "protein expression", "count": 37}, {"letter": "therapy adherence", "count": 11}, {"letter": "Plasma volume measurement", "count": 1}, {"letter": "VEGF protein, human", "count": 1}, {"letter": "VEGFC protein, human", "count": 1}, {"letter": "Commit Lozenge", "count": 3}, {"letter": "Endocannabinoids", "count": 2}, {"letter": "C-terminal type I collagen telopeptide", "count": 1}, {"letter": "Erbitux", "count": 1}, {"letter": "Velcade", "count": 1}, {"letter": "ANXA2 protein, human", "count": 2}, {"letter": "sunitinib", "count": 16}, {"letter": "Mimic brand of tebufenozide", "count": 2}, {"letter": "aprepitant", "count": 6}, {"letter": "bortezomib", "count": 2}, {"letter": "Erythrocyte sedimentation rate measurement", "count": 1}, {"letter": "Ductal Carcinoma", "count": 3}, {"letter": "Snap brand of resin", "count": 2}, {"letter": "ZOLEDRONIC", "count": 1}, {"letter": "Fibroglandular mass of breast", "count": 1}, {"letter": "Set of mammary lymphatic vessels", "count": 1}, {"letter": "Inframammary fold", "count": 4}, {"letter": "Cell cluster", "count": 4}, {"letter": "Protein Component", "count": 2}, {"letter": "T5 innervation", "count": 2}, {"letter": "T6 innervation", "count": 1}, {"letter": "T10 - Thoracic segmental innervation", "count": 1}, {"letter": "L1 innervation", "count": 13}, {"letter": "Anterosuperior", "count": 2}, {"letter": "Tissue space", "count": 1}, {"letter": "Principal tissue", "count": 3}, {"letter": "Surface of skin", "count": 2}, {"letter": "Female adult human body", "count": 1}, {"letter": "Functional system", "count": 1}, {"letter": "Variation value", "count": 4}, {"letter": "Squamous", "count": 13}, {"letter": "Solocyte", "count": 2}, {"letter": "Base of breast", "count": 7}, {"letter": "Epithelial phenotype", "count": 1}, {"letter": "Palmar", "count": 2}, {"letter": "Extensor", "count": 8}, {"letter": "Pennate muscle", "count": 1}, {"letter": "Groove", "count": 2}, {"letter": "Set of regional lymph nodes", "count": 89}, {"letter": "bony process", "count": 55}, {"letter": "Plexus", "count": 1}, {"letter": "Anatomical compartments", "count": 16}, {"letter": "Tract", "count": 1}, {"letter": "Fascicle - nerve fibers", "count": 2}, {"letter": "Salinispora", "count": 1}, {"letter": "Aka <sponge>", "count": 4}, {"letter": "Selene", "count": 2}, {"letter": "Requena", "count": 3}, {"letter": "Pero", "count": 2}, {"letter": "Notch", "count": 4}, {"letter": "Indicator bird", "count": 1}, {"letter": "Aa (Plant)", "count": 1}, {"letter": "capecitabine Oral Tablet", "count": 1}, {"letter": "Pericardial effusion body substance", "count": 2}, {"letter": "Pleural effusion fluid", "count": 6}, {"letter": "3-D Image", "count": 4}, {"letter": "Anatomical maturation", "count": 3}, {"letter": "Firmicutes", "count": 3}, {"letter": "Nasa (Plant)", "count": 1}, {"letter": "Pharmacologic Substance", "count": 113}, {"letter": "Culture of Body Fluid", "count": 2}, {"letter": "Patient Problem", "count": 5}, {"letter": "Color Test", "count": 2}, {"letter": "Time Measurements", "count": 28}, {"letter": "Laboratory Results", "count": 12}, {"letter": "Serum Free Testosterone Test", "count": 1}, {"letter": "Serum Autoantibody Test", "count": 3}, {"letter": "24 Hour Urine Test", "count": 1}, {"letter": "Insulin Secretion", "count": 1}, {"letter": "Surface of foot", "count": 1}, {"letter": "Intima", "count": 1}, {"letter": "Postural Balance", "count": 1}, {"letter": "Vascular Endothelial Growth Factors", "count": 32}, {"letter": "lonafarnib", "count": 2}, {"letter": "Angiogenic Proteins", "count": 1}, {"letter": "Population Group", "count": 184}, {"letter": "Diploid Cell", "count": 17}, {"letter": "Cyclooxygenase 2 Inhibitors", "count": 1}, {"letter": "Data Compression", "count": 1}, {"letter": "Microbubbles", "count": 1}, {"letter": "Myxoid cyst", "count": 1}, {"letter": "AXL protein, human", "count": 1}, {"letter": "CCNE1 protein, human", "count": 1}, {"letter": "hydroxytamoxifen", "count": 3}, {"letter": "BRAF protein, human", "count": 1}, {"letter": "FGFR2 protein, human", "count": 1}, {"letter": "Plant fiber", "count": 2}, {"letter": "Kneeling (finding)", "count": 1}, {"letter": "Romberg test procedure", "count": 1}, {"letter": "Suppressed", "count": 8}, {"letter": "Morphologically altered structure", "count": 2}, {"letter": "Red color", "count": 2}, {"letter": "Blue color", "count": 14}, {"letter": "Skin of vulva", "count": 1}, {"letter": "Second toe structure", "count": 1}, {"letter": "Drug measurement", "count": 4}, {"letter": "Ratio measurement", "count": 3}, {"letter": "Effects of occupational exposure to radiation", "count": 1}, {"letter": "Karyotype (cell structure)", "count": 1}, {"letter": "Right coronary artery structure", "count": 1}, {"letter": "Evaluation procedure", "count": 575}, {"letter": "Changing job (finding)", "count": 2}, {"letter": "Family history of malignant neoplasm of breast", "count": 4}, {"letter": "Total protein result", "count": 9}, {"letter": "Family history of stroke", "count": 4}, {"letter": "Destructive procedure (surgical)", "count": 1}, {"letter": "Body weight measure", "count": 3}, {"letter": "Sarcoma", "count": 4}, {"letter": "Lactuca sativa", "count": 1}, {"letter": "Step (specific stage)", "count": 53}, {"letter": "Evacuation of hematoma", "count": 1}, {"letter": "Ocular Toxicity", "count": 2}, {"letter": "Lymphocytic infiltration", "count": 3}, {"letter": "Weight Loss", "count": 88}, {"letter": "Negative attitude", "count": 1}, {"letter": "Natures", "count": 78}, {"letter": "Body position", "count": 3}, {"letter": "urine tests kit", "count": 1}, {"letter": "Specific gravity (device)", "count": 1}, {"letter": "Effects of chemotherapy", "count": 24}, {"letter": "Fraction of", "count": 99}, {"letter": "Property (qualifier value)", "count": 1}, {"letter": "Substance amount", "count": 130}, {"letter": "Date/Time", "count": 110}, {"letter": "Percentile", "count": 17}, {"letter": "Susceptibility (property) (qualifier value)", "count": 2}, {"letter": "Quantity rate", "count": 1}, {"letter": "Number rate", "count": 6}, {"letter": "Time ratio", "count": 1}, {"letter": "Mass ratio", "count": 1}, {"letter": "Number ratio", "count": 4}, {"letter": "Relative ratio", "count": 2}, {"letter": "Impression AND/OR interpretation of study", "count": 1}, {"letter": "Arbitrary (property) (qualifier value)", "count": 2}, {"letter": "Genus Sus", "count": 5}, {"letter": "Solitary mass", "count": 5}, {"letter": "Decreased density", "count": 1}, {"letter": "Quantity", "count": 202}, {"letter": "Acute radiation injury", "count": 1}, {"letter": "Torsion (malposition)", "count": 1}, {"letter": "Disintegration (morphologic abnormality)", "count": 13}, {"letter": "Cytologic finding", "count": 1}, {"letter": "Abnormal cell structure", "count": 1}, {"letter": "In situ neoplasm (morphology)", "count": 2}, {"letter": "Metaplastic carcinoma", "count": 1}, {"letter": "Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation", "count": 1}, {"letter": "Prostaglandin measurement", "count": 6}, {"letter": "Ubiquinone 10 Measurement", "count": 3}, {"letter": "Total skin electron beam therapy", "count": 1}, {"letter": "Biological Relative", "count": 2}, {"letter": "Eating habit", "count": 1}, {"letter": "Smooth muscle (tissue)", "count": 1}, {"letter": "CD4+ CD25+ Regulatory T Cells", "count": 22}, {"letter": "Neutrophilic granulocytic cell", "count": 6}, {"letter": "Body structure", "count": 88}, {"letter": "Upper body structure", "count": 19}, {"letter": "Lower body structure", "count": 17}, {"letter": "Breast part", "count": 2}, {"letter": "Heart part", "count": 2}, {"letter": "Region of upper extremity", "count": 2}, {"letter": "Patient chart", "count": 2}, {"letter": "Protein-tyrosine kinase inhibitor", "count": 1}, {"letter": "Mammography finding", "count": 5}, {"letter": "Mammographic breast composition finding (finding)", "count": 3}, {"letter": "Increase in size since previous mammogram", "count": 22}, {"letter": "Mammographic Breast Density", "count": 39}, {"letter": "Mammographic difference in size (finding)", "count": 16}, {"letter": "Difference in shape", "count": 4}, {"letter": "Blood pressure alteration (finding)", "count": 12}, {"letter": "Optical density function", "count": 1}, {"letter": "Plasma LH measurement", "count": 1}, {"letter": "Congenital Thrombotic Thrombocytopenic Purpura", "count": 1}, {"letter": "Entire breast", "count": 1}, {"letter": "Entire coronary artery", "count": 1}, {"letter": "Entire brain", "count": 7}, {"letter": "Entire cell", "count": 1}, {"letter": "Major Depressive Disorder", "count": 11}, {"letter": "Skin pigmentation - finding", "count": 1}, {"letter": "Safety procedure", "count": 3}, {"letter": "Assisted (qualifier value)", "count": 62}, {"letter": "Gray color", "count": 12}, {"letter": "Surgical pathology identifier", "count": 1}, {"letter": "Presence of neoplasm at excised surgical margin", "count": 2}, {"letter": "pN category", "count": 15}, {"letter": "pM category", "count": 135}, {"letter": "Patient identification", "count": 6}, {"letter": "Tumor Cell Invasion", "count": 4}, {"letter": "TNM category pT", "count": 3}, {"letter": "Mild cognitive disorder", "count": 1}, {"letter": "Support group facilitation", "count": 1}, {"letter": "Hospital nurse", "count": 2}, {"letter": "Blood pressure finding", "count": 27}, {"letter": "Genus Dolichotis (organism)", "count": 3}, {"letter": "Recombinant human granulocyte colony stimulating factor", "count": 1}, {"letter": "Phospholipid ratio", "count": 1}, {"letter": "Cardiac markers", "count": 9}, {"letter": "Total white blood count", "count": 1}, {"letter": "T cell total percent", "count": 2}, {"letter": "Polymorphonuclear leukocyte count", "count": 1}, {"letter": "Dual energy X-ray absorptiometry of hip", "count": 2}, {"letter": "Family history: Cardiomyopathy (situation)", "count": 3}, {"letter": "Presence of virus (procedure)", "count": 1}, {"letter": "Autoantibody measurement", "count": 1}, {"letter": "Safety education", "count": 1}, {"letter": "Not Applicable", "count": 84}, {"letter": "Test control", "count": 1}, {"letter": "Skin fibroblast", "count": 1}, {"letter": "Systemic arterial pressure", "count": 4}, {"letter": "Request - action", "count": 13}, {"letter": "Accepted", "count": 98}, {"letter": "status - In progress", "count": 87}, {"letter": "Started", "count": 181}, {"letter": "To be stopped", "count": 22}, {"letter": "Abandoned", "count": 1}, {"letter": "Done (qualifier value)", "count": 95}, {"letter": "Straightforward", "count": 1}, {"letter": "Successful", "count": 62}, {"letter": "Unsuccessful", "count": 2}, {"letter": "Interval", "count": 194}, {"letter": "Outcome of action", "count": 5}, {"letter": "Improving (qualifier value)", "count": 14}, {"letter": "Change patterns", "count": 13}, {"letter": "Does - Ability interpretation value", "count": 1}, {"letter": "Institution (social concept)", "count": 26}, {"letter": "Lowered (qualifier value)", "count": 1}, {"letter": "Tumor size, largest dimension", "count": 1}, {"letter": "Injection", "count": 1}, {"letter": "Intravenous infusion (product)", "count": 1}, {"letter": "Parenteral dosage form", "count": 1}, {"letter": "Gene studies", "count": 1}, {"letter": "Epithelial cell count (procedure)", "count": 15}, {"letter": "Curative Therapy", "count": 7}, {"letter": "Urine ratio", "count": 1}, {"letter": "Outside reference range", "count": 3}, {"letter": "High priority", "count": 1}, {"letter": "Responsible to (attribute)", "count": 5}, {"letter": "Diagnostic device", "count": 1}, {"letter": "Pre-operative chemotherapy", "count": 13}, {"letter": "Postoperative chemotherapy", "count": 1}, {"letter": "Brain region", "count": 1}, {"letter": "Health Authority", "count": 2}, {"letter": "Past medication", "count": 1}, {"letter": "Intervention regimes", "count": 816}, {"letter": "Management procedure", "count": 124}, {"letter": "Test request", "count": 4}, {"letter": "Significance values", "count": 17}, {"letter": "Not significant", "count": 7}, {"letter": "Clinical specialty", "count": 3}, {"letter": "Employer", "count": 1}, {"letter": "Clinical Oncology", "count": 7}, {"letter": "General surgery specialty", "count": 288}, {"letter": "Result", "count": 1350}, {"letter": "Alkaline phosphatase bone isoenzyme measurement, serum", "count": 1}, {"letter": "Tumor finding", "count": 1}, {"letter": "Clinical hematology", "count": 9}, {"letter": "Symptom control (regime/therapy)", "count": 9}, {"letter": "Verbal communication interventions", "count": 1}, {"letter": "Necrosis of skin flap", "count": 6}, {"letter": "Finding of serum tumor marker level", "count": 2}, {"letter": "New York Heart Association Classification", "count": 9}, {"letter": "Imaging modality", "count": 31}, {"letter": "Every three days", "count": 1}, {"letter": "Every forty eight hours", "count": 1}, {"letter": "Every four weeks", "count": 10}, {"letter": "Once a day, at bedtime", "count": 1}, {"letter": "Collateral branch of vessel", "count": 1}, {"letter": "Percentage diameter reduction", "count": 2}, {"letter": "Co-morbid conditions", "count": 5}, {"letter": "Complete therapeutic response", "count": 2}, {"letter": "Partial therapeutic response", "count": 5}, {"letter": "Total number of tissue cores", "count": 2}, {"letter": "Misalignment", "count": 2}, {"letter": "E test (procedure)", "count": 1}, {"letter": "Plasma inorganic phosphate measurement", "count": 1}, {"letter": "Structure of antecubital vein", "count": 6}, {"letter": "Curative - procedure intent", "count": 28}, {"letter": "Staging - procedure intent", "count": 1}, {"letter": "Group exercise", "count": 2}, {"letter": "Therapeutic regimen", "count": 3}, {"letter": "Dividing cell structure", "count": 3}, {"letter": "Red blood cells, blood product", "count": 8}, {"letter": "Left ventricular systolic dysfunction", "count": 4}, {"letter": "Suspected breast cancer", "count": 1}, {"letter": "Maintenance stage", "count": 3}, {"letter": "Preparation stage", "count": 4}, {"letter": "Serum C reactive protein level", "count": 3}, {"letter": "patient in remission", "count": 3}, {"letter": "Persistent mastalgia", "count": 1}, {"letter": "Initial patient assessment", "count": 3}, {"letter": "Serum prolactin measurement", "count": 5}, {"letter": "Plasma estradiol measurement", "count": 2}, {"letter": "Plasma androstenedione measurement", "count": 1}, {"letter": "Serum lactate dehydrogenase measurement", "count": 1}, {"letter": "Plasma lipid measurement", "count": 3}, {"letter": "Serum tryptophan measurement", "count": 1}, {"letter": "Urine sample volume measurement", "count": 1}, {"letter": "Nicotine replacement therapy", "count": 2}, {"letter": "Judicial execution (event)", "count": 6}, {"letter": "Abdominal wall muscle (body structure)", "count": 1}, {"letter": "Deterioration of status", "count": 15}, {"letter": "Firstly", "count": 635}, {"letter": "Early", "count": 387}, {"letter": "Precocious", "count": 2}, {"letter": "Late stage", "count": 6}, {"letter": "Faulty", "count": 1}, {"letter": "Entire supraclavicular lymph node", "count": 1}, {"letter": "Thick", "count": 38}, {"letter": "Manifestation of", "count": 11}, {"letter": "Transfer factor - respiratory measure", "count": 1}, {"letter": "Progress", "count": 46}, {"letter": "Effectiveness", "count": 166}, {"letter": "Dog family", "count": 2}, {"letter": "Exploration procedure", "count": 21}, {"letter": "Fatty acid measurement", "count": 2}, {"letter": "Total Thyroxine Measurement", "count": 1}, {"letter": "At risk of disease", "count": 7}, {"letter": "Refractory heart failure", "count": 3}, {"letter": "24 hour blood pressure", "count": 1}, {"letter": "Structure of region of bone", "count": 1}, {"letter": "Cellular descriptor", "count": 1}, {"letter": "Prescription status", "count": 1}, {"letter": "Metastasis from malignant tumor of prostate", "count": 6}, {"letter": "Evacuation procedure", "count": 4}, {"letter": "Deep lymphatic vessel", "count": 2}, {"letter": "Low Grade", "count": 8}, {"letter": "Upper", "count": 180}, {"letter": "Upward", "count": 7}, {"letter": "Circular", "count": 1}, {"letter": "Surrounding (qualifier value)", "count": 16}, {"letter": "Shortened", "count": 84}, {"letter": "Pressure garments", "count": 5}, {"letter": "Release - action (qualifier value)", "count": 10}, {"letter": "Monitoring - action", "count": 51}, {"letter": "Checking (action)", "count": 24}, {"letter": "Mapping (action)", "count": 10}, {"letter": "Hand rail", "count": 1}, {"letter": "Absenteeism at work", "count": 4}, {"letter": "Region of lymph node", "count": 1}, {"letter": "intent", "count": 114}, {"letter": "Unintentional", "count": 41}, {"letter": "Gland", "count": 10}, {"letter": "Manual method", "count": 6}, {"letter": "Ultrasonography by mode", "count": 2}, {"letter": "Associated procedure", "count": 2}, {"letter": "Purpose", "count": 52}, {"letter": "Palliative", "count": 3}, {"letter": "Negative contrast media", "count": 1}, {"letter": "Has focus", "count": 43}, {"letter": "Interprets", "count": 32}, {"letter": "Phenotype determination", "count": 23}, {"letter": "Genotype determination", "count": 12}, {"letter": "Body composition measure", "count": 9}, {"letter": "Memory performance", "count": 4}, {"letter": "Aspect of behavior", "count": 3}, {"letter": "Measure of globe", "count": 7}, {"letter": "Blood vessel feature", "count": 1}, {"letter": "Length of lymph node in excised specimen", "count": 2}, {"letter": "Measure of liver", "count": 1}, {"letter": "Appearance of breast", "count": 15}, {"letter": "Form of breast", "count": 1}, {"letter": "Consistency of breast", "count": 2}, {"letter": "Dietary Intake", "count": 18}, {"letter": "Measure of hand", "count": 1}, {"letter": "Measure of skin", "count": 1}, {"letter": "Form of bone", "count": 1}, {"letter": "Musculoskeletal measure", "count": 3}, {"letter": "Birth outcome", "count": 2}, {"letter": "Characteristic of pain", "count": 4}, {"letter": "Lesion feature", "count": 7}, {"letter": "employment history", "count": 3}, {"letter": "Work Performance", "count": 2}, {"letter": "Finding of antibody titer", "count": 2}, {"letter": "Finding of red blood cell count", "count": 2}, {"letter": "Finding of platelet count", "count": 2}, {"letter": "Finding of glucose concentration, dipstick", "count": 2}, {"letter": "Measurement of level of drug in blood", "count": 1}, {"letter": "Finding of presence of poison", "count": 8}, {"letter": "Finding of enzyme level", "count": 4}, {"letter": "Finding of liver enzyme levels", "count": 3}, {"letter": "Finding of hormone level", "count": 21}, {"letter": "Finding of serum lipid levels", "count": 2}, {"letter": "Imaging finding", "count": 27}, {"letter": "Biopsy finding", "count": 1}, {"letter": "Entire lateral cubital region", "count": 8}, {"letter": "Entire medial cubital region", "count": 8}, {"letter": "Pulsed Dye Lasers", "count": 1}, {"letter": "Reservoir device", "count": 1}, {"letter": "Intravenous fluid", "count": 2}, {"letter": "Chronic disease of musculoskeletal system", "count": 1}, {"letter": "Neoplasm of axilla", "count": 12}, {"letter": "Disorder of skull", "count": 2}, {"letter": "Disorder of axilla", "count": 3}, {"letter": "Discrepancy (finding)", "count": 9}, {"letter": "Radiologic finding", "count": 1}, {"letter": "Baseline state", "count": 1}, {"letter": "Basic activity of daily living", "count": 1}, {"letter": "Instrumental activities of daily living", "count": 4}, {"letter": "Independent for Transfer", "count": 3}, {"letter": "Climbing stairs", "count": 1}, {"letter": "Taking medication (activity)", "count": 3}, {"letter": "drug dependent", "count": 9}, {"letter": "Integumentary System Finding", "count": 2}, {"letter": "Abdominal bloating", "count": 2}, {"letter": "Metabolic Pathway", "count": 2}, {"letter": "Increased carbohydrate", "count": 1}, {"letter": "Collagen cross linked N-telopeptide", "count": 1}, {"letter": "treatment pain", "count": 2}, {"letter": "Human alphaherpesvirus 1 antibody", "count": 1}, {"letter": "Hematopoietic system finding", "count": 42}, {"letter": "Coagulation protein", "count": 3}, {"letter": "Gerbich blood group system", "count": 15}, {"letter": "72 Hours", "count": 20}, {"letter": "Single point in time", "count": 6}, {"letter": "2 Hours", "count": 9}, {"letter": "4 Hours", "count": 1}, {"letter": "6 Hours", "count": 10}, {"letter": "8 Hours", "count": 9}, {"letter": "12 hours (qualifier value)", "count": 12}, {"letter": "Procedure phase", "count": 2}, {"letter": "Peripheral blood specimen", "count": 20}, {"letter": "Tissue specimen", "count": 277}, {"letter": "part of", "count": 189}, {"letter": "Associated function", "count": 1}, {"letter": "Procedural approach", "count": 7}, {"letter": "Condition activity", "count": 2}, {"letter": "Investigates", "count": 133}, {"letter": "Preventing (action)", "count": 3}, {"letter": "Treatment intent", "count": 58}, {"letter": "Introduces", "count": 11}, {"letter": "Precursor B-cell lymphoblastic leukemia", "count": 4}, {"letter": "Complex procedure", "count": 1}, {"letter": "Management - action", "count": 1}, {"letter": "Education - action", "count": 1}, {"letter": "Stimulation procedure", "count": 11}, {"letter": "Therapeutic evaluation", "count": 5}, {"letter": "Pre-surgery evaluation", "count": 1}, {"letter": "Reexploration procedure", "count": 2}, {"letter": "Division (surgical procedure)", "count": 1}, {"letter": "Expulsion (procedure)", "count": 2}, {"letter": "Augmentation procedure", "count": 1}, {"letter": "Stabilization", "count": 17}, {"letter": "Anchoring procedure", "count": 17}, {"letter": "Enlargement procedure", "count": 1}, {"letter": "Surgical extraction", "count": 1}, {"letter": "Reduction procedure", "count": 317}, {"letter": "Arm implantation", "count": 1}, {"letter": "Injection into thigh", "count": 1}, {"letter": "Nerve reconstruction", "count": 1}, {"letter": "Hand grip", "count": 29}, {"letter": "Stress protocol", "count": 3}, {"letter": "Vagal stimulation", "count": 1}, {"letter": "Modified Naughton protocol", "count": 1}, {"letter": "Manual laboratory procedure", "count": 2}, {"letter": "Total measurement", "count": 4}, {"letter": "Specimen description", "count": 1}, {"letter": "Mononuclear cell count", "count": 2}, {"letter": "Macrophage count", "count": 1}, {"letter": "Pathologist evaluation", "count": 4}, {"letter": "Nucleic acid sequencing", "count": 12}, {"letter": "Measurement of human anti-mouse antibody", "count": 1}, {"letter": "Interleukin measurement", "count": 2}, {"letter": "Chromogranin A measurement", "count": 3}, {"letter": "Estrone sulfate measurement", "count": 3}, {"letter": "Insulin-like growth factor binding protein 1 measurement", "count": 1}, {"letter": "Perpendicular axis", "count": 5}, {"letter": "Perimeter topographical modifier", "count": 15}, {"letter": "Non-Reactive", "count": 5}, {"letter": "Single tumor", "count": 2}, {"letter": "Surgical excision specimen", "count": 4}, {"letter": "Cytokine agent", "count": 1}, {"letter": "Routine procedure", "count": 2}, {"letter": "no", "count": 67}, {"letter": "Ocular (qualifier)", "count": 5}, {"letter": "Primary malignant neoplasm of breast", "count": 58}, {"letter": "Sarcoma - category (morphologic abnormality)", "count": 5}, {"letter": "Abnormally high", "count": 268}, {"letter": "Percentile ranking", "count": 2}, {"letter": "One standard deviation above mean", "count": 1}, {"letter": "Two standard deviations below mean", "count": 1}, {"letter": "Mild to moderate", "count": 39}, {"letter": "Moderate to severe", "count": 17}, {"letter": "Minimally significant", "count": 2}, {"letter": "Clinical report", "count": 3}, {"letter": "Radiology report", "count": 3}, {"letter": "Video imaging", "count": 1}, {"letter": "Treatment modification", "count": 44}, {"letter": "Delay of chemotherapy", "count": 5}, {"letter": "Able (finding)", "count": 10}, {"letter": "Unable", "count": 22}, {"letter": "Independently able", "count": 186}, {"letter": "Has difficulty doing (qualifier value)", "count": 89}, {"letter": "Fine motor coordination", "count": 1}, {"letter": "Excision of neoplasm", "count": 7}, {"letter": "Base wide", "count": 1}, {"letter": "Replaced by", "count": 4}, {"letter": "Moved to", "count": 12}, {"letter": "Measurement method", "count": 9}, {"letter": "Time aspect", "count": 1}, {"letter": "Tumor Weight", "count": 8}, {"letter": "Tumor stage", "count": 65}, {"letter": "Tumor quantitation procedure", "count": 1}, {"letter": "Distance of tumor from closest margin", "count": 3}, {"letter": "Organized", "count": 15}, {"letter": "Anesthesia management", "count": 1}, {"letter": "Genus Homo", "count": 1}, {"letter": "Nucleic acid hybridization procedure", "count": 1}, {"letter": "Cubic Meter", "count": 20}, {"letter": "Per cubic millimeter", "count": 14}, {"letter": "Unit/kilogram", "count": 1}, {"letter": "Gram per Kilogram", "count": 1}, {"letter": "mL/kg", "count": 1}, {"letter": "Tumor focality", "count": 2}, {"letter": "Identification number", "count": 3}, {"letter": "CyberKnife", "count": 2}, {"letter": "Abdominal Circumference", "count": 1}, {"letter": "Biopsy site", "count": 2}, {"letter": "World Health Organization tumor classification", "count": 1}, {"letter": "Objective refraction", "count": 16}, {"letter": "Dendritic cell sarcoma, not otherwise specified", "count": 2}, {"letter": "Vessel origin", "count": 1}, {"letter": "Medical contraindication", "count": 1}, {"letter": "Assertion", "count": 1}, {"letter": "Format (qualifier value)", "count": 36}, {"letter": "Patient source", "count": 2}, {"letter": "Time of delivery", "count": 1}, {"letter": "Relieving", "count": 6}, {"letter": "Max 5", "count": 1}, {"letter": "Documented", "count": 534}, {"letter": "Planned", "count": 194}, {"letter": "Documents", "count": 27}, {"letter": "No effect", "count": 1}, {"letter": "Type of line", "count": 2}, {"letter": "Step 1", "count": 2}, {"letter": "Geographic state", "count": 49}, {"letter": "Obtain", "count": 507}, {"letter": "In transit", "count": 2}, {"letter": "Falling injury", "count": 1}, {"letter": "Armband", "count": 6}, {"letter": "minute 1", "count": 16}, {"letter": "Start time", "count": 60}, {"letter": "Bispectral index (assessment scale)", "count": 2}, {"letter": "Diameter (qualifier value)", "count": 191}, {"letter": "Method of identification", "count": 1}, {"letter": "minute 0.1", "count": 1}, {"letter": "Time of death", "count": 42}, {"letter": "Physical activity assessment", "count": 6}, {"letter": "B mode ultrasound", "count": 2}, {"letter": "Chemotherapy cycle", "count": 165}, {"letter": "Image mode", "count": 1}, {"letter": "Primary procedure", "count": 4}, {"letter": "Secondary tumor site", "count": 4}, {"letter": "Primary tumor size", "count": 5}, {"letter": "Secondary tumor size", "count": 4}, {"letter": "Abrasion", "count": 2}, {"letter": "Baseline weight", "count": 4}, {"letter": "Natural killer cell level", "count": 1}, {"letter": "Sample analysis", "count": 25}, {"letter": "Group exercise program", "count": 1}, {"letter": "Disease management program (regime/therapy)", "count": 9}, {"letter": "Radio", "count": 2}, {"letter": "Tissue fiber", "count": 1}, {"letter": "Observation of attack", "count": 2}, {"letter": "Lactate level result", "count": 4}, {"letter": "Urine magnesium level result", "count": 1}, {"letter": "Lymphocyte subset measurement", "count": 6}, {"letter": "Screening - procedure intent", "count": 4}, {"letter": "Surgical patch", "count": 1}, {"letter": "Entire calf of leg (body structure)", "count": 1}, {"letter": "Dressing- activity of daily living", "count": 1}, {"letter": "oxygen 100 %", "count": 1}, {"letter": "Urine protein", "count": 1}, {"letter": "Carer (occupation)", "count": 15}, {"letter": "Cytology procedure", "count": 10}, {"letter": "Ward (environment)", "count": 2}, {"letter": "Oxygen consumption measurement", "count": 13}, {"letter": "Skeletal and/or smooth muscle structure", "count": 1}, {"letter": "Diastolic blood pressure measurement", "count": 18}, {"letter": "Body measure result", "count": 2}, {"letter": "Body mass index", "count": 67}, {"letter": "Anesthesia type", "count": 1}, {"letter": "Weighing patient", "count": 88}, {"letter": "Polypeptides", "count": 1}, {"letter": "Cardiac troponin I", "count": 3}, {"letter": "Forced expiratory volume procedure", "count": 1}, {"letter": "Worker", "count": 2}, {"letter": "Severing", "count": 7}, {"letter": "Mass, a measure of quantity of matter", "count": 45}, {"letter": "Primary malignant neoplasm", "count": 645}, {"letter": "Primary malignant neoplasm of lung", "count": 3}, {"letter": "Light color", "count": 7}, {"letter": "Green light", "count": 1}, {"letter": "Death (finding)", "count": 601}, {"letter": "Psychiatric problem", "count": 52}, {"letter": "Systolic blood pressure measurement", "count": 19}, {"letter": "Plain x-ray", "count": 15}, {"letter": "Stage", "count": 66}, {"letter": "FRAP1 protein, human", "count": 4}, {"letter": "GATA3 protein, human", "count": 1}, {"letter": "AFP protein, human", "count": 1}, {"letter": "CCR6 protein, human", "count": 1}, {"letter": "SDHB protein, human", "count": 4}, {"letter": "LAMP3 protein, human", "count": 1}, {"letter": "GYPA protein, human", "count": 1}, {"letter": "glutamate carboxypeptidase II, human", "count": 8}, {"letter": "trabectedin", "count": 1}, {"letter": "SMO protein, human", "count": 1}, {"letter": "montanide ISA 51", "count": 1}, {"letter": "AHR protein, human", "count": 1}, {"letter": "ADM protein, human", "count": 2}, {"letter": "Singleton", "count": 1}, {"letter": "Redundancy", "count": 2}, {"letter": "Blood pressure measured (CKD)(DM)", "count": 2}, {"letter": "SUPPLY, NOT OTHERWISE SPECIFIED", "count": 2}, {"letter": "Maintaining (action)", "count": 31}, {"letter": "Sexual intercourse - finding", "count": 24}, {"letter": "Distal interphalangeal joint structure of second finger", "count": 1}, {"letter": "Phenotyping (qualifier value)", "count": 1}, {"letter": "Etiology", "count": 157}, {"letter": "Involvement with", "count": 122}, {"letter": "Response to antigens", "count": 2}, {"letter": "Cardiac attachment", "count": 4}, {"letter": "Gastrointestinal attachment", "count": 1}, {"letter": "Cell markers", "count": 9}, {"letter": "Clinical NEC (not elsewhere classified in LNC)", "count": 86}, {"letter": "Drug dose (for transmitting doses for pharmacokinetics)", "count": 109}, {"letter": "Electrocardiogram measures", "count": 2}, {"letter": "Coagulation order set", "count": 1}, {"letter": "Input/Output order set", "count": 1}, {"letter": "Specimen characteristics", "count": 2}, {"letter": "Urological ultrasound", "count": 1}, {"letter": "Flow cytometry study:Find:Pt:XXX:Doc:Flow cytometry", "count": 1}, {"letter": "Tumor site:Anat:Pt:Specimen:Nom", "count": 8}, {"letter": "Pathologic findings:Finding:Point in time:Specimen:Narrative", "count": 2}, {"letter": "Collection date:Date:Pt:^Specimen:Qn", "count": 1}, {"letter": "Status:Class:Pt:{Diagnosis}:Nom", "count": 3}, {"letter": "Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}", "count": 9}, {"letter": "Collection Date", "count": 1}, {"letter": "Diameter product", "count": 3}, {"letter": "Histology type", "count": 1}, {"letter": "Immunoglobulin panel", "count": 3}, {"letter": "Initial evaluation note", "count": 1}, {"letter": "Natural killer cell function", "count": 1}, {"letter": "Note (document)", "count": 42}, {"letter": "patient symptoms", "count": 23}, {"letter": "Phagocytic index", "count": 1}, {"letter": "Protein pattern", "count": 1}, {"letter": "Resection completeness", "count": 1}, {"letter": "Study report", "count": 10}, {"letter": "Urine levels result", "count": 5}, {"letter": "Blood oxygen concentration result", "count": 1}, {"letter": "{Setting}", "count": 68}, {"letter": "Root body part", "count": 8}, {"letter": "Blood hormone levels", "count": 1}, {"letter": "Vitamin level result", "count": 3}, {"letter": "Market", "count": 1}, {"letter": "Tumor marker level result", "count": 29}, {"letter": "Core needle biopsy", "count": 78}, {"letter": "Serum progesterone level result", "count": 1}, {"letter": "Cell phenotype", "count": 3}, {"letter": "Cosmetic surgery", "count": 1}, {"letter": "Occupational therapy regime", "count": 3}, {"letter": "Lubrication procedure", "count": 1}, {"letter": "Finding of hemoglobin concentration", "count": 1}, {"letter": "Immunofluorescent stain method", "count": 6}, {"letter": "Trypan blue stain method", "count": 1}, {"letter": "Readiness", "count": 25}, {"letter": "Point-of-Care Testing", "count": 1}, {"letter": "Level of stress", "count": 25}, {"letter": "Knowledge level: parenting", "count": 1}, {"letter": "Symptom severity (finding)", "count": 64}, {"letter": "Medication response", "count": 1}, {"letter": "Caregiver wellbeing status", "count": 2}, {"letter": "Family resiliency capacity", "count": 1}, {"letter": "Timed up and go mobility test", "count": 4}, {"letter": "Blood loss status", "count": 1}, {"letter": "Level of depression", "count": 19}, {"letter": "Level of fear", "count": 3}, {"letter": "mg/m2", "count": 10}, {"letter": "Hematoxylin stain method", "count": 3}, {"letter": "Hemoglobin G", "count": 1}, {"letter": "Imaging result abnormal", "count": 1}, {"letter": "Six item cognitive impairment test", "count": 1}, {"letter": "mg/mg", "count": 6}, {"letter": "No value", "count": 1}, {"letter": "New York Heart Association Classification - Class I", "count": 1}, {"letter": "Sitting systolic blood pressure", "count": 1}, {"letter": "Sitting diastolic blood pressure", "count": 1}, {"letter": "Informing partner", "count": 6}, {"letter": "Incubation period", "count": 1}, {"letter": "Clinical trial group", "count": 4}, {"letter": "Date of visit", "count": 18}, {"letter": "Time of visit", "count": 8}, {"letter": "In paid employment", "count": 1}, {"letter": "Maternal status", "count": 1}, {"letter": "Urinary elimination status", "count": 4}, {"letter": "Population health status", "count": 3}, {"letter": "Pathologic stage", "count": 11}, {"letter": "Time of symptom onset", "count": 1}, {"letter": "Procedure device", "count": 1}, {"letter": "Planned procedure", "count": 5}, {"letter": "Cardiovascular event", "count": 14}, {"letter": "Critical incident", "count": 2}, {"letter": "Direct questioning", "count": 2}, {"letter": "Attending physician", "count": 4}, {"letter": "Hydration status", "count": 7}, {"letter": "Single leg standing test", "count": 1}, {"letter": "Craniosacral therapy", "count": 1}, {"letter": "Drop Dosing Unit", "count": 5}, {"letter": "Spontaneous hemorrhage", "count": 2}, {"letter": "Ambulatory surgery center", "count": 1}, {"letter": "Gynecologic Oncology", "count": 2}, {"letter": "Peripheral blood mononuclear cell (cell)", "count": 71}, {"letter": "Incongruous", "count": 5}, {"letter": "strip medical device", "count": 1}, {"letter": "Compliance behavior", "count": 122}, {"letter": "Wrist joint", "count": 16}, {"letter": "Dilate procedure", "count": 3}, {"letter": "Pleural catheter", "count": 1}, {"letter": "Surgical Units", "count": 1}, {"letter": "tumor necrosis factor binding", "count": 1}, {"letter": "methanol-5-hydroxybenzimidazolylcobamide Co-methyltransferase activity", "count": 1}, {"letter": "Nuclear chromatin", "count": 4}, {"letter": "vimentin location", "count": 5}, {"letter": "Sensitization (observable entity)", "count": 3}, {"letter": "Positive Regulation of Apoptosis", "count": 2}, {"letter": "Cholesterol Homeostasis", "count": 1}, {"letter": "cytokine production", "count": 1}, {"letter": "Cell secretion", "count": 6}, {"letter": "Regulation of biological process", "count": 9}, {"letter": "enzastaurin", "count": 5}, {"letter": "Bevacizumab/Erlotinib Regimen", "count": 1}, {"letter": "Infrared Photocoagulation Therapy", "count": 18}, {"letter": "pertuzumab", "count": 89}, {"letter": "SULT gene", "count": 1}, {"letter": "High Dose Chemotherapy", "count": 4}, {"letter": "Breast Duct Lavage", "count": 5}, {"letter": "Paclitaxel/Pegfilgrastim", "count": 1}, {"letter": "anastrozole/fulvestrant", "count": 1}, {"letter": "ADI PEG20", "count": 2}, {"letter": "ZD4054", "count": 1}, {"letter": "Hormone refractory prostate cancer", "count": 1}, {"letter": "edotecarin", "count": 1}, {"letter": "AS 1402", "count": 1}, {"letter": "Coagulation process", "count": 3}, {"letter": "Exercise activity", "count": 1}, {"letter": "Elastin activity", "count": 1}, {"letter": "Deep breathing", "count": 2}, {"letter": "Metabolomics", "count": 15}, {"letter": "Diffuse Optical Tomography", "count": 12}, {"letter": "genetic association", "count": 3}, {"letter": "genome sequencing", "count": 1}, {"letter": "magnetic beads", "count": 1}, {"letter": "Telehealth", "count": 16}, {"letter": "Mus sp.", "count": 3}, {"letter": "Comfort", "count": 55}, {"letter": "Has development", "count": 5}, {"letter": "ABCG2 gene", "count": 2}, {"letter": "AGR2 protein, human", "count": 1}, {"letter": "AKAP9 gene", "count": 1}, {"letter": "AKT3 gene", "count": 1}, {"letter": "APEX1 gene", "count": 1}, {"letter": "RHOH gene", "count": 8}, {"letter": "Atypical Ductal Breast Hyperplasia", "count": 1}, {"letter": "BIRC6 gene", "count": 7}, {"letter": "BLNK gene", "count": 3}, {"letter": "CXCR5 gene", "count": 1}, {"letter": "CALM1 gene", "count": 1}, {"letter": "CCNB1 gene", "count": 1}, {"letter": "CCR5 gene", "count": 4}, {"letter": "CDK1 gene", "count": 1}, {"letter": "CHGA gene", "count": 1}, {"letter": "CSF2 gene", "count": 2}, {"letter": "CSF3 gene", "count": 6}, {"letter": "CTF1 gene", "count": 1}, {"letter": "CTNNB1 gene", "count": 1}, {"letter": "CXCL12 gene", "count": 1}, {"letter": "CXCL9 gene", "count": 1}, {"letter": "CXCR3 gene", "count": 1}, {"letter": "CYP2C19 gene", "count": 2}, {"letter": "CYP2D6 gene", "count": 20}, {"letter": "Candidate Disease Gene", "count": 7}, {"letter": "Chest Wall Disorder", "count": 5}, {"letter": "Comedo Necrosis", "count": 1}, {"letter": "Compact Pattern", "count": 1}, {"letter": "Cytokine Gene", "count": 1}, {"letter": "Diffuse Pattern", "count": 1}, {"letter": "Disorder by Site", "count": 3}, {"letter": "Drosophila Patched Gene", "count": 1}, {"letter": "Enzyme Gene", "count": 1}, {"letter": "Extracellular Protein", "count": 1}, {"letter": "FLT3LG gene", "count": 1}, {"letter": "Hereditary Malignant Neoplasm", "count": 5}, {"letter": "Gastrointestinal System Finding", "count": 7}, {"letter": "HSPB1 gene", "count": 1}, {"letter": "Hereditary Nonpolyposis Colorectal Cancer", "count": 1}, {"letter": "Hereditary Ovarian Carcinoma", "count": 1}, {"letter": "Homologous Gene", "count": 8}, {"letter": "Hot Nodule", "count": 1}, {"letter": "Genes, Housekeeping", "count": 1}, {"letter": "ICAM1 gene", "count": 1}, {"letter": "IFNG gene", "count": 2}, {"letter": "IGF1R gene", "count": 12}, {"letter": "IGF1 gene", "count": 15}, {"letter": "IGFBP2 gene", "count": 1}, {"letter": "IGFBP3 gene", "count": 1}, {"letter": "IL10 gene", "count": 2}, {"letter": "IL18 gene", "count": 1}, {"letter": "IL1A gene", "count": 2}, {"letter": "IL6 gene", "count": 7}, {"letter": "IL7 gene", "count": 2}, {"letter": "CXCR1 gene", "count": 1}, {"letter": "In Situ Lesion", "count": 1}, {"letter": "Breast Ductal Carcinoma In Situ, Intermediate Grade", "count": 1}, {"letter": "Invasive Carcinoma", "count": 35}, {"letter": "Invasive Lesion", "count": 98}, {"letter": "JAK2 gene", "count": 4}, {"letter": "JUP gene", "count": 2}, {"letter": "KDR gene", "count": 3}, {"letter": "KISS1 gene", "count": 1}, {"letter": "Low Grade Lesion", "count": 1}, {"letter": "SMAD2 gene", "count": 1}, {"letter": "MAP2K1 gene", "count": 1}, {"letter": "MKI67 gene", "count": 158}, {"letter": "MSLN gene", "count": 3}, {"letter": "Malignant Intracranial Neoplasm", "count": 1}, {"letter": "Intraductal Proliferative Lesion of the Breast", "count": 1}, {"letter": "Metachronous Malignant Neoplasm", "count": 2}, {"letter": "Microinvasive Malignant Neoplasm", "count": 1}, {"letter": "Mitotic Activity", "count": 2}, {"letter": "NCAM1 gene", "count": 1}, {"letter": "NCOA3 gene", "count": 1}, {"letter": "NOTCH1 gene", "count": 1}, {"letter": "NPM1 gene", "count": 6}, {"letter": "NR0B2 gene", "count": 1}, {"letter": "NR3C1 gene", "count": 1}, {"letter": "Necrotic changes (finding)", "count": 1}, {"letter": "Nodular Neoplasm", "count": 1}, {"letter": "Non-Measurable Lesion", "count": 84}, {"letter": "PTPN22 protein, human", "count": 1}, {"letter": "Nuclear Atypia", "count": 1}, {"letter": "Occupational Malignant Neoplasm", "count": 1}, {"letter": "CDK16 gene", "count": 1}, {"letter": "PIK3CA gene", "count": 64}, {"letter": "PIK3CB gene", "count": 4}, {"letter": "PRLR gene", "count": 1}, {"letter": "PRTN3 gene", "count": 1}, {"letter": "Polymerase", "count": 1}, {"letter": "Positive Laboratory Test Result", "count": 4}, {"letter": "RANGAP1 gene", "count": 27}, {"letter": "RIPK2 gene", "count": 1}, {"letter": "RPL10 gene", "count": 2}, {"letter": "RRM2 gene", "count": 1}, {"letter": "Refractory Neoplasm", "count": 4}, {"letter": "SELL gene", "count": 1}, {"letter": "SKP2 gene", "count": 1}, {"letter": "SLC2A1 gene", "count": 4}, {"letter": "STAT1 gene", "count": 3}, {"letter": "Stage IIA Breast Carcinoma", "count": 1}, {"letter": "Stromal Change", "count": 2}, {"letter": "TACC3 gene", "count": 2}, {"letter": "TEK gene", "count": 1}, {"letter": "TGFBI gene", "count": 1}, {"letter": "TLR3 gene", "count": 2}, {"letter": "TMPRSS2 gene", "count": 2}, {"letter": "TNFRSF10B gene", "count": 1}, {"letter": "TNFRSF11B gene", "count": 1}, {"letter": "TNFSF10 gene", "count": 1}, {"letter": "TOP2A gene", "count": 3}, {"letter": "Topoisomerase", "count": 1}, {"letter": "Transcription Coactivator", "count": 1}, {"letter": "Transport Protein Gene", "count": 1}, {"letter": "Treatment-Induced Anemia", "count": 2}, {"letter": "Tubular Neoplasm", "count": 1}, {"letter": "VEGFC gene", "count": 2}, {"letter": "VWF gene", "count": 1}, {"letter": "SELE gene", "count": 1}, {"letter": "SESTAMIBI", "count": 1}, {"letter": "Bulk (conceptual)", "count": 1}, {"letter": "Mediator of activation protein", "count": 9}, {"letter": "Therapy Object (animal model)", "count": 10}, {"letter": "Grape Flavor", "count": 1}, {"letter": "SHBG gene", "count": 6}, {"letter": "CYP19A1 gene", "count": 17}, {"letter": "PGR gene", "count": 4}, {"letter": "LIMS1 gene", "count": 1}, {"letter": "SET gene", "count": 2}, {"letter": "CCL20 gene", "count": 1}, {"letter": "FH gene", "count": 1}, {"letter": "DPYD gene", "count": 5}, {"letter": "TGFB1 gene", "count": 5}, {"letter": "CCL27 gene", "count": 3}, {"letter": "CXCL8 gene", "count": 7}, {"letter": "S100A8 gene", "count": 1}, {"letter": "MCL1 gene", "count": 1}, {"letter": "Neomycin resistance gene", "count": 44}, {"letter": "TYMS gene", "count": 2}, {"letter": "TNFSF11 gene", "count": 1}, {"letter": "ipilimumab", "count": 6}, {"letter": "FASN gene", "count": 10}, {"letter": "NR4A1 gene", "count": 10}, {"letter": "CD14 gene", "count": 4}, {"letter": "MAP3K1 protein, human", "count": 1}, {"letter": "Paget Disease", "count": 1}, {"letter": "Soluble ErbB-1", "count": 1}, {"letter": "Pediatric Neoplasm", "count": 1}, {"letter": "Atypical Lobular Breast Hyperplasia", "count": 1}, {"letter": "Late effect of medical intervention", "count": 14}, {"letter": "Distraction - pain management method", "count": 1}, {"letter": "Note:Find:Pt:{Setting}:Doc:Surgery", "count": 1}, {"letter": "Specimen volume:Vol:Pt:Pericard fld:Qn", "count": 1}, {"letter": "Patient history:-:Point in time:^Patient:-", "count": 1}, {"letter": "PATIENT PHYSICAL", "count": 5}, {"letter": "Intrathecal Space", "count": 5}, {"letter": "MAP Kinase Gene", "count": 1}, {"letter": "Interstitial emphysema", "count": 1}, {"letter": "Increased Cytokine Production", "count": 1}, {"letter": "Ventricular Repolarization [PE]", "count": 3}, {"letter": "Increased by food", "count": 1}, {"letter": "First Order", "count": 3}, {"letter": "Childhood Central Nervous System Neoplasm", "count": 1}, {"letter": "Pleural Mesothelioma", "count": 1}, {"letter": "Solid Dose Form", "count": 6}, {"letter": "powder physical state", "count": 1}, {"letter": "Clearance of substance", "count": 16}, {"letter": "Compartments [PK]", "count": 7}, {"letter": "Maximum breathing capacity function", "count": 2}, {"letter": "Scratch marks", "count": 1}, {"letter": "Metastatic Carcinoma", "count": 2}, {"letter": "ACTB gene", "count": 1}, {"letter": "CSN1S1 gene", "count": 1}, {"letter": "Blood group antigen P2", "count": 1}, {"letter": "Sedimentation process", "count": 1}, {"letter": "Green tea (dietary)", "count": 1}, {"letter": "GW572016", "count": 3}, {"letter": "Personal history of primary malignant neoplasm of breast", "count": 1}, {"letter": "Cognitive changes", "count": 30}, {"letter": "Constipation due to neurogenic bowel", "count": 1}, {"letter": "Imbalance", "count": 9}, {"letter": "Post-term birth", "count": 1}, {"letter": "skin fold (abnormality)", "count": 8}, {"letter": "Primary Lesion", "count": 12}, {"letter": "Necrosis due to ionizing radiation", "count": 1}, {"letter": "Kidney damage", "count": 1}, {"letter": "Undiagnosed", "count": 1}, {"letter": "Sensory Change", "count": 4}, {"letter": "ACAA1 gene", "count": 1}, {"letter": "ACACA gene", "count": 2}, {"letter": "SLC33A1 gene", "count": 67}, {"letter": "ACR gene", "count": 4}, {"letter": "TLE5 gene", "count": 522}, {"letter": "AGER gene", "count": 3}, {"letter": "AKR1B1 gene", "count": 1}, {"letter": "ALDH1A1 gene", "count": 4}, {"letter": "ALDH3A1 gene", "count": 2}, {"letter": "AMH gene", "count": 12}, {"letter": "AMT gene", "count": 5}, {"letter": "ANXA1 gene", "count": 1}, {"letter": "AP4B1 gene", "count": 1}, {"letter": "AQP1 gene", "count": 31}, {"letter": "ARG1 gene", "count": 1}, {"letter": "ARHGDIB gene", "count": 1}, {"letter": "ASAH1 gene", "count": 11}, {"letter": "B2M gene", "count": 1}, {"letter": "BCS1L gene", "count": 13}, {"letter": "BGLAP gene", "count": 7}, {"letter": "BSG gene", "count": 1}, {"letter": "BTF3P11 gene", "count": 1}, {"letter": "BTK gene", "count": 2}, {"letter": "SUCO gene", "count": 5}, {"letter": "C9 gene", "count": 1}, {"letter": "CA9 gene", "count": 2}, {"letter": "CAPG gene", "count": 2}, {"letter": "CBFA2T2 gene", "count": 1}, {"letter": "CBR1 gene", "count": 16}, {"letter": "CBX1 gene", "count": 1}, {"letter": "CCND1 gene", "count": 5}, {"letter": "CCR4 gene", "count": 1}, {"letter": "CCR7 gene", "count": 4}, {"letter": "CD5 gene", "count": 202}, {"letter": "CD86 gene", "count": 1}, {"letter": "CD8A gene", "count": 2}, {"letter": "CDAN1 gene", "count": 104}, {"letter": "CDC20 gene", "count": 1}, {"letter": "CDH17 gene", "count": 3}, {"letter": "CDIPT gene", "count": 2}, {"letter": "CDK6 gene", "count": 3}, {"letter": "CDK9 gene", "count": 8}, {"letter": "CEACAM8 gene", "count": 1}, {"letter": "CFTR gene", "count": 2}, {"letter": "CKM gene", "count": 1}, {"letter": "CLOCK gene", "count": 2}, {"letter": "COL14A1 gene", "count": 2}, {"letter": "COL6A2 gene", "count": 1}, {"letter": "COX8A gene", "count": 2}, {"letter": "CPT1A gene", "count": 2}, {"letter": "CRLF1 gene", "count": 1}, {"letter": "CRP gene", "count": 48}, {"letter": "CSHL1 gene", "count": 1}, {"letter": "CST7 gene", "count": 1}, {"letter": "CTNNA1 gene", "count": 1}, {"letter": "CTSE gene", "count": 1}, {"letter": "MAMLD1 gene", "count": 1}, {"letter": "CYP11B2 gene", "count": 1}, {"letter": "CYP3A5 gene", "count": 7}, {"letter": "CCN1 gene", "count": 2}, {"letter": "DBT gene", "count": 63}, {"letter": "DHCR24 gene", "count": 4}, {"letter": "DIO2 gene", "count": 4}, {"letter": "DKK1 gene", "count": 1}, {"letter": "DLAT gene", "count": 16}, {"letter": "DLL1 gene", "count": 1}, {"letter": "DLST gene", "count": 2}, {"letter": "DLX4 gene", "count": 3}, {"letter": "DNMT1 gene", "count": 1}, {"letter": "DONSON gene", "count": 1}, {"letter": "EEF1A2 gene", "count": 1}, {"letter": "EFNA4 gene", "count": 1}, {"letter": "EGFR gene", "count": 5}, {"letter": "EGR3 gene", "count": 4}, {"letter": "EIF4E gene", "count": 2}, {"letter": "EIF4EBP1 gene", "count": 1}, {"letter": "ELANE gene", "count": 2}, {"letter": "EMD gene", "count": 1}, {"letter": "ENO2 gene", "count": 1}, {"letter": "ENO3 gene", "count": 1}, {"letter": "ENPP2 gene", "count": 1}, {"letter": "ESR1 gene", "count": 16}, {"letter": "ESR2 gene", "count": 4}, {"letter": "F12 gene", "count": 2}, {"letter": "F2 gene", "count": 2}, {"letter": "FCGR3A gene", "count": 7}, {"letter": "FGF23 gene", "count": 1}, {"letter": "FOLR1 gene", "count": 8}, {"letter": "FOXC1 gene", "count": 1}, {"letter": "FOXM1 gene", "count": 1}, {"letter": "FOXP1 gene", "count": 1}, {"letter": "MTOR gene", "count": 10}, {"letter": "FUS gene", "count": 25}, {"letter": "FUT1 gene", "count": 4}, {"letter": "FUT2 gene", "count": 1}, {"letter": "FUT3 gene", "count": 3}, {"letter": "FXYD1 gene", "count": 4}, {"letter": "GAPDH gene", "count": 1}, {"letter": "GCNT2 gene", "count": 2}, {"letter": "GDF11 gene", "count": 2}, {"letter": "GFAP gene", "count": 1}, {"letter": "GGT1 gene", "count": 2}, {"letter": "CBLIF gene", "count": 22}, {"letter": "GJA1 gene", "count": 6}, {"letter": "GLS gene", "count": 2}, {"letter": "GOT1 gene", "count": 23}, {"letter": "GP2 gene", "count": 4}, {"letter": "GP5 gene", "count": 6}, {"letter": "GPNMB gene", "count": 2}, {"letter": "GPT gene", "count": 7}, {"letter": "GPX7 gene", "count": 1}, {"letter": "GRAP2 gene", "count": 1}, {"letter": "GRN gene", "count": 12}, {"letter": "GRPR gene", "count": 2}, {"letter": "GSK3B gene", "count": 1}, {"letter": "GSTM2 gene", "count": 1}, {"letter": "GTF2I gene", "count": 1}, {"letter": "GTPBP1 gene", "count": 1}, {"letter": "GYPE gene", "count": 1}, {"letter": "GZMM gene", "count": 1}, {"letter": "H1-2 gene", "count": 2}, {"letter": "H3C3 gene", "count": 1}, {"letter": "HEXA gene", "count": 1}, {"letter": "HINT1 gene", "count": 1}, {"letter": "HLA-B gene", "count": 204}, {"letter": "HLA-C gene", "count": 1}, {"letter": "HLA-DQA1 gene", "count": 7}, {"letter": "HMBS gene", "count": 1}, {"letter": "HMGCR gene", "count": 1}, {"letter": "TLX2 gene", "count": 2}, {"letter": "HOXB4 gene", "count": 1}, {"letter": "HP gene", "count": 4}, {"letter": "ERAS gene", "count": 1}, {"letter": "HSPA4 gene", "count": 4}, {"letter": "HSPA5 gene", "count": 2}, {"letter": "HSPA8 gene", "count": 1}, {"letter": "HTN3 gene", "count": 7}, {"letter": "ICAM5 gene", "count": 1}, {"letter": "ICOS gene", "count": 1}, {"letter": "IDH2 gene", "count": 1}, {"letter": "IFIT3 gene", "count": 1}, {"letter": "IFNA1 gene", "count": 2}, {"letter": "IGKV5-2 gene", "count": 14}, {"letter": "IL1R1 gene", "count": 1}, {"letter": "IL1RN gene", "count": 1}, {"letter": "IL21 gene", "count": 3}, {"letter": "INPP4B gene", "count": 1}, {"letter": "FOXP3 gene", "count": 15}, {"letter": "IPP gene", "count": 2}, {"letter": "ITGB1 gene", "count": 1}, {"letter": "ITGBL1 gene", "count": 1}, {"letter": "IVD gene", "count": 2}, {"letter": "KCNE1 gene", "count": 1}, {"letter": "KEL gene", "count": 10}, {"letter": "KIN gene", "count": 1}, {"letter": "KIT gene", "count": 5}, {"letter": "KLK5 gene", "count": 2}, {"letter": "KLRC2 gene", "count": 1}, {"letter": "KLRG1 gene", "count": 1}, {"letter": "KRT1 gene", "count": 3}, {"letter": "KRT10 gene", "count": 2}, {"letter": "KRT18 gene", "count": 1}, {"letter": "LAG3 gene", "count": 6}, {"letter": "LAMP1 gene", "count": 1}, {"letter": "STMN1 gene", "count": 2}, {"letter": "LCAT gene", "count": 1}, {"letter": "LCN2 gene", "count": 1}, {"letter": "LEP gene", "count": 27}, {"letter": "LGALS9 gene", "count": 1}, {"letter": "LIMK2 gene", "count": 1}, {"letter": "LMOD1 gene", "count": 12}, {"letter": "LPL gene", "count": 2}, {"letter": "LRP4 gene", "count": 5}, {"letter": "LTF gene", "count": 14}, {"letter": "LUM gene", "count": 1}, {"letter": "NCR1 gene", "count": 1}, {"letter": "SMAD5 gene", "count": 1}, {"letter": "MAGEA5P gene", "count": 1}, {"letter": "MAP1LC3A gene", "count": 1}, {"letter": "MAP2 gene", "count": 1}, {"letter": "MAPKAPK3 gene", "count": 1}, {"letter": "MARS1 gene", "count": 2}, {"letter": "MBNL1 gene", "count": 4}, {"letter": "MDM4 gene", "count": 1}, {"letter": "MFAP1 gene", "count": 4}, {"letter": "MICB gene", "count": 1}, {"letter": "MLF2 gene", "count": 1}, {"letter": "MMP7 gene", "count": 1}, {"letter": "MMRN1 gene", "count": 1}, {"letter": "MPG gene", "count": 1}, {"letter": "MRC1 gene", "count": 1}, {"letter": "MSH5 gene", "count": 2}, {"letter": "MT1E gene", "count": 11}, {"letter": "NEFL gene", "count": 1}, {"letter": "NHS gene", "count": 6}, {"letter": "NODAL gene", "count": 69}, {"letter": "NOS2 gene", "count": 2}, {"letter": "NPDC1 gene", "count": 1}, {"letter": "NPPB gene", "count": 7}, {"letter": "NPTXR gene", "count": 4}, {"letter": "NR2E1 gene", "count": 1}, {"letter": "NT5E gene", "count": 7}, {"letter": "NUMB gene", "count": 1}, {"letter": "OAS2 gene", "count": 1}, {"letter": "OPRM1 gene", "count": 2}, {"letter": "ORM1 gene", "count": 1}, {"letter": "CLDN11 gene", "count": 2}, {"letter": "OXT gene", "count": 1}, {"letter": "OXTR gene", "count": 1}, {"letter": "PAFAH1B1 gene", "count": 1}, {"letter": "PALM gene", "count": 1}, {"letter": "PDCD1 gene", "count": 20}, {"letter": "PDCD4 gene", "count": 1}, {"letter": "PDXK gene", "count": 1}, {"letter": "TWNK gene", "count": 2}, {"letter": "PFDN4 gene", "count": 2}, {"letter": "PFDN5 gene", "count": 4}, {"letter": "PFKM gene", "count": 1}, {"letter": "PGD gene", "count": 2}, {"letter": "PIGF gene", "count": 2}, {"letter": "PISD gene", "count": 1}, {"letter": "PKD1 gene", "count": 4}, {"letter": "PLA2G2D gene", "count": 1}, {"letter": "PLIN1 gene", "count": 1}, {"letter": "PLN gene", "count": 1}, {"letter": "PNMA2 gene", "count": 10}, {"letter": "POLQ gene", "count": 1}, {"letter": "PPP1CB gene", "count": 5}, {"letter": "PPP1R1A gene", "count": 1}, {"letter": "PPP1R3C gene", "count": 1}, {"letter": "PPT1 gene", "count": 2}, {"letter": "PQBP1 gene", "count": 2}, {"letter": "PRB1 gene", "count": 2}, {"letter": "PRDX2 gene", "count": 5}, {"letter": "PRF1 gene", "count": 3}, {"letter": "PRH1 gene", "count": 8}, {"letter": "PROCR gene", "count": 1}, {"letter": "PROS1 gene", "count": 10}, {"letter": "CYTIP gene", "count": 3}, {"letter": "PTPRU gene", "count": 2}, {"letter": "PTS gene", "count": 8}, {"letter": "PVR gene", "count": 1}, {"letter": "NECTIN1 gene", "count": 1}, {"letter": "PYY gene", "count": 1}, {"letter": "RAB1A gene", "count": 1}, {"letter": "RAB3D gene", "count": 1}, {"letter": "RAD51 gene", "count": 4}, {"letter": "RASGRF2 gene", "count": 1}, {"letter": "RFC2 gene", "count": 1}, {"letter": "RLN2 gene", "count": 11}, {"letter": "SNORA62 gene", "count": 1}, {"letter": "RNY1 gene", "count": 1}, {"letter": "RPA2 gene", "count": 1}, {"letter": "RPL39 gene", "count": 1}, {"letter": "RPL4 gene", "count": 25}, {"letter": "RPL7 gene", "count": 1}, {"letter": "RPLP0 gene", "count": 1}, {"letter": "RPS6 gene", "count": 2}, {"letter": "RPS6KA3 gene", "count": 3}, {"letter": "RPS6KB1 gene", "count": 3}, {"letter": "RPS9 gene", "count": 1}, {"letter": "RYR1 gene", "count": 3}, {"letter": "SAA1 gene", "count": 3}, {"letter": "SCN5A gene", "count": 1}, {"letter": "SDC1 gene", "count": 1}, {"letter": "SDHA gene", "count": 6}, {"letter": "SELENBP1 gene", "count": 1}, {"letter": "SEMA4C gene", "count": 2}, {"letter": "SFTPA1 gene", "count": 3}, {"letter": "SH2D1A gene", "count": 1}, {"letter": "PMEL gene", "count": 1}, {"letter": "SIM2 gene", "count": 2}, {"letter": "SLC16A1 gene", "count": 2}, {"letter": "SLC17A5 gene", "count": 31}, {"letter": "SLCO1B1 gene", "count": 2}, {"letter": "SLC4A1 gene", "count": 3}, {"letter": "SLC6A4 gene", "count": 2}, {"letter": "SLC6A6 gene", "count": 1}, {"letter": "SLN gene", "count": 31}, {"letter": "SNAI2 gene", "count": 2}, {"letter": "SMN1 gene", "count": 4}, {"letter": "SNAI1 gene", "count": 2}, {"letter": "SIK1 gene", "count": 1}, {"letter": "SOD1 gene", "count": 1}, {"letter": "SOX2 gene", "count": 3}, {"letter": "SPARC gene", "count": 4}, {"letter": "SQSTM1 gene", "count": 2}, {"letter": "SRY gene", "count": 3}, {"letter": "AURKA gene", "count": 2}, {"letter": "STX8 gene", "count": 1}, {"letter": "SUCLA2 gene", "count": 3}, {"letter": "TAPBP gene", "count": 1}, {"letter": "TBCE gene", "count": 10}, {"letter": "TBX21 gene", "count": 1}, {"letter": "TCF21 gene", "count": 2}, {"letter": "TCF4 gene", "count": 1}, {"letter": "TCN1 gene", "count": 1}, {"letter": "TDGF1 gene", "count": 2}, {"letter": "TECTA gene", "count": 1}, {"letter": "TH gene", "count": 3}, {"letter": "TCHH gene", "count": 2}, {"letter": "TK1 gene", "count": 2}, {"letter": "TLN1 gene", "count": 1}, {"letter": "TM6SF1 gene", "count": 1}, {"letter": "TMEFF2 gene", "count": 1}, {"letter": "TNFRSF9 gene", "count": 4}, {"letter": "TNNI3 gene", "count": 1}, {"letter": "TNNT1 gene", "count": 2}, {"letter": "TP53BP1 gene", "count": 1}, {"letter": "TPI1 gene", "count": 9}, {"letter": "TRA-TGC7-1 gene", "count": 1}, {"letter": "TRE-TTC3-1 gene", "count": 1}, {"letter": "TREH gene", "count": 5}, {"letter": "TRGV9 gene", "count": 1}, {"letter": "TRPC6 gene", "count": 1}, {"letter": "TST gene", "count": 5}, {"letter": "TTR gene", "count": 3}, {"letter": "TUBB gene", "count": 1}, {"letter": "TWIST1 gene", "count": 1}, {"letter": "UCHL1 gene", "count": 1}, {"letter": "UGT2B17 gene", "count": 2}, {"letter": "UGT2B7 gene", "count": 1}, {"letter": "UPP1 gene", "count": 4}, {"letter": "VCAM1 gene", "count": 1}, {"letter": "VEGFB gene", "count": 1}, {"letter": "WASF1 gene", "count": 1}, {"letter": "XIST gene", "count": 1}, {"letter": "XK gene", "count": 26}, {"letter": "YWHAZ gene", "count": 1}, {"letter": "ZNF35 gene", "count": 2}, {"letter": "AICDA gene", "count": 1}, {"letter": "HDAC8 gene", "count": 1}, {"letter": "MAP1LC3B gene", "count": 2}, {"letter": "LAPTM4B gene", "count": 1}, {"letter": "GTSE1 gene", "count": 2}, {"letter": "SOST gene", "count": 1}, {"letter": "LZTS1 gene", "count": 1}, {"letter": "ITCH gene", "count": 1}, {"letter": "GPANK1 gene", "count": 1}, {"letter": "NPRL3 gene", "count": 1}, {"letter": "CIC gene", "count": 1}, {"letter": "C1QTNF6 gene", "count": 1}, {"letter": "GP6 gene", "count": 1}, {"letter": "MEG8 gene", "count": 1}, {"letter": "CDCA8 gene", "count": 26}, {"letter": "F11R gene", "count": 1}, {"letter": "TAS2R13 gene", "count": 1}, {"letter": "SIRT1 gene", "count": 1}, {"letter": "PIGT gene", "count": 1}, {"letter": "MUC15 gene", "count": 1}, {"letter": "MBTPS1 gene", "count": 1}, {"letter": "NCKIPSD gene", "count": 1}, {"letter": "MUC16 gene", "count": 15}, {"letter": "ARHGEF7 gene", "count": 1}, {"letter": "MTPN gene", "count": 44}, {"letter": "LDB3 gene", "count": 3}, {"letter": "ERMAP gene", "count": 53}, {"letter": "SDCBP2 gene", "count": 1}, {"letter": "CTNNBL1 gene", "count": 4}, {"letter": "NELFCD gene", "count": 6}, {"letter": "UBE2C gene", "count": 1}, {"letter": "NLN gene", "count": 1}, {"letter": "YAP1 gene", "count": 2}, {"letter": "PPP1R2C gene", "count": 4}, {"letter": "IL17F gene", "count": 1}, {"letter": "EFS gene", "count": 17}, {"letter": "NDC80 gene", "count": 1}, {"letter": "MLC1 gene", "count": 2}, {"letter": "SYNE1 gene", "count": 1}, {"letter": "CENPJ gene", "count": 2}, {"letter": "RNF34 gene", "count": 6}, {"letter": "RXFP2 gene", "count": 1}, {"letter": "ALLC gene", "count": 3}, {"letter": "IL17RD gene", "count": 13}, {"letter": "PITRM1 gene", "count": 1}, {"letter": "C8orf17 gene", "count": 1}, {"letter": "UCN3 gene", "count": 1}, {"letter": "LIN7A gene", "count": 11}, {"letter": "LIN7B gene", "count": 4}, {"letter": "CHPT1 gene", "count": 2}, {"letter": "SLC22A12 gene", "count": 2}, {"letter": "PRNT gene", "count": 18}, {"letter": "A4GALT gene", "count": 1}, {"letter": "IFNL1 gene", "count": 1}, {"letter": "IFNL2 gene", "count": 2}, {"letter": "IFNL3 gene", "count": 1}, {"letter": "HAVCR2 gene", "count": 6}, {"letter": "ZHX2 gene", "count": 1}, {"letter": "FEV gene", "count": 6}, {"letter": "PALS1 gene", "count": 1}, {"letter": "TAMALIN gene", "count": 1}, {"letter": "PDCD1LG2 gene", "count": 1}, {"letter": "IL31RA gene", "count": 4}, {"letter": "ALYREF gene", "count": 3}, {"letter": "SNHG32 gene", "count": 6}, {"letter": "PLAC8 gene", "count": 3}, {"letter": "IL31 gene", "count": 1}, {"letter": "SOCS1 gene", "count": 3}, {"letter": "ZMYND10 gene", "count": 2}, {"letter": "NECTIN4 gene", "count": 8}, {"letter": "TOMM20 gene", "count": 1}, {"letter": "RNF128 gene", "count": 3}, {"letter": "SOSTDC1 gene", "count": 9}, {"letter": "SLC13A5 gene", "count": 6}, {"letter": "EAF2 gene", "count": 3}, {"letter": "TBATA gene", "count": 14}, {"letter": "TIPARP gene", "count": 5}, {"letter": "DYNC2I2 gene", "count": 1}, {"letter": "CBARP gene", "count": 2}, {"letter": "SCPEP1 gene", "count": 9}, {"letter": "GLS2 gene", "count": 5}, {"letter": "MLPH gene", "count": 10}, {"letter": "SHC2 gene", "count": 1}, {"letter": "NAMPT gene", "count": 4}, {"letter": "RASL12 gene", "count": 1}, {"letter": "FGR protein, human", "count": 4}, {"letter": "TPO protein, human", "count": 1}, {"letter": "CCL4 protein, human", "count": 2}, {"letter": "VCAN protein, human", "count": 4}, {"letter": "MSLN protein, human", "count": 1}, {"letter": "FOXM1 protein, human", "count": 1}, {"letter": "PTEN protein, human", "count": 21}, {"letter": "GDF15 protein, human", "count": 3}, {"letter": "FOXC1 protein, human", "count": 1}, {"letter": "PGRMC1 protein, human", "count": 4}, {"letter": "FGF23 protein, human", "count": 2}, {"letter": "CD226 protein, human", "count": 1}, {"letter": "UL83 protein, Human herpesvirus 5", "count": 1}, {"letter": "MAP2K1 protein, human", "count": 1}, {"letter": "TOMM20 protein, human", "count": 2}, {"letter": "Rintatolimod", "count": 2}, {"letter": "TS 108", "count": 3}, {"letter": "AKR1B1 protein, human", "count": 1}, {"letter": "DMD protein, human", "count": 6}, {"letter": "SLC6A8 protein, human", "count": 1}, {"letter": "NDC80 protein, human", "count": 1}, {"letter": "ADIPOQ protein, human", "count": 19}, {"letter": "SENP1 protein, human", "count": 1}, {"letter": "LPA gene", "count": 1}, {"letter": "unadjusted", "count": 7}, {"letter": "12 hours post dose", "count": 1}, {"letter": "24 hours post dose", "count": 9}, {"letter": "6 hours post dose", "count": 1}, {"letter": "72 hours post dose", "count": 1}, {"letter": "Incubated", "count": 4}, {"letter": "Pre excercise", "count": 7}, {"letter": "A,B", "count": 5}, {"letter": "AE 1 (Immunologic Factor)", "count": 2}, {"letter": "AE 3 (Immunologic Factor)", "count": 4}, {"letter": "Alveolar", "count": 1}, {"letter": "Cells.CD69", "count": 1}, {"letter": "Estrogen+Progesterone receptor", "count": 1}, {"letter": "Hydrogen+Methane", "count": 2}, {"letter": "Lithium.plasma", "count": 1}, {"letter": "Radioactive Iodine", "count": 1}, {"letter": "Viable cells", "count": 7}, {"letter": "100 cells", "count": 7}, {"letter": "Cells.total", "count": 2}, {"letter": "Scan.total", "count": 1}, {"letter": "Serum.total", "count": 5}, {"letter": "2D ECHO", "count": 1}, {"letter": "Auto", "count": 9}, {"letter": "Automated count", "count": 1}, {"letter": "Calculation", "count": 1103}, {"letter": "Computed (procedure)", "count": 123}, {"letter": "Derivation", "count": 163}, {"letter": "Elution", "count": 1}, {"letter": "High Sensitivity Method", "count": 6}, {"letter": "Manual count", "count": 1}, {"letter": "Observed", "count": 542}, {"letter": "Ultrasound 2D", "count": 3}, {"letter": "Ultrasound+Estimated", "count": 1}, {"letter": "US+Measured", "count": 1}, {"letter": "Address", "count": 51}, {"letter": "Fluid Resistance", "count": 1}, {"letter": "Instructions", "count": 18}, {"letter": "Relative Volume", "count": 15}, {"letter": "Resistance", "count": 35}, {"letter": "Time Difference", "count": 70}, {"letter": "Cutoff", "count": 169}, {"letter": "Gene Deletion Abnormality", "count": 1}, {"letter": "GIVEN", "count": 150}, {"letter": "Chest and abdomen", "count": 2}, {"letter": "Buffy Coat", "count": 1}, {"letter": "Bld.dot", "count": 3}, {"letter": "Blood^Control", "count": 1}, {"letter": "XXX bone", "count": 48}, {"letter": "Bronchial system", "count": 1}, {"letter": "Serum and Prostate", "count": 1}, {"letter": "10 Hours", "count": 5}, {"letter": "10 Minutes", "count": 20}, {"letter": "15 Minutes", "count": 5}, {"letter": "18 Hours", "count": 1}, {"letter": "1 Day", "count": 2}, {"letter": "1 Hour", "count": 16}, {"letter": "1 Month", "count": 44}, {"letter": "1 Week", "count": 34}, {"letter": "2 Days", "count": 30}, {"letter": "2 Months", "count": 1}, {"letter": "2 Weeks", "count": 33}, {"letter": "30 Minutes", "count": 18}, {"letter": "3 Days", "count": 47}, {"letter": "3 Hours", "count": 1}, {"letter": "3 Months", "count": 110}, {"letter": "3 Weeks", "count": 16}, {"letter": "45 Minutes", "count": 6}, {"letter": "48 Hours", "count": 4}, {"letter": "4 Weeks", "count": 48}, {"letter": "5 Days", "count": 83}, {"letter": "7 Hours", "count": 4}, {"letter": "Duration of Encounter", "count": 7}, {"letter": "Baseline", "count": 3165}, {"letter": "Set scale", "count": 157}, {"letter": "SFTPB gene", "count": 2}, {"letter": "4 Days", "count": 11}, {"letter": "24 Hours", "count": 77}, {"letter": "State", "count": 85}, {"letter": "Point in time", "count": 3}, {"letter": "Nutrition function", "count": 4}, {"letter": "Plasma C-reactive protein", "count": 1}, {"letter": "Standard (qualifier)", "count": 52}, {"letter": "Alertness", "count": 4}, {"letter": "BPI gene", "count": 28}, {"letter": "Cat hair antigen", "count": 1}, {"letter": "Cardiac end-systolic volume", "count": 1}, {"letter": "Reason for Treatment", "count": 11}, {"letter": "Severe diarrhea", "count": 4}, {"letter": "Laboratory biosafety level", "count": 1}, {"letter": "Physical therapy assessment", "count": 1}, {"letter": "Physical examination assessment", "count": 3}, {"letter": "Personal care management", "count": 1}, {"letter": "Slit lamp fundus examination", "count": 1}, {"letter": "In the past", "count": 35}, {"letter": "Known absent", "count": 1}, {"letter": "At risk", "count": 18}, {"letter": "Wanted", "count": 2}, {"letter": "Offered", "count": 18}, {"letter": "Indicated", "count": 220}, {"letter": "Contraindicated", "count": 1}, {"letter": "Discontinued", "count": 271}, {"letter": "Physical examination status", "count": 1}, {"letter": "Confrontation visual field test", "count": 1}, {"letter": "Specified time", "count": 31}, {"letter": "Subject of record", "count": 1}, {"letter": "Donor site", "count": 5}, {"letter": "Triggered by", "count": 9}, {"letter": "Exacerbated", "count": 3}, {"letter": "Length", "count": 61}, {"letter": "Drug therapy status", "count": 1}, {"letter": "Shooting sensation quality", "count": 1}, {"letter": "Sharp sensation quality", "count": 3}, {"letter": "Instability", "count": 2}, {"letter": "BRCA1 gene mutation negative", "count": 1}, {"letter": "Serum total cholesterol measurement", "count": 2}, {"letter": "Menopausal profile", "count": 1}, {"letter": "Immature reticulocyte fraction", "count": 6}, {"letter": "Tumor destruction", "count": 4}, {"letter": "Decreased vascular pattern", "count": 1}, {"letter": "Oozing (Hemorrhage)", "count": 1}, {"letter": "Mental health problem", "count": 2}, {"letter": "Physical health problem", "count": 6}, {"letter": "Positive", "count": 34}, {"letter": "Electrophysiology studies", "count": 1}, {"letter": "Concentration measurement", "count": 506}, {"letter": "Convergent gaze", "count": 1}, {"letter": "skin fold (procedure)", "count": 3}, {"letter": "Scheduling (procedure)", "count": 37}, {"letter": "HGF protein, human", "count": 2}, {"letter": "MCC protein, human", "count": 8}, {"letter": "STK3 protein, human", "count": 1}, {"letter": "SH2D1B protein, human", "count": 1}, {"letter": "TNFRSF1B protein, human", "count": 1}, {"letter": "INSR protein, human", "count": 13}, {"letter": "TNF protein, human", "count": 53}, {"letter": "TRIO protein, human", "count": 1}, {"letter": "CCL2 protein, human", "count": 5}, {"letter": "CSF2RB protein, human", "count": 1}, {"letter": "Cardiomyopathy, Familial Idiopathic", "count": 10}, {"letter": "Microarray Analysis", "count": 27}, {"letter": "Procyanidins", "count": 1}, {"letter": "Tumor Burden", "count": 40}, {"letter": "Nuchal Translucency Screen", "count": 6}, {"letter": "plant bulb", "count": 1}, {"letter": "Artificial nanoparticles", "count": 1}, {"letter": "Luminescent Measurements", "count": 1}, {"letter": "Nomograms", "count": 2}, {"letter": "IL25 protein, human", "count": 3}, {"letter": "Systems Biology", "count": 2}, {"letter": "GUCY2C protein, human", "count": 5}, {"letter": "PIK3CA protein, human", "count": 2}, {"letter": "TAS-102", "count": 11}, {"letter": "MAP2 protein, human", "count": 1}, {"letter": "MAPKAPK2 protein, human", "count": 2}, {"letter": "East Timor", "count": 23}, {"letter": "PXD101", "count": 4}, {"letter": "SDHD protein, human", "count": 1}, {"letter": "GRN protein, human", "count": 2}, {"letter": "CLU protein, human", "count": 1}, {"letter": "LIPC protein, human", "count": 3}, {"letter": "PIN1 protein, human", "count": 1}, {"letter": "RRM2 protein, human", "count": 1}, {"letter": "MYC protein, human", "count": 1}, {"letter": "MAPT protein, human", "count": 49}, {"letter": "degarelix", "count": 2}, {"letter": "dasatinib", "count": 27}, {"letter": "DCT protein, human", "count": 3}, {"letter": "NEFL protein, human", "count": 3}, {"letter": "Sensation quality", "count": 2}, {"letter": "Recipient site", "count": 1}, {"letter": "Psychosocial assessment (procedure)", "count": 3}, {"letter": "Episodic", "count": 4}, {"letter": "Dull sensation quality", "count": 3}, {"letter": "Sore sensation", "count": 1}, {"letter": "Stabbing sensation", "count": 1}, {"letter": "lymphocyte-activation gene 3 protein, human", "count": 4}, {"letter": "Confirm", "count": 4}, {"letter": "COMP gene", "count": 1}, {"letter": "SLC6A2 protein, human", "count": 10}, {"letter": "Attended (qualifier value)", "count": 9}, {"letter": "Preventive intent", "count": 1}, {"letter": "Global Health", "count": 140}, {"letter": "Health System", "count": 6}, {"letter": "Cancer--Living with Cancer", "count": 1}, {"letter": "Childhood Vaccines", "count": 1}, {"letter": "Prenatal Testing", "count": 1}, {"letter": "Fitness", "count": 57}, {"letter": "APCS gene", "count": 1}, {"letter": "Ultrasonics (sound)", "count": 9}, {"letter": "Tumor Necrosis Factor-alpha", "count": 62}, {"letter": "MET protein, human", "count": 2}, {"letter": "Complementary and Alternative Therapies", "count": 1}, {"letter": "Worse", "count": 435}, {"letter": "Defect", "count": 4}, {"letter": "Symptoms", "count": 478}, {"letter": "growth-differentiation factor 8", "count": 1}, {"letter": "Each (qualifier value)", "count": 191}, {"letter": "Treatment/Psychosocial Effects", "count": 2}, {"letter": "TOP1 protein, human", "count": 1}, {"letter": "Mammary Neoplasms", "count": 173}, {"letter": "Recurrent Malignant Neoplasm", "count": 110}, {"letter": "Skiffia francesae", "count": 1}, {"letter": "Genus Cis", "count": 27}, {"letter": "Bias genus", "count": 5}, {"letter": "Stem cell transplant", "count": 1}, {"letter": "Herbal Supplements", "count": 1}, {"letter": "Pain scale", "count": 65}, {"letter": "SLC2A1 protein, human", "count": 1}, {"letter": "TXN protein, human", "count": 1}, {"letter": "Nes (fish)", "count": 1}, {"letter": "Genus Valgus", "count": 1}, {"letter": "IL1RN protein, human", "count": 5}, {"letter": "PGF protein, human", "count": 4}, {"letter": "lapatinib ditosylate", "count": 11}, {"letter": "RRAD protein, human", "count": 1}, {"letter": "TP53BP1 protein, human", "count": 2}, {"letter": "SPP1 protein, human", "count": 1}, {"letter": "LBP protein, human", "count": 1}, {"letter": "herstatin protein, human", "count": 14}, {"letter": "ZFP36 protein, human", "count": 15}, {"letter": "MAX protein, human", "count": 46}, {"letter": "reparixin", "count": 4}, {"letter": "lapatinib", "count": 91}, {"letter": "CTNNA1 protein, human", "count": 2}, {"letter": "Pain duration", "count": 3}, {"letter": "Pain radiation", "count": 2}, {"letter": "Pain severity", "count": 153}, {"letter": "Clinical trial protocol document", "count": 11}, {"letter": "Assessment section", "count": 1}, {"letter": "View Rosenberg", "count": 1}, {"letter": "Urinary system", "count": 1}, {"letter": "post meridiem", "count": 1}, {"letter": "Physical assessment findings", "count": 254}, {"letter": "Sample pool", "count": 1}, {"letter": "pear preparation", "count": 4}, {"letter": "acetylcarnitine hydrochloride", "count": 1}, {"letter": "Sense of smell altered", "count": 1}, {"letter": "metaplastic cell transformation", "count": 167}, {"letter": "Cavitation", "count": 8}, {"letter": "Radiation Sickness", "count": 48}, {"letter": "Assay", "count": 56}, {"letter": "Widow", "count": 2}, {"letter": "trauma qualifier", "count": 2}, {"letter": "Drug Dependence", "count": 6}, {"letter": "Fine needle aspiration biopsy", "count": 27}, {"letter": "Dual-Energy X-Ray Absorptiometry", "count": 78}, {"letter": "Response Inhibition", "count": 1}, {"letter": "Content Validity", "count": 1}, {"letter": "Models, Mental", "count": 1}, {"letter": "Hospital environment", "count": 52}, {"letter": "Academia (organization)", "count": 3}, {"letter": "Accrual", "count": 28}, {"letter": "Addendum", "count": 14}, {"letter": "Adenovirus Vector", "count": 1}, {"letter": "Adherence (attribute)", "count": 189}, {"letter": "Adjuvant Analgesic", "count": 2}, {"letter": "Adjuvant Study", "count": 4}, {"letter": "Administered Component Designation", "count": 2}, {"letter": "Adverse Event Attribution to Product or Procedure", "count": 1}, {"letter": "Advocate (person)", "count": 1}, {"letter": "Aerobic", "count": 20}, {"letter": "Affiliated", "count": 1}, {"letter": "Affinity", "count": 2}, {"letter": "Age-Years", "count": 11}, {"letter": "Aliquot", "count": 3}, {"letter": "Array", "count": 20}, {"letter": "Average", "count": 399}, {"letter": "BRCA1 gene mutation", "count": 7}, {"letter": "BRCA2 gene mutation", "count": 1}, {"letter": "Basaloid cell", "count": 2}, {"letter": "Base of the Brain", "count": 10}, {"letter": "Belief System", "count": 1}, {"letter": "Bimanual", "count": 1}, {"letter": "Biological Testing", "count": 1}, {"letter": "Blood-Brain Barrier Disruption Chemotherapy", "count": 1}, {"letter": "Blood Flow Cytometry", "count": 4}, {"letter": "Blur", "count": 2}, {"letter": "bolus infusion", "count": 5}, {"letter": "Bottom", "count": 5}, {"letter": "Bouvet Island", "count": 1}, {"letter": "Breast Cancer Detection Research", "count": 7}, {"letter": "Breast Cancer Education", "count": 1}, {"letter": "Breast Cancer Prevention Trial", "count": 13}, {"letter": "Breast Cancer Prognostic Factor", "count": 1}, {"letter": "Breast Cancer Risk Assessment Tool", "count": 3}, {"letter": "Breast Cancer Risk Factor", "count": 1}, {"letter": "Breast Cancer Surveillance Consortium", "count": 1}, {"letter": "Breast Cancer Therapeutic Procedure", "count": 102}, {"letter": "Breast Imaging Reporting and Data System", "count": 52}, {"letter": "Brief Pain Inventory", "count": 70}, {"letter": "Consent", "count": 3}, {"letter": "Constitutional", "count": 3}, {"letter": "Continuous Intravenous Infusion", "count": 1}, {"letter": "Cooking Practices", "count": 1}, {"letter": "Copy Number Polymorphism", "count": 17}, {"letter": "Correlative Study", "count": 6}, {"letter": "Cost-Effectiveness Analysis", "count": 9}, {"letter": "Country Code", "count": 22}, {"letter": "Critical", "count": 14}, {"letter": "Cumulative", "count": 65}, {"letter": "Curative Surgery", "count": 5}, {"letter": "event cycle", "count": 976}, {"letter": "Cyclin-Dependent Kinase Inhibitor Agents", "count": 1}, {"letter": "Cystic lesions", "count": 1}, {"letter": "Cytokine Signaling Process", "count": 2}, {"letter": "cytotoxic", "count": 14}, {"letter": "DNA Breaks, Double-Stranded", "count": 5}, {"letter": "DNA Sequence Rearrangement", "count": 10}, {"letter": "Data", "count": 739}, {"letter": "Date Available", "count": 1}, {"letter": "Declining", "count": 3}, {"letter": "Detection", "count": 305}, {"letter": "Developmental process", "count": 1}, {"letter": "Diagnostic Factor", "count": 1}, {"letter": "Diagnostic Imaging Network", "count": 1}, {"letter": "Diagnostic Radiology Specialty", "count": 95}, {"letter": "Diagnostic Sensitivity", "count": 31}, {"letter": "Diagnostic Specificity", "count": 13}, {"letter": "Diagnostics, Cancer", "count": 1}, {"letter": "Dietary Questionnaire", "count": 4}, {"letter": "Differentiating Neuroblastoma", "count": 1}, {"letter": "Histopathologic Grade differentiation", "count": 16}, {"letter": "Digital Photography", "count": 9}, {"letter": "Direct Costs", "count": 5}, {"letter": "Disease Association", "count": 1}, {"letter": "Disease Grade Qualifier", "count": 1}, {"letter": "Disease Marker", "count": 2}, {"letter": "Disease Stage Qualifier", "count": 4}, {"letter": "Dose-Limiting", "count": 11}, {"letter": "Dose Rate", "count": 14}, {"letter": "Dose-dependent", "count": 3}, {"letter": "Double Minutes", "count": 2}, {"letter": "Dryness (characteristic)", "count": 21}, {"letter": "Ductal", "count": 11}, {"letter": "Ductal Epithelial Cell", "count": 1}, {"letter": "Dynamic Enhanced CT", "count": 5}, {"letter": "HER2 gene amplification", "count": 3}, {"letter": "ERBB2 Signaling Pathway", "count": 3}, {"letter": "Eastern Cooperative Oncology Group", "count": 52}, {"letter": "Effectiveness of Interventions", "count": 2}, {"letter": "Global Change", "count": 15}, {"letter": "Glycolysis Pathway", "count": 1}, {"letter": "Gynecologic Oncology Group", "count": 8}, {"letter": "Harvest Procedure", "count": 10}, {"letter": "Patient Visit", "count": 89}, {"letter": "Health Communication", "count": 6}, {"letter": "Health Information National Trends Survey", "count": 6}, {"letter": "Health Sciences", "count": 1}, {"letter": "HER2/Neu Status", "count": 2}, {"letter": "HercepTest", "count": 1}, {"letter": "Herceptin/Paclitaxel", "count": 4}, {"letter": "High Resolution Computed Tomography", "count": 10}, {"letter": "Homodimerization", "count": 1}, {"letter": "Breast Cancer Cell", "count": 7}, {"letter": "Human Papilloma Virus Vaccine", "count": 3}, {"letter": "hydrochloride", "count": 5}, {"letter": "Hypermethylation", "count": 1}, {"letter": "Hypothesis", "count": 43}, {"letter": "ITIM", "count": 1}, {"letter": "Ideal", "count": 10}, {"letter": "Medicinal product acting as imaging agent (product)", "count": 1}, {"letter": "Imaging Device", "count": 5}, {"letter": "Inclusion", "count": 98}, {"letter": "Yes or No Response", "count": 71}, {"letter": "Ineligibility", "count": 6}, {"letter": "Inferential Current Treatment", "count": 2}, {"letter": "Insulin Signaling Pathway", "count": 7}, {"letter": "Intake", "count": 39}, {"letter": "Integrated Pain Scale", "count": 1}, {"letter": "Radiotherapy, Intensity-Modulated", "count": 21}, {"letter": "Intermediate Grade", "count": 2}, {"letter": "Interruption", "count": 72}, {"letter": "intraepithelial", "count": 1}, {"letter": "Intraepithelial Lymphocytes", "count": 1}, {"letter": "intrahepatic", "count": 1}, {"letter": "intralesional", "count": 5}, {"letter": "Marker Discovery", "count": 2}, {"letter": "Measurable", "count": 143}, {"letter": "Measurable Disease", "count": 119}, {"letter": "Medical-Surgical Nursing", "count": 1}, {"letter": "Memorial Sloan-Kettering Cancer Center", "count": 3}, {"letter": "Mesenchymal", "count": 5}, {"letter": "Metabolic Control", "count": 1}, {"letter": "Metabolic Marker", "count": 12}, {"letter": "Metastatic Lesion", "count": 13}, {"letter": "Metastatic/Recurrent", "count": 3}, {"letter": "Micellar Paclitaxel", "count": 12}, {"letter": "Neoplasm Micrometastasis", "count": 4}, {"letter": "Mild Adverse Event", "count": 2}, {"letter": "Moderate Adverse Event", "count": 6}, {"letter": "Moderate Exercise", "count": 3}, {"letter": "Molecular Analysis", "count": 6}, {"letter": "Molecular Genetic Technique", "count": 1}, {"letter": "Molecular Diagnosis", "count": 1}, {"letter": "Molecular Fingerprinting of Tumor", "count": 6}, {"letter": "Molecular Marker Activity", "count": 6}, {"letter": "Molecular Profiling", "count": 27}, {"letter": "Molecular Target", "count": 1}, {"letter": "Mononuclear", "count": 5}, {"letter": "Most Recent", "count": 4}, {"letter": "motor movement", "count": 22}, {"letter": "Multimodal Imaging", "count": 5}, {"letter": "Mutation Detection", "count": 2}, {"letter": "NCI-Designated Cancer Center", "count": 4}, {"letter": "NCI Center for Cancer Research", "count": 1}, {"letter": "Consortium or Network", "count": 9}, {"letter": "NIH Mouse", "count": 4}, {"letter": "NOD.CB17-Prkdc-scid/J Mouse", "count": 1}, {"letter": "National Cancer Institute", "count": 291}, {"letter": "National Cancer Institute of Canada", "count": 5}, {"letter": "National Comprehensive Cancer Network", "count": 15}, {"letter": "National Health Interview Survey", "count": 1}, {"letter": "National Surgical Adjuvant Breast and Bowel Project", "count": 17}, {"letter": "Positive Regulation of Necrotic Process", "count": 1}, {"letter": "Negative Finding", "count": 31}, {"letter": "Negative Predictive Value of Diagnostic Test", "count": 70}, {"letter": "Neoadjuvant Study", "count": 5}, {"letter": "Population-Based Registry", "count": 1}, {"letter": "Population Analysis", "count": 16}, {"letter": "Population Attributable Risk", "count": 8}, {"letter": "Positive Finding", "count": 530}, {"letter": "Positive Predictive Value", "count": 58}, {"letter": "Postal", "count": 1}, {"letter": "Pre-Clinical Model", "count": 1}, {"letter": "Predictive Value", "count": 28}, {"letter": "Premalignant", "count": 3}, {"letter": "Preoperative Endocrine Therapy", "count": 4}, {"letter": "Preservation Technique", "count": 7}, {"letter": "Primary peritoneal carcinoma", "count": 3}, {"letter": "Prior Chemotherapy", "count": 7}, {"letter": "Prior Hormone Therapy", "count": 2}, {"letter": "Prior Therapy", "count": 63}, {"letter": "product", "count": 41}, {"letter": "Progenitor Cell Engraftment", "count": 1}, {"letter": "Progesterone Receptor Status", "count": 8}, {"letter": "Prognostic Factors", "count": 17}, {"letter": "Prognostic Marker", "count": 5}, {"letter": "Proliferation", "count": 2}, {"letter": "Proliferation Marker", "count": 14}, {"letter": "Proliferative Index", "count": 9}, {"letter": "Protein Analysis", "count": 1}, {"letter": "Protein Overexpression", "count": 24}, {"letter": "Protocol Forms Template", "count": 2}, {"letter": "Proton Radiation", "count": 3}, {"letter": "Province", "count": 1}, {"letter": "Proximity", "count": 2}, {"letter": "Psychological Impact", "count": 5}, {"letter": "Qualifying", "count": 13}, {"letter": "Quantitative Reverse Transcriptase PCR", "count": 9}, {"letter": "Radiation Oncologists", "count": 24}, {"letter": "Radiation Therapy Oncology Group", "count": 65}, {"letter": "High-LET Radiotherapy", "count": 3}, {"letter": "Reader of medical images", "count": 49}, {"letter": "Receive", "count": 829}, {"letter": "Receptor Activation Process", "count": 1}, {"letter": "Negative Regulation of Receptor Activation", "count": 1}, {"letter": "Recombinants", "count": 7}, {"letter": "Bibliographic Reference", "count": 139}, {"letter": "Refractory Disease", "count": 1}, {"letter": "Regional Disease", "count": 140}, {"letter": "Registration", "count": 28}, {"letter": "Representation Component", "count": 12}, {"letter": "Reproducibility", "count": 32}, {"letter": "Requirement", "count": 210}, {"letter": "Research Infrastructure", "count": 4}, {"letter": "Resectable", "count": 5}, {"letter": "Resistance Process", "count": 21}, {"letter": "physiologic resolution", "count": 2}, {"letter": "Resource Sharing", "count": 1}, {"letter": "Restart", "count": 3}, {"letter": "Retrieval - action", "count": 28}, {"letter": "Retrospective", "count": 14}, {"letter": "Stage at Diagnosis", "count": 7}, {"letter": "Strategic Planning", "count": 1}, {"letter": "Stratification", "count": 16}, {"letter": "Stratification Factors", "count": 12}, {"letter": "Strenuous Exercise", "count": 7}, {"letter": "Study Section", "count": 5}, {"letter": "Subgroup", "count": 160}, {"letter": "Submission", "count": 2}, {"letter": "Submitted", "count": 6}, {"letter": "Sum", "count": 878}, {"letter": "Surgical Management", "count": 5}, {"letter": "Surgical Oncology specialty", "count": 2}, {"letter": "Surgically-Created Resection Cavity", "count": 1}, {"letter": "Surveillance Methods", "count": 1}, {"letter": "Surveillance Modeling", "count": 3}, {"letter": "Systemic Therapy", "count": 62}, {"letter": "TE03", "count": 1}, {"letter": "TE06", "count": 3}, {"letter": "TNM Staging System", "count": 20}, {"letter": "Gamma/Delta T-Lymphocyte", "count": 1}, {"letter": "Take", "count": 678}, {"letter": "Biological Taxon", "count": 6}, {"letter": "Microbial Taxonomy", "count": 2}, {"letter": "TdT-Mediated dUTP Nick End Labeling Assay", "count": 3}, {"letter": "Telephone Number", "count": 26}, {"letter": "Term (temporal)", "count": 160}, {"letter": "Therapeutic Clinical Trial", "count": 2}, {"letter": "Therapeutic Exploratory Study", "count": 4}, {"letter": "Recombinant Transforming Growth Factor-Beta 1", "count": 5}, {"letter": "Therapeutic Tumor Infiltrating Lymphocytes", "count": 41}, {"letter": "Therapy Evaluation", "count": 21}, {"letter": "8q22", "count": 1}, {"letter": "de novo", "count": 6}, {"letter": "In Vitro Assay", "count": 1}, {"letter": "In Vitro Model", "count": 1}, {"letter": "In Vivo", "count": 22}, {"letter": "In Vivo Model", "count": 2}, {"letter": "mRNA Expression", "count": 14}, {"letter": "mTOR Signaling Pathway BioCarta", "count": 2}, {"letter": "activate biological process", "count": 1}, {"letter": "Activated Lymphocyte", "count": 4}, {"letter": "Acupuncture and Oriental Medicine", "count": 3}, {"letter": "Allogeneic", "count": 1}, {"letter": "Alteration", "count": 67}, {"letter": "American College of Radiology", "count": 2}, {"letter": "American College of Surgeons", "count": 2}, {"letter": "American Indian or Alaska Native", "count": 1}, {"letter": "American Joint Committee on Cancer", "count": 32}, {"letter": "American Society of Clinical Oncology", "count": 4}, {"letter": "Anatomic Site", "count": 66}, {"letter": "Anatomic Sites, Other", "count": 2}, {"letter": "Ancillary Study", "count": 2}, {"letter": "And", "count": 1691}, {"letter": "Anti-inflammatory effect", "count": 8}, {"letter": "Antibody Repertoire", "count": 1}, {"letter": "Antitumor Response", "count": 14}, {"letter": "Apoptotic", "count": 5}, {"letter": "Assignment - action", "count": 35}, {"letter": "Astler-Coller B1 Rectal Carcinoma", "count": 20}, {"letter": "At", "count": 646}, {"letter": "Attempt", "count": 16}, {"letter": "sorafenib", "count": 7}, {"letter": "Calendar", "count": 7}, {"letter": "Cancer Biology", "count": 1}, {"letter": "Cancer Burden", "count": 4}, {"letter": "Cancer Control", "count": 10}, {"letter": "Cancer Death Rate", "count": 7}, {"letter": "Cancer Detection", "count": 28}, {"letter": "Cancer Etiology", "count": 3}, {"letter": "Cancer Family", "count": 1}, {"letter": "Cancer Gene Mutation", "count": 2}, {"letter": "Cancer Histology", "count": 2}, {"letter": "Cancer Intervention", "count": 18}, {"letter": "Cancer Model", "count": 2}, {"letter": "Cancer Patient", "count": 161}, {"letter": "Cancer Prognosis", "count": 2}, {"letter": "Cancer Research", "count": 7}, {"letter": "Cancer Surveillance Research", "count": 1}, {"letter": "Cancer Survivors", "count": 87}, {"letter": "Cancer Survivorship Research", "count": 42}, {"letter": "Cancer Therapy Evaluation Program", "count": 3}, {"letter": "Capacity", "count": 47}, {"letter": "Cardiopulmonary Physiology", "count": 1}, {"letter": "Case Report Form", "count": 31}, {"letter": "Cell Cycle Completion", "count": 1}, {"letter": "Negative Regulation of Cell Cycle", "count": 1}, {"letter": "Cell Cycle Phase", "count": 1}, {"letter": "Positive Regulation of Cell Differentiation", "count": 1}, {"letter": "Celsius Scale", "count": 2}, {"letter": "Research or Clinical Assessment Tool", "count": 1}, {"letter": "Clinical Data", "count": 51}, {"letter": "Clinical Management", "count": 6}, {"letter": "Clinical/Radiologic", "count": 8}, {"letter": "Clinical Research Associate", "count": 1}, {"letter": "Clinical Sensitivity", "count": 1}, {"letter": "research clinical testing", "count": 31}, {"letter": "Clinical Treatment", "count": 16}, {"letter": "Clinical Trials Design", "count": 4}, {"letter": "Clinical Trial Eligibility Criteria", "count": 8}, {"letter": "Clinical Trial, Other", "count": 1}, {"letter": "Clonal Evolution", "count": 1}, {"letter": "Clonal Expansion", "count": 1}, {"letter": "Cognitive", "count": 137}, {"letter": "Collected", "count": 51}, {"letter": "Collection (action)", "count": 513}, {"letter": "National Cancer Institute common terminology criteria for adverse events", "count": 941}, {"letter": "Community Clinical Oncology Program", "count": 4}, {"letter": "Community Practice", "count": 1}, {"letter": "Computational Technique", "count": 3}, {"letter": "Conceptual Domain", "count": 1}, {"letter": "Engineered Gene", "count": 1}, {"letter": "Enrollment", "count": 206}, {"letter": "Epidemiology, Descriptive", "count": 1}, {"letter": "Epigenetic Process", "count": 4}, {"letter": "Estrogen Metabolism Alteration", "count": 1}, {"letter": "Estrogen Receptor Status - Clinical Trial Eligibility Criteria", "count": 32}, {"letter": "European Organization for Research and Treatment of Cancer", "count": 100}, {"letter": "Evaluable Disease", "count": 213}, {"letter": "Exercise Physiology", "count": 3}, {"letter": "Exogenous Factors", "count": 2}, {"letter": "Expected (qualifier)", "count": 114}, {"letter": "Experimental Pathology", "count": 1}, {"letter": "Expression Measurement Object", "count": 7}, {"letter": "Extensive Stage", "count": 5}, {"letter": "External Beam Radiation Therapy", "count": 10}, {"letter": "Extracellular Domain", "count": 1}, {"letter": "Extrahepatic", "count": 2}, {"letter": "Extramedullary", "count": 1}, {"letter": "Extranodal", "count": 1}, {"letter": "Extraprostatic", "count": 1}, {"letter": "Facilities and Administrative Costs", "count": 6}, {"letter": "Flare", "count": 1}, {"letter": "Focused Ultrasound Therapy", "count": 3}, {"letter": "Food Patterns", "count": 4}, {"letter": "From", "count": 2604}, {"letter": "Functional Imaging", "count": 4}, {"letter": "Further", "count": 121}, {"letter": "Gain", "count": 28}, {"letter": "Gene Amplification Technique", "count": 8}, {"letter": "Gene Expression Process", "count": 106}, {"letter": "Gene Feature", "count": 1}, {"letter": "Genetic Risk", "count": 11}, {"letter": "Genetic Status", "count": 2}, {"letter": "Geographic", "count": 4}, {"letter": "Gleason Pattern 1 (classification)", "count": 1}, {"letter": "Intrathecal Chemotherapy", "count": 1}, {"letter": "Intratumoral", "count": 44}, {"letter": "Intratumoral Route of Drug Administration", "count": 1}, {"letter": "Intraventricular", "count": 2}, {"letter": "Invaded", "count": 1}, {"letter": "Investigational", "count": 67}, {"letter": "LDL Pathway", "count": 2}, {"letter": "Last", "count": 399}, {"letter": "Lesion by Morphology", "count": 1}, {"letter": "Leucine-Rich Repeat", "count": 8}, {"letter": "Life Threatening Adverse Event", "count": 41}, {"letter": "Lifetime Risk", "count": 3}, {"letter": "Light Exercise", "count": 4}, {"letter": "Limited stage (cancer stage)", "count": 6}, {"letter": "Links List", "count": 25}, {"letter": "Lipid Metabolism Pathway", "count": 1}, {"letter": "DepoCyte", "count": 2}, {"letter": "Local Therapy", "count": 13}, {"letter": "Locally", "count": 63}, {"letter": "Long Interspersed Elements", "count": 1}, {"letter": "Long Term Survivorship", "count": 6}, {"letter": "Long-term Follow-up", "count": 11}, {"letter": "Loss", "count": 75}, {"letter": "Lot (entire collection)", "count": 8}, {"letter": "Low Dose Radiation Therapy", "count": 1}, {"letter": "Low Prevalence", "count": 1}, {"letter": "Lower Limit of Normal", "count": 9}, {"letter": "Luteinizing Hormone-releasing Hormone Agonist", "count": 1}, {"letter": "Lymph Node Drainage", "count": 1}, {"letter": "Lymphatic mapping", "count": 4}, {"letter": "Subcapsular sinus of lymph node", "count": 1}, {"letter": "Lymphoid", "count": 2}, {"letter": "Neurologic Effect", "count": 1}, {"letter": "Neurologic Oncology", "count": 9}, {"letter": "No Evidence of Disease", "count": 9}, {"letter": "Nodular lesions", "count": 5}, {"letter": "Non-Invasive Cancer Detection", "count": 1}, {"letter": "Non-Malignant", "count": 2}, {"letter": "Non-Measurable", "count": 22}, {"letter": "Non-Protocol", "count": 9}, {"letter": "Non-Steroidal Aromatase Inhibitor", "count": 2}, {"letter": "Non-Surgical", "count": 3}, {"letter": "Non-Target", "count": 431}, {"letter": "Non-Visceral", "count": 3}, {"letter": "Non-serious Adverse Event", "count": 43}, {"letter": "North Central Cancer Treatment Group", "count": 24}, {"letter": "Negation", "count": 2163}, {"letter": "Nuclear Grade", "count": 4}, {"letter": "Nuclear pleomorphism", "count": 5}, {"letter": "Number of First Degree Relatives (Affected)", "count": 3}, {"letter": "Numeric Pain Scale", "count": 36}, {"letter": "Nutritional study of macronutrients", "count": 1}, {"letter": "Object Class", "count": 1}, {"letter": "Observational Study", "count": 5}, {"letter": "Off", "count": 2}, {"letter": "Off Treatment", "count": 1}, {"letter": "Off Study", "count": 335}, {"letter": "Surgical Oncologist", "count": 1}, {"letter": "Oncology Group", "count": 5}, {"letter": "Ontology", "count": 1}, {"letter": "Optional", "count": 32}, {"letter": "Options", "count": 64}, {"letter": "Organ Model", "count": 2}, {"letter": "Organism Modification", "count": 7}, {"letter": "Organism Strain", "count": 33}, {"letter": "Osteolytic", "count": 1}, {"letter": "Outcome of Therapy", "count": 105}, {"letter": "Pain Assessment Tool", "count": 9}, {"letter": "Pain Nature", "count": 1}, {"letter": "Pain Research", "count": 1}, {"letter": "Palestinian Territory, Occupied", "count": 3}, {"letter": "Patient-Focused Outcomes", "count": 2}, {"letter": "Patient Outcome Questionnaire", "count": 3}, {"letter": "Pattern Recognition", "count": 3}, {"letter": "peak expiratory flow (procedure)", "count": 3}, {"letter": "Performance Status", "count": 32}, {"letter": "perioperative", "count": 17}, {"letter": "Peripheral Blood Lymphocyte", "count": 2}, {"letter": "Personal Attribute", "count": 34}, {"letter": "Phase II/III Trial", "count": 7}, {"letter": "Phase I/II Trial", "count": 28}, {"letter": "Phosphorylation Inhibition", "count": 3}, {"letter": "Risk Estimate", "count": 6}, {"letter": "Risk Marker", "count": 8}, {"letter": "SF-12", "count": 19}, {"letter": "SF-36", "count": 76}, {"letter": "Scheme", "count": 14}, {"letter": "Growth Inhibition Screening Result", "count": 13}, {"letter": "Security - service", "count": 13}, {"letter": "Seed Implantation", "count": 1}, {"letter": "Self-Administered", "count": 125}, {"letter": "Send (transmission)", "count": 24}, {"letter": "Sentinel lymph node mapping", "count": 1}, {"letter": "Sequence", "count": 23}, {"letter": "Sequential Treatment", "count": 3}, {"letter": "Serious Adverse Event", "count": 64}, {"letter": "Serving", "count": 4}, {"letter": "Grade 3 Severe Adverse Event", "count": 38}, {"letter": "Shotgun Sequencing", "count": 6}, {"letter": "Signal Transduction Inhibition", "count": 1}, {"letter": "Signature", "count": 79}, {"letter": "Skin Papule", "count": 1}, {"letter": "Slice", "count": 2}, {"letter": "Tobacco Smoking History", "count": 5}, {"letter": "Splice-Site Mutation", "count": 1}, {"letter": "Stage Grouping", "count": 42}, {"letter": "Tissue-Specific Gene Expression", "count": 3}, {"letter": "Fresh Tissue", "count": 2}, {"letter": "Tissue Microarray", "count": 1}, {"letter": "Tissue Model", "count": 1}, {"letter": "Paraffin Embedded Tissue", "count": 10}, {"letter": "RNA Transcript", "count": 9}, {"letter": "Genetic Translation Process", "count": 19}, {"letter": "Translational Research, Biomedical", "count": 3}, {"letter": "Tumor-Derived", "count": 3}, {"letter": "Tumor Angiogenesis", "count": 11}, {"letter": "Cancer Biobank", "count": 2}, {"letter": "Tumor Biology", "count": 4}, {"letter": "Tumor Expansion", "count": 1}, {"letter": "Tumor Immunity", "count": 3}, {"letter": "Tumor Oxygenation", "count": 2}, {"letter": "Tumor Pathology", "count": 6}, {"letter": "Histologic Subtype", "count": 3}, {"letter": "Tumorigenicity", "count": 2}, {"letter": "Tyrosine Kinase Domain", "count": 1}, {"letter": "Unfiltered", "count": 1}, {"letter": "Unit of Measure", "count": 36}, {"letter": "University of Southern California Norris Comprehensive Cancer Center", "count": 1}, {"letter": "University of Texas MD Anderson Cancer Center", "count": 6}, {"letter": "Unresectable", "count": 23}, {"letter": "Update", "count": 13}, {"letter": "Upper Limit of Normal", "count": 21}, {"letter": "Vaccine Antigen", "count": 2}, {"letter": "Vaccine Production", "count": 1}, {"letter": "Valid Value", "count": 2}, {"letter": "Validation", "count": 47}, {"letter": "Validation of Technology", "count": 1}, {"letter": "Vasomotor", "count": 6}, {"letter": "WHO Analgesic Method", "count": 1}, {"letter": "Wnt Signaling Pathway", "count": 1}, {"letter": "Warburg Effect", "count": 1}, {"letter": "Whole brain radiation therapy", "count": 19}, {"letter": "Wisconsin Brief Pain Questionnaire", "count": 1}, {"letter": "Xenograft Model", "count": 1}, {"letter": "Xp", "count": 1}, {"letter": "Yp", "count": 1}, {"letter": "ECOG performance status", "count": 39}, {"letter": "15q26", "count": 1}, {"letter": "Chromosome 5 Short Arm", "count": 2}, {"letter": "Supportive assistance", "count": 87}, {"letter": "Alzheimer's Disease Pathway KEGG", "count": 1}, {"letter": "Pediatric", "count": 3}, {"letter": "partial response", "count": 1315}, {"letter": "Pathologic", "count": 313}, {"letter": "Pectoral", "count": 5}, {"letter": "Field", "count": 20}, {"letter": "Nutritional", "count": 10}, {"letter": "Monitor, occupation", "count": 12}, {"letter": "Conventional Surgery", "count": 2}, {"letter": "Mammary Gland Parenchyma", "count": 64}, {"letter": "Combination Chemotherapy", "count": 12}, {"letter": "Protein Acetylation", "count": 2}, {"letter": "Factor", "count": 188}, {"letter": "trend", "count": 22}, {"letter": "Adverse Drug Experience Report", "count": 21}, {"letter": "Having administered", "count": 407}, {"letter": "Opposite", "count": 18}, {"letter": "Clinical Trials Cooperative Group", "count": 2}, {"letter": "Cellular Morphology", "count": 2}, {"letter": "Protocol Agent", "count": 429}, {"letter": "Preparation", "count": 42}, {"letter": "Rate", "count": 1065}, {"letter": "Target", "count": 572}, {"letter": "Zip Code", "count": 1}, {"letter": "estrogen receptor alpha, human", "count": 5}, {"letter": "Amplification", "count": 1}, {"letter": "GAGE", "count": 3}, {"letter": "Principal Investigator", "count": 4}, {"letter": "To specify", "count": 20}, {"letter": "Chromosome band", "count": 3}, {"letter": "prescription document", "count": 29}, {"letter": "Characteristics", "count": 278}, {"letter": "Entered", "count": 21}, {"letter": "Hot Spots (Area of Increased Mortality)", "count": 1}, {"letter": "Molecular", "count": 124}, {"letter": "Resected", "count": 90}, {"letter": "immunology aspects", "count": 3}, {"letter": "Hypercholesterolemia result", "count": 2}, {"letter": "shared attribute", "count": 393}, {"letter": "Informed", "count": 36}, {"letter": "Worst", "count": 318}, {"letter": "Soft Tissue Route of Drug Administration", "count": 3}, {"letter": "Interstitial Route of Drug Administration", "count": 2}, {"letter": "Intravenous Bolus", "count": 1}, {"letter": "Process", "count": 53}, {"letter": "Grouping", "count": 4}, {"letter": "End Time", "count": 7}, {"letter": "Treating", "count": 371}, {"letter": "sex", "count": 5}, {"letter": "Recombinant Interleukin-2", "count": 5}, {"letter": "Coating (film)", "count": 4}, {"letter": "Highest", "count": 147}, {"letter": "A Mouse", "count": 1}, {"letter": "Longest", "count": 12}, {"letter": "best (quality)", "count": 274}, {"letter": "Recombinant Interleukin-1", "count": 3}, {"letter": "Recombinant Interleukin-1-beta", "count": 4}, {"letter": "resting phase", "count": 1}, {"letter": "Recombinant Nerve Growth Factor", "count": 2}, {"letter": "Cutaneous Route of Drug Administration", "count": 2}, {"letter": "Therapeutic radiology procedure", "count": 159}, {"letter": "Recombinant Flt3 Ligand", "count": 1}, {"letter": "section sample", "count": 64}, {"letter": "metastatic qualifier", "count": 5}, {"letter": "Tracer", "count": 33}, {"letter": "Professional Organization or Group", "count": 35}, {"letter": "Formation", "count": 247}, {"letter": "Sentinel Lymph Node", "count": 73}, {"letter": "Axis", "count": 7}, {"letter": "Nutrition, Trace Elements Research Activity", "count": 1}, {"letter": "Recombinant Fibroblast Growth Factor-2", "count": 1}, {"letter": "Details", "count": 81}, {"letter": "Recombinant Interferon", "count": 1}, {"letter": "Recombinant Interleukin-4", "count": 1}, {"letter": "Protocol Treatment Arm", "count": 378}, {"letter": "Recombinant Interleukin-10", "count": 4}, {"letter": "Recombinant Interleukin-13", "count": 1}, {"letter": "Recombinant Monocyte Chemoattractant Protein-1", "count": 1}, {"letter": "Recombinant RANTES", "count": 1}, {"letter": "Recombinant Brain-Derived Growth Factors", "count": 1}, {"letter": "Myocardial", "count": 6}, {"letter": "Vaginal Route of Drug Administration", "count": 1}, {"letter": "Recombinant Vascular Endothelial Growth Factor", "count": 10}, {"letter": "follow-up", "count": 756}, {"letter": "Histology, Cytology", "count": 2}, {"letter": "Cardiac - anatomy qualifier", "count": 40}, {"letter": "Indicator", "count": 3}, {"letter": "Lymphatic", "count": 5}, {"letter": "anatomical topography", "count": 3}, {"letter": "Numerical value", "count": 491}, {"letter": "Esophageal", "count": 6}, {"letter": "Question (inquiry)", "count": 784}, {"letter": "stimulus sensitivity", "count": 1}, {"letter": "Clone", "count": 1}, {"letter": "Filed", "count": 11}, {"letter": "sample fixation", "count": 4}, {"letter": "Closest", "count": 14}, {"letter": "Recombinant Tumor Necrosis Factor-Alpha", "count": 25}, {"letter": "Adjuvant", "count": 153}, {"letter": "Doxorubicin Hydrochloride Liposome Injection", "count": 3}, {"letter": "doxorubicin hydrochloride liposome", "count": 4}, {"letter": "Exercise Pain Management", "count": 127}, {"letter": "magnetic resonance spectroscopic imaging", "count": 11}, {"letter": "Recombinant Interferon-alpha Inducible Protein 10", "count": 2}, {"letter": "Pleural", "count": 6}, {"letter": "Circadian Rhythm Pathway 2", "count": 4}, {"letter": "Circadian Rhythm Pathway KEGG", "count": 3}, {"letter": "Intravenous Route of Drug Administration", "count": 3}, {"letter": "Library Protocol", "count": 14}, {"letter": "rhythmic process (biological)", "count": 2}, {"letter": "positive regulation of transport", "count": 1}, {"letter": "phosphoprotein binding", "count": 1}, {"letter": "response to yeast", "count": 1}, {"letter": "receptor complex", "count": 1}, {"letter": "estrogen receptor beta, human", "count": 2}, {"letter": "Alternative", "count": 34}, {"letter": "Diagnostic, Therapeutic, and Research Equipment", "count": 5}, {"letter": "Science of Etiology", "count": 642}, {"letter": "Authorization documentation", "count": 3}, {"letter": "community health discipline", "count": 1}, {"letter": "Radiation Ionizing Radiotherapy", "count": 32}, {"letter": "Radiotherapy Research", "count": 47}, {"letter": "Radiation-Induced Change", "count": 1}, {"letter": "analysis aspect", "count": 36}, {"letter": "Metabolic Process, Cellular", "count": 53}, {"letter": "Mouse MIN NOS", "count": 4}, {"letter": "Minimum", "count": 242}, {"letter": "Shipping", "count": 3}, {"letter": "Compatible", "count": 1}, {"letter": "mechanism of action qualifier", "count": 4}, {"letter": "psychology qualifier", "count": 2}, {"letter": "Additional", "count": 229}, {"letter": "Use of", "count": 4977}, {"letter": "chain of objects", "count": 10}, {"letter": "Designated", "count": 37}, {"letter": "Recombinant Cytokines", "count": 42}, {"letter": "Chairperson", "count": 46}, {"letter": "Recombinant Interleukin-12", "count": 6}, {"letter": "urinary", "count": 8}, {"letter": "W flexion", "count": 12}, {"letter": "Text", "count": 1}, {"letter": "romidepsin", "count": 1}, {"letter": "Recombinant Chemokine", "count": 1}, {"letter": "Pre-study", "count": 5}, {"letter": "Recombinant Inhibin A", "count": 2}, {"letter": "Revision procedure", "count": 80}, {"letter": "SNP Info", "count": 8}, {"letter": "Receiver Operator Characteristics", "count": 14}, {"letter": "Workers", "count": 3}, {"letter": "Personnel", "count": 1}, {"letter": "Protein Function", "count": 1}, {"letter": "Radiolabeled", "count": 2}, {"letter": "Nottingham Score", "count": 1}, {"letter": "Recombinant Interleukin-3", "count": 2}, {"letter": "Recombinant Interleukin-5", "count": 1}, {"letter": "Recombinant Interleukin-6", "count": 20}, {"letter": "Therapeutic Effect", "count": 61}, {"letter": "Development", "count": 141}, {"letter": "Encounter due to being a donor", "count": 8}, {"letter": "Basis - conceptual entity", "count": 48}, {"letter": "Dominant", "count": 17}, {"letter": "Recombinant Transforming Growth Factor-Beta", "count": 9}, {"letter": "130-nm albumin-bound paclitaxel", "count": 51}, {"letter": "Radiation-induced disorder", "count": 1}, {"letter": "Recombinant Immune Globulin", "count": 6}, {"letter": "Derivative", "count": 2}, {"letter": "ethics qualifier", "count": 1}, {"letter": "17-(dimethylaminoethylamino)-17-demethoxygeldanamycin", "count": 1}, {"letter": "Allergic Reaction", "count": 7}, {"letter": "Feelings", "count": 175}, {"letter": "Dysphonia", "count": 1}, {"letter": "Ductal Breast Carcinoma", "count": 2}, {"letter": "Heterosexuals", "count": 3}, {"letter": "Group Therapy", "count": 2}, {"letter": "Neoplasms, Intracranial", "count": 10}, {"letter": "Anterior thoracic region", "count": 10}, {"letter": "Emergency Care", "count": 2}, {"letter": "Rectal Route of Drug Administration", "count": 1}, {"letter": "Remaining", "count": 53}, {"letter": "JAK1 protein, human", "count": 2}, {"letter": "JAK2 protein, human", "count": 1}, {"letter": "TNFRSF10B protein, human", "count": 8}, {"letter": "T protein, human", "count": 1}, {"letter": "FGFR1 protein, human", "count": 3}, {"letter": "CAV1 protein, human", "count": 1}, {"letter": "Vigil", "count": 1}, {"letter": "HIF1A protein, human", "count": 1}, {"letter": "FITC-annexin A5", "count": 2}, {"letter": "BAX protein, human", "count": 2}, {"letter": "BRCA1 protein, human", "count": 31}, {"letter": "CDKN1A protein, human", "count": 4}, {"letter": "CDKN2C protein, human", "count": 1}, {"letter": "STAT3 protein, human", "count": 1}, {"letter": "BID protein, human", "count": 5}, {"letter": "BAD protein, human", "count": 49}, {"letter": "PTEN Phosphohydrolase", "count": 1}, {"letter": "GDNF protein, human", "count": 1}, {"letter": "HRH2 protein, human", "count": 1}, {"letter": "Smoldering myeloma", "count": 1}, {"letter": "Blood velocity", "count": 1}, {"letter": "Chest imaging", "count": 3}, {"letter": "dL/day", "count": 1}, {"letter": "Ability to make decisions", "count": 1}, {"letter": "Axillary temperature", "count": 1}, {"letter": "Ratio value", "count": 4}, {"letter": "Oral temperature", "count": 8}, {"letter": "Sedentary lifestyle", "count": 7}, {"letter": "Family history of prostate cancer", "count": 1}, {"letter": "Infra-red", "count": 4}, {"letter": "Percentile value", "count": 7}, {"letter": "Nottingham prognostic index", "count": 3}, {"letter": "Millimole per Liter", "count": 15}, {"letter": "Microunit", "count": 4}, {"letter": "mg/m2/day", "count": 2}, {"letter": "Obtaining consent", "count": 1}, {"letter": "U/min", "count": 1}, {"letter": "Kilodalton", "count": 2}, {"letter": "kg-m", "count": 20}, {"letter": "kg/min", "count": 1}, {"letter": "Nanomole per millimole", "count": 4}, {"letter": "Protective cup", "count": 2}, {"letter": "Euro currency", "count": 7}, {"letter": "Specific imaging methods", "count": 1}, {"letter": "Case unit dose", "count": 84}, {"letter": "Block Specimens", "count": 6}, {"letter": "Teaspoonful", "count": 1}, {"letter": "erlotinib hydrochloride", "count": 2}, {"letter": "physiologic migration", "count": 5}, {"letter": "Therapeutic Insulin", "count": 36}, {"letter": "Lymphatic tissue operation", "count": 1}, {"letter": "Injection procedure", "count": 41}, {"letter": "in vitro", "count": 1}, {"letter": "Information", "count": 276}, {"letter": "Administration procedure", "count": 38}, {"letter": "Placement action", "count": 49}, {"letter": "Splitting", "count": 9}, {"letter": "Recombinant Thyroid-Stimulating Hormone", "count": 3}, {"letter": "Procalcitonin measurement", "count": 3}, {"letter": "Pneumocystis jiroveci pneumonia", "count": 6}, {"letter": "Ejection fraction normal", "count": 3}, {"letter": "Bypass surgery", "count": 1}, {"letter": "Computed Tomography Angiography", "count": 1}, {"letter": "pathologic cytolysis", "count": 3}, {"letter": "Symptom Management", "count": 8}, {"letter": "antigen specificity", "count": 1}, {"letter": "Diffusion Tensor Imaging", "count": 12}, {"letter": "goal directed behavior", "count": 1}, {"letter": "Molecular Imaging", "count": 2}, {"letter": "neoplasm angiogenesis", "count": 1}, {"letter": "Skin tanning function", "count": 4}, {"letter": "ZC4H2 gene", "count": 1}, {"letter": "CFAP97 gene", "count": 1}, {"letter": "CIP2A gene", "count": 1}, {"letter": "KRAS gene", "count": 7}, {"letter": "LUZP4 gene", "count": 2}, {"letter": "MALAT1 gene", "count": 1}, {"letter": "MIR21 gene", "count": 3}, {"letter": "MIR373 gene", "count": 2}, {"letter": "MT-RNR1 gene", "count": 1}, {"letter": "MT-RNR2 gene", "count": 10}, {"letter": "VTCN1 gene", "count": 1}, {"letter": "YY1AP1 gene", "count": 2}, {"letter": "BLOC1S3 gene", "count": 3}, {"letter": "CANT1 gene", "count": 2}, {"letter": "CFH gene", "count": 14}, {"letter": "OLFM4 gene", "count": 2}, {"letter": "PAGE2 gene", "count": 2}, {"letter": "PAGE4 gene", "count": 1}, {"letter": "PAGE5 gene", "count": 1}, {"letter": "PODXL2 gene", "count": 6}, {"letter": "REM1 gene", "count": 3}, {"letter": "CNDP1 gene", "count": 2}, {"letter": "DCLK3 gene", "count": 1}, {"letter": "DDX58 gene", "count": 1}, {"letter": "DEGS1 gene", "count": 1}, {"letter": "FATE1 gene", "count": 1}, {"letter": "GTF2H5 gene", "count": 5}, {"letter": "SMR3A gene", "count": 12}, {"letter": "SPG21 gene", "count": 1}, {"letter": "ST8SIA4 gene", "count": 1}, {"letter": "SYNC gene", "count": 3}, {"letter": "TFDP3 gene", "count": 1}, {"letter": "TICAM2 gene", "count": 1}, {"letter": "TP53INP2 gene", "count": 14}, {"letter": "TRIM54 gene", "count": 1}, {"letter": "TRIM63 gene", "count": 1}, {"letter": "TUBB3 gene", "count": 1}, {"letter": "CD200 gene", "count": 3}, {"letter": "CD274 gene", "count": 89}, {"letter": "CD276 gene", "count": 1}, {"letter": "MRO gene", "count": 1}, {"letter": "Social support (regime/therapy)", "count": 11}, {"letter": "Transferring (function)", "count": 2}, {"letter": "Lapatinib/Trastuzumab Regimen", "count": 5}, {"letter": "XL647", "count": 3}, {"letter": "TLR7 Agonist 852A", "count": 7}, {"letter": "MST 997", "count": 2}, {"letter": "AMG 706", "count": 2}, {"letter": "MAGE-A3 Peptide Vaccine", "count": 2}, {"letter": "RAV12", "count": 1}, {"letter": "AMG 386", "count": 5}, {"letter": "AZD2171", "count": 3}, {"letter": "Capecitabine/Trastuzumab Regimen", "count": 1}, {"letter": "FEZ1/LZTS1", "count": 2}, {"letter": "Main", "count": 84}, {"letter": "Temperature:Finding:Point in time:Skin:Nominal", "count": 2}, {"letter": "Breast scan", "count": 1}, {"letter": "Person present", "count": 1}, {"letter": "Program participation", "count": 4}, {"letter": "Drainage amount", "count": 4}, {"letter": "Parabasal epithelial cell", "count": 1}, {"letter": "Firmness", "count": 5}, {"letter": "Protection", "count": 12}, {"letter": "Views delayed", "count": 50}, {"letter": "Wound edge observable", "count": 2}, {"letter": "at time of {event}", "count": 1}, {"letter": "post concentration", "count": 3}, {"letter": "pre dose dexamethasone", "count": 2}, {"letter": "Age at death", "count": 1}, {"letter": "No Information Available", "count": 1}, {"letter": "Problems - What subject filter", "count": 101}, {"letter": "What subject filter - Result", "count": 43}, {"letter": "Diagnosis Type - Final", "count": 200}, {"letter": "Relationship - Care giver", "count": 1}, {"letter": "Relationship - Friend", "count": 1}, {"letter": "Relationship - Manager", "count": 1}, {"letter": "Specimen Source Codes - Lesion", "count": 3}, {"letter": "Liquid NOS - Specimen Source Codes", "count": 1}, {"letter": "Lesion, Oral", "count": 1}, {"letter": "Site, Pin", "count": 1}, {"letter": "Arranged (transportation)", "count": 3}, {"letter": "Tissue diagnosis", "count": 18}, {"letter": "Medicare DRG Payor", "count": 2}, {"letter": "Part-time student", "count": 3}, {"letter": "30 day report", "count": 1}, {"letter": "Additional information", "count": 7}, {"letter": "Non-Healthcare Professional", "count": 1}, {"letter": "Event Qualification - Dependency", "count": 3}, {"letter": "Event Qualification - Overdose", "count": 2}, {"letter": "Event Qualification - Drug withdrawal", "count": 2}, {"letter": "Event Seriousness - Significant", "count": 152}, {"letter": "Congenital anomaly/birth defect", "count": 46}, {"letter": "Life threatening - Event Consequence", "count": 167}, {"letter": "Patient Outcome - Died", "count": 96}, {"letter": "Patient Outcome - Worsening", "count": 6}, {"letter": "*Constant", "count": 3}, {"letter": "Kind of quantity - Equilibrium", "count": 1}, {"letter": "*Relative Time", "count": 1}, {"letter": "*Susceptibility", "count": 2}, {"letter": "*Time Difference - Kind of quantity", "count": 2}, {"letter": "*Velocity", "count": 12}, {"letter": "*Velocity Ratio - Kind of quantity", "count": 1}, {"letter": "Volume Ratio", "count": 2}, {"letter": "10 days", "count": 24}, {"letter": "Electro-Cardiogram", "count": 53}, {"letter": "Coding system - Medicaid", "count": 1}, {"letter": "Sequencing - Ascending", "count": 7}, {"letter": "Sequencing - Descending", "count": 6}, {"letter": "Physician Clinic", "count": 2}, {"letter": "Organization unit type - Long Term Care", "count": 2}, {"letter": "Start up", "count": 2}, {"letter": "Insufficient Tissue", "count": 1}, {"letter": "the primary procedure", "count": 1}, {"letter": "Draft", "count": 1}, {"letter": "Show", "count": 194}, {"letter": "Satisfactory - Patient Condition Code", "count": 12}, {"letter": "Patient Condition Code - Stable", "count": 125}, {"letter": "Unconfirmed", "count": 20}, {"letter": "Data types- Composite", "count": 4}, {"letter": "Data types - Date", "count": 2}, {"letter": "Person Name", "count": 33}, {"letter": "Data types - String", "count": 1}, {"letter": "Value range", "count": 23}, {"letter": "Attending (provider role)", "count": 3}, {"letter": "Primary Care Provider - Provider role", "count": 7}, {"letter": "Log Event", "count": 1}, {"letter": "Facility (object)", "count": 13}, {"letter": "Subdivision - organization unit type", "count": 1}, {"letter": "Charge Type Reason - Treatment Failure", "count": 12}, {"letter": "Authorization Mode - Electronic", "count": 20}, {"letter": "Authorization Mode - In Person", "count": 6}, {"letter": "Authorization Mode - Mail", "count": 2}, {"letter": "Paper Authorization", "count": 19}, {"letter": "Administration Method", "count": 8}, {"letter": "Derived specimen", "count": 4}, {"letter": "Response level", "count": 34}, {"letter": "Active/Inactive", "count": 3}, {"letter": "Diagnosis Classification", "count": 1}, {"letter": "Patient Outcome", "count": 46}, {"letter": "Status of Evaluation", "count": 8}, {"letter": "Relatedness Assessment", "count": 2}, {"letter": "Diagnostic Radiology Modality", "count": 52}, {"letter": "Document type", "count": 46}, {"letter": "Referral type", "count": 1}, {"letter": "MIME encoding", "count": 3}, {"letter": "Building process", "count": 2}, {"letter": "Floor - story of building", "count": 213}, {"letter": "Coverage type", "count": 2}, {"letter": "Repeat Pattern", "count": 23}, {"letter": "referral reason", "count": 1}, {"letter": "Board certification status", "count": 1}, {"letter": "Alert level", "count": 1}, {"letter": "Modify indicator", "count": 1}, {"letter": "Provider role", "count": 3}, {"letter": "Specimen Quality", "count": 1}, {"letter": "Precision - temporal", "count": 6}, {"letter": "Serum, Trough", "count": 9}, {"letter": "Blood Bank Section ID", "count": 2}, {"letter": "Diagnostic Service Section ID - Pulmonary Function", "count": 1}, {"letter": "Diagnostic Service Section ID - Toxicology", "count": 1}, {"letter": "Diagnostic Service Section ID - Vascular Ultrasound", "count": 2}, {"letter": "Document response", "count": 74}, {"letter": "Partial results", "count": 1}, {"letter": "Re-admission", "count": 3}, {"letter": "Unified - Type of Agreement", "count": 1}, {"letter": "Bed Status - Isolated", "count": 15}, {"letter": "Occupied", "count": 3}, {"letter": "Combined result", "count": 2}, {"letter": "Data errors", "count": 1}, {"letter": "Charge type - Grant", "count": 4}, {"letter": "Numeric - Value type", "count": 81}, {"letter": "Pages", "count": 2}, {"letter": "Quantity limited request - Records", "count": 19}, {"letter": "Specialty Type - Intensive care", "count": 2}, {"letter": "Document Completion - incomplete", "count": 9}, {"letter": "purged", "count": 1}, {"letter": "Referral disposition - Second Opinion", "count": 2}, {"letter": "Rejected", "count": 2}, {"letter": "Referral category - Inpatient", "count": 3}, {"letter": "Hypertext Markup Language", "count": 3}, {"letter": "Job Status - Temporary", "count": 10}, {"letter": "Etc.", "count": 86}, {"letter": "Dispense Method - Traditional", "count": 14}, {"letter": "Action Code - No change", "count": 2}, {"letter": "Licensed - Location characteristic ID", "count": 2}, {"letter": "Overflow", "count": 1}, {"letter": "user - Facility type", "count": 20}, {"letter": "Accept - Source type", "count": 1}, {"letter": "Initiate (source type)", "count": 63}, {"letter": "Referral reason - Work Load", "count": 3}, {"letter": "Eligible", "count": 113}, {"letter": "Varies", "count": 13}, {"letter": "Specimen Collection Method - Venipuncture", "count": 1}, {"letter": "Excellent - Specimen Quality", "count": 107}, {"letter": "Inappropriate", "count": 1}, {"letter": "Preferred - Specimen Appropriateness", "count": 7}, {"letter": "Live - Specimen Condition", "count": 23}, {"letter": "Body Site Modifier - Lower", "count": 78}, {"letter": "Anesthesia - Questionnaire - Consent type", "count": 1}, {"letter": "Consent Type - Colonoscopy", "count": 1}, {"letter": "Consent Type - Hysterectomy", "count": 1}, {"letter": "Consent Type - Lumbar Puncture", "count": 1}, {"letter": "Consent Type - Photographs", "count": 37}, {"letter": "Radiologic Procedure - Consent Type", "count": 2}, {"letter": "Release of Body - Consent Type", "count": 1}, {"letter": "Use of Investigational Device - Consent Type", "count": 1}, {"letter": "Consent Type - Videotape", "count": 1}, {"letter": "Sequential - Sequence/Results Flag", "count": 35}, {"letter": "Exclusive", "count": 4}, {"letter": "Service Request Relationship - Simultaneous", "count": 3}, {"letter": "Blood Product Processing Requirements - Irradiated", "count": 30}, {"letter": "Washed", "count": 5}, {"letter": "Transfused", "count": 1}, {"letter": "Absolute Change", "count": 18}, {"letter": "No Information - Expanded yes/no indicator", "count": 1}, {"letter": "Termination - Inactive Reason Code", "count": 8}, {"letter": "Auricular", "count": 2}, {"letter": "Breast fluid", "count": 2}, {"letter": "Common law marital status", "count": 1}, {"letter": "Patient Class - Inpatient", "count": 2}, {"letter": "Patient Class - Outpatient", "count": 9}, {"letter": "Procedure Practitioner Identifier Code Type - Radiologist", "count": 25}, {"letter": "Resident - Procedure Practitioner Identifier Code Type", "count": 1}, {"letter": "No - yes/no indicator", "count": 13}, {"letter": "Yes - Yes/no indicator", "count": 1}, {"letter": "Room type - Intensive care unit", "count": 3}, {"letter": "Unlimited - Amount type", "count": 1}, {"letter": "Ancillary", "count": 1}, {"letter": "Amount type - Percentage", "count": 49}, {"letter": "Any status", "count": 1}, {"letter": "Diet Code Specification Type - Preference", "count": 7}, {"letter": "Chew (administration method)", "count": 1}, {"letter": "Perfuse", "count": 3}, {"letter": "Limit - Amount class", "count": 2}, {"letter": "Unspecified - Name type", "count": 1}, {"letter": "Emergency Number", "count": 1}, {"letter": "Business Telephone Number", "count": 1}, {"letter": "Doctor number", "count": 2}, {"letter": "Identifier type - Person number", "count": 6}, {"letter": "Provider number", "count": 1}, {"letter": "Visit Number", "count": 11}, {"letter": "Relational Operator - Equal", "count": 9}, {"letter": "MFA Message Structure", "count": 5}, {"letter": "R01", "count": 1}, {"letter": "R23", "count": 1}, {"letter": "ROR - Message structure", "count": 2}, {"letter": "V02", "count": 1}, {"letter": "Diploma", "count": 1}, {"letter": "Primary Reason", "count": 1}, {"letter": "Clearing", "count": 1}, {"letter": "Normal Operation", "count": 1}, {"letter": "location - remote", "count": 8}, {"letter": "Lock - Remote control command", "count": 1}, {"letter": "Load - Remote control command", "count": 23}, {"letter": "Resume - Remote control command", "count": 4}, {"letter": "Setup - Remote control command", "count": 5}, {"letter": "Control specimen", "count": 4}, {"letter": "Container status - Identified", "count": 6}, {"letter": "In Position", "count": 6}, {"letter": "M4 Additive/Preservative", "count": 23}, {"letter": "Plasma, NOS (not otherwise specified)", "count": 1}, {"letter": "Specimen Type - Serum", "count": 268}, {"letter": "Supernatant", "count": 4}, {"letter": "control substance", "count": 230}, {"letter": "Pretreatment (substance)", "count": 61}, {"letter": "Batch (Response Modality)", "count": 8}, {"letter": "Real Time", "count": 21}, {"letter": "Health Outcomes", "count": 12}, {"letter": "ICCS", "count": 1}, {"letter": "Gluteal", "count": 1}, {"letter": "Ambulatory Status", "count": 1}, {"letter": "Patient type", "count": 4}, {"letter": "Order status", "count": 1}, {"letter": "Diagnosis type", "count": 1}, {"letter": "Performed By", "count": 79}, {"letter": "Result Status", "count": 2}, {"letter": "value type field", "count": 1}, {"letter": "Person Disability Type - Hearing impaired", "count": 3}, {"letter": "definition - ActMoodCompletionTrack", "count": 105}, {"letter": "Act Mood - intent", "count": 2}, {"letter": "event criterion", "count": 3}, {"letter": "option - ActMoodPredicate", "count": 1}, {"letter": "Observation Interpretation - intermediate", "count": 37}, {"letter": "low confidentiality", "count": 161}, {"letter": "informant", "count": 1}, {"letter": "tracker", "count": 4}, {"letter": "anesthesist", "count": 1}, {"letter": "record target", "count": 1}, {"letter": "consumable", "count": 1}, {"letter": "Participation Type - origin", "count": 1}, {"letter": "via", "count": 9}, {"letter": "Target Awareness - uninformed", "count": 1}, {"letter": "Target Awareness - partial", "count": 227}, {"letter": "Target Awareness - marginal", "count": 6}, {"letter": "incapable", "count": 1}, {"letter": "Fulfill", "count": 138}, {"letter": "Act Relationship Checkpoint - through", "count": 1}, {"letter": "Act Relationship Checkpoint - exit", "count": 7}, {"letter": "Nitrogen Handling", "count": 1}, {"letter": "additive ingredient", "count": 2}, {"letter": "color additive", "count": 15}, {"letter": "Instance", "count": 14}, {"letter": "Specimen Type - Abscess", "count": 2}, {"letter": "Line Specimen", "count": 118}, {"letter": "Specimen Type - Macrophages", "count": 5}, {"letter": "Specimen Type - Stool = Fecal", "count": 9}, {"letter": "Compress (Compression Algorithm)", "count": 1}, {"letter": "Address Part Type- municipality", "count": 1}, {"letter": "Entity Name Part Type - given", "count": 10}, {"letter": "Prefix", "count": 1}, {"letter": "JB - GTSAbbreviation", "count": 3}, {"letter": "Units Of Measure - Siemens", "count": 4}, {"letter": "Tesla - unit", "count": 4}, {"letter": "Units Of Measure - lumen", "count": 4}, {"letter": "are unit of measure", "count": 64}, {"letter": "Erg - unit of measure", "count": 2}, {"letter": "Urgent Care Clinic/Center", "count": 1}, {"letter": "diagnostic image", "count": 4}, {"letter": "Entity", "count": 1926}, {"letter": "Entity Class - imaging modality", "count": 22}, {"letter": "acute inpatient encounter", "count": 31}, {"letter": "Initial Volume", "count": 7}, {"letter": "intended - ParticipationSignature", "count": 26}, {"letter": "Incident", "count": 25}, {"letter": "coverage - financial contract", "count": 7}, {"letter": "holder", "count": 1}, {"letter": "Recalcification", "count": 1}, {"letter": "In Process", "count": 4}, {"letter": "Container status - Missing", "count": 7}, {"letter": "Observation Method - Magnetic resonance", "count": 3}, {"letter": "Ottawa (ethnic group)", "count": 10}, {"letter": "Tewa (ethnic group)", "count": 5}, {"letter": "Stewart (ethnic group)", "count": 1}, {"letter": "Circle Tribe (ethnic group)", "count": 10}, {"letter": "Eagle (ethnic group)", "count": 1}, {"letter": "Nome (ethnic group)", "count": 1}, {"letter": "Mono language", "count": 1}, {"letter": "subscriber - self", "count": 64}, {"letter": "inform", "count": 3}, {"letter": "indirect target", "count": 1}, {"letter": "active moiety", "count": 2}, {"letter": "clinical research investigator", "count": 1}, {"letter": "personal relationship", "count": 1}, {"letter": "scoring - solid dosage form", "count": 3}, {"letter": "Staff Member", "count": 5}, {"letter": "Maxillary right canine implant", "count": 2}, {"letter": "Maxillary right second premolar mesial prosthesis", "count": 1}, {"letter": "Respiratory Therapist, Registered - Patient Education", "count": 2}, {"letter": "Any", "count": 301}, {"letter": "Act Class - investigation", "count": 16}, {"letter": "Arabic <List Style>", "count": 4}, {"letter": "Style Type - Square", "count": 26}, {"letter": "PersonNameUse - assigned", "count": 132}, {"letter": "search - EntityNameUse", "count": 1}, {"letter": "Act Relationship Subset - previous", "count": 9}, {"letter": "ActRelationshipSubset - minimum", "count": 26}, {"letter": "Act Relationship Subset - maximum", "count": 178}, {"letter": "summary - ActRelationshipSubset", "count": 13}, {"letter": "Act Class - review", "count": 155}, {"letter": "Greek letter gamma", "count": 12}, {"letter": "exponential", "count": 4}, {"letter": "chi square", "count": 13}, {"letter": "Parameterized Data Type - Interval", "count": 170}, {"letter": "Periodic Interval - ParameterizedDataType", "count": 2}, {"letter": "Annotated - ParameterizedDataType", "count": 4}, {"letter": "Historical - ParameterizedDataType", "count": 35}, {"letter": "Boolean", "count": 4}, {"letter": "described", "count": 187}, {"letter": "Entity Determiner - specific", "count": 5}, {"letter": "living subject", "count": 1}, {"letter": "Wound clinic", "count": 1}, {"letter": "justify", "count": 2}, {"letter": "TableCellVerticalAlign - bottom", "count": 1}, {"letter": "Table Cell Vertical Align - middle", "count": 3}, {"letter": "Table Frame - above", "count": 28}, {"letter": "Table Frame - below", "count": 6}, {"letter": "row - Table", "count": 4}, {"letter": "Row (arrangement)", "count": 5}, {"letter": "contents - HtmlLinkType", "count": 1}, {"letter": "Html Link Type - index", "count": 2}, {"letter": "Subsection", "count": 5}, {"letter": "Help document", "count": 12}, {"letter": "include - SetOperator", "count": 13}, {"letter": "Universal - VocabularyDomainQualifier", "count": 11}, {"letter": "Adenovirus Vaccine", "count": 1}, {"letter": "hand - unit of measure", "count": 1}, {"letter": "Square Mile", "count": 4}, {"letter": "pace - unit of measure", "count": 6}, {"letter": "Line Unit of Length", "count": 15}, {"letter": "point - UnitsOfMeasure", "count": 471}, {"letter": "Hounsfield unit", "count": 2}, {"letter": "High Power Field", "count": 5}, {"letter": "bit - unit of measure", "count": 70}, {"letter": "Giga", "count": 1}, {"letter": "Kilo", "count": 1}, {"letter": "Milli", "count": 2}, {"letter": "Unit Of Measure Prefix - micro", "count": 21}, {"letter": "Observation Method - Dipstick", "count": 2}, {"letter": "Platinum (ethnic group)", "count": 17}, {"letter": "St. Paul Aleuts", "count": 1}, {"letter": "registration - ActClass", "count": 77}, {"letter": "Hold - dosing instruction fragment", "count": 18}, {"letter": "summarized by", "count": 81}, {"letter": "Role Status - suspended", "count": 2}, {"letter": "terminated - RoleStatus", "count": 2}, {"letter": "Bed Location", "count": 1}, {"letter": "Suite", "count": 2}, {"letter": "System - kit", "count": 4}, {"letter": "monitoring program", "count": 1}, {"letter": "virtual patient encounter", "count": 18}, {"letter": "home health encounter", "count": 42}, {"letter": "Verifying specimen", "count": 1}, {"letter": "Face to face", "count": 9}, {"letter": "Participation Mode - videoconferencing", "count": 5}, {"letter": "Mandibular right second molar prosthesis", "count": 1}, {"letter": "Maxillary right first premolar abutment", "count": 1}, {"letter": "Maxillary right canine abutment", "count": 2}, {"letter": "Maxillary right central incisor abutment", "count": 29}, {"letter": "Maxillary left central incisor abutment", "count": 2}, {"letter": "Maxillary left lateral incisor abutment", "count": 1}, {"letter": "Maxillary left canine abutment", "count": 1}, {"letter": "Neighbor", "count": 1}, {"letter": "Currency - CodeSystem", "count": 1}, {"letter": "Sequencing - CodeSystem", "count": 20}, {"letter": "Code System Type - Internal", "count": 46}, {"letter": "Concept Status - Proposed", "count": 63}, {"letter": "risk factors - observation list", "count": 36}, {"letter": "Mitigate", "count": 1}, {"letter": "continuing therapy", "count": 2}, {"letter": "Observation Method - algorithm", "count": 14}, {"letter": "Excluded - Conformance Inclusion", "count": 4}, {"letter": "Replace - HL7UpdateMode", "count": 1}, {"letter": "ignored", "count": 6}, {"letter": "HL7CommitteeIDInRIM <Patient Administration>", "count": 71}, {"letter": "MDF Attribute Type - Quantity", "count": 12}, {"letter": "Time Range", "count": 1}, {"letter": "Text - MDFAttributeType", "count": 2}, {"letter": "Mandatory - HL7DefinedRoseProperty", "count": 1}, {"letter": "Dual", "count": 17}, {"letter": "Gender Status - Intact", "count": 5}, {"letter": "ActClass - consent", "count": 30}, {"letter": "Role Class - access", "count": 22}, {"letter": "dedicated service delivery location", "count": 1}, {"letter": "Act Relationship Type - occurrence", "count": 345}, {"letter": "Act Relationship Type - schedules", "count": 7}, {"letter": "exception - ResponseLevel", "count": 25}, {"letter": "completion - ResponseLevel", "count": 24}, {"letter": "ResponseLevel - modification", "count": 43}, {"letter": "HTTP", "count": 5}, {"letter": "Patient Deceased", "count": 30}, {"letter": "reverses", "count": 1}, {"letter": "Assessed patient - therapy appropriate", "count": 83}, {"letter": "promise", "count": 6}, {"letter": "intermediate diagnosis", "count": 1}, {"letter": "inpatient encounter", "count": 5}, {"letter": "Oncology Service", "count": 1}, {"letter": "Not Eligible", "count": 2}, {"letter": "Leave of Absence Supply", "count": 1}, {"letter": "Initial (abbreviation)", "count": 263}, {"letter": "Loan", "count": 1}, {"letter": "Transaction counts and value totals - provider", "count": 1}, {"letter": "Great extent", "count": 1}, {"letter": "Washoe language", "count": 17}, {"letter": "travel charge", "count": 5}, {"letter": "Transaction counts and value totals - Payor", "count": 2}, {"letter": "recovery - adjustment", "count": 35}, {"letter": "electronic health record - ActClassContainer", "count": 7}, {"letter": "Act Class - Attestable unit", "count": 2}, {"letter": "topic - ActClassContainer", "count": 22}, {"letter": "Nation", "count": 1}, {"letter": "Physicians - Internal Medicine - Medical Oncology", "count": 6}, {"letter": "Physicians - Nuclear Medicine", "count": 2}, {"letter": "Technician", "count": 3}, {"letter": "English (ethnic group)", "count": 4}, {"letter": "French (ethnic group)", "count": 8}, {"letter": "Germans", "count": 15}, {"letter": "Nigerians (ethnic group)", "count": 2}, {"letter": "Unknown - Relationship", "count": 3}, {"letter": "Nutrition, Calories", "count": 2}, {"letter": "Grade 3 Hypertension, CTCAE", "count": 1}, {"letter": "Grade 4 Hypertension, CTCAE", "count": 1}, {"letter": "Grade 2 Pericarditis, CTCAE", "count": 1}, {"letter": "Grade 3 Fatigue, CTCAE", "count": 6}, {"letter": "Grade 3 Nausea, CTCAE", "count": 12}, {"letter": "Grade 4 Nausea, CTCAE", "count": 2}, {"letter": "Grade 5 Nausea, CTCAE", "count": 1}, {"letter": "Grade 3 Febrile Neutropenia, CTCAE", "count": 5}, {"letter": "Grade 4 Febrile Neutropenia, CTCAE", "count": 3}, {"letter": "Adverse Event Associated with the Lymphatic System", "count": 1}, {"letter": "Adverse Event Associated with Metabolic and Laboratory Abnormalities", "count": 1}, {"letter": "Grade 3 Amylase, CTCAE", "count": 2}, {"letter": "Blurred Vision, CTCAE", "count": 1}, {"letter": "Grade 3 Breast Pain, CTCAE", "count": 1}, {"letter": "Grade 1 Pain NOS, CTCAE", "count": 1}, {"letter": "Grade 2 Pain NOS, CTCAE", "count": 1}, {"letter": "Grade 3 Pain NOS, CTCAE", "count": 3}, {"letter": "Grade 4 Pain NOS, CTCAE", "count": 1}, {"letter": "Adverse Event Associated with the Kidney and Genitourinary System", "count": 2}, {"letter": "Adverse Event Associated with Secondary Malignancy", "count": 8}, {"letter": "Adverse Event Associated with Syndromes", "count": 2}, {"letter": "Adverse Event Associated with Vascular", "count": 1}, {"letter": "Grade 5 Death NOS, CTCAE", "count": 8}, {"letter": "Alopecia, CTCAE", "count": 26}, {"letter": "Grade 1 Alopecia, CTCAE", "count": 1}, {"letter": "Pruritus, CTCAE", "count": 10}, {"letter": "Grade 2 Radiation Excluding Chemoradiation, CTCAE", "count": 4}, {"letter": "Grade 3 Radiation Excluding Chemoradiation, CTCAE", "count": 2}, {"letter": "Grade 4 Radiation Excluding Chemoradiation, CTCAE", "count": 1}, {"letter": "Urticaria, CTCAE", "count": 1}, {"letter": "Hot Flashes or Flushes Adverse Event", "count": 1}, {"letter": "Grade 2 Diarrhea, CTCAE", "count": 2}, {"letter": "Grade 3 Diarrhea, CTCAE", "count": 10}, {"letter": "Grade 4 Diarrhea, CTCAE", "count": 1}, {"letter": "Grade 5 Diarrhea, CTCAE", "count": 1}, {"letter": "Grade 3 Vomiting, CTCAE", "count": 2}, {"letter": "Grade 4 Vomiting, CTCAE", "count": 1}, {"letter": "Grade 4 Creatinine, CTCAE", "count": 2}, {"letter": "Grade 3 Lipase, CTCAE", "count": 2}, {"letter": "Grade 2 Autoimmune Reaction, CTCAE", "count": 1}, {"letter": "Grade 3 Hemoglobin, CTCAE", "count": 1}, {"letter": "Grade 4 Hemoglobin, CTCAE", "count": 1}, {"letter": "Grade 3 Platelets, CTCAE", "count": 2}, {"letter": "Grade 4 Platelets, CTCAE", "count": 1}, {"letter": "Dysphagia, CTCAE", "count": 3}, {"letter": "Grade 3 Brachial Plexopathy, CTCAE", "count": 1}, {"letter": "HL7 2.5 Event type", "count": 20}, {"letter": "Sequencing", "count": 2}, {"letter": "Liquid Specimen", "count": 6}, {"letter": "Act Relationship Join - detached", "count": 1}, {"letter": "Specimen Source Codes - Mucosa", "count": 2}, {"letter": "Quality Control Specimen", "count": 3}, {"letter": "Money or percentage indicator - Percentage", "count": 2040}, {"letter": "Creatinine, CTCAE", "count": 11}, {"letter": "*Activity (kind of quantity)", "count": 224}, {"letter": "Kind of quantity - Frequency", "count": 80}, {"letter": "Glomerular Filtration Rate, CTCAE", "count": 1}, {"letter": "CTCAE CD4 count", "count": 2}, {"letter": "detail - Response Level", "count": 1}, {"letter": "film - layer", "count": 5}, {"letter": "counselor", "count": 1}, {"letter": "Overall", "count": 296}, {"letter": "Admission Level of Care Code - Improved", "count": 10}, {"letter": "Chronic Kidney Diseases", "count": 2}, {"letter": "History of fall", "count": 1}, {"letter": "Supernumerary mandibular left central primary incisor", "count": 64}, {"letter": "Positioning patient (procedure)", "count": 5}, {"letter": "Number of minutes", "count": 2}, {"letter": "Peptide hormone precursor", "count": 2}, {"letter": "End diastole", "count": 1}, {"letter": "Chest, abdomen, and pelvis", "count": 1}, {"letter": "Light chain level", "count": 1}, {"letter": "PACU record", "count": 2}, {"letter": "Hoover technique", "count": 8}, {"letter": "Patient in partial remission", "count": 9}, {"letter": "Cell feature", "count": 2}, {"letter": "Oblique axis", "count": 1}, {"letter": "End systole", "count": 1}, {"letter": "Ropiness", "count": 1}, {"letter": "Still technique", "count": 2}, {"letter": "Intra-Abdominal Fat", "count": 2}, {"letter": "Visceral Fat", "count": 4}, {"letter": "Subcutaneous Fat, Abdominal", "count": 1}, {"letter": "Abdominal Fat", "count": 1}, {"letter": "adiposity", "count": 2}, {"letter": "Abraxane", "count": 21}, {"letter": "monomethyl auristatin E", "count": 5}, {"letter": "MAF protein, human", "count": 1}, {"letter": "NFE2L2 protein, human", "count": 2}, {"letter": "Renal Insufficiency", "count": 8}, {"letter": "FGFR4 protein, human", "count": 1}, {"letter": "PTGS1 protein, human", "count": 46}, {"letter": "PTGS2 protein, human", "count": 7}, {"letter": "LBH589", "count": 5}, {"letter": "SMAD5 protein, human", "count": 3}, {"letter": "AEG 35156", "count": 2}, {"letter": "GZMB protein, human", "count": 3}, {"letter": "CASP3 protein, human", "count": 5}, {"letter": "PARP1 protein, human", "count": 8}, {"letter": "icaritin", "count": 2}, {"letter": "MST1 protein, human", "count": 3}, {"letter": "Genes, Neoplasm", "count": 12}, {"letter": "Study Characteristics", "count": 1}, {"letter": "IFNAR2 protein, human", "count": 1}, {"letter": "Endocrine Disruptors", "count": 1}, {"letter": "FLT1 protein, human", "count": 27}, {"letter": "SOX2 protein, human", "count": 1}, {"letter": "PD 0332991", "count": 29}, {"letter": "Oral Mucositis", "count": 16}, {"letter": "HGS protein, human", "count": 22}, {"letter": "insulin-like growth factor 2, human", "count": 1}, {"letter": "CD163 protein, human", "count": 4}, {"letter": "ATF7IP protein, human", "count": 1}, {"letter": "C3 protein, human", "count": 1}, {"letter": "dabigatran etexilate", "count": 17}, {"letter": "AN 7A (peptide)", "count": 2}, {"letter": "Objective observation", "count": 1329}, {"letter": "Act Mood - Goal", "count": 27}, {"letter": "Follicle", "count": 11}, {"letter": "Doing housework", "count": 4}, {"letter": "Number of breaths", "count": 2}, {"letter": "Visceral manipulation", "count": 1}, {"letter": "Relative density", "count": 2}, {"letter": "Write - language ability", "count": 3}, {"letter": "Patient location type - Operating Room", "count": 9}, {"letter": "Data types - Date/time", "count": 4}, {"letter": "Specimen Source Codes - tumor", "count": 513}, {"letter": "Neutralization (Chemistry)", "count": 1}, {"letter": "Insulin [EPC]", "count": 4}, {"letter": "Blister of skin AND/OR mucosa", "count": 1}, {"letter": "Sore mouth", "count": 2}, {"letter": "Act Reason - Error", "count": 19}, {"letter": "Gastrointestinal Leak NOS, CTCAE", "count": 2}, {"letter": "Vascular Access Ports", "count": 1}, {"letter": "Computed Axial Tomography Scanners", "count": 1}, {"letter": "whole blood specimen", "count": 15}, {"letter": "Preventive surgery", "count": 1}, {"letter": "Uniform - ProbabilityDistributionType", "count": 1}, {"letter": "TNFRSF4 protein, human", "count": 2}, {"letter": "DataType", "count": 1}, {"letter": "tocilizumab", "count": 4}, {"letter": "Document completion status - Documented", "count": 80}, {"letter": "cDNA Microarray Analysis", "count": 5}, {"letter": "aborted - ActStatus", "count": 1}, {"letter": "Residual", "count": 176}, {"letter": "Interferon Alpha, Human", "count": 6}, {"letter": "Specimen Source Codes - Quality Control", "count": 1}, {"letter": "wait", "count": 4}, {"letter": "flurbiprofen axetil", "count": 1}, {"letter": "Kind of quantity - Ratios", "count": 21}, {"letter": "Urine - SpecimenType", "count": 20}, {"letter": "Calcification of coronary artery", "count": 1}, {"letter": "KRT14 protein, human", "count": 1}, {"letter": "Cell marker (procedure)", "count": 9}, {"letter": "Specialist", "count": 1}, {"letter": "Tears - SpecimenType", "count": 1}, {"letter": "CD1C protein, human", "count": 1}, {"letter": "human MUC1 protein", "count": 34}, {"letter": "Pandemics", "count": 1}, {"letter": "erythrocyte sedimentation rate result", "count": 3}, {"letter": "Pain, Procedural", "count": 7}, {"letter": "SERPINE1 protein, human", "count": 9}, {"letter": "Intravenous Drip Route of Administration", "count": 1}, {"letter": "polyhedral organelle", "count": 1}, {"letter": "Administer - dosing instruction imperative", "count": 22}, {"letter": "Garcia <plant>", "count": 3}, {"letter": "Metaphase", "count": 1}, {"letter": "Glioblastoma Multiforme", "count": 4}, {"letter": "Tissue Growth", "count": 2}, {"letter": "envelope", "count": 2}, {"letter": "Genus Psyche", "count": 1}, {"letter": "death receptor ligand", "count": 1}, {"letter": "Migration, Cell", "count": 1}, {"letter": "SUMO activating enzyme complex", "count": 127}, {"letter": "Data Systems", "count": 2}, {"letter": "Protein Degradation, Regulatory", "count": 1}, {"letter": "tissue regeneration", "count": 1}, {"letter": "peptide modification", "count": 1}, {"letter": "Cola", "count": 1}, {"letter": "Electrocardiography", "count": 31}, {"letter": "deficiency aspects", "count": 2}, {"letter": "Eos <bird>", "count": 3}, {"letter": "Milliliter/milliliter", "count": 1}, {"letter": "Flexion.passive range of motion", "count": 1}, {"letter": "Anti-Antibodies", "count": 38}, {"letter": "Outcome of Event", "count": 3}, {"letter": "LOINC Event type", "count": 3}, {"letter": "Cells.CD3+CD16+CD56+", "count": 1}, {"letter": "Flexion.active range of motion", "count": 3}, {"letter": "Pain assessment:Prid:Pt:Cancer.XXX:Nom", "count": 1}, {"letter": "Denuded skin", "count": 6}, {"letter": "Unit dose - Base", "count": 1}, {"letter": "Stepdown unit", "count": 2}, {"letter": "Flexion test", "count": 1}, {"letter": "6/45", "count": 1}, {"letter": "Microgram per Kilogram", "count": 1}, {"letter": "erlotinib 150 MG", "count": 1}, {"letter": "Percent inhibition", "count": 45}, {"letter": "Inconclusive (qualifier value)", "count": 1}, {"letter": "Age at menopause", "count": 3}, {"letter": "6/3", "count": 2}, {"letter": "Quadrant", "count": 5}, {"letter": "apply - action", "count": 2}, {"letter": "Times", "count": 1}, {"letter": "bottle - unit dose", "count": 1}, {"letter": "CT angiography of coronary arteries", "count": 1}, {"letter": "Percentage live", "count": 2}, {"letter": "Percentage deficient", "count": 5}, {"letter": "Percentage index", "count": 206}, {"letter": "Box - unit dose", "count": 1}, {"letter": "Gently", "count": 4}, {"letter": "Percentage negative control", "count": 3}, {"letter": "Specimen obtained by surgical procedure", "count": 93}, {"letter": "Basal rate", "count": 5}, {"letter": "Number of steps", "count": 12}, {"letter": "Camera <invertebrate>", "count": 3}, {"letter": "NIH Roadmap Initiative tag", "count": 2}, {"letter": "positive regulation of biological process", "count": 1}, {"letter": "Human Papillomavirus Test", "count": 3}, {"letter": "Echo (insect)", "count": 42}, {"letter": "negative regulation of biological process", "count": 1}, {"letter": "Phosphorylated Epidermal Growth Factor Receptor", "count": 4}, {"letter": "heart morphology", "count": 3}, {"letter": "blood oxygen level dependent", "count": 6}, {"letter": "study of epigenetics", "count": 7}, {"letter": "skin development", "count": 5}, {"letter": "Patient Safety LOINC Clinical Class", "count": 7}, {"letter": "UTP-monosaccharide-1-phosphate uridylyltransferase activity", "count": 1}, {"letter": "cardiac muscle tissue development", "count": 1}, {"letter": "tissue morphogenesis", "count": 1}, {"letter": "Syringe Caps", "count": 4}, {"letter": "pregabalin 75 MG", "count": 2}, {"letter": "tumor vasculature", "count": 2}, {"letter": "Breast Density", "count": 40}, {"letter": "consult with surgeon", "count": 1}, {"letter": "developmental growth", "count": 1}, {"letter": "IL33 protein, human", "count": 4}, {"letter": "Iso", "count": 10}, {"letter": "RASGRF1 protein, human", "count": 1}, {"letter": "Nepa", "count": 1}, {"letter": "Feeling unhappy", "count": 2}, {"letter": "Percentage excreted", "count": 9}, {"letter": "KLRB1 protein, human", "count": 1}, {"letter": "% bound (qualifier value)", "count": 7}, {"letter": "Exposure to light", "count": 1}, {"letter": "Absence (morphologic abnormality)", "count": 339}, {"letter": "% volume (qualifier value)", "count": 102}, {"letter": "denosumab", "count": 13}, {"letter": "Kit Dosing Unit", "count": 27}, {"letter": "nmol BCE", "count": 3}, {"letter": "TEC protein, human", "count": 1}, {"letter": "20/25", "count": 3}, {"letter": "log10", "count": 1}, {"letter": "Referral placed", "count": 6}, {"letter": "Amended", "count": 1}, {"letter": "Cellular infiltrate", "count": 21}, {"letter": "termination - ActReason", "count": 41}, {"letter": "enrollment - ResearchSubjectRoleBasis", "count": 3}, {"letter": "Diffusion - RouteOfAdministration", "count": 5}, {"letter": "Burnout, Psychological", "count": 1}, {"letter": "Friends - (Religious Affiliation)", "count": 1}, {"letter": "CDISC SDTM Respiratory Test Name Terminology", "count": 22}, {"letter": "per protocol", "count": 54}, {"letter": "Malignant Solid Neoplasm", "count": 1}, {"letter": "Muscle Weakness Upper Limb", "count": 1}, {"letter": "cediranib", "count": 4}, {"letter": "short stay encounter", "count": 3}, {"letter": "work related", "count": 3}, {"letter": "Third Party", "count": 13}, {"letter": "Upper extremity dysfunction", "count": 3}, {"letter": "IL6 protein, human", "count": 70}, {"letter": "CXCL8 protein, human", "count": 1}, {"letter": "research subject screening", "count": 1}, {"letter": "Storage", "count": 37}, {"letter": "symbol - solid dosage form", "count": 8}, {"letter": "Digital Imaging and Communications in Medicine (DICOM)", "count": 1}, {"letter": "IL7 protein, human", "count": 2}, {"letter": "PET/CT scan", "count": 96}, {"letter": "unscheduled - ClinicalResearchEventReason", "count": 14}, {"letter": "IL9 protein, human", "count": 1}, {"letter": "IL10 protein, human", "count": 32}, {"letter": "fingolimod", "count": 1}, {"letter": "IL20 protein, human", "count": 2}, {"letter": "sunitinib malate", "count": 2}, {"letter": "SNRPN protein, human", "count": 2}, {"letter": "IL2RA protein, human", "count": 9}, {"letter": "IL22 protein, human", "count": 1}, {"letter": "ITGAM protein, human", "count": 2}, {"letter": "CD9 protein, human", "count": 1}, {"letter": "interleukin-4, human", "count": 1}, {"letter": "IL17A protein, human", "count": 3}, {"letter": "Conditional", "count": 19}, {"letter": "ERBB2 protein, human", "count": 309}, {"letter": "IL2 protein, human", "count": 2}, {"letter": "IL5 protein, human", "count": 3}, {"letter": "IL1A protein, human", "count": 7}, {"letter": "IL1B protein, human", "count": 11}, {"letter": "Specialized", "count": 4}, {"letter": "Physicians, Family", "count": 1}, {"letter": "Metastatic Malignant Neoplasm to the Leptomeninges", "count": 6}, {"letter": "Principal component analysis of arterial velocity waveform", "count": 1}, {"letter": "Magnitude", "count": 34}, {"letter": "complex (molecular entity)", "count": 27}, {"letter": "Greater", "count": 494}, {"letter": "Peritoneal Cavity", "count": 1}, {"letter": "Medical Image", "count": 3}, {"letter": "transforming growth factor beta 1", "count": 2}, {"letter": "Molecular Genetic Abnormality", "count": 3}, {"letter": "Abnormality", "count": 29}, {"letter": "Biochemical Pathway", "count": 40}, {"letter": "Interleukin 1 Receptor Antagonist Protein", "count": 2}, {"letter": "Spasmodic movement", "count": 2}, {"letter": "Clinical Services", "count": 1}, {"letter": "Recombinant Luteinizing Hormone", "count": 2}, {"letter": "Health Professional", "count": 41}, {"letter": "Orientation (spatial)", "count": 29}, {"letter": "Scientific Publication", "count": 21}, {"letter": "Cluster", "count": 30}, {"letter": "Skeletal Myocytes", "count": 1}, {"letter": "diagnosis aspect", "count": 11}, {"letter": "tesmilifene", "count": 5}, {"letter": "Reviewing", "count": 6}, {"letter": "Carcinoma of Endocrine Gland", "count": 2}, {"letter": "Treatment Step", "count": 6}, {"letter": "Imaging Technology", "count": 1}, {"letter": "Clonality", "count": 5}, {"letter": "Tolerance", "count": 4}, {"letter": "Valve Device", "count": 2}, {"letter": "Effective", "count": 7}, {"letter": "Geriatric (qualifier)", "count": 13}, {"letter": "Multiplicative Product", "count": 1}, {"letter": "Ventral", "count": 3}, {"letter": "Filter (function)", "count": 2}, {"letter": "Numeric - Data types", "count": 2}, {"letter": "Top (position)", "count": 27}, {"letter": "Active Method", "count": 16}, {"letter": "Direct Method", "count": 3}, {"letter": "Osteopathic Combined Method", "count": 5}, {"letter": "Longitudinal Axis", "count": 2}, {"letter": "Pin Device Component", "count": 2}, {"letter": "Still Method", "count": 2}, {"letter": "Data Value", "count": 9}, {"letter": "International Medical Terminology", "count": 18}, {"letter": "Unrelated to Intervention", "count": 42}, {"letter": "Exposure Domain", "count": 5}, {"letter": "Vital Signs Domain", "count": 21}, {"letter": "Expiration", "count": 2}, {"letter": "Disease Response", "count": 503}, {"letter": "Matrix Array", "count": 4}, {"letter": "Analysis Dataset Domain", "count": 1}, {"letter": "Diagnosis Study", "count": 93}, {"letter": "Hyperlink", "count": 2}, {"letter": "Window Device", "count": 16}, {"letter": "Interaction", "count": 87}, {"letter": "Staining (finding)", "count": 1}, {"letter": "probe gene fragment", "count": 16}, {"letter": "Follow-Up Report", "count": 225}, {"letter": "Initiation", "count": 228}, {"letter": "Post Device", "count": 8}, {"letter": "Run action", "count": 1}, {"letter": "Bearing Device", "count": 3}, {"letter": "FCGR3A wt Allele", "count": 13}, {"letter": "RELA wt Allele", "count": 1}, {"letter": "Medical History Domain", "count": 13}, {"letter": "Computer program package", "count": 4}, {"letter": "Distribution", "count": 60}, {"letter": "Can - object", "count": 1}, {"letter": "EWSR1 wt Allele", "count": 1}, {"letter": "FGFR1 wt Allele", "count": 3}, {"letter": "Statistical Confidence", "count": 7}, {"letter": "Confidence", "count": 9}, {"letter": "Department", "count": 14}, {"letter": "Page (document)", "count": 13}, {"letter": "Regulator", "count": 8}, {"letter": "Bioelectric Impedance Analysis", "count": 18}, {"letter": "Trial Inclusion and Exclusion Criteria Submission Domain", "count": 2}, {"letter": "Bar Dosing Unit", "count": 1}, {"letter": "Place - dosing instruction imperative", "count": 24}, {"letter": "Programming Parameter", "count": 209}, {"letter": "Association Class", "count": 2}, {"letter": "Load Component of Device", "count": 1}, {"letter": "Definitely Related to Intervention", "count": 15}, {"letter": "Definition", "count": 4698}, {"letter": "Demographics Domain", "count": 2}, {"letter": "CCR5 wt Allele", "count": 1}, {"letter": "PPP3R1 wt Allele", "count": 7}, {"letter": "EPCAM wt Allele", "count": 5}, {"letter": "Item Collection", "count": 6}, {"letter": "EPHA4 wt Allele", "count": 1}, {"letter": "MET wt Allele", "count": 7}, {"letter": "ERBB2 wt Allele", "count": 7}, {"letter": "ERBB3 wt Allele", "count": 2}, {"letter": "HIF1A wt Allele", "count": 2}, {"letter": "DDR1 wt Allele", "count": 1}, {"letter": "NPM1 wt Allele", "count": 1}, {"letter": "Computer Programming Object", "count": 2}, {"letter": "Molecular Signature", "count": 19}, {"letter": "TAF1 wt Allele", "count": 131}, {"letter": "Tape Device", "count": 9}, {"letter": "Image", "count": 195}, {"letter": "ACTG2 wt Allele", "count": 16}, {"letter": "ACVR1 wt Allele", "count": 1}, {"letter": "ABCB1 wt Allele", "count": 1}, {"letter": "NAMPT wt Allele", "count": 1}, {"letter": "Means", "count": 296}, {"letter": "TEK wt Allele", "count": 1}, {"letter": "TNC wt Allele", "count": 3}, {"letter": "NBN wt Allele", "count": 1}, {"letter": "2-Dimensional", "count": 8}, {"letter": "Circumferential Resection Margin", "count": 16}, {"letter": "CCL27 wt Allele", "count": 6}, {"letter": "Volume (publication)", "count": 9}, {"letter": "Importance Weight", "count": 18}, {"letter": "Yes (indicator)", "count": 73}, {"letter": "Cylinder Device", "count": 1}, {"letter": "Refused", "count": 4}, {"letter": "Increment", "count": 46}, {"letter": "FLT4 wt Allele", "count": 1}, {"letter": "TNFRSF10B wt Allele", "count": 8}, {"letter": "FLT1 wt Allele", "count": 1}, {"letter": "Trace Dosing Unit", "count": 1}, {"letter": "Data Transformation", "count": 5}, {"letter": "Biomaterial Treatment", "count": 21}, {"letter": "Order (document)", "count": 26}, {"letter": "Order (arrangement)", "count": 78}, {"letter": "Order (taxonomic)", "count": 6}, {"letter": "Order (action)", "count": 15}, {"letter": "Reading (datum presentation)", "count": 10}, {"letter": "Recall (activity)", "count": 6}, {"letter": "Rod Device", "count": 1}, {"letter": "Safety Study", "count": 916}, {"letter": "Second Suffix", "count": 28}, {"letter": "Section (object)", "count": 2}, {"letter": "Seeding", "count": 17}, {"letter": "Server (computer)", "count": 2}, {"letter": "set (group)", "count": 5}, {"letter": "Slide Device", "count": 20}, {"letter": "Spot (mark)", "count": 12}, {"letter": "Recombinant Human Endostatin", "count": 2}, {"letter": "Drug Kit", "count": 1}, {"letter": "Tablet Dosing Unit", "count": 2}, {"letter": "THPO wt Allele", "count": 24}, {"letter": "Death Related to Adverse Event", "count": 62}, {"letter": "Detector Device", "count": 2}, {"letter": "Protocol Deviation", "count": 9}, {"letter": "Device Evaluation - process", "count": 1}, {"letter": "Delta (difference)", "count": 554}, {"letter": "Different", "count": 386}, {"letter": "Coloring Excipient", "count": 1}, {"letter": "Component (part)", "count": 68}, {"letter": "Logical Condition", "count": 46}, {"letter": "Neonatal Deformity", "count": 3}, {"letter": "Concept History", "count": 1}, {"letter": "Organ Measurement Domain", "count": 1}, {"letter": "Mathematical Operator", "count": 187}, {"letter": "Operator of Medical Device", "count": 2}, {"letter": "CDKN2A wt Allele", "count": 35}, {"letter": "Mutation Abnormality", "count": 30}, {"letter": "SEG Algorithm", "count": 16}, {"letter": "Sequential", "count": 10}, {"letter": "NR0B2 wt Allele", "count": 5}, {"letter": "PMEL wt Allele", "count": 2}, {"letter": "Term (lexical)", "count": 73}, {"letter": "Terminal Device", "count": 1}, {"letter": "TERT wt Allele", "count": 1}, {"letter": "PTGS2 wt Allele", "count": 4}, {"letter": "IGF1R wt Allele", "count": 7}, {"letter": "Programmed Death Ligand 2 Protein", "count": 1}, {"letter": "PDCD1LG2 wt Allele", "count": 2}, {"letter": "GLI2 wt Allele", "count": 1}, {"letter": "GLI3 wt Allele", "count": 3}, {"letter": "Adverse Event Domain", "count": 25}, {"letter": "Communication Contact", "count": 14}, {"letter": "Device Display Device", "count": 2}, {"letter": "Integration (data processing)", "count": 5}, {"letter": "Pharmaceutical Product Label", "count": 1}, {"letter": "Group Object", "count": 5}, {"letter": "User Group", "count": 451}, {"letter": "Female-to-Male Transsexual, Self-Report", "count": 6}, {"letter": "Male-to-Female Transsexual, Self-Report", "count": 4}, {"letter": "Blood Oxygen Level Dependant Functional Magnetic Resonance Imaging", "count": 1}, {"letter": "Missing", "count": 90}, {"letter": "West (direction)", "count": 13}, {"letter": "Female Phenotype", "count": 7}, {"letter": "Chemical Formula", "count": 7}, {"letter": "Statistical Frequency", "count": 32}, {"letter": "VCL wt Allele", "count": 1}, {"letter": "KAT5 wt Allele", "count": 3}, {"letter": "Bolus Dosing Unit", "count": 1}, {"letter": "MAPK3 wt Allele", "count": 5}, {"letter": "TP53 wt Allele", "count": 5}, {"letter": "SERPINE1 wt Allele", "count": 3}, {"letter": "Substance Use Domain", "count": 5}, {"letter": "suggestion", "count": 62}, {"letter": "Summation (document)", "count": 5}, {"letter": "Suspension (action)", "count": 1}, {"letter": "Trial Arms Domain", "count": 16}, {"letter": "Packaging Tank", "count": 1}, {"letter": "Trial Elements Domain", "count": 2}, {"letter": "Template", "count": 1}, {"letter": "Count Dosing Unit", "count": 36}, {"letter": "Allogeneic Hematopoietic Stem Cell Transplantation", "count": 2}, {"letter": "AKAP13 wt Allele", "count": 3}, {"letter": "Adverse Event Outcome", "count": 4}, {"letter": "PIK3CB wt Allele", "count": 7}, {"letter": "CXCL8 wt Allele", "count": 16}, {"letter": "Routine Signature", "count": 4}, {"letter": "Text Line", "count": 3}, {"letter": "TFRC wt Allele", "count": 1}, {"letter": "Concept Relationship", "count": 170}, {"letter": "BLNK wt Allele", "count": 5}, {"letter": "Dropping", "count": 12}, {"letter": "Electrocardiogram Domain", "count": 8}, {"letter": "Entry (data)", "count": 108}, {"letter": "SMARCA2 wt Allele", "count": 2}, {"letter": "Initial Usage", "count": 20}, {"letter": "Inversion Mutation Abnormality", "count": 3}, {"letter": "With - dosing instruction fragment", "count": 325}, {"letter": "ETV3 wt Allele", "count": 3}, {"letter": "KDR wt Allele", "count": 5}, {"letter": "Statistical Mode", "count": 7}, {"letter": "Gene Amplification Abnormality", "count": 5}, {"letter": "Doubling", "count": 1}, {"letter": "Double Value Type", "count": 18}, {"letter": "Contralateral Prophylactic Mastectomy", "count": 4}, {"letter": "CD82 wt Allele", "count": 3}, {"letter": "MAPK1 wt Allele", "count": 1}, {"letter": "National Center for Biotechnology Information", "count": 1}, {"letter": "Generic Role", "count": 10}, {"letter": "Timeline", "count": 7}, {"letter": "Transfer Technique", "count": 63}, {"letter": "Trial Title", "count": 8}, {"letter": "Senior - Suffix", "count": 24}, {"letter": "RHOH wt Allele", "count": 1}, {"letter": "Exception - Property or Attribute", "count": 23}, {"letter": "Execution", "count": 4}, {"letter": "Before - dosing instruction fragment", "count": 29}, {"letter": "Frame Device", "count": 4}, {"letter": "Possibly Related to Intervention", "count": 265}, {"letter": "Pharmacokinetic Parameters Domain", "count": 13}, {"letter": "Repeat Object", "count": 1}, {"letter": "Species", "count": 11}, {"letter": "Base - General Qualifier", "count": 1717}, {"letter": "Class (taxonomic)", "count": 1}, {"letter": "COILS Program", "count": 1}, {"letter": "Pharmaceutical Formulation", "count": 1}, {"letter": "E-mail Address", "count": 2}, {"letter": "Cartridge Dosing Unit", "count": 4}, {"letter": "Electrical Current", "count": 12}, {"letter": "ERCC2 wt Allele", "count": 2}, {"letter": "CCN3 wt Allele", "count": 11}, {"letter": "FCGR2B wt Allele", "count": 2}, {"letter": "IL2RA wt Allele", "count": 1}, {"letter": "Pathway (interactions)", "count": 42}, {"letter": "Device Motor", "count": 11}, {"letter": "CD40LG wt Allele", "count": 1}, {"letter": "Finish - dosing instruction imperative", "count": 7}, {"letter": "Data Table", "count": 69}, {"letter": "System User -- individual", "count": 9}, {"letter": "Arrival - action", "count": 6}, {"letter": "Departure - action", "count": 9}, {"letter": "Compound (substance)", "count": 14}, {"letter": "Both", "count": 17}, {"letter": "Box Dosing Unit", "count": 5}, {"letter": "Marked", "count": 48}, {"letter": "Channel Object", "count": 7}, {"letter": "Phase II B Trial", "count": 9}, {"letter": "EGFR wt Allele", "count": 2}, {"letter": "Pellet Dosing Unit", "count": 2}, {"letter": "Column (arrangement)", "count": 4}, {"letter": "PNP wt Allele", "count": 4}, {"letter": "Tree Node", "count": 1}, {"letter": "PTPA wt Allele", "count": 1}, {"letter": "Male Gender, Self Report", "count": 9}, {"letter": "Search - action", "count": 9}, {"letter": "Subject - topic", "count": 431}, {"letter": "Creation", "count": 49}, {"letter": "Body of axis", "count": 1}, {"letter": "Silo (dataset)", "count": 1}, {"letter": "SELL wt Allele", "count": 1}, {"letter": "Summary (document)", "count": 209}, {"letter": "Precision - characteristic", "count": 20}, {"letter": "PLAUR wt Allele", "count": 2}, {"letter": "Clinical Study Case", "count": 29}, {"letter": "SH2D3C wt Allele", "count": 1}, {"letter": "Near", "count": 7}, {"letter": "Object Relationship", "count": 3}, {"letter": "Interleukin-27", "count": 2}, {"letter": "Phlebotomist", "count": 7}, {"letter": "Fourth (suffix)", "count": 9}, {"letter": "Head - Component of Device", "count": 2}, {"letter": "Irritation (finding)", "count": 4}, {"letter": "Lambda (parameter)", "count": 1}, {"letter": "Length of Trial", "count": 129}, {"letter": "Long Variable", "count": 46}, {"letter": "CXCR3 wt Allele", "count": 1}, {"letter": "GNRH1 wt Allele", "count": 1}, {"letter": "Core Device", "count": 7}, {"letter": "Device Panel", "count": 42}, {"letter": "Mechanism Component of Device", "count": 1}, {"letter": "Periodic Report", "count": 1}, {"letter": "Device Evaluation Method", "count": 11}, {"letter": "Experiment Object", "count": 12}, {"letter": "Issue (document)", "count": 3}, {"letter": "STK11 wt Allele", "count": 1}, {"letter": "Placebo Control", "count": 63}, {"letter": "Port Device", "count": 1}, {"letter": "Interleukin-3 Receptor alpha Subunit", "count": 1}, {"letter": "Prevention Study", "count": 5}, {"letter": "Questionnaire Domain", "count": 129}, {"letter": "Inductive Resistance", "count": 1}, {"letter": "Concept (Terminology Entity)", "count": 4}, {"letter": "Trial Phase 2A", "count": 47}, {"letter": "Legal Adult", "count": 28}, {"letter": "Stem cell product", "count": 2}, {"letter": "Reader Device Component", "count": 8}, {"letter": "Reference Object", "count": 455}, {"letter": "Subject Characteristics Domain", "count": 21}, {"letter": "Discontinue - dosing instruction imperative", "count": 10}, {"letter": "Functional Map", "count": 21}, {"letter": "Swallow - dosing instruction imperative", "count": 3}, {"letter": "Device Cord", "count": 5}, {"letter": "Gene Symbol", "count": 3}, {"letter": "Matrix substance", "count": 4}, {"letter": "And/Or", "count": 7}, {"letter": "Greek letter phi", "count": 4}, {"letter": "During - dosing instruction fragment", "count": 18}, {"letter": "GRP wt Allele", "count": 1}, {"letter": "GRM1 wt Allele", "count": 1}, {"letter": "Stick Dosing Unit", "count": 1}, {"letter": "Adverse Effect Mitigation Study", "count": 2}, {"letter": "AZD 0530", "count": 3}, {"letter": "Absence of Invasion", "count": 1}, {"letter": "Acquisition (action)", "count": 69}, {"letter": "Additional Surgical Procedure", "count": 5}, {"letter": "Additional Therapy", "count": 5}, {"letter": "Adjuvant Radiation Therapy", "count": 2}, {"letter": "Administered Item", "count": 1}, {"letter": "Administrative Activity", "count": 7}, {"letter": "Adverse Event Characteristics", "count": 2}, {"letter": "Adverse Event Classification", "count": 7}, {"letter": "Agarose Gel", "count": 1}, {"letter": "Alignment", "count": 5}, {"letter": "Allocation", "count": 8}, {"letter": "AMACR wt Allele", "count": 18}, {"letter": "Annotation", "count": 5}, {"letter": "Response (statement)", "count": 194}, {"letter": "Applicable", "count": 16}, {"letter": "Article", "count": 4}, {"letter": "CXCR5 wt Allele", "count": 1}, {"letter": "Background", "count": 35}, {"letter": "Ball Device", "count": 4}, {"letter": "BARRIER", "count": 67}, {"letter": "Base Unit of International System of Units", "count": 2}, {"letter": "Binary", "count": 43}, {"letter": "Bioactive Food Component", "count": 1}, {"letter": "Bioavailability Study", "count": 2}, {"letter": "Blockage (obstruction - finding)", "count": 3}, {"letter": "Box Plot", "count": 13}, {"letter": "Brain White Matter", "count": 1}, {"letter": "Brief Symptom Inventory 18", "count": 3}, {"letter": "Pre-release version of a computer program", "count": 7}, {"letter": "CALM1 wt Allele", "count": 5}, {"letter": "temsirolimus", "count": 2}, {"letter": "CD44 wt Allele", "count": 1240}, {"letter": "CHEK1 wt Allele", "count": 3}, {"letter": "CP 751871", "count": 3}, {"letter": "CTBP1 wt Allele", "count": 1}, {"letter": "CTSL1 wt Allele, Human", "count": 1}, {"letter": "Cancer Other", "count": 3}, {"letter": "Cancer Research Group", "count": 3}, {"letter": "Capsular Contracture", "count": 16}, {"letter": "Carboxy-Terminal Amino Acid", "count": 4}, {"letter": "Cascade Device", "count": 10}, {"letter": "Cell Microenvironment", "count": 1}, {"letter": "Central Reviewer", "count": 3}, {"letter": "Brain Gray Matter", "count": 1}, {"letter": "Change in Emotional State", "count": 7}, {"letter": "Checklist", "count": 28}, {"letter": "bavituximab", "count": 2}, {"letter": "Choose (action)", "count": 307}, {"letter": "Coefficient", "count": 77}, {"letter": "Collision-Induced Dissociation", "count": 7}, {"letter": "Comparator Device", "count": 4}, {"letter": "Comparison", "count": 2131}, {"letter": "Complete Method of Relative Survival Calculation", "count": 1}, {"letter": "Conclusion", "count": 10}, {"letter": "Concomitant Therapy", "count": 13}, {"letter": "Connectivity", "count": 11}, {"letter": "Consecutive", "count": 119}, {"letter": "Consent Withdrawn", "count": 11}, {"letter": "Consumer", "count": 4}, {"letter": "Contrast-enhanced Magnetic Resonance Imaging", "count": 13}, {"letter": "Control Interaction", "count": 1}, {"letter": "Converter Device", "count": 1}, {"letter": "Coordinate on an axis or a grid", "count": 2}, {"letter": "Copy Number", "count": 11}, {"letter": "Correlation Test", "count": 4}, {"letter": "Created By", "count": 10}, {"letter": "Data Extraction", "count": 1}, {"letter": "Device Evaluation Result", "count": 15}, {"letter": "Speaker Device", "count": 1}, {"letter": "Switch Device", "count": 26}, {"letter": "Device Usage", "count": 1}, {"letter": "Digitizer Device", "count": 1}, {"letter": "Dimensionality", "count": 20}, {"letter": "Discrete Device", "count": 1}, {"letter": "Disease Relationship Object", "count": 1}, {"letter": "Dose Modification", "count": 40}, {"letter": "Dose Reduced", "count": 9}, {"letter": "PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1", "count": 2}, {"letter": "East", "count": 3}, {"letter": "Efficacy Study", "count": 597}, {"letter": "Elapse", "count": 23}, {"letter": "Electronic Health Record System", "count": 1}, {"letter": "Embedding", "count": 2}, {"letter": "Emitter Device", "count": 1}, {"letter": "Encoder Device", "count": 8}, {"letter": "Enumeration", "count": 9}, {"letter": "Evaluator - personnel", "count": 7}, {"letter": "Example", "count": 59}, {"letter": "Expander Device", "count": 14}, {"letter": "FACT-G Questionnaire", "count": 37}, {"letter": "FAT1 wt Allele", "count": 3}, {"letter": "FES wt Allele", "count": 1}, {"letter": "FGF2 wt Allele", "count": 1}, {"letter": "FLT3LG wt Allele", "count": 4}, {"letter": "Feature Information", "count": 1}, {"letter": "Optical Fiber Device", "count": 1}, {"letter": "Fiducial", "count": 1}, {"letter": "Fill", "count": 31}, {"letter": "Finished Pharmaceutical Product", "count": 15}, {"letter": "First line treatment", "count": 74}, {"letter": "Fisher's Exact Test", "count": 45}, {"letter": "Five-Day Report", "count": 2}, {"letter": "Flag", "count": 2}, {"letter": "GSTM1 wt Allele", "count": 1}, {"letter": "Gene Signature", "count": 16}, {"letter": "Genomic Identifier", "count": 1}, {"letter": "Genomic Molecule Entity", "count": 1}, {"letter": "Genus", "count": 1}, {"letter": "Sector", "count": 2}, {"letter": "Tumor Grading System", "count": 20}, {"letter": "Ex Vivo-Expanded HER2-Specific T Cells", "count": 1}, {"letter": "HP wt Allele", "count": 1}, {"letter": "HTATIP2 wt Allele", "count": 1}, {"letter": "Handle - program access", "count": 10}, {"letter": "Headphones", "count": 1}, {"letter": "Health Care Organization", "count": 1}, {"letter": "Healthy Volunteers", "count": 19}, {"letter": "Hospitalization Required", "count": 11}, {"letter": "Hydraulic System Device", "count": 2}, {"letter": "IFNA2 wt Allele", "count": 1}, {"letter": "IFNAR1 wt Allele", "count": 1}, {"letter": "IFNGR1 wt Allele", "count": 1}, {"letter": "IGF1 wt Allele", "count": 16}, {"letter": "IPI 504", "count": 3}, {"letter": "Image Acquisition", "count": 9}, {"letter": "Imager Device", "count": 6}, {"letter": "Imaging Center", "count": 1}, {"letter": "Implementation", "count": 42}, {"letter": "In Utero", "count": 1}, {"letter": "Inadequate pain relief", "count": 1}, {"letter": "Incidence Rate", "count": 44}, {"letter": "Mode of inheritance", "count": 1}, {"letter": "Input", "count": 8}, {"letter": "Integer (number)", "count": 6}, {"letter": "Interface Device", "count": 4}, {"letter": "Interval Scale", "count": 2}, {"letter": "Junior", "count": 1}, {"letter": "KISS1 wt Allele", "count": 2}, {"letter": "K Prime", "count": 5}, {"letter": "Kruskal-Wallis Test", "count": 4}, {"letter": "Labeled (qualifier)", "count": 19}, {"letter": "Lane", "count": 1}, {"letter": "Leaflet Device", "count": 2}, {"letter": "Let-7", "count": 1}, {"letter": "Loading Technique", "count": 5}, {"letter": "Gene Locus", "count": 1}, {"letter": "Event Log", "count": 226}, {"letter": "Low-Dose Treatment", "count": 10}, {"letter": "Lowest", "count": 144}, {"letter": "Lymphatic Invasion", "count": 6}, {"letter": "MK-0752", "count": 1}, {"letter": "Mann-Whitney Test", "count": 1}, {"letter": "Match", "count": 33}, {"letter": "Maximum Likelihood Estimation", "count": 1}, {"letter": "Median Income", "count": 1}, {"letter": "Medical Monitor", "count": 2}, {"letter": "Microdose", "count": 1}, {"letter": "Missed dose", "count": 2}, {"letter": "Mitotic Count", "count": 1}, {"letter": "Moderate-Dose Treatment", "count": 2}, {"letter": "Module", "count": 210}, {"letter": "Mutual", "count": 3}, {"letter": "N3a Stage Finding", "count": 1}, {"letter": "N3b Stage Finding", "count": 1}, {"letter": "N3c Stage Finding", "count": 1}, {"letter": "NCOA5 wt Allele", "count": 2}, {"letter": "Negative Surgical Margin", "count": 41}, {"letter": "Neoplastic", "count": 2}, {"letter": "Non-Neoplastic Disorder", "count": 3}, {"letter": "Non-Parametric Test", "count": 14}, {"letter": "North", "count": 3}, {"letter": "Observed Incidence", "count": 3}, {"letter": "Observed Survival", "count": 1}, {"letter": "Occur (action)", "count": 830}, {"letter": "Oncotype DX Breast Cancer Assay", "count": 13}, {"letter": "One-way Analysis of Variance", "count": 11}, {"letter": "One Sample t-Test", "count": 11}, {"letter": "Open Label Study", "count": 6}, {"letter": "Ordinal Scale", "count": 59}, {"letter": "system output", "count": 11}, {"letter": "P-Value", "count": 56}, {"letter": "PARP1 wt Allele", "count": 2}, {"letter": "PIK3CA wt Allele", "count": 16}, {"letter": "Rose Bengal Solution PV-10", "count": 2}, {"letter": "Painful Stimulation", "count": 1}, {"letter": "Pair", "count": 49}, {"letter": "Paired t-Test", "count": 74}, {"letter": "Part Dosing Unit", "count": 506}, {"letter": "Patient Base", "count": 22}, {"letter": "Patient Load", "count": 1}, {"letter": "Patient Navigators", "count": 2}, {"letter": "Pearson Correlation Test", "count": 5}, {"letter": "Percent Mass per Mass", "count": 12}, {"letter": "Personalized", "count": 15}, {"letter": "Pharmacodynamic Study", "count": 68}, {"letter": "Pharmacogenomic Study", "count": 2}, {"letter": "Pharmacokinetic Effect", "count": 1}, {"letter": "Physician Decision", "count": 2}, {"letter": "Pivot Device", "count": 3}, {"letter": "Pixel", "count": 3}, {"letter": "Point Estimation", "count": 1}, {"letter": "Pooled Sample", "count": 12}, {"letter": "Population Based Study", "count": 1}, {"letter": "Positive Surgical Margins", "count": 52}, {"letter": "Possibly Better", "count": 1}, {"letter": "Postcondition", "count": 1}, {"letter": "Practitioner", "count": 4}, {"letter": "Preclinical", "count": 6}, {"letter": "Precontrast", "count": 1}, {"letter": "Precursor", "count": 4}, {"letter": "Preferred Name", "count": 28}, {"letter": "Present/Absent Object", "count": 8}, {"letter": "Adverse Event Probably Related to Intervention", "count": 19}, {"letter": "Processing (action)", "count": 12}, {"letter": "Project", "count": 19}, {"letter": "Proportion", "count": 1157}, {"letter": "Proprotein", "count": 5}, {"letter": "Prospective Cohort Study", "count": 1}, {"letter": "Protein Turn", "count": 5}, {"letter": "Protocol Violation", "count": 1}, {"letter": "Pyrogenic", "count": 1}, {"letter": "Qualification", "count": 2}, {"letter": "Quantile", "count": 1}, {"letter": "Quantitation", "count": 172}, {"letter": "ROS1 wt Allele", "count": 2}, {"letter": "Ratio Scale", "count": 1}, {"letter": "Raw", "count": 32}, {"letter": "Real-Time Polymerase Chain Reaction", "count": 24}, {"letter": "Reason for Study Discontinuation", "count": 1}, {"letter": "Received By", "count": 13}, {"letter": "Recipient", "count": 4}, {"letter": "Recovered or Resolved", "count": 4}, {"letter": "RefSeq", "count": 1}, {"letter": "Reference Point", "count": 1}, {"letter": "Relay Device", "count": 1}, {"letter": "Remedial Action", "count": 2}, {"letter": "Reminder", "count": 5}, {"letter": "Reported By", "count": 113}, {"letter": "Response Evaluation Criteria in Solid Tumors", "count": 1523}, {"letter": "Rexin G", "count": 1}, {"letter": "Reviewed", "count": 28}, {"letter": "Reviewed By (qualifier)", "count": 1}, {"letter": "SNCG wt Allele", "count": 2}, {"letter": "Scalar", "count": 1}, {"letter": "Scanner Device", "count": 4}, {"letter": "Scope", "count": 4}, {"letter": "Disease Screening", "count": 160}, {"letter": "Screening", "count": 12}, {"letter": "Second line treatment", "count": 17}, {"letter": "Serious Injury", "count": 1}, {"letter": "Seriousness of Adverse Event", "count": 55}, {"letter": "Seven-Day Report", "count": 11}, {"letter": "Severity of Adverse Event", "count": 145}, {"letter": "Signal", "count": 56}, {"letter": "Site Investigator", "count": 10}, {"letter": "South", "count": 2}, {"letter": "Spearman Correlation Test", "count": 12}, {"letter": "Staircase", "count": 2}, {"letter": "Standard Biochemical Activity", "count": 1}, {"letter": "Standard Error", "count": 18}, {"letter": "Standard Transformed Enthalpy Change", "count": 1}, {"letter": "Standard Transformed Entropy Change", "count": 1}, {"letter": "Statement", "count": 83}, {"letter": "Statistical Technique", "count": 20}, {"letter": "Stock (in-store merchandise)", "count": 3}, {"letter": "Study Chair", "count": 2}, {"letter": "Research study coordinator", "count": 3}, {"letter": "Study Stop Rule", "count": 1}, {"letter": "Substrate Device", "count": 10}, {"letter": "Subtlety Score", "count": 2}, {"letter": "Suppressor Device", "count": 2}, {"letter": "Surgical Pathology Report", "count": 3}, {"letter": "Swedish ethnic group", "count": 19}, {"letter": "Synchronizer Device", "count": 1}, {"letter": "Systemic Reaction", "count": 2}, {"letter": "TNF wt Allele", "count": 16}, {"letter": "TPI-287", "count": 1}, {"letter": "TRRAP wt Allele", "count": 1}, {"letter": "Technical Problem", "count": 3}, {"letter": "Technology Platform", "count": 43}, {"letter": "Telemetry Equipment Device", "count": 1}, {"letter": "Term Type", "count": 4}, {"letter": "Test Context", "count": 1}, {"letter": "Total Nottingham Score", "count": 37}, {"letter": "Treating Physician", "count": 27}, {"letter": "Trial Phase", "count": 23}, {"letter": "Trial Screen Failure", "count": 1}, {"letter": "Trial Screening", "count": 15}, {"letter": "Tumor Model", "count": 1}, {"letter": "Type of Follow-Up Report", "count": 2}, {"letter": "Uniform Distribution", "count": 1}, {"letter": "Uniform Resource Locator", "count": 1}, {"letter": "Unilateral Breast Carcinoma", "count": 1}, {"letter": "Unique", "count": 26}, {"letter": "Unit of Fraction", "count": 2}, {"letter": "Unlikely Related to Intervention", "count": 9}, {"letter": "Upload", "count": 3}, {"letter": "Use with caution", "count": 1}, {"letter": "User Interface Device", "count": 1}, {"letter": "VIPR1 wt Allele", "count": 10}, {"letter": "Vacuum assisted biopsy", "count": 2}, {"letter": "Value Domain", "count": 1}, {"letter": "VEGF-AS", "count": 2}, {"letter": "Verbatim", "count": 3}, {"letter": "Viewer Device", "count": 3}, {"letter": "Visible To", "count": 1}, {"letter": "Vmax", "count": 1}, {"letter": "Washout Period", "count": 3}, {"letter": "Whole-Abdominal Irradiation", "count": 1}, {"letter": "Withdrawal by Subject", "count": 15}, {"letter": "Workflow", "count": 5}, {"letter": "World Health Organization Drug Dictionary", "count": 1}, {"letter": "YES1 wt Allele", "count": 42}, {"letter": "Zone", "count": 3}, {"letter": "c-MET Gene Amplification", "count": 3}, {"letter": "pT1a Stage Finding", "count": 2}, {"letter": "t-Distribution", "count": 1}, {"letter": "Acquired Lesion", "count": 1}, {"letter": "Biorepository", "count": 3}, {"letter": "Edit Action", "count": 10}, {"letter": "Stereotactic Biopsy", "count": 7}, {"letter": "Partnership", "count": 2}, {"letter": "Continuous Distribution", "count": 7}, {"letter": "Since", "count": 21}, {"letter": "Vaginal Squamous Epithelium", "count": 1}, {"letter": "Variance", "count": 14}, {"letter": "Span - parameter", "count": 9}, {"letter": "Sponsor (person)", "count": 6}, {"letter": "Coordinator", "count": 2}, {"letter": "Offset", "count": 2}, {"letter": "Graduation", "count": 2}, {"letter": "Nominal Scale", "count": 14}, {"letter": "Deriving", "count": 3}, {"letter": "Interquartile Range", "count": 14}, {"letter": "Administration via Implantation", "count": 20}, {"letter": "Hepatobiliary System", "count": 1}, {"letter": "Marginal Zone", "count": 1}, {"letter": "Postcontrast", "count": 1}, {"letter": "Verification", "count": 42}, {"letter": "Medical problem:Finding:Point in time:^Patient:Nominal", "count": 3}, {"letter": "Social security number:Identifier:Point in time:^Patient:Nominal", "count": 1}, {"letter": "Room number:Location:Point in time:^Patient:Nominal", "count": 4}, {"letter": "Edema:Finding:Point in time:^Patient:Ordinal", "count": 32}, {"letter": "Allergies:Find:Pt:^Patient:Ord", "count": 2}, {"letter": "date of analysis of specimen", "count": 6}, {"letter": "Incisional pain", "count": 1}, {"letter": "Involvement patterns", "count": 1}, {"letter": "New medications", "count": 1}, {"letter": "Number of medications", "count": 3}, {"letter": "Other indicators", "count": 2}, {"letter": "Pain site", "count": 4}, {"letter": "Pathological bone fracture", "count": 7}, {"letter": "Patient health questionnaire 9 item total score", "count": 1}, {"letter": "Reason for assessment", "count": 1}, {"letter": "Special care (attribute)", "count": 3}, {"letter": "Balance test", "count": 7}, {"letter": "Time of analysis", "count": 91}, {"letter": "Tubule Formation", "count": 1}, {"letter": "Tumor Regression", "count": 71}, {"letter": "View spot", "count": 2}, {"letter": "Tissue Core", "count": 1}, {"letter": "W stress", "count": 54}, {"letter": "High resolution", "count": 15}, {"letter": "Glucose/Insulin", "count": 3}, {"letter": "Subtract - dosing instruction fragment", "count": 16}, {"letter": "Multiply - dosing instruction fragment", "count": 81}, {"letter": "Follow - dosing instruction imperative", "count": 110}, {"letter": "Omega", "count": 1}, {"letter": "Skin condition (observable entity)", "count": 6}, {"letter": "Push - dosing instruction imperative", "count": 1}, {"letter": "hyaluronidase, human recombinant", "count": 2}, {"letter": "Awakening (time frame)", "count": 25}, {"letter": "Once - dosing instruction fragment", "count": 23}, {"letter": "Inject - dosing instruction imperative", "count": 15}, {"letter": "Upon - dosing instruction fragment", "count": 161}, {"letter": "On (qualifier value)", "count": 469}, {"letter": "Until", "count": 295}, {"letter": "Greek letter lambda", "count": 2}, {"letter": "Every - dosing instruction fragment", "count": 17}, {"letter": "Under anesthesia", "count": 2}, {"letter": "Only - dosing instruction fragment", "count": 63}, {"letter": "When - dosing instruction fragment", "count": 7}, {"letter": "Sniff", "count": 2}, {"letter": "As needed for (qualifier value)", "count": 2}, {"letter": "Mix", "count": 4}, {"letter": "Stereotactic Body Radiotherapy", "count": 3}, {"letter": "Kaplan-Meier Estimate", "count": 189}, {"letter": "Kaplan-Meier Survival Curves", "count": 11}, {"letter": "Receptors, Death Domain", "count": 1}, {"letter": "Keratin-5", "count": 1}, {"letter": "Skin Tape", "count": 5}, {"letter": "AKR1C1 protein, human", "count": 1}, {"letter": "nilotinib", "count": 2}, {"letter": "Vestibular Labyrinth", "count": 1}, {"letter": "Workstation", "count": 2}, {"letter": "Laptop computer", "count": 1}, {"letter": "apricoxib", "count": 1}, {"letter": "Tracking system", "count": 1}, {"letter": "CART protein, human", "count": 9}, {"letter": "EGFR protein, human", "count": 37}, {"letter": "Acute cardiac toxicity", "count": 1}, {"letter": "PDC protein, human", "count": 2}, {"letter": "CDH1 protein, human", "count": 5}, {"letter": "ACPP protein, human", "count": 6}, {"letter": "Chronic chest pain", "count": 4}, {"letter": "LILRB1 protein, human", "count": 1}, {"letter": "CCND1 protein, human", "count": 4}, {"letter": "BLM protein, human", "count": 3}, {"letter": "CISH protein, human", "count": 2}, {"letter": "CLOCK protein, human", "count": 1}, {"letter": "18F-fluorobenzyl triphenyl phosphonium", "count": 1}, {"letter": "SOD2 protein, human", "count": 2}, {"letter": "Structure of flexor muscle of forearm", "count": 1}, {"letter": "system development -- biological", "count": 1}, {"letter": "prolactin binding", "count": 3}, {"letter": "establishment and maintenance of localization", "count": 5}, {"letter": "Physical Exam Domain", "count": 62}, {"letter": "granulocyte colony-stimulating factor binding", "count": 1}, {"letter": "soluble", "count": 24}, {"letter": "mitogenic activity", "count": 1}, {"letter": "cellular entity storage", "count": 1}, {"letter": "cellular entity retention", "count": 33}, {"letter": "cellular entity sequestering", "count": 1}, {"letter": "insulin-like growth factor activity", "count": 5}, {"letter": "Structure of muscle of forearm", "count": 1}, {"letter": "Weak", "count": 27}, {"letter": "Date last dose", "count": 3}, {"letter": "PT 100", "count": 1}, {"letter": "Vascular", "count": 3}, {"letter": "Short", "count": 32}, {"letter": "sprouting angiogenesis", "count": 1}, {"letter": "response to tumor cell", "count": 3}, {"letter": "detection of tumor cell", "count": 1}, {"letter": "Immune System Processes", "count": 7}, {"letter": "Granuloma formation", "count": 1}, {"letter": "Cellular Immune Response", "count": 3}, {"letter": "granulocyte macrophage colony-stimulating factor production", "count": 1}, {"letter": "Host Cell", "count": 4}, {"letter": "Frequency of vomiting", "count": 1}, {"letter": "Frequency of nausea", "count": 1}, {"letter": "Social relationships", "count": 1}, {"letter": "RESTING HEART RATE", "count": 7}, {"letter": "Close Relationship", "count": 2}, {"letter": "Vulnerability", "count": 4}, {"letter": "Wound tissue undermining", "count": 1}, {"letter": "Monitoring response to treatment", "count": 1}, {"letter": "SAT1 gene", "count": 7}, {"letter": "GORAB gene", "count": 30}, {"letter": "SHE gene", "count": 1}, {"letter": "SLC6A10P gene", "count": 2}, {"letter": "SMUG1 gene", "count": 5}, {"letter": "SPIN1 gene", "count": 1}, {"letter": "AMIGO1 gene", "count": 1}, {"letter": "PACC1 gene", "count": 2}, {"letter": "TBC1D9 gene", "count": 4}, {"letter": "TBCEL gene", "count": 2}, {"letter": "TNS1 gene", "count": 9}, {"letter": "TRV-AAC1-5 gene", "count": 1}, {"letter": "TRV-AAC3-1 gene", "count": 1}, {"letter": "TSKU gene", "count": 1}, {"letter": "TSPAN31 gene", "count": 2}, {"letter": "TSPO gene", "count": 1}, {"letter": "VEGFA gene", "count": 15}, {"letter": "TIGIT gene", "count": 2}, {"letter": "WIPF2 gene", "count": 1}, {"letter": "ZNF689 gene", "count": 1}, {"letter": "ZNF699 gene", "count": 1}, {"letter": "ARL6IP1 gene", "count": 1}, {"letter": "CYREN gene", "count": 1}, {"letter": "RESF1 gene", "count": 26}, {"letter": "CASZ1 gene", "count": 3}, {"letter": "CC2D1A gene", "count": 1}, {"letter": "CD8B gene", "count": 1}, {"letter": "CD55 gene", "count": 23}, {"letter": "CEP55 gene", "count": 1}, {"letter": "CFB gene", "count": 2}, {"letter": "GINS2 gene", "count": 9}, {"letter": "GPR162 gene", "count": 41}, {"letter": "IKZF2 gene", "count": 2}, {"letter": "IL17A gene", "count": 6}, {"letter": "IMPACT gene", "count": 448}, {"letter": "IRGC gene", "count": 1}, {"letter": "LBH gene", "count": 1}, {"letter": "ZACN gene", "count": 3}, {"letter": "ACSM3 gene", "count": 6}, {"letter": "B3GALNT1 gene", "count": 1}, {"letter": "MCAT gene", "count": 1}, {"letter": "MMEL1 gene", "count": 1}, {"letter": "MTDH gene", "count": 1}, {"letter": "NAA50 gene", "count": 3}, {"letter": "ADI1 gene", "count": 1}, {"letter": "NLRC5 gene", "count": 1}, {"letter": "NOC2L gene", "count": 4}, {"letter": "NUF2 gene", "count": 1}, {"letter": "PRLHR gene", "count": 3}, {"letter": "PRMT5 gene", "count": 8}, {"letter": "PTCH1 gene", "count": 1}, {"letter": "Serum magnesium finding", "count": 1}, {"letter": "Distance vision 6/30", "count": 5}, {"letter": "Drug Tapering", "count": 80}, {"letter": "Infusion route", "count": 5}, {"letter": "Depth of lesion", "count": 1}, {"letter": "Identification code", "count": 2}, {"letter": "Device form", "count": 1}, {"letter": "Cardiac assessment", "count": 11}, {"letter": "Injection Route of Drug Administration", "count": 3}, {"letter": "Mean deviation", "count": 9}, {"letter": "Age at diagnosis", "count": 2}, {"letter": "Clinical document", "count": 1}, {"letter": "Homeostasis model assessment", "count": 13}, {"letter": "Mental health.status", "count": 2}, {"letter": "Skin.status", "count": 1}, {"letter": "{Non-patient}", "count": 24}, {"letter": "Homeostasis model assessment:Arbitrary Concentration:Point in time:Serum/Plasma:Quantitative", "count": 1}, {"letter": "Risk factors:Finding:Point in time:^Patient:Nominal", "count": 9}, {"letter": "Depressive feelings", "count": 1}, {"letter": "Shopping:-:Point in time:^Patient:-", "count": 1}, {"letter": "Stand &or walk", "count": 1}, {"letter": "Study report:Finding:Point in time:{Setting}:Document:{Provider}", "count": 10}, {"letter": "Elasticity (tissue integrity)", "count": 6}, {"letter": "genexol-PM", "count": 3}, {"letter": "bosutinib", "count": 5}, {"letter": "Tomotherapy", "count": 3}, {"letter": "Exercise Intervention", "count": 33}, {"letter": "Autologous Hematopoietic Stem Cell Transplantation", "count": 7}, {"letter": "Natural Killer Cell Therapy", "count": 1}, {"letter": "Hypofractionated radiation therapy", "count": 9}, {"letter": "pazopanib", "count": 10}, {"letter": "apixaban", "count": 4}, {"letter": "talimogene laherparepvec", "count": 1}, {"letter": "MK-0646", "count": 1}, {"letter": "RTA 744", "count": 8}, {"letter": "ThermoDox", "count": 7}, {"letter": "eltrombopag", "count": 3}, {"letter": "Colloidal Gold-Bound Tumor Necrosis Factor", "count": 1}, {"letter": "Dynamic Contrast-Enhanced Magnetic Resonance Imaging", "count": 24}, {"letter": "Hyperfractioned Radiation Therapy", "count": 1}, {"letter": "NOV 002", "count": 1}, {"letter": "ABT 888", "count": 4}, {"letter": "ECO-4601", "count": 6}, {"letter": "F-18 16 alpha-fluoroestradiol", "count": 5}, {"letter": "selective internal radiation therapy", "count": 1}, {"letter": "AZD 6244", "count": 3}, {"letter": "Mental health.behavior", "count": 1}, {"letter": "Handling", "count": 2}, {"letter": "BLOOD GROUP--SWANN SYSTEM", "count": 1}, {"letter": "DERMATITIS HERPETIFORMIS, FAMILIAL", "count": 4}, {"letter": "Verloes Bourguignon syndrome", "count": 4}, {"letter": "White matter changes", "count": 1}, {"letter": "SRCIN1 gene", "count": 1}, {"letter": "PALB2 gene", "count": 2}, {"letter": "Total Hypotrichosis, Mari type", "count": 2}, {"letter": "Developmental regression", "count": 3}, {"letter": "FANCONI ANEMIA, COMPLEMENTATION GROUP I", "count": 1}, {"letter": "DHX58 gene", "count": 1}, {"letter": "ARHGAP32 gene", "count": 1}, {"letter": "Arm flexion", "count": 7}, {"letter": "PWAR5 gene", "count": 1}, {"letter": "Rapidly progressive", "count": 2}, {"letter": "NUCLEAR RIBONUCLEIC ACID", "count": 1}, {"letter": "Prieto syndrome", "count": 4}, {"letter": "IMMUNE SUPPRESSION", "count": 2}, {"letter": "NEUROTICISM", "count": 4}, {"letter": "Alzheimer disease, familial, type 3", "count": 13}, {"letter": "Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis", "count": 1}, {"letter": "Immune dysregulation", "count": 1}, {"letter": "OTOPALATODIGITAL SYNDROME, TYPE II", "count": 2}, {"letter": "CT83 gene", "count": 1}, {"letter": "FANCONI ANEMIA, COMPLEMENTATION GROUP B", "count": 1}, {"letter": "CELIAC DISEASE, SUSCEPTIBILITY TO, 5", "count": 2}, {"letter": "Abnormality of coagulation", "count": 4}, {"letter": "VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)", "count": 1}, {"letter": "Increased echogenicity", "count": 1}, {"letter": "Neuropathy, Painful", "count": 1}, {"letter": "CATARACT, COPPOCK-LIKE", "count": 1}, {"letter": "LABORATORY ABNORMALITIES", "count": 104}, {"letter": "PRAC1 gene", "count": 1}, {"letter": "Iterations", "count": 3}, {"letter": "BREAST CANCER 3", "count": 4}, {"letter": "CARD18 gene", "count": 1}, {"letter": "Marles Greenberg Persaud syndrome", "count": 1}, {"letter": "Very rare", "count": 1}, {"letter": "Hydranencephaly with Renal Aplasia-Dysplasia", "count": 1}, {"letter": "HEMIHYPERPLASIA, ISOLATED", "count": 1}, {"letter": "Chest asymmetry", "count": 1}, {"letter": "Trichohepatoenteric Syndrome", "count": 1}, {"letter": "Reduced subcutaneous adipose tissue", "count": 2}, {"letter": "APPL1 gene", "count": 1}, {"letter": "COPPER TOXICOSIS, IDIOPATHIC", "count": 5}, {"letter": "Syndactyly Cenani Lenz type", "count": 2}, {"letter": "Severe generalized osteoporosis", "count": 1}, {"letter": "Joint arthralgia", "count": 1}, {"letter": "ADRENOCORTICAL CARCINOMA, HEREDITARY", "count": 2}, {"letter": "Venous Thromboembolism", "count": 1}, {"letter": "SURFACE ANTIGEN 5", "count": 1}, {"letter": "CCI gene", "count": 3}, {"letter": "SPERMATOGENIC FAILURE 2", "count": 1}, {"letter": "Wound healing normal", "count": 1}, {"letter": "PREMATURE CHROMATID SEPARATION TRAIT", "count": 1}, {"letter": "Soft thin skin", "count": 1}, {"letter": "HPGDS gene", "count": 1}, {"letter": "Peroxisome Biogenesis Disorder, Complementation Group 1", "count": 1}, {"letter": "TRANSFER RNA ARGININE", "count": 2}, {"letter": "HIGH BONE MASS", "count": 1}, {"letter": "Peroxisome Biogenesis Disorder, Complementation Group H", "count": 2}, {"letter": "Peroxisome Biogenesis Disorder, Complementation Group 3", "count": 1}, {"letter": "SCALP-EAR-NIPPLE SYNDROME", "count": 1}, {"letter": "RING DERMOID OF CORNEA", "count": 2}, {"letter": "PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE", "count": 1}, {"letter": "PHOTOPAROXYSMAL RESPONSE 1", "count": 2}, {"letter": "SERPINA3 protein, human", "count": 7}, {"letter": "PTPRC protein, human", "count": 7}, {"letter": "sigma-2 receptor, human", "count": 1}, {"letter": "GHRL protein, human", "count": 2}, {"letter": "gallium selenide", "count": 3}, {"letter": "glutaminyl-arginyl-phenylalanyl-seryl-arginine", "count": 1}, {"letter": "CCL3 protein, human", "count": 1}, {"letter": "IGFBP3 protein, human", "count": 10}, {"letter": "PIEZO1 protein, human", "count": 1}, {"letter": "tesetaxel", "count": 3}, {"letter": "N,N-dimethyl-N-(18F)fluoromethyl-2-hydroxyethylammonium", "count": 3}, {"letter": "CHKA protein, human", "count": 1}, {"letter": "IL17C protein, human", "count": 2}, {"letter": "Basis", "count": 64}, {"letter": "Boost Nutrition Supplement", "count": 18}, {"letter": "DELIVER (Dietary Supplement)", "count": 11}, {"letter": "ELLIPSE (device)", "count": 6}, {"letter": "ESTROGENS,VAGINAL", "count": 1}, {"letter": "INVESTIGATIONAL AGENTS", "count": 2}, {"letter": "ISOLATE COMPOUND", "count": 6}, {"letter": "NON-STEROIDAL ANTI-INFLAMMATORY ANALGESICS", "count": 1}, {"letter": "PRO-PEPTIDE", "count": 5}, {"letter": "REGAIN", "count": 5}, {"letter": "STEP 2", "count": 3}, {"letter": "ultrasound device", "count": 110}, {"letter": "Vital High Nitrogen Enteral Nutrition", "count": 6}, {"letter": "Patient Health Questionnaire", "count": 31}, {"letter": "Brief", "count": 9}, {"letter": "Transfusion (procedure)", "count": 1}, {"letter": "Acute Myeloid Leukemia (AML-M2)", "count": 12}, {"letter": "Apply (instruction)", "count": 40}, {"letter": "Flexor (Anatomical coordinate)", "count": 5}, {"letter": "Measures (attribute)", "count": 7}, {"letter": "Adriamycin-Cytoxan Regimen", "count": 6}, {"letter": "Acceptable", "count": 43}, {"letter": "Activation action", "count": 88}, {"letter": "Active Range of Motion", "count": 3}, {"letter": "Affected Area", "count": 1}, {"letter": "Bioconductor caAffy Average Difference Probe Summary Method", "count": 26}, {"letter": "Central Minus", "count": 85}, {"letter": "Agent Combination", "count": 4}, {"letter": "Ambient", "count": 2}, {"letter": "Amine Group", "count": 1}, {"letter": "Area Code", "count": 1}, {"letter": "As Much as Desired", "count": 5}, {"letter": "PRN (schedule frequency)", "count": 1}, {"letter": "Aspect (characteristic)", "count": 58}, {"letter": "Benjamini-Hochberg Procedure", "count": 6}, {"letter": "Billion Cells", "count": 1}, {"letter": "Biologic Sample Preservation Procedure", "count": 3}, {"letter": "Biomarker Analysis", "count": 26}, {"letter": "Biomedicine", "count": 4}, {"letter": "Backflow", "count": 3}, {"letter": "Bonferroni Adjustment", "count": 4}, {"letter": "CAPOX Regimen", "count": 1}, {"letter": "CDISC SDTM Route of Administration Terminology", "count": 1}, {"letter": "CDISC SDTM Yes No Unknown or Not Applicable Response Terminology", "count": 1}, {"letter": "CCN2 wt Allele", "count": 1}, {"letter": "calorie unit of energy", "count": 2}, {"letter": "Capecitabine/Docetaxel Regimen", "count": 2}, {"letter": "Carboplatin-Taxol Regimen", "count": 2}, {"letter": "Central Laboratory", "count": 9}, {"letter": "Cerebrovascular", "count": 1}, {"letter": "Cessation", "count": 12}, {"letter": "Characterization", "count": 141}, {"letter": "Choriogonadotropin Beta Measurement", "count": 2}, {"letter": "Circumflex", "count": 1}, {"letter": "Collapse of Device", "count": 1}, {"letter": "Complementary or Alternative Medical Procedure", "count": 1}, {"letter": "Comprehensive", "count": 34}, {"letter": "Computation (action)", "count": 17}, {"letter": "Consensus Clustering", "count": 1}, {"letter": "Consortium (group)", "count": 1}, {"letter": "Contact Information", "count": 1}, {"letter": "Contribution", "count": 48}, {"letter": "convoluted shape", "count": 4}, {"letter": "Cube - faceted volume", "count": 3}, {"letter": "Cup Dosing Unit", "count": 4}, {"letter": "Cure (remedy)", "count": 4}, {"letter": "Customize", "count": 2}, {"letter": "Propoxyphene, (+/-)-", "count": 2}, {"letter": "DNA Methylation Analysis", "count": 1}, {"letter": "Data Port", "count": 4}, {"letter": "Decoupling", "count": 1}, {"letter": "Decrease in Pressure Medical Device Problem", "count": 1}, {"letter": "Defense", "count": 1}, {"letter": "Deletion (action)", "count": 5}, {"letter": "Deregulation", "count": 2}, {"letter": "desvenlafaxine", "count": 3}, {"letter": "Disabled", "count": 7}, {"letter": "Disconnection", "count": 1}, {"letter": "Discover", "count": 17}, {"letter": "Dispense (Activity)", "count": 7}, {"letter": "Diversity", "count": 29}, {"letter": "Carboplatin/Docetaxel Regimen", "count": 2}, {"letter": "Domain (area of knowledge)", "count": 138}, {"letter": "Delta Wave by ECG Finding", "count": 1}, {"letter": "EC Breast Regimen", "count": 16}, {"letter": "Empiric", "count": 4}, {"letter": "Empty (qualifier)", "count": 114}, {"letter": "Endocrine Drug Therapy", "count": 1}, {"letter": "Enzyme Unit", "count": 21}, {"letter": "European Quality of Life Five Dimension Three Level Questionnaire", "count": 7}, {"letter": "Every two months", "count": 1}, {"letter": "FACT-BR Questionnaire", "count": 3}, {"letter": "Failure to Deploy", "count": 1}, {"letter": "False Discovery Rate", "count": 17}, {"letter": "False Negative Result Medical Device Problem", "count": 2}, {"letter": "Family-Wise Error Rate", "count": 1}, {"letter": "Five per Second", "count": 1}, {"letter": "Fold Change", "count": 9}, {"letter": "Forma (botanical taxonomic category below variety)", "count": 1}, {"letter": "Gadolinium-Chelate", "count": 1}, {"letter": "Hierarchical Clustering", "count": 1}, {"letter": "High Impedance", "count": 2}, {"letter": "Homogeneity", "count": 6}, {"letter": "imaging studies", "count": 22}, {"letter": "Inclusion Exclusion Domain", "count": 7}, {"letter": "Index Value", "count": 20}, {"letter": "Individualized", "count": 15}, {"letter": "Informational Intervention", "count": 1}, {"letter": "Isodose", "count": 3}, {"letter": "LMNA wt Allele", "count": 3}, {"letter": "Large Mass", "count": 1}, {"letter": "Lead Organization", "count": 15}, {"letter": "Light (qualifier)", "count": 6}, {"letter": "Lineage", "count": 2}, {"letter": "Lipemic (qualifier)", "count": 1}, {"letter": "Lysate", "count": 1}, {"letter": "Make - Instruction Imperative", "count": 241}, {"letter": "Medical Device Contamination during Use", "count": 1}, {"letter": "Medical Device Break", "count": 4}, {"letter": "Material Degradation", "count": 1}, {"letter": "Merge", "count": 1}, {"letter": "Metastasis Protein", "count": 1}, {"letter": "Metronomic Chemotherapy", "count": 3}, {"letter": "1000000", "count": 12}, {"letter": "Million Cells", "count": 3}, {"letter": "Minimally Invasive Lesion", "count": 1}, {"letter": "Mismatch", "count": 2}, {"letter": "Moderation", "count": 205}, {"letter": "Multidimensional Fatigue Inventory", "count": 22}, {"letter": "Multiple Comparison Adjustment", "count": 2}, {"letter": "Mural Nodule", "count": 1}, {"letter": "Nanoemulsion", "count": 2}, {"letter": "Natural Number", "count": 1}, {"letter": "Neoplastic disease", "count": 1}, {"letter": "Network", "count": 10}, {"letter": "Neutral pH", "count": 7}, {"letter": "New York Heart Association Class", "count": 1}, {"letter": "New York Heart Association Class I", "count": 1}, {"letter": "New York Heart Association Class II", "count": 7}, {"letter": "New York Heart Association Class III", "count": 11}, {"letter": "New York Heart Association Class IV", "count": 3}, {"letter": "Normality Unit", "count": 11}, {"letter": "Normalize (activity)", "count": 129}, {"letter": "Object Attribute", "count": 4}, {"letter": "Of Each", "count": 1}, {"letter": "Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter", "count": 2}, {"letter": "Opening", "count": 8}, {"letter": "Operative", "count": 25}, {"letter": "PCR Regimen", "count": 2}, {"letter": "pazopanib hydrochloride", "count": 1}, {"letter": "Percent in White Blood Count Differential", "count": 7}, {"letter": "Percent of Predicted Value", "count": 1}, {"letter": "performance - action", "count": 24}, {"letter": "Permutation", "count": 59}, {"letter": "Phenomenon", "count": 1}, {"letter": "Physiological Support", "count": 2}, {"letter": "Plaque Forming Unit", "count": 3}, {"letter": "Poly(ADP-ribose) Polymerase Inhibitors", "count": 1}, {"letter": "Polymorphism", "count": 6}, {"letter": "Post-Therapy", "count": 288}, {"letter": "Pre-Therapy", "count": 146}, {"letter": "Precaution", "count": 6}, {"letter": "Preprocess", "count": 1}, {"letter": "Processor Core", "count": 74}, {"letter": "Program Thread", "count": 1}, {"letter": "Protein Expression Analysis", "count": 1}, {"letter": "Purity", "count": 1}, {"letter": "put - instruction imperative", "count": 7}, {"letter": "Questionnaire Administration", "count": 53}, {"letter": "RASSF1 wt Allele", "count": 1}, {"letter": "Radiation Field", "count": 18}, {"letter": "Radioactive Seed Implant Dosing Unit", "count": 6}, {"letter": "Recombinant parathyroid hormone", "count": 2}, {"letter": "Recurrent Disease, Distant Site", "count": 397}, {"letter": "Representation (action)", "count": 419}, {"letter": "Retinol Activity Equivalent", "count": 1}, {"letter": "Reviewer (person)", "count": 1}, {"letter": "Schedule Frequency", "count": 1}, {"letter": "Scientific Control", "count": 30}, {"letter": "Self-conscious", "count": 2}, {"letter": "Serum Chemistry Measurement", "count": 10}, {"letter": "Activity Session", "count": 166}, {"letter": "Small Lesion", "count": 2}, {"letter": "Soft Tissue Necrosis, CTCAE", "count": 1}, {"letter": "Space - property", "count": 12}, {"letter": "Spearman Rank-Order Correlation", "count": 7}, {"letter": "Electromagnetic Spectrum", "count": 10}, {"letter": "Streaming SIMD Extensions", "count": 6}, {"letter": "Material Stretched", "count": 4}, {"letter": "Superfamily", "count": 1}, {"letter": "Superkingdom (taxonomic category)", "count": 123}, {"letter": "Surgical Wound Closure", "count": 4}, {"letter": "Survey Administration", "count": 1}, {"letter": "Synthesis", "count": 2}, {"letter": "Systemic Chemotherapy", "count": 15}, {"letter": "TAC Regimen", "count": 3}, {"letter": "Therapeutic Surgical Procedure", "count": 1}, {"letter": "One Thousand", "count": 11}, {"letter": "Thousand Cells", "count": 1}, {"letter": "Tissue Breakdown", "count": 1}, {"letter": "Titrate", "count": 3}, {"letter": "Together", "count": 83}, {"letter": "Total Basophil Count", "count": 7}, {"letter": "Tumor-Related Protein", "count": 1}, {"letter": "Two-Sided Test", "count": 16}, {"letter": "Unacceptable", "count": 22}, {"letter": "Unevaluable", "count": 27}, {"letter": "Unit of Cell Concentration", "count": 1}, {"letter": "Until Disease Progression", "count": 45}, {"letter": "Upon Awakening-schedule frequency", "count": 2}, {"letter": "Vacutainer", "count": 3}, {"letter": "Variety (taxon)", "count": 3}, {"letter": "WHO Central Nervous System Grade I", "count": 107}, {"letter": "Whole Number", "count": 2}, {"letter": "Wild Type", "count": 13}, {"letter": "Working Group", "count": 10}, {"letter": "Yoga", "count": 6}, {"letter": "SIR-Spheres", "count": 1}, {"letter": "Z-Average", "count": 2}, {"letter": "log2", "count": 7}, {"letter": "Digital", "count": 53}, {"letter": "Positive Control", "count": 2}, {"letter": "Focality", "count": 1}, {"letter": "Supernumerary", "count": 38}, {"letter": "Then", "count": 390}, {"letter": "Add - instruction imperative", "count": 113}, {"letter": "Insert (object)", "count": 3}, {"letter": "Removing (action)", "count": 1}, {"letter": "Replicate", "count": 7}, {"letter": "Taken", "count": 241}, {"letter": "Death Due to Disease Progression Not Associated with More Specific Term NOS, CTCAE", "count": 731}, {"letter": "Cancer Progression", "count": 157}, {"letter": "See", "count": 5}, {"letter": "Sorting", "count": 1}, {"letter": "biologic consumption", "count": 13}, {"letter": "On Staff", "count": 42}, {"letter": "Pulse phenomenon", "count": 6}, {"letter": "combination of objects", "count": 914}, {"letter": "Integrity", "count": 1}, {"letter": "Local-Regional anatomy", "count": 166}, {"letter": "Marginal (quality)", "count": 4}, {"letter": "Application (Document)", "count": 3}, {"letter": "Stop (Instruction Imperative)", "count": 4}, {"letter": "Cleaning (activity)", "count": 7}, {"letter": "Direct (qualifier)", "count": 77}, {"letter": "Smear - instruction imperative", "count": 23}, {"letter": "care activity", "count": 185}, {"letter": "Glass Packaging Device", "count": 2}, {"letter": "Use - dosing instruction imperative", "count": 15}, {"letter": "Aim (idea)", "count": 107}, {"letter": "anatomical bulb", "count": 4}, {"letter": "Goes <invertebrate>", "count": 8}, {"letter": "Ia <mammal>", "count": 5}, {"letter": "Call (Instruction)", "count": 35}, {"letter": "Give - dosing instruction imperative", "count": 149}, {"letter": "Correction (change)", "count": 10}, {"letter": "Encounter", "count": 1}, {"letter": "Negative Control", "count": 1}, {"letter": "Thera <invertebrate>", "count": 1}, {"letter": "Overlap", "count": 6}, {"letter": "Proband (person)", "count": 5}, {"letter": "Stimulation (motivation)", "count": 31}, {"letter": "Couple (action)", "count": 17}, {"letter": "Held - activity status", "count": 21}, {"letter": "Once (schedule frequency)", "count": 30}, {"letter": "Twice (Numerical Qualifier)", "count": 34}, {"letter": "Now (temporal qualifier)", "count": 26}, {"letter": "Period (temporal qualifier)", "count": 475}, {"letter": "When (temporal qualifier)", "count": 1}, {"letter": "Collateral", "count": 1}, {"letter": "Constant (qualifier)", "count": 37}, {"letter": "Every (qualifier)", "count": 4}, {"letter": "Copy (object)", "count": 16}, {"letter": "belinostat", "count": 2}, {"letter": "Board (committee)", "count": 4}, {"letter": "physical therapy care", "count": 1}, {"letter": "Chromosome number", "count": 1}, {"letter": "Amino acid change:Finding:Point in time:Whole blood/Tissue, unspecified:Nominal:Molecular Genetics", "count": 1}, {"letter": "pH:LsCnc:Pt:Vag:Qn", "count": 2}, {"letter": "Fibrosis score", "count": 2}, {"letter": "Treatment Cycle Day Number", "count": 134}, {"letter": "Tl-201", "count": 1}, {"letter": "Clusters of differentiation", "count": 2}, {"letter": "Female fertility", "count": 2}, {"letter": "Multiple markers", "count": 1}, {"letter": "Other markers", "count": 3}, {"letter": "Patient Information", "count": 22}, {"letter": "Tissue specific", "count": 2}, {"letter": "Fixed tissue", "count": 1}, {"letter": "Others - Allergy", "count": 6}, {"letter": "Intra-operative electron radiation therapy", "count": 3}, {"letter": "CCR Receptors", "count": 6}, {"letter": "Adipokines", "count": 3}, {"letter": "Elasticity Imaging Techniques", "count": 1}, {"letter": "Vibro-Acoustography", "count": 2}, {"letter": "Precursor Cells, T-Lymphoid", "count": 1}, {"letter": "National Eye Institute (U.S.)", "count": 1}, {"letter": "INDEL Mutation", "count": 5}, {"letter": "Deep Sedation", "count": 1}, {"letter": "Microbiome", "count": 29}, {"letter": "Cone-Beam Computed Tomography", "count": 5}, {"letter": "Acronyms", "count": 1}, {"letter": "Gene Expression Profiles", "count": 37}, {"letter": "Gray Units", "count": 1}, {"letter": "Coronary Artery Disease", "count": 5}, {"letter": "Plasmacytoid Dendritic Cells", "count": 2}, {"letter": "Paroxysmal nocturnal dyspnea", "count": 4}, {"letter": "Neoplastic Stem Cells", "count": 1}, {"letter": "Cancer Stem Cells", "count": 11}, {"letter": "bivatuzumab mertansine", "count": 2}, {"letter": "veliparib", "count": 14}, {"letter": "MVAp53 vaccine", "count": 1}, {"letter": "Histone-Lysine N-Methyltransferase SETD2, Human", "count": 1}, {"letter": "11-methoxy-4,16-difluoroestradiol", "count": 5}, {"letter": "Dual-Energy X-Ray Absorptiometry Scan", "count": 21}, {"letter": "Gene Modules", "count": 1}, {"letter": "Seizure, CTCAE 3.0", "count": 1}, {"letter": "Eye Pain, CTCAE 3.0", "count": 5}, {"letter": "Spatial guidance for medical procedure", "count": 17}, {"letter": "H group", "count": 3}, {"letter": "Nonrebreather oxygen mask", "count": 1}, {"letter": "RECONCILE", "count": 1}, {"letter": "Balance Assessment Test", "count": 7}, {"letter": "HER2-positive carcinoma of breast", "count": 70}, {"letter": "Type 6", "count": 2}, {"letter": "Intima media thickness", "count": 2}, {"letter": "Female of child bearing age", "count": 1}, {"letter": "Measles virus genotype D3", "count": 2}, {"letter": "Measles virus genotype D5", "count": 1}, {"letter": "Measles virus genotype G2", "count": 1}, {"letter": "Pain intensity rating scale", "count": 2}, {"letter": "Laparoscopic sleeve gastrectomy", "count": 2}, {"letter": "Milligram percent", "count": 10}, {"letter": "Oriented to place", "count": 13}, {"letter": "paclitaxel protein-bound", "count": 4}, {"letter": "Erectile Dysfunction, CTCAE", "count": 1}, {"letter": "Microvolt", "count": 3}, {"letter": "Cough, CTCAE", "count": 4}, {"letter": "Excellent (qualifier value)", "count": 8}, {"letter": "Grafting procedure", "count": 2}, {"letter": "Anti-Histamine", "count": 1}, {"letter": "Radiographic imaging procedure", "count": 4}, {"letter": "Flatulence, CTCAE", "count": 1}, {"letter": "Hematoma, CTCAE", "count": 34}, {"letter": "Hyperpigmentation, CTCAE 3", "count": 1}, {"letter": "Myocarditis, CTCAE 3.0", "count": 2}, {"letter": "Urinary Incontinence, CTCAE 3.0", "count": 2}, {"letter": "Face Pain, CTCAE", "count": 2}, {"letter": "Ventricular Fibrillation, CTCAE 3.0", "count": 1}, {"letter": "Pain NOS, CTCAE", "count": 756}, {"letter": "Ascend (action)", "count": 2}, {"letter": "Chest Wall Pain, CTCAE 3.0", "count": 2}, {"letter": "Joint Pain, CTCAE 3", "count": 15}, {"letter": "Atrial Fibrillation, CTCAE", "count": 1}, {"letter": "Skin Atrophy, CTCAE 3.0", "count": 1}, {"letter": "Back Pain, CTCAE 3.0", "count": 3}, {"letter": "Platelets, CTCAE", "count": 7}, {"letter": "Bone Pain, CTCAE 3.0", "count": 29}, {"letter": "Brachial Plexopathy, CTCAE 3.0", "count": 3}, {"letter": "Colitis, CTCAE", "count": 6}, {"letter": "Confusion, CTCAE 3.0", "count": 6}, {"letter": "Constipation, CTCAE", "count": 40}, {"letter": "Diarrhea, CTCAE", "count": 87}, {"letter": "Dizziness, CTCAE 3.0", "count": 2}, {"letter": "Dyspnea, CTCAE", "count": 24}, {"letter": "Esophagitis, CTCAE", "count": 2}, {"letter": "Gynecomastia, CTCAE 3.0", "count": 2}, {"letter": "Hypertension, CTCAE", "count": 17}, {"letter": "Joint Function, CTCAE", "count": 1}, {"letter": "Renal Failure, CTCAE", "count": 1}, {"letter": "Larynx Edema, CTCAE 3", "count": 3}, {"letter": "Left Ventricular Systolic Dysfunction, CTCAE 3.0", "count": 10}, {"letter": "Lymphocele, CTCAE", "count": 1}, {"letter": "Lymphopenia, CTCAE 3", "count": 2}, {"letter": "Memory Impairment, CTCAE 3.0", "count": 2}, {"letter": "Muscle Pain, CTCAE 3", "count": 2}, {"letter": "Nausea, CTCAE 3.0", "count": 140}, {"letter": "Nystagmus, CTCAE 3.0", "count": 1}, {"letter": "Obesity, CTCAE", "count": 8}, {"letter": "Pancreatitis, CTCAE 3.0", "count": 1}, {"letter": "Pericarditis, CTCAE", "count": 7}, {"letter": "Sensory Neuropathy, CTCAE", "count": 1}, {"letter": "Seroma, CTCAE", "count": 61}, {"letter": "Insomnia, CTCAE 3.0", "count": 66}, {"letter": "Stomach Pain, CTCAE 3.0", "count": 1}, {"letter": "Ventricular Tachycardia, CTCAE 3.0", "count": 2}, {"letter": "Telangiectasia, CTCAE 3.0", "count": 4}, {"letter": "Tumor Lysis Syndrome, CTCAE 3.0", "count": 2}, {"letter": "Ulceration, CTCAE", "count": 12}, {"letter": "Vaginal Dryness, CTCAE 3.0", "count": 38}, {"letter": "Vomiting, CTCAE", "count": 136}, {"letter": "Knee region structure", "count": 14}, {"letter": "Radiation necrosis", "count": 3}, {"letter": "Immunomodulation", "count": 1}, {"letter": "Quality of life decreased", "count": 2}, {"letter": "Sudden Death Not Associated with More Specific CTCAE Term, CTCAE", "count": 9}, {"letter": "early/brief intervention/therapy (treatment)", "count": 3}, {"letter": "Observation - diagnostic procedure", "count": 36}, {"letter": "Loss of appetite (finding)", "count": 14}, {"letter": "Specimen age", "count": 1}, {"letter": "WT-1 Ag", "count": 1}, {"letter": "Date of entry", "count": 10}, {"letter": "Neuromuscular", "count": 2}, {"letter": "Other cells", "count": 1}, {"letter": "Protein carbonyl", "count": 1}, {"letter": "Psychiatric drugs", "count": 1}, {"letter": "Routine coag", "count": 20}, {"letter": "Alpha-1", "count": 2}, {"letter": "Contrast", "count": 7}, {"letter": "Micro-Electrical-Mechanical Systems", "count": 4}, {"letter": "MLO (Medio-Lateral Oblique)", "count": 5}, {"letter": "post exercise", "count": 3}, {"letter": "Set of muscles", "count": 7}, {"letter": "Postero-Anterior", "count": 1}, {"letter": "Input/Output molecular (intake)", "count": 1}, {"letter": "Emptying", "count": 3}, {"letter": "History of radiation therapy", "count": 1}, {"letter": "History of malignant neoplasm of breast", "count": 9}, {"letter": "Blunted", "count": 1}, {"letter": "Psychosocial counseling about cancer", "count": 4}, {"letter": "Spontaneous pain", "count": 1}, {"letter": "Skin sparing mastectomy", "count": 1}, {"letter": "Left ventricular cardiac dysfunction", "count": 3}, {"letter": "Language preference", "count": 2}, {"letter": "Clinical trial participant (person)", "count": 33}, {"letter": "Disability of arm", "count": 55}, {"letter": "Lymphocele after surgical procedure", "count": 1}, {"letter": "panobinostat", "count": 2}, {"letter": "Postoperative seroma", "count": 5}, {"letter": "International Prostate Symptom Score", "count": 2}, {"letter": "Functional capacity", "count": 15}, {"letter": "Environmental Infrastructure", "count": 1}, {"letter": "Meal (occasion for eating)", "count": 10}, {"letter": "Effective Communication", "count": 1}, {"letter": "Adequate Knowledge", "count": 1}, {"letter": "Purifying", "count": 11}, {"letter": "Sometimes", "count": 103}, {"letter": "Spiritual Well Being", "count": 7}, {"letter": "Anterior-Posterior", "count": 1}, {"letter": "Old age", "count": 3}, {"letter": "Inhibitor", "count": 11}, {"letter": "Attachments (document)", "count": 4}, {"letter": "Providing (action)", "count": 334}, {"letter": "Attending (action)", "count": 25}, {"letter": "Cover - action", "count": 12}, {"letter": "ASAH1 protein, human", "count": 1}, {"letter": "MMP2 protein, human", "count": 2}, {"letter": "protein S, human", "count": 1}, {"letter": "RPS6KA3 protein, human", "count": 2}, {"letter": "Lower (action)", "count": 25}, {"letter": "Never (frequency)", "count": 306}, {"letter": "Always (frequency)", "count": 67}, {"letter": "Profiling (action)", "count": 475}, {"letter": "History of previous events", "count": 10}, {"letter": "TKI 258", "count": 5}, {"letter": "Recovery - healing process", "count": 10}, {"letter": "Artificial (qualifier value)", "count": 2}, {"letter": "Regurgitation", "count": 1}, {"letter": "Cicatrix", "count": 9}, {"letter": "Alert note", "count": 6}, {"letter": "Walking Speed", "count": 16}, {"letter": "diffuse carcinoma of stomach", "count": 1}, {"letter": "Multiple birth (finding)", "count": 2}, {"letter": "bone density studies", "count": 4}, {"letter": "home environment testing", "count": 1}, {"letter": "blood profile", "count": 1}, {"letter": "cardiac evaluation", "count": 3}, {"letter": "cerebrospinal fluid analysis", "count": 3}, {"letter": "surgical drainage (treatment) (general)", "count": 1}, {"letter": "12-lead electrocardiogram: interval change", "count": 4}, {"letter": "electrocardiogram RR interval", "count": 12}, {"letter": "plasma amino acids", "count": 1}, {"letter": "change in relationship", "count": 13}, {"letter": "patient goals", "count": 13}, {"letter": "thoracic lymphadenectomy", "count": 1}, {"letter": "chest pain radiating to neck", "count": 3}, {"letter": "Postoperative Pain, Chronic", "count": 8}, {"letter": "Recurrent Laryngeal Nerve Injuries", "count": 1}, {"letter": "physician involvement", "count": 1}, {"letter": "radiation treatment delivery", "count": 1}, {"letter": "infant birth defect", "count": 1}, {"letter": "left ventricular ejection fraction assessment", "count": 1}, {"letter": "procedure record", "count": 4}, {"letter": "wound number (#___)", "count": 3}, {"letter": "molecular diagnostics (lab procedure)", "count": 1}, {"letter": "neuropsychological testing battery", "count": 2}, {"letter": "magnetic resonance imaging of both breasts", "count": 1}, {"letter": "skin spot", "count": 1}, {"letter": "Abnormal blistering of the skin", "count": 1}, {"letter": "Sleeping Habits", "count": 2}, {"letter": "activity level during leisure activity (___ METs)", "count": 2}, {"letter": "reported tissue injury", "count": 1}, {"letter": "Oral intake", "count": 1}, {"letter": "coordination / cerebellum reaction time (___ sec)", "count": 10}, {"letter": "psychometric Edinburgh postnatal depression scale (___0-30)", "count": 1}, {"letter": "Lack of social support", "count": 2}, {"letter": "irradiation of breast", "count": 4}, {"letter": "cytochrome p450 2D6 genotype", "count": 9}, {"letter": "radiation therapy dose (___cGy)", "count": 24}, {"letter": "radiation therapy site", "count": 2}, {"letter": "recurrent muscle twitches (symptom)", "count": 4}, {"letter": "diagnostic service sources radiology labs radiation oncology", "count": 1}, {"letter": "Family history of heart disease", "count": 1}, {"letter": "Prophylactic Mastectomy", "count": 10}, {"letter": "estradiol / estrone", "count": 1}, {"letter": "Serum serotonin", "count": 1}, {"letter": "Postoperative Pain, Acute", "count": 9}, {"letter": "malignant neoplasm of breast stage I", "count": 11}, {"letter": "malignant neoplasm of breast stage IIb", "count": 1}, {"letter": "Stage IIIC Breast Cancer AJCC v6", "count": 1}, {"letter": "malignant neoplasm of breast staging", "count": 10}, {"letter": "S1 heart sound", "count": 4}, {"letter": "Daytime Somnolence", "count": 2}, {"letter": "Blister of skin", "count": 5}, {"letter": "Motor disturbances", "count": 1}, {"letter": "exposure history", "count": 1}, {"letter": "Macromastia", "count": 1}, {"letter": "assessment of vision", "count": 2}, {"letter": "birth data single birth", "count": 3}, {"letter": "body fluid cytology (lab test)", "count": 1}, {"letter": "molecular genetic studies", "count": 1}, {"letter": "assessment of mood", "count": 1}, {"letter": "Hip flexion", "count": 1}, {"letter": "examination of head", "count": 1}, {"letter": "Liver carcinoma", "count": 4}, {"letter": "Controlling (action)", "count": 7}, {"letter": "GEN1 gene", "count": 4}, {"letter": "HLA-T gene", "count": 1}, {"letter": "SPNS1 gene", "count": 46}, {"letter": "thyroid function", "count": 3}, {"letter": "Pathologic calcification, calcified structure", "count": 1}, {"letter": "Fecal Microbiota Transplantation", "count": 4}, {"letter": "Hypertransaminasaemia", "count": 1}, {"letter": "clinical trial participant (history)", "count": 3}, {"letter": "Urinary Frequency or Urgency, CTCAE 3", "count": 1}, {"letter": "Microbial culture (procedure)", "count": 2}, {"letter": "Has tingling sensation", "count": 14}, {"letter": "needle aspiration, NOS", "count": 1}, {"letter": "peripheral blood mononuclear cells (lab test)", "count": 2}, {"letter": "range of motion of shoulder", "count": 10}, {"letter": "Echocardiogram (image)", "count": 8}, {"letter": "inhibition of cell growth", "count": 1}, {"letter": "insulin-responsive compartment", "count": 23}, {"letter": "cholesterol efflux", "count": 1}, {"letter": "skin barrier function", "count": 10}, {"letter": "mammary gland epithelial cell proliferation", "count": 3}, {"letter": "biphenyl synthase activity", "count": 1}, {"letter": "vetispiradiene synthase activity", "count": 1}, {"letter": "5-(carboxyamino)imidazole ribonucleotide mutase activity", "count": 5}, {"letter": "cyclomaltodextrin glucanotransferase activity", "count": 3}, {"letter": "activation of Notch signaling pathway", "count": 8}, {"letter": "inhibition of growth", "count": 1}, {"letter": "photoreactivating enzyme activity", "count": 3}, {"letter": "activation of developmental process", "count": 1}, {"letter": "assessment of memory", "count": 1}, {"letter": "Reduction Activity", "count": 2}, {"letter": "Argentina sphyraena", "count": 2}, {"letter": "Every three minutes", "count": 1}, {"letter": "Journaling", "count": 4}, {"letter": "olaparib", "count": 95}, {"letter": "Tissue section", "count": 9}, {"letter": "CT of thorax, abdomen and pelvis with contrast", "count": 1}, {"letter": "Packed red blood cells", "count": 1}, {"letter": "Subcutaneous tissue structure of limb", "count": 1}, {"letter": "Date of diagnosis", "count": 59}, {"letter": "Saturation of Peripheral Oxygen", "count": 4}, {"letter": "Health coach", "count": 2}, {"letter": "Late effect of radiation therapy", "count": 2}, {"letter": "MRI of breast implant", "count": 1}, {"letter": "Assessment of mobility", "count": 3}, {"letter": "Family history of coronary arteriosclerosis", "count": 4}, {"letter": "chest pain radiating to back", "count": 3}, {"letter": "Region of ribosome", "count": 2}, {"letter": "Muscle organ component", "count": 1}, {"letter": "Iliac spine", "count": 2}, {"letter": "Portion of muscle tissue", "count": 1}, {"letter": "Whole portion of blood", "count": 3}, {"letter": "Right primary motor cortex", "count": 1}, {"letter": "Trapezoidal", "count": 23}, {"letter": "Brodmann area 18", "count": 18}, {"letter": "Portion of venous blood", "count": 1}, {"letter": "Genome - anatomical entity", "count": 8}, {"letter": "Free wall of right ventricle", "count": 1}, {"letter": "BD Alcohol", "count": 14}, {"letter": "OSI 906", "count": 5}, {"letter": "ISS Stage III Plasma Cell Myeloma", "count": 6}, {"letter": "ISS Stage II Plasma Cell Myeloma", "count": 124}, {"letter": "Image Feature", "count": 13}, {"letter": "Immune Cell Function Assay", "count": 1}, {"letter": "Intervention Duration", "count": 2}, {"letter": "Investigational Medical Device", "count": 2}, {"letter": "Kilogram per Square Centimeter", "count": 1}, {"letter": "Knowledge Field", "count": 1}, {"letter": "LCN2 wt Allele", "count": 4}, {"letter": "Linear Regression Body Surface Area Formula for Infants and Children", "count": 27}, {"letter": "Liter per Hour", "count": 1}, {"letter": "Liver Flavor", "count": 4}, {"letter": "About The Same", "count": 10}, {"letter": "Abundance", "count": 19}, {"letter": "American Society of Anesthesiologists", "count": 1}, {"letter": "Amplitude", "count": 12}, {"letter": "Anonymous", "count": 1}, {"letter": "daratumumab", "count": 6}, {"letter": "TRC105", "count": 1}, {"letter": "IMC 1121B", "count": 3}, {"letter": "apatinib", "count": 10}, {"letter": "Appreciation", "count": 6}, {"letter": "Approval (document)", "count": 1}, {"letter": "Approved Protocol - clinical study status", "count": 1}, {"letter": "Assortment", "count": 21}, {"letter": "Attractive", "count": 6}, {"letter": "magnesium cation", "count": 8}, {"letter": "Bead shape", "count": 12}, {"letter": "Biospecimen", "count": 324}, {"letter": "Biospecimen Collection", "count": 3}, {"letter": "Blinded Clinical Study", "count": 1}, {"letter": "Boyd Body Surface Area Formula", "count": 3}, {"letter": "Material Absorption", "count": 2}, {"letter": "Maternal Relative", "count": 9}, {"letter": "Mean Percent of Normal", "count": 5}, {"letter": "MedDRA System Organ Class", "count": 19}, {"letter": "Medical Drop", "count": 3}, {"letter": "Medical Product Stability", "count": 5}, {"letter": "Mercury 2+", "count": 2}, {"letter": "Methylation Site", "count": 2}, {"letter": "British Mile", "count": 1}, {"letter": "Minute Unit of Plane Angle", "count": 17}, {"letter": "Mitogen-Activated Protein Kinase Kinase Inhibitor", "count": 1}, {"letter": "Acquired Image", "count": 4}, {"letter": "Acquisition Protocol", "count": 1}, {"letter": "Activity Status", "count": 1}, {"letter": "CDISC SDTM ECG Finding Terminology", "count": 2}, {"letter": "CDISC SDTM ECG Test Method Terminology", "count": 1}, {"letter": "Mononucleated Blood Cell", "count": 1}, {"letter": "Mucin-16", "count": 7}, {"letter": "Multidimensional", "count": 46}, {"letter": "NCI Criterion", "count": 28}, {"letter": "Nutrient (property)", "count": 1}, {"letter": "Observation Result", "count": 3}, {"letter": "Official", "count": 4}, {"letter": "Original Regulatory Submission", "count": 3}, {"letter": "XL147", "count": 9}, {"letter": "BEZ235", "count": 2}, {"letter": "BGT226", "count": 2}, {"letter": "Paternal Relative", "count": 1}, {"letter": "Patient Alert", "count": 2}, {"letter": "Percent of Abnormal Cells", "count": 3}, {"letter": "Person Observer", "count": 24}, {"letter": "Pharmacogenomic Testing", "count": 1}, {"letter": "Physical Shift", "count": 27}, {"letter": "Plant-Derived Hematopoiesis Enhancer PG2", "count": 1}, {"letter": "MSX-122", "count": 2}, {"letter": "Central Pathology Review", "count": 7}, {"letter": "Chemical Probe", "count": 15}, {"letter": "Chemosensitivity", "count": 3}, {"letter": "Point Name", "count": 343}, {"letter": "Population Deviation", "count": 1}, {"letter": "Population Mean", "count": 131}, {"letter": "Population Median", "count": 312}, {"letter": "Population Mode", "count": 1}, {"letter": "Population Standard Deviation", "count": 7}, {"letter": "Post-intervention", "count": 165}, {"letter": "Potential Study Subject", "count": 1}, {"letter": "Pre-Medication", "count": 5}, {"letter": "Pre-existing", "count": 30}, {"letter": "Pre-intervention Imaging", "count": 33}, {"letter": "Preferred Term", "count": 3}, {"letter": "Preoperative Chemotherapy", "count": 15}, {"letter": "Quadrupole", "count": 1}, {"letter": "Quotient", "count": 3}, {"letter": "Clinical Breast Examination", "count": 17}, {"letter": "NIH Clinical Center", "count": 2}, {"letter": "Clinical Endpoint", "count": 9}, {"letter": "Clinical Study Population Subgroup", "count": 30}, {"letter": "Study Site Status", "count": 1}, {"letter": "Clinical Study Sponsor", "count": 12}, {"letter": "Clinical Trial Epoch", "count": 2}, {"letter": "Clinical Trial Period", "count": 2}, {"letter": "Cmax", "count": 455}, {"letter": "cobaltous cation", "count": 2}, {"letter": "Commit Operation", "count": 4}, {"letter": "Concomitant Agent", "count": 13}, {"letter": "Conservation", "count": 47}, {"letter": "Content Creation Date", "count": 4}, {"letter": "Beam - rays of radiation or stream of particles", "count": 10}, {"letter": "Radio Frequency", "count": 14}, {"letter": "Radioactivity Concentration Unit", "count": 1}, {"letter": "Radioisotopic Labeling (lab procedure)", "count": 1}, {"letter": "Randomization Indicator", "count": 1}, {"letter": "Rate of Administration", "count": 6}, {"letter": "Reason For Procedure", "count": 1}, {"letter": "Refrigerated Specimen", "count": 3}, {"letter": "Regulatory Application", "count": 1}, {"letter": "Regulatory Submission", "count": 1}, {"letter": "Relevance", "count": 143}, {"letter": "Reliability (characteristic)", "count": 75}, {"letter": "Reluctance", "count": 1}, {"letter": "Report from Study", "count": 1}, {"letter": "Reservation (action)", "count": 6}, {"letter": "Root Mean Square", "count": 5}, {"letter": "afimoxifene", "count": 4}, {"letter": "Agent Administration", "count": 5}, {"letter": "Cross-Correlation", "count": 1}, {"letter": "Parallel Lesion", "count": 8}, {"letter": "Estimated Potential Vessel Value", "count": 24}, {"letter": "Series - set of composite instances", "count": 42}, {"letter": "DNMT3A wt Allele", "count": 1}, {"letter": "dabigatran", "count": 14}, {"letter": "Daily Dose", "count": 26}, {"letter": "Degree Unit of Plane Angle", "count": 15}, {"letter": "SN-38-Loaded Polymeric Micelles NK012", "count": 2}, {"letter": "SPIO Nanoparticle", "count": 4}, {"letter": "Sample Mean", "count": 225}, {"letter": "Sample Median", "count": 158}, {"letter": "Sample Mode", "count": 12}, {"letter": "Sample Statistic", "count": 17}, {"letter": "Sample Variance", "count": 3}, {"letter": "Screening Study", "count": 8}, {"letter": "Sequence Number", "count": 5}, {"letter": "Serial Number", "count": 37}, {"letter": "Similarity", "count": 72}, {"letter": "Specialist Physician", "count": 2}, {"letter": "Specification", "count": 4}, {"letter": "Specimen at Room Temperature", "count": 5}, {"letter": "Diagnostic Efficacy", "count": 1}, {"letter": "Dietary Magnesium", "count": 5}, {"letter": "Dietary Mercury", "count": 1}, {"letter": "Dietary Nickel", "count": 5}, {"letter": "Dietary Polyphenol", "count": 1}, {"letter": "Dietary Selenium", "count": 2}, {"letter": "Digital Image Analysis", "count": 1}, {"letter": "Doctor - Title", "count": 14}, {"letter": "Dose Regimen", "count": 21}, {"letter": "Drop British", "count": 48}, {"letter": "Drug Master File", "count": 1}, {"letter": "Drug Started Identifier", "count": 14}, {"letter": "XL765", "count": 3}, {"letter": "Duration of Administration", "count": 1}, {"letter": "EDNRA wt Allele", "count": 1}, {"letter": "Effect, Appearance", "count": 12}, {"letter": "Elimination Half Life", "count": 40}, {"letter": "Spontaneous Report", "count": 1}, {"letter": "KX2-391", "count": 5}, {"letter": "ex vivo", "count": 19}, {"letter": "Exemption", "count": 1}, {"letter": "Exposed Population", "count": 1}, {"letter": "X-Ray Exposure Time", "count": 1}, {"letter": "Fasting Specimen", "count": 4}, {"letter": "Feature", "count": 12}, {"letter": "Standard Cubic Foot", "count": 2}, {"letter": "Standard Cubic Meter", "count": 1}, {"letter": "Standardized Uptake Value", "count": 95}, {"letter": "Study Activity", "count": 2}, {"letter": "Study Completed", "count": 139}, {"letter": "Study Start Date", "count": 29}, {"letter": "Study Population (group)", "count": 31}, {"letter": "Study Protocol", "count": 58}, {"letter": "Study Terminated", "count": 18}, {"letter": "Study Withdrawn", "count": 6}, {"letter": "Subject Completed Participation in Study", "count": 1}, {"letter": "Subtraction process", "count": 20}, {"letter": "Supplement", "count": 37}, {"letter": "Supportive Care Study", "count": 2}, {"letter": "Survey Inch", "count": 2}, {"letter": "System of Measurement", "count": 11}, {"letter": "Targeted Accrual", "count": 1}, {"letter": "Fingertip Dosing Unit", "count": 2}, {"letter": "Flux", "count": 4}, {"letter": "Font", "count": 1}, {"letter": "Genomic Biomarker", "count": 2}, {"letter": "Therapeutic Efficacy", "count": 8}, {"letter": "Therapeutic Estetrol", "count": 4}, {"letter": "Time-of-Flight", "count": 1}, {"letter": "Timepoint", "count": 407}, {"letter": "Tmax", "count": 268}, {"letter": "Tolerable_Level", "count": 2}, {"letter": "Total Marrow Irradiation", "count": 1}, {"letter": "Transabdominal Ultrasound", "count": 2}, {"letter": "Triple-Negative Breast Cancer Finding", "count": 44}, {"letter": "Regulatory Application Type", "count": 5}, {"letter": "US_Recommended_Intake", "count": 1}, {"letter": "Global", "count": 242}, {"letter": "Gram per Square Centimeter", "count": 1}, {"letter": "Great Relative", "count": 1}, {"letter": "HER2/Neu Negative", "count": 63}, {"letter": "HER2/Neu Positive", "count": 77}, {"letter": "High-Intensity Focused Ultrasound Ablation", "count": 6}, {"letter": "Meddra High Level Term", "count": 1}, {"letter": "Histogram", "count": 15}, {"letter": "Historical Cohort", "count": 1}, {"letter": "OGX-427", "count": 7}, {"letter": "AUY922", "count": 6}, {"letter": "Human Study Subject", "count": 336}, {"letter": "Valid", "count": 67}, {"letter": "Validity (characteristic)", "count": 46}, {"letter": "V4+", "count": 297}, {"letter": "Vanadium 5+", "count": 190}, {"letter": "Web Site", "count": 14}, {"letter": "Worksheet", "count": 12}, {"letter": "Yard British", "count": 3}, {"letter": "End Point", "count": 190}, {"letter": "Correct (qualifier)", "count": 75}, {"letter": "Force Field", "count": 7}, {"letter": "Signal Sensitivity", "count": 5}, {"letter": "Fit (action)", "count": 23}, {"letter": "Mrs - title", "count": 4}, {"letter": "Pool (action)", "count": 12}, {"letter": "On examination - heart normal (finding)", "count": 1}, {"letter": "Miss - Title", "count": 3}, {"letter": "Bound (value)", "count": 6}, {"letter": "Deformity of reconstructed breast", "count": 2}, {"letter": "Encounter due to prophylactic use of aromatase inhibitors", "count": 1}, {"letter": "Ms. - Title", "count": 17}, {"letter": "Withdraw (activity)", "count": 76}, {"letter": "Boron 3+", "count": 1}, {"letter": "Contamination", "count": 3}, {"letter": "Enhance (action)", "count": 108}, {"letter": "Gamma - unit of measure", "count": 1}, {"letter": "On Study", "count": 243}, {"letter": "Study start time", "count": 20}, {"letter": "Percent of Lymphocytes", "count": 2}, {"letter": "Test Result Report", "count": 3}, {"letter": "Emission substance", "count": 1}, {"letter": "Population Parameter", "count": 65}, {"letter": "Short Value", "count": 157}, {"letter": "Financial (qualifier)", "count": 40}, {"letter": "Alpha Value", "count": 88}, {"letter": "Data Type -Character", "count": 1}, {"letter": "Cone shape", "count": 17}, {"letter": "Metabolic Stress", "count": 1}, {"letter": "Physiological Stress Response", "count": 1}, {"letter": "Sensitive Populations", "count": 6}, {"letter": "Early Detection of Disease", "count": 2}, {"letter": "Warm-Up Exercise", "count": 3}, {"letter": "Hot Temperature", "count": 1}, {"letter": "Genome-Wide Association Study", "count": 4}, {"letter": "X-Ray Microtomography", "count": 1}, {"letter": "Exosomes", "count": 7}, {"letter": "CTLA4 protein, human", "count": 2}, {"letter": "Perfusion Imaging", "count": 3}, {"letter": "Metabolome", "count": 8}, {"letter": "Volatile Organic Compounds", "count": 2}, {"letter": "Natural Killer T-Cells", "count": 3}, {"letter": "NK Cell Lectin-Like Receptor Subfamily K, Member 1", "count": 1}, {"letter": "Touch Perception", "count": 1}, {"letter": "Microvessels", "count": 3}, {"letter": "Microvascular Network", "count": 1}, {"letter": "Radiation Fibrosis", "count": 5}, {"letter": "Macrophage Inflammatory Protein-1", "count": 2}, {"letter": "KOS 1022", "count": 3}, {"letter": "eribulin", "count": 99}, {"letter": "Bone Mineralization", "count": 1}, {"letter": "tremelimumab", "count": 24}, {"letter": "CEACAM5 protein, human", "count": 33}, {"letter": "necitumumab", "count": 6}, {"letter": "GRP protein, human", "count": 1}, {"letter": "dapagliflozin", "count": 3}, {"letter": "DPA 714", "count": 5}, {"letter": "Ward (person)", "count": 1}, {"letter": "Metabolic equivalent measurement", "count": 5}, {"letter": "Therapeutic Equivalency Study", "count": 16}, {"letter": "Intolerance - biological effect of chemicals", "count": 5}, {"letter": "Co-Q10", "count": 1}, {"letter": "Cholesterol.in HDL", "count": 1}, {"letter": "Assessment information", "count": 6}, {"letter": "Additional assessment", "count": 7}, {"letter": "Treatment encounter", "count": 11}, {"letter": "Medication rate", "count": 4}, {"letter": "Immunosuppressive drugs attachment:Find:Pt:^Patient:Doc", "count": 1}, {"letter": "Assessment note", "count": 1}, {"letter": "Letter:Finding:Point in time:{Setting}:Document:{Provider}", "count": 25}, {"letter": "Note:Find:Pt:{Setting}:Doc:Patient", "count": 2}, {"letter": "Number of patients", "count": 564}, {"letter": "Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative", "count": 1}, {"letter": "Discharge date", "count": 1}, {"letter": "Continuity Assessment Record and Evaluation (CARE) survey", "count": 1}, {"letter": "Co^a", "count": 2}, {"letter": "WT-1 protein", "count": 2}, {"letter": "Computer assisted method", "count": 1}, {"letter": "Temporal -Temporal Qualifier", "count": 17}, {"letter": "Sexual Health", "count": 26}, {"letter": "Safety Issues", "count": 2}, {"letter": "Sexual Health Issues", "count": 2}, {"letter": "Health Literacy", "count": 22}, {"letter": "Electronic Health Records", "count": 30}, {"letter": "Urgent Care", "count": 4}, {"letter": "Physical Therapist", "count": 12}, {"letter": "Complication (attribute)", "count": 1}, {"letter": "T cell subsets (finding)", "count": 1}, {"letter": "Possible diagnosis", "count": 179}, {"letter": "Muscle of upper limb", "count": 5}, {"letter": "Muscle of lower limb", "count": 2}, {"letter": "Clinical depression", "count": 1}, {"letter": "Early stage", "count": 20}, {"letter": "Developers, X-Ray Film", "count": 4}, {"letter": "Sentinel lymphadenectomy", "count": 3}, {"letter": "Natural Killer Cell Count", "count": 2}, {"letter": "Acute radiation toxicity", "count": 1}, {"letter": "Able to cope", "count": 1}, {"letter": "Discomfort", "count": 130}, {"letter": "Personal care disability", "count": 1}, {"letter": "Adherence To Medication Regime", "count": 37}, {"letter": "Actual Positive Nutritional Status", "count": 1}, {"letter": "romiplostim", "count": 1}, {"letter": "Muse", "count": 7}, {"letter": "condition evaluation", "count": 9}, {"letter": "Assessing Pain", "count": 11}, {"letter": "intraoperative ultrasound (procedure)", "count": 2}, {"letter": "Administration of vaccine", "count": 8}, {"letter": "Align", "count": 2}, {"letter": "Trustworthiness", "count": 1}, {"letter": "Shifting attention", "count": 1}, {"letter": "Emotional Regulation", "count": 16}, {"letter": "Range of emotion", "count": 1}, {"letter": "Cognitive Flexibility", "count": 11}, {"letter": "Simple calculation", "count": 1}, {"letter": "Experience of time", "count": 2}, {"letter": "Touch function", "count": 1}, {"letter": "Aerobic capacity", "count": 3}, {"letter": "Watching", "count": 1}, {"letter": "Socializing", "count": 26}, {"letter": "Assets", "count": 1}, {"letter": "Sound quality", "count": 1}, {"letter": "Predictability", "count": 2}, {"letter": "Manual dominance", "count": 1}, {"letter": "Acquiring information", "count": 4}, {"letter": "Medical and Surgical @ Muscles @ Change", "count": 1}, {"letter": "Bending - Changing basic body position", "count": 1}, {"letter": "Sitting Function", "count": 12}, {"letter": "Climbing", "count": 5}, {"letter": "Listening", "count": 3}, {"letter": "Writing (function)", "count": 9}, {"letter": "Intimate relationships", "count": 8}, {"letter": "Discussion (communication)", "count": 31}, {"letter": "Throwing", "count": 2}, {"letter": "Reaching", "count": 172}, {"letter": "Bodies of water (physical geography)", "count": 1}, {"letter": "Frequency of urination (function)", "count": 1}, {"letter": "Lymphedema of limb", "count": 13}, {"letter": "Postoperative physical examination", "count": 2}, {"letter": "Date of procedure", "count": 2}, {"letter": "Alive (finding)", "count": 289}, {"letter": "Experimental therapeutic procedure", "count": 1}, {"letter": "Blood glucose concentration", "count": 1}, {"letter": "Level of agitation", "count": 1}, {"letter": "Focused ultrasound ablation", "count": 1}, {"letter": "Date of event", "count": 58}, {"letter": "Canadian occupational performance measure", "count": 1}, {"letter": "New diagnosis (finding)", "count": 5}, {"letter": "Level of fatigue", "count": 25}, {"letter": "Thrombosis of blood vessel", "count": 7}, {"letter": "Therapy outcome measure", "count": 2}, {"letter": "Control function", "count": 39}, {"letter": "Index case", "count": 1}, {"letter": "HIPAA attachments", "count": 2}, {"letter": "Assessment Type", "count": 1}, {"letter": "Medications:-:Point in time:^Patient:-", "count": 50}, {"letter": "Anthropometric Measures", "count": 11}, {"letter": "Swallowing:-:Point in time:^Patient:-", "count": 1}, {"letter": "Grip Strength:-:Point in time:^Patient:-", "count": 2}, {"letter": "Overall status", "count": 21}, {"letter": "Clinical trial protocol", "count": 7}, {"letter": "Fractional shortening", "count": 1}, {"letter": "Immune response markers", "count": 2}, {"letter": "Prior functioning.functional cognition", "count": 1}, {"letter": "Provider type", "count": 1}, {"letter": "Study", "count": 1675}, {"letter": "Aesthetics (quality)", "count": 8}, {"letter": "Dose form", "count": 1}, {"letter": "XRP 9881", "count": 1}, {"letter": "ANG1005", "count": 8}, {"letter": "CTSB protein, human", "count": 3}, {"letter": "GDC 0941", "count": 3}, {"letter": "Institution", "count": 12}, {"letter": "Physical performance", "count": 8}, {"letter": "Version (morphologic abnormality)", "count": 390}, {"letter": "abiraterone acetate", "count": 7}, {"letter": "Pet Therapy", "count": 4}, {"letter": "Discomfort of vulva", "count": 1}, {"letter": "Early Detection of Cancer", "count": 3}, {"letter": "findings aspects", "count": 21}, {"letter": "eribulin mesylate", "count": 9}, {"letter": "Intelligence test/WAIS (procedure)", "count": 1}, {"letter": "flight (process)", "count": 6}, {"letter": "natural killer cell apoptotic process", "count": 1}, {"letter": "monocyte aggregation", "count": 2}, {"letter": "autophagosome assembly", "count": 1}, {"letter": "signaling cascade", "count": 1}, {"letter": "MAPK signaling", "count": 1}, {"letter": "protein lysine acetylation", "count": 2}, {"letter": "Padilla", "count": 1}, {"letter": "Lanugo (invertebrate)", "count": 2}, {"letter": "Libra", "count": 1}, {"letter": "Assessor (genus)", "count": 4}, {"letter": "Atla (fungus)", "count": 4}, {"letter": "Blautia", "count": 2}, {"letter": "Vascular tortuosity", "count": 1}, {"letter": "Autonomic symptoms", "count": 9}, {"letter": "SPHEROCYTOSIS, TYPE 1 (disorder)", "count": 3}, {"letter": "Limited Walking Ability", "count": 1}, {"letter": "Severe bone pain", "count": 1}, {"letter": "MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 2 (finding)", "count": 4}, {"letter": "Thrombocytopenia 4", "count": 10}, {"letter": "Thrombocytopenia 3", "count": 7}, {"letter": "P4HTM gene", "count": 1}, {"letter": "TTC37 gene", "count": 1}, {"letter": "C4orf3 gene", "count": 3}, {"letter": "C12orf73 gene", "count": 22}, {"letter": "CMTR2 gene", "count": 1}, {"letter": "KIDINS220 gene", "count": 1}, {"letter": "Excision of skin", "count": 1}, {"letter": "Graph Edge", "count": 1}, {"letter": "Graph Node", "count": 2}, {"letter": "HPGD wt Allele", "count": 1}, {"letter": "Health Assessment Questionnaire-II", "count": 2}, {"letter": "Heatmap", "count": 1}, {"letter": "IDH1 wt Allele", "count": 1}, {"letter": "Image Registration", "count": 11}, {"letter": "Image Segmentation", "count": 2}, {"letter": "Imaging System", "count": 16}, {"letter": "Immunoenzyme Procedure", "count": 3}, {"letter": "Independent Rater", "count": 1}, {"letter": "Infinity", "count": 80}, {"letter": "Infusion Site", "count": 1}, {"letter": "Interleukin 3 Measurement", "count": 1}, {"letter": "LogE", "count": 8}, {"letter": "Malignant Cell Count", "count": 4}, {"letter": "Mathematical Graph", "count": 11}, {"letter": "Member Organization", "count": 5}, {"letter": "Midline 1 RING Finger Protein", "count": 1}, {"letter": "Normal Reference Range", "count": 4}, {"letter": "Body of Data", "count": 1}, {"letter": "Breakfast", "count": 1}, {"letter": "Brief Fatigue Inventory", "count": 48}, {"letter": "CD86 wt Allele", "count": 1}, {"letter": "CDISC SDTM Evaluator Terminology", "count": 1}, {"letter": "CDISC SEND Terminology", "count": 1}, {"letter": "Optimization", "count": 3}, {"letter": "Optimum", "count": 95}, {"letter": "Other Toxicity Studies: Metabolites", "count": 4}, {"letter": "Outlier", "count": 7}, {"letter": "Imprime PGG", "count": 2}, {"letter": "PKM wt Allele", "count": 1}, {"letter": "CF-1 Mouse", "count": 1}, {"letter": "Participant Object", "count": 605}, {"letter": "Pediatric Quality of Life Inventory", "count": 1}, {"letter": "Pharmacokinetics: Absorption", "count": 5}, {"letter": "Pharmacokinetics: Drug Interactions", "count": 2}, {"letter": "Predictor", "count": 68}, {"letter": "Professional Occupation", "count": 19}, {"letter": "Protocol Event", "count": 43}, {"letter": "RAI1 wt Allele", "count": 2}, {"letter": "Cancer Diagnostic Procedure", "count": 3}, {"letter": "Capability", "count": 21}, {"letter": "Rationale", "count": 1}, {"letter": "Reflexive Relationship", "count": 2}, {"letter": "Relative Quantity", "count": 3}, {"letter": "Rh Positive Blood Group", "count": 1}, {"letter": "ARPP21 gene", "count": 2}, {"letter": "Cell Invasion", "count": 1}, {"letter": "Cell Wash", "count": 2}, {"letter": "Center For Epidemiologic Studies depression scale questionnaire", "count": 35}, {"letter": "SD, Rat Strain", "count": 223}, {"letter": "SS, Rat Strain", "count": 33}, {"letter": "Salesperson", "count": 2}, {"letter": "Scanning Auger Spectrometer (device)", "count": 22}, {"letter": "sodium glycididazole", "count": 6}, {"letter": "Abnormal Reference Range", "count": 2}, {"letter": "Clinical Summary", "count": 1}, {"letter": "Committee", "count": 26}, {"letter": "Concern", "count": 141}, {"letter": "Conjunction", "count": 10}, {"letter": "Criterion Validity", "count": 1}, {"letter": "Resolution", "count": 54}, {"letter": "Absent Adverse Event", "count": 106}, {"letter": "Cytokine Measurement", "count": 2}, {"letter": "Statistical Imputation", "count": 29}, {"letter": "Distribution Data", "count": 7}, {"letter": "Disturbance", "count": 26}, {"letter": "Donor Cellular Infusion", "count": 1}, {"letter": "Dovitinib", "count": 2}, {"letter": "EYA1 wt Allele", "count": 9}, {"letter": "Molecular Targeted Therapy", "count": 1}, {"letter": "Toxicology: Carcinogenicity", "count": 2}, {"letter": "Toxicology: Single Dose Toxicity [Species and Route]", "count": 1}, {"letter": "Family Collection", "count": 1}, {"letter": "Transition (action)", "count": 1}, {"letter": "Unpaired", "count": 3}, {"letter": "Unusual", "count": 1}, {"letter": "Value Above Reference Range", "count": 30}, {"letter": "Ad-sig-hMUC-1/ecdCD40L Vaccine", "count": 1}, {"letter": "Fecal Immunochemical Test", "count": 1}, {"letter": "Fish Flavor", "count": 10}, {"letter": "Friendly", "count": 1}, {"letter": "Functional Relationship", "count": 18}, {"letter": "Volume Measurement", "count": 50}, {"letter": "Voxel", "count": 6}, {"letter": "White Button Mushroom Extract", "count": 1}, {"letter": "World", "count": 49}, {"letter": "Darjeeling - zebrafish", "count": 3}, {"letter": "Wild Type Unspecified - zebrafish", "count": 4}, {"letter": "Lymphoseek", "count": 8}, {"letter": "Adjudication Committee", "count": 1}, {"letter": "Measurement of Left Ventricular Ejection Fraction", "count": 2}, {"letter": "Ejection fraction (finding)", "count": 7}, {"letter": "Poor - qualifier", "count": 103}, {"letter": "Urban - qualifier", "count": 1}, {"letter": "Convergence (action)", "count": 2}, {"letter": "Plant nodule", "count": 1}, {"letter": "Procedure (set of actions)", "count": 95}, {"letter": "Smallest", "count": 387}, {"letter": "Injection site", "count": 3}, {"letter": "Include (action)", "count": 139}, {"letter": "Contain (action)", "count": 266}, {"letter": "Deny (action)", "count": 7}, {"letter": "COL6A4P1 gene", "count": 1}, {"letter": "prevention aspects", "count": 12}, {"letter": "Node - plant part", "count": 3}, {"letter": "Self-Report", "count": 251}, {"letter": "India - zebrafish", "count": 2}, {"letter": "Package", "count": 3}, {"letter": "Decay (action)", "count": 1}, {"letter": "farletuzumab", "count": 7}, {"letter": "Irritation - emotion", "count": 3}, {"letter": "Test Strip (device)", "count": 1}, {"letter": "Encode (action)", "count": 3}, {"letter": "tobacco leaf allergenic extract", "count": 2}, {"letter": "method of environmental exposure", "count": 3}, {"letter": "CYT107", "count": 10}, {"letter": "AZD 8931", "count": 5}, {"letter": "GSK 1120212", "count": 8}, {"letter": "MM-121", "count": 1}, {"letter": "ACE-011", "count": 1}, {"letter": "MCS110", "count": 4}, {"letter": "V934/V935", "count": 1}, {"letter": "Normal control", "count": 5}, {"letter": "Feeling Sad:-:Point in time:^Patient:-", "count": 1}, {"letter": "Time of death:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative", "count": 6}, {"letter": "Behavior:-:Point in time:^Patient:-", "count": 8}, {"letter": "Behavioral symptoms:-:Point in time:^Patient:-", "count": 1}, {"letter": "Metabolic:-:Point in time:^Patient:-", "count": 8}, {"letter": "Musculoskeletal:-:Point in time:^Patient:-", "count": 11}, {"letter": "Nutritional:-:Point in time:^Patient:-", "count": 3}, {"letter": "Pulmonary:-:Point in time:^Patient:-", "count": 2}, {"letter": "Vision:-:Point in time:^Patient:-", "count": 5}, {"letter": "Additional diagnoses:-:Point in time:^Patient:-", "count": 1}, {"letter": "Shortness of breath:-:Point in time:^Patient:-", "count": 7}, {"letter": "Measure:Find:Pt:XXX:Doc", "count": 1}, {"letter": "Patient data", "count": 28}, {"letter": "HbA1c (Bld)", "count": 1}, {"letter": "Assessment administration:-:Point in time:^Patient:-", "count": 5}, {"letter": "Assessment administration", "count": 17}, {"letter": "Version code", "count": 2}, {"letter": "Clinical presentation", "count": 4}, {"letter": "Exercise type", "count": 1}, {"letter": "Exercise duration", "count": 2}, {"letter": "Clinical information", "count": 7}, {"letter": "Treatment information", "count": 14}, {"letter": "Thyrotropin:-:Pt:Ser/Plas:-", "count": 2}, {"letter": "Lean body weight", "count": 4}, {"letter": "During Treatment", "count": 35}, {"letter": "Pedometers", "count": 5}, {"letter": "Pulmonary (qualifier value)", "count": 2}, {"letter": "Natriuretic peptide", "count": 1}, {"letter": "Mammography view", "count": 2}, {"letter": "Life threatening severity", "count": 1}, {"letter": "Consented (qualifier value)", "count": 6}, {"letter": "Osteonecrosis of Jaw", "count": 4}, {"letter": "Minimally invasive procedure", "count": 5}, {"letter": "International Consultation on Incontinence questionnaire", "count": 2}, {"letter": "SCH 727965", "count": 1}, {"letter": "cediranib maleate", "count": 3}, {"letter": "Actual Effective Cognition", "count": 1}, {"letter": "Normal heart rate", "count": 4}, {"letter": "Normal weight", "count": 5}, {"letter": "Perioperative Period", "count": 3}, {"letter": "Preoperative Period", "count": 7}, {"letter": "Actual Positive Self Esteem", "count": 2}, {"letter": "Dense breasts NOS", "count": 8}, {"letter": "Vacuuming (activity)", "count": 3}, {"letter": "Treadmill (physical activity)", "count": 11}, {"letter": "Ironing (activity)", "count": 3}, {"letter": "neratinib", "count": 38}, {"letter": "figitumumab", "count": 7}, {"letter": "Tissue type", "count": 1}, {"letter": "CDX 1307", "count": 1}, {"letter": "Mood:-:Point in time:^Patient:-", "count": 3}, {"letter": "Olecranon Process", "count": 14}, {"letter": "Medical Home", "count": 1}, {"letter": "Spectroscopy (discipline)", "count": 9}, {"letter": "PIK3CG protein, human", "count": 3}, {"letter": "SERPINA5 protein, human", "count": 1}, {"letter": "antitumor A", "count": 1}, {"letter": "Metagenome", "count": 4}, {"letter": "Cancer Screening Tests", "count": 2}, {"letter": "Nipple Aspirate Fluid", "count": 7}, {"letter": "Teaching Rounds", "count": 6}, {"letter": "Metagenomics", "count": 2}, {"letter": "Bacterial Structures", "count": 3}, {"letter": "Genotype-Phenotype Associations", "count": 1}, {"letter": "Candidate Gene Analysis", "count": 2}, {"letter": "Bispectral Index Monitor", "count": 1}, {"letter": "Upper Extremity Deep Vein Thrombosis, Secondary", "count": 1}, {"letter": "DNA Copy Number Changes", "count": 1}, {"letter": "Enzyme Assays", "count": 1}, {"letter": "Stroop Test", "count": 7}, {"letter": "Intention to Treat Analysis", "count": 3}, {"letter": "Late Diagnosis", "count": 1}, {"letter": "Propensity Score", "count": 2}, {"letter": "Limit of Detection", "count": 6}, {"letter": "Climate Change", "count": 1}, {"letter": "Precision Medicine", "count": 1}, {"letter": "Mobile Health", "count": 4}, {"letter": "Gametes", "count": 1}, {"letter": "Biometry and Biostatistics (occupation or discipline)", "count": 1}, {"letter": "canakinumab", "count": 5}, {"letter": "Mental health assessment", "count": 1}, {"letter": "Present +++ out of ++++", "count": 1}, {"letter": "Program", "count": 123}, {"letter": "Sustain", "count": 2}, {"letter": "Ductal Carcinoma In Situ with Microinvasion", "count": 1}, {"letter": "Brief pain inventory score", "count": 9}, {"letter": "Pyrosequencing", "count": 1}, {"letter": "Edema of chest wall", "count": 1}, {"letter": "Body Image Dissatisfaction", "count": 1}, {"letter": "Possible clinical finding", "count": 1}, {"letter": "Number of lymph nodes containing metastatic neoplasm in excised specimen", "count": 2}, {"letter": "Visual analog scale pain score", "count": 4}, {"letter": "Quantitative PCR analysis", "count": 3}, {"letter": "Behavioral activation therapy", "count": 1}, {"letter": "EuroQoL five dimension questionnaire", "count": 5}, {"letter": "Stemmer sign", "count": 1}, {"letter": "Left ventricular ejection", "count": 19}, {"letter": "Fatigue impact scale", "count": 1}, {"letter": "High molecular weight adiponectin", "count": 1}, {"letter": "Length of arm span", "count": 7}, {"letter": "Healthcare communication", "count": 1}, {"letter": "Population criteria", "count": 1}, {"letter": "Measure observations", "count": 1}, {"letter": "Primary care provider", "count": 17}, {"letter": "Patient location", "count": 1}, {"letter": "Problem frequency", "count": 1}, {"letter": "Cardiac biomarkers", "count": 13}, {"letter": "Privacy policy", "count": 1}, {"letter": "Care management", "count": 3}, {"letter": "Initial sample", "count": 3}, {"letter": "Household tasks", "count": 1}, {"letter": "Medication intervention", "count": 2}, {"letter": "Depression intervention", "count": 1}, {"letter": "Current sample", "count": 2}, {"letter": "Reasons for modification", "count": 1}, {"letter": "Correction number", "count": 1}, {"letter": "Data entry error", "count": 1}, {"letter": "Follow-up expectation", "count": 2}, {"letter": "In^b", "count": 2}, {"letter": "Pain presence", "count": 11}, {"letter": "Vw", "count": 1}, {"letter": "INK", "count": 10}, {"letter": "Excel", "count": 1}, {"letter": "Account number:Identifier:Point in time:^Patient:Nominal", "count": 92}, {"letter": "RO 4929097", "count": 3}, {"letter": "enobosarm", "count": 1}, {"letter": "ramucirumab", "count": 9}, {"letter": "obinutuzumab", "count": 2}, {"letter": "TYMP protein, human", "count": 3}, {"letter": "AK2 protein, human", "count": 1}, {"letter": "entinostat", "count": 24}, {"letter": "17-dihydroexemestane", "count": 1}, {"letter": "niraparib", "count": 6}, {"letter": "CD69 protein, human", "count": 1}, {"letter": "THBD protein, human", "count": 3}, {"letter": "ATP8A2 protein, human", "count": 6}, {"letter": "AMG-479", "count": 3}, {"letter": "Profil", "count": 1}, {"letter": "Hyalinosis, Systemic", "count": 8}, {"letter": "Occurrence", "count": 137}, {"letter": "Emergencies [Disease/Finding]", "count": 1}, {"letter": "MTOR Inhibitors", "count": 1}, {"letter": "Stop (qualifier value)", "count": 631}, {"letter": "Bacterial colonisation", "count": 2}, {"letter": "Executive dysfunction", "count": 1}, {"letter": "Transient elastography", "count": 6}, {"letter": "Cognitive function, variable", "count": 1}, {"letter": "Mild weakness", "count": 2}, {"letter": "response to platinum ion", "count": 1}, {"letter": "UV-damage excision repair", "count": 1}, {"letter": "subsynaptic reticulum", "count": 2}, {"letter": "specification of symmetry", "count": 1}, {"letter": "neuronal signal transduction", "count": 1}, {"letter": "Interferon gamma [EPC]", "count": 3}, {"letter": "Aromatase Inhibitors [MoA]", "count": 60}, {"letter": "Withdrawal (dysfunction)", "count": 6}, {"letter": "Analgesia [PE]", "count": 16}, {"letter": "Kinetics (discipline)", "count": 12}, {"letter": "Energy Absorption", "count": 1}, {"letter": "Pack unit", "count": 1}, {"letter": "Recurrence (disease attribute)", "count": 179}, {"letter": "Clearance [PK]", "count": 117}, {"letter": "Vitamin A [EPC]", "count": 1}, {"letter": "Thyroid Stimulating Hormone [EPC]", "count": 1}, {"letter": "Milk - dietary", "count": 1}, {"letter": "AlloStim", "count": 4}, {"letter": "Experimental Finding", "count": 32}, {"letter": "Experimental Result", "count": 433}, {"letter": "Fasting Blood Sugar Measurement", "count": 1}, {"letter": "Study Site", "count": 30}, {"letter": "Pre-Test Probability of Coronary Artery Disease", "count": 1}, {"letter": "Date of Therapeutic Procedure", "count": 91}, {"letter": "Union", "count": 2}, {"letter": "Denominator", "count": 13}, {"letter": "Numerator", "count": 1}, {"letter": "Cytokeratin 5/6 Immunohistochemical Expression", "count": 1}, {"letter": "VTX-2337", "count": 2}, {"letter": "Computer Grid", "count": 5}, {"letter": "immunoglobulin A, human", "count": 3}, {"letter": "Quarter", "count": 4}, {"letter": "Half", "count": 44}, {"letter": "Stair (equipment)", "count": 8}, {"letter": "Paired Data", "count": 1}, {"letter": "Negative Number", "count": 40}, {"letter": "Positive Charge", "count": 48}, {"letter": "Negative Charge", "count": 7}, {"letter": "Neutral Charge", "count": 21}, {"letter": "Non-Enhancing Lesion", "count": 4}, {"letter": "Age Appropriate Screening", "count": 2}, {"letter": "Birth Method of Delivery", "count": 1}, {"letter": "Measurement Device", "count": 2}, {"letter": "Last Observation Carried Forward Imputation Technique", "count": 12}, {"letter": "Worst Case Imputation Technique", "count": 3}, {"letter": "Interpolation Imputation Technique", "count": 4}, {"letter": "Average of Value Derivation Technique", "count": 18}, {"letter": "Crown to Rump Length Measurement", "count": 2}, {"letter": "Imaging Information", "count": 2}, {"letter": "Mental Scale", "count": 9}, {"letter": "Numeric Value", "count": 8}, {"letter": "Point in Time Test Given", "count": 6}, {"letter": "Estimation Method", "count": 1}, {"letter": "Physical Symmetry", "count": 1}, {"letter": "Deploy", "count": 1}, {"letter": "Interferon Gamma Measurement", "count": 1}, {"letter": "Type I Collagen C-Telopeptide Measurement", "count": 1}, {"letter": "Type I Collagen N-Telopeptide Measurement", "count": 1}, {"letter": "Autologous Stem Cell Rescue", "count": 1}, {"letter": "Adjunctive Orthodontic Procedure", "count": 5}, {"letter": "Dental Intrusion", "count": 20}, {"letter": "Echo Time", "count": 1}, {"letter": "onartuzumab", "count": 2}, {"letter": "Acellular Cadaveric Dermal Matrix", "count": 2}, {"letter": "Fluid Attenuated Inversion Recovery", "count": 2}, {"letter": "Study Day", "count": 33}, {"letter": "Complete Recovery", "count": 1}, {"letter": "No Assessment", "count": 1}, {"letter": "Dose Adjustment", "count": 14}, {"letter": "Clinical Trial Branch", "count": 1}, {"letter": "Result Category", "count": 4}, {"letter": "Life Threatening", "count": 7}, {"letter": "Pre-specified", "count": 26}, {"letter": "Collection Date Time", "count": 6}, {"letter": "Prior Medication Usage", "count": 81}, {"letter": "Toxicity Grade", "count": 78}, {"letter": "Evaluation Interval", "count": 15}, {"letter": "Test Name", "count": 1}, {"letter": "Abnormal Finding", "count": 8}, {"letter": "Outcome Death", "count": 3}, {"letter": "Planned Dose", "count": 17}, {"letter": "Dose Adjustment Reason", "count": 2}, {"letter": "Related to Cancer", "count": 100}, {"letter": "Clinical Relevance", "count": 11}, {"letter": "Transition Rule", "count": 6}, {"letter": "Reported Term", "count": 34}, {"letter": "Elapsed Time", "count": 9}, {"letter": "Reference Start Time Point", "count": 1}, {"letter": "Serious Event", "count": 6}, {"letter": "Lower Limit of Quantitation", "count": 18}, {"letter": "Fiducial Markers", "count": 2}, {"letter": "Factorial Study", "count": 4}, {"letter": "Parallel Study", "count": 3}, {"letter": "Single Group Study", "count": 1}, {"letter": "Invitation", "count": 20}, {"letter": "89Zr-bevacizumab", "count": 7}, {"letter": "PEGPH20", "count": 2}, {"letter": "Minimum Value Derivation Technique", "count": 14}, {"letter": "Maximum Value Derivation Technique", "count": 467}, {"letter": "Ischemic Change", "count": 1}, {"letter": "Computer Job", "count": 3}, {"letter": "Tissue Congestion", "count": 1}, {"letter": "Architectural Distortion", "count": 1}, {"letter": "Laboratory Test Category", "count": 1}, {"letter": "Physical Examination Clinically Significant", "count": 1}, {"letter": "Physical Examination Abnormal Finding", "count": 1}, {"letter": "Physical Examination Date", "count": 1}, {"letter": "Exposure Dose", "count": 2}, {"letter": "Physical Exam Result", "count": 2}, {"letter": "Electrocardiogram Test", "count": 1}, {"letter": "Physical Examination Test", "count": 1}, {"letter": "Electrocardiogram Time", "count": 1}, {"letter": "Physical Examination Time", "count": 2}, {"letter": "Vital Signs Time", "count": 1}, {"letter": "Birth Year", "count": 1}, {"letter": "Duration of Use", "count": 4}, {"letter": "Adverse Event Category", "count": 1}, {"letter": "Adverse Event Duration", "count": 7}, {"letter": "Adverse Event Pattern", "count": 2}, {"letter": "Exposure Duration", "count": 10}, {"letter": "Medical History Completion Status", "count": 1}, {"letter": "Physical Examination Category", "count": 1}, {"letter": "Occurrence of Adverse Event", "count": 49}, {"letter": "Questionnaire Test", "count": 2}, {"letter": "Visit Day", "count": 2}, {"letter": "Vital Signs Category", "count": 1}, {"letter": "Occupancy", "count": 8}, {"letter": "Unintentional Material Aspiration", "count": 6}, {"letter": "Saint Barthelemy", "count": 4}, {"letter": "Attendance", "count": 42}, {"letter": "Contaminant", "count": 1}, {"letter": "RPS6KB1 wt Allele", "count": 3}, {"letter": "Collaborator", "count": 3}, {"letter": "Scientific Equipment", "count": 211}, {"letter": "Primary Data", "count": 7}, {"letter": "MammaPrint", "count": 7}, {"letter": "Distant Intracranial Metastasis", "count": 1}, {"letter": "Construct", "count": 77}, {"letter": "Mathematical Factor", "count": 20}, {"letter": "Spectrum", "count": 7}, {"letter": "Imaging Signal", "count": 1}, {"letter": "Diagnostic Quality", "count": 3}, {"letter": "Fixed Specimen", "count": 56}, {"letter": "Fresh Specimen", "count": 10}, {"letter": "Labeling Activity", "count": 18}, {"letter": "PF-04691502", "count": 1}, {"letter": "DEC-205/NY-ESO-1 Fusion Protein CDX-1401", "count": 1}, {"letter": "dHER2 + AS15 ASCI", "count": 1}, {"letter": "KW-2450", "count": 2}, {"letter": "Navigation", "count": 9}, {"letter": "Disabilities of the Arm Shoulder and Hand Outcome Measure", "count": 2}, {"letter": "grooved pegboard test", "count": 1}, {"letter": "Dichotomous Response Format", "count": 18}, {"letter": "Open-ended Response Format", "count": 25}, {"letter": "Close-ended Response Format", "count": 3}, {"letter": "Kaplan Meier Survival Plot", "count": 11}, {"letter": "Spreadsheet", "count": 2}, {"letter": "Graphics Visualization", "count": 1}, {"letter": "Clinical Events Domain", "count": 15}, {"letter": "Variability", "count": 73}, {"letter": "CDISC SDTM Pharmacokinetic Parameter Long Name Terminology", "count": 94}, {"letter": "Anteroposterior Orientation", "count": 2}, {"letter": "1+ Score", "count": 454}, {"letter": "2+ Score", "count": 422}, {"letter": "3+ Score", "count": 357}, {"letter": "4+ Score", "count": 6}, {"letter": "Interim", "count": 7}, {"letter": "Excretion Rate", "count": 29}, {"letter": "Mean Residence Time", "count": 11}, {"letter": "Area Under First Moment Curve", "count": 2}, {"letter": "Steady State Volume of Distribution", "count": 5}, {"letter": "R Squared", "count": 2}, {"letter": "Antimicrobial Intermediate Susceptibility Result", "count": 2}, {"letter": "Antimicrobial Resistance Result", "count": 2}, {"letter": "Area Under the Curve Over Dosing Interval", "count": 47}, {"letter": "Area Under the First Moment Curve Over Dosing Interval", "count": 2}, {"letter": "Average Concentration", "count": 7}, {"letter": "Cmin", "count": 31}, {"letter": "Concentration Variability Between Dose Time and Tau", "count": 2}, {"letter": "Current Therapy", "count": 9}, {"letter": "Hour Times Nanogram per Milliliter", "count": 2}, {"letter": "Initial Concentration", "count": 2}, {"letter": "Lambda Z", "count": 4}, {"letter": "Last Concentration", "count": 9}, {"letter": "Liter per Gram per Day", "count": 1}, {"letter": "Picogram per Day", "count": 1}, {"letter": "Terminal Half Life", "count": 73}, {"letter": "Time of Last Nonzero Concentration", "count": 1}, {"letter": "Time until First Nonzero Concentration", "count": 2}, {"letter": "Tmin", "count": 1}, {"letter": "Trial Primary Objective", "count": 69}, {"letter": "Trial Secondary Objective", "count": 40}, {"letter": "Clinical Trial Site", "count": 2}, {"letter": "Grayscale Color Map", "count": 3}, {"letter": "Burden", "count": 101}, {"letter": "Dietary Supplement Marketing Category", "count": 2}, {"letter": "Modal Chromosome Number", "count": 1}, {"letter": "Conclusive", "count": 1}, {"letter": "Sagittal Abdominal Diameter", "count": 1}, {"letter": "Quartile", "count": 18}, {"letter": "Traverse", "count": 37}, {"letter": "Do (activity)", "count": 2}, {"letter": "Implanted Medical Device (finding)", "count": 1}, {"letter": "Extract (substance)", "count": 10}, {"letter": "Block (unit of measure)", "count": 33}, {"letter": "Border (boundary)", "count": 5}, {"letter": "Pass (indicator)", "count": 12}, {"letter": "Exclusion", "count": 75}, {"letter": "Standard (document)", "count": 401}, {"letter": "Exact (qualifier)", "count": 119}, {"letter": "Zeta (eukaryote)", "count": 2}, {"letter": "MTUS2 gene", "count": 3}, {"letter": "Somnolence", "count": 6}, {"letter": "Smoothened Antagonist LDE225", "count": 5}, {"letter": "afuresertib", "count": 9}, {"letter": "GSK2141795", "count": 5}, {"letter": "cabazitaxel", "count": 6}, {"letter": "MEDI-573", "count": 10}, {"letter": "Other fatigue", "count": 1}, {"letter": "Fear of injury", "count": 1}, {"letter": "Vomiting without nausea", "count": 1}, {"letter": "Encounter for screening for osteoporosis", "count": 1}, {"letter": "Postmenopausal status NOS", "count": 2}, {"letter": "Weight Loss, CTCAE", "count": 74}, {"letter": "Weight Gain, CTCAE", "count": 5}, {"letter": "Multiplication", "count": 3}, {"letter": "Growth action", "count": 1}, {"letter": "Evaluation Method", "count": 17}, {"letter": "Fair (qualifier)", "count": 66}, {"letter": "Disease Controlled", "count": 18}, {"letter": "Feedback - evaluative response process", "count": 14}, {"letter": "Response (communication)", "count": 11}, {"letter": "Blood Pressure Alteration [PE]", "count": 1}, {"letter": "Serotonin 3 Receptor Antagonists", "count": 1}, {"letter": "Erythropoiesis-stimulating Agent [EPC]", "count": 1}, {"letter": "Acetaminophen [EPC]", "count": 2}, {"letter": "Amino Acid [EPC]", "count": 5}, {"letter": "CEA Assay", "count": 1}, {"letter": "Distortion", "count": 1}, {"letter": "Severe Adverse Event - CTCAE v4 Grade 3", "count": 2}, {"letter": "Huntington's Disease Pathway", "count": 1}, {"letter": "Shot (injury)", "count": 1}, {"letter": "Encounter due to estrogen receptor status", "count": 2}, {"letter": "Residual cancer burden index (observable entity)", "count": 13}, {"letter": "Residual cancer burden class", "count": 7}, {"letter": "Residual cancer burden score", "count": 9}, {"letter": "Residual cancer burden index (assessment scale)", "count": 6}, {"letter": "Tap water", "count": 1}, {"letter": "Glucose in blood specimen above reference range", "count": 8}, {"letter": "Boost radiation therapy (procedure)", "count": 7}, {"letter": "Allred score for neoplasm", "count": 2}, {"letter": "Duration of recurrence-free survival", "count": 3}, {"letter": "Survival time", "count": 60}, {"letter": "Malignant neoplasm detection during interval between recommended screening examinations", "count": 25}, {"letter": "Romanian (ethnic group)", "count": 1}, {"letter": "Surviving free of recurrence of neoplastic disease", "count": 74}, {"letter": "Dynamic gait index", "count": 2}, {"letter": "Polypharmacy", "count": 2}, {"letter": "Time to peak", "count": 1}, {"letter": "Tissue velocity", "count": 1}, {"letter": "Consent:Finding:Point in time:{Setting}:Document:Patient", "count": 9}, {"letter": "Risk level", "count": 3}, {"letter": "Immunization series:Finding:Point in time:^Patient:Nominal", "count": 1}, {"letter": "Immunization series", "count": 1}, {"letter": "corrected for heart rate", "count": 2}, {"letter": "Genetic disorders screening", "count": 1}, {"letter": "Procedure-related", "count": 12}, {"letter": "Volume.atrium.left", "count": 2}, {"letter": "Cephalometric point A", "count": 299}, {"letter": "Cephalometric point B", "count": 1}, {"letter": "Frankfort horizontal plane", "count": 1}, {"letter": "Cockcroft-Gault formula", "count": 1}, {"letter": "Myocardial infarction:Finding:Point in time:^Patient:Ordinal", "count": 17}, {"letter": "Procedure implants:Finding:Point in time:^Patient:Narrative", "count": 4}, {"letter": "Discharge, body substance", "count": 6}, {"letter": "Procedure findings:Finding:Point in time:^Patient:Narrative", "count": 42}, {"letter": "Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal", "count": 3}, {"letter": "Duration", "count": 7}, {"letter": "ARTEMISIA", "count": 4}, {"letter": "General Anesthesia [PE]", "count": 3}, {"letter": "Goals of Care", "count": 9}, {"letter": "Sex Differentiation Disorders", "count": 1}, {"letter": "ST-101", "count": 3}, {"letter": "nintedanib", "count": 3}, {"letter": "Absent breasts and nipples", "count": 1}, {"letter": "Malignant hyperthermia susceptibility type 1", "count": 1}, {"letter": "Radiation induced brachial plexopathy", "count": 2}, {"letter": "Array-Based Comparative Genomic Hybridization", "count": 1}, {"letter": "T-Lymphocytopenia", "count": 1}, {"letter": "Nasopharyngeal carcinoma", "count": 3}, {"letter": "Renal cell carcinoma 1", "count": 1}, {"letter": "ruxolitinib", "count": 1}, {"letter": "N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide", "count": 1}, {"letter": "NT5E protein, human", "count": 4}, {"letter": "MK 2206", "count": 21}, {"letter": "gedatolisib", "count": 2}, {"letter": "ABY-025", "count": 5}, {"letter": "kallikrein-related peptidase 3, human", "count": 9}, {"letter": "FKBP1A protein, human", "count": 1}, {"letter": "ado-trastuzumab emtansine", "count": 86}, {"letter": "Obesity, Visceral", "count": 3}, {"letter": "Cardiac Imaging Techniques", "count": 3}, {"letter": "Epigenomics", "count": 2}, {"letter": "Circadian Clocks", "count": 1}, {"letter": "Multifactor Dimensionality Reduction", "count": 2}, {"letter": "Cognitive Reserve", "count": 1}, {"letter": "Th17 Cells", "count": 3}, {"letter": "Blood Buffy Coat", "count": 1}, {"letter": "Cold Plasma", "count": 1}, {"letter": "Molecular Typing", "count": 1}, {"letter": "Pancreatic Stellate Cells", "count": 4}, {"letter": "Organs at Risk", "count": 3}, {"letter": "Vitrification", "count": 1}, {"letter": "Quality Improvement", "count": 3}, {"letter": "High-Throughput Nucleotide Sequencing", "count": 15}, {"letter": "Deep Sequencing", "count": 4}, {"letter": "Tumor Microenvironment", "count": 24}, {"letter": "Clinical Coding", "count": 1}, {"letter": "Laboratory Proficiency Testing", "count": 1}, {"letter": "Diagnostic Self Evaluation", "count": 2}, {"letter": "Self-Evaluation", "count": 7}, {"letter": "Standard of Care", "count": 103}, {"letter": "Mechanical Allodynia", "count": 1}, {"letter": "Health Information Technology", "count": 1}, {"letter": "Phosphatidylinositol 3-Kinases", "count": 25}, {"letter": "Folate Receptor 1", "count": 2}, {"letter": "Vitamin D [EPC]", "count": 4}, {"letter": "Estrogen [EPC]", "count": 4}, {"letter": "ZK-epothilone", "count": 2}, {"letter": "sliding scale", "count": 1}, {"letter": "hours of sleep", "count": 3}, {"letter": "Adapt (substance)", "count": 2}, {"letter": "Thrive", "count": 4}, {"letter": "Central Nervous System Sensitization", "count": 6}, {"letter": "Estrogen receptor positive breast cancer", "count": 19}, {"letter": "Nodule excision", "count": 1}, {"letter": "Nuclear magnetic resonance imaging breast", "count": 3}, {"letter": "General wellbeing", "count": 4}, {"letter": "Disturbance in mood", "count": 7}, {"letter": "Secondary Neoplasm", "count": 2}, {"letter": "housewife", "count": 1}, {"letter": "Myeloid neoplasm", "count": 2}, {"letter": "Unit per Milliliter", "count": 2}, {"letter": "Mild (qualifier value)", "count": 35}, {"letter": "mass chromatography", "count": 4}, {"letter": "First web space", "count": 2}, {"letter": "compromise", "count": 3}, {"letter": "severe allergy", "count": 1}, {"letter": "metabolic effects", "count": 1}, {"letter": "past treatment", "count": 1}, {"letter": "typology", "count": 1}, {"letter": "Conventional Treatment", "count": 1}, {"letter": "resistance genes", "count": 2}, {"letter": "phenyl", "count": 1}, {"letter": "Site of", "count": 76}, {"letter": "Cold Spot", "count": 3}, {"letter": "Recruitment", "count": 80}, {"letter": "Rostromedial auditory cortex", "count": 17}, {"letter": "Set of arms", "count": 1}, {"letter": "Left rostrotemporal auditory area", "count": 1}, {"letter": "bioimpedance spectroscopy", "count": 12}, {"letter": "International index of erectile function score", "count": 1}, {"letter": "Lutetium-177", "count": 5}, {"letter": "Volume of upper limb", "count": 1}, {"letter": "Penn State worry questionnaire", "count": 8}, {"letter": "Cardiopulmonary Exercise Test", "count": 4}, {"letter": "Dermoscopic photography", "count": 1}, {"letter": "Frontal assessment battery score", "count": 1}, {"letter": "International index of erectile function", "count": 3}, {"letter": "Beck depression inventory score", "count": 2}, {"letter": "Lymphedema care", "count": 1}, {"letter": "Visual analog scale score", "count": 29}, {"letter": "Overtime", "count": 11}, {"letter": "Cancer and Pregnancy", "count": 1}, {"letter": "Vital signs measurements", "count": 9}, {"letter": "Cell phase", "count": 1}, {"letter": "Expected outcomes", "count": 1}, {"letter": "Infusion Rate", "count": 1}, {"letter": "Pain Protocols", "count": 2}, {"letter": "Plateau", "count": 1}, {"letter": "Short Forms", "count": 115}, {"letter": "Total score", "count": 476}, {"letter": "Patient Reported Outcomes Measurement Information System", "count": 229}, {"letter": "Diet and nutrition:Finding:Point in time:^Patient:Narrative", "count": 1}, {"letter": "Health Checkup", "count": 7}, {"letter": "Clinical impression", "count": 1}, {"letter": "WWTR1 protein, human", "count": 6}, {"letter": "crizotinib", "count": 3}, {"letter": "Nerofe", "count": 4}, {"letter": "navitoclax", "count": 2}, {"letter": "EPO protein, human", "count": 1}, {"letter": "With distance", "count": 2}, {"letter": "Vaginal Hemorrhage", "count": 6}, {"letter": "medical technology", "count": 2}, {"letter": "selumetinib", "count": 16}, {"letter": "Variable Characteristic", "count": 6}, {"letter": "Pharmacokinetic Concentration Timepoint", "count": 1}, {"letter": "CDISC SEND Tumor Findings Results Terminology", "count": 46}, {"letter": "Regulatory Authority", "count": 1}, {"letter": "Adverse Event Treatment", "count": 63}, {"letter": "1+ Score, WHO", "count": 244}, {"letter": "2+ Score, WHO", "count": 311}, {"letter": "Milligram per Square Meter per Week", "count": 2}, {"letter": "Cardiorespiratory Fitness", "count": 22}, {"letter": "Service Item", "count": 1}, {"letter": "Quotation", "count": 3}, {"letter": "Base Number", "count": 15}, {"letter": "AZD4547", "count": 6}, {"letter": "PLX3397", "count": 4}, {"letter": "AZD2014", "count": 30}, {"letter": "Dose Frequency", "count": 8}, {"letter": "Piece Unit", "count": 25}, {"letter": "Fixed-Point Number", "count": 2}, {"letter": "CDISC SEND Study Category Terminology", "count": 1}, {"letter": "Persistent Disease", "count": 1}, {"letter": "Clinical Trial Agent", "count": 1}, {"letter": "Food Consumption", "count": 9}, {"letter": "Terminal Body Weight", "count": 1}, {"letter": "Total Tissue", "count": 5}, {"letter": "Tumor Examination", "count": 4}, {"letter": "AJCC v6 Stage", "count": 7}, {"letter": "AJCC v7 Stage", "count": 7}, {"letter": "Adenovirus-p53 Transduced Dendritic Cell Vaccine", "count": 1}, {"letter": "LTX-315", "count": 2}, {"letter": "INK128", "count": 5}, {"letter": "zirconium-89-trastuzumab", "count": 5}, {"letter": "CT-P6", "count": 1}, {"letter": "Suboptimal", "count": 1}, {"letter": "DPX-0907", "count": 2}, {"letter": "LCL161", "count": 11}, {"letter": "POL6326", "count": 25}, {"letter": "Bothered By Side Effects of Treatment", "count": 1}, {"letter": "Content with Quality of Life", "count": 1}, {"letter": "Emotional Support from Family", "count": 1}, {"letter": "I get support from my friends question", "count": 2}, {"letter": "Worry About Worsening Condition", "count": 1}, {"letter": "Worry About Dying", "count": 1}, {"letter": "A little bit", "count": 2}, {"letter": "Somewhat", "count": 31}, {"letter": "Very Much", "count": 8}, {"letter": "Very Often", "count": 24}, {"letter": "Not at All Good", "count": 3}, {"letter": "Likert Score 4", "count": 2}, {"letter": "Likert Score 5", "count": 2}, {"letter": "F16-IL2 Fusion Protein", "count": 5}, {"letter": "Cancer Pathway", "count": 1}, {"letter": "Natural Killer Cell-Mediated Cytotoxicity Pathway", "count": 1}, {"letter": "Epidermal Growth Factor Receptor Pathway", "count": 1}, {"letter": "Insulin Pathway", "count": 1}, {"letter": "Saponin-based Immunoadjuvant OBI-821", "count": 5}, {"letter": "GDC 0980", "count": 1}, {"letter": "Technetium Tc-99m Glycopeptide", "count": 2}, {"letter": "Emotional Well-being", "count": 93}, {"letter": "Functional Well-being", "count": 128}, {"letter": "How True", "count": 12}, {"letter": "Tyrer-Cuzick Model", "count": 1}, {"letter": "Wire-Guided Localization", "count": 2}, {"letter": "Device Cell Evaluation Method", "count": 1}, {"letter": "Device Radiologic Evaluation Method", "count": 41}, {"letter": "Signal Loss", "count": 1}, {"letter": "Z Isomer", "count": 1}, {"letter": "Best Case Imputation Technique", "count": 87}, {"letter": "ARID1A wt Allele", "count": 1}, {"letter": "CC-223", "count": 9}, {"letter": "Body Weight Measurement", "count": 2}, {"letter": "Steroid Cream", "count": 1}, {"letter": "Systemic Radiation Therapy", "count": 2}, {"letter": "Intestinal Microbiome", "count": 8}, {"letter": "Reconstructive Surgeon", "count": 2}, {"letter": "Deleterious Mutation", "count": 11}, {"letter": "Hazard Ratio", "count": 39}, {"letter": "Time to Progression", "count": 292}, {"letter": "Mutation Carrier", "count": 1}, {"letter": "Resorption", "count": 4}, {"letter": "Surface Electrode", "count": 1}, {"letter": "Biological Profile", "count": 6}, {"letter": "Radiologic Examination", "count": 16}, {"letter": "Scintimammography", "count": 1}, {"letter": "DIEP Flap", "count": 5}, {"letter": "Mindfulness Relaxation", "count": 6}, {"letter": "Targeted Therapy", "count": 23}, {"letter": "Defined Study Activity", "count": 1}, {"letter": "Study Condition", "count": 29}, {"letter": "Defined Imaging", "count": 1}, {"letter": "Study Protocol Document", "count": 2}, {"letter": "Healthcare Provider Group", "count": 1}, {"letter": "Study Objective", "count": 43}, {"letter": "Performed Protocol Deviation", "count": 1}, {"letter": "Study Personnel", "count": 2}, {"letter": "Oversight Committee", "count": 1}, {"letter": "Study Protocol Version", "count": 1}, {"letter": "Active Indicator", "count": 1}, {"letter": "Actual Duration", "count": 3}, {"letter": "Assessment Date", "count": 137}, {"letter": "Change Reason", "count": 5}, {"letter": "Dimension Product", "count": 5}, {"letter": "Enhancement Description", "count": 1}, {"letter": "Group Number", "count": 1}, {"letter": "Informed Consent Date", "count": 6}, {"letter": "Missed Reason", "count": 1}, {"letter": "Off Study Date", "count": 1}, {"letter": "Recurrence Indicator", "count": 1}, {"letter": "Repetition Number", "count": 13}, {"letter": "Required Response", "count": 1}, {"letter": "Resolution Date", "count": 1}, {"letter": "Status Date", "count": 2}, {"letter": "Study Registration Date", "count": 26}, {"letter": "Version Date", "count": 1}, {"letter": "Organization Description", "count": 4}, {"letter": "Adverse Event Summary", "count": 3}, {"letter": "VARIANT OF UNKNOWN SIGNIFICANCE", "count": 3}, {"letter": "Involuntary", "count": 2}, {"letter": "BYL719", "count": 26}, {"letter": "Improvement", "count": 163}, {"letter": "Objective Improvement", "count": 1}, {"letter": "Subjective Improvement", "count": 1}, {"letter": "Unaffected", "count": 35}, {"letter": "Chemoimmunotherapy", "count": 1}, {"letter": "Androgen Receptor Positive", "count": 5}, {"letter": "Metallic", "count": 3}, {"letter": "Antitumor", "count": 96}, {"letter": "Neurobehavioral", "count": 1}, {"letter": "Healthy Control", "count": 19}, {"letter": "Subset Analysis", "count": 17}, {"letter": "Chemoprevention Study", "count": 1}, {"letter": "Informative", "count": 3}, {"letter": "Genetic Hotspot", "count": 6}, {"letter": "Recurrence Risk", "count": 13}, {"letter": "Optical Spectroscopy", "count": 6}, {"letter": "Noninvasive", "count": 17}, {"letter": "Cumulative Dose", "count": 37}, {"letter": "Genetic Profile", "count": 28}, {"letter": "Extraosseous", "count": 3}, {"letter": "Accelerated Radiation Therapy", "count": 2}, {"letter": "Evaluable Patient", "count": 50}, {"letter": "Research Base", "count": 4}, {"letter": "Germline DNA", "count": 7}, {"letter": "Intervention Group", "count": 57}, {"letter": "Primary Endpoint", "count": 187}, {"letter": "Five-year Survival Rate", "count": 5}, {"letter": "Non-Target Lesion Identification", "count": 4}, {"letter": "New Lesion Identification", "count": 532}, {"letter": "Tumor Identification", "count": 16}, {"letter": "Response in Target Lesion", "count": 15}, {"letter": "Response in Non-Target Lesion", "count": 3}, {"letter": "Best Overall Response", "count": 209}, {"letter": "Dose-dense Chemotherapy", "count": 6}, {"letter": "Stained Appearance", "count": 30}, {"letter": "Median Survival Time", "count": 18}, {"letter": "Definitive Treatment", "count": 3}, {"letter": "Tailored Intervention", "count": 1}, {"letter": "Third line treatment", "count": 2}, {"letter": "Complex Decongestive Therapy", "count": 1}, {"letter": "Grade 2/3", "count": 13}, {"letter": "Multicentric Lesion", "count": 2}, {"letter": "Multicentric Breast Carcinoma", "count": 4}, {"letter": "Early Stage Breast Carcinoma", "count": 34}, {"letter": "Clarify", "count": 2}, {"letter": "TNFSF13B wt Allele", "count": 5}, {"letter": "Locally Recurrent Malignant Neoplasm", "count": 30}, {"letter": "Food Frequency Questionnaire", "count": 7}, {"letter": "Compartmental Models", "count": 2}, {"letter": "CT Number", "count": 1}, {"letter": "Dynamic Scan", "count": 2}, {"letter": "Emission scan", "count": 2}, {"letter": "Gated Scan", "count": 3}, {"letter": "Geometric Mean", "count": 24}, {"letter": "Influx Constant", "count": 1}, {"letter": "Injected Dose", "count": 7}, {"letter": "Line of Response", "count": 2}, {"letter": "Logarithm", "count": 6}, {"letter": "Myocardial Blood Flow", "count": 5}, {"letter": "Normalized Time", "count": 1}, {"letter": "Parameter Identification", "count": 1}, {"letter": "Parametric Image", "count": 3}, {"letter": "Percent Injected Dose", "count": 2}, {"letter": "Phase Analysis", "count": 2}, {"letter": "Planar Imaging", "count": 1}, {"letter": "Polar Map", "count": 2}, {"letter": "Quantitative Constraint", "count": 1}, {"letter": "Radioactive Activity", "count": 1}, {"letter": "Rate Constant", "count": 44}, {"letter": "Reference Region", "count": 1}, {"letter": "Robust", "count": 13}, {"letter": "Scanner Color Scale", "count": 1}, {"letter": "Signal-To-Noise Ratio", "count": 1}, {"letter": "Transaxial Plane", "count": 2}, {"letter": "Tumor to Normal", "count": 4}, {"letter": "Visual Interpretation", "count": 1}, {"letter": "Volume of Interest", "count": 5}, {"letter": "Binding Potential", "count": 1}, {"letter": "Effective Half-life", "count": 1}, {"letter": "Standardized Uptake Value Maximum", "count": 41}, {"letter": "Standardized Uptake Value Peak", "count": 10}, {"letter": "Time Activity Curve", "count": 4}, {"letter": "Anti-human GITR Monoclonal Antibody TRX518", "count": 5}, {"letter": "Iodine I 131 Monoclonal Antibody F16SIP", "count": 3}, {"letter": "Clinical Observation Domain", "count": 11}, {"letter": "Palpable Masses Domain", "count": 1}, {"letter": "Subject Stages Domain", "count": 4}, {"letter": "Nonclinical Study Length", "count": 1}, {"letter": "lenvatinib", "count": 11}, {"letter": "Interlaboratory", "count": 1}, {"letter": "Almost Never", "count": 11}, {"letter": "Fairly Often", "count": 2}, {"letter": "Medical Internal Radiation Dose", "count": 1}, {"letter": "Avid", "count": 2}, {"letter": "Defined Adverse Event", "count": 44}, {"letter": "Product Dose", "count": 6}, {"letter": "Patient Reported Outcome", "count": 168}, {"letter": "Past Week", "count": 125}, {"letter": "Pleasant", "count": 10}, {"letter": "Light Work", "count": 5}, {"letter": "Hard Work", "count": 1}, {"letter": "Run Errand", "count": 1}, {"letter": "SPP1 wt Allele", "count": 1}, {"letter": "Low Interval Data Type", "count": 1}, {"letter": "Physical Quantity Data Type", "count": 1}, {"letter": "LEE011", "count": 11}, {"letter": "Endoxifen Hydrochloride", "count": 2}, {"letter": "BMN 673", "count": 1}, {"letter": "Helplessness (feeling)", "count": 5}, {"letter": "Exist", "count": 180}, {"letter": "Scratch -action", "count": 1}, {"letter": "Deficit", "count": 13}, {"letter": "Feel Sad Question", "count": 1}, {"letter": "Anatomical base", "count": 1}, {"letter": "Cervix Intraepithelial Neoplasia Grade 3 AJCC v7", "count": 6}, {"letter": "Billing", "count": 1}, {"letter": "dalotuzumab", "count": 1}, {"letter": "Agonist", "count": 4}, {"letter": "Alisertib", "count": 11}, {"letter": "afatinib", "count": 18}, {"letter": "Population risk", "count": 2}, {"letter": "Hong Kong Zebrafish", "count": 1}, {"letter": "Phyllodes", "count": 1}, {"letter": "Self awareness", "count": 2}, {"letter": "HER-2/neu Intracellular Domain Protein", "count": 2}, {"letter": "Recombinant Gonadorelin", "count": 3}, {"letter": "Well (container)", "count": 6}, {"letter": "Generation (action)", "count": 74}, {"letter": "RBFOX3 gene", "count": 1}, {"letter": "US State", "count": 1}, {"letter": "Peripheral neuropathy, mild", "count": 1}, {"letter": "TOR complex 2", "count": 3}, {"letter": "Possess", "count": 15}, {"letter": "Urogenital atrophy", "count": 1}, {"letter": "Controlled ovarian stimulation", "count": 1}, {"letter": "Angiogenesis biomarker", "count": 7}, {"letter": "Model", "count": 97}, {"letter": "Treatment Study", "count": 66}, {"letter": "Spanish Person", "count": 1}, {"letter": "timed up and go test", "count": 5}, {"letter": "decrease alcohol intake", "count": 1}, {"letter": "Clinical sepsis", "count": 4}, {"letter": "No fatigue", "count": 2}, {"letter": "Patients activity level", "count": 5}, {"letter": "Pin sensibility", "count": 5}, {"letter": "Current state", "count": 5}, {"letter": "Push-ups", "count": 2}, {"letter": "Side affected", "count": 5}, {"letter": "Strength - arms", "count": 2}, {"letter": "Tm antigen", "count": 12}, {"letter": "Type of chemotherapy", "count": 4}, {"letter": "Ultraviolet light exposure", "count": 1}, {"letter": "Framingham", "count": 2}, {"letter": "PhenX domain - Cancer:-:Point in time:^Patient:-:PhenX", "count": 6}, {"letter": "2 minutes", "count": 2}, {"letter": "6 minutes", "count": 1}, {"letter": "Number of Births", "count": 8}, {"letter": "First cancer diagnosis", "count": 2}, {"letter": "Date of cancer recurrence", "count": 2}, {"letter": "Absolute volume", "count": 1}, {"letter": "Baseline time:Clock Time:Point in time:^Patient:Quantitative", "count": 33}, {"letter": "Date Reviewed", "count": 4}, {"letter": "Medication strength", "count": 2}, {"letter": "CARD.RISK", "count": 1}, {"letter": "Activity intensity", "count": 10}, {"letter": "Clinical setting", "count": 6}, {"letter": "Condition status", "count": 27}, {"letter": "Hand trial", "count": 1}, {"letter": "Older adult activity", "count": 1}, {"letter": "Early Therapy", "count": 9}, {"letter": "Pain Catastrophizing", "count": 10}, {"letter": "CyberKnife Radiosurgery", "count": 2}, {"letter": "Laboratory Personnel", "count": 1}, {"letter": "Administration, Metronomic", "count": 1}, {"letter": "RNA Motifs", "count": 1}, {"letter": "DNA Motifs", "count": 2}, {"letter": "Transcriptome", "count": 7}, {"letter": "Exome", "count": 8}, {"letter": "Mutation Rate", "count": 7}, {"letter": "Text Messaging", "count": 2}, {"letter": "Text Messages", "count": 7}, {"letter": "Sense of Coherence", "count": 2}, {"letter": "Pharmacovigilance", "count": 2}, {"letter": "Disease Eradication", "count": 3}, {"letter": "Neoplasm Grading", "count": 1}, {"letter": "Induction Chemotherapy", "count": 5}, {"letter": "Multiplex Polymerase Chain Reaction", "count": 1}, {"letter": "Root Cause Analysis", "count": 1}, {"letter": "Water Wells", "count": 2}, {"letter": "Radiotherapy, Image-Guided", "count": 3}, {"letter": "Social Media", "count": 2}, {"letter": "Weight Reduction Programs", "count": 10}, {"letter": "Multidetector Computed Tomography", "count": 1}, {"letter": "Hypnotic Effect", "count": 1}, {"letter": "Adrenergic Effect", "count": 3}, {"letter": "ANG protein, human", "count": 1}, {"letter": "Anti-Angiogenesis Effect", "count": 1}, {"letter": "Androgen Effect", "count": 1}, {"letter": "PRO 140", "count": 4}, {"letter": "99mTc-tilmanocept", "count": 1}, {"letter": "Ultrasonic Waves", "count": 1}, {"letter": "Vascular Medicine", "count": 1}, {"letter": "Decision Making, Shared", "count": 21}, {"letter": "IMC-A12", "count": 1}, {"letter": "LY-2157299", "count": 4}, {"letter": "cabozantinib", "count": 5}, {"letter": "Prescribed medications:-:Point in time:^Patient:-", "count": 1}, {"letter": "Antigens, CD274", "count": 3}, {"letter": "Rupture", "count": 2}, {"letter": "Psychological Trauma", "count": 2}, {"letter": "CYP2D6 polymorphism", "count": 3}, {"letter": "CYP2C19 polymorphism", "count": 4}, {"letter": "Change in sleep pattern", "count": 2}, {"letter": "Stadiometer", "count": 9}, {"letter": "Smartphone", "count": 6}, {"letter": "Proin", "count": 1}, {"letter": "calcitriol Topical Product", "count": 1}, {"letter": "capsaicin Topical Product", "count": 1}, {"letter": "minoxidil Topical Product", "count": 1}, {"letter": "Nonalcoholic Steatohepatitis", "count": 1}, {"letter": "Current Smoker", "count": 3}, {"letter": "one time", "count": 11}, {"letter": "Immunization note", "count": 1}, {"letter": "patient adverse event", "count": 8}, {"letter": "incomplete data", "count": 2}, {"letter": "altered decision", "count": 4}, {"letter": "information change", "count": 6}, {"letter": "new information", "count": 5}, {"letter": "ineffective", "count": 8}, {"letter": "response to monitoring", "count": 1}, {"letter": "program use", "count": 2}, {"letter": "new therapy", "count": 13}, {"letter": "system administration", "count": 3}, {"letter": "symptomatic relief", "count": 3}, {"letter": "re-challenge", "count": 1}, {"letter": "operate", "count": 30}, {"letter": "modify status", "count": 11}, {"letter": "Assumed", "count": 17}, {"letter": "informational", "count": 8}, {"letter": "clinical genomics", "count": 1}, {"letter": "decision support", "count": 5}, {"letter": "living expense", "count": 1}, {"letter": "measure population", "count": 3}, {"letter": "transportation expense", "count": 1}, {"letter": "expression level", "count": 58}, {"letter": "Credit card", "count": 1}, {"letter": "information collection", "count": 2}, {"letter": "period maximum", "count": 2}, {"letter": "all categories", "count": 1}, {"letter": "orders - HL7PublishingDomain", "count": 1}, {"letter": "Data call receiving device", "count": 4}, {"letter": "Colombia", "count": 36}, {"letter": "National citizen", "count": 58}, {"letter": "Potential", "count": 225}, {"letter": "Derived value", "count": 5}, {"letter": "MYOTONIC DYSTROPHY 1", "count": 39}, {"letter": "Cell positive for CD4 antigen", "count": 1}, {"letter": "Contrave", "count": 2}, {"letter": "IL15 protein, human", "count": 1}, {"letter": "strattice", "count": 1}, {"letter": "CYP19A1 protein, human", "count": 2}, {"letter": "Red 3", "count": 1}, {"letter": "Other Symptom", "count": 2}, {"letter": "Patient Health Questionnaire - 15 Item", "count": 1}, {"letter": "Patient Health Questionnaire-4", "count": 5}, {"letter": "Region of origin", "count": 2}, {"letter": "Response to procedure", "count": 1}, {"letter": "Study year", "count": 25}, {"letter": "Total population", "count": 12}, {"letter": "Type of complication", "count": 2}, {"letter": "Valvular disease", "count": 1}, {"letter": "NeuroQol", "count": 1}, {"letter": "Difference in rate", "count": 8}, {"letter": "Date of observation:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative", "count": 18}, {"letter": "Measurement sequence", "count": 1}, {"letter": "Treatment duration:Time:Pt:^Patient:Qn", "count": 4}, {"letter": "Coagulation Index Measurement", "count": 67}, {"letter": "Cellularity assessment", "count": 1}, {"letter": "Type of complication:Type:Pt:^Patient:Nom", "count": 1}, {"letter": "Surgical operation date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative", "count": 2}, {"letter": "Form version", "count": 5}, {"letter": "Note:Find:Pt:{Setting}:Doc:Primary care", "count": 2}, {"letter": "Generalized anxiety disorder 7 item", "count": 1}, {"letter": "patient destination", "count": 2}, {"letter": "Traumatic AND/OR non-traumatic injury", "count": 13}, {"letter": "Lymphedema of upper limb", "count": 4}, {"letter": "Wound Epithelialization", "count": 1}, {"letter": "Bone density below reference range (finding)", "count": 4}, {"letter": "Smokes tobacco daily", "count": 9}, {"letter": "Referred by self", "count": 1}, {"letter": "Performance measure status", "count": 2}, {"letter": "Family history of colorectal cancer", "count": 1}, {"letter": "Methodology", "count": 1}, {"letter": "HL7 data type", "count": 1}, {"letter": "PTEN gene mutation", "count": 2}, {"letter": "nuclear receptor activity", "count": 1}, {"letter": "large latent transforming growth factor-beta complex", "count": 4}, {"letter": "capsanthin-capsorubin synthase", "count": 1}, {"letter": "Urgent Procedure", "count": 18}, {"letter": "American College of Cardiology/American Heart Association Lesion Complexity Score B", "count": 4}, {"letter": "Post-Procedure", "count": 4}, {"letter": "Coronary Vessel Lesion", "count": 1}, {"letter": "T1mi Stage Finding", "count": 1}, {"letter": "Character String Data Type", "count": 5}, {"letter": "Integer Data Type", "count": 4}, {"letter": "Sequence Data Type", "count": 1}, {"letter": "PIGA wt Allele", "count": 2}, {"letter": "Genomic DNA", "count": 5}, {"letter": "FACIT Fatigue Scale", "count": 7}, {"letter": "Paclitaxel Injection Concentrate for Nanodispersion", "count": 1}, {"letter": "MM-302", "count": 5}, {"letter": "Storage Condition", "count": 4}, {"letter": "WHO Temperature/Humidity Storage Condition", "count": 31}, {"letter": "Proprietary Storage Condition", "count": 6}, {"letter": "PIK3CA Gene Mutation", "count": 27}, {"letter": "Embryonic remnant", "count": 11}, {"letter": "ACY-1215", "count": 2}, {"letter": "PTGIS wt Allele", "count": 3}, {"letter": "Microvessel Density", "count": 7}, {"letter": "Circulating Tumor Cell Count", "count": 16}, {"letter": "Stack", "count": 1}, {"letter": "N-Terminal ProB-type Natriuretic Peptide Measurement", "count": 3}, {"letter": "Overall Response", "count": 550}, {"letter": "Percent Change From Baseline", "count": 34}, {"letter": "Procollagen 1 N-Terminal Propeptide Measurement", "count": 1}, {"letter": "Sum of Diameters", "count": 340}, {"letter": "Sum of Longest Diameters", "count": 474}, {"letter": "Sum of Longest Perpendiculars", "count": 3}, {"letter": "Sum of Viable Diameters", "count": 8}, {"letter": "Sum of Volumes", "count": 10}, {"letter": "Unequivocal Progression", "count": 208}, {"letter": "Median Fluorescence Intensity", "count": 20}, {"letter": "Non Complete Response/Non Progressive Disease", "count": 10}, {"letter": "Anti-prolactin Receptor Antibody LFA102", "count": 2}, {"letter": "ABT-767", "count": 1}, {"letter": "Vantictumab", "count": 2}, {"letter": "ERBB2 Gene Mutation", "count": 1}, {"letter": "Drug Sample", "count": 1}, {"letter": "Audio Media", "count": 19}, {"letter": "Anti-mesothelin CIR mRNA-electroporated Autologous T Cells", "count": 2}, {"letter": "Antral follicle count", "count": 4}, {"letter": "18F-FPPRGD2", "count": 1}, {"letter": "NCKIPSD wt Allele", "count": 6}, {"letter": "famitinib", "count": 9}, {"letter": "Fill Out Form", "count": 24}, {"letter": "HOXD13 wt Allele", "count": 3}, {"letter": "Healthcare Support Occupations", "count": 2}, {"letter": "Pre-filled Pen Syringe", "count": 4}, {"letter": "Period Circadian Protein Homolog 1", "count": 1}, {"letter": "Disseminated Tumor Cell", "count": 8}, {"letter": "Sodium-Glucose Transporter 2 Inhibitors", "count": 3}, {"letter": "MMP7 wt Allele", "count": 1}, {"letter": "Hafnium Oxide-containing Nanoparticles NBTXR3", "count": 2}, {"letter": "Pseudoprogression", "count": 1}, {"letter": "Interventional Study", "count": 8}, {"letter": "Data Cutoff Date", "count": 43}, {"letter": "Exploratory Outcome Measure", "count": 5}, {"letter": "Food Effect Study", "count": 14}, {"letter": "Intervention Model", "count": 5}, {"letter": "Intervention Type", "count": 11}, {"letter": "Primary Outcome Measure", "count": 40}, {"letter": "Run-in Period", "count": 23}, {"letter": "Secondary Outcome Measure", "count": 41}, {"letter": "Tolerability Study", "count": 477}, {"letter": "Six Times Monthly", "count": 1}, {"letter": "CDISC SDTM Intervention Model Terminology", "count": 1}, {"letter": "Content Item", "count": 1}, {"letter": "Procure", "count": 1}, {"letter": "Nonclinical Study Start Date", "count": 3}, {"letter": "Neoviderm", "count": 1}, {"letter": "ARQ 092", "count": 2}, {"letter": "Probable Control Status", "count": 1}, {"letter": "Neither Case or Control Status", "count": 6}, {"letter": "Core Specimen", "count": 2}, {"letter": "Catalog Number", "count": 1}, {"letter": "Product Reference Number", "count": 1}, {"letter": "Recombinant Oncolytic Poliovirus PVS-RIPO", "count": 1}, {"letter": "Inhibitory Nerve Control", "count": 5}, {"letter": "Severely Abnormal Ventricular Ejection Fraction", "count": 3}, {"letter": "Commence", "count": 3}, {"letter": "Disease Presentation", "count": 1}, {"letter": "Disapproval", "count": 1}, {"letter": "Unmet", "count": 4}, {"letter": "Oral Aminolevulinic Acid Hydrochloride", "count": 1}, {"letter": "Concern About Future", "count": 1}, {"letter": "Hardly Ever", "count": 1}, {"letter": "MM-151", "count": 3}, {"letter": "Fatty replacement", "count": 2}, {"letter": "Cardiac dysfunction", "count": 8}, {"letter": "Defect in DNA repair", "count": 1}, {"letter": "Episodic bleeding", "count": 1}, {"letter": "'Happy' face", "count": 1}, {"letter": "TUMOR PREDISPOSITION SYNDROME", "count": 1}, {"letter": "Prominent nucleoli", "count": 4}, {"letter": "BLOOD GROUP, JUNIOR SYSTEM", "count": 3}, {"letter": "Foa", "count": 1}, {"letter": "Proteomic Profile", "count": 6}, {"letter": "Feel Fatigue", "count": 11}, {"letter": "Inhibition", "count": 6}, {"letter": "MYELODYSPLASTIC SYNDROME", "count": 1}, {"letter": "Encore", "count": 1}, {"letter": "Ganetespib", "count": 1}, {"letter": "BREAST CANCER, SUSCEPTIBILITY TO", "count": 2}, {"letter": "erbb2 gene analysis", "count": 2}, {"letter": "Administration of medication", "count": 8}, {"letter": "TDGF1P3 gene", "count": 1}, {"letter": "TDGF1P4 gene", "count": 3}, {"letter": "IFNG-AS1 gene", "count": 2}, {"letter": "SMIM10L2A gene", "count": 12}, {"letter": "Single Photon Emission Computed Tomography Computed Tomography", "count": 17}, {"letter": "Patient ventilator dyssynchrony", "count": 1}, {"letter": "Digital Breast Tomosynthesis", "count": 8}, {"letter": "Impact of event scale revised", "count": 7}, {"letter": "Western Ontario and McMaster Universities osteoarthritis index", "count": 3}, {"letter": "Edmonton symptom assessment system", "count": 6}, {"letter": "Perjeta", "count": 1}, {"letter": "Quality of Life Impact", "count": 13}, {"letter": "Interpersonal", "count": 6}, {"letter": "Medication frequency", "count": 1}, {"letter": "Minnesota Living with Heart Failure Questionnaire", "count": 2}, {"letter": "Perceived cognitive abilities", "count": 5}, {"letter": "Perceived cognitive impairments", "count": 9}, {"letter": "Quality of life score", "count": 84}, {"letter": "Record status", "count": 3}, {"letter": "Social - family well being", "count": 57}, {"letter": "Social well being", "count": 23}, {"letter": "Symptoms score", "count": 111}, {"letter": "Technical quality", "count": 2}, {"letter": "Treatment satisfaction", "count": 30}, {"letter": "Functional Assessment of Chronic Illness Therapy", "count": 118}, {"letter": "Post traumatic stress disorder (PTSD) checklist - civilian version", "count": 1}, {"letter": "Watson", "count": 3}, {"letter": "Mental Health Survey", "count": 1}, {"letter": "Additional concerns", "count": 31}, {"letter": "General perceptions", "count": 12}, {"letter": "Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire", "count": 2}, {"letter": "Comments from others", "count": 3}, {"letter": "Date catheter placement:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative", "count": 1}, {"letter": "Route:Find:Pt:Medication:Nom", "count": 1}, {"letter": "Anxiety score", "count": 1}, {"letter": "Vitamin D panel", "count": 2}, {"letter": "Edema present:Finding:Point in time:^Patient:Ordinal", "count": 3}, {"letter": "Blessed orientation-memory-concentration test", "count": 2}, {"letter": "Activities of daily living score", "count": 3}, {"letter": "Programs", "count": 4}, {"letter": "binetrakin", "count": 9}, {"letter": "Hospital Stay", "count": 73}, {"letter": "Body Representation", "count": 1}, {"letter": "Cell Microarray Analysis", "count": 2}, {"letter": "Volumetric-Modulated Arc Therapy", "count": 3}, {"letter": "Air Travel", "count": 2}, {"letter": "GRN1005", "count": 1}, {"letter": "NVP-BKM120", "count": 33}, {"letter": "ricolinostat", "count": 2}, {"letter": "piflufolastat F-18", "count": 1}, {"letter": "1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane", "count": 3}, {"letter": "SID530", "count": 2}, {"letter": "Operative Time", "count": 144}, {"letter": "Time-to-Treatment", "count": 97}, {"letter": "Optical Imaging", "count": 1}, {"letter": "Craniospinal Irradiation", "count": 1}, {"letter": "Inventions", "count": 1}, {"letter": "Acellular Dermal Matrix", "count": 3}, {"letter": "Databases, Pharmaceutical", "count": 1}, {"letter": "Patient Navigation", "count": 3}, {"letter": "Secondary Care", "count": 2}, {"letter": "Tertiary Healthcare", "count": 1}, {"letter": "Pulse Wave Velocity", "count": 4}, {"letter": "Symptom Assessment", "count": 33}, {"letter": "Symptom Evaluation", "count": 11}, {"letter": "Anatomic Variation", "count": 1}, {"letter": "Bloody stool specimen", "count": 2}, {"letter": "Health literacy assessment", "count": 1}, {"letter": "lithium cation", "count": 5}, {"letter": "Female sex hormone level", "count": 1}, {"letter": "Locally advanced breast cancer", "count": 6}, {"letter": "Point-of-service (POS) plan", "count": 3}, {"letter": "nucleus X", "count": 1}, {"letter": "frontal white matter", "count": 1}, {"letter": "temporal white matter", "count": 1}, {"letter": "Mini-Cog:-:Point in time:^Patient:-:Mini-Cog", "count": 1}, {"letter": "Tobacco smoking status", "count": 5}, {"letter": "enzalutamide", "count": 25}, {"letter": "ibrutinib", "count": 6}, {"letter": "telapristone acetate", "count": 3}, {"letter": "PG 600", "count": 1}, {"letter": "AZD5363", "count": 12}, {"letter": "Patient Engagement", "count": 6}, {"letter": "Carnitine level", "count": 1}, {"letter": "Antibody evaluation", "count": 3}, {"letter": "Therapeutic radiology treatment planning", "count": 1}, {"letter": "Assessment of lymphedema", "count": 2}, {"letter": "Performance rate", "count": 4}, {"letter": "Reporting rate", "count": 1}, {"letter": "Symptom burden score", "count": 2}, {"letter": "Total symptom score", "count": 3}, {"letter": "Self-efficacy score", "count": 6}, {"letter": "Photographic image", "count": 1}, {"letter": "Mean score", "count": 163}, {"letter": "Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire", "count": 1}, {"letter": "Serum glucose", "count": 2}, {"letter": "Before contrast", "count": 2}, {"letter": "post excision", "count": 1}, {"letter": "Massage Therapy", "count": 1}, {"letter": "Muscle of arm", "count": 3}, {"letter": "Sad mood", "count": 8}, {"letter": "Dietitian", "count": 2}, {"letter": "Visual Analog Scale", "count": 6}, {"letter": "Life Threatening or Disabling Adverse Event", "count": 155}, {"letter": "abexinostat", "count": 3}, {"letter": "Podoplanin", "count": 1}, {"letter": "Cause of death.primary:Finding:Point in time:^Patient:Nominal", "count": 1}, {"letter": "KADCYLA", "count": 11}, {"letter": "Mitochondrion-associated adherens complex location", "count": 1}, {"letter": "Linear Analogue Self-Assessment", "count": 5}, {"letter": "HSPD1 wt Allele", "count": 1}, {"letter": "CD8 Expressing Cell Count", "count": 59}, {"letter": "CD34 Measurement", "count": 1}, {"letter": "TNNT2 wt Allele", "count": 1}, {"letter": "Axial R", "count": 2}, {"letter": "QPCT wt Allele, Human", "count": 1}, {"letter": "CD27 wt Allele", "count": 3}, {"letter": "Usual", "count": 143}, {"letter": "Procedure Domain", "count": 6}, {"letter": "Social Risk Factor", "count": 1}, {"letter": "Treatment Epoch", "count": 1}, {"letter": "Brief Pain Inventory Questionnaire", "count": 11}, {"letter": "Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire", "count": 1}, {"letter": "Breast Size Difference Since Cancer Treatment question", "count": 2}, {"letter": "Nipple Appearance Difference Since Breast Cancer Treatment question", "count": 1}, {"letter": "Pretreatment Period", "count": 2}, {"letter": "Pretreatment", "count": 172}, {"letter": "CST12P gene", "count": 2}, {"letter": "Chiral", "count": 12}, {"letter": "Hospital Anxiety and Depression Scale Questionnaire", "count": 100}, {"letter": "NCI CTEP SDC Non-Small Cell Lung Cancer Sub-Category Terminology", "count": 6}, {"letter": "Triple Negative Breast Neoplasms", "count": 2}, {"letter": "gamma-interferon", "count": 16}, {"letter": "Have", "count": 11}, {"letter": "Duplicate component (foundation metadata concept)", "count": 1}, {"letter": "CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS", "count": 49}, {"letter": "CD69 wt Allele", "count": 3}, {"letter": "CTSG wt Allele", "count": 2}, {"letter": "Body Image Scale", "count": 23}, {"letter": "RPS6KA1 wt Allele", "count": 1}, {"letter": "U2AF1 wt Allele", "count": 1}, {"letter": "Task", "count": 116}, {"letter": "VARIOUS DRUG CLASSES IN ATC", "count": 119}, {"letter": "MAP4 wt Allele", "count": 1}, {"letter": "Sign or Symptom", "count": 14}, {"letter": "Device to Subject Relationship Domain", "count": 15}, {"letter": "Bonaire, Sint Eustatius and Saba", "count": 2}, {"letter": "Device Events Domain", "count": 1}, {"letter": "Hamilton Anxiety Rating Scale Questionnaire", "count": 2}, {"letter": "Moca (eukaryote)", "count": 1}, {"letter": "Epworth Sleepiness Scale Questionnaire", "count": 3}, {"letter": "Pairing Events Domain", "count": 26}, {"letter": "UGT1A7 wt Allele", "count": 7}, {"letter": "Metacarpophalangeal Joint 1", "count": 8}, {"letter": "USP9X wt Allele", "count": 1}, {"letter": "FCGR1A wt Allele", "count": 1}, {"letter": "FOLR2 wt Allele", "count": 1}, {"letter": "slc6a4 gene (procedure)", "count": 1}, {"letter": "Preexisting Condition Coverage", "count": 5}, {"letter": "CD3 Expressing Cell Count", "count": 37}, {"letter": "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "count": 3}, {"letter": "Module (core metadata concept)", "count": 3}, {"letter": "Surgical incision wound (morphologic abnormality)", "count": 2}, {"letter": "TONICS", "count": 2}, {"letter": "muscle arm", "count": 1}, {"letter": "changes in DNA methylation", "count": 1}, {"letter": "cellular response to peptide", "count": 1}, {"letter": "response to peptide", "count": 2}, {"letter": "response to metformin", "count": 1}, {"letter": "response to paclitaxel", "count": 3}, {"letter": "response to carboplatin", "count": 3}, {"letter": "response to lapatinib", "count": 1}, {"letter": "response to gemcitabine", "count": 1}, {"letter": "PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 2", "count": 1}, {"letter": "HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA", "count": 1}, {"letter": "Midline liver", "count": 1}, {"letter": "Systemic inflammatory response", "count": 3}, {"letter": "Severe cognitive impairment", "count": 1}, {"letter": "Pensacola", "count": 7}, {"letter": "CDISC ADAS-Cog - Word Recall Average Score", "count": 1}, {"letter": "CDISC ADAS-Cog - Commands Summary Score", "count": 6}, {"letter": "Diethylene Triamine Pentaacetic Acid Clearance", "count": 1}, {"letter": "Homeostatic Model Assessment of Insulin Resistance", "count": 7}, {"letter": "Brief Pain Inventory Short Form Questionnaire", "count": 44}, {"letter": "Short-Form McGill Pain Questionnaire-2", "count": 1}, {"letter": "Discordance", "count": 13}, {"letter": "Unbearable Pain", "count": 6}, {"letter": "Medical Device Deployment", "count": 1}, {"letter": "Appropriate Treatment", "count": 8}, {"letter": "Random Periareolar Fine-Needle Aspiration", "count": 1}, {"letter": "Hormone Receptor Positive", "count": 24}, {"letter": "Whole Genome Sequencing", "count": 5}, {"letter": "Whole Exome Sequencing", "count": 18}, {"letter": "Tumor bed", "count": 26}, {"letter": "PALB2 Gene Mutation", "count": 1}, {"letter": "French Catheter Gauge", "count": 4}, {"letter": "lipegfilgrastim", "count": 2}, {"letter": "European Quality of Life Five Dimension Five Level Scale Questionnaire", "count": 55}, {"letter": "Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire", "count": 8}, {"letter": "Blinded Treatment Epoch", "count": 4}, {"letter": "Peak Trough Ratio", "count": 2}, {"letter": "Trough Concentration", "count": 90}, {"letter": "Unfavorable", "count": 45}, {"letter": "Clinical Failure", "count": 1}, {"letter": "Fruquintinib", "count": 5}, {"letter": "Recombinant Dimeric G-CSF Fusion Protein F627", "count": 2}, {"letter": "Hopkins Verbal Learning Test Revised", "count": 6}, {"letter": "Bioassay Measurement", "count": 3}, {"letter": "Study Treatment Causality", "count": 3}, {"letter": "Subject Visit Type", "count": 1}, {"letter": "Data Standard", "count": 3}, {"letter": "MEDI4736", "count": 26}, {"letter": "Epimeric", "count": 17}, {"letter": "Meso Compound", "count": 6}, {"letter": "Photoacoustic Spectroscopy", "count": 3}, {"letter": "PROMIS Global Health Questionnaire", "count": 3}, {"letter": "Narrow Surgical Margin", "count": 4}, {"letter": "Breast Cancer Treatment Outcomes Scale-Cosmetic Status", "count": 2}, {"letter": "Breast Shape Difference Since Cancer Treatment", "count": 20}, {"letter": "Very good (qualifier value)", "count": 16}, {"letter": "CDISC Trial Design Class", "count": 1}, {"letter": "FDG-Positron Emission Tomography", "count": 22}, {"letter": "FLT-Positron Emission Tomography", "count": 17}, {"letter": "New Lesion Progression", "count": 4}, {"letter": "Target Nodule Tumor Identification", "count": 29}, {"letter": "Likert Score 1", "count": 1}, {"letter": "Likert Score 7", "count": 2}, {"letter": "Worst Imaginable Pain", "count": 35}, {"letter": "High Performance Liquid Chromatography Mass Spectrometry", "count": 1}, {"letter": "Positron emission tomography-magnetic resonance imaging", "count": 16}, {"letter": "Generalized Anxiety Disorder Scale", "count": 17}, {"letter": "International Index of Erectile Function Questionnaire", "count": 1}, {"letter": "FACT-P Questionnaire", "count": 3}, {"letter": "FACT-Cognitive Function", "count": 19}, {"letter": "Regardless", "count": 49}, {"letter": "Internalized-arginylglycylaspartic Acid Cyclic Peptide", "count": 2}, {"letter": "Human anti-human antibody", "count": 4}, {"letter": "Technetium Tc 99m-3PRGD2", "count": 2}, {"letter": "Hot Flash Related Daily Inference Scale", "count": 3}, {"letter": "RO-5479599", "count": 14}, {"letter": "Naive T-Lymphocyte", "count": 1}, {"letter": "Effector T-Lymphocyte", "count": 4}, {"letter": "Cell-Free RNA", "count": 3}, {"letter": "Feel Tense", "count": 1}, {"letter": "Very Poor", "count": 37}, {"letter": "European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30", "count": 368}, {"letter": "Agree", "count": 143}, {"letter": "Disagree", "count": 143}, {"letter": "Overall Quality of Life", "count": 40}, {"letter": "Overall Physical Well-Being", "count": 2}, {"letter": "Average Severity of Pain", "count": 3}, {"letter": "Notice Change in the Way Food Tastes", "count": 1}, {"letter": "Electronic Portal Imaging", "count": 1}, {"letter": "Cathepsin-Activatable Cy5 Fluorescent Imaging Probe LUM015", "count": 2}, {"letter": "Fraction of 1", "count": 3}, {"letter": "Per Deciliter", "count": 13}, {"letter": "Per Liter", "count": 22}, {"letter": "Thousand Per Liter", "count": 11}, {"letter": "Pain at its Worst", "count": 4}, {"letter": "high grade serous adenocarcinoma of ovary", "count": 1}, {"letter": "Luminal B breast cancer", "count": 17}, {"letter": "Topical Compound 31543", "count": 2}, {"letter": "Troublesome Pain", "count": 1}, {"letter": "Acceptability (foundation metadata concept)", "count": 6}, {"letter": "Active value", "count": 2}, {"letter": "Description type", "count": 2}, {"letter": "Primitive", "count": 2}, {"letter": "admission to hospital unit", "count": 1}, {"letter": "Traditional therapy", "count": 2}, {"letter": "ANTIBACTERIALS FOR SYSTEMIC USE", "count": 1}, {"letter": "ANTIANEMIC PREPARATIONS", "count": 1}, {"letter": "Other immunostimulants in ATC", "count": 1}, {"letter": "Other blood products in ATC", "count": 1}, {"letter": "TUMOUR DETECTION RADIOPHARMACEUTICALS", "count": 7}, {"letter": "Signal quality", "count": 1}, {"letter": "Body muscle mass", "count": 2}, {"letter": "Body fat mass", "count": 7}, {"letter": "nivolumab", "count": 36}, {"letter": "vegfr3 protein, human", "count": 1}, {"letter": "VDR protein, human", "count": 2}, {"letter": "Nutrition Guidelines", "count": 1}, {"letter": "Computer Applications Software", "count": 2}, {"letter": "Mobile Applications", "count": 17}, {"letter": "Social Determinants of Health", "count": 2}, {"letter": "Acceptance and Commitment Therapy", "count": 1}, {"letter": "Portion Size", "count": 1}, {"letter": "Aurora Kinases", "count": 1}, {"letter": "pembrolizumab", "count": 135}, {"letter": "GDC-0032", "count": 30}, {"letter": "MK-3475", "count": 6}, {"letter": "MLN0128", "count": 2}, {"letter": "rucaparib", "count": 11}, {"letter": "Assessment for risk of cancer", "count": 1}, {"letter": "Organ-space surgical site infection", "count": 3}, {"letter": "Unspecified visual loss", "count": 1}, {"letter": "Chemotherapy", "count": 1}, {"letter": "chemotherapy administration", "count": 47}, {"letter": "Ehrlich units per deciliter", "count": 2}, {"letter": "bazedoxifene / estrogens, conjugated (USP)", "count": 14}, {"letter": "Displacement of abomasum", "count": 8}, {"letter": "Bone structure of proximal phalanx", "count": 1}, {"letter": "Start time:Time Stamp -- Date and Time:Point in time:Study:Quantitative", "count": 17}, {"letter": "Exercise intensity", "count": 4}, {"letter": "Races (activity)", "count": 1}, {"letter": "Utility (animal life circumstance)", "count": 1}, {"letter": "Normal response to pain", "count": 1}, {"letter": "Lymph node draining externally", "count": 1}, {"letter": "Mass of subcutaneous tissue", "count": 1}, {"letter": "Consistency:Type:Pt:Lymph node:Nom", "count": 1}, {"letter": "Change in diet", "count": 21}, {"letter": "Probability of developing disease assessed:RelRto:Pt:^Patient:Qn", "count": 2}, {"letter": "First stream urine sample", "count": 3}, {"letter": "Effusion of blood", "count": 1}, {"letter": "Structure of blood vessel of dermis", "count": 2}, {"letter": "Epidermitis", "count": 1}, {"letter": "Structure of first digit", "count": 1}, {"letter": "Structure of scale on dorsum", "count": 1}, {"letter": "Structure of base of tail", "count": 9}, {"letter": "Poor quality of life", "count": 12}, {"letter": "Passive", "count": 6}, {"letter": "Rear", "count": 1}, {"letter": "Martin", "count": 1}, {"letter": "Produces milk for human food", "count": 4}, {"letter": "Demonstrates", "count": 2}, {"letter": "Delayed Treatment", "count": 17}, {"letter": "radiation therapy frequency every ___Days", "count": 2}, {"letter": "local recurrence of malignant breast neoplasm", "count": 9}, {"letter": "Social wellbeing", "count": 27}, {"letter": "Clostridium novyi-NT", "count": 1}, {"letter": "Reflection illumination", "count": 5}, {"letter": "Spiritual wellbeing", "count": 7}, {"letter": "Pittsburgh sleep quality index", "count": 75}, {"letter": "Measurement of body mass index", "count": 1}, {"letter": "Axillary web syndrome", "count": 1}, {"letter": "Report.section heading:-:Point in time:To be specified in another part of the message:Nominal", "count": 2}, {"letter": "Questionnaire response", "count": 8}, {"letter": "Lymphocytes assessment", "count": 1}, {"letter": "Type of service", "count": 1}, {"letter": "Mass difference", "count": 1}, {"letter": "IGF1 protein, human", "count": 17}, {"letter": "ipatasertib", "count": 23}, {"letter": "Health Belief Model", "count": 10}, {"letter": "Loading dose", "count": 1}, {"letter": "Maintenance dose", "count": 4}, {"letter": "Nutrition Disorders", "count": 1}, {"letter": "Infection", "count": 21}, {"letter": "Section - Geographic Area", "count": 1}, {"letter": "Weakness", "count": 4}, {"letter": "Individual Physical Condition", "count": 12}, {"letter": "Fix", "count": 29}, {"letter": "Pain Perception", "count": 10}, {"letter": "Neural", "count": 7}, {"letter": "Month of the Year", "count": 1}, {"letter": "Operation on breast", "count": 2}, {"letter": "Central Nervous System", "count": 97}, {"letter": "Cytochrome P-450 CYP3A4", "count": 8}, {"letter": "SCID-Repopulating Cell", "count": 5}, {"letter": "Resolved", "count": 3}, {"letter": "Charlson Comorbidity Index Chart Review Version", "count": 1}, {"letter": "piccolo-bassoon transport vesicle", "count": 5}, {"letter": "Angiotensin-2, Human", "count": 1}, {"letter": "Brachyury Protein Antibody", "count": 1}, {"letter": "BOADICEA", "count": 1}, {"letter": "April", "count": 2}, {"letter": "Twenty Four", "count": 2}, {"letter": "HSD11B1 wt Allele", "count": 9}, {"letter": "Thirteen", "count": 2}, {"letter": "Fourteen", "count": 4}, {"letter": "Fifteen", "count": 1}, {"letter": "Hypertension clinic", "count": 1}, {"letter": "Twenty One", "count": 1}, {"letter": "Ergospirometry", "count": 2}, {"letter": "Stromal inflammatory infiltrate", "count": 1}, {"letter": "LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3", "count": 2}, {"letter": "IMMUNODEFICIENCY, COMMON VARIABLE, 10", "count": 2}, {"letter": "PSAT1 wt Allele", "count": 7}, {"letter": "KRT14 wt Allele", "count": 1}, {"letter": "FLNA wt Allele", "count": 3}, {"letter": "Breast clinic", "count": 8}, {"letter": "Absolute Blood Lymphocyte Count", "count": 6}, {"letter": "SLC27A4 wt Allele", "count": 1}, {"letter": "PSMB8 wt Allele", "count": 1}, {"letter": "GLB1 wt Allele", "count": 1}, {"letter": "RNF130 wt Allele", "count": 5}, {"letter": "Estrogen Receptor Measurement", "count": 112}, {"letter": "Platelet Activating Factor Measurement", "count": 4}, {"letter": "Anti-Drug Antibody", "count": 78}, {"letter": "Hypoxia Inducible Factor Family", "count": 1}, {"letter": "ENTPD1 wt Allele", "count": 1}, {"letter": "Treated Volume", "count": 2}, {"letter": "Positive Number", "count": 30}, {"letter": "SEMA6A wt Allele", "count": 10}, {"letter": "Month of May", "count": 5}, {"letter": "Pre-dose Measure", "count": 1}, {"letter": "Immunogenicity Specimen Assessments Domain", "count": 180}, {"letter": "Study Element", "count": 2}, {"letter": "Endometrioid intraepithelial neoplasia", "count": 1}, {"letter": "Author", "count": 1}, {"letter": "ADM wt Allele", "count": 4}, {"letter": "Oral Rehydration Solution OS-1", "count": 1}, {"letter": "Fatigue Severity Scale", "count": 5}, {"letter": "PTGES wt Allele", "count": 1}, {"letter": "Overall Well Being", "count": 26}, {"letter": "CYP3A Gene Locus", "count": 2}, {"letter": "FST wt Allele", "count": 5}, {"letter": "Full Term Birth", "count": 1}, {"letter": "Core Histone Macro-H2A.1, human", "count": 1}, {"letter": "CD1D wt Allele", "count": 2}, {"letter": "ATP2A2 wt Allele", "count": 3}, {"letter": "Grade X", "count": 1}, {"letter": "Interleukin 1 Beta Measurement", "count": 24}, {"letter": "Expenditures, Out-of-Pocket", "count": 4}, {"letter": "B-Cell Receptor Complex", "count": 1}, {"letter": "Neutralizing Anti-Drug Antibody", "count": 1}, {"letter": "Pathogenic Variant", "count": 3}, {"letter": "Dose Escalation", "count": 241}, {"letter": "Percutaneous Absorption", "count": 2}, {"letter": "400", "count": 19}, {"letter": "500", "count": 40}, {"letter": "600", "count": 10}, {"letter": "Ninety", "count": 6}, {"letter": "Nucleus Accumbens-Associated Protein 2", "count": 1}, {"letter": "100%", "count": 649}, {"letter": "Pharmacogenomics Biomarker Domain", "count": 1}, {"letter": "hydrogen biosynthetic process", "count": 1}, {"letter": "activation of intracellular signaling pathway", "count": 1}, {"letter": "HER-2 protein", "count": 3}, {"letter": "Volumetric analysis", "count": 5}, {"letter": "Surgery--Complications", "count": 5}, {"letter": "Radiology, Medical", "count": 2}, {"letter": "Medical consultation", "count": 3}, {"letter": "Medical care--Finance", "count": 1}, {"letter": "Geriatric oncology", "count": 1}, {"letter": "Dynamics", "count": 7}, {"letter": "Diagnostic specimens", "count": 2}, {"letter": "Diagnostic ultrasonic imaging", "count": 1}, {"letter": "Cell metabolism", "count": 1}, {"letter": "Blood--Examination", "count": 1}, {"letter": "Visual Analogue Fatigue Scale", "count": 4}, {"letter": "Modified Medical Research Council Dyspnea Scale Questionnaire", "count": 2}, {"letter": "Immature Myeloid Cell", "count": 3}, {"letter": "Dose Volume Histogram", "count": 10}, {"letter": "Circulating Tumor DNA", "count": 96}, {"letter": "Controlled Oral Word Association Test", "count": 11}, {"letter": "RO6870810", "count": 5}, {"letter": "TAK-659", "count": 3}, {"letter": "RTA 408", "count": 4}, {"letter": "VT-464", "count": 2}, {"letter": "ONC201", "count": 3}, {"letter": "SGN-LIV1A", "count": 1}, {"letter": "SGN-CD33A", "count": 1}, {"letter": "RX-5902", "count": 1}, {"letter": "NY-ESO-1/GLA-SE Vaccine ID-G305", "count": 2}, {"letter": "Foxy-5", "count": 23}, {"letter": "CB-839", "count": 2}, {"letter": "BP-Cx1-Platinum Complex BP-C1", "count": 5}, {"letter": "AZD8186", "count": 21}, {"letter": "Carbohydrate Supplement Drink", "count": 1}, {"letter": "High Sensitivity Troponin T Assay", "count": 1}, {"letter": "Pain Interferes with General Activity", "count": 1}, {"letter": "Wrong", "count": 14}, {"letter": "Worst Possible Symptom", "count": 3}, {"letter": "Worst Possible Pain", "count": 19}, {"letter": "Worst Imaginable Health", "count": 14}, {"letter": "Very Happy", "count": 3}, {"letter": "Useful", "count": 34}, {"letter": "Undetectable", "count": 3}, {"letter": "Tumor Size Measurement", "count": 2}, {"letter": "Tumor Microenvironment of Metastasis Density", "count": 2}, {"letter": "Treatment Satisfaction Questionnaire for Medication", "count": 1}, {"letter": "Timely", "count": 11}, {"letter": "Terrible", "count": 2}, {"letter": "Some of the time", "count": 10}, {"letter": "Software Version", "count": 1}, {"letter": "September", "count": 4}, {"letter": "Sensate", "count": 1}, {"letter": "Semi-Recumbent", "count": 2}, {"letter": "Selatinib Ditosilate", "count": 1}, {"letter": "Satisfaction with Medication", "count": 2}, {"letter": "Roche Diagnostics", "count": 2}, {"letter": "Reprogram", "count": 4}, {"letter": "Replication Competent Retrovirus", "count": 2}, {"letter": "Radionuclide Specific Activity", "count": 14}, {"letter": "Radiation Damage", "count": 1}, {"letter": "pyrotinib", "count": 14}, {"letter": "Pulse Sequence", "count": 2}, {"letter": "Physical Laboratory Testing", "count": 1}, {"letter": "Past 6 Months", "count": 3}, {"letter": "Past 4 Weeks", "count": 11}, {"letter": "Pain Right Now", "count": 4}, {"letter": "Pain at its Least", "count": 1}, {"letter": "Oraxol", "count": 2}, {"letter": "Oncoplastic Partial Mastectomy/Lumpectomy with Oncoplastic Closure", "count": 1}, {"letter": "October", "count": 14}, {"letter": "Objective Evidence", "count": 6}, {"letter": "November", "count": 2}, {"letter": "Not Meeting Criteria", "count": 1}, {"letter": "No Problems with Self-Care", "count": 1}, {"letter": "99", "count": 17}, {"letter": "Nearly", "count": 15}, {"letter": "Most of the time", "count": 14}, {"letter": "Menopause Status", "count": 16}, {"letter": "Medical Outcomes Study Social Support Survey", "count": 3}, {"letter": "MD Anderson Symptom Inventory - Brain Tumor", "count": 5}, {"letter": "Mass Measurement", "count": 1}, {"letter": "March (month)", "count": 4}, {"letter": "Macrometastasis", "count": 2}, {"letter": "Lymphedema and Breast Cancer Questionnaire", "count": 1}, {"letter": "Kinome", "count": 6}, {"letter": "Karnofsky Performance Status 100", "count": 1}, {"letter": "June", "count": 13}, {"letter": "July", "count": 7}, {"letter": "Interference with Social Activities", "count": 1}, {"letter": "Interested in Sex", "count": 2}, {"letter": "Indium In 111 Pertuzumab", "count": 3}, {"letter": "Index Lesion", "count": 9}, {"letter": "Image Slice Thickness", "count": 1}, {"letter": "How Much of the Time", "count": 4}, {"letter": "Homogenate", "count": 4}, {"letter": "HO/02/02", "count": 1}, {"letter": "Haploidentical Donor", "count": 1}, {"letter": "February", "count": 3}, {"letter": "FACT-Taxane Questionnaire", "count": 16}, {"letter": "FACT-C Questionnaire", "count": 1}, {"letter": "FAACT Questionnaire", "count": 1}, {"letter": "Extended-release Onapristone", "count": 1}, {"letter": "Extended Release Depot Dosage Form", "count": 2}, {"letter": "Enzymatic Colorimetry", "count": 4}, {"letter": "Enhancing Lesion", "count": 6}, {"letter": "Electrochemiluminescence Immunoassay", "count": 2}, {"letter": "Electrochemiluminescence", "count": 1}, {"letter": "ECG Recording Quality", "count": 1}, {"letter": "Dried Blood Spot", "count": 1}, {"letter": "Distress over Spiritual or Religious Concerns", "count": 3}, {"letter": "Distant Lymph Node", "count": 2}, {"letter": "Disabling Adverse Event", "count": 1}, {"letter": "Detectable", "count": 50}, {"letter": "Destroyed Medical Device", "count": 1}, {"letter": "December", "count": 12}, {"letter": "Convenient", "count": 9}, {"letter": "Completely Unable", "count": 2}, {"letter": "Claudin-Low", "count": 2}, {"letter": "Chart Abstraction", "count": 8}, {"letter": "Breast Fibroglandular Tissue", "count": 9}, {"letter": "Bothered by Hair Loss", "count": 20}, {"letter": "Best Imaginable Health", "count": 13}, {"letter": "Barnes County, ND", "count": 1}, {"letter": "A little of the time", "count": 5}, {"letter": "Alanine Aminotransferase to Aspartate Aminotransferase Ratio Measurement", "count": 1}, {"letter": "Adverse Event Doctor Visit", "count": 2}, {"letter": "Activities of Daily Living Dimension of Functioning Questionnaire", "count": 1}, {"letter": "GOG", "count": 1}, {"letter": "4+ Answer to question", "count": 659}, {"letter": "Lymphedema clinic", "count": 1}, {"letter": "Ribonucleic acid extraction technique", "count": 4}, {"letter": "Oncology clinic", "count": 6}, {"letter": "Deoxyribonucleic acid extraction technique", "count": 10}, {"letter": "Perimenopausal state", "count": 2}, {"letter": "Nonprogressive", "count": 30}, {"letter": "Diminished ovarian reserve", "count": 1}, {"letter": "Level of nausea", "count": 1}, {"letter": "Pediatric care", "count": 1}, {"letter": "Medically Unexplained Symptoms", "count": 3}, {"letter": "Zoledronic acid therapy", "count": 5}, {"letter": "ERBB2 gene duplication associated observations panel", "count": 1}, {"letter": "Soluble Vascular Endothelial Growth Factor Receptor 2, human", "count": 5}, {"letter": "Exactly true", "count": 2}, {"letter": "2 - moderate", "count": 7}, {"letter": "Heavy gardening", "count": 2}, {"letter": "<3/4", "count": 3}, {"letter": "5 - 9", "count": 6}, {"letter": "Itchiness", "count": 5}, {"letter": "10-14", "count": 14}, {"letter": "Greatly", "count": 3}, {"letter": "Very likely", "count": 3}, {"letter": "75+ years", "count": 2}, {"letter": "Traffic", "count": 1}, {"letter": "5 mm", "count": 24}, {"letter": "Fewer than 50", "count": 2}, {"letter": "Day 4", "count": 24}, {"letter": "35 - 39", "count": 2}, {"letter": "Medication 2", "count": 3}, {"letter": "40-49", "count": 1}, {"letter": "11-15 minutes", "count": 1}, {"letter": "Other Reason", "count": 1}, {"letter": "Dose omission", "count": 3}, {"letter": "Potential problem", "count": 2}, {"letter": "Very bad", "count": 7}, {"letter": "equivocal test", "count": 1}, {"letter": "Moderate exercise intensity", "count": 1}, {"letter": "Medical reasons", "count": 1}, {"letter": "Patient reasons", "count": 4}, {"letter": "At each treatment", "count": 1}, {"letter": "Other medical", "count": 3}, {"letter": "Much better", "count": 2}, {"letter": "Other destination", "count": 1}, {"letter": "Slightly better", "count": 1}, {"letter": "Slightly worse", "count": 1}, {"letter": "System One", "count": 2}, {"letter": "1 - Moderate", "count": 1}, {"letter": "Social/family", "count": 25}, {"letter": "Person 4", "count": 1}, {"letter": "Person 3", "count": 1}, {"letter": "Person 1", "count": 1}, {"letter": "Dark brown", "count": 1}, {"letter": "Not Very Much", "count": 1}, {"letter": "Medical-diarrhea", "count": 3}, {"letter": "Sluggish", "count": 3}, {"letter": "6 mm", "count": 6}, {"letter": "3 mm", "count": 1}, {"letter": "2 mm", "count": 1}, {"letter": "1 mm", "count": 1}, {"letter": "Else", "count": 3}, {"letter": "6000", "count": 3}, {"letter": "Manually", "count": 8}, {"letter": "Automatically", "count": 8}, {"letter": "0 days", "count": 6}, {"letter": "5th edition", "count": 1}, {"letter": "4th edition", "count": 5}, {"letter": "No malignancy", "count": 3}, {"letter": "Fever requiring antibiotics", "count": 1}, {"letter": "Record review", "count": 1}, {"letter": "No difference", "count": 4}, {"letter": "Area 3", "count": 2}, {"letter": "Area 1", "count": 4}, {"letter": "Not true", "count": 8}, {"letter": "Not True at All", "count": 7}, {"letter": "Proud", "count": 1}, {"letter": "More than 50", "count": 5}, {"letter": "2 - scaly", "count": 2}, {"letter": "90 - 100%", "count": 2}, {"letter": "10 - 29%", "count": 2}, {"letter": "1 - 9%", "count": 3}, {"letter": "3 - severe", "count": 1}, {"letter": "0 - absent", "count": 10}, {"letter": "Surgery 3", "count": 13}, {"letter": "Surgery 2", "count": 28}, {"letter": "Surgery 1", "count": 13}, {"letter": "Can Do With Much Difficulty", "count": 1}, {"letter": "Booster 3", "count": 2}, {"letter": "80%", "count": 130}, {"letter": "70%", "count": 65}, {"letter": "60%", "count": 155}, {"letter": "40%", "count": 145}, {"letter": "30%", "count": 1116}, {"letter": "20%", "count": 894}, {"letter": "10%", "count": 1237}, {"letter": "Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 0", "count": 3289}, {"letter": "Cognitive problems", "count": 3}, {"letter": "At work", "count": 2}, {"letter": "Day 7", "count": 102}, {"letter": "Day 6", "count": 16}, {"letter": "Day 5", "count": 29}, {"letter": "Day 3", "count": 44}, {"letter": "Day 2", "count": 47}, {"letter": "20 meters", "count": 1}, {"letter": "Trial 2", "count": 1}, {"letter": "Definitely False", "count": 1}, {"letter": "Definitely True", "count": 1}, {"letter": "> 24 hrs", "count": 2}, {"letter": "Reduced in fingers/toes", "count": 1}, {"letter": "Proximal arms", "count": 1}, {"letter": "First half", "count": 4}, {"letter": "Every Time", "count": 1}, {"letter": "One thing", "count": 1}, {"letter": "Far above", "count": 2}, {"letter": "Measurement 4", "count": 5}, {"letter": "Measurement 3", "count": 1}, {"letter": "Measurement 2", "count": 10}, {"letter": "Measurement 1", "count": 3}, {"letter": "Extreme difficulty", "count": 2}, {"letter": "Moderate Difficulty", "count": 7}, {"letter": "Line 10", "count": 4}, {"letter": "Line 6", "count": 1}, {"letter": "Line 2", "count": 1}, {"letter": "In the last 7 days", "count": 1}, {"letter": "1 time", "count": 5}, {"letter": "50 - 54", "count": 2}, {"letter": "45 - 49", "count": 2}, {"letter": "40 - 44", "count": 2}, {"letter": "Very Difficult", "count": 10}, {"letter": "Extremely Difficult", "count": 1}, {"letter": "Not Difficult", "count": 1}, {"letter": "9-18", "count": 7}, {"letter": "36+ months", "count": 20}, {"letter": "20-24", "count": 1}, {"letter": "15-19", "count": 4}, {"letter": "1-4 months", "count": 1}, {"letter": "About the same time", "count": 4}, {"letter": "Abstinence", "count": 4}, {"letter": "Medication 3", "count": 2}, {"letter": "Medication 1", "count": 8}, {"letter": "Deeply", "count": 3}, {"letter": "10 - severe", "count": 2}, {"letter": "1 - mild", "count": 3}, {"letter": "2/day", "count": 1}, {"letter": "17-24", "count": 1}, {"letter": "1-10", "count": 18}, {"letter": "Too much", "count": 4}, {"letter": "Too little", "count": 4}, {"letter": "29+", "count": 59}, {"letter": "22-28", "count": 7}, {"letter": "15-21", "count": 12}, {"letter": "13-14", "count": 1}, {"letter": "9-10", "count": 1}, {"letter": "7-8", "count": 2}, {"letter": "None of these", "count": 2}, {"letter": "65+", "count": 22}, {"letter": "<50", "count": 289}, {"letter": "65-69", "count": 2}, {"letter": "60-64", "count": 2}, {"letter": "55-59", "count": 2}, {"letter": "4 - 6", "count": 23}, {"letter": "10 - 19", "count": 1}, {"letter": "Aug.", "count": 3}, {"letter": "Feb.", "count": 14}, {"letter": "Jan.", "count": 1}, {"letter": "5.5", "count": 3}, {"letter": "Very much like me", "count": 1}, {"letter": "450", "count": 1}, {"letter": "425 (qualifier value)", "count": 2}, {"letter": "800", "count": 3}, {"letter": "Almost All of the Time", "count": 13}, {"letter": "Can Do Very Little", "count": 2}, {"letter": "Robotic assisted.", "count": 1}, {"letter": "Less than five minutes", "count": 2}, {"letter": "Out-of-Hospital", "count": 2}, {"letter": "One day", "count": 12}, {"letter": "Not sure", "count": 3}, {"letter": "Maybe", "count": 1}, {"letter": "Initial screening", "count": 1}, {"letter": "Either", "count": 229}, {"letter": "Combat Exposure Scale CES0104 Original Result - 26-50%", "count": 4}, {"letter": "No improvement", "count": 1}, {"letter": "Not at All Important", "count": 6}, {"letter": "Very Important", "count": 1}, {"letter": "No Response - Disease Response", "count": 4}, {"letter": "Change of therapy assessment", "count": 12}, {"letter": "Start of therapy assessment", "count": 2}, {"letter": "Pre-Birth", "count": 1}, {"letter": "50-59", "count": 5}, {"letter": "Unpaid Assistance", "count": 1}, {"letter": "Severe activity", "count": 1}, {"letter": "Germline", "count": 29}, {"letter": "Weak positive", "count": 2}, {"letter": "Strong positive", "count": 1}, {"letter": "Out of range", "count": 1}, {"letter": "Permanent placement", "count": 1}, {"letter": "Scheduled surgical procedure", "count": 6}, {"letter": "Within 30 days", "count": 7}, {"letter": "Major change", "count": 2}, {"letter": "Slight change", "count": 5}, {"letter": "Combat Exposure Scale CES0104 Original Result - 51-75%", "count": 3}, {"letter": "Mild intensity", "count": 4}, {"letter": "Pain daily", "count": 5}, {"letter": "Partial loss", "count": 4}, {"letter": "Toxicity/Side Effects", "count": 1}, {"letter": "Nearly every day", "count": 5}, {"letter": "Several days", "count": 5}, {"letter": "Shift change", "count": 1}, {"letter": "Omission", "count": 3}, {"letter": "Computer error", "count": 1}, {"letter": "Operator problem", "count": 1}, {"letter": "Wrong patient", "count": 2}, {"letter": "Radiology/imaging", "count": 8}, {"letter": "No limitation", "count": 1}, {"letter": "Nonreactive", "count": 1}, {"letter": "No heart rate", "count": 1}, {"letter": "To doctor", "count": 3}, {"letter": "Life threatening illness", "count": 2}, {"letter": "No radiation therapy", "count": 2}, {"letter": "Fifth Edition", "count": 1}, {"letter": "Staged, NOS", "count": 1}, {"letter": "No surgical procedure", "count": 6}, {"letter": "Chemotherapy, single agent", "count": 16}, {"letter": "Positive Cytology", "count": 3}, {"letter": "Confidential", "count": 3}, {"letter": "Walk-in, not otherwise specified", "count": 12}, {"letter": "Verbal response", "count": 2}, {"letter": "Body condition score:Score:Pt:^Patient:Ord:Jefferies", "count": 2}, {"letter": "Repository", "count": 7}, {"letter": "Action plan", "count": 1}, {"letter": "ferric cation", "count": 1}, {"letter": "TGFA protein, human", "count": 1}, {"letter": "EPHB2 protein, human", "count": 5}, {"letter": "interleukin 18 protein, human", "count": 4}, {"letter": "1H NMR", "count": 1}, {"letter": "Proton Magnetic Resonance Spectroscopy", "count": 2}, {"letter": "Fluorine-19 Magnetic Resonance Imaging", "count": 1}, {"letter": "Delay Discounting", "count": 1}, {"letter": "Systemic Absorption", "count": 1}, {"letter": "Historically Controlled Study", "count": 1}, {"letter": "Clinical Effectiveness", "count": 2}, {"letter": "Mini Nutritional Assessment", "count": 3}, {"letter": "Robotic Surgical Procedures", "count": 3}, {"letter": "Protein Aggregates", "count": 1}, {"letter": "Seoul", "count": 4}, {"letter": "Ovarian Reserve", "count": 8}, {"letter": "COMT protein, human", "count": 3}, {"letter": "LGK974", "count": 4}, {"letter": "18F-alfatide II", "count": 2}, {"letter": "selinexor", "count": 1}, {"letter": "PEG-rhG-CSF", "count": 3}, {"letter": "LY2835219", "count": 2}, {"letter": "abemaciclib", "count": 62}, {"letter": "Biome", "count": 1}, {"letter": "Patient Activation", "count": 6}, {"letter": "Patient Empowerment", "count": 3}, {"letter": "Cost Comparison", "count": 1}, {"letter": "Cost-Utility Analysis", "count": 4}, {"letter": "Well controlled", "count": 1}, {"letter": "Sea urchin (substance)", "count": 1}, {"letter": "Standard formula", "count": 2}, {"letter": "Sixty minutes", "count": 5}, {"letter": "30 seconds", "count": 16}, {"letter": "ARAF protein, human", "count": 1}, {"letter": "Receptor Tyrosine-Protein Kinase ErbB-4, human", "count": 2}, {"letter": "Cup (physical object)", "count": 1}, {"letter": "MOS protein, human", "count": 19}, {"letter": "Platelet-Derived Growth Factor Receptor Alpha, human", "count": 1}, {"letter": "Metabolic Profile", "count": 8}, {"letter": "DF 1681Y", "count": 4}, {"letter": "palbociclib", "count": 182}, {"letter": "irosustat", "count": 4}, {"letter": "Digital Model Attachment", "count": 245}, {"letter": "alectinib", "count": 1}, {"letter": "Functional performance", "count": 7}, {"letter": "Laser speckle contrast imaging", "count": 1}, {"letter": "T score", "count": 38}, {"letter": "timeframe for reporting", "count": 5}, {"letter": "measure type", "count": 1}, {"letter": "initial population", "count": 1}, {"letter": "preference strength", "count": 1}, {"letter": "purpose of use", "count": 2}, {"letter": "health outcome measure", "count": 5}, {"letter": "performance measure", "count": 6}, {"letter": "support network", "count": 1}, {"letter": "external-internal", "count": 1}, {"letter": "described group", "count": 1}, {"letter": "anonymized", "count": 1}, {"letter": "Data Mapping", "count": 5}, {"letter": "highly reliable", "count": 1}, {"letter": "Reliable", "count": 72}, {"letter": "diagnostic mammogram of both breasts", "count": 1}, {"letter": "digital tomosynthesis", "count": 1}, {"letter": "Peripheral sensory neuropathy grade", "count": 1}, {"letter": "Personal belief", "count": 2}, {"letter": "4 - severe", "count": 2}, {"letter": "3 - serious", "count": 1}, {"letter": "6 - maximal", "count": 2}, {"letter": "Large amount", "count": 2}, {"letter": "Moderate amount", "count": 1}, {"letter": "Note:Find:Pt:{Setting}:Doc:Physician", "count": 6}, {"letter": "Score range", "count": 353}, {"letter": "Score difference", "count": 16}, {"letter": "Percent Difference", "count": 2}, {"letter": "NIH Toolbox", "count": 19}, {"letter": "NCICTC", "count": 1}, {"letter": "At discharge", "count": 1}, {"letter": "Lynparza", "count": 3}, {"letter": "On menstrual cycle day 3", "count": 8}, {"letter": "On menstrual cycle day 21", "count": 1}, {"letter": "Cares for self", "count": 1}, {"letter": "Device Setting", "count": 1}, {"letter": "Every fourteen days", "count": 3}, {"letter": "Peripheral neuropathy due to and following antineoplastic therapy", "count": 34}, {"letter": "Absorbent", "count": 1}, {"letter": "Console", "count": 2}, {"letter": "Ultrasound imaging system", "count": 1}, {"letter": "Breast imaging system", "count": 2}, {"letter": "External prosthesis", "count": 1}, {"letter": "Attitude towards exercise", "count": 1}, {"letter": "Attitude towards care", "count": 1}, {"letter": "Towards", "count": 1}, {"letter": "Relative to", "count": 251}, {"letter": "Wall mount", "count": 1}, {"letter": "sarilumab", "count": 1}, {"letter": "CFI-400945", "count": 6}, {"letter": "Buparlisib", "count": 6}, {"letter": "Head and Neck Carcinoma", "count": 1}, {"letter": "MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1", "count": 3}, {"letter": "Evidence", "count": 285}, {"letter": "Peroxisome Proliferator-Activated Receptor Gamma, human", "count": 3}, {"letter": "Autophagosome", "count": 1}, {"letter": "Percent Volume per Volume", "count": 11}, {"letter": "Gap (space)", "count": 1}, {"letter": "Job Performance", "count": 1}, {"letter": "DNA Nucleotidylexotransferase, human", "count": 1}, {"letter": "Ever", "count": 17}, {"letter": "Lymphotoxin-Alpha, human", "count": 1}, {"letter": "Pelvic Bones", "count": 1}, {"letter": "Purine Nucleoside Phosphorylase, human", "count": 1}, {"letter": "Kathy Mercer", "count": 13}, {"letter": "Human B-Lymphocyte Antigen CD20, human", "count": 1}, {"letter": "Platelet Glycoprotein 4, human", "count": 2}, {"letter": "Kit Ligand, human", "count": 2}, {"letter": "Feeling upset", "count": 4}, {"letter": "Microbiota (environment)", "count": 1}, {"letter": "Indoleamine 2,3-Dioxygenase, human", "count": 2}, {"letter": "Disability Rating Scale Questionnaire", "count": 2}, {"letter": "enrollment - coverage", "count": 6}, {"letter": "mechanistic target of rapamycin complex 1", "count": 4}, {"letter": "Computed Tomography Study File", "count": 138}, {"letter": "Laboratory Normal Ranges", "count": 5}, {"letter": "SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 2, PSEUDOGENE", "count": 1}, {"letter": "Intravascular systolic.tibial artery/Brachial artery:PresRto:Pt:Arterial system:Qn", "count": 1}, {"letter": "Columbia Suicide Severity Rating Scale", "count": 1}, {"letter": "Clinical Trial Oversight Committee Information", "count": 1}, {"letter": "LTBR wt Allele", "count": 1}, {"letter": "Ultrasound Study File", "count": 11}, {"letter": "OPRM1 wt Allele", "count": 1}, {"letter": "Statistical Analysis Plan", "count": 3}, {"letter": "Standard Operating Procedure List", "count": 6}, {"letter": "Clinical Trial Protocol Deviation Document", "count": 5}, {"letter": "OPTN wt Allele", "count": 3}, {"letter": "LAMC2 wt Allele", "count": 11}, {"letter": "Healthcare Encounters Domain", "count": 1}, {"letter": "Trial Disease Assessments Domain", "count": 2}, {"letter": "FACT-ES Questionnaire", "count": 4}, {"letter": "Carbon Nanoparticle-based Formulation", "count": 5}, {"letter": "Clinical Trial Protocol Amendment Summary", "count": 4}, {"letter": "Taxonomy Category Name", "count": 1}, {"letter": "Censor", "count": 565}, {"letter": "area 25", "count": 4}, {"letter": "Clinical Trial Investigator Brochure", "count": 2}, {"letter": "Magnetic Resonance Imaging Study File", "count": 1}, {"letter": "MedDRA Preferred Term Code", "count": 6}, {"letter": "Apparent Diffusion Coefficient", "count": 15}, {"letter": "SOS1 wt Allele", "count": 1}, {"letter": "PON1 wt Allele", "count": 1}, {"letter": "IL17F wt Allele", "count": 3}, {"letter": "Active Breathing Coordinator-Mediated Radiation Therapy", "count": 3}, {"letter": "FGF13 wt Allele", "count": 1}, {"letter": "Exposure as Collected Domain", "count": 13}, {"letter": "Natural Killer Cell Activity Measurement", "count": 3}, {"letter": "Paravertebral Block", "count": 3}, {"letter": "Children's Memory Scale", "count": 2}, {"letter": "PRKAA1 wt Allele", "count": 2}, {"letter": "Liquid Tumor", "count": 1}, {"letter": "Physical Inactivity", "count": 1}, {"letter": "Functional Tests Domain", "count": 5}, {"letter": "Institutional Review Board Independent Ethics Committee Subject Questionnaire", "count": 6}, {"letter": "Subject Diary", "count": 15}, {"letter": "Bodily Pain", "count": 22}, {"letter": "Clinical Trial Insurance Documentation", "count": 10}, {"letter": "Complete Response with Incomplete Platelet Recovery", "count": 34}, {"letter": "FDPS wt Allele", "count": 1}, {"letter": "Clinical Trial Interactive Response Technology Documentation", "count": 1}, {"letter": "Subject Status Domain", "count": 2}, {"letter": "Symbol Digit Modalities Functional Test", "count": 1}, {"letter": "LNCAROD gene", "count": 2}, {"letter": "Tumor-Associated Macrophage", "count": 2}, {"letter": "biological phase", "count": 3}, {"letter": "activation of cellular secretion", "count": 1}, {"letter": "Extracellular Vesicles", "count": 1}, {"letter": "estradiol binding", "count": 1}, {"letter": "Stereotactic Body Radiation Therapy", "count": 22}, {"letter": "Accelerated Partial Breast Irradiation", "count": 19}, {"letter": "CDISC Define-XML Analysis Purpose Terminology", "count": 2}, {"letter": "PF-06647263", "count": 16}, {"letter": "trastuzumab duocarmazine", "count": 5}, {"letter": "Activin Type 2B Receptor Fc Fusion Protein STM 434", "count": 3}, {"letter": "CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine", "count": 1}, {"letter": "Anti-EGFR Monoclonal Antibody SCT200", "count": 3}, {"letter": "RAD1901", "count": 9}, {"letter": "PF-06650808", "count": 6}, {"letter": "FGF/FGFR Pathway Inhibitor E7090", "count": 3}, {"letter": "ASTX727", "count": 2}, {"letter": "Galunisertib", "count": 2}, {"letter": "varlilumab", "count": 1}, {"letter": "Spinous Processes", "count": 1}, {"letter": "Nanomole Bone Collagen Equivalent per Millimole", "count": 2}, {"letter": "Anti-Estrogen Receptor Antibody", "count": 1}, {"letter": "Childhood Breast Carcinoma", "count": 4}, {"letter": "Pain Rating Score 2", "count": 1}, {"letter": "Response Assessment in Neuro-Oncology Criteria", "count": 56}, {"letter": "Worst Imaginable", "count": 5}, {"letter": "Work Limitations Questionnaire", "count": 4}, {"letter": "Whole Breast Irradiation", "count": 1}, {"letter": "Wechsler Memory Scale - Fourth Edition", "count": 1}, {"letter": "Wechsler Adult Intelligence Scale fourth edition", "count": 5}, {"letter": "Uninterpretable", "count": 1}, {"letter": "Ultrasound Elasticity Imaging", "count": 2}, {"letter": "TP53 gene mutation", "count": 2}, {"letter": "T2 and Fluid Attenuated Inversion Recovery MRI", "count": 6}, {"letter": "T-47D", "count": 3}, {"letter": "Subject Unblinding Event Record", "count": 1}, {"letter": "Study Day of Tumor Identification", "count": 1}, {"letter": "Standard Follow-Up Care", "count": 3}, {"letter": "Special Event of Interest Document", "count": 12}, {"letter": "Soluble Tumor Necrosis Factor Receptor Measurement", "count": 1}, {"letter": "Skin Care Product", "count": 2}, {"letter": "Single Nucleotide Polymorphism Array", "count": 2}, {"letter": "Severity of Symptom Score 9", "count": 10}, {"letter": "Severity of Symptom Score 8", "count": 36}, {"letter": "Severity of Symptom Score 7", "count": 30}, {"letter": "Severity of Symptom Score 6", "count": 26}, {"letter": "Severity of Symptom Score 5", "count": 52}, {"letter": "Severity of Symptom Score 10", "count": 29}, {"letter": "Severity of Symptom Likert Scale", "count": 2}, {"letter": "Serious Adverse Event Report", "count": 3}, {"letter": "Scaled Score", "count": 7}, {"letter": "Satisfaction With Life Scale Questionnaire", "count": 4}, {"letter": "Sample Size Calculation", "count": 5}, {"letter": "Randomization Documentation", "count": 13}, {"letter": "Positron Emission Mammography", "count": 2}, {"letter": "Placebo Administration", "count": 4}, {"letter": "Photoacoustic Imaging", "count": 7}, {"letter": "Peritumoral", "count": 4}, {"letter": "Periodontal Screening and Recording Code 4", "count": 2}, {"letter": "Periodontal Screening and Recording Code 3", "count": 2}, {"letter": "Periodontal Screening and Recording Code 1", "count": 3}, {"letter": "Periodontal Screening and Recording Code 0", "count": 3}, {"letter": "Pericyte Coverage Measurement", "count": 1}, {"letter": "Past 24 Hours", "count": 8}, {"letter": "Partial Breast Irradiation", "count": 7}, {"letter": "Pain Rating Score 1", "count": 1}, {"letter": "Pain Rating Score 10", "count": 1}, {"letter": "Pain Rating Score 0", "count": 1}, {"letter": "Pain Interference Score 2", "count": 3}, {"letter": "Oncotype DX DCIS Score", "count": 2}, {"letter": "Multiparametric Magnetic Resonance Imaging", "count": 8}, {"letter": "Microscopic Findings Sequence Number", "count": 2}, {"letter": "Memory Intervention", "count": 2}, {"letter": "MDA-MB-468", "count": 3}, {"letter": "Likert Score 0", "count": 3}, {"letter": "Joint Vendor Quality Assurance Plan", "count": 1}, {"letter": "Intraparenchymal Route of Administration", "count": 3}, {"letter": "Intraoperative Imaging", "count": 2}, {"letter": "Internet-Based Intervention", "count": 4}, {"letter": "Intensity of Average Pain", "count": 1}, {"letter": "Important", "count": 13}, {"letter": "Hyperpolarized Carbon C 13 Pyruvate", "count": 3}, {"letter": "How Often", "count": 21}, {"letter": "Hospitalization Due to Heart Failure", "count": 3}, {"letter": "Helpful", "count": 15}, {"letter": "Healthy", "count": 83}, {"letter": "Functional Assessment of Chronic Illness Therapy-Diarrhea", "count": 2}, {"letter": "Follow-Up Care", "count": 9}, {"letter": "FACT/GOG-Ntx Questionnaire", "count": 12}, {"letter": "FACT-En Questionnaire", "count": 1}, {"letter": "FACT-B Questionnaire", "count": 215}, {"letter": "Extremely Important", "count": 6}, {"letter": "Exceptional Responder", "count": 1}, {"letter": "ECG Technical Quality", "count": 1}, {"letter": "Direct Sequencing", "count": 1}, {"letter": "Diffusion Coefficient", "count": 4}, {"letter": "Diffuse Optical Imaging", "count": 1}, {"letter": "Dermatology Life Quality Index Questionnaire", "count": 1}, {"letter": "Definitely", "count": 5}, {"letter": "Date and Time of First Study Treatment", "count": 3}, {"letter": "Database Validation Plan", "count": 1}, {"letter": "Crown-Like Structures of the Breast", "count": 2}, {"letter": "Copper Cu 64-DOTA-AE105", "count": 4}, {"letter": "Copper Cu 64 Anti-CEA Monoclonal Antibody M5A", "count": 2}, {"letter": "Clinical Trial Recruitment Plan", "count": 1}, {"letter": "Clinical Trial Protocol Synopsis", "count": 2}, {"letter": "Clinical Trial Monitoring Visit Log", "count": 2}, {"letter": "cirmtuzumab", "count": 2}, {"letter": "Circulating Tumor Cell Analysis", "count": 3}, {"letter": "Circulating Adipose Stromal Cell", "count": 1}, {"letter": "Chemical Exchange Saturation Transfer Magnetic Resonance Imaging", "count": 4}, {"letter": "Cell Proliferation Assay", "count": 2}, {"letter": "California Verbal Learning Test - Second Edition", "count": 1}, {"letter": "CXCL12-Abundant Reticular Cell", "count": 2}, {"letter": "CNS1 (classification)", "count": 1}, {"letter": "Bioelectric Field Imaging", "count": 13}, {"letter": "binimetinib", "count": 1}, {"letter": "BRCA2 Mutation Carrier", "count": 1}, {"letter": "BRCA1 Mutation Carrier", "count": 4}, {"letter": "BPI Pain Interference Likert Scale", "count": 2}, {"letter": "Apoptosis Marker", "count": 7}, {"letter": "Anti-KI-67 Antibody", "count": 4}, {"letter": "Analysis Specified in Protocol", "count": 6}, {"letter": "Analysis Method", "count": 12}, {"letter": "Amenable", "count": 24}, {"letter": "Alkaline Water", "count": 1}, {"letter": "Adversity", "count": 2}, {"letter": "Adverse Event MedDRA System Organ Class", "count": 1}, {"letter": "A Lot of the Time", "count": 8}, {"letter": "6 Minute Walk Functional Test", "count": 9}, {"letter": "Oar", "count": 4}, {"letter": "Increase in CD8+ T cells", "count": 2}, {"letter": "STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET", "count": 1}, {"letter": "Respiratory insufficiency, severe", "count": 1}, {"letter": "Social difficulties", "count": 1}, {"letter": "Normal thyroid-stimulating hormone level", "count": 2}, {"letter": "Jitter", "count": 2}, {"letter": "Helpless", "count": 3}, {"letter": "Gastrointestinal Microbiome", "count": 24}, {"letter": "Exchange (clinical)", "count": 1}, {"letter": "Hospital stay duration", "count": 2}, {"letter": "Collar Bone", "count": 1}, {"letter": "Dietary behavior:Find:Pt:^Patient:Nom", "count": 1}, {"letter": "RR interval.standard deviation", "count": 4}, {"letter": "Abnormality of mitochondrial metabolism", "count": 1}, {"letter": "Abnormality of metabolism/homeostasis", "count": 13}, {"letter": "Inertia", "count": 10}, {"letter": "Late onset", "count": 2}, {"letter": "WMS-IV logical memory I subtest", "count": 2}, {"letter": "Nuclear magnetic resonance imaging brain", "count": 23}, {"letter": "30 days", "count": 130}, {"letter": "Care setting", "count": 2}, {"letter": "Pain interference score", "count": 10}, {"letter": "End-systolic volume", "count": 4}, {"letter": "End-diastolic volume", "count": 4}, {"letter": "Brief Pain Inventory (BPI)", "count": 1}, {"letter": "National Health and Nutrition Examination Survey (NHANES)", "count": 1}, {"letter": "1 - Excellent", "count": 2}, {"letter": "10 - Extremely", "count": 2}, {"letter": "Always True", "count": 6}, {"letter": "Within 24 hours", "count": 8}, {"letter": "Post Anesthesia Care Unit", "count": 17}, {"letter": "3 times", "count": 3}, {"letter": "More than 10 drinks", "count": 2}, {"letter": "6-10 times", "count": 1}, {"letter": "5 - Good", "count": 1}, {"letter": "10 - Severe pain", "count": 6}, {"letter": "9 - Severe pain", "count": 2}, {"letter": "8 - Moderate pain", "count": 1}, {"letter": "9 - Extremely", "count": 1}, {"letter": "5 - Moderate", "count": 3}, {"letter": "Doubly", "count": 1}, {"letter": "Use error", "count": 1}, {"letter": "Data Accuracy", "count": 1}, {"letter": "Support staff", "count": 1}, {"letter": "Drug-disease", "count": 1}, {"letter": "Drug-drug", "count": 3}, {"letter": "Very confident", "count": 11}, {"letter": "Ambulate", "count": 1}, {"letter": "Sometimes True", "count": 1}, {"letter": "10 - worst imaginable pain", "count": 1}, {"letter": "Contacts", "count": 8}, {"letter": "Reporting Period", "count": 3}, {"letter": "Prosigna", "count": 13}, {"letter": "Low resolution", "count": 4}, {"letter": "Isotopic", "count": 4}, {"letter": "Radiotherapy to thorax", "count": 1}, {"letter": "Assessment of anxiety", "count": 4}, {"letter": "Lesion of endometrium", "count": 1}, {"letter": "Lymphs/uL", "count": 9}, {"letter": "Assessment of self-efficacy", "count": 1}, {"letter": "Assessment of social support", "count": 1}, {"letter": "Assessment of expectations", "count": 1}, {"letter": "Administration of vitamin", "count": 1}, {"letter": "Assessment of fatigue", "count": 27}, {"letter": "BCL2 protein, human", "count": 3}, {"letter": "Presenteeism", "count": 5}, {"letter": "Re-Irradiation", "count": 8}, {"letter": "Radiation Dose Hypofractionation", "count": 1}, {"letter": "Beijing", "count": 1}, {"letter": "Potentially Inappropriate Medication List", "count": 2}, {"letter": "Clinical Decision-Making", "count": 2}, {"letter": "Health Equity", "count": 3}, {"letter": "Seroconversion", "count": 1}, {"letter": "Genetic Background", "count": 1}, {"letter": "Whole Grains", "count": 2}, {"letter": "talazoparib", "count": 46}, {"letter": "CLR1404", "count": 5}, {"letter": "IGF1R protein, human", "count": 4}, {"letter": "anetumab ravtansine", "count": 4}, {"letter": "ribociclib", "count": 52}, {"letter": "DEBIO-1143", "count": 34}, {"letter": "Indoximod", "count": 1}, {"letter": "Tablet Computers", "count": 1}, {"letter": "Overtreatment", "count": 14}, {"letter": "low exposure", "count": 1}, {"letter": "T-Cell Surface Glycoprotein CD4, human", "count": 44}, {"letter": "Airway resistance", "count": 57}, {"letter": "Platelet Endothelial Cell Adhesion Molecule, human", "count": 1}, {"letter": "Lacks Energy", "count": 1}, {"letter": "Anti-Mullerian Hormone Measurement", "count": 1}, {"letter": "Unable to Do", "count": 30}, {"letter": "Apply", "count": 84}, {"letter": "copanlisib", "count": 9}, {"letter": "cobimetinib", "count": 10}, {"letter": "TKM-080301", "count": 3}, {"letter": "Hormone refractory breast cancer", "count": 1}, {"letter": "Cardiac radiofrequency ablation", "count": 2}, {"letter": "HLA Complex", "count": 7}, {"letter": "Homologous Recombination Deficiency", "count": 3}, {"letter": "Marrow Complete Response", "count": 1}, {"letter": "Symbol Search Subtest (WISC-V)", "count": 1}, {"letter": "Molecular Major Response", "count": 1}, {"letter": "Picture Naming Subtest (WPPSI-IV)", "count": 1}, {"letter": "Depression Scale (BASC-2)", "count": 4}, {"letter": "Borg Category-Ratio 10 Perceived Exertion Score 10", "count": 1}, {"letter": "PedsQL-4 Scale Score", "count": 316}, {"letter": "Stable Metabolic Disease", "count": 1}, {"letter": "Feel Anxious", "count": 1}, {"letter": "VSIR wt Allele", "count": 1}, {"letter": "WDFY2 wt Allele", "count": 1}, {"letter": "Physical Function Subordinate Domain", "count": 1}, {"letter": "Liquid Chromatography/Tandem Mass Spectrometry", "count": 4}, {"letter": "Physical Activity Measurement", "count": 1}, {"letter": "Ki67 Measurement", "count": 218}, {"letter": "Impact", "count": 3}, {"letter": "Induction Therapy Epoch", "count": 2}, {"letter": "Clavien-Dindo Grade I", "count": 1}, {"letter": "Arm or Leg Response Group 1", "count": 1}, {"letter": "Arm or Leg Response Group 2", "count": 1}, {"letter": "Unknown GENC", "count": 5}, {"letter": "Clinical Partial Response", "count": 11}, {"letter": "Clinical Complete Response", "count": 35}, {"letter": "Numeric Rating Scale", "count": 54}, {"letter": "Borg Category-Ratio 10 Perceived Exertion Score 0", "count": 1}, {"letter": "No Hand Mobility", "count": 1}, {"letter": "Complete Hematologic Response", "count": 1}, {"letter": "Behavior Rating Inventory of Executive Function", "count": 67}, {"letter": "Bug Search Subtest (WPPSI-IV)", "count": 4}, {"letter": "Progressive Metabolic Disease", "count": 3}, {"letter": "Bassas da India", "count": 2}, {"letter": "Pathologic Complete Response", "count": 396}, {"letter": "Rating of Perceived Exertion", "count": 2}, {"letter": "Tumor Complete Metabolic Response", "count": 1}, {"letter": "Central Nervous System Involvement", "count": 1}, {"letter": "Patient Derived Xenograft", "count": 2}, {"letter": "Brinkman index:Score:Pt:^Patient:Qn", "count": 10}, {"letter": "Comprehensive Score for Financial Toxicity", "count": 4}, {"letter": "Strength:Imp:Pt:Musculoskeletal system:Ord", "count": 8}, {"letter": "Self-Esteem Scale (BASC-2)", "count": 1}, {"letter": "Borg Category-Ratio 10 Perceived Exertion Score 7", "count": 50}, {"letter": "Cutaneous Assessment Tool", "count": 5}, {"letter": "Minor Response", "count": 1}, {"letter": "Activities of Daily Living Scale (BASC-2)", "count": 1}, {"letter": "Toronto Extremity Salvage Score, Upper Extremity", "count": 2}, {"letter": "Anxiety Scale (BASC-2)", "count": 31}, {"letter": "Flexibility Index", "count": 2}, {"letter": "Surrogate", "count": 8}, {"letter": "Fluorine F 18 Fluorthanatrace", "count": 3}, {"letter": "4-Methoxyestrone", "count": 1}, {"letter": "Tromelin Island", "count": 3}, {"letter": "Coral Sea Islands", "count": 1}, {"letter": "LY3023414", "count": 7}, {"letter": "PDR-001", "count": 13}, {"letter": "LY-3039478", "count": 5}, {"letter": "LAG 525", "count": 3}, {"letter": "EGFR Antagonist Hemay022", "count": 4}, {"letter": "BAY 1841788", "count": 3}, {"letter": "AZD9496", "count": 2}, {"letter": "18F-FSPG", "count": 4}, {"letter": "margetuximab", "count": 15}, {"letter": "capmatinib", "count": 3}, {"letter": "Taselisib", "count": 10}, {"letter": "Surgical Margins Status", "count": 7}, {"letter": "Worse than Ever", "count": 1}, {"letter": "Unequivocal", "count": 9}, {"letter": "Tumor Antigen Response", "count": 1}, {"letter": "Tolerable", "count": 10}, {"letter": "Subsequent Relapse", "count": 1}, {"letter": "Social Domain", "count": 3}, {"letter": "Seated Row", "count": 1}, {"letter": "Regimen-Limiting Toxicity", "count": 425}, {"letter": "Rating Myself", "count": 11}, {"letter": "Radiologic Response", "count": 31}, {"letter": "Quality of Life Questionnaire-Brain Neoplasm 20", "count": 4}, {"letter": "Per Kilogram", "count": 2}, {"letter": "PedsQL-4 Total Scale Score", "count": 58}, {"letter": "PedsQL-4 Physical Functioning Scale", "count": 7}, {"letter": "Patient Assessment of Overall Well-Being", "count": 2}, {"letter": "Pathologic Response", "count": 101}, {"letter": "PROMIS-43 Adult Profile v2.0", "count": 10}, {"letter": "PROMIS Adult Global Health Domain", "count": 1}, {"letter": "PD-L1 Overexpression", "count": 30}, {"letter": "PAM50 Gene Expression Signature", "count": 18}, {"letter": "Overall Sleep Quality Rating", "count": 2}, {"letter": "One Repetition Maximum", "count": 15}, {"letter": "Non Progressive Disease", "count": 44}, {"letter": "Monitor Scale", "count": 1}, {"letter": "Molecular Response", "count": 4}, {"letter": "Modest Extremity Pain", "count": 2}, {"letter": "Mimotope-P10s-PADRE Peptide Vaccine", "count": 1}, {"letter": "Metabolic Response", "count": 6}, {"letter": "Mean Thickness", "count": 1}, {"letter": "MD Anderson Symptom Inventory - Spine Tumor", "count": 1}, {"letter": "Leg Press", "count": 5}, {"letter": "Lack of Expression of PD-L1", "count": 4}, {"letter": "Influence", "count": 57}, {"letter": "Immunohistochemical Status of PD-L1", "count": 1}, {"letter": "High-performance Liquid Chromatography/Tandem Mass Spectrometry", "count": 1}, {"letter": "Gallium Ga 68-NOTA-AE105", "count": 4}, {"letter": "Functional Assessment of Chronic Illness Therapy-Treatment Satisfaction-General", "count": 5}, {"letter": "First Relapse", "count": 71}, {"letter": "Favorable Response", "count": 7}, {"letter": "Fairly Good", "count": 1}, {"letter": "Fairly Bad", "count": 1}, {"letter": "FACT-N Questionnaire", "count": 1}, {"letter": "FACT-B+4 Questionnaire", "count": 12}, {"letter": "Extremity Functional Restrictions, Total Disability", "count": 2}, {"letter": "Emotional Distress-Anxiety Subordinate Domain", "count": 8}, {"letter": "Emotional Dislike of Extremity", "count": 1}, {"letter": "Early Relapse", "count": 9}, {"letter": "durvalumab", "count": 62}, {"letter": "Dose Response Control", "count": 11}, {"letter": "WAIS-IV digit span subtest", "count": 10}, {"letter": "Continuation Therapy Epoch", "count": 6}, {"letter": "Composite Score", "count": 26}, {"letter": "Cognitive Function-Abilities", "count": 5}, {"letter": "Clinical Response", "count": 197}, {"letter": "Circulating MicroRNA", "count": 4}, {"letter": "Choi Response Criteria in the Evaluation of Gastrointestinal Stromal Tumors", "count": 2}, {"letter": "Chest Press", "count": 7}, {"letter": "Cellular Debris", "count": 1}, {"letter": "Cancer Cellularity Measurement", "count": 5}, {"letter": "CEP 7 Probe", "count": 2}, {"letter": "Borg Category-Ratio 10 Perceived Exertion Score 1", "count": 3}, {"letter": "Billion per Gram", "count": 10}, {"letter": "Beta-Cell Function Measurement", "count": 1}, {"letter": "avelumab", "count": 41}, {"letter": "atezolizumab", "count": 73}, {"letter": "alpelisib", "count": 64}, {"letter": "Accumulation", "count": 48}, {"letter": "ABBV-221", "count": 4}, {"letter": "Significantly high", "count": 3}, {"letter": "Significantly low", "count": 7}, {"letter": "online written", "count": 1}, {"letter": "Unexpected", "count": 23}, {"letter": "Fruit servings", "count": 3}, {"letter": "Soluble CD27", "count": 2}, {"letter": "Pain score change", "count": 16}, {"letter": "Quality of life score change", "count": 18}, {"letter": "Fractional Area Change", "count": 9}, {"letter": "Study diagnosis", "count": 1}, {"letter": "Volume.remaining", "count": 1}, {"letter": "Dose Administered", "count": 9}, {"letter": "1.8", "count": 4}, {"letter": "Coherent", "count": 14}, {"letter": "Early diastolic", "count": 2}, {"letter": "Vascularity", "count": 3}, {"letter": "0.9", "count": 29}, {"letter": "0.75", "count": 6}, {"letter": "0.6", "count": 32}, {"letter": "0.45", "count": 5}, {"letter": "0.3", "count": 94}, {"letter": "0.15", "count": 14}, {"letter": "25-49%", "count": 1}, {"letter": "Mood:Find:Pt:^Patient:Nom", "count": 2}, {"letter": "Form:Find:Pt:{Setting}:Doc:Mental health", "count": 3}, {"letter": "Body temperature:Temp:Pt:Surface:Qn", "count": 1}, {"letter": "180 days", "count": 9}, {"letter": "Calcium score", "count": 2}, {"letter": "Lifetime", "count": 8}, {"letter": "90 days", "count": 19}, {"letter": "7 days", "count": 39}, {"letter": "6 months", "count": 255}, {"letter": "1 year", "count": 56}, {"letter": "14 days", "count": 47}, {"letter": "Area/Area", "count": 3}, {"letter": "IV contrast", "count": 1}, {"letter": "uncorrected", "count": 1}, {"letter": "Difficulty taking medication", "count": 1}, {"letter": "Short Physical Performance Battery score", "count": 1}, {"letter": "Pain Self-efficacy Questionnaire", "count": 2}, {"letter": "Short Physical Performance Battery", "count": 12}, {"letter": "Flap necrosis", "count": 3}, {"letter": "Cytology aspiration needle", "count": 1}, {"letter": "Low dose computed tomography of thorax", "count": 1}, {"letter": "Cyclophosphamide therapy", "count": 2}, {"letter": "Autologous fat", "count": 2}, {"letter": "venetoclax", "count": 3}, {"letter": "High intensity", "count": 5}, {"letter": "Moderate intensity", "count": 9}, {"letter": "Focused ultrasound ablation using magnetic resonance imaging guidance", "count": 9}, {"letter": "Three weeks", "count": 5}, {"letter": "One month", "count": 39}, {"letter": "One year", "count": 62}, {"letter": "Two weeks", "count": 37}, {"letter": "Three months", "count": 34}, {"letter": "Six months", "count": 49}, {"letter": "Preparation level", "count": 1}, {"letter": "Progesterone Receptor, human", "count": 12}, {"letter": "KRT19 protein, human", "count": 4}, {"letter": "Integrin Alpha-X , human", "count": 1}, {"letter": "C-X-C Chemokine Receptor Type 1, human", "count": 1}, {"letter": "Insulin Receptor-Related Receptor, human", "count": 3}, {"letter": "CAM Exercise Therapy", "count": 1}, {"letter": "Resting Metabolic Rate", "count": 1}, {"letter": "Gamma-Glutamyl Hydrolase, human", "count": 1}, {"letter": "Cyclin-Dependent Kinase Inhibitor 2A, human", "count": 9}, {"letter": "TAPS Tool - Interviewer Version", "count": 5}, {"letter": "Patient Health Questionnaire - 9 Item", "count": 16}, {"letter": "REPLETE", "count": 2}, {"letter": "SLC45A2 wt Allele", "count": 22}, {"letter": "Symptom Distress Scale", "count": 8}, {"letter": "How Often Weight Loss", "count": 1}, {"letter": "Bristol Stool Scale", "count": 2}, {"letter": "How Often Worry", "count": 1}, {"letter": "Life Expectancy Greater than Twenty Years", "count": 1}, {"letter": "Importance Rating Score 0", "count": 129}, {"letter": "Decisional Conflict Scale", "count": 26}, {"letter": "Have Noticed New Changes in Skin", "count": 3}, {"letter": "Administrative - Clinical Class", "count": 4}, {"letter": "Pharmacogenomic Analysis", "count": 5}, {"letter": "Conventional Dendritic Cell", "count": 1}, {"letter": "Pain Distress Question", "count": 47}, {"letter": "area 8", "count": 1}, {"letter": "area 9", "count": 2}, {"letter": "Neck Disability Index", "count": 1}, {"letter": "Extreme Response", "count": 1}, {"letter": "Extremely Agree", "count": 2}, {"letter": "AL-RAQAD SYNDROME", "count": 1}, {"letter": "Carboplatin/Etoposide/Melphalan Regimen", "count": 28}, {"letter": "Moderate Response", "count": 1}, {"letter": "Memorial Symptom Assessment Scale", "count": 4}, {"letter": "Affymetrix", "count": 2}, {"letter": "ARX788", "count": 9}, {"letter": "ADC PF-06647020", "count": 19}, {"letter": "Breast Cancer Prevention Trial Symptom Scales", "count": 13}, {"letter": "Clinical Interpretation", "count": 3}, {"letter": "Clinical Trial Setting", "count": 1}, {"letter": "ClinicalTrials.gov", "count": 2}, {"letter": "Differential Methylation", "count": 1}, {"letter": "Disease Phenotype", "count": 1}, {"letter": "Escalation", "count": 53}, {"letter": "Exacerbation", "count": 3}, {"letter": "Gene Enrichment Probability", "count": 1}, {"letter": "How Big a Problem is Watery Bowel Movements", "count": 1}, {"letter": "How Big a Problem is Your Change in Body Weight", "count": 9}, {"letter": "How Much Distress Other Symptom 1", "count": 1}, {"letter": "How Much Distress Other Symptom 2", "count": 1}, {"letter": "How True Feel Vigorous Right Now", "count": 52}, {"letter": "Huaier Extract Granule", "count": 2}, {"letter": "Importance Rating Score 1 (4-Point Importance Scale)", "count": 1}, {"letter": "Importance Rating Score 2 (4-Point Importance Scale)", "count": 1}, {"letter": "Life Expectancy Less than Five Years", "count": 74}, {"letter": "Life Expectancy Less than Ten Years", "count": 45}, {"letter": "Lymph Node State", "count": 14}, {"letter": "M2 Macrophage", "count": 6}, {"letter": "eFT508", "count": 3}, {"letter": "Memorial Symptom Assessment Scale - Short Form", "count": 3}, {"letter": "Milligram per Dose", "count": 17}, {"letter": "Milligram per Kilogram per Dose", "count": 1}, {"letter": "Minimal Residual Disease Negativity", "count": 1}, {"letter": "Nausea Distress", "count": 11}, {"letter": "Neoadjuvant Therapy Clinical Trial Setting", "count": 199}, {"letter": "Non-Palpable", "count": 6}, {"letter": "Number of Episodes", "count": 2}, {"letter": "Number of Hospitalizations", "count": 3}, {"letter": "Number of Lymph Nodes Positive", "count": 16}, {"letter": "Overall Satisfaction with Treatment Received for Prostate Cancer", "count": 20}, {"letter": "Overall Survival", "count": 1046}, {"letter": "PF-06671008", "count": 8}, {"letter": "IPI-549", "count": 2}, {"letter": "PSA Level Five to Ten", "count": 2}, {"letter": "PSA Level Ten to Fifty", "count": 15}, {"letter": "PSA Level", "count": 3}, {"letter": "Pain Interference Subordinate Domain", "count": 60}, {"letter": "Past 3 Months", "count": 3}, {"letter": "Past Year", "count": 5}, {"letter": "Pathologic Examination", "count": 30}, {"letter": "Pathology Result", "count": 23}, {"letter": "Patient Satisfaction Questionnaire Short Form", "count": 1}, {"letter": "Reduced Number", "count": 21}, {"letter": "Response Evaluation Criteria in Solid Tumors Version 1.0", "count": 77}, {"letter": "Response Evaluation Criteria in Solid Tumors Version 1.1", "count": 1065}, {"letter": "TTI-621", "count": 3}, {"letter": "sacituzumab govitecan", "count": 10}, {"letter": "Slow Growing", "count": 1}, {"letter": "Symptomatic Deterioration", "count": 8}, {"letter": "Therapeutic gamma delta T-lymphocytes", "count": 2}, {"letter": "Use of Stimulant Medication Not as Prescribed or Without a Prescription", "count": 1}, {"letter": "Very Much Better", "count": 4}, {"letter": "Very Much Worse", "count": 3}, {"letter": "Was It Worth It Questionnaire", "count": 2}, {"letter": "Whole Transcriptome Sequencing", "count": 8}, {"letter": "ASTX-660", "count": 6}, {"letter": "ANF-Rho", "count": 10}, {"letter": "Nitroglycerin/Sodium Citrate/Ethanol Solution", "count": 1}, {"letter": "Pegfilgrastim Biosimilar HSP-130", "count": 5}, {"letter": "Immune-mediated adverse reaction", "count": 10}, {"letter": "Ucla", "count": 3}, {"letter": "React", "count": 1}, {"letter": "Sensitive skin", "count": 1}, {"letter": "Electrocardiogram abnormalities", "count": 2}, {"letter": "Patchy desquamation", "count": 5}, {"letter": "Alcohol use disorder, moderate", "count": 4}, {"letter": "Alcohol use disorder, severe", "count": 4}, {"letter": "Surgical term", "count": 1}, {"letter": "Muscle body", "count": 1}, {"letter": "Region of arm", "count": 10}, {"letter": "SPS", "count": 3}, {"letter": "Structural variant HGVS name", "count": 2}, {"letter": "Hiking", "count": 1}, {"letter": "Probable associated phenotype:Finding:Point in time:^Patient:Nominal", "count": 2}, {"letter": "Date and time of surgery:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative", "count": 3}, {"letter": "Medication administration flowsheet:Finding:Point in time:{Setting}:Document:{Role}", "count": 4}, {"letter": "Postoperative photo", "count": 1}, {"letter": "Ultrasound attenuation", "count": 1}, {"letter": "Output assessment", "count": 3}, {"letter": "Recommended cancer surveillance", "count": 1}, {"letter": "Structural variant", "count": 1}, {"letter": "Multisection for metastasis", "count": 5}, {"letter": "Symptoms & diseases", "count": 3}, {"letter": "Physical activity questionnaire", "count": 13}, {"letter": "Activity Trackers", "count": 10}, {"letter": "Owen", "count": 1}, {"letter": "Mixed Carcinoma", "count": 1}, {"letter": "Middle 1/3", "count": 1}, {"letter": "4 times", "count": 2}, {"letter": "Type C", "count": 1}, {"letter": "Type A", "count": 19}, {"letter": "Normal metabolizer", "count": 1}, {"letter": "Variant Likely Benign", "count": 1}, {"letter": "Likely Pathogenic Variant", "count": 4}, {"letter": "IV number:ID:Pt:^Patient:Nom", "count": 108}, {"letter": "Diet:Type:Pt:^Patient:Nom", "count": 1}, {"letter": "Multisection^W radionuclide IV:Find:Pt:XXX>Lymph node:Doc:NM.SPECT+CT", "count": 1}, {"letter": "Everolimus:Mass:Pt:Dose:Qn", "count": 5}, {"letter": "CD8 ratio", "count": 8}, {"letter": "Tissue sampling", "count": 1}, {"letter": "Gated", "count": 5}, {"letter": "Multiple areas", "count": 1}, {"letter": "Blood pool", "count": 5}, {"letter": "Reference source", "count": 2}, {"letter": "Head>Face", "count": 1}, {"letter": "Chest>Chest wall", "count": 2}, {"letter": "repeat analysis", "count": 3}, {"letter": "100 CD3+CD4+ cells", "count": 1}, {"letter": "Vigorous physical activity", "count": 24}, {"letter": "Total physical activity", "count": 9}, {"letter": "NETSPOT", "count": 2}, {"letter": "PECS II block", "count": 1}, {"letter": "Beck Depression Inventory II score", "count": 1}, {"letter": "Cardiovascular care", "count": 2}, {"letter": "Outcome Rating Scale", "count": 1}, {"letter": "Symbol Digit Modalities Test score", "count": 1}, {"letter": "Pain Catastrophizing Scale", "count": 11}, {"letter": "Cerebral oxygen saturation", "count": 1}, {"letter": "Frenchay Activities Index score", "count": 3}, {"letter": "Cancer-related fatigue", "count": 54}, {"letter": "Baseline diastolic blood pressure", "count": 2}, {"letter": "Pain Catastrophizing Scale score", "count": 1}, {"letter": "Verbal Rating Scale score", "count": 1}, {"letter": "Beck Anxiety Inventory score", "count": 2}, {"letter": "Task adaptation", "count": 1}, {"letter": "Breast Cancer Lymphedema", "count": 11}, {"letter": "Preventive Care", "count": 3}, {"letter": "Myeloid-Derived Suppressor Cells", "count": 20}, {"letter": "Tertiary Lymphoid Structures", "count": 1}, {"letter": "Patient Portals", "count": 1}, {"letter": "Oxysterols", "count": 9}, {"letter": "Maximal Respiratory Pressures", "count": 1}, {"letter": "Immunogenicity, Vaccine", "count": 2}, {"letter": "Pharmacogenomic Variants", "count": 1}, {"letter": "Healthy Lifestyle", "count": 4}, {"letter": "Attentional Bias", "count": 2}, {"letter": "Sleep Hygiene", "count": 1}, {"letter": "Ecological Momentary Assessment", "count": 7}, {"letter": "Mycobiome", "count": 4}, {"letter": "Parenchymal Tissue", "count": 1}, {"letter": "In Vivo Dosimetry", "count": 2}, {"letter": "Minimal Clinically Important Difference", "count": 4}, {"letter": "Patient Reported Outcome Measures", "count": 32}, {"letter": "Walk Test", "count": 14}, {"letter": "Patient Comfort", "count": 5}, {"letter": "Exercise Training", "count": 5}, {"letter": "Acute Exercise", "count": 3}, {"letter": "Health-Related Quality Of Life", "count": 259}, {"letter": "Personal Fitness Trackers", "count": 1}, {"letter": "Healthy Eating Index", "count": 1}, {"letter": "Incremental Shuttle Walk Test", "count": 1}, {"letter": "Progressive brain disease", "count": 2}, {"letter": "Much", "count": 19}, {"letter": "GC, vitamin D binding protein, human", "count": 5}, {"letter": "Tumor Necrosis Factor Receptor Superfamily Member 8, human", "count": 1}, {"letter": "T-Cell-Specific Surface Glycoprotein CD28, human", "count": 6}, {"letter": "Follow", "count": 261}, {"letter": "PEG", "count": 11}, {"letter": "Toll-Like Receptor 1, human", "count": 18}, {"letter": "Bcl-2-Like Protein 11, human", "count": 2}, {"letter": "[AA000] INTRODUCTION", "count": 5}, {"letter": "Grn163l", "count": 3}, {"letter": "Taladegib", "count": 2}, {"letter": "PCSK1 wt Allele", "count": 4}, {"letter": "Ceramide Glucosyltransferase, human", "count": 3}, {"letter": "CD46 wt Allele", "count": 3}, {"letter": "International Scale for BCR-ABL1 Measurement", "count": 2}, {"letter": "Androgen Receptor Splice Variant 3, Human", "count": 1}, {"letter": "degarelix single use injection", "count": 1}, {"letter": "Adverse Childhood Experience Survey", "count": 1}, {"letter": "Zero Activity Time", "count": 146}, {"letter": "Cobalt Gray Equivalent", "count": 1}, {"letter": "Big Five Inventory", "count": 2}, {"letter": "Modifiers", "count": 3}, {"letter": "C-C Chemokine Receptor Type 4, human", "count": 1}, {"letter": "PD-L1 Positive", "count": 9}, {"letter": "Drug Enforcement Administration", "count": 1}, {"letter": "Mood Disorder Questionnaire", "count": 1}, {"letter": "Twenty Two", "count": 1}, {"letter": "Picture Sequence Memory Test", "count": 2}, {"letter": "Occurrence Indicator", "count": 2}, {"letter": "Patient reported outcome response", "count": 1}, {"letter": "Patient reported outcome response:Find:Pt:^Patient:Nom", "count": 1}, {"letter": "General Self-Efficacy Scale", "count": 5}, {"letter": "Fibrosis Assessment", "count": 1}, {"letter": "Self-care activities panel:-:Pt:^Patient:-", "count": 1}, {"letter": "Reason for dose change", "count": 1}, {"letter": "Cytokines panel:-:Pt:Ser/Plas:-", "count": 3}, {"letter": "Actigraph record", "count": 8}, {"letter": "Kinesiophobia", "count": 9}, {"letter": "Serous Tubal Intraepithelial Carcinoma", "count": 1}, {"letter": "PET Response Criteria in Solid Tumors", "count": 18}, {"letter": "CFI-402257", "count": 6}, {"letter": "CDK4/6 Inhibitor SHR6390", "count": 20}, {"letter": "MetAP2 Inhibitor SDX-7320", "count": 1}, {"letter": "MK-8628", "count": 7}, {"letter": "MEDI4276", "count": 4}, {"letter": "LSZ102", "count": 5}, {"letter": "INCB057643", "count": 9}, {"letter": "GS 5829", "count": 3}, {"letter": "EDO-S101", "count": 6}, {"letter": "DS-8201a", "count": 8}, {"letter": "prexasertib", "count": 7}, {"letter": "Metastatic Malignant Solid Neoplasm", "count": 6}, {"letter": "Liver Partial Response GvHD", "count": 1}, {"letter": "DLST wt Allele", "count": 82}, {"letter": "HLA Mismatch", "count": 1}, {"letter": "Wolchok Solid Tumors 2009 Oncology Response Criteria", "count": 25}, {"letter": "Unexplained", "count": 1}, {"letter": "Train Staff about Medication Use Process", "count": 1}, {"letter": "Total Number", "count": 166}, {"letter": "Staining Intensity", "count": 11}, {"letter": "Sorted Cells", "count": 2}, {"letter": "Smoked Cigarettes During the Course of Treatment", "count": 1}, {"letter": "Severity Score 4", "count": 1}, {"letter": "Severity Score 0", "count": 4}, {"letter": "Resting State Functional Connectivity Magnetic Resonance Imaging", "count": 1}, {"letter": "Recurrent Malignant Solid Neoplasm", "count": 1}, {"letter": "REMS Stakeholder", "count": 2}, {"letter": "Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20", "count": 12}, {"letter": "Quality of Life Linear Analogue Scale", "count": 1}, {"letter": "PubMed Identifier for Citation Used in Study", "count": 1}, {"letter": "Polysomy 7", "count": 2}, {"letter": "Pharmacotherapy Initiation", "count": 1}, {"letter": "Pharmacotherapy Discontinuation", "count": 3}, {"letter": "Past 2 Weeks", "count": 8}, {"letter": "PCWG Scher Prostate Cancer 2008 Oncology Response Criteria", "count": 6}, {"letter": "PAXgene Blood Tissue System", "count": 1}, {"letter": "One Activity Hour", "count": 11}, {"letter": "Notable", "count": 54}, {"letter": "Non-Pathological", "count": 9}, {"letter": "NCAM1 Positive", "count": 13}, {"letter": "Modified RECIST Byrne Mesothelioma 2004 Oncology Response Criteria", "count": 19}, {"letter": "mirvetuximab soravtansine", "count": 4}, {"letter": "Metastatic urothelial carcinoma", "count": 4}, {"letter": "Lugano Classification Oncology Response Criteria", "count": 3}, {"letter": "Local Pathology Review", "count": 3}, {"letter": "Liver Progression GvHD", "count": 2}, {"letter": "In-House", "count": 5}, {"letter": "IGF1R Positive", "count": 2}, {"letter": "Human Papillomavirus Positive", "count": 1}, {"letter": "Gallium Ga 68-NOTA-BBN(7-14)-RGD", "count": 1}, {"letter": "Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire", "count": 2}, {"letter": "fluzoparib", "count": 1}, {"letter": "Female Sexual Function Index", "count": 33}, {"letter": "Feel Low in Energy", "count": 1}, {"letter": "Eleven or More Activity Hours", "count": 1}, {"letter": "Effector Memory T Cells", "count": 1}, {"letter": "Decipher Prostate Cancer Test", "count": 1}, {"letter": "DNA Repair Capacity", "count": 1}, {"letter": "Copies per Microgram", "count": 2}, {"letter": "Complete Patient Questionnaire", "count": 3}, {"letter": "Colonization", "count": 4}, {"letter": "Cell-Free DNA", "count": 22}, {"letter": "Chimeric Antigen Receptor T-Cell Therapy", "count": 5}, {"letter": "Central Memory T-Lymphocyte", "count": 2}, {"letter": "Center for Epidemiologic Studies Depression Scale Revised", "count": 1}, {"letter": "CD19 Positive", "count": 8}, {"letter": "Aqua", "count": 2}, {"letter": "classifier", "count": 4}, {"letter": "Response to neoadjuvant therapy", "count": 2}, {"letter": "Pattern Comparison Processing Speed Test", "count": 1}, {"letter": "Oral Reading Recognition Test", "count": 1}, {"letter": "List Sorting Working Memory Test", "count": 2}, {"letter": "Dimensional Change Card Sort Test", "count": 1}, {"letter": "Adverse Childhood Experiences", "count": 1}, {"letter": "Non-focal", "count": 1}, {"letter": "Normal function", "count": 29}, {"letter": "Increase dose", "count": 14}, {"letter": "Decrease dose", "count": 10}, {"letter": "Curated", "count": 1}, {"letter": "Highest level of education:History:Point in time:^Patient:Ordinal", "count": 1}, {"letter": "Harris", "count": 9}, {"letter": "Portable", "count": 9}, {"letter": "3 years", "count": 30}, {"letter": "2 years", "count": 23}, {"letter": "Upper extremity>Shoulder", "count": 1}, {"letter": "Tumor board", "count": 1}, {"letter": "Radiology Nurse", "count": 1}, {"letter": "QIDS", "count": 1}, {"letter": "PSS-10", "count": 10}, {"letter": "Palliative care Team", "count": 1}, {"letter": "HRQOL method", "count": 53}, {"letter": "FEAS", "count": 1}, {"letter": "Programmed cell death ligand 1", "count": 4}, {"letter": "Doses of vaccine", "count": 6}, {"letter": "fully adjusted", "count": 3}, {"letter": "age adjusted", "count": 9}, {"letter": "Non-invasive blood pressure", "count": 3}, {"letter": "Average blood pressure", "count": 2}, {"letter": "Bleeding requiring transfusion", "count": 1}, {"letter": "Treatment for osteoporosis", "count": 1}, {"letter": "PSS (Perceived Stress Scale) score", "count": 4}, {"letter": "SCORE Index of Family Function and Change 15", "count": 19}, {"letter": "Telehealth monitoring", "count": 1}, {"letter": "Moderately severe depression", "count": 1}, {"letter": "Decline in functional status", "count": 1}, {"letter": "Fever due to infection", "count": 1}, {"letter": "WHODAS (World Health Organization Disability Assessment Schedule) 2.0", "count": 1}, {"letter": "McGill Pain Questionnaire score", "count": 1}, {"letter": "Minimal depression", "count": 4}, {"letter": "INCB7839", "count": 1}, {"letter": "thrombospondin-1, human", "count": 1}, {"letter": "RB1 protein, human", "count": 8}, {"letter": "GSK3B protein, human", "count": 1}, {"letter": "Ocoxin", "count": 2}, {"letter": "sitravatinib", "count": 1}, {"letter": "NKTR-214", "count": 3}, {"letter": "SYN-004", "count": 9}, {"letter": "lumretuzumab", "count": 15}, {"letter": "Hippocampal atrophy", "count": 1}, {"letter": "Her-2/neu positive", "count": 1}, {"letter": "Discussed with physician", "count": 1}, {"letter": "Surveillance for cancer", "count": 5}, {"letter": "Cell positive for CD8 antigen", "count": 1}, {"letter": "Endothelin-2, human", "count": 1}, {"letter": "Joy", "count": 3}, {"letter": "Reactive Lymphocyte", "count": 1}, {"letter": "Metabolic Equivalent of Task Unit", "count": 1}, {"letter": "immunohistochemical stains", "count": 1}, {"letter": "Bet inhibitor gsk525762", "count": 3}, {"letter": "Sum of Products of Perpendicular Diameters", "count": 12}, {"letter": "GvHD Lung Symptom Score 3", "count": 50}, {"letter": "ciliary vesicle", "count": 8}, {"letter": "ACS - Activity Card Sort", "count": 3}, {"letter": "tangential", "count": 1}, {"letter": "Sleep medicine", "count": 1}, {"letter": "trastuzumab single use injection", "count": 1}, {"letter": "Superior margin", "count": 1}, {"letter": "10000", "count": 1}, {"letter": "200", "count": 21}, {"letter": "Forty-two", "count": 1}, {"letter": "27", "count": 66}, {"letter": "300", "count": 24}, {"letter": "35", "count": 57}, {"letter": "36", "count": 146}, {"letter": "360", "count": 4}, {"letter": "48", "count": 35}, {"letter": "480", "count": 1}, {"letter": "5000", "count": 5}, {"letter": "63", "count": 29}, {"letter": "75", "count": 58}, {"letter": "76", "count": 19}, {"letter": "84", "count": 21}, {"letter": "96", "count": 42}, {"letter": "98", "count": 10}, {"letter": "72", "count": 23}, {"letter": "16.1", "count": 3}, {"letter": "Molecular breast imaging", "count": 17}, {"letter": "BSA Involvement Score 1", "count": 93}, {"letter": "Treatment Compliance", "count": 3}, {"letter": "Change -- procedure", "count": 12}, {"letter": "Receptor Tyrosine-Protein Kinase erbB-2 Carboxyl Terminal Fragment, human", "count": 7}, {"letter": "High Level", "count": 173}, {"letter": "Decision Regret Scale", "count": 7}, {"letter": "CDKN2A Negative", "count": 1}, {"letter": "CGA wt Allele", "count": 3}, {"letter": "Care team:Type:Pt:^Patient:Nom", "count": 11}, {"letter": "Moderate Level", "count": 1}, {"letter": "Skin Features Score 0", "count": 370}, {"letter": "Low Level", "count": 4}, {"letter": "GvHD Lung Symptom Score 2", "count": 46}, {"letter": "Relational and Item-Specific Encoding Task", "count": 14}, {"letter": "Examination", "count": 82}, {"letter": "Guideline Concordant Care", "count": 3}, {"letter": "Revised Dyadic Adjustment Scale", "count": 1}, {"letter": "Health Assessment Questionnaire Disability Index", "count": 3}, {"letter": "Distress Score Visual Analogue Scale", "count": 38}, {"letter": "T-Cell Receptor Profile", "count": 2}, {"letter": "Date of last evaluation:Date:Pt:^Patient:Qn", "count": 12}, {"letter": "CD56+ NK lymphocyte", "count": 1}, {"letter": "Fold of mucosa", "count": 1}, {"letter": "Cardiovascular Risk", "count": 3}, {"letter": "Cardiomyopathy secondary to doxorubicin administration", "count": 1}, {"letter": "AJCC v8 Stage", "count": 10}, {"letter": "Ability to Use Stairs", "count": 5}, {"letter": "Advanced Malignant Solid Neoplasm", "count": 48}, {"letter": "Bladder Cancer Muscle-Invasive 30 Questionnaire", "count": 4}, {"letter": "Bone Response", "count": 2}, {"letter": "Bothered by Anxiety", "count": 1}, {"letter": "CTAG1 Antibody", "count": 5}, {"letter": "Checkpoint Blockade Immunotherapy", "count": 1}, {"letter": "Chemotherapy-induced Nausea and Vomiting Questionnaire", "count": 4}, {"letter": "Cytokine Expression Profile", "count": 3}, {"letter": "Deleterious Germline Mutation", "count": 1}, {"letter": "Distress Score 6", "count": 1}, {"letter": "ERBB2 Antibody", "count": 7}, {"letter": "Epigenetic Profile", "count": 1}, {"letter": "Extremely Poor", "count": 1}, {"letter": "Fluorescent Dye LS301", "count": 4}, {"letter": "Global DNA Methylation Profile", "count": 3}, {"letter": "Global Satisfaction with Sex Life Subordinate Domain", "count": 1}, {"letter": "Glucocorticoid Sensitivity", "count": 1}, {"letter": "Household Member", "count": 1}, {"letter": "Human Anti-Chimeric Antibody", "count": 1}, {"letter": "Hypothyroxinemia", "count": 1}, {"letter": "Immune Cell", "count": 57}, {"letter": "Immune-mediated", "count": 1}, {"letter": "Instrumental Activities Domain", "count": 15}, {"letter": "Low Confidence", "count": 1}, {"letter": "MUC1 Antibody", "count": 1}, {"letter": "MicroRNA Expression Profile", "count": 6}, {"letter": "More Often than Once a Day", "count": 1}, {"letter": "Myelosuppressive Chemotherapy", "count": 3}, {"letter": "New Bone Lesion Lesion Identification", "count": 3}, {"letter": "Non-Target Nodal Lesion Identification", "count": 25}, {"letter": "Number of Events", "count": 98}, {"letter": "PCWG Scher Prostate Cancer 2016 Oncology Response Criteria", "count": 20}, {"letter": "PROMIS Sexual Function and Satisfaction Measures", "count": 2}, {"letter": "PROMIS-29 Adult Profile v1.0", "count": 3}, {"letter": "Partial Resection", "count": 2}, {"letter": "Per Millimeter", "count": 331}, {"letter": "Physical Fatigue Dimension", "count": 11}, {"letter": "Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire", "count": 1}, {"letter": "RAS Wild Type", "count": 1}, {"letter": "RB1 Negative", "count": 1}, {"letter": "Rater", "count": 6}, {"letter": "Red Cell Fatty Acid Profile", "count": 1}, {"letter": "Reduced Activity Dimension", "count": 3}, {"letter": "Restaging", "count": 6}, {"letter": "Rotterdam Symptom Checklist", "count": 8}, {"letter": "seviteronel", "count": 8}, {"letter": "Single Nucleotide Polymorphism Profile", "count": 3}, {"letter": "Soft Tissue Response", "count": 1}, {"letter": "Soluble Intercellular Adhesion Molecule 1 Measurement", "count": 1}, {"letter": "Somatostatin Receptor 2 Positive", "count": 1}, {"letter": "Telomere Length", "count": 4}, {"letter": "Telomeric Allelic Imbalance Region", "count": 1}, {"letter": "Th1 Cell/Th2 Cell Ratio Measurement", "count": 1}, {"letter": "Total RNA Expression Profile", "count": 1}, {"letter": "Tumor Marker Response", "count": 1}, {"letter": "Tumor RNA", "count": 1}, {"letter": "utomilumab", "count": 3}, {"letter": "Very High Confidence", "count": 1}, {"letter": "Worst Observed Case Imputation Technique", "count": 9}, {"letter": "mRNA Sequencing", "count": 5}, {"letter": "a.m.", "count": 3}, {"letter": "Past 30 days", "count": 31}, {"letter": "SFX-01", "count": 1}, {"letter": "Anti-HER2/HER2 Bispecific Antibody ZW25", "count": 3}, {"letter": "Apoptotic Index", "count": 5}, {"letter": "Eucalyptus intertexta", "count": 1}, {"letter": "Dermatomal", "count": 3}, {"letter": "LETROZOLE/RIBOCICLIB", "count": 1}, {"letter": "Metaphase II oocytes", "count": 1}, {"letter": "Increased apoptosis", "count": 3}, {"letter": "Cancer specimen", "count": 1}, {"letter": "Breast cancer specimen", "count": 3}, {"letter": "Moderate physical activity", "count": 19}, {"letter": "Emotional score", "count": 7}, {"letter": "Physical score", "count": 19}, {"letter": "week 1", "count": 69}, {"letter": "week 2", "count": 86}, {"letter": "International Physical Activity Questionnaire", "count": 40}, {"letter": "Inferior margin", "count": 5}, {"letter": "Readmission", "count": 3}, {"letter": "Intermediate care", "count": 1}, {"letter": "Family/Relatives", "count": 1}, {"letter": "Extremely bothersome", "count": 1}, {"letter": "Not at all bothersome", "count": 1}, {"letter": "tomosynthesis", "count": 21}, {"letter": "Clip placement", "count": 1}, {"letter": "Integrative Oncology", "count": 1}, {"letter": "Rey Auditory Verbal Learning Test", "count": 2}, {"letter": "Non-communicable Chronic Diseases", "count": 1}, {"letter": "Psycho-Oncology", "count": 2}, {"letter": "Cell-Free Nucleic Acids", "count": 1}, {"letter": "Liquid Biopsy", "count": 17}, {"letter": "Prescription Drug Monitoring Programs", "count": 1}, {"letter": "Immune Reconstitution", "count": 3}, {"letter": "Preliminary Data", "count": 22}, {"letter": "Sleep Onset Latency", "count": 21}, {"letter": "Mass Drug Administration", "count": 1}, {"letter": "Treatment Adherence", "count": 13}, {"letter": "One Health", "count": 6}, {"letter": "Employee Participation", "count": 1}, {"letter": "Proof of Concept Study", "count": 3}, {"letter": "Clinical Deterioration", "count": 10}, {"letter": "Wearable Electronic Devices", "count": 8}, {"letter": "Maytansinoid DM4", "count": 10}, {"letter": "Cambridge Neuropsychological Test Automated Battery", "count": 3}, {"letter": "Delis-Kaplan Executive Function System", "count": 1}, {"letter": "Psychologic Processes", "count": 2}, {"letter": "Smoking Habit", "count": 2}, {"letter": "Wechsler Test of Adult Reading", "count": 1}, {"letter": "Clinical Laboratory Tests", "count": 18}, {"letter": "Online Learning", "count": 1}, {"letter": "LJM-716", "count": 2}, {"letter": "GOT1 protein, human", "count": 4}, {"letter": "HMGCS1 protein, human", "count": 1}, {"letter": "carboxymethyllysine", "count": 1}, {"letter": "Other heart failure", "count": 1}, {"letter": "Neutrophil recovery", "count": 1}, {"letter": "Bisphosphonate therapy", "count": 1}, {"letter": "Tamoxifen therapy", "count": 5}, {"letter": "After fasting", "count": 4}, {"letter": "Contrast enhanced spectral mammography", "count": 2}, {"letter": "0.01", "count": 3}, {"letter": "0.0125", "count": 4}, {"letter": "0.02", "count": 1}, {"letter": "0.03", "count": 3}, {"letter": "0.04", "count": 4}, {"letter": "0.05", "count": 56}, {"letter": "0.066", "count": 1}, {"letter": "0.083", "count": 1}, {"letter": "0.1", "count": 95}, {"letter": "0.106", "count": 1}, {"letter": "0.108", "count": 15}, {"letter": "0.11", "count": 2}, {"letter": "0.12", "count": 22}, {"letter": "0.13", "count": 9}, {"letter": "0.14", "count": 2}, {"letter": "0.16", "count": 5}, {"letter": "0.17", "count": 1}, {"letter": "0.18", "count": 2}, {"letter": "0.2", "count": 60}, {"letter": "0.21", "count": 55}, {"letter": "0.24", "count": 46}, {"letter": "0.25", "count": 8}, {"letter": "0.28", "count": 21}, {"letter": "0.29", "count": 2}, {"letter": "0.32", "count": 1}, {"letter": "0.33", "count": 2}, {"letter": "0.35", "count": 2}, {"letter": "0.36", "count": 7}, {"letter": "0.38", "count": 2}, {"letter": "0.4", "count": 197}, {"letter": "0.42", "count": 5}, {"letter": "0.44", "count": 3}, {"letter": "0.48", "count": 3}, {"letter": "0.59", "count": 4}, {"letter": "0.625", "count": 1}, {"letter": "0.63", "count": 7}, {"letter": "0.64", "count": 3}, {"letter": "0.65", "count": 1}, {"letter": "0.67", "count": 3}, {"letter": "0.68", "count": 3}, {"letter": "0.7", "count": 29}, {"letter": "0.72", "count": 4}, {"letter": "0.74", "count": 3}, {"letter": "0.77", "count": 1}, {"letter": "0.78", "count": 2}, {"letter": "0.8", "count": 34}, {"letter": "0.82", "count": 2}, {"letter": "0.85", "count": 2}, {"letter": "0.88", "count": 4}, {"letter": "0.92", "count": 9}, {"letter": "0.93", "count": 2}, {"letter": "0.94", "count": 3}, {"letter": "0.99", "count": 3}, {"letter": "1.15", "count": 1}, {"letter": "10.16", "count": 2}, {"letter": "10.3", "count": 2}, {"letter": "10.42", "count": 1}, {"letter": "10.5", "count": 6}, {"letter": "10.8", "count": 12}, {"letter": "12.5", "count": 5}, {"letter": "12.6", "count": 2}, {"letter": "12.8", "count": 1}, {"letter": "13.4", "count": 1}, {"letter": "1440", "count": 1}, {"letter": "15.4", "count": 4}, {"letter": "1500", "count": 6}, {"letter": "2.2", "count": 2}, {"letter": "2.4", "count": 1}, {"letter": "2.6", "count": 8}, {"letter": "2.7", "count": 12}, {"letter": "2.72", "count": 1}, {"letter": "2.9", "count": 3}, {"letter": "22.5", "count": 6}, {"letter": "22500", "count": 2}, {"letter": "2400", "count": 4}, {"letter": "25.5", "count": 7}, {"letter": "3.1", "count": 14}, {"letter": "3.15", "count": 6}, {"letter": "312", "count": 2}, {"letter": "322 (qualifier value)", "count": 9}, {"letter": "324 (qualifier value)", "count": 1}, {"letter": "350", "count": 1}, {"letter": "385", "count": 1}, {"letter": "4.2", "count": 2}, {"letter": "4.4", "count": 5}, {"letter": "4.8", "count": 5}, {"letter": "405", "count": 1}, {"letter": "408", "count": 1}, {"letter": "4500", "count": 2}, {"letter": "5.2", "count": 2}, {"letter": "5.4", "count": 1}, {"letter": "5.6", "count": 1}, {"letter": "5.8", "count": 1}, {"letter": "520", "count": 3}, {"letter": "Numeral 54", "count": 9}, {"letter": "545", "count": 4}, {"letter": "57", "count": 6}, {"letter": "6.6", "count": 1}, {"letter": "6.9", "count": 1}, {"letter": "61", "count": 4}, {"letter": "62", "count": 6}, {"letter": "625", "count": 1}, {"letter": "64", "count": 7}, {"letter": "67", "count": 1}, {"letter": "7.2", "count": 1}, {"letter": "7.4", "count": 1}, {"letter": "7.5", "count": 2}, {"letter": "7.7", "count": 1}, {"letter": "700", "count": 4}, {"letter": "720", "count": 4}, {"letter": "74 (qualifier value)", "count": 3}, {"letter": "750", "count": 1}, {"letter": "770", "count": 4}, {"letter": "8.1", "count": 9}, {"letter": "8.4", "count": 6}, {"letter": "8.5", "count": 9}, {"letter": "8.6", "count": 5}, {"letter": "81", "count": 10}, {"letter": "83", "count": 5}, {"letter": "85", "count": 29}, {"letter": "87", "count": 4}, {"letter": "88", "count": 10}, {"letter": "9.5", "count": 5}, {"letter": "900", "count": 2}, {"letter": "95", "count": 462}, {"letter": "960", "count": 1}, {"letter": "Electronic report", "count": 1}, {"letter": "tucatinib", "count": 14}, {"letter": "azeliragon", "count": 1}, {"letter": "rebastinib", "count": 12}, {"letter": "enfortumab vedotin", "count": 1}, {"letter": "olaparib Oral Tablet", "count": 2}, {"letter": "Insomnia severity index", "count": 29}, {"letter": "Implemented", "count": 4}, {"letter": "Stage 0 Breast Cancer AJCC v6 and v7", "count": 9}, {"letter": "Stage 0 Colon Cancer AJCC v6 and v7", "count": 2}, {"letter": "Skin Tissue, Human", "count": 2}, {"letter": "VACUOLAR-TYPE PROTON-TRANSLOCATING ATPase SUBUNIT E1", "count": 4}, {"letter": "FAC Regimen", "count": 1}, {"letter": "Dose Expansion Cohort", "count": 28}, {"letter": "Myosin-Binding Protein C, Cardiac-Type, human", "count": 4}, {"letter": "European Pharmacopeia", "count": 2}, {"letter": "Platelet Endothelial Cell Adhesion Molecule 1 Measurement", "count": 8}, {"letter": "United States Military enlisted E4 (qualifier value)", "count": 5}, {"letter": "United States Military Commissioned Officer O3 (qualifier value)", "count": 11}, {"letter": "FDG-Positron Emission Tomography and Computed Tomography Scan", "count": 28}, {"letter": "Docetaxel/Trastuzumab Regimen", "count": 1}, {"letter": "US Military enlisted E5", "count": 1}, {"letter": "US Military enlisted E7", "count": 2}, {"letter": "United States Military enlisted E3 (qualifier value)", "count": 6}, {"letter": "Cyclooxygenase-2 inhibitor (disposition)", "count": 1}, {"letter": "United States Military Commissioned Officer O8 (qualifier value)", "count": 1}, {"letter": "US Military Commissioned Officer O1", "count": 2}, {"letter": "US Military enlisted E9", "count": 2}, {"letter": "US Military Commissioned Officer O5", "count": 1}, {"letter": "Better than Others", "count": 155}, {"letter": "Group B", "count": 5}, {"letter": "TC Regimen", "count": 6}, {"letter": "Group A (blood group)", "count": 9}, {"letter": "Reproductive Human Cells, Tissues, and Cellular and Tissue-Based Products from Known Donor to Directed Recipient", "count": 21}, {"letter": "Other Blood Form Product", "count": 2}, {"letter": "Response to cancer treatment:Find:Pt:^Patient:Nom", "count": 3}, {"letter": "Paclitaxel/Trastuzumab Regimen", "count": 1}, {"letter": "Carboplatin/Gemcitabine Regimen", "count": 3}, {"letter": "Product of Perpendicular Diameters", "count": 5}, {"letter": "AC Followed by Docetaxel Regimen", "count": 1}, {"letter": "Foundation Medicine Inc", "count": 1}, {"letter": "G-8 Screening Tool", "count": 3}, {"letter": "PAM (measure)", "count": 15}, {"letter": "larotrectinib", "count": 4}, {"letter": "trilaciclib", "count": 11}, {"letter": "Fluorine F 18 alphaVbeta6-Binding Peptide", "count": 2}, {"letter": "Dedicated Blood Product Donation", "count": 8}, {"letter": "Whole Blood or Product Procurement", "count": 32}, {"letter": "Line of Therapy", "count": 48}, {"letter": "Missing Information", "count": 2}, {"letter": "Homologous Recombination Repair Gene Mutation", "count": 1}, {"letter": "Clavien-Dindo Classification", "count": 9}, {"letter": "Polyclonality", "count": 2}, {"letter": "Analytical Procedure Linearity", "count": 3}, {"letter": "Analytical Procedure Robustness", "count": 3}, {"letter": "EGFR Positive", "count": 1}, {"letter": "CX-2009", "count": 2}, {"letter": "LOXO-292", "count": 8}, {"letter": "Tumor Tissue Origin", "count": 3}, {"letter": "DNA Fragmentation Index", "count": 1}, {"letter": "Disease Response in Liver", "count": 1}, {"letter": "Communication with Doctor", "count": 1}, {"letter": "Autologous Tumor Infiltrating Lymphocytes LN-145", "count": 7}, {"letter": "Mammoplasty Patient", "count": 3}, {"letter": "Clinical Global Impression Generic Modification Version Questionnaire", "count": 1}, {"letter": "The PTSD Checklist for DSM-5 Questionnaire", "count": 1}, {"letter": "Last 2 Days", "count": 2}, {"letter": "How Sad", "count": 1}, {"letter": "Neck Pain Score 8", "count": 3}, {"letter": "Immune-Modified Response Evaluation Criteria in Solid Tumors", "count": 64}, {"letter": "Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310", "count": 1}, {"letter": "U3-1402", "count": 4}, {"letter": "Infiltrative Tumor Margin", "count": 1}, {"letter": "Electronic Patient-reported Outcome System", "count": 7}, {"letter": "Biopsy Specimen Radiography", "count": 3}, {"letter": "Core Biopsy with Placement of Image-Detectable Marker", "count": 1}, {"letter": "Ultrasound-Guided Core Biopsy", "count": 1}, {"letter": "Quality of Life in Neurological Disorders", "count": 5}, {"letter": "Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100", "count": 2}, {"letter": "Interruption of Chemotherapy", "count": 1}, {"letter": "Patient Decision", "count": 16}, {"letter": "ADC ABBV-176", "count": 12}, {"letter": "Gleason Grade Group 5", "count": 9}, {"letter": "Chimeric Antigen Receptor T-cells", "count": 10}, {"letter": "Dose-dense AC Regimen", "count": 2}, {"letter": "Capecitabine/Lapatinib Regimen", "count": 9}, {"letter": "Pertuzumab/Trastuzumab Regimen", "count": 6}, {"letter": "Candidate", "count": 26}, {"letter": "Total Urinary Control", "count": 4}, {"letter": "Magnetic Resonance Whole Body Diffusion-Weighted Imaging", "count": 2}, {"letter": "TRK Receptor Family Fusion Positive", "count": 1}, {"letter": "G1t38 free base", "count": 4}, {"letter": "Visceral Crisis", "count": 1}, {"letter": "Assistance Reading Questions", "count": 1}, {"letter": "Had Neuropsychological Problems", "count": 1}, {"letter": "IGF1 Positive", "count": 1}, {"letter": "Isometric Muscle Strength", "count": 3}, {"letter": "New Non-Target Lesion Identification", "count": 6}, {"letter": "New Target Lesion Identification", "count": 8}, {"letter": "Decreased Cellularity Present", "count": 1}, {"letter": "Date of First Enrollment into Study", "count": 31}, {"letter": "Target Sample Size", "count": 2}, {"letter": "Secondary Endpoint", "count": 68}, {"letter": "Device Feasibility Study", "count": 1}, {"letter": "Extrapolation Imputation Technique", "count": 7}, {"letter": "Fluorescent Tag Type", "count": 5}, {"letter": "IPSS Risk Category Intermediate-1", "count": 1}, {"letter": "Genomic Data Commons", "count": 3}, {"letter": "Analytical Procedure Quantitation Limit", "count": 3}, {"letter": "Increased Bone Tissue", "count": 1}, {"letter": "Anti-CD40 Agonist Monoclonal Antibody ABBV-927", "count": 2}, {"letter": "Benefits of Exercise", "count": 2}, {"letter": "Heart Health Tests", "count": 3}, {"letter": "Negative affectivity", "count": 1}, {"letter": "Patient Activation Measure - 13", "count": 2}, {"letter": "Multisection for left ventricular function", "count": 1}, {"letter": "Sedentary activity", "count": 1}, {"letter": "Settings (qualitative concept)", "count": 14}, {"letter": "Bone.total", "count": 2}, {"letter": "Supplemental oxygen", "count": 1}, {"letter": "Deep surgical site infection", "count": 4}, {"letter": "At home", "count": 16}, {"letter": "Undecided", "count": 2}, {"letter": "Nutrition/diet", "count": 1}, {"letter": "Psychosocial well-being", "count": 12}, {"letter": "Mood state", "count": 7}, {"letter": "Often True", "count": 1}, {"letter": "Never True", "count": 3}, {"letter": "Intra duct", "count": 1}, {"letter": "Air gap", "count": 1}, {"letter": "1 level", "count": 2}, {"letter": "Initial day", "count": 1}, {"letter": "Final day", "count": 8}, {"letter": "Financial concerns", "count": 3}, {"letter": "Additional day", "count": 2}, {"letter": "berzosertib", "count": 1}, {"letter": "Mitochondrial oxidative stress", "count": 1}, {"letter": "Sandwich", "count": 1}, {"letter": "EuroQol visual analogue score", "count": 2}, {"letter": "CYP2D6 poor metabolizer", "count": 2}, {"letter": "Perioperative complication", "count": 1}, {"letter": "CYP3A5 poor metabolizer", "count": 1}, {"letter": "Administration of human papilloma virus vaccine", "count": 1}, {"letter": "Karnofsky Performance Status score", "count": 5}, {"letter": "Pittsburgh Sleep Quality Index score", "count": 13}, {"letter": "HAM-D (Hamilton Rating Scale for Depression) score", "count": 1}, {"letter": "Therapy prescription record", "count": 1}, {"letter": "At time of measurement", "count": 2}, {"letter": "PLAU protein, human", "count": 5}, {"letter": "balixafortide", "count": 18}, {"letter": "Residual tumor present", "count": 2}, {"letter": "US Military Warrant Officer W3", "count": 1}, {"letter": "Electronic case report form", "count": 20}, {"letter": "Monitor heart rate", "count": 2}, {"letter": "Folate supplementation", "count": 3}, {"letter": "Prone positioning", "count": 1}, {"letter": "Event-Free Survival", "count": 96}, {"letter": "Anguilla island", "count": 2}, {"letter": "Cryotherapy", "count": 4}, {"letter": "Problem with Sleep", "count": 1}, {"letter": "Excessive Daytime Sleepiness", "count": 1}, {"letter": "instruments", "count": 31}, {"letter": "Dermatitis Radiation, CTCAE", "count": 2}, {"letter": "Arthralgia, CTCAE 5", "count": 1}, {"letter": "Thymidine Kinase (-) Vaccinia-GM-CSF JX-594 Vaccine", "count": 25}, {"letter": "Nevus Sebaceus of Jadassohn", "count": 1}, {"letter": "BMS-936558", "count": 1}, {"letter": "SHR-1210", "count": 2}, {"letter": "NPPA wt Allele", "count": 2}, {"letter": "Myalgia, CTCAE 5", "count": 1}, {"letter": "Daily Living", "count": 10}, {"letter": "Baseline Nausea and Vomiting Scale", "count": 1}, {"letter": "Interleukin 2 Receptor Subunit Alpha Measurement", "count": 1}, {"letter": "Graded Prognostic Assessment", "count": 1}, {"letter": "Lugano Lymphoma Response Classification Progressive Disease by PET", "count": 369}, {"letter": "Clinical Outcome Assessment", "count": 3}, {"letter": "European Medicines Agency", "count": 1}, {"letter": "Lugano Lymphoma Response Classification Complete Remission by PET", "count": 6}, {"letter": "NELFE wt Allele", "count": 11}, {"letter": "Anxiety Visual Analogue Scale", "count": 1}, {"letter": "Study Control", "count": 10}, {"letter": "iRECIST Stable Disease", "count": 4}, {"letter": "Concordance", "count": 15}, {"letter": "National Program of Cancer Registries", "count": 1}, {"letter": "Huntingtin Protein Measurement", "count": 10}, {"letter": "Study Variable", "count": 9}, {"letter": "Well Being Visual Analogue Scale", "count": 109}, {"letter": "Unblinding", "count": 1}, {"letter": "Non-Cardiac Chest Pain, CTCAE", "count": 2}, {"letter": "Superficial Soft Tissue Fibrosis, CTCAE", "count": 1}, {"letter": "irCR", "count": 4}, {"letter": "Extracompartmental Tumor", "count": 67}, {"letter": "irPD", "count": 2}, {"letter": "irPR Thrombosis", "count": 3}, {"letter": "irSD", "count": 1}, {"letter": "irSD Thrombosis", "count": 2}, {"letter": "FF genotype", "count": 7}, {"letter": "Performance status:Score:Point in time:^Patient:Quantitative:Karnofsky", "count": 2}, {"letter": "Area of wound:Area:Point in time:Wound:Quantitative", "count": 1}, {"letter": "RR genotype", "count": 13}, {"letter": "Human metapneumovirus A2", "count": 4}, {"letter": "3 phase", "count": 1}, {"letter": "Immunogenicity (package insert)", "count": 61}, {"letter": "Breast Pain, CTCAE 5.0", "count": 2}, {"letter": "Soluble Tumor Necrosis Factor Receptor Superfamily Member 1A, human", "count": 1}, {"letter": "LL genotype", "count": 9}, {"letter": "AA genotype", "count": 2}, {"letter": "Assessment using Montreal cognitive assessment", "count": 6}, {"letter": "Disco", "count": 1}, {"letter": "capivasertib", "count": 7}, {"letter": "elacestrant", "count": 7}, {"letter": "spartalizumab", "count": 5}, {"letter": "camrelizumab", "count": 5}, {"letter": "Oligometastasis", "count": 1}, {"letter": "Status of Tumor Eligibility for Definitive Local Therapy", "count": 16}, {"letter": "Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502", "count": 5}, {"letter": "Post-Mastectomy Pain Syndrome", "count": 1}, {"letter": "Immune-related Response Evaluation Criteria In Solid Tumors", "count": 36}, {"letter": "Selective Estrogen Receptor Degrader SAR439859", "count": 19}, {"letter": "Total Measured Tumor Burden", "count": 3}, {"letter": "Contact Date", "count": 7}, {"letter": "BREAST-Q", "count": 86}, {"letter": "Phosphorylated Proto-Oncogene Tyrosine-Protein Kinase Src", "count": 1}, {"letter": "Phosphorylated Signal Transducer and Activator of Transcription 3 Positive", "count": 1}, {"letter": "Driven", "count": 5}, {"letter": "milademetan", "count": 2}, {"letter": "Recode", "count": 3}, {"letter": "Pain Score 0", "count": 10}, {"letter": "Pain Score 1", "count": 1}, {"letter": "Pain Score 2", "count": 2}, {"letter": "Pain Score 3", "count": 7}, {"letter": "Pain Score 4", "count": 1}, {"letter": "Pain Score 5", "count": 1}, {"letter": "Pain Score 6", "count": 1}, {"letter": "Pain Score 7", "count": 2}, {"letter": "Depression Score 4", "count": 1}, {"letter": "Anxiety Score 4", "count": 2}, {"letter": "Well-Being Score 0", "count": 1}, {"letter": "Well-Being Score 3", "count": 2}, {"letter": "NP-G2-044", "count": 1}, {"letter": "Delineate", "count": 12}, {"letter": "Abscopal Effect", "count": 5}, {"letter": "On Treatment", "count": 82}, {"letter": "GSK-3326595", "count": 1}, {"letter": "Subject Received Unplanned Treatment", "count": 1}, {"letter": "Supraclavicular Fossa", "count": 3}, {"letter": "Silver-Enhanced in Situ Hybridization", "count": 2}, {"letter": "iRECIST Confirmed Progressive Disease", "count": 2}, {"letter": "iRECIST Unconfirmed Progressive Disease", "count": 2}, {"letter": "Data Entry", "count": 1}, {"letter": "Alpha Error", "count": 1}, {"letter": "Analysis Variable", "count": 3}, {"letter": "Applet", "count": 51}, {"letter": "Baseline Assessment", "count": 118}, {"letter": "Baseline Characteristics", "count": 15}, {"letter": "Baseline Imbalance", "count": 5}, {"letter": "Blind Review", "count": 21}, {"letter": "Categorical Data", "count": 6}, {"letter": "Clinical Benefit", "count": 511}, {"letter": "Clinical Encounter", "count": 1}, {"letter": "Clinical Generalizability", "count": 3}, {"letter": "Laboratories, Clinical", "count": 27}, {"letter": "Data Acquisition", "count": 2}, {"letter": "Data Model", "count": 2}, {"letter": "Database Lock", "count": 3}, {"letter": "Demographic Data", "count": 9}, {"letter": "Direct Access", "count": 2}, {"letter": "Independent Data Monitoring Committee", "count": 2}, {"letter": "Interim Analysis", "count": 11}, {"letter": "Missing Data", "count": 36}, {"letter": "Non-Interventional Study", "count": 3}, {"letter": "Null Hypothesis", "count": 14}, {"letter": "Objective Measurement", "count": 27}, {"letter": "Observer Assessment", "count": 4}, {"letter": "Original Data", "count": 1}, {"letter": "Patient File", "count": 3}, {"letter": "Patient-reported Outcome Item", "count": 3}, {"letter": "Primary Completion Date", "count": 4}, {"letter": "Psychometric Instrument Reliability", "count": 1}, {"letter": "Psychometric Validation", "count": 4}, {"letter": "Quantitative Variable", "count": 2}, {"letter": "Raw Data", "count": 2}, {"letter": "Recruitment Period", "count": 11}, {"letter": "Research Hypothesis", "count": 5}, {"letter": "Response Option", "count": 76}, {"letter": "SAFE-Biopharma Standard", "count": 15}, {"letter": "Serious Adverse Drug Reaction", "count": 6}, {"letter": "Source Document", "count": 3}, {"letter": "Standard Treatment", "count": 7}, {"letter": "Stochastic", "count": 1}, {"letter": "Stopping Rules", "count": 1}, {"letter": "Study Description", "count": 1}, {"letter": "Study Monitoring Report", "count": 3}, {"letter": "Study Start", "count": 102}, {"letter": "Study Subject Enrolled", "count": 163}, {"letter": "Treatment-Emergent Adverse Event", "count": 251}, {"letter": "Trial Compliance", "count": 1}, {"letter": "Imaging Core Lab", "count": 3}, {"letter": "Conventional Imaging", "count": 13}, {"letter": "Breast Cancer Locator", "count": 8}, {"letter": "Presumed", "count": 1}, {"letter": "Lapatinib/Letrozole Regimen", "count": 1}, {"letter": "Everolimus/Exemestane Regimen", "count": 2}, {"letter": "Real Imager 8", "count": 2}, {"letter": "Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343", "count": 2}, {"letter": "H3B-6545", "count": 3}, {"letter": "Inoperable Disease", "count": 4}, {"letter": "Formalin-Fixed Paraffin-Embedded", "count": 27}, {"letter": "National Cancer Institute Terminology", "count": 107}, {"letter": "Restriction Spectrum Imaging", "count": 1}, {"letter": "Immune Checkpoint Inhibitors", "count": 3}, {"letter": "Systematic Programmed Illumination", "count": 1}, {"letter": "Blood Inflammatory Marker", "count": 2}, {"letter": "Grade 2 Hyperglycemia, CTCAE", "count": 1}, {"letter": "Grade 2 Peripheral Sensory Neuropathy, CTCAE", "count": 1}, {"letter": "Grade 2 Pneumonitis, CTCAE", "count": 1}, {"letter": "Grade 3 Allergic Reaction, CTCAE", "count": 1}, {"letter": "Grade 3 Anemia, CTCAE", "count": 1}, {"letter": "Grade 3 Breast Atrophy, CTCAE", "count": 1}, {"letter": "Grade 3 Breast Infection, CTCAE", "count": 1}, {"letter": "Grade 3 Fever, CTCAE", "count": 3}, {"letter": "Grade 3 Flu Like Symptoms, CTCAE", "count": 3}, {"letter": "Grade 3 Glucose Intolerance, CTCAE", "count": 1}, {"letter": "Grade 3 Headache, CTCAE", "count": 1}, {"letter": "Grade 3 Heart Failure, CTCAE", "count": 1}, {"letter": "Grade 3 Hyperglycemia, CTCAE", "count": 1}, {"letter": "Grade 3 Hyperuricemia, CTCAE", "count": 1}, {"letter": "Grade 3 Infusion Related Reaction, CTCAE", "count": 1}, {"letter": "Grade 3 Lymphedema, CTCAE", "count": 2}, {"letter": "Grade 3 Peripheral Motor Neuropathy, CTCAE", "count": 1}, {"letter": "Grade 3 Peripheral Sensory Neuropathy, CTCAE", "count": 1}, {"letter": "Grade 3 Skin Atrophy, CTCAE", "count": 1}, {"letter": "Grade 4 Anemia, CTCAE", "count": 2}, {"letter": "Grade 4 Dermatitis Radiation, CTCAE", "count": 1}, {"letter": "Grade 4 Heart Failure, CTCAE", "count": 1}, {"letter": "Grade 4 Hyperglycemia, CTCAE", "count": 2}, {"letter": "Grade 5 Allergic Reaction, CTCAE", "count": 2}, {"letter": "Disseminated Tumor Cells Positive", "count": 1}, {"letter": "MKI67 Positive", "count": 12}, {"letter": "Circulating Tumor Cells Positive", "count": 3}, {"letter": "BRCA Mutation Analysis", "count": 7}, {"letter": "Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM", "count": 10}, {"letter": "Index Date", "count": 12}, {"letter": "Child-Pugh Class A5", "count": 4}, {"letter": "Child-Pugh Class B7", "count": 2}, {"letter": "Child-Pugh Class C12", "count": 1}, {"letter": "Illumina Sequencing", "count": 7}, {"letter": "Salvage Surgery", "count": 2}, {"letter": "GDC-9545", "count": 3}, {"letter": "Block Randomization", "count": 1}, {"letter": "Anti-NY-ESO-1 TCR LV-transduced Autologous T-Cells TAEST16001", "count": 6}, {"letter": "Exploratory Research", "count": 3}, {"letter": "Hypothesis Generation", "count": 1}, {"letter": "Bone Mineral Density T-Score", "count": 2}, {"letter": "Maximum Predicted Heart Rate", "count": 1}, {"letter": "Severity One Out of Three", "count": 2}, {"letter": "Severity One Out of Five", "count": 3}, {"letter": "Severity Two Out of Three", "count": 1}, {"letter": "Severity Two Out of Five", "count": 1}, {"letter": "Severity Three Out of Four", "count": 1}, {"letter": "Severity Four Out of Five", "count": 2}, {"letter": "Breast Carcinoma Grade", "count": 1}, {"letter": "Symptom Checklist 90", "count": 6}, {"letter": "Refractory Breast Carcinoma", "count": 2}, {"letter": "Intergroup Rhabdomyosarcoma Group II", "count": 4}, {"letter": "BRCA-Associated Ovarian Carcinoma", "count": 2}, {"letter": "PIK3CA Gene Mutation Negative", "count": 17}, {"letter": "TP53 Gene Mutation Negative", "count": 3}, {"letter": "adavosertib", "count": 2}, {"letter": "Pain Score 10", "count": 5}, {"letter": "Decision Rule", "count": 1}, {"letter": "Investigational Product", "count": 31}, {"letter": "Treatment Benefit", "count": 18}, {"letter": "Letrozole/Palbociclib Regimen", "count": 19}, {"letter": "Severity One Out of Four", "count": 1}, {"letter": "BRAF Gene Mutation Negative", "count": 1}, {"letter": "Adagloxad simolenin", "count": 5}, {"letter": "New Day", "count": 1}, {"letter": "export across plasma membrane", "count": 2}, {"letter": "polyamine uptake", "count": 1}, {"letter": "Clinical risk", "count": 2}, {"letter": "Quality of life panel", "count": 1}, {"letter": "Phone number:Telephone number:Point in time:^Contact:Nominal", "count": 1}, {"letter": "Beck Depression Inventory II", "count": 3}, {"letter": "Cells.CD4+CD25-CD127+", "count": 1}, {"letter": "during anesthesia", "count": 1}, {"letter": "Dispatch", "count": 6}, {"letter": "Fresh frozen", "count": 2}, {"letter": "Echogenic", "count": 21}, {"letter": "Spouse/partner", "count": 3}, {"letter": "Dermal pattern", "count": 2}, {"letter": "Normal Activity", "count": 6}, {"letter": "Regional Tissue", "count": 1}, {"letter": "IIIA (virus)", "count": 5}, {"letter": "Shallow", "count": 1}, {"letter": "C-Pap", "count": 1}, {"letter": "Centrifuged", "count": 5}, {"letter": "D10", "count": 2}, {"letter": "Genotype 2", "count": 2}, {"letter": "H1047R", "count": 2}, {"letter": "E542K", "count": 1}, {"letter": "E545K", "count": 2}, {"letter": "Homogenous", "count": 1}, {"letter": "1 - 3", "count": 30}, {"letter": "Supplementing", "count": 1}, {"letter": "BREAS", "count": 1}, {"letter": "Unplanned", "count": 25}, {"letter": "age of patient", "count": 11}, {"letter": "Rather", "count": 4}, {"letter": "2-5-2", "count": 1}, {"letter": "Increased risk", "count": 5}, {"letter": "Decreased function", "count": 1}, {"letter": "A pattern", "count": 5}, {"letter": "Skin Electrode", "count": 1}, {"letter": "Monopolar", "count": 1}, {"letter": "20/100", "count": 1}, {"letter": "20/80", "count": 12}, {"letter": ">50 cells", "count": 4}, {"letter": "Day-to-day", "count": 5}, {"letter": "Non-self", "count": 2}, {"letter": "After delivery", "count": 1}, {"letter": "Elevated Expression", "count": 15}, {"letter": "Decreased Expression", "count": 13}, {"letter": "No expression", "count": 2}, {"letter": "Severe cancer", "count": 2}, {"letter": "Too young", "count": 1}, {"letter": "Pathological findings", "count": 8}, {"letter": "?-2-1", "count": 2}, {"letter": "Moderate fibrosis", "count": 4}, {"letter": "Severe fibrosis", "count": 1}, {"letter": "Significant activity", "count": 2}, {"letter": "High probability", "count": 6}, {"letter": "Low probability", "count": 3}, {"letter": "Lay person", "count": 2}, {"letter": "Totally", "count": 20}, {"letter": ">12 months", "count": 234}, {"letter": ">65 years", "count": 2}, {"letter": ">40 years", "count": 5}, {"letter": "High activity", "count": 2}, {"letter": "Just right", "count": 2}, {"letter": "Too long", "count": 1}, {"letter": "Discarded", "count": 1}, {"letter": "Rhythmic", "count": 2}, {"letter": "Increased heart rate variability", "count": 1}, {"letter": "Negative Results", "count": 6}, {"letter": "GRADE Approach", "count": 3}, {"letter": "Latent Class Model", "count": 1}, {"letter": "Deep Learning", "count": 2}, {"letter": "History of Pharmacy", "count": 1}, {"letter": "Screen Time", "count": 1}, {"letter": "Posttraumatic Growth, Psychological", "count": 6}, {"letter": "Change Management", "count": 8}, {"letter": "Services Utilization", "count": 1}, {"letter": "Mammary Carcinoma, Human", "count": 1}, {"letter": "Intermittent Fasting", "count": 8}, {"letter": "Time Restricted Feeding", "count": 1}, {"letter": "Antibody-Drug Conjugates", "count": 14}, {"letter": "Health Metrics", "count": 1}, {"letter": "DLQI (Dermatology Life Quality Index) score", "count": 2}, {"letter": "Patient Global Impression of Improvement", "count": 1}, {"letter": "ESS (Epworth Sleepiness Scale) score", "count": 1}, {"letter": "Obesity care", "count": 1}, {"letter": "Infuse", "count": 1}, {"letter": "Doppler ultrasonography of blood vessel", "count": 1}, {"letter": "Fluorothymidine", "count": 1}, {"letter": "Thoroughly", "count": 1}, {"letter": "Gene Alterations", "count": 9}, {"letter": "Richmond Agitation-Sedation Scale", "count": 2}, {"letter": "Palliative performance scale", "count": 1}, {"letter": "QuickDash outcome measure", "count": 9}, {"letter": "Sensory organization test", "count": 1}, {"letter": "Quick inventory of depressive symptomatology", "count": 2}, {"letter": "Post-mastectomy radiotherapy", "count": 1}, {"letter": "Metastatic castration-resistant prostate cancer", "count": 1}, {"letter": "Metastatic human epidermal growth factor 2 positive carcinoma of breast", "count": 8}, {"letter": "Montreal cognitive assessment score", "count": 1}, {"letter": "Peripheral Nervous System Diseases", "count": 12}, {"letter": "rnrx personal care (treatment)", "count": 79}, {"letter": "LEP-ETU", "count": 2}, {"letter": "Skin Basal Cell Carcinoma", "count": 7}, {"letter": "SGT-53", "count": 2}, {"letter": "CDX-301", "count": 3}, {"letter": "Implantation - action", "count": 2}, {"letter": "Radiographic Examination", "count": 1}, {"letter": "ABI-008", "count": 2}, {"letter": "GW003", "count": 2}, {"letter": "Substance with effector mechanism of action (substance)", "count": 10}, {"letter": "CD68 Expressing Cell Count", "count": 7}, {"letter": "STEPS to Enhance Physical Activity", "count": 1}, {"letter": "Variant Allele Frequency", "count": 3}, {"letter": "National Drug Code Milligram", "count": 2}, {"letter": "Tumor Cell Count", "count": 117}, {"letter": "Algorithm-Based Enrollment", "count": 1}, {"letter": "Proximity Ligation Assay", "count": 1}, {"letter": "Total Sleep Time", "count": 12}, {"letter": "Enrollment Period", "count": 1}, {"letter": "Very Mild Hallucination", "count": 1}, {"letter": "National Drug Code Gram", "count": 16}, {"letter": "Cancer-Related Death", "count": 82}, {"letter": "SPI-2012", "count": 15}, {"letter": "Blood Vessel Tumors", "count": 2}, {"letter": "765IGF-MTX", "count": 3}, {"letter": "SYD985", "count": 13}, {"letter": "Underlying", "count": 39}, {"letter": "GS/pan-Notch Inhibitor AL101", "count": 1}, {"letter": "Immune-Related Response Criteria", "count": 20}, {"letter": "ONT-380", "count": 1}, {"letter": "International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Favorable-Risk Group", "count": 32}, {"letter": "EDQM-HC Combined Term Terminology", "count": 2}, {"letter": "Other Than", "count": 5}, {"letter": "Metastatic Breast Carcinoma", "count": 4}, {"letter": "irPD (Immune-Related Response Criteria)", "count": 3}, {"letter": "Contrast-Enhanced Mammography", "count": 15}, {"letter": "MARK1 wt Allele", "count": 1}, {"letter": "PLEKHG5 wt Allele", "count": 5}, {"letter": "RYR1 wt Allele", "count": 4}, {"letter": "DDX41 wt Allele", "count": 1}, {"letter": "Smartphone Application", "count": 6}, {"letter": "Archived", "count": 8}, {"letter": "Edmonton Frail Scale", "count": 1}, {"letter": "Institutional Professional Consultation", "count": 5}, {"letter": "LYRIC Indeterminate Response", "count": 3}, {"letter": "Confidence 2 (5-Point Confidence Scale)", "count": 3}, {"letter": "EDQM-HC Container Terminology", "count": 4}, {"letter": "Soluble Interleukin-6 Receptor Subunit Alpha, Human", "count": 3}, {"letter": "Tangential Fields", "count": 3}, {"letter": "Event Unit", "count": 1}, {"letter": "subharmonic aided pressure estimation", "count": 4}, {"letter": "Confidence 1 (5-Point Confidence Scale)", "count": 1}, {"letter": "coordination of care", "count": 2}, {"letter": "Fula Language", "count": 1}, {"letter": "Event description:Finding:Point in time:^Event:Narrative", "count": 2}, {"letter": "Dogri Language", "count": 4}, {"letter": "SURE Test", "count": 2}, {"letter": "Enrichment (technique)", "count": 2}, {"letter": "Mandar Language", "count": 1}, {"letter": "Ladino Language", "count": 2}, {"letter": "Confidence 3 (5-Point Confidence Scale)", "count": 4}, {"letter": "Southern Altai Language", "count": 22}, {"letter": "Pampanga Language", "count": 7}, {"letter": "Confidence 5 (5-Point Confidence Scale)", "count": 1}, {"letter": "Control Preference Scale", "count": 8}, {"letter": "How Much Bothered by Arm Weakness in Affected Arm", "count": 3}, {"letter": "Romani Language", "count": 2}, {"letter": "Milligram Morphine Equivalent", "count": 1}, {"letter": "Lymphoma Response to Immunomodulatory Therapy Criteria", "count": 2}, {"letter": "bemarituzumab", "count": 3}, {"letter": "cemiplimab", "count": 1}, {"letter": "pemigatinib", "count": 35}, {"letter": "ciforadenant", "count": 1}, {"letter": "Trastuzumab Conjugate BI-CON-02", "count": 8}, {"letter": "How Much Bothered by Arm Heaviness in Affected Arm", "count": 2}, {"letter": "Quality of Life Questionnaire BR-23", "count": 106}, {"letter": "Contrast-Enhanced Ultrasound", "count": 9}, {"letter": "Patient Satisfaction with Cancer Care Questionnaire", "count": 1}, {"letter": "Fluorine F 18-Al-NOTA-MATBBN", "count": 1}, {"letter": "CDC7 Kinase Inhibitor LY3143921 Hydrate", "count": 8}, {"letter": "Three to Five Years", "count": 1}, {"letter": "Unclear State of Matter", "count": 3}, {"letter": "Tumor Mutation Burden", "count": 1}, {"letter": "Abbreviated Breast MRI Protocol", "count": 3}, {"letter": "Clinically Significant Anxiety Symptoms", "count": 1}, {"letter": "Deep Inspiration Breath Hold", "count": 2}, {"letter": "EGFR Negative", "count": 1}, {"letter": "Anti-CD40 Agonist Monoclonal Antibody CDX-1140", "count": 3}, {"letter": "Incomplete Response/Stable Disease", "count": 10}, {"letter": "Advanced Magnetic Resonance Imaging", "count": 1}, {"letter": "Secondary malignant neoplasm of viscera", "count": 2}, {"letter": "Germline BRCA1 Gene Mutation", "count": 1}, {"letter": "IGF1R Negative", "count": 1}, {"letter": "Oncology Unit", "count": 1}, {"letter": "Non-Protocol Disposition Event", "count": 1}, {"letter": "Organ of Interest", "count": 1}, {"letter": "Beyond", "count": 3}, {"letter": "NT-I7", "count": 2}, {"letter": "Fluorescence Imaging Agent IC2000", "count": 4}, {"letter": "Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a", "count": 1}, {"letter": "Weak Opioids", "count": 1}, {"letter": "selicrelumab", "count": 1}, {"letter": "trastuzumab deruxtecan", "count": 18}, {"letter": "Guardant360", "count": 1}, {"letter": "Study Conduct", "count": 3}, {"letter": "Transcriptomics", "count": 10}, {"letter": "Lipidomics", "count": 1}, {"letter": "Morisky Medication Adherence Scale", "count": 4}, {"letter": "International Myeloma Working Group", "count": 6}, {"letter": "Brief Resilience Scale", "count": 2}, {"letter": "Sequencing Data", "count": 5}, {"letter": "Sequencing Target Region", "count": 4}, {"letter": "Phosphorylated EIF4E", "count": 1}, {"letter": "Preparation for Decision Making Scale", "count": 11}, {"letter": "PTEN Alteration Positive", "count": 8}, {"letter": "Perceived Efficacy in Patient-Physician Interactions", "count": 4}, {"letter": "5-Point Confidence Scale", "count": 3}, {"letter": "Soluble Tumor Necrosis Factor Receptor Superfamily Member 9", "count": 1}, {"letter": "Tumor-Infiltrating Immune Cell", "count": 6}, {"letter": "Peak Oxygen Consumption", "count": 12}, {"letter": "10-Point Importance Scale", "count": 3}, {"letter": "PTEN Positive", "count": 1}, {"letter": "PTEN Negative", "count": 6}, {"letter": "Cognitively-Based Compassion Training", "count": 16}, {"letter": "Pectoral Nerve Block", "count": 1}, {"letter": "External Qigong Therapy", "count": 1}, {"letter": "Carbon Dioxide Fractional Laser", "count": 2}, {"letter": "Recombinant HSA/Filgrastim Fusion Protein", "count": 2}, {"letter": "LY3295668", "count": 4}, {"letter": "ERBB2 Overexpression", "count": 4}, {"letter": "Chemically-Induced Menopause", "count": 2}, {"letter": "HexaBody-DR5-01/DR5-05", "count": 1}, {"letter": "Metastatic Triple-Negative Breast Carcinoma", "count": 13}, {"letter": "CAN 04", "count": 6}, {"letter": "leronlimab", "count": 4}, {"letter": "Cancer grade", "count": 14}, {"letter": "Sienna+", "count": 1}, {"letter": "KHK2375", "count": 1}, {"letter": "Trastuzumab Biosimilar SB3", "count": 2}, {"letter": "intratumoral administration", "count": 8}, {"letter": "ASLAN001", "count": 3}, {"letter": "parenteral chemotherapy", "count": 1}, {"letter": "positron emission tomography-tomodensitometry", "count": 3}, {"letter": "estrogen receptor-negative breast cancer", "count": 6}, {"letter": "progesterone receptor-negative breast cancer", "count": 1}, {"letter": "Progesterone receptor positive breast cancer", "count": 2}, {"letter": "HER2 negative breast cancer", "count": 16}, {"letter": "laser spectroscopy", "count": 1}, {"letter": "preventive radiation therapy", "count": 1}, {"letter": "dual-energy contrast-enhanced digital mammography", "count": 6}, {"letter": "Chinese herbal medicine compound TPE-1", "count": 2}, {"letter": "intrathoracic chemotherapy", "count": 1}, {"letter": "BRN01", "count": 2}, {"letter": "OPB-111001", "count": 1}, {"letter": "subharmonic imaging", "count": 4}, {"letter": "pressurized intraperitoneal aerosol chemotherapy", "count": 1}, {"letter": "tislelizumab", "count": 5}, {"letter": "SPARC 1613", "count": 1}, {"letter": "Anti-CD27 Agonistic Monoclonal Antibody MK-5890", "count": 4}, {"letter": "Gallium Ga 68-NOTA-anti-HER2 Nanobody VHH1", "count": 3}, {"letter": "CAB-ROR2-ADC BA3021", "count": 1}, {"letter": "Anti-B7-H4 Monoclonal Antibody FPA150", "count": 9}, {"letter": "PI3K alpha/delta Inhibitor TQ-B3525", "count": 3}, {"letter": "Monoclonal Microbial EDP1503", "count": 3}, {"letter": "DHES0815A", "count": 7}, {"letter": "talazoparib 1 MG", "count": 1}, {"letter": "Final score", "count": 20}, {"letter": "Impact level", "count": 3}, {"letter": "Cause of fatalities", "count": 1}, {"letter": "Operating", "count": 12}, {"letter": "Weighted score", "count": 4}, {"letter": "Suppression of tumorigenicity 2.soluble", "count": 1}, {"letter": "Deactivate", "count": 1}, {"letter": "No days", "count": 2}, {"letter": "Specific population", "count": 3}, {"letter": "Moderate severity", "count": 5}, {"letter": "High severity", "count": 5}, {"letter": "Adhoc", "count": 1}, {"letter": "Negative to date", "count": 1}, {"letter": "Very high risk", "count": 2}, {"letter": "Moderate disease", "count": 3}, {"letter": "HMGA2 protein, human", "count": 2}, {"letter": "vofatamab", "count": 6}, {"letter": "ceralasertib", "count": 2}, {"letter": "Primary Outcome Variable", "count": 4}, {"letter": "Secondary Outcome Variable", "count": 2}, {"letter": "Definitive Surgical Resection", "count": 2}, {"letter": "Adherence Starts With Knowledge 12 Questionnaire", "count": 1}, {"letter": "Impossible", "count": 5}, {"letter": "Adverse Event by Type", "count": 3}, {"letter": "Histologic Type of Cancer", "count": 1}, {"letter": "Tumor Proportion Score", "count": 1}, {"letter": "Absolute Bioavailability", "count": 2}, {"letter": "Activator", "count": 1}, {"letter": "AKT Inhibitor", "count": 7}, {"letter": "Cognitive Behavior Therapy for Insomnia", "count": 1}, {"letter": "M1 Macrophage", "count": 3}, {"letter": "MicroRNA Sequencing", "count": 1}, {"letter": "CPI-006", "count": 5}, {"letter": "Very Unhappy", "count": 1}, {"letter": "Proactive Therapy", "count": 1}, {"letter": "Extremely Severe Hallucination", "count": 10}, {"letter": "Moderately Severe Hallucination", "count": 5}, {"letter": "Everolimus/Fulvestrant Regimen", "count": 3}, {"letter": "Sao Paulo", "count": 3}, {"letter": "Fulvestrant/Palbociclib Regimen", "count": 10}, {"letter": "Fulvestrant/Ribociclib Regimen", "count": 1}, {"letter": "Year of Death", "count": 5}, {"letter": "Non-Cancer Related Death", "count": 7}, {"letter": "Metastatic Tumor Sample", "count": 10}, {"letter": "Post Neoadjuvant Therapy Sample", "count": 12}, {"letter": "Area Under the Curve Ratio", "count": 4}, {"letter": "Anti-HER2 Antibody-drug Conjugate A166", "count": 1}, {"letter": "Phosphorylated STAT3 Measurement", "count": 1}, {"letter": "Wake After Sleep Onset", "count": 6}, {"letter": "Cmax to Cmax Ratio Measurement", "count": 6}, {"letter": "Menses Duration", "count": 1}, {"letter": "Extent of Exposure", "count": 2}, {"letter": "HER2/Neu Low Expression", "count": 1}, {"letter": "Anti-PVRIG Monoclonal Antibody COM701", "count": 4}, {"letter": "New Primary Tumor", "count": 3}, {"letter": "Medical Condition", "count": 16}, {"letter": "Date of Last Administration", "count": 1}, {"letter": "Follow-Up Period", "count": 48}, {"letter": "24 Months", "count": 61}, {"letter": "48 Months", "count": 5}, {"letter": "Follow-Up Information", "count": 12}, {"letter": "Tumor Free", "count": 5}, {"letter": "With Tumor", "count": 63}, {"letter": "Fractionated Stereotactic Radiation Therapy", "count": 1}, {"letter": "Exercise Log", "count": 6}, {"letter": "CHAMPS Activities Questionnaire for Older Adults", "count": 4}, {"letter": "Fair Health", "count": 1}, {"letter": "LUM Imaging System", "count": 1}, {"letter": "Hormone Receptor-Positive Breast Carcinoma", "count": 6}, {"letter": "Refractory Hormone Receptor-Positive Breast Carcinoma", "count": 2}, {"letter": "Anti-S15 Monoclonal Antibody NC318", "count": 2}, {"letter": "Relative Bioavailability", "count": 4}, {"letter": "Abemaciclib/Fulvestrant Regimen", "count": 2}, {"letter": "Anatomic Response", "count": 1}, {"letter": "Initial Diagnosis", "count": 12}, {"letter": "Date of New Tumor Event", "count": 20}, {"letter": "Intraabdominal fat", "count": 2}, {"letter": "Traumatic event", "count": 5}, {"letter": "Assessment score", "count": 29}, {"letter": "Regional nodal irradiation of breast", "count": 1}, {"letter": "Time of event", "count": 9}, {"letter": "With quality (attribute)", "count": 1}, {"letter": "Confounding Variables", "count": 1}, {"letter": "Benchmarks", "count": 5}, {"letter": "Standard Environmental Condition", "count": 3}, {"letter": "CTCAE v4 Grade 2", "count": 2}, {"letter": "Report status:Type:Point in time:Report:Nominal", "count": 1}, {"letter": "Best Value (cigarettes)", "count": 1}, {"letter": "VS Antigen", "count": 12}, {"letter": "RNA-Seq", "count": 15}, {"letter": "Postural Control", "count": 10}, {"letter": "pegilodecakin", "count": 1}, {"letter": "PI3K Gene Mutation", "count": 6}, {"letter": "Lisu Chinese", "count": 11}, {"letter": "Yao Chinese", "count": 2}, {"letter": "Worry Subscale", "count": 1}, {"letter": "Round Nodule", "count": 3}, {"letter": "Lahu Chinese", "count": 5}, {"letter": "College of American Pathologists", "count": 2}, {"letter": "Oroqen Chinese", "count": 488}, {"letter": "Dongxiang Chinese", "count": 2}, {"letter": "Buyei Chinese", "count": 63}, {"letter": "Epidermal cGVHD Score 4", "count": 57}, {"letter": "Vascular Study", "count": 1}, {"letter": "Gin Chinese", "count": 1}, {"letter": "Challenge Agent Treatment Efficacy Study", "count": 17}, {"letter": "Lhoba Chinese", "count": 14}, {"letter": "Monba Chinese", "count": 3}, {"letter": "NCT (pharmacologic substance)", "count": 2}, {"letter": "Pumi Chinese", "count": 17}, {"letter": "Axillary Reverse Mapping", "count": 4}, {"letter": "Russ Chinese", "count": 14}, {"letter": "Tatar Chinese", "count": 21}, {"letter": "use information", "count": 5}, {"letter": "collect information", "count": 2}, {"letter": "Oleclumab", "count": 5}, {"letter": "Perometer", "count": 10}, {"letter": "High Sensitivity C-Reactive Protein Measurement", "count": 1}, {"letter": "Reimbursement", "count": 4}, {"letter": "FLX475", "count": 2}, {"letter": "Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752", "count": 2}, {"letter": "Ki-67 Labeling Index", "count": 12}, {"letter": "Serum CEA Measurement", "count": 1}, {"letter": "Antibody-drug Conjugate ABBV-155", "count": 8}, {"letter": "Somatic Mutation Analysis", "count": 1}, {"letter": "First Degree Family History of Cancer", "count": 1}, {"letter": "Single Agent Therapy", "count": 194}, {"letter": "Therapy Used at Visit", "count": 10}, {"letter": "Survivorship Care Plan", "count": 4}, {"letter": "Mastectomy Patient", "count": 3}, {"letter": "Anti-PD-L1/CTLA-4 Bispecific Antibody KN046", "count": 1}, {"letter": "Super Enhancer Inhibitor GZ17-6.02", "count": 1}, {"letter": "Anti-CD73 Monoclonal Antibody NZV930", "count": 3}, {"letter": "Transplant Registry Unified Management Program", "count": 5}, {"letter": "Treatment Amount", "count": 1}, {"letter": "Fat Mass", "count": 30}, {"letter": "Lean Mass", "count": 20}, {"letter": "Visual Analog Scale (100 mm)", "count": 13}, {"letter": "Numerical Rating Scale 11-Point", "count": 15}, {"letter": "Verbal Rating Scale 4-Point", "count": 1}, {"letter": "Dose Finding Study", "count": 3}, {"letter": "Surgery Patient", "count": 6}, {"letter": "Blood DNA", "count": 3}, {"letter": "Frozen Tissue", "count": 1}, {"letter": "Biological Property", "count": 1}, {"letter": "Autologous Anti-MUC1*-CAR-4-1BB-CD3zeta-expressing T-lymphocytes", "count": 1}, {"letter": "Androgen Receptor Status", "count": 2}, {"letter": "iPSC-derived Natural Killer Cells FT500", "count": 2}, {"letter": "Ontruzant", "count": 2}, {"letter": "tivozanib hydrochloride", "count": 6}, {"letter": "Severe infection", "count": 6}, {"letter": "CB-103", "count": 8}, {"letter": "ONC-201", "count": 1}, {"letter": "parsaclisib", "count": 5}, {"letter": "GDC-0927", "count": 8}, {"letter": "Rogaratinib", "count": 1}, {"letter": "18F-FLUOROACETATE", "count": 1}, {"letter": "PRIMUS", "count": 3}, {"letter": "INSPIRE", "count": 2}, {"letter": "CAPTURE", "count": 93}, {"letter": "Piqray", "count": 3}, {"letter": "Bacterial strain", "count": 1}, {"letter": "Plan development", "count": 2}, {"letter": "Tangible support", "count": 1}, {"letter": "Insulin resistance score", "count": 2}, {"letter": "Personal characteristics", "count": 1}, {"letter": "Patient demographics", "count": 7}, {"letter": "Probably true", "count": 1}, {"letter": "Very much so", "count": 2}, {"letter": "More than 14 days", "count": 2}, {"letter": "Cambridge", "count": 4}, {"letter": "Residential", "count": 1}, {"letter": "Less than 7 days", "count": 1}, {"letter": "7-14 days", "count": 3}, {"letter": "More than one", "count": 22}, {"letter": "Cortisol^baseline", "count": 1}, {"letter": "Cost group", "count": 2}, {"letter": "Diameter^baseline", "count": 12}, {"letter": "Estradiol^baseline", "count": 3}, {"letter": "Everolimus^trough", "count": 5}, {"letter": "Glucose^baseline", "count": 2}, {"letter": "Insulin^baseline", "count": 1}, {"letter": "CD14 Monocytes", "count": 1}, {"letter": "Blood^Patient", "count": 8}, {"letter": "RBC^Patient", "count": 1}, {"letter": "9.2", "count": 5}, {"letter": "10.7", "count": 1}, {"letter": "595", "count": 1}, {"letter": "10.4", "count": 5}, {"letter": "Wide excision", "count": 4}, {"letter": "Full face", "count": 1}, {"letter": "STEEP1 protein, human", "count": 10}, {"letter": "SST protein, human", "count": 1}, {"letter": "Symptom Exacerbation", "count": 6}, {"letter": "Extranodal Tumor Deposits", "count": 3}, {"letter": "Historical Trauma", "count": 1}, {"letter": "Broadly Neutralizing Antibodies", "count": 1}, {"letter": "Microwave Imaging", "count": 1}, {"letter": "Augmented Reality", "count": 14}, {"letter": "Immunogenic Cell Death", "count": 1}, {"letter": "Lymph Node Ratio", "count": 1}, {"letter": "REMD-477", "count": 2}, {"letter": "Healthy Nutrition", "count": 2}, {"letter": "modifies", "count": 1}, {"letter": "Delayed healing of wound", "count": 9}, {"letter": "Low Platelet Count", "count": 1}, {"letter": "Sudden (qualifier value)", "count": 9}, {"letter": "Three (answer to question)", "count": 5}, {"letter": "E7449", "count": 2}, {"letter": "Inorganic Pyrophosphate Measurement", "count": 1}, {"letter": "H1-0 wt Allele", "count": 1}, {"letter": "TNFRSF19 wt Allele", "count": 7}, {"letter": "Is there a Cancer History", "count": 7}, {"letter": "RECIL MR", "count": 3}, {"letter": "MR Fingerprinting", "count": 1}, {"letter": "Sleep Diary", "count": 14}, {"letter": "True or Present Nearly Every Day", "count": 2}, {"letter": "No Effort", "count": 1}, {"letter": "Continuous Glucose Monitoring System", "count": 1}, {"letter": "Residual Cancer Burden Class 0", "count": 19}, {"letter": "Hyperspectral Camera System", "count": 2}, {"letter": "Can Do Very Well", "count": 6}, {"letter": "V-Series Nerve Agent VM", "count": 1}, {"letter": "Every Twelve Weeks", "count": 8}, {"letter": "Neoplasm Polygenic Risk Score", "count": 2}, {"letter": "Year Date", "count": 1}, {"letter": "Global Complete Response in Lymph Nodes", "count": 2}, {"letter": "Caregiver Oncology Needs Evaluation Tool", "count": 11}, {"letter": "Latissimus Dorsi Flap Reconstruction", "count": 1}, {"letter": "Threshold Cycle", "count": 1}, {"letter": "Stereotactic Accelerated Partial Breast Irradiation", "count": 3}, {"letter": "Global Stable Disease in Blood", "count": 2}, {"letter": "Intensity and Distress 5", "count": 2}, {"letter": "Symptom distress level:Find:Pt:^Patient:Ord", "count": 1}, {"letter": "EMSLR gene", "count": 4}, {"letter": "Non-specific active suicidal thoughts", "count": 1}, {"letter": "Ventilatory threshold:VRatCnt:Pt:^Patient:Qn", "count": 1}, {"letter": "Anxiety score:Score:Pt:^Patient:Qn", "count": 32}, {"letter": "Anxiety severity", "count": 4}, {"letter": "Depression score:Score:Pt:^Patient:Qn", "count": 19}, {"letter": "Depression severity", "count": 8}, {"letter": "Methylene Blue Liquid Injection", "count": 3}, {"letter": "Suicidal intent:Find:Pt:^Patient:Ord", "count": 1}, {"letter": "COVID19 (disease)", "count": 5}, {"letter": "Post-Adjuvant Therapy", "count": 2}, {"letter": "Oncolytic Adenovirus CAdVEC", "count": 1}, {"letter": "Autologous HER2-CAR-modified Adenovirus-specific Cytotoxic T-lymphocytes", "count": 1}, {"letter": "Anti-ErbB3 Antibody ISU104", "count": 5}, {"letter": "Concurrent Chemotherapy", "count": 2}, {"letter": "At Time of Diagnosis", "count": 4}, {"letter": "Neutrophil Recovery Time", "count": 3}, {"letter": "EGFR Mutation Analysis", "count": 1}, {"letter": "Primary Site of Disease", "count": 1}, {"letter": "TP53 Mutation Analysis", "count": 1}, {"letter": "Anti-CD73 Monoclonal Antibody TJ4309", "count": 1}, {"letter": "Raw Score", "count": 65}, {"letter": "Date of Surgical Procedure", "count": 31}, {"letter": "A Small Amount of Effort", "count": 1}, {"letter": "Atezolizumab/Nab-paclitaxel Regimen", "count": 1}, {"letter": "Percent of Positive Nuclei", "count": 2}, {"letter": "Percent of Monocytes", "count": 1}, {"letter": "Percent of Necrosis", "count": 2}, {"letter": "Percent of Neutrophils", "count": 1}, {"letter": "Percent of Stromal Cells", "count": 2}, {"letter": "Percent of Tumor Cells", "count": 2}, {"letter": "Education Type", "count": 1}, {"letter": "RECIST Stable Disease", "count": 12}, {"letter": "RECIST Partial Response", "count": 45}, {"letter": "Was the Individual Exposed to Second-Hand Smoke", "count": 1}, {"letter": "Response Evaluation Criteria In Lymphoma 2017", "count": 2}, {"letter": "Gray per Fraction", "count": 4}, {"letter": "Prevalent", "count": 4}, {"letter": "RECIST Complete Response", "count": 10}, {"letter": "RECIST Progressive Disease", "count": 9}, {"letter": "Rarely True", "count": 4}, {"letter": "True Nearly All of the Time", "count": 9}, {"letter": "Is Individual Lost to Follow-Up", "count": 2}, {"letter": "Global Response in Lymph Nodes", "count": 1}, {"letter": "Global Response in Blood", "count": 5}, {"letter": "Bendamustine Regimen", "count": 1}, {"letter": "Capecitabine Regimen", "count": 3}, {"letter": "Cyclophosphamide Regimen", "count": 3}, {"letter": "Docetaxel Regimen", "count": 1}, {"letter": "Doxorubicin Regimen", "count": 2}, {"letter": "Eribulin Regimen", "count": 1}, {"letter": "Everolimus Regimen", "count": 1}, {"letter": "Exemestane Regimen", "count": 1}, {"letter": "Goserelin Regimen", "count": 1}, {"letter": "Lapatinib Regimen", "count": 2}, {"letter": "Paclitaxel Regimen", "count": 1}, {"letter": "Paclitaxel Weekly Regimen", "count": 3}, {"letter": "Pazopanib Regimen", "count": 1}, {"letter": "CCS1477", "count": 2}, {"letter": "Enterococcus gallinarum Strain MRx0518", "count": 6}, {"letter": "Anti-HER2 Immune Stimulator-antibody Conjugate NJH395", "count": 3}, {"letter": "Exemestane/Leuprolide Regimen", "count": 1}, {"letter": "AZD9833", "count": 33}, {"letter": "Tissue Expander-Implant Breast Reconstruction", "count": 3}, {"letter": "Archival Tissue", "count": 14}, {"letter": "Current Hormonal Contraceptive User", "count": 1}, {"letter": "Residual Cancer Burden", "count": 83}, {"letter": "Residual Cancer Burden Class 1", "count": 8}, {"letter": "Residual Cancer Burden Class 2", "count": 6}, {"letter": "Residual Cancer Burden Class 3", "count": 6}, {"letter": "Malignant Lesion", "count": 25}, {"letter": "Anchor Date", "count": 4}, {"letter": "Elevated Type I Collagen Cross-Linked N-Telopeptide", "count": 2}, {"letter": "Biopsy Clip", "count": 2}, {"letter": "Non-mass-like Enhancement", "count": 1}, {"letter": "Oligometastatic Disease", "count": 1}, {"letter": "Treatment Group", "count": 87}, {"letter": "Experimental Group", "count": 12}, {"letter": "Demographic Group", "count": 1}, {"letter": "Dynamometry", "count": 11}, {"letter": "PK Swing", "count": 13}, {"letter": "Lung Radiation Injury", "count": 1}, {"letter": "Multi-kinase Inhibitor XL092", "count": 10}, {"letter": "IPI Score 0-1", "count": 8}, {"letter": "Gene-edited Autologous Neoantigen-targeted NeoTCR-P1 T-cells", "count": 9}, {"letter": "European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0", "count": 7}, {"letter": "Galinpepimut-S", "count": 5}, {"letter": "ZW-49", "count": 3}, {"letter": "First Study Treatment Date", "count": 28}, {"letter": "Last Study Treatment Date", "count": 1}, {"letter": "First Study Treatment Time", "count": 6}, {"letter": "Informed Consent Time", "count": 1}, {"letter": "Somatic BRCA1 Gene Mutation", "count": 1}, {"letter": "Metastatic Diagnosis", "count": 8}, {"letter": "Multiple Kinase Inhibitor TT-00420", "count": 13}, {"letter": "Anti-HER-2 Bispecific Antibody KN026", "count": 1}, {"letter": "Protein Expression Analysis by Immunohistochemistry", "count": 3}, {"letter": "QC Slide Review", "count": 1}, {"letter": "Tumor Segment", "count": 2}, {"letter": "Advanced Breast Carcinoma", "count": 39}, {"letter": "Highest Grade", "count": 16}, {"letter": "New Patient", "count": 7}, {"letter": "Montreal Cognitive Assessment Delayed Recall Test", "count": 8}, {"letter": "Baker Classification of Capsular Contracture of Breast", "count": 3}, {"letter": "Localized Breast Carcinoma", "count": 7}, {"letter": "Sorafenib Regimen", "count": 1}, {"letter": "Lymfactin", "count": 7}, {"letter": "FitBit", "count": 26}, {"letter": "OBI 822", "count": 5}, {"letter": "Clinical relevance subontology", "count": 4}, {"letter": "New York Heart Association Functional Classification", "count": 3}, {"letter": "Insulin sensitivity index", "count": 2}, {"letter": "during activity", "count": 1}, {"letter": "during running", "count": 1}, {"letter": "during walking", "count": 2}, {"letter": "Exercise capacity", "count": 18}, {"letter": "Monocytes.HLA-DR", "count": 1}, {"letter": "Fulvestrant Injection", "count": 1}, {"letter": "Somatic disorders", "count": 1}, {"letter": "AGTR2 protein, human", "count": 1}, {"letter": "magrolimab", "count": 2}, {"letter": "Genetic consultation", "count": 1}, {"letter": "Clavien-Dindo complication grade", "count": 2}, {"letter": "Insulin sensitivity factor", "count": 1}, {"letter": "Risk of cardiovascular disease", "count": 5}, {"letter": "Anxiety, severe", "count": 16}, {"letter": "Single words", "count": 5}, {"letter": "Few words", "count": 1}, {"letter": "Non-verbal", "count": 1}, {"letter": "Study Branch", "count": 2}, {"letter": "Positive Attitude", "count": 10}, {"letter": "Nutrient Intake", "count": 1}, {"letter": "taking medication (history)", "count": 3}, {"letter": "Psychosocial Support", "count": 1}, {"letter": "Peptide Transporter TAP1 Measurement", "count": 1}, {"letter": "Camidanlumab tesirine", "count": 27}, {"letter": "Fluorescence Intensity Unit", "count": 2}, {"letter": "Serratus Plane Block", "count": 2}, {"letter": "Safety Monitoring", "count": 4}, {"letter": "Bilateral Sequential Radiotherapy", "count": 1}, {"letter": "Targeted Therapy Agent", "count": 5}, {"letter": "Feasibility", "count": 327}, {"letter": "Active Recreation", "count": 1}, {"letter": "Reproductive Concerns After Cancer", "count": 1}, {"letter": "Solid Tissue Specimen", "count": 1}, {"letter": "First Patient Visit Date", "count": 2}, {"letter": "First Treatment Date", "count": 222}, {"letter": "Very Comfortable", "count": 1}, {"letter": "FT516", "count": 1}, {"letter": "Mepitel Film", "count": 5}, {"letter": "Post-Surgical Complication", "count": 4}, {"letter": "Chemotherapy-Induced Alopecia", "count": 7}, {"letter": "Biopsy Patient", "count": 3}, {"letter": "Lumpectomy Patient", "count": 1}, {"letter": "Breast Measurement", "count": 6}, {"letter": "Identified By", "count": 55}, {"letter": "Imaging Patient", "count": 5}, {"letter": "Radiation Therapy Patient", "count": 1}, {"letter": "MRI Patient", "count": 4}, {"letter": "PET/CT Patient", "count": 3}, {"letter": "AVATAR", "count": 1}, {"letter": "Repeat Unit", "count": 1}, {"letter": "Cancer Vision Goggles", "count": 1}, {"letter": "Adverse Event Dose", "count": 9}, {"letter": "Adverse Event Term", "count": 13}, {"letter": "Drug Name", "count": 2}, {"letter": "Date of First Dose", "count": 114}, {"letter": "Treatment Data", "count": 12}, {"letter": "Study Procedure Deviation", "count": 9}, {"letter": "Change Summary", "count": 3}, {"letter": "Product Relationship", "count": 4}, {"letter": "Passage Number", "count": 2}, {"letter": "Reconstruction Interval", "count": 1}, {"letter": "Sequence Read Count", "count": 1}, {"letter": "Conventional Radiotherapy", "count": 1}, {"letter": "CDK4/6 Inhibitor FCN-437", "count": 9}, {"letter": "Mixed Response", "count": 1}, {"letter": "Radiographic Progressive Disease", "count": 8}, {"letter": "Diagnostic Slide", "count": 1}, {"letter": "Tissue Slide", "count": 1}, {"letter": "Nuclear Staining Method", "count": 1}, {"letter": "Expression Negative", "count": 8}, {"letter": "ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471", "count": 64}, {"letter": "Modified Radiation-induced Skin Reaction Assessment Scale", "count": 4}, {"letter": "Dry Desquamation", "count": 13}, {"letter": "Moist Desquamation", "count": 21}, {"letter": "Less than Twenty Five Percent", "count": 4}, {"letter": "Between Twenty Five and Fifty Percent", "count": 10}, {"letter": "Between Fifty and Seventy Five Percent", "count": 6}, {"letter": "RAD51 Inhibitor CYT-0851", "count": 4}, {"letter": "Epidiferphane", "count": 13}, {"letter": "Time-to-Event Dataset", "count": 55}, {"letter": "Integrated", "count": 17}, {"letter": "Shared Decision Making Questionnaire", "count": 4}, {"letter": "Hormone Receptor-Negative Breast Carcinoma", "count": 1}, {"letter": "Hormone Receptor Negative", "count": 3}, {"letter": "Cold Cap Therapy", "count": 1}, {"letter": "Rescue Medications", "count": 5}, {"letter": "Alpelisib/Fulvestrant Regimen", "count": 1}, {"letter": "Safety Monitoring Committee", "count": 1}, {"letter": "Human Anti-Human Antibody Measurement", "count": 1}, {"letter": "Soluble Vascular Endothelial Growth Factor Receptor Type 1 Measurement", "count": 1}, {"letter": "Soluble Vascular Endothelial Growth Factor Receptor Type 3 Measurement", "count": 1}, {"letter": "Digital Polymerase Chain Reaction", "count": 6}, {"letter": "Mouse Protection Assay", "count": 4}, {"letter": "RSK1-4 Inhibitor PMD-026", "count": 5}, {"letter": "Trier Social Stress Test", "count": 8}, {"letter": "Neurotoxic Chemotherapy", "count": 1}, {"letter": "Adverse Event Severity Grade", "count": 53}, {"letter": "Chemotherapeutic Cycle Number", "count": 21}, {"letter": "Cohort Dose", "count": 21}, {"letter": "Date of Disease Progression", "count": 184}, {"letter": "Complete Lymph Node Dissection", "count": 1}, {"letter": "Evaluation Sequence Number", "count": 5}, {"letter": "Tumor Tissue Area", "count": 2}, {"letter": "Number of Prior Regimens", "count": 1}, {"letter": "Percent Stromal Tissue", "count": 4}, {"letter": "Percent Tumor Tissue", "count": 25}, {"letter": "Anti-TROP2 Antibody-drug Conjugate SKB264", "count": 3}, {"letter": "Satoreotide Trizoxetan", "count": 2}, {"letter": "Disease Risk Index Low Risk", "count": 29}, {"letter": "Disease Risk Index Intermediate Risk", "count": 3}, {"letter": "Wee1 Inhibitor ZN-c3", "count": 3}, {"letter": "BRCA-Associated Breast Carcinoma", "count": 6}, {"letter": "Measurable Lesion", "count": 94}, {"letter": "SERD ZN-c5", "count": 8}, {"letter": "PARP Inhibitor NMS-03305293", "count": 1}, {"letter": "Mild Difficulty", "count": 2}, {"letter": "Severe Difficulty", "count": 9}, {"letter": "PD-L1 IHC 22C3 PharmDx", "count": 1}, {"letter": "Canine Quality of Life Survey", "count": 6}, {"letter": "Survey Date", "count": 1}, {"letter": "Pet Responds to Presence", "count": 2}, {"letter": "High Frequency Heart Sound", "count": 1}, {"letter": "Abnormal Cardiac Event Monitoring Finding", "count": 6}, {"letter": "Family History of Chronic Disease", "count": 1}, {"letter": "Long Heart Murmur", "count": 1}, {"letter": "Multifrequency Heart Murmur", "count": 2}, {"letter": "Vibratory Heart Murmur", "count": 1}, {"letter": "Kawasaki Disease Symptom Onset Date", "count": 2}, {"letter": "ExAblate 4000 Type 2.0", "count": 2}, {"letter": "PARP 1/2 Inhibitor IMP4297", "count": 2}, {"letter": "Selective Estrogen Receptor Degrader LX-039", "count": 34}, {"letter": "Therapeutic Indicator", "count": 1}, {"letter": "Spinal Region", "count": 1}, {"letter": "Metastatic HER2-Negative Breast Carcinoma", "count": 5}, {"letter": "Advanced HER2-Negative Breast Carcinoma", "count": 1}, {"letter": "Chemotherapy Course 2", "count": 4}, {"letter": "Chemotherapy Course 3", "count": 1}, {"letter": "Chemotherapy Course 6", "count": 1}, {"letter": "Adverse Event Grading System", "count": 1}, {"letter": "Site of Relapse", "count": 4}, {"letter": "Medical Research Council", "count": 2}, {"letter": "Minimal Residual Disease Molecular Marker", "count": 1}, {"letter": "End of Planned Treatment", "count": 1}, {"letter": "CNS Response", "count": 31}, {"letter": "Flow Cytometry Different from Normal", "count": 1}, {"letter": "Death due to Disease Progression", "count": 10}, {"letter": "Thorium Th 227 Anti-HER2 Monoclonal Antibody BAY2701439", "count": 3}, {"letter": "Percent per Second", "count": 8}, {"letter": "White Light Endoscopy", "count": 4}, {"letter": "Last Follow-Up Date", "count": 1}, {"letter": "Umbrella Protocol", "count": 1}, {"letter": "Droplet Digital PCR", "count": 7}, {"letter": "Pressure Chest Pain", "count": 10}, {"letter": "Variant Pathogenic/Likely Pathogenic", "count": 1}, {"letter": "State of known exposure:Loc:Pt:^Patient:Nom", "count": 4}, {"letter": "PANEL.SURVEY.SEEK", "count": 7}, {"letter": "H3P23 gene", "count": 4}, {"letter": "Known exposure date:Date:Pt:^Patient:Qn", "count": 1}, {"letter": "dostarlimab", "count": 5}, {"letter": "Access to Therapy", "count": 1}, {"letter": "Cognitive Testing", "count": 14}, {"letter": "sacituzumab govitecan-hziy", "count": 9}, {"letter": "Tanita", "count": 15}, {"letter": "Tampa", "count": 8}, {"letter": "Default Mode Network", "count": 1}, {"letter": "Cell suspension", "count": 1}, {"letter": "Bacterial 16S rRNA gene", "count": 1}, {"letter": "Physical limitation", "count": 10}, {"letter": "No time", "count": 10}, {"letter": "Pillbox", "count": 3}, {"letter": "Financial institution", "count": 2}, {"letter": "0.5 umol/L", "count": 2}, {"letter": "RT-LAMP assay", "count": 1}, {"letter": "Immune Checkpoint Blockade", "count": 7}, {"letter": "PD-L1 Inhibitors", "count": 1}, {"letter": "Immune Checkpoint Proteins", "count": 1}, {"letter": "Reinjuries", "count": 1}, {"letter": "Persistent Organic Pollutants", "count": 1}, {"letter": "Psychosocial Intervention", "count": 1}, {"letter": "Chemotherapy-Related Cognitive Impairment", "count": 2}, {"letter": "Internet Use", "count": 5}, {"letter": "Glycemic Control", "count": 1}, {"letter": "Detection Dogs", "count": 2}, {"letter": "Financial Stress", "count": 12}, {"letter": "Clinical Reasoning", "count": 2}, {"letter": "Risk Scores", "count": 18}, {"letter": "Oxidative Damage", "count": 1}, {"letter": "Neoadjuvant Radiotherapy", "count": 3}, {"letter": "Neoadjuvant Systemic Therapy", "count": 46}, {"letter": "Neoadjuvant Chemotherapy", "count": 165}, {"letter": "Neoadjuvant Chemoradiotherapy", "count": 1}, {"letter": "Effective Reproduction Number", "count": 108}, {"letter": "Digital Technology", "count": 1}, {"letter": "Psychosocial Functioning", "count": 2}, {"letter": "68Ga-FAPI", "count": 4}, {"letter": "FAPI-04", "count": 3}, {"letter": "Vascular Density", "count": 2}, {"letter": "Functional Independence", "count": 11}, {"letter": "Macronutrient Intake", "count": 1}, {"letter": "Digital Image Processing", "count": 1}, {"letter": "Lifestyle Factors", "count": 5}, {"letter": "Perceived Social Support", "count": 12}, {"letter": "Point Prevalence", "count": 5}, {"letter": "Likelihood Ratio Test", "count": 3}, {"letter": "Sedentary Time", "count": 7}, {"letter": "Magnetic Resonance Image", "count": 4}, {"letter": "Cutaneous lesions", "count": 1}, {"letter": "Speckle tracking echocardiography", "count": 4}, {"letter": "Primary malignant neoplasm of breast with axillary lymph node invasion", "count": 1}, {"letter": "2.3", "count": 3}, {"letter": "Clinical Global Impression", "count": 5}, {"letter": "Annual visit", "count": 2}, {"letter": "Functional Assessment of Cancer Therapy - Brain", "count": 3}, {"letter": "Sensory suppression", "count": 2}, {"letter": "GLUCOSE TRANSMITTER DEXCOM G6", "count": 1}, {"letter": "Drug Accumulation Greater than 5", "count": 1}, {"letter": "C-peptide, Human", "count": 1}, {"letter": "Anti-VEGF Humanized Monoclonal Antibody", "count": 4}, {"letter": "68Ga-RM2", "count": 4}, {"letter": "INCMGA 0012", "count": 6}, {"letter": "Anti-NRP1 Antibody ASP1948", "count": 11}, {"letter": "MATCH Arm EAY131-C2", "count": 17}, {"letter": "Clinical Status Ordinal Scale Outcome 7", "count": 1}, {"letter": "Neoplastic Disease Extent Indicator", "count": 1}, {"letter": "Retrospective Tissue Collection", "count": 1}, {"letter": "Burkholderia vietnamiensis Measurement", "count": 2}, {"letter": "Bright White Light Therapy", "count": 59}, {"letter": "Acceptance of treatment", "count": 3}, {"letter": "Non-Compartmental Analysis Dataset", "count": 4}, {"letter": "AML Adverse Events Table", "count": 1}, {"letter": "Feelings about Genomic Testing Results", "count": 1}, {"letter": "Immune status:Finding:Point in time:^Patient:Ordinal", "count": 3}, {"letter": "Drug Accumulation Less than 1.2", "count": 2}, {"letter": "Drug Accumulation 2.0 to 4.99", "count": 1}, {"letter": "Processing Speed Scaled Score", "count": 2}, {"letter": "CDISC Provisional Standard", "count": 3}, {"letter": "Prospective Tissue Collection", "count": 1}, {"letter": "Mitochondrial Fission Factor, Human", "count": 30}, {"letter": "Study Treatment Phase Participation", "count": 2}, {"letter": "EWS Disease Characteristics Table", "count": 3}, {"letter": "Quality (document type)", "count": 1}, {"letter": "Add", "count": 63}, {"letter": "3,4-methylenedioxy-N-ethylamphetamine Measurement", "count": 8}, {"letter": "Global Longitudinal Strain", "count": 18}, {"letter": "USDA Six-Item Standard Measure", "count": 3}, {"letter": "Concerns About Recurrence Scale", "count": 2}, {"letter": "Burkholderia cenocepacia Measurement", "count": 3}, {"letter": "Limits of Stability Test", "count": 4}, {"letter": "Retifanlimab", "count": 6}, {"letter": "CDISC Define-XML Standard Type Terminology", "count": 1}, {"letter": "Single-Cell RNA-Seq", "count": 2}, {"letter": "Investigation Description Format", "count": 24}, {"letter": "Prostaglandin E2 EP4 Receptor Inhibitor AN0025", "count": 1}, {"letter": "Plasmid DNA Vaccine pING-hHER3FL", "count": 2}, {"letter": "EphA2-targeting Bicycle Toxin Conjugate BT5528", "count": 25}, {"letter": "Oncolytic Herpes Simplex Virus-1 ONCR-177", "count": 3}, {"letter": "SY-5609", "count": 8}, {"letter": "Anti-Ribonucleoprotein Antibody ATRC-101", "count": 4}, {"letter": "STING Agonist TAK-676", "count": 1}, {"letter": "Autologous Tumor Infiltrating Lymphocytes LN-145-S1", "count": 1}, {"letter": "Anti-CTLA-4 Monoclonal Antibody ONC-392", "count": 2}, {"letter": "Anti-HER2 Antibody-drug Conjugate BAT8001", "count": 3}, {"letter": "HER2-directed TLR8 Agonist SBT6050", "count": 3}, {"letter": "PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480", "count": 9}, {"letter": "LY3484356", "count": 6}, {"letter": "Sasanlimab", "count": 5}, {"letter": "giredestrant", "count": 5}, {"letter": "Samuraciclib", "count": 1}, {"letter": "Downstaging", "count": 4}, {"letter": "Exploratory Endpoint", "count": 12}, {"letter": "Composite Endpoint", "count": 15}, {"letter": "Prepared Amount", "count": 2}, {"letter": "Study Participation", "count": 13}, {"letter": "Electronic Health Record Review", "count": 2}, {"letter": "Electron Paramagnetic Resonance Oximetry", "count": 1}, {"letter": "Medical Status", "count": 1}, {"letter": "Study Status", "count": 5}, {"letter": "Richmond Agitation-Sedation Scale Clinical Classification", "count": 1}, {"letter": "Outpatient Encounter", "count": 1}, {"letter": "Intensive Care Unit Stay", "count": 1}, {"letter": "Telemedicine Visit", "count": 1}, {"letter": "Numeracy Understanding in Medicine Instrument", "count": 1}, {"letter": "No Treatment due to Device Malfunction", "count": 3}, {"letter": "Permanent Impairment", "count": 1}, {"letter": "Tumor Cell Seeding", "count": 1}, {"letter": "Unanticipated Adverse Device Effect", "count": 1}, {"letter": "Oncotype DX Breast Recurrence Score", "count": 6}, {"letter": "GAITRite Mat", "count": 1}, {"letter": "Regional Metastasis Present", "count": 2}, {"letter": "Metastasis Present in Distant Organ", "count": 4}, {"letter": "Site of Metastasis", "count": 9}, {"letter": "Protocol Treatment Arm Drug Name", "count": 3}, {"letter": "Formalin-Fixed Paraffin-Embedded Tissue Sample", "count": 1}, {"letter": "Web Application", "count": 3}, {"letter": "Multispectral Optoacoustic Tomography", "count": 1}, {"letter": "Sit to Stand Test", "count": 11}, {"letter": "Exercise Compliance", "count": 4}, {"letter": "Soluble Programmed Death Ligand 1 Measurement", "count": 3}, {"letter": "Linear Trapezoidal Method", "count": 38}, {"letter": "Likert Scale 5-Point", "count": 97}, {"letter": "Likert Scale 3-Point", "count": 2}, {"letter": "Physical Activity Level", "count": 41}, {"letter": "Average Amount", "count": 3}, {"letter": "Smoke-Free Home Program", "count": 1}, {"letter": "Skindex-29 Questionnaire", "count": 3}, {"letter": "Pruritus Work or School Disability", "count": 1}, {"letter": "Unbearable", "count": 16}, {"letter": "File Validated", "count": 354}, {"letter": "FoundationOne Genomic Profiling", "count": 9}, {"letter": "Ability Question", "count": 1}, {"letter": "Taste Response", "count": 1}, {"letter": "Confidence Question", "count": 1}, {"letter": "Off Protocol Therapy", "count": 24}, {"letter": "Disease Involvement Site", "count": 13}, {"letter": "Total Radiation Dose", "count": 2}, {"letter": "Response Assessment Category", "count": 18}, {"letter": "Bone Marrow Response", "count": 1}, {"letter": "Adverse Event Medication", "count": 2}, {"letter": "Adverse Event Intervention", "count": 1}, {"letter": "Pain Question", "count": 6}, {"letter": "Fatigue Question", "count": 1}, {"letter": "Anxiety Question", "count": 3}, {"letter": "Quality of Life Question", "count": 4}, {"letter": "Preference Question", "count": 1}, {"letter": "Non-response per Protocol", "count": 31}, {"letter": "Response Assessment in Neuro-Oncology Brain Metastases", "count": 22}, {"letter": "Robot-assisted Nipple Sparing Mastectomy", "count": 1}, {"letter": "Breast Question", "count": 5}, {"letter": "Satisfaction Question", "count": 3}, {"letter": "Treatment Question", "count": 5}, {"letter": "Multidimensional Fatigue Symptom Inventory-Short Form", "count": 16}, {"letter": "Sleep Question", "count": 2}, {"letter": "Bowel Question", "count": 1}, {"letter": "Unpaid Hours", "count": 1}, {"letter": "CaringGuidance Program", "count": 4}, {"letter": "Medication Question", "count": 1}, {"letter": "Decision Question", "count": 2}, {"letter": "Genetic Counseling Satisfaction Scale", "count": 1}, {"letter": "Strenuous", "count": 10}, {"letter": "Godin Leisure-Time Exercise Questionnaire", "count": 24}, {"letter": "No Response in Aplastic Anemia", "count": 2}, {"letter": "Control Arm", "count": 38}, {"letter": "Investigational Arm", "count": 10}, {"letter": "Active Comparator Arm", "count": 1}, {"letter": "Study Product", "count": 2}, {"letter": "Length of Resection", "count": 1}, {"letter": "Glucose Management Indicator", "count": 2}, {"letter": "Numerical Rating Scale 5-Point", "count": 1}, {"letter": "Amcenestrant", "count": 1}, {"letter": "Disease Relapse/Progression", "count": 1}, {"letter": "Less Than 200 ml Tumor Volume", "count": 4}, {"letter": "Prior to Study", "count": 11}, {"letter": "Partial Regression", "count": 2}, {"letter": "Adverse Event by Severity", "count": 7}, {"letter": "Neuropathy Assessment", "count": 5}, {"letter": "axatilimab", "count": 1}, {"letter": "Shortened sleep cycle", "count": 4}, {"letter": "Vaccine Safety", "count": 1}, {"letter": "Contractility", "count": 1}, {"letter": "Skindex-16", "count": 7}, {"letter": "Emotion score", "count": 2}, {"letter": "Function score", "count": 31}, {"letter": "Ischemia grade", "count": 1}, {"letter": "SURVEY.BRIEF", "count": 8}, {"letter": "Ultra-low", "count": 1}, {"letter": "5+", "count": 449}, {"letter": "6+", "count": 271}, {"letter": "Sedation level:Find:Pt:^Patient:Ord", "count": 3}, {"letter": "Memory score", "count": 1}, {"letter": "WIfI", "count": 1}, {"letter": "Donor+Patient", "count": 1}, {"letter": "Erythema, mild", "count": 2}, {"letter": "THROMBOCYTOPENIA 7", "count": 1}, {"letter": "Physical activity barrier", "count": 1}, {"letter": "0.79", "count": 4}, {"letter": "0.56", "count": 2}, {"letter": "0.95", "count": 8}, {"letter": "Target parameter", "count": 4}, {"letter": "Decimal", "count": 1}, {"letter": "AstraZeneca", "count": 1}, {"letter": "Urgent care service", "count": 1}, {"letter": "NCCN (National Comprehensive Cancer Network) distress thermometer", "count": 3}, {"letter": "Lysis buffer", "count": 2}, {"letter": "Complaint (finding)", "count": 30}, {"letter": "Receptor-Type Tyrosine-Protein Phosphatase C Isoform CD45RA, human", "count": 6}, {"letter": "Brodmann area 27", "count": 1}, {"letter": "Secondary malignant neoplasm of breast", "count": 5}, {"letter": "Absorbed Radiation Dose", "count": 1}, {"letter": "Emergency Department (DEEDS) variables", "count": 11}, {"letter": "GK protein, human", "count": 1}, {"letter": "TDO2 protein, human", "count": 5354}, {"letter": "CD34 protein, human", "count": 8}, {"letter": "DPYD protein, human", "count": 3}, {"letter": "GPHN protein, human", "count": 1}, {"letter": "Number of Doses", "count": 23}, {"letter": "Distant Metastasis", "count": 15}, {"letter": "DIARRHEA 8, SECRETORY SODIUM, CONGENITAL", "count": 1}, {"letter": "Prodrug J1", "count": 1}, {"letter": "Day 1", "count": 262}, {"letter": "TTI-101", "count": 7}, {"letter": "Biomodulin T", "count": 12}, {"letter": "Oncolytic Herpes Simplex Virus-1 Expressing Anti-CTLA-4 Antibody-like Molecule and GM-CSF RP2", "count": 3}, {"letter": "Metastatic Bone Disease", "count": 3}, {"letter": "Cancer Worry Scale", "count": 5}, {"letter": "Decentralized Clinical Trial", "count": 1}, {"letter": "Self-Administered Comorbidity Questionnaire", "count": 2}, {"letter": "Financial Hardship", "count": 2}, {"letter": "Coefficient of Nitrogen Absorption Measurement", "count": 3}, {"letter": "Clinician Dashboard", "count": 3}, {"letter": "Conventional Magnetic Resonance Imaging", "count": 2}, {"letter": "Gene Variant Positive", "count": 2}, {"letter": "Combined Positive Score", "count": 8}, {"letter": "Expression Positive", "count": 8}, {"letter": "Proto-Oncogene Mas", "count": 1}, {"letter": "Coping Strategies", "count": 9}, {"letter": "Glycochenodeoxycholate Measurement", "count": 1}, {"letter": "Dosing Interval", "count": 54}, {"letter": "Cyclin-dependent Kinase 6 Inhibitors [MoA]", "count": 1}, {"letter": "Informed Consent for Research", "count": 1}, {"letter": "tusamitamab ravtansine", "count": 7}, {"letter": "Inavolisib", "count": 2}, {"letter": "Tebotelimab", "count": 8}, {"letter": "zimberelimab", "count": 3}, {"letter": "Etrumadenant", "count": 5}, {"letter": "Upon Progression", "count": 5}, {"letter": "Upon Relapse", "count": 4}, {"letter": "Image File", "count": 1}, {"letter": "Diseased", "count": 2}, {"letter": "CDK2 Inhibitor PF-07104091", "count": 8}, {"letter": "Exceed", "count": 2}, {"letter": "Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011", "count": 4}, {"letter": "P2RX3 Antagonist BAY 1817080", "count": 4}, {"letter": "IDH1 Mutant Inhibitor LY3410738", "count": 4}, {"letter": "Simplified Chinese", "count": 1}, {"letter": "Traditional Chinese", "count": 1}, {"letter": "Technetium Tc-99m Anti-HER2 Affibody HPArk2", "count": 1}, {"letter": "Number of Cases", "count": 29}, {"letter": "Scientific Data Type", "count": 2}, {"letter": "CDK4 Inhibitor PF-07220060", "count": 20}, {"letter": "Experience Question", "count": 8}, {"letter": "Breast Cancer Self Efficacy Scale", "count": 3}, {"letter": "Activity Question", "count": 1}, {"letter": "District", "count": 2}, {"letter": "Concentration Ratio", "count": 3}, {"letter": "Study Phase", "count": 4}, {"letter": "Aspartate Aminotransferase to Alanine Aminotransferase Ratio Measurement", "count": 3}, {"letter": "Coefficient of Fat Absorption Measurement", "count": 1}, {"letter": "Epithelial Integrity Assessment", "count": 1}, {"letter": "Ratio AUC Over Dosing Interval", "count": 2}, {"letter": "Gram per Liter per Day", "count": 1}, {"letter": "T-Cells and Natural Killer Cells Absent B-Cells Normal", "count": 1}, {"letter": "Vessel Biventricular Override", "count": 1}, {"letter": "Modified Health Care Climate Questionnaire for Breast Cancer Treatment", "count": 1}, {"letter": "Locally Recurrent Disease", "count": 1}, {"letter": "Air Displacement Agent", "count": 2}, {"letter": "Cancer-related Symptom", "count": 23}, {"letter": "Ancestry", "count": 1}, {"letter": "AZD5305", "count": 18}, {"letter": "Medical Expenditure Panel Survey", "count": 2}, {"letter": "Fear of Cancer Recurrence Questionnaire", "count": 25}, {"letter": "CDK2/4/6 Inhibitor NUV-422", "count": 3}, {"letter": "Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being 12 Item Scale", "count": 3}, {"letter": "Supportive Care Needs Survey-Short Form 34", "count": 1}, {"letter": "Pneumatic Compression Therapy with Reminders", "count": 4}, {"letter": "Healthcare Utilization", "count": 33}, {"letter": "Complete Estrogen Receptor Antagonist OP-1250", "count": 6}, {"letter": "Metastatic Visceral Disease", "count": 1}, {"letter": "HLA DR Histocompatibility Antigen Measurement", "count": 1}, {"letter": "Anti-PD-L1/CD27 Bispecific Antibody CDX-527", "count": 3}, {"letter": "Autologous HER2-targeted Dual-switch CAR-T Cells BPX-603", "count": 5}, {"letter": "Zirconium Zr 89-ss-Pertuzumab", "count": 1}, {"letter": "CIBMTR Supportive Care Survey", "count": 4}, {"letter": "Dana Farber Cancer Institute", "count": 1}, {"letter": "Nodal Site", "count": 1}, {"letter": "FACT Ntx Questionnaire", "count": 7}, {"letter": "Diagnosis Pathologically Confirmed Indicator", "count": 1}, {"letter": "Necrosis Indicator", "count": 1}, {"letter": "Instrument Model", "count": 2}, {"letter": "TCGA BCR Tumor Code Name", "count": 1}, {"letter": "Gene Amplification Positive", "count": 8}, {"letter": "Normal Expression", "count": 1}, {"letter": "LYT 100", "count": 4}, {"letter": "PF 06946860", "count": 3}, {"letter": "pegfilgrastim Injection", "count": 5}, {"letter": "cytokine secretion", "count": 1}, {"letter": "REP", "count": 1}, {"letter": "interferon-gamma secretion", "count": 1}, {"letter": "Social contact score", "count": 1}, {"letter": "Total risk score", "count": 1}, {"letter": "Sleep total score", "count": 12}, {"letter": "2-3 hours", "count": 1}, {"letter": "<100 ml", "count": 1}, {"letter": "20 minutes", "count": 8}, {"letter": "40 minutes", "count": 2}, {"letter": "120 minutes", "count": 3}, {"letter": "160 minutes", "count": 2}, {"letter": "More than 7 days", "count": 2}, {"letter": "6 weeks", "count": 46}, {"letter": "Functional improvement", "count": 2}, {"letter": "Home-based", "count": 11}, {"letter": "Further follow-up", "count": 1}, {"letter": "Reintervention", "count": 8}, {"letter": "9 months", "count": 33}, {"letter": "Arm/shoulder pain", "count": 4}, {"letter": "Helped", "count": 6}, {"letter": "Good response", "count": 4}, {"letter": "Poor response", "count": 1}, {"letter": "Posttraumatic", "count": 9}, {"letter": "F1", "count": 2}, {"letter": "Persisting", "count": 10}, {"letter": "Achieved", "count": 44}, {"letter": "Restrained", "count": 1}, {"letter": "Arm/shoulder", "count": 6}, {"letter": "Wrong level", "count": 3}, {"letter": "4 years", "count": 7}, {"letter": "Patient number", "count": 21}, {"letter": "Technical procedure", "count": 1}, {"letter": "Organism by Subtype", "count": 5}, {"letter": "based on lab data", "count": 1}, {"letter": "Cancer case", "count": 16}, {"letter": "Olympus", "count": 1}, {"letter": "Navigator", "count": 4}, {"letter": "Cognitive fatigue", "count": 4}, {"letter": "Tissue ischemia", "count": 1}, {"letter": "Posttraumatic stress symptom", "count": 4}, {"letter": "Housing Instability", "count": 1}, {"letter": "support services", "count": 3}, {"letter": "Edema, mild", "count": 1}, {"letter": "Emotional dysregulation", "count": 1}, {"letter": "Immunomodulating Agents", "count": 1}, {"letter": "Self-Compassion", "count": 8}, {"letter": "Vaccine Efficacy", "count": 1}, {"letter": "Chronic Condition", "count": 7}, {"letter": "Physically well", "count": 1}, {"letter": "7.9", "count": 12}, {"letter": "Adult population", "count": 2}, {"letter": "Histologic feature (property)", "count": 2}, {"letter": "Broken", "count": 1}, {"letter": "Good quality of life", "count": 7}, {"letter": "Treatment parameter", "count": 1}, {"letter": "Fixed dose", "count": 8}, {"letter": "Less than half", "count": 1}, {"letter": "High risk of cardiovascular disease", "count": 1}, {"letter": "Cyclin-dependent Kinase 4 Inhibitors", "count": 12}, {"letter": "Nucleotide Sequence Sample Name", "count": 1}, {"letter": "RPS6KA3 wt Allele", "count": 2}, {"letter": "SSRP1 wt Allele", "count": 83}, {"letter": "Administration of prophylactic chemotherapy", "count": 1}, {"letter": "Immunophenotype", "count": 8}, {"letter": "Natural History Study", "count": 1}, {"letter": "Activity level 4", "count": 1}, {"letter": "Fibers (finding)", "count": 2}, {"letter": "Satisfied with treatment", "count": 1}, {"letter": "Zaidi Recurrence Risk Score", "count": 2}, {"letter": "Urban Cluster", "count": 4}, {"letter": "Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy", "count": 13}, {"letter": "Circulating Endothelial Cell", "count": 8}, {"letter": "Ultrasound Microvessel Imaging", "count": 1}, {"letter": "Breast Cancer Index", "count": 3}, {"letter": "Soluble CD40 Ligand Measurement", "count": 3}, {"letter": "Transcript Fragment Count per Million Formula", "count": 7}, {"letter": "Bordetella pertussis Measurement", "count": 3}, {"letter": "Serious Adverse Events Domain", "count": 249}, {"letter": "Solicit", "count": 3}, {"letter": "Imaging Magnification", "count": 7}, {"letter": "Drug Product Component", "count": 1}, {"letter": "Quantification Test", "count": 1}, {"letter": "Arterial-phase Magnetic Resonance Imaging", "count": 8}, {"letter": "CFB protein, human", "count": 4}, {"letter": "Tumor Mutation Burden Assessment", "count": 7}, {"letter": "Lymphocytes Subpopulation Count", "count": 2}, {"letter": "Pathologic Partial Response", "count": 10}, {"letter": "Receptivity", "count": 18}, {"letter": "Cryoprecipitated Plasma", "count": 3}, {"letter": "Genomics Findings Domain", "count": 2}, {"letter": "Pylarify", "count": 1}, {"letter": "Intracellular Cytokine Stain Flow Cytometric Assay", "count": 1}, {"letter": "Specimen Appearance Assessment", "count": 22}, {"letter": "Dendritic Cells Count", "count": 4}, {"letter": "N-(1-(3-fluoropropyl)azetidin-3-yl)-6-((6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-3,6,8,9-tetrahydropyrazolo(4,3-f)isoquinolin-6-yl)pyridin-3-amine", "count": 4}, {"letter": "Genetic Predisposition to Malignant Neoplasm", "count": 1}, {"letter": "Knowledge Question", "count": 6}, {"letter": "Diameter of Primary Lesion", "count": 1}, {"letter": "Healthcare Professional Visit", "count": 1}, {"letter": "Pathological Diagnosis", "count": 4}, {"letter": "Skeletal Muscle Mass", "count": 8}, {"letter": "Task Functional Magnetic Resonance Imaging", "count": 2}, {"letter": "Resting Functional Magnetic Resonance Imaging", "count": 3}, {"letter": "Competitive Enzyme-linked Immunosorbent Assay", "count": 2}, {"letter": "Calf Circumference", "count": 2}, {"letter": "Follow-Up Completed", "count": 3}, {"letter": "Clinical Evidence", "count": 10}, {"letter": "Messenger RNA Underexpression", "count": 1}, {"letter": "Response Assessment Method", "count": 1}, {"letter": "Single Cell Specimen", "count": 16}, {"letter": "Maximal Oxygen Uptake", "count": 15}, {"letter": "SORT1-targeted Docetaxel TH1902", "count": 3}, {"letter": "Anti-TREM1 Agonistic Monoclonal Antibody PY159", "count": 10}, {"letter": "Acute Radiation Skin Toxicity", "count": 1}, {"letter": "Autologous Anti-HER2 TAC T Cells TAC01-HER2", "count": 3}, {"letter": "Autologous Natural Killer Cells SNK01", "count": 16}, {"letter": "Recombinant HSA/G-CSF Fusion Protein MW05", "count": 1}, {"letter": "Autologous Anti-HER2 CAR T-cells CCT303-406", "count": 4}, {"letter": "Nectin-4-targeting Bicyclic Peptide/MMAE BT8009", "count": 21}, {"letter": "A2A/A2B Adenosine Receptor Antagonist INCB106385", "count": 5}, {"letter": "Anti-PD-1/CTLA-4 Bispecific Antibody SI-B003", "count": 8}, {"letter": "Microbiota-based Formulation RBX7455", "count": 2}, {"letter": "Case Classification", "count": 1}, {"letter": "60 Months", "count": 34}, {"letter": "Mutation Load", "count": 8}, {"letter": "Biopsy Twinkling Marker Ultrasound Detection", "count": 1}, {"letter": "Platinum-Refractory Ovarian Carcinoma", "count": 1}, {"letter": "Behavior Question", "count": 2}, {"letter": "Number of True Positives", "count": 4}, {"letter": "Peripheral Blood Mononuclear Cell Sample", "count": 2}, {"letter": "Multiplex Assay", "count": 6}, {"letter": "Negative Biospecimen", "count": 1}, {"letter": "Positive Biospecimen", "count": 7}, {"letter": "Unsolicited Adverse Event", "count": 1}, {"letter": "Motor Function Assessment", "count": 1}, {"letter": "Proprioception Assessment", "count": 1}, {"letter": "SERD ZB-716", "count": 10}, {"letter": "Rescreening", "count": 1}, {"letter": "Plasma Tumor DNA", "count": 10}, {"letter": "BRCA Gene Mutation", "count": 24}, {"letter": "High Risk Breast Carcinoma", "count": 7}, {"letter": "Cohesive Pattern", "count": 2}, {"letter": "Distant Site Receiving Treatment", "count": 27}, {"letter": "Operable Breast Carcinoma Finding", "count": 8}, {"letter": "Anti-TREM2 Monoclonal Antibody PY314", "count": 10}, {"letter": "Gallium Ga 68 FF58", "count": 11}, {"letter": "Heterogeneity Diffusion Imaging", "count": 3}, {"letter": "itRECIST Goldmacher 2020 Oncology Response Criteria", "count": 1}, {"letter": "Physical Activity Lifestyle", "count": 3}, {"letter": "1+ Staining", "count": 1}, {"letter": "2+ Staining", "count": 1}, {"letter": "3+ Staining", "count": 1}, {"letter": "Combat Exposure Scale CES0102 Original Result - 1-3 Months", "count": 2}, {"letter": "Combat Exposure Scale CES0104 Original Result - 1-25%", "count": 5}, {"letter": "Gadolinium Enhancement", "count": 2}, {"letter": "Discretion", "count": 17}, {"letter": "Digital Scale", "count": 13}, {"letter": "Palliative Chemotherapy", "count": 3}, {"letter": "Anti-B7-H4 Monoclonal Antibody NC762", "count": 2}, {"letter": "T1-Weighted Magnetic Resonance Imaging", "count": 2}, {"letter": "T2-Weighted Magnetic Resonance Imaging", "count": 1}, {"letter": "Digital Cognitive Behavioral Stress Management", "count": 1}, {"letter": "pH Low Insertion Peptide-exatecan Conjugate CBX-12", "count": 8}, {"letter": "Anti-ILT2/Anti-ILT4 Monoclonal Antibody NGM707", "count": 3}, {"letter": "Lenvatinib/Pembrolizumab Regimen", "count": 2}, {"letter": "Metastatic HER2-Positive Breast Carcinoma", "count": 2}, {"letter": "Number of Days Between Index Date and Treatment End", "count": 1}, {"letter": "Early Stage Triple-Negative Breast Carcinoma", "count": 1}, {"letter": "Target Engagement Assay", "count": 2}, {"letter": "Non-Viable", "count": 1}, {"letter": "Stimulation Index Count", "count": 1}, {"letter": "Cytotoxic T-Lymphocytes to Total T-Lymphocytes Ratio Measurement", "count": 1}, {"letter": "Apoptotic Cell Count", "count": 1}, {"letter": "Concentration at End Infusion", "count": 3}, {"letter": "Standardized Uptake Value Mean", "count": 15}, {"letter": "Maximum Standardized Uptake Value Corrected for Lean Body Mass", "count": 3}, {"letter": "Peak Standardized Uptake Value Corrected for Lean Body Mass", "count": 6}, {"letter": "Current Biospecimen Weight", "count": 1}, {"letter": "MRI Surface Coil", "count": 1}, {"letter": "Locally Advanced HER2-Positive Breast Carcinoma", "count": 1}, {"letter": "Nab-Paclitaxel/Pembrolizumab Regimen", "count": 2}, {"letter": "EGFR/HER2 Inhibitor TAS2940", "count": 3}, {"letter": "Paclitaxel/Pembrolizumab Regimen", "count": 3}, {"letter": "First Usual Pace Walk Time", "count": 1}, {"letter": "Autologous Anti-KK-LC-1 TCR-expressing T-cells", "count": 3}, {"letter": "Multiplexed Immunofluorescence", "count": 2}, {"letter": "Tissue-Based Cyclic Immunofluorescence", "count": 1}, {"letter": "CO-Detection by indEXing", "count": 1}, {"letter": "Anti-HER2/CD3/CD28 Tri-specific Antibody SAR443216", "count": 12}, {"letter": "HydroMARK", "count": 1}, {"letter": "PSMA PET Scan", "count": 1}, {"letter": "Oncolytic Vaccinia Virus Expressing Anti-CTLA-4 Antibody and GM-CSF BT-001", "count": 2}, {"letter": "Staining Strength", "count": 2}, {"letter": "Myc Inhibitor OMO-103", "count": 1}, {"letter": "Mean Standardized Uptake Value Corrected for Lean Body Mass", "count": 1}, {"letter": "Imlunestrant", "count": 3}, {"letter": "Identification band", "count": 1}, {"letter": "Numeric rating scale score", "count": 16}, {"letter": "Myelosuppression due to chemotherapy", "count": 1}, {"letter": "High perceived stress", "count": 4}, {"letter": "Thickness:Len:Pt:Heart.ventricle.left:Qn", "count": 1}, {"letter": "Traumatic cause", "count": 2}, {"letter": "No problems", "count": 5}, {"letter": "Single unit", "count": 2}, {"letter": "Level 10", "count": 15}, {"letter": "Level 9", "count": 1}, {"letter": "Level 8", "count": 2}, {"letter": "Level 6", "count": 7}, {"letter": "Level 0", "count": 15}, {"letter": "Very active", "count": 2}, {"letter": "Somewhat likely", "count": 1}, {"letter": "Transcutaneous", "count": 3}, {"letter": "Yes, definitely", "count": 1}, {"letter": "The child", "count": 1}, {"letter": "You", "count": 16}, {"letter": "Very easy", "count": 8}, {"letter": "Wound size", "count": 2}, {"letter": "WHOQOL_BREF", "count": 4}, {"letter": "Magnetic resonance perfusion", "count": 1}, {"letter": "post transplant", "count": 2}, {"letter": "A-scan", "count": 3}, {"letter": "Tractography", "count": 1}]